AM13 Final-Program LowRes PDF

FINAL PROGRAM
Welcome
Dear Colleagues,
Welcome to San Antonio, where thousands of experts from around the world are on site for the
AAAAI Annual Meeting.
Table of Contents
General Information
It is our hope that the five days of essential research and best practices presented at the
meeting will translate into new knowledge, ideas and experiences to help you lead in providing
optimal patient care.
Annual Meeting Program Committees..... 2
Youre here to experience the result of 18 months of planning by the members of the Annual
Meeting Program Committee (AMPC). We would like to recognize the work of the AMPC in
putting this educational program together and ensuring it offers the latest advances in the
research, diagnosis and treatment of allergic and immunologic disease.
Other Meetings and Events................... 10
The keynote lecture on Saturday features Dr. Jeffrey Gordon, Director of the Center for Genome
Sciences and Systems Biology at Washington University in St. Louis. Known for his expertise in
addressing the human microbiome, Dr. Gordon presents Dining in with Trillions of Fascinating
Friends: The Microbiome in Health and Disease.
Lectureships......................................... 17
This years Presidential Plenary, Sensitization and Tolerance in Allergic Disease, examines the
role of genetics and environment in the development of allergic disease and how tolerance may
develop. Hear more on Saturday, February 23 from 8:15 to 9:45 am. Special thanks to Prof. Alan
David Irvine and Susan Prescott, MD PhD, for speaking at this session.
Continuing Education & Accreditation.... 22
New Offerings
The 2013 Annual Meeting provides a world-class educational and scientific program,
opportunities to network with each other and interact with our vendor community. You can
also use your time in San Antonio to make important career connections. The first Career
Connections Job Fair takes place in the AAAAI Member Resource Center on Saturday and
Sunday. Top employers will be on hand to share information on open positions and interview
candidates in private meeting rooms.
In addition, weve updated the Sunday Interest Section Forums, combining the business
meeting portion of the previous forums with the educational content of the former State-of-theArt sessions. The new forums start earlier in the afternoon and include lunch.
Headlining Events
Everyone is excited for this years two headlining ARTrust events. Lights, Camera, Auction!,
our red carpet benefit, takes place Saturday evening at the beautiful Lila Cockrell Theatre and
stars Steve and Nancy Carell from The Office as Honorary Auctioneers. On Sunday, the ARTrust
hosts the First Annual Race for Allergy and Asthma Research 5K Run/Walk in HemisFair Park.
Join your peers to have fun and raise funds to support the mission of the ARTrust.
Meeting Information................................ 4
Business and Committee Meetings......... 8
ARTrust Activities.............................. 13
Guest/Associate Activities..................... 16
Awards................................................. 18
Education Program
Military Allergy Program........................ 29
Fellows-in-Training Program................. 29
Advanced Practice Course.................... 30
Chrysalis Program................................ 30
TIGERS Program................................... 31
Asthma Educators Course..................... 63
Friday Sessions..................................... 29
Saturday Sessions................................ 42
Sunday Sessions.................................. 57
Monday Sessions.................................. 67
Tuesday Sessions................................. 77
Directories
Abstracts.............................................. 86
ACGME Competency Index.................. 141
Exhibits............................................... 142
On behalf of the American Academy of Allergy, Asthma & Immunology, thank you for attending
the 2013 Annual Meeting!
Floor Plans.......................................... 160
Sincerely,
Speaker Index..................................... 169
Keywords........................................... 167
Staff................................................... 175
A. Wesley Burks, MD FAAAAI

AAAAI President
Stuart L. Abramson, MD PhD FAAAAI

Chair, Annual Meeting Program Committee
AAAAI-1212-022
The AAAAI Annual Meeting is not a public event. Programs presented at the Annual Meeting are for the education of attendees and purchasers of recorded presentations as authorized by the AAAAI.
Any use of program content, the name of a speaker and/or program title or the name of the AAAAI without the written consent of the AAAAI is prohibited. The program content includes, but is not
limited to, oral presentations, audio visual materials used by the speakers and program handouts. This rule applies before, during and/or after the meeting.
The AAAAI endorses only those activities described in this printed program. Any other events occurring in the city of San Antonio, TX during the AAAAI Annual Meeting are not sanctioned by the AAAAI.
Annual Meeting Program Committees

Executive Council
Plenary Subcommittee
Stuart L. Abramson, MD PhD FAAAAI, Chair

Paul V. Williams, MD FAAAAI, Vice Chair
John Bienenstock, MD FAAAAI
Linda Cox, MD FAAAAI
Jeffrey G. Demain, MD FAAAAI
Mark S. Dykewicz, MD FAAAAI
Maureen George, PhD RN AE-C
Phillip E. Korenblat, MD FAAAAI
Michael H. Land, MD FAAAAI
James T. Li, MD PhD FAAAAI
Elizabeth Matsui, MD
Jordan Orange, MD PhD FAAAAI
Dennis R. Ownby, MD FAAAAI
Robert P. Schleimer, PhD FAAAAI
Alkis Togias, MD FAAAAI
Jonathan M. Spergel, MD PhD FAAAAI, Chair

Tala A. Chatila, MD, Vice Chair
Jack M. Becker, MD, ADT Representative
Carol A. Saltoun, MD FAAAAI, ADT Vice Representative
Gary I. Kleiner, MD PhD FAAAAI, BCI Representative
Steve N. Georas, MD, BCI Vice Representative
Jonathan A. Bernstein, MD FAAAAI, EORD Representative
Christopher Chang, MD PhD FAAAAI, EORD Vice Representative
Marc E. Rothenberg, MD PhD FAAAAI, FADDA Representative
Stephen C. Dreskin, MD PhD FAAAAI, FADDA Vice Representative
Michael B. Foggs, MD FAAAAI, HEDQ Representative
Bruce G. Bender, PhD FAAAAI, HEDQ Vice Representative
Leonard Bielory, MD FAAAAI, IRSOC Representative
Anju Peters, MD FAAAAI, IRSOC Vice Representative
Nives Zimmermann, MD FAAAAI, MAAI Representative
Cem Akin, MD PhD FAAAAI, MAAI Vice Representative
Christine W. Wagner, CPNP CFNP AE-C, Allied Health Representative
Dee Mallam, RN AE-C, Allied Health Vice Representative
Interest Section Chairs,Vice Chairs and

Secretaries
John Oppenheimer, MD FAAAAI, ADT Chair
Timothy J. Craig, DO FAAAAI, ADT Vice Chair
Mark F. Sands, DO FAAAAI, ADT Secretary
Jordan Orange, MD PhD FAAAAI, BCI Chair
Francisco A. Bonilla, MD PhD FAAAAI, BCI Vice Chair
Gurjit K. Khurana Hershey, MD PhD FAAAAI, BCI Secretary
Karin A. Pacheco, MD MSPH FAAAAI, EORD Chair
Jeffrey G. Demain, MD FAAAAI, EORD Vice Chair
Wanda Phipatanakul, MD MS FAAAAI, EORD Secretary
Mariana C. Castells, MD PhD FAAAAI, FADDA Chair
David A. Khan, MD FAAAAI, FADDA Vice Chair
Sarbjit Singh Saini, MD FAAAAI, FADDA Secretary
Andrew G. Weinstein, MD FAAAAI, HEDQ Chair
Giselle Mosnaim, MD MS FAAAAI, HEDQ Vice Chair
Bruce G. Bender, PhD FAAAAI, HEDQ Secretary
Fuad M. Baroody, MD FAAAAI, IRSOC Chair
Dsire E.S. Larenas Linnemann, MD FAAAAI, IRSOC Vice Chair
Martin Wagenmann, MD FAAAAI, IRSOC Secretary
Susan M. MacDonald, MD FAAAAI, MAAI Chair
Mitchell H. Grayson, MD FAAAAI, MAAI Vice Chair
Nives Zimmermann, MD FAAAAI, MAAI Secretary
Symposia Subcommittee
Wanda Phipatanakul, MD MS FAAAAI, Chair
Mariana C. Castells, MD PhD FAAAAI, Vice Chair
Nancy K. Ostrom, MD FAAAAI, ADT Representative
Paula J. Busse, MD FAAAAI, ADT Vice Representative
Ivan Chinn, MD, BCI Representative
Christina L. Nance, PhD, BCI Vice Representative
Wanda Phipatanakul, MD MS FAAAAI, EORD Representative
Neil Alexis, PhD, EORD Vice Representative
Roland Solensky, MD FAAAAI, FADDA Representative
Aleena Banerji, MD, FADDA Vice Representative
Kaiser G. Lim, MD FAAAAI, HEDQ Representative
David J. Shulan, MD FAAAAI, HEDQ Vice Representative
B. Lauren Charous, MD FAAAAI, IRSOC Representative
Bernard A. Feigenbaum, MD FAAAAI, IRSOC Vice Representative
Nora A. Barrett, MD, MAAI Representative
Roma Sehmi, PhD FAAAAI, MAAI Vice Representative
Karen J. Murphy-Berendts, BS RRT CCRC, Allied Health Representative
Melissa T. Korenblat-Hanin, ACSW LCSW, Allied Health Vice Representative
Annual Meeting Program Committees

Workshops Subcommittee
Allied Health Education Committee
Christine M. Seroogy, MD FAAAAI, Chair

Angela Haczku, MD PhD FAAAAI, Vice Chair
Ray S. Davis, MD FAAAAI, ADT Representative
Ronina A. Covar, MD, ADT Vice Representative
Christine M. Seroogy, MD FAAAAI, BCI Representative
Antonella Cianferoni, MD PhD, BCI Vice Representative
Susan E. Pacheco, MD, EORD Representative
Alisa M. Smith, PhD FAAAAI, EORD Vice Representative
Vivian P. Hernandez-Trujillo, MD FAAAAI, FADDA Representative
Javed Sheikh, MD FAAAAI, FADDA Vice Representative
Marcus S. Shaker, MD MS FAAAAI, HEDQ Representative
Asriani M. Chiu, MD FAAAAI, HEDQ Vice Representative
John E. Duplantier, MD FAAAAI, IRSOC Representative
David J. Amrol, MD FAAAAI, IRSOC Vice Representative
Hans-Uwe Simon, MD PhD FAAAAI, MAAI Representative
Monica Vasudev, MD, MAAI Vice Representative
Anne E. Borgmeyer, RN CPNP AE-C, Allied Health Representative
Judith C. Taylor-Fishwick, MSc, Allied Health Vice Representative
Stephen J. McGeady, MD FAAAAI, Co-Chair

Debra A. Sedlak, MSN CPNP, Co-Chair
Edward O. Corazalla, MS RPFT, AAHCP Representative
Sheelagh M. Stewart, MPH RN, AAHCP Representative
Anne E. Borgmeyer, RN CPNP AE-C
Marion E. Groetch, MS RD
Donna W. Mitchell, RN MSN NP
Glenna L. Mote Yates, RN
Jonathan M. Spergel, MD PhD FAAAAI
Kathy L. Pinzone, RN AE-C CCRC, CR Representative
Jeanette Booker, MA Representative
John D. Milewski, MA Representative
William R. Blouin, ARNP, Allied Health Advanced Practice Representative
Nina A. Zimmermann, MSN RN ANP-BC AE-C, Allied Health Advanced
Practice Representative
Seminars Subcommittee
Giselle Mosnaim, MD MS FAAAAI, Chair
Mitchell H. Grayson, MD FAAAAI, Vice Chair
Mark F. Sands, MD FAAAAI, ADT Representative
Jonathan Corren, MD, ADT Vice Representative
Javier Chinen, MD PhD FAAAAI, BCI Representative
Rebecca Scherzer, MD FAAAAI, BCI Vice Representative
Jeffrey G. Demain, MD FAAAAI, EORD Representative
Charles S. Barnes, PhD, EORD Vice Representative
Joseph H. Butterfield, MD FAAAAI, FADDA Representative
Anna H. Nowak-Wegrzyn, MD FAAAAI, FADDA Vice Representative
Melinda M. Rathkopf, MD FAAAAI, HEDQ Representative
Alton Lee Melton, Jr., MD, HEDQ Vice Representative
Samuel L. Friedlander, MD, IRSOC Representative
Mark C. Glaum, MD PhD FAAAAI, IRSOC Vice Representative
Harald E. Renz, MD, MAAI Representative
Angela Haczku, MD PhD FAAAAI, MAAI Vice Representative
Margaret R. Dodds, RN MS CPNP, Allied Health Representative
Maureen C. Damitz, AE-C, Allied Health Vice Representative
Put your
Program in
your Pocket
Download the
2013 Annual Meeting
app to your iPhone, iPad,
Blackberry or Android.
Easily locate session handouts,
abstracts and evaluations.
Research speakers and
add their sessions to your
calendar.
Learn about last minute
program changes.
Navigate with interactive
maps.
Sponsored by Teva Respiratory.
AAAAI-1112-334
http://aaaai.org/AMapp
Meeting Information
Abstracts
Exhibits
Abstracts programmed at the 2013 Annual Meeting were published

as an online supplement to The Journal of Allergy and Clinical
Immunology (JACI) and can be accessed on the JACI website,
jacionline.org. Abstracts are also included with handouts on the flash
drives available at the Member Resource Center.
Convention Center, Street Level, Exhibit Hall C

The exhibiting companies and organizations will provide you with the
latest information on products and services available to physicians,
researchers and allied health professionals in the field of allergy/
immunology. The directory on page 142 will provide you with the
information you need to take full advantage of the opportunities offered
by the exhibitors.
Admission to Sessions
Admission to AAAAI educational sessions is reserved for meeting
registrants and registered members of the press only. Guests and
exhibitors will not be admitted to educational sessions. Ushers will
monitor the name badges of all meeting attendees to control access to
educational sessions.
Some sessions require tickets for entry, which are indicated in this
Ticketed sessions have limited
program with a ticket icon.
attendance and may have an additional fee associated with them. The
listing of educational sessions by day includes additional fees, if
applicable. To register for ticketed sessions please visit the registration
desk. In consideration of state fire codes and as a courtesy to others,
those without tickets will not be allowed into ticketed sessions.
Exhibit and Resource Hall Hours

Saturday, February 23

Sunday, February 24
Monday, February 25
9:45 am to 3:15 pm
9:45 am to 3:15 pm
9:45 am to 3:15 pm
Food Outlets
Charging Stations
There will be various coffee, food and beverage carts located on the
street and concourse levels at the Convention Center. There are also
several restaurants within walking distance.
Convention Center, Concourse Level

Sponsored by Mylan Specialty.
Handouts
Children and Guests

The AAAAI asks delegates to refrain from taking children, spouses or
guests to any educational session offered at the 2013 Annual Meeting.
Registered guests are welcome to relax in the Hospitality Suite or visit
the Exhibit and Resource Hall; however, an adult must accompany
children under the age of 18 at all times. Most San Antonio hotels
can provide their guests with a list of independent babysitters and
babysitting agencies frequently used by visitors. For more information,
please contact the concierge at the appropriate hotel.
Evaluations
Delegates will be able to provide feedback on their experiences at the
Annual Meeting in three ways:
Participants will be asked to provide input on the educational
program of the 2013 Annual Meeting through the online CME Claim
System when claiming credit for participation.
Delegates can provide feedback on Annual Meeting faculty
members and the sessions they attend by using the Annual
Meeting mobile app or on paper evaluation forms.
The Annual Meeting website will include an online comments form
where delegates can record their observations during and after the
meeting.
Exhibit Hall Coffee Break

Coffee break follows Plenary Session at 9:45 am, Saturday, Sunday
and Monday.
Coffee cups and napkins sponsored by Sunovion Pharmaceuticals Inc.
Please allow adequate time in your daily schedule to visit the exhibits
located in the Exhibit and Resource Hall in the Convention Center. Take
time to speak with representatives of companies that provide services
or market products directly to your professional interest.
Handouts at the 2013 Annual Meeting will be available in two formats:

Online Handouts
The most up-to date versions of the 2013 Annual Meeting handouts
are available to meeting delegates online at annualmeeting.aaaai.
org during and after the Annual Meeting. Delegates are able to view,
download and print available session handouts. Handouts can be
searched by session number, session title or a speakers last name.
Login and password are case-sensitive.
Login: Texas
Password: handouts
Handouts and Abstracts on Flash Drive
Delegates can receive a complimentary copy of the Annual Meeting
handouts and abstracts on flash drive at the Member Resource Center.
Delegates will be able to search by session number, session title or a
speakers last name to find specific handouts.
Handout Station
Convention Center, Street Level
Sponsored by Meda Pharmaceuticals.
Hospitality Suite
Marriott Riverwalk, Second Level, Crockett Room
Attendees with guest badges are welcome to relax in the Hospitality
Suite. Stop in for information on local attractions and shopping, or just
relax and enjoy some friendly conversation.
Hospitality Suite Hours
Friday, February 22
Sunday, February 24
Monday, February 25
8:00 am to 1:00 pm
8:00 am to 1:00 pm
8:00 am to 1:00 pm
8:00 am to 1:00 pm
Meeting Information
Internet Stations
Name Badges
Three Internet Stations are available to check your email and access
the Internet.
All registered attendees at the 2013 Annual Meeting will receive a

name badge as part of their onsite registration package. These badges
have a barcode on the back that is embedded with the attendees
name, mailing address, fax number and email address. Delegates
may scan their badges in the Exhibit and Resource Hall and give their
contact information to specific exhibitors.
Convention Center, River Level

Convention Center, Street Level
Sponsored by McNeil Consumer Healthcare.
JACI and JACI: In Practice

Key representatives from The Journal of Allergy and Clinical
Immunology (JACI) and JACI: In Practice will be on-hand within the
Member Resource Center to answer your questions regarding your
subscriptions and submissions.
Member Resource Center

Convention Center, Street Level, East Registration
Within the Member Resource Center you can:
Connect with colleagues and visit the AAAAI Career Connections
Job Fair
Post jobs or review resumes in the Career Connections Cyber
Center
Take advantage of Annual Meeting-only discounts on all public
education products
Obtain information about the 2013 Practice Management Workshop
Pay your dues, update your membership information or learn how
to become a member
Speak with representatives from The Journal of Allergy and
Clinical Immunology (JACI) and The Journal of Allergy and Clinical
Immunology: In Practice
Member Resource Center Hours
Thursday, February 21
Friday, February 22
Sunday, February 24
Monday, February 25
Tuesday, February 26
4:00 to 7:00 pm
6:45 am to 5:30 pm
6:45 am to 5:30 pm
6:45 am to 5:30 pm
6:45 am to 5:30 pm
6:45 am to 12:00 pm
Mobile Annual Meeting App

The AAAAI has a mobile application dedicated specifically to the 2013
Annual Meeting. This useful app features tools to search by speaker
or session type, organize your schedule, stay current with changes as
they occur during the meeting and navigate the convention center with
floor plans and exhibitor information. Instructions on downloading the
app will be provided onsite near the registration desk.
Please note: When you allow an exhibitor to scan your badge, you are
authorizing them to contact you and send you materials via postal mail,
fax and/or email. The AAAAI cannot be responsible for the use of your
contact information once you have given it to an exhibitor.
Networking and Recharging Lounge

Photography
Due to the distraction to the speakers, personal photography is not
permitted within any educational sessions or in the Poster Hall.
Delegates are welcome to take photographs at all other AAAAI
functions and activities.
Poster Hall
The poster sessions, featuring presentations of abstracts in thematic
groupings, are open Saturday through Tuesday. Authors will be present
with their posters from 9:45 to 10:45 am daily.
Poster Hall Hours
Sunday, February 24
Monday, February 25
7:00 am to 6:00 pm
7:00 am to 7:30 pm
7:00 am to 6:00 pm
7:00 am to 5:00 pm
Press Room
Convention Center, Concourse Level, 206A
Members of the press representing print, broadcast and electronic
consumer and healthcare trade media are invited to attend the
2013 AAAAI Annual Meeting if they have pre-registered through
the AAAAI website. To claim a press pass onsite, journalists must
provide media identification or a business card issued by their news
organization. Freelance writers must provide a letter of assignment on
a news organization letterhead or bylined articles from a recognized
news organization. Press passes will only be issued to journalists
representing the editorial staff of print, broadcast or Internet media.
Journalists must display their press passes at all times while attending
the meeting or covering meeting-sponsored events.
The AAAAI does not issue press passes to: a publications advertising,
marketing, public relations or sales representatives; publishers,
editors or reporters from manufacturers house organs or promotional
publications; public relations staff of exhibitors or educational
institutions; writers creating analyses or reports sold as a commodity
to customers; or other individuals who are not actually reporting on the
meeting or specific media outlet. Exhibitors may not register as press.
Meeting Information
Recording of Sessions
Special Dietary Requirements
Many of the scientific sessions will be audio recorded and available

for purchase on site, after the meeting or by download as a part of the
Virtual Annual Meeting. Individual recording of educational sessions is
not permitted.
If items on the daily, pre-arranged menu do not meet your special

dietary requirements (e.g., allergies, kosher) an alternative option
can be made available. Please notify an AAAAI staff member at
the registration desk to ensure arrangements are made. Special
arrangements require at least 24 hours advance notice. Please inform
the server assigned to the room at the beginning of the session if you
would like a vegetarian selection.
Registration Desk
Convention Center, Street Level, Bridge Hall
Visit the registration desk to pick up your name badge, tickets and
registration bag. You can also purchase tickets, register onsite and
receive your CME / CE or Attendance Certificates.
Registration Desk Hours
Friday, February 22
Sunday, February 24
Monday, February 25
4:00 to 7:00 pm
6:45 am to 5:30 pm
6:45 am to 5:30 pm
6:45 am to 5:30 pm
6:45 am to 5:30 pm
6:45 am to 4:00 pm
Ribbons
Ribbons are available at a kiosk located in the lobby area near
registration.
Ticket Exchange
Tickets to available sessions will be sold at the onsite registration desk.
Please check the session monitor for available sessions. To exchange
or cancel a session ticket, please bring the ticket to the onsite
registration desk no less than thirty (30) minutes prior to the start of
the session. Refunds for returned tickets will be mailed from the AAAAI
executive office after the meeting.
Smoking
Smoking is prohibited at all 2013 Annual Meeting sessions and events.
Speaker Disclosures
Copies of all speakers disclosure information are available at the
Registration Desk, the Member Resource Center and the Speaker
Resource Room.
Speaker Resource Room

Convention Center, Concourse Level, Room 207
All speakers are asked to report to the Speaker Resource Room
immediately upon arrival in San Antonio to deliver their presentation
materials. Computers and technical support are available for speakers
to use in this room. Presenters will receive their speaker ribbons in the
Speaker Resource Room.
Speaker Resource Room Hours
Friday, February 22
Sunday, February 24
Monday, February 25
4:00 to 7:00 pm
6:45 am to 5:30 pm
6:45 am to 5:30 pm
6:45 am to 5:30 pm
6:45 am to 5:30 pm
6:45 am to 4:00 pm
Training Stations
Epinephrine Auto-Injector Training
The Anaphylaxis Education Subcommittee will offer training in the
use of epinephrine auto-injectors at the Annual Meeting. This is an
outstanding opportunity to Practice with a Live One. Participation
in the session will be available on a first-come, first-served basis.
Educators will be available on Saturday from 10:00 am to 12:00 pm in
the Training Stations.
Virtual Annual Meeting Recordings

Purchase the 2013 Virtual Annual Meeting at the booth located in the
lobby near registration. The Virtual Annual Meeting is available on
Data DVD and online. It includes presentation slides along with video
and audio for the Plenary and Keynote sessions, presentation slides
synchronized with the audio recordings for selected courses, symposia,
state-of-the-art sessions, workshops, pro/con debates and allied health
sessions. Sessions included in the Virtual Annual Meeting are indicated
with a icon in this program.
Wi-Fi
Complimentary Wi-Fi access is available throughout the Convention
Center and Marriott Rivercenter and Marriott Riverwalk.
Convention Center
Marriott Rivercenter and Marriott Riverwalk
Business and Committee Meetings

AAAAI Business Meeting
Monday, February 25, 12:30 to 1:30 pm
Convention Center, Ballroom Level, Ballroom C3
All AAAAI Fellows and members should attend the annual Business
Meeting. Box lunches will be provided. No fee. No pre-registration
required.
Allied Health Professional Assembly

Forum
Saturday, February 23, 12:30 to 1:30 pm
Marriott Rivercenter, Third Floor, Grand Ballroom Salon G
All AAAAI allied health professionals should attend this forum. Box
lunches will be provided. No fee. No pre-registration required.
Allied Health Wine & Cheese Reception

Friday, February 22, 5:30 to 6:30 pm
Marriott Riverwalk, Floor P1, Riverview Room
All allied health members and their guests are invited to attend. No fee.
No pre-registration required.
Interest Section Forums

Sunday, February 24, 12:30 to 2:30 pm
AAAAI Fellows and members, as well as other delegates, are invited
to attend an Interest Section Forum. Each interest section of the AAAAI
will host a separate forum. Fellows and members may designate their
interest section affiliation, while non-members may inquire about
AAAAI membership opportunities. Continuing education credits are
available for these activities. See page 62 for more information.
International Business Meeting and

Reception
Convention Center, Concourse Level, Room 210AB
The AAAAI International Assembly invites all international members and
delegates to attend this business meeting and reception. No fee. No
pre-registration required.
New Allergist/Immunologist Assembly

Business Meeting and Reception
Marriott Rivercenter, Third Floor, Grand Ballroom Salon F
The AAAAI invites all new allergy/immunology specialists to attend this
business meeting and reception. No fee. No pre-registration required.
Program Directors Business Meeting

All Training Program Directors and Co-Directors are invited to attend
this business meeting.
AAAAI Federation of RSLAAIS Assembly

Forum and Business Meeting
Convention Center, River Level, Room 008
The Federation of Regional, State and Local Allergy, Asthma and
Immunology Societies RSLAAIS Assembly invites all AAAAI members
and delegates to attend this meeting. No fee. No pre-registration
required.
Assembly/Board/Division Committee
Meetings
If you are a current member of an assembly, Board or division
committee, please plan to attend your committee meeting. Committee
meetings are open to current AAAAI members only. All members of
these committees must be named by the AAAAI President-Elect. If you
are an AAAAI member and you are interested in becoming a member of
any of these committees, please contact the AAAAI executive office at
(414) 272-6071 or info@aaaai.org.
Advocacy Committee
Marriott Riverwalk, Second Floor, Alamo Ballroom Salon E
A/I Division Directors Meeting
Saturday, February 23, 7:00 to 8:00 am
Marriott Riverwalk, Second Floor, Alamo Ballroom Salon B
Allied Health Education Committee
Marriott Rivercenter, Third Floor, Grand Ballroom Salon A
Allied Health Professional Assembly Leadership Committee
Monday, February 25, 7:00 to 8:00 am
Annual Meeting Awards Subcommittee
Marriott Riverwalk, Second Floor, Bonham Room
Annual Meeting Program Subcommittee
Tuesday, February 26, 10:00 am to 12:00 pm
Asia and the Pacific Basin Region Committee
Marriott Riverwalk, Second Floor, Bowie Room
Credentials Committee
Marriott Riverwalk, Floor P2, River Terrace Room
Ethics/Conflict of Interest Committee
Marriott Rivercenter, Third Floor, Conference Room 16
Europe and CIS Region Committee
Fellows-in-Training Committee
Marriott Riverwalk, Second Floor, Travis Room
International Assembly Leadership Group
Sunday, February 24, 7:00 to 8:00 am
Grant Review Committee

Joint Task Force on Health Care Reform
Marriott Rivercenter, Third Floor, Grand Ballroom Salon I
Symposia Workgroup
Joint Task Force on Quality and Performance Measures

Marriott Riverwalk, Second Floor, Valero Room
Veterans Health Administration Allergists Committee

Latin America Region Committee

Website, Internet and Related Technologies Committee

Middle East and Africa Region Committee Meeting

Workforce Committee
Convention Center, Concourse Level, Room 216B
Needs Assessment and Outcomes Subcommittee

Workshops Workgroup
New Allergist/Immunologist Assembly Executive Committee

Interest Section Committee Meetings
Plenary Workgroup
Marriott Riverwalk, Second Floor, Alamo Ballroom Salon C
Practice, Diagnostics and Therapeutics Committee and Interest
Section Coordinating Committee Joint Meeting
Practice Improvement (formerly CME/PI) Committee
Marriott Riverwalk, Second Floor, Milam Room
Practice Improvement and Education Committee Executive
Council
Practice Management Committee
Marriott Riverwalk, Second Floor, Alamo Ballroom Salon D
Program Directors Assembly Executive Committee Meeting
Program Directors Core Curriculum, Education and Residency
Review Subcommittee
Marriott Rivercenter, Third Floor, Grand Ballroom Salon K
Committee meetings are held during the Annual Meeting for the
purpose of conducting AAAAI related business. If you are a current
member of an interest section committee, please plan to attend
your committee meeting. If you are an AAAAI member and you are
interested in joining an interest section committee, please attend the
meeting and notify the chair that you are interested in joining. For more
information on AAAAI committees, please contact the AAAAI executive
office at (414) 272-6071 or info@aaaai.org.
Adverse Reactions to Drugs, Biologicals and Latex Committee
Marriott Riverwalk, Second Floor, Alamo Ballroom Salon A
Adverse Reactions to Foods Committee
Aerobiology Committee
Air Pollution and Indoor Allergen Committee
Allergic Skin Diseases Committee
Altered Immune Response Committee
Program Directors In-Training Examination Committee

Friday, February 22, 11:00 am to 1:00 pm
Anaphylaxis Committee
Seminars Workgroup
Asthma and Allergic Diseases in the Elderly Committee


Asthma Diagnosis, Assessment and Treatment Committee
Rhinitis, Rhinosinusitis and Ocular Allergy Committee

Cells and Mediators of Allergic Inflammation Committee

Sports Medicine Committee

Marriott Riverwalk, Second Floor, Alamo Ballroom Salon F
Committee on the Underserved

Vaccines and Biological Threats Committee

Complimentary and Alternative Practices in Allergy Committee

Other AAAAI Meetings
Cough Committee
Eosinophilic Gastrointestinal Disorders Committee
Fungal Diseases of the Lower Airway Committee
Genetics, Molecular Biology and Epidemiology Committee
Health Informatics, Technology and Education Committee
Immunotherapy, Allergen Standardization and Allergy Diagnostics
Committee
JACI In Practice Editorial Board Meeting

Lay Organization Breakfast
Marriott Rivercenter, Third Floor, Grand Ballroom Salon J
National Allergy Bureau (NAB) Counters
RSLAAIS Assembly Governors Meeting
Other Meetings and Events

American Association of Allergists & Immunologists of Indian
Origin Dinner
Infections and Asthma Committee

Marriott Riverwalk, Second Floor, Alamo Ballroom Salon F
Allergists for Israel Board Meeting

Mast Cell Disorders Committee

Allergists for Israel Kiddush

Occupational Diseases Committee

Congresso Internacional de Alergia

Thursday, February 21, 8:00 am to 5:00 pm
Primary Immunodeficiency Diseases Committee

Innovations in the Treatment of Allergic Rhinitis, Complimentary

Dessert Reception
Marriott Rivercenter, Third Floor, Grand Ballroom I
A $50 donation will be made to the ARTrust for each attendee that
participates in the program.
Quality Adherence and Outcomes Committee

10
JACI Editorial Board Meeting


Other Meetings and Events - continued
IUIS Allergen Nomenclature Meeting
Sunday, February 24, 11:30 am to 1:00 pm
Grand Hyatt, Third Level, Travis C
The New York State Allergy Society Quarterly Meeting

National Jewish Health Faculty & Fellows Reception

Grand Hyatt, Fourth Level, Crockett CD
Saint Louis University Reception

Lke Restaurant
Non-CME Educational Program
This program is not sponsored or programmed by the AAAAI.
Advances in Seasonal Allergic Rhinitis: Optimal Therapeutic

Strategies to Improve Patient Outcomes
Friday, February 22
6:30 to 8:30 pm
Sponsored by Meda Pharmaceuticals.
New Developments in Diagnosis of Primary Immunodeficiency:

Consideration of the 2012 AAAAI Diagnostic Vaccination
Workgroup Report and Additional Novel Screens from Dried Blood
Spots
Friday, February 22
6:30 to 8:30 pm
Sponsored by Baxter Healthcare Corporation.
Michael A. Kaliner, MD
Phillip L. Lieberman, MD
Michael S. Blaiss, MD
Warner Carr, MD
TheAdvances in Seasonal Allergic Rhinitis: Optimal Therapeutic
Strategies to Improve Patient Outcomespresentation, sponsored
by Meda Pharmaceuticals, will review considerations and
advancementsin the treatment of Seasonal Allergic Rhinitis. The
presentation will cover the unmet medical need in seasonal allergic
rhinitis, topical therapy advantages and emerging therapeutic options
in the treatment of Seasonal Allergic Rhinitis. This is a complimentary
dinner program.

Innovations in the Treatment of Allergic Rhinitis
Friday, February 22
6:30 to 8:30 pm
Marriott Rivercenter, Third Floor, Grand Ballroom Salon H
Paul H. Ratner, MD
Ketan K. Sheth, MD
William W. Storms, MD
Shailen Shah, MD
The Innovations in the Treatment of Allergic Rhinitis program,
sponsored by Teva Respiratory, is an interactive presentation that will
explore an aerosolized therapy alternative for the treatment of allergic
rhinitis. A complimentary dinner will be served and a $50 donation will
be made to the ARTrust for each attendee that participates in the
program.
Jordan Orange, MD PhD

Troy R. Torgerson, MD PhD
Mark Ballow, MD
This complimentary dinner program will focus on new developments
on the use and interpretation of diagnostic vaccination in primary
immunodeficiency (PI) as well as diseases other than SCID that can be
screened using dried blood spots. The program begins with the newly
published AAAAI guidance on the use and interpretation of diagnostic
vaccination in PI, and how efforts have been made to reduce this
complicated art to its objective consensus elements for the detection
of PI; followed by a case-based review of issues associated with
diagnostic vaccination and its application; and concluding with an
overview of newer methods, including quantification of T-cell receptor
excision circles (TRECs) and newer screens that can be applied using
dried blood spots to detect PI before infectious disease becomes
apparent.

ZETONNA (ciclesonide) Nasal Aerosol: A Dry Alternative for the
Treatment of Allergic Rhinitis
Friday, February 22
8:30 to 10:30 pm
Sponsored by Sunovion Pharmaceuticals Inc.
Eli O. Meltzer, MD
This session will provide an opportunity to network with your peers
in an informal reception setting which will include a brief interactive
scientific presentation. A variety of desserts, cordials and a myriad of
other delectable treats will be served.
11

The Clinical Relevance of Molecular Allergy Diagnostics

Sunday, February 24
6:30 to 8:30 pm
Marriott Rivercenter, Third Floor, Grand Ballroom Salon E
Sponsored by Thermo Fisher Scientific.
The Value of Targeting the Small Airways in Asthma

Sunday, February 24
6:30 to 8:30 pm
Marriott Rivercenter, Third Floor, Grand Ballroom H
Thomas A.E. Platts-Mills, MD PhD

Hugh A. Sampson, MD
Elizabeth Matsui, MD MHS
Paolo Matricardi, MD
Phil Lieberman, MD
Donald P. Tashkin, MD
Explore clinical and research applications of molecular allergy/

component diagnostic testing by leading Allergists during a non-CME
dinner program.
Learning Objectives
Discuss the clinical relevance of component resolved diagnostics
(CRD) for food allergy.
Examine the clinical utility of CRD in the management of asthma
and allergy.
Review emerging CRD data.

Rethinking Anaphylaxis
Sunday, February 24
6:30 to 8:30 pm
John Oppenheimer, MD
Eli O. Meltzer, MD
Allan T. Luskin, MD
This interactive presentation, over dinner, will explore a number of
hot topics in anaphylaxis using a combination of case-based studies,
point-counterpoint debates and audience polling. This session is
designed to challenge some of the current concepts of anaphylaxis and
invites you and your peers to weigh in on some of the controversial
areas.
12
The Value of Targeting the Small Airways in Asthma dinner program

presentation, sponsored by Teva Respiratory, LLC, will review important
evidence showing how small airway dysfunction correlates with poor
asthma control. In addition, the presentation will cover advances in
asthma treatment options and how they affect lung function.

Advances in Exercise-Induced Bronchospasm: Therapeutic
Considerations
Monday, February 25
6:30 to 8:30 pm
John M. Weiler, MD MBA
LeRoy M. Graham, MD
Nancy K. Ostrom, MD CPI
Christopher C. Randolph, MD
The Advances in Exercise-Induced Bronchospasm: Therapeutic
Considerations dinner program presentation, sponsored by Teva
Respiratory, will review considerations in asthma therapy and discuss
the impacts of different aerosol inhaler designs on patient treatment.
The presentation will also cover the under-recognition and potential
under-treatment of exercise-induced bronchospasm in America.
ARTrust Activities
RACE for
ALLERGY
& ASTHMA
RESEARCH
Allergy, Asthma & Immunology Education

and Research Organization, Inc.
5K RUN/WALK
February 24, 2013 | 5:30 pm | HemisFair Park | San Antonio, TX
Lights, Camera, Auction! Starring

comedian/actors Steve and Nancy Carell
First Annual 5K Run/Walk - Race for

Allergy & Asthma Research
7:00 to 10:00 pm
Lila Cockrell Theatre
Henry B. Gonzalez Convention Center
Sunday, February 24
5:30 pm
HemisFair Park
This event is open to everyone: serious runners, casual runners,
walkers, families and the general public. All runners/walkers will
receive a race T-shirt in their registration packet. Packet pick-up will be
available during regular meeting registration hours (Thursday through
Sunday) on the street level of the Henry B. Gonzalez Convention Center
in Bridge Hall. You may also register onsite Sunday prior to the run.
Admission by ticket only. Black tie optional.

Tickets available at the ART Booth or at the event.
Cocktails, Dinner, Auction!
Join friends and colleagues for this red carpet event benefiting the
ARTrust. You know them from The Office, The 40-Year-Old Virgin and
Saturday Night Live. The Carells will serve as Honorary Auctioneers
donating their time and talent to lead this exciting event for the ARTrust
which supports funding for allergy and asthma research and education.
Silent auction items will also be available for additional bidding.
The mission of the Allergy, Asthma & Immunology Education and
Research Organization is to find treatments and cures for the millions
of people suffering from allergies, asthma and other immunologic
diseases by supporting education and research.
This event is open to all delegates, their guests and the general public.
Doors open at 7:00 pm.
Ticket Information:
Patron Row of 10 tickets $3,000
Patron Individual
$300
Allied Health Individual $125
Student Individual
$100
Industry Row of 10 tickets $12,000
Ticket price, less cost of good and services, may be tax deductible.
Ribbons
Friend of the President
Show your support of the current AAAAI President, A. Wesley Burks, MD
FAAAAI, with a $100 donation to the ARTrust. With your contribution
you will receive a special ribbon to wear throughout the meeting to
demonstrate your support.
Help bring awareness to the ARTrust and raise money to support the
ARTrust mission!
Friends of the President
und
Your donation of $100 or more in support of the
Friends of the President Fund

entitles you to wear a Friend of the President
Ribbon at the 2013 Annual Meeting.
This ribbon symbolizes your contribution to increased funding

for education and research in allergy/immunology and honors
AAAAI President, A. Wesley Burks, MD, FAAAAI.
NAIA Supports ARTrust

Show the New Allergist/Immunologist Assemblys support of the
ARTrust with a $50 donation.
Pick up or purchase ribbons at the ARTrust booth near registration.
Allergy, Asthma & Immunology Education

and Research Organization, Inc.
Purchase or pick up your ribbon at the ARTrust booth near registration.
13
2013ARTrust
BenefitAuction
Starring Steve
and Nancy Carell
February 23, 2013
San Antonio, TX
Lila Cockrell Theatre, 7:0010:00 pm
Cocktails Dinner Auction
AUCTION!
AAAAI-0912-156
Lights,Camera,
Guest/Associate Activities
Associates (Spouses & Friends) to the

AAAAI
Since 1982, the Associates (Spouses & Friends) to the AAAAI have
provided social events and networking opportunities for the spouses
and friends of the AAAAI.
Associates Breakfast and Business

Meeting
Marriott Riverwalk, First Floor, River Terrace Room
Pre-registration and ticket required.
The Board of Directors of the Associates would like to invite you to
being your Annual Meeting experience by joining us for the celebration
of the Associates at the Marriott Riverwalk. This breakfast event is
open to registered guests only. For guests interested in bringing a child
under the age of 17, pre-registration and ticket is required; children
under the age of 6 are complimentary.
Hospitality Suite
Marriott Riverwalk, Second Floor, Crockett Room
Make sure you visit the Hospitality Suite, which is open Friday,
February 22 to Monday, February 25 from 8:00 am to 1:00 pm daily. A
host will be on-hand to assist with restaurant recommendations and
to make reservations. Stop by, have a cup of coffee and learn how you
can get involved!
Associates Committee Meetings

2012-2013 Associates Board of Directors Meeting
Friday, February 22, 1:30 pm
Marriott Riverwalk, Second Floor, Crockett Room
2013-2014 Associates Board of Directors Meeting
16
Annual
Business
Meeting
to include the induction of all

new Fellows and members
Monday, February 25, 2013
12:30-1:30 pm
Convention Center, Ballroom Level,
Ballroom C3
AAAAI-0112-176
Full membership in the Associates to the AAAAI is included in each

spouse/guest registration fee. Membership includes volunteer
opportunities, newsletters, a chance to participate in future
programming for the Associates and a networking membership
directory on the AAAAI website.
Attend the 2013 AAAAI
Lectureships
Annual Meeting Lectureships
For nearly five decades, members of the American Academy of Allergy, Asthma & Immunology have honored outstanding individuals who have
contributed to this field as leaders and teachers by the establishment of Annual Meeting lectureships.The Annual Meeting Program Committee
is pleased to announce the lectureships and lectureship speakers for the 2013 Annual Meeting. Biographies and photographs are available at
annualmeeting.aaaai.org.
The Rebecca Buckley Lectureship: 2nd year
The Harold S. Nelson Lectureship: 13th year
Lecturer: Lisa Filipovich, MD

Award presentation at Plenary Session 4101: Immune Defects: Insights
and Opportunities on Monday, February 25, 8:15 to 9:45 am
Lecturer: Steven Holland, MD

The Robert A. Cooke Memorial Lectureship:

51th year
The John E. Salvaggio Memorial Lectureship:

12th year
Lecturer: Donald Leung, MD PhD FAAAAI

Award presentation at Symposium Session 3301: Dermatology for the
Allergist on Sunday, February 24, 10:45 am to 12:00 pm
Lecturer: Susan Prescott, MD PhD

Award presentation at Plenary Session 2101: Sensitization and
Tolerance in Allergic Disease on Saturday, February 23, 8:15 to 9:45 am
The Jerry Dolovich Memorial Lectureship:

15th year
The Gail G. Shapiro Memorial Lectureship:

7th year
Lecturer: Alan Irvine, MD

Award presentation at Plenary Session 2101: Sensitization and
Tolerance in Allergic Disease on Saturday, February 23, 8:15 to
9:45 am
Lecturer: Amy Klion, MD

Award presentation at Symposium Session 5301: Assessing Eosinophil
Functions in Asthma, Eosinophilic Esophagitis and Hypereosinophilic
Syndromes on Tuesday, February 26, 10:45 am to 12:00 pm
The Elliot F. Ellis Lectureship: 15th year
The Burton Zweiman Lectureship: 13th year
Lecturer: Steven Ziegler, PhD

Award presentation at Symposium Session 4303: Key Players in the
Immune Basis of Atopic Dermatitis on Monday, February 25, 10:45 am
to 12:00 pm
Lecturer: Cem Akin, MD PhD FAAAAI

Symposium Session 4301: Anaphylaxis: Novel Mechanisms and
Therapeutic Implications on Monday, February 25, 10:45 am to
12:00 pm
The Elliott Middleton Memorial Lectureship:

12th year
Lecturer: Bruce Beutler, MD

ARTrust: Investing Together in Our Future Lectureships

The ARTrust Lectureships: Investing Together in Our Future are established to recognize substantial contributions of at least $100,000 to the
ARTrust through collaborative contributions of others or individual contributions honoring an individual or entity. The ARTrust Leadership is proud
to announce the lectureships and lectureship speakers for the 2013 Annual Meeting. Biographies and photographs are available at
annualmeeting.aaaai.org.
ARTrust and Donald Y. M. Leung, MD PhD
FAAAAI-JACI Lecture: Investing Together in
Our Future
Lecturer: Alkis Togias, MD FAAAAI

Award Presentation at Plenary Session 5101: Neurogenic Pathways of
Inflammation on Tuesday, February 26, 8:15 to 9:45 am
ARTrust and Anjuli Seth Nayak, MD FAAAAI

Lecture: Investing Together in Our Future
Lecturer: Larry Borish, MD FAAAAI

Award Presentation at Symposium Session 5306: Response to Viral
Infections in the Atopic Host: Is it Deficient? on Tuesday, February 26,
10:45 am to 12:00 pm
ARTrust and Stephen D. Lockey, Jr., MD

Lecture: Investing Together in Our Future
Lecturer: John OShea Jr., MD

Award Presentation at Plenary Session 3101: Epigenetics: How the
Environment Affects Gene Expression and the Development of Asthma
and Allergic Disease on Sunday, February 24, 8:15 to 9:45 am
17
Awards
AAAAI Allied Health
$750 Travel Scholarship
Recipients
AAAAI Interest Section

Fellow-in-Training (FIT)
Abstract Award Recipients
Amy Arneson
Childrens Medical Center
Dallas, Texas
ADT
Sindhura Bandi, MD
BCI
Michael Keller, MD
EORD
Watcharoot Kanchongkittiphon, MD PhD
FADDA
Joseph S. Zhou, MD PhD
HEDQ
Kelli W. Williams, MD PhD
IRSOC
Shefali Samant, MD
MAAI
Takumi Kiwamoto, MD PhD
April Clark
Childrens Medical Center
Dallas, Texas
Mary Jane Ong
Johns Hopkins University
Shannon Seopaul
Johns Hopkins University
2013 Bernard B. Siegel

Memorial Abstract Award
Eduardo Shahar, MD
Haifa, Israel
American Academy of
Pediatrics (AAP) Section on
Allergy and Immunology
Outstanding Pediatric
Abstract Award Recipients
Consuelo M. Carcel, RN
Childrens Hospital of Orange County
Breathmobile
Maureen C. Damitz, AE-C
Stroger Hospital of Chicago
Nancy A. Long, RN MSN CNS
DallasAllergyImmunology
Nancy Adler Moye, CRNP MSN MA
Allergy and Asthma Healthcare
Claire M. Murphy, NP-C
New England VA Healthcare
Sandy Odenwald, RN
Washington University School of Medicine
Marc Rosen, AE-C
Respiratory Health Association of Metropolitan
Chicago
Elisabeth S. Stieb, RN BSN AE-C
Massachusetts General Hospital
Pamela A. Frischmeyer-Guerrerio, MD PhD

Johns Hopkins University School of Medicine
Melanie Morgan Thomas, RN

Georgia Institute of Technology/ Allergy Clinic
- Stamps Health Services
Corinne Keet, MD MS,

Johns Hopkins University School of Medicine
Sarah Kaye Westfall, CMA AE-C

Allergy and Asthma Specialists PA
Watcharoot Kanchongkittiphon, PhD MD

Boston Childrens Hospital
Kirsten Kloepfer, MD
University of Wisconsin School of Medicine
and Public Health
Dr. Tara J. Federly, MD
University of Missouri-Kansas City
18
AAAAI Allied Health

Professional Assembly
Scholarship Travel Award
Winners
Awards
2013 International Travel Scholarship Recipients
The following international in-training members have been awarded International Travel Scholarships to attend the Annual Meeting. The 2013
International Travel Scholarships are funded by the AAAAI and administered by the International Assembly leadership.
East Asia
Mari Kondo, MD
Mie National Hospital
Eun Lee
University of Ulsan College of Medicine
Europe, EAACI FIT Representatives

Indre Butiene, MD
Vilnius University
South America
Mariana N. Cardoso, MD
Federal University of Parana
Paraskevi Mangina, MD
University of Athens
Marcos R. Goncalves, MD
School of Medicine of Ribeirao Preto
Europe/CIS
Rosa M. Munoz Cano, MD
Hospital Clinic, Barcelona
Middle East/Africa
Hamid Ahanchian, MD
Mashad University of Medical Sciences
Adriana Moreno, PhD

University of Sao Paulo
Maeve M. Kelleher, MBBch

University College Cork
Dalia El-Ghoneimy, MD PhD

Ain Shams University
Mogib El-Rahman Khedr, PhD

University of Southampton
Tamara Kerbelker, MD
Red Cross War Memorial Childrens Hospital
Sai Hurng Kham Murng, MBBS

The Sheffield Teaching Hospitals NHS
Foundation Trust
Liat Nachshon, MD
Assaf Harofeh
Pedro Ayuso Parejo, PhD

Hospital Infanta Leonor
South Asia
Preeti Bansal
CSIR Institute of Genomics and Integrative
Biology
Govindaraj Dhanapal
IGIB - Institute of Genomics and Integrative
Biology
Somying Indradat, MD
Siriraj Hospital, Mahidol University
Maria Del Carmen Plaza Seron

Infanta Leonor Hospital
Sagar Laxman Kale

CSIR-Institute of Genomics and Integrative
Biology
Adriana Ariza Veguillas

Fundacion IMABIS - Hospital Carlos Haya
Savitree Padungpak, MD
Ramathibodi Hospital, Mahidol University
Varuit Thongbai, MD
Queen Sirikit National Institute of Child Health
2013 International Young Investigator Award Recipients

The following international young investigators have been awarded International Young Investigator Awards to attend the Annual Meeting. The
2013 International Young Investigator Awards are funded by the AAAAI and administered by the International Assembly leadership.
Asia
Ho-Chang Kuo, MD PhD
Chang Gung University College of Medicine
and Kaohsiung Chang Gung Memorial
Hopsital, Tawain
Mentor: Li-Tung Huang, MD
Europe/CIS
Jean-Christoph Caubet, MD
Geneva University Hospital
Mentor: Philippe A. Eigenmann, MD FAAAAI
Middle East/Africa
Nima Rezaei, MD PhD
Tehran University of Medical Sciences
Mentor: Maryam Mahmoudi, MD
Latin America
Maria Fernanda Ferraro, MD PhD
School of Medicine of Ribeiro Preto
University of Sn Paulo
Mentor: Luisa Karla Arruda, MD PhD FAAAAI
19
Awards
2013 FIT Travel Scholarships
The FIT Travel Scholarships for Fellows-In-Training in the United States and Canada allow FIT attendees to supplement their training by attending
the Annual Meeting.
Funded by the AAAAI and in part through grants from Genentech, McNeil Consumer Healthcare, Merck, Sanofi-US and Sunovion Pharmaceuticals Inc.
$1,100 Travel Scholarships
Sharon Ahluwalia, MD
Stephanie Albin, MD
Matthew Altman, MD
Priyal Amin, DO
Doerthe Adriana Andreae, MD PhD
Sunena Argo, MD
Tania Aung, MD
Puneet Bajaj, MD
Sindhura Bandi, MD
Lora Bankova, MD
Taylor Banks, MD
Selene Bantz, MD
Hiba Bashir, MD
Matthew Bell, MD
Neeti Bhardwaj, MD
Mark Biagton, MD
Jeremiah Bivins, MD
Lori Broderick, MD PhD
Jean Brown, MD
Katherine Cahill, MD
Jennifer Camacho, MD
Timothy Campbell, MD
Angela Canady, MD
Juan-Carlos Cardet, MD
S. Nicole Chadha, MD
Alice Chan, MD PhD
Sanny Chan, MD PhD
Leejah Chang, MD
Gang Cheng, MD PhD
Michael Cheung, MS
Niti Chokshi, MD
Kobkul Chotikanatis, MD
Christina Christianson, PhD
Chris Cleveland, MD
Kathryn Convers, MD
Gregory Cowan, MD
Michelle Crank, MD
Elena Crestani, MD
Julia Cronin, MD
Casey Curtis, MD
Harold Delasalas, MD
Marylin Desjardins, MD
Rohit Divekar, MD PhD
Daniel Dulek, MD
Sandy Durrani, MD
Brandi Dyer, MD
Ping Fang, MD PhD
Nabeel Farooqui, MD
Tara Federly, MD
20
Matthew Feldman, MD
Timothy Franxman, MD
Irene Fung, MD
Michael Gates, MD
Moyar Ge, PhD
Manika Girdhar, DO
Maria Gutierrez, MD
Autumn Guyer, MD
Michelle Halbrich, MD
Michelle Henson, MD
Caroline Hobbs, MD
Margaret Hollister, MD
Laura Howe, MD
Joy Hsu, MD
Yiqun Hui, MD PhD
Tracy Hwangpo, MD PhD
Marc Ikeda, MD
Artemio Jongco, MD PhD MPH
Neelu Kalra, MD
Watcharoot Kanchongkittiphon, MD PhD
Jacob Kattan, MD
Michael Keller, MD
Joshua Kennedy, MD
Anjeni Keswani, MD
Farah Khan, DO
Edward Kleiman, MD
Hazar Kobayaa, MD
Anna Kochin, MD
Yelena Kopyltsova, MD
I-Hsin Kuo, MS
Eun Soo Kwak, MD
Priyanka Lall, MD
Emily Langley, MD
Min Jung Lee, MD
Sun Lee, PhD
John Leung, MD
Kellie Lim, MD
Morris Ling, MD
Bradley Locke, DO
Stephanie Logsdon, MD
Hongfei Lou, MD
Solrun Melkorka Maggadottir, MD
Paul Maglione, MD PhD
Mahboobeh Mahdavinia, MD PhD
Krikor Manoukian, MD
Zahida (Rani) Maskatia, MD
Amir Hossein Massoud, PhD
Hironori Masuko, MD PhD
Ashlei Mathew, MD
Emily McGowan, MD
Laurie McWilliams, MD
Archana Mehta, MD
Harshna Mehta, MD
Natalie Miller, MD
Katie Miro, MD
Ronald Mittel, MD
Maaz Mohiuddin, MD
Joanne Moreau, MD
Talal Mousallem, MD
Susan Mozzicato, MD
Tania Mucci, MD
Lisaanne Newton, MD
Amy OBrian, MD
Christopher Ocampo, MD PhD
Min-Hee Oh, MS
Eric Oliver, MD
Kanami Orihara, PhD
Purvi Parikh, MD
Nisha Patel, MD
Payal Patel, MD
Sarita Patil, MD
Mary Paul, MD
Sarah Peterson, MD
Jenna Podjasek, MD
Regan Pyle, DO
Nikita Raje, MD
Gita Ram, MD
Manish Ramesh, MD PhD
Anupama Ravi, MD
Ashwini Reddy, MD
Karen Robbins, MD
Jonathan Romeo, DO
Bert Ruiter, PhD
Adriano Salicru, MD PhD
Shefali Samant, MD
Carah Santos, MD
Edan Sarid, MD
Julia Savitz, MD
Sarena Sawlani, MD
Sudarshan Seshadri, PhD
Neha Seth, MD
Heena Shah, MD
Saira Sheikh, MD
Janelle M. Sher, MD
Jerome Sigua, MD
Umesh Singh, MD PhD
Ahila Subramanian, MD
Nithya Swamy, MD
Awards
$1,100 Travel Scholarships - continued
Neetu Talreja, MD
Jonathan Tam, MD
Sasipa Tanyaratsrisakul, PhD
Millard Tierce, DO
Russell Traister, MD PhD
Anubha Tripathi, MD
Timothy Trojan, MD
Kevin Tse, MD
Maria-Anna Vastardi, MD
Natalias Vernon, MD
Yamini Virkud, MD
Ravi Viswanathan, MD
Luke Wall, MD
Brant Ward, MD PhD
Jennifer Welch, MD
Kelli Williams, MD MPH
Wayne Wolverton, DO
Terianne Wong
Tiffany Wong, MD
Eveline Wu, MD
Ya Sophia Xu, MD
Lihua Yang, MD
Yarden Yanishevsky, MD
Mohammad Younus, MD
Joseph Zhou, MD PhD
Ningxi Zhu, MD PhD
$800 Travel Scholarships
Amina Abdeldaim, MD
Rigoberto Acosta, MD
Salman Aljubran, MD
Neil Amar, MD
William Anderson, MD
Tahira Batool, MD
Pavana Beerelli, MD
Elizabeth Bertucci, MD
Kanwaljit Brar, MD
Trever Burnett, MD
John Chase, MD
Rebecca Chinthrajah, MD
Katherine Conner, MD
Susan Culverhouse, MD
Poneh Davoodi, MD
Marine Demirjian, MD
Jennifer Diaz, MD
Arunmozhi Dominic, MD
Tiffany Dy, MD
Nancy Ekeke, MD
Ezinma Ezealah, MD MPH
Amy Feldman, MD
Charles A. Filion, MD
Andrea Fong, MD
Renu Gandhe, MD
Aries Gavino, MD
Bob Geng, MD
Matthew Germinaro, MD
Mark Gorelik, MD
Rony Greemberg, MD
Alekh Gupta, MD
Dave Gupta, MD
David Hagin, MD
Joud Hajjar, MD
Ashley Hall, MD
Corinne Happel, MD
Alison Haynes, MD
Darren Hirsch, MD
Kathleen Hise, MD
Sandra Ho, MD
Jillian Hochfelder, MD
Roland Honeine, MD
Brett Hronek, MD
Elena Hsieh, MD
Joyce Hsu, MD
David Huang, MD
Karine Issa-El-Khoury, MD
Tammy Jacobs, MD
Sangeeta Jain, MD
Amol Kamboj, MD
Qurat-ul-Ain Kamili, MD
Lukena Karkhanis, MD
Brian Kelly, MD
Fatima Khan, MD
Yasmeen Khan, MD
Maleewan Kitcharoensakkul, MD
Jonathan Lacombe Barrios, MD
Hava Ladinsky, MD
Uyenphuong Le, MD
Sara Leo, MD
Newton Li, MD
Henry Lin, MD
Jonathan Lyons, MD
Gil Magpantay, MD
Megan Morsheimer, MD
Leslie Moss, MD
Hassan Nasir, DO
Sarah Nicolai, MD
Andrew OKeefe, MD
Andrea Pappalardo, MD
Brenda Paquet, MD
Neil Parikh, MD
Greg Peters, MD
Jennifer Petts, DO
David Petty, DO
Benjamin Price, MD
Jessica Rajan, MD
Juan Ravell, MD
Manujendra Ray, MD PhD
Kelli Rose, MD
Amanda Rudman Spergel, MD
Kathryn Samaan, MD
Yana Samarasena, MD
David Scott, MD
Alireza Shakouri, MD
Marissa Shams, MD
Meagan Shepherd, MD
Janell Sherr, MD
Raga Sirror, MD
Robert Sporter, MD
Whitney Stevens, MD PhD
Jenny Stitt, MD
Krista Todoric, MD
Gina Tsai, MD
Sahana Vishanath, MD
Shamim Wadiwalla, MD
Emily Weis, MD
Benjamin Wright, MD
Lakiea Wright, MD
Sharon Yee, MD
Karine Zakarian, MD
$650 Travel Scholarships
Joseph Hernandez, MD PhD
Timothy Kyin, MD
Monica Lawrence, MD
Matthieu Picard, MD
Kathryn Sowerwine, MD
James Tarbox, MD
Burcin Uygungil, MD MPH
21
Continuing Education and Accreditation

Two types of continuing education credit will be available at the 2013
Annual Meeting: Continuing Medical Education (CME) credits for
physicians and Continuing Education (CE) contact hours for nurses.
Not all Annual Meeting sessions offer credit, and of those that do, not
all of them offer both CME and CE. The types and amount of credit
offered for each session are indicated in the session descriptions
beginning on page 29. Attendance certificates are available to all
delegates. Professional delegates are encouraged to complete the
self-report form to receive their CME /CE or participation certificates.
Visit the registration desk, complete the self-report form and print your
certificate.
If you do not have time to visit the registration desk before you depart
San Antonio, the self-report form will be available online beginning
March 11, 2013 and will be accessible until December 31, 2013 on the
AAAAI website, annualmeeting.aaaai.org.
Physicians Continuing Medical

Education (CME) Credits
Accreditation Statement
The American Academy of Allergy, Asthma & Immunology (AAAAI)
is accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for
physicians.
Which job is
right for you?
Credit Designation
The AAAAI designates this live activity for a maximum of 50.25 AMA
PRA Category 1 Credits. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not
licensed in the U.S. who participate in this CME activity are eligible for
AMA PRA Category 1 Credits
Target Audience
The Annual Meeting is designed for clinicians, researchers, trainees/
students and allied health professionals involved and/or interested in
the study of allergy, asthma and immunology.
Program Objective
Upon completion of the Annual Meeting, participants should be able to
discuss the latest advances in the research, diagnosis and treatment of
allergic and immunologic disease. Please refer to the individual session
descriptions in this program for session-specific learning objectives.
ABAI Continuing Medical Education

(CME) Credits
In 2007 the American Board of Allergy and Immunology (ABAI)
transitioned from a recertification process to a Maintenance of
Certification (MOC) program, which requires board certified physicians
to complete a minimum of 25 Continuing Medical Education credits
in allergy/immunology each year. The educational sessions offered at
the 2013 AAAAI Annual Meeting are linked to the content classification
system used by ABAI to develop its examinations and will help
physicians to meet MOC requirements by enhancing their knowledge
of the specialty for optimal patient care. The Keyword Index on page
167 lists all Annual Meeting sessions by the relevant ABAI topics. This
index can be used by delegates to tailor their itineraries to meet their
needs when preparing for Certification or Maintenance of Certification.
For more information about Maintenance of Certification, visit the ABAI
website at www.abai.org.
Allied Health Continuing Education (CE)

Credits
Nurses Continuing Education (CE) Contact Hours
The American Academy of Allergy, Asthma & Immunology (AAAAI) is
a Provider, approved by the California Board of Registered Nursing,
Provider #10704, for up to 60.30 Contact Hours.
AAAAI Career
Connections Job Fair
Dates: Saturday & Sunday
Time: 2:30 - 5:30 pm
Location: AAAAI Member Resource Center
22
Medical Administrators
Delegates who attend Medical Administrators (MA) sessions at the
2013 Annual Meeting may apply for credit through the American
College of Medical Practice Executives (ACMPE). For additional
information, please contact the Medical Group Management
Association at www.mgma.com.
Advanced Practitioners
The AAPA, ANCC and AANP accept reports of participation in activities
offering AMA PRA Category 1 CreditsTM for continuing education
and credentialing purposes from advanced practitioners. For more
information, please contact the appropriate organization.
Continuing Education and Accreditation

Pharmacists
Pharmacists are encouraged to contact their state boards of pharmacy
to determine if reports of participation in the AAAAI Annual Meeting are
accepted for relicensure.
Allergy and Asthma for the Health Care

Professional (AAHCP) Program
Target Audience
Health care professionals who assist with and provide care to persons
with asthma, allergy and immunologic disease, specifically: RNs,
LPNs, nurse practitioners, physician assistants, respiratory therapists,
medical technologists and medical assistants.
Learning Objective
Upon completion of the Annual Meeting, participants should be able
to discuss and expand upon the latest advances in medications,
equipment and procedures necessary to promote health for their
patients; and describe and discuss new therapies, information, patient
care and education in the field of allergy, asthma and immunology.
Please refer to the individual AAHCP session descriptions in this
program for session-specific learning objectives.
Give patients a way to take

your expert advice home
Indoor
Allergens
A Trusted
Healthy Tips
xx There are two forms of rhinitis: allergic and nonallergic. This distinction is important in order to
provide the best plan for controlling your symptoms.
xx The allergic form of rhinitis can be caused by outdoor
allergens such as pollen and mold spores. This is
referred to as seasonal allergic rhinitis or hay fever.
xx Allergic rhinitis can also be caused by indoor allergens
such as dust mites or pets. This is called perennial
allergic rhinitis, as symptoms are usually year-round.
Feel Better. Live Better.

An allergist/immunologist, often referred to as an
allergist, is a pediatrician or internist with at least
two additional years of specialized training in the
diagnosis and treatment of allergies, asthma, immune
deficiencies and other immunologic diseases.
Reso
Tip
urce
The Amer
Immunologican Academy
of
specialists, y (AAAAI) represAllergy, Asthm
ents allergi a &
professionalclinical immu
sts,
nolog
Healthy Tips
xx Allerg
ic rhinit
lungs, throat is symptoms
can occur
, sinuses,
The American Academy of Allergy, Asthma &
in the nose,
ears and
xx Your
allergistasthma
eyes.
Immunology (AAAAI) represents
allergists,
can help
home, workp
you
specialists, clinical immunologists, allied
health
lace or schoo identify things
worse.
in your
professionals and others with a special
interest in the
l that make
your sympt
xx Allerg
research and treatment of allergic
disease.
ens can
oms
with allergi trigger asthm
a sympt
oms in people
For More Informationxx Avoiding c asthma.
allergens
that
You depend on authoritative,effecti
expert
resources to
make
ve way
to treat cause symptoms
informed decisions.
symptoms.
is the most
Feel Bette
Patients and healthcare professionalsr.alike
on:
LiverelyBette
An allergi
r.
st/immunolo
www.aaaai.org
allergist,
gist,
is
two additi a pediatrician often referred to
or
diagnosis onal years of speciainternist with as an
and
lized trainin at least
deficiencies treatment
and other of allergies, asthmg in the
immunolog
By visitin
a,
g
ic diseas immune
accurate the office of an
es.
diagn
allergist,
educational osis, a treatm
you
information ent plan that can expect an
disease
works and
and feel
to help
you manag
better.
e your
Find an
allergist
near
www.aaaa
you at:
i.org
A Trusted Resource
Rhinitis
asthma
s and others
ists, allied
research
health
with a specia
Rhinitis
and treatm
ent of
l intere
allergic
disease. st in the
For More
Informatio
You depen
n
informed d on authoritativ
decisions.
e, expert
resources
Patients
to make
and health
care profes
www.aaasionals alike rely on:
Indoor
Allergens
Clinical Research (CR) Program

Target Audience
Physicians, clinical research coordinators, nurses, respiratory
therapists, pharmacists, laboratory research associates, nurse
practitioners, certified medical associates, physician assistants and
other health professionals who are interested in research in clinical,
academic, community, industry or private settings.
Learning Objective
Upon completion of the Annual Meeting, participants should be able
to discuss the various issues in clinical research; describe diverse
aspects of responsible research; and identify new approaches to
clinical research which will improve efficiency and effectiveness.
Please refer to the individual CR session descriptions in this program
for additional, detailed learning objectives.
Medical Administrators (MA) Program

Target Audience
Administrators, assistants, and office managers directly responsible for
effective office management and development.
Learning Objective
Upon completion of the Annual Meeting, participants should be able to
provide an overview of managed care concepts focusing on local and
regional markets; discuss coding issues and changes; and discuss
and develop strategies for dealing with patients. Please refer to the
individual MA session descriptions in this program for additional, more
detailed learning objectives.
Tip
ai.org
/physref
By visiting the office of an allergist, you can expect an

accurate diagnosis, a treatment plan that works and
educational information to help you manage your
disease and feel better.
Find an allergist near you at:
Allergy
2012
Ameri
All rights can Academy
of Allergy
reserved.
, Asthm
May not
a & Immu
be duplic
nology
without
ated or
permission.
appropriated .
A book about asthma for kids.
Brochures
Scratchin
g
Surface the
Skin Alle on
rgies
Signs
Warning ylaxis
of Anaph
Skin allerg
ies can
but an
allergist/imbe frustrating
has the
munologist ,
exper
which cond tise to diagn
ose
ition you
provide
have and
relief.
An Asthm
a
Action
Plan:
) is
-fi-LAK-sis
is (an-a
ic reacAnaphylax ning allerg
Eczema
anaphyreate
a life-th most common d by
Infants
Helps
tion. The ions are cause stings,
and peop
contr
tory of
le with
, insect
the long- ol your asthm
allerg
lactic react
a
to foods
term
more likely ies or asthm hisa for
allergies ns and latex.
a are
Has zones
to have
scaly
medicatio
affect more ally , itchy rash. this red,
your symp to help you track
Eczema
typically
and
affects
usuthe face,
your asthmtoms and know
Symptomspart of the body
knees.
elbows
when
Be sure
a is gettin
and
than one de:
to avoid
ing
g worse
Expla
s or itchin Doing
scratchins when
g the rash.Well
may inclu
hives/welt
to
with
No coughing, wheezing, or go to an emer call the docto
red rash
Hives and
Itchy
gency room r
Angioede
About Your
chest tightness or difficulty
ed skin
Hives are
throat
Flush
ma
tight
Plan
or
breathing
red,
en
Your asthm
itchy raise
that may
Swoll voice
a actio
d areas
be
Can work,
play, exercise, pere
breathing
unique
n plan
Hoars swallowing or lergic react caused by an
to your
al- activities without
form usual
le
condition.is
foods or ion to medi
Make
Troub
cough
cations,
sure your
insect bitessymptoms
zing or
also be
Whee
plan inclu
emer
ess
. They
caused Peak
can______ to ______ gency phon
flow
t tightn
des
ng out
by
triggers
Ches
e numb
best)
like heat non-a
Share your
(80%llergi
to 100%
ess or passi
ers.
c of personal
or exerc
Dizzin
plan with
Angioedem
ise.
family,
ting
friends,
teachers
Vomi
deep layer a is a swelling
hea
in the
WorseThen they can or coaches.
s of the Caution/Getting
ping
Diarr
help if
doom
ach cram occur
s with hives skin
and often wheezing, a flare-up.
you have
Stom of impending
pears on
. It Coughing,
g
*This inform
withi
theneyelid typica
llytightness
chest
or difficulty
Feelin
apstart
s or mout
poses and ation is for genera
typically
ng in
breathing
h.
l purCont
comi
advice of is not intended
Symptoms tes of
act But
in
a qualifi
to
minu
en. Dermatitis Symptoms with daily activied health replace the
Allerg
5 to 30
allergic
an
professional
with
conta
morect
ties, work, play and exercise
.
curstake
contact
it may
hy-dermatitis
when
awakenings
with
skin
e anap
ocMy physi
comes Nighttime
conta
notic
some cases to
cians phon
ct with
hour
direct
an allerg in symptoms
. l.
nicke
than an
e numb
toms
en such
Red, bump
er is:
Peak flow ___________
to ______
an
_____
lactic symp or swoll
having y, scaly,(50% as
itchyto 80% of personal best) __________
you are en skin
your
use can
the
________
pointion,
deve
If you thinktic react
of conta
and lop at
e ct.
anaphylac able epinephrin life
Alert!
ly. Your
autoinject
immediate
Difficulty breathing, coughcall 911 nd on it!
ing, wheezing not helped with
may depe
medications
Pub Ed
Trouble walking or talking due
Bookm
arks-Sk
in-v3.in
dd 1
to asthma symptoms
2011,to quick-relief
1/3/201
Not responding
America
n Academ
2 4:32:15Immunology
medication
y of Allergy,
All rights
PMPM
Asthma
reserve
d.
2 1:38:10
&
1/4/201
Peak
flow ______ to ______
Childrens Books
YELLOW ZONE
GREEN ZONE
Your Asthma
Action Plan
RED ZONE
AAAAI-1012-572
2012 American Academy of Allergy, Asthma & Immunology.

All rights reserved. May not be duplicated or appropriated
without permission.
Allergy
2-572
AAAAI-101
The conten
ts of this
only. It
brochu
is
you have not intended to re are for inform
replace
questions
evaluation ational purpos
allergist/imm
or medica
es
by
l concer
unologist.
ns, please a physician. If
contact
your
The contents of this brochure are for informational purposes

only. It is not intended to replace evaluation by a physician. If
you have questions or medical concerns, please contact your
allergist/immunologist.
Allergy
Allergy
www.aaaai.org/physref
dd 2
is-v5.in
Pub Ed
aphylax
(50% of personal best)
arks-An
Bookm
Warning: For extreme difficulty

breathing, call 911.
Otherwise, if you are in the Red
Zone, contact your physician.
Mr. Nose-it-All Stickers
Bookmarks
AAAAI-1112-280
Visit the Member Resource Center at the Annual Meeting

to receive FREE samples and to take advantage
of special discounts.
23
NOW AVAILABLE FOR PATIENTS 12 YEARS OF AGE AND OLDER SUFFERING FROM ALLERGIC RHINITIS
A DRY NASAL AEROSOL WITH
ZETONNA (ciclesonide)
Nasal Aerosol offers
relief with
STAYABILITY
STAYABILITY
- HFA-propelled dry nasal aerosol delivery
- retention measured in 2 scintigraphy trials1,2
Satisfaction data for ZETONNA as reported
by patients in a clinical trial 3
Significantly improved relief from
- seasonal ocular allergy symptoms in patients
with seasonal allergic rhinitis4
- seasonal and year-round nasal allergy symptoms4
One spray per nostril, once-daily dosing
INDICATION: ZETONNA (ciclesonide) Nasal Aerosol is a corticosteroid indicated for the treatment of symptoms associated with seasonal
and perennial allergic rhinitis in adults and adolescents 12 years of age and older.
IMPORTANT SAFETY INFORMATION: In clinical studies local nasal effects of epistaxis, ulcerations, and nasal septal perforations were
observed with ZETONNA (ciclesonide) Nasal Aerosol. In the short-term and long-term trials combined, nasal septal perforations were
reported in 2 patients of 2335 treated with ZETONNA compared with none of 892 treated with placebo. Both perforations occurred in
2-week SAR trials while none occurred in the longer term trials. In clinical trials with another formulation of ciclesonide, the development
of localized infections of the nose or pharynx with Candida albicans has occurred. Corticosteroids can interfere with wound healing.
Prior to initiating therapy, examine patients for evidence of septal perforation, erosions, ulceration, nasal surgery, and trauma. Avoid
spraying ZETONNA directly onto the nasal septum. Avoid use in patients with recent septal perforation, nasal erosion, nasal ulcers, nasal
surgery, or nasal trauma. Monitor patients periodically for signs of adverse reactions on the nasal mucosa. Discontinue ZETONNA if
erosions, ulcerations or perforations occur.
Nasal and inhaled corticosteroids may result in the development of glaucoma and cataracts. Monitor patients closely with a change in
vision or with a history of increased intraocular pressure, glaucoma, or cataracts.
ZETONNA is contraindicated in patients with a known hypersensitivity to ciclesonide or any of the ingredients of ZETONNA. Cases of
hypersensitivity reactions following administration of ciclesonide with manifestations such as angioedema, with swelling of the lips,
tongue and pharynx have been reported.
Patients using immunosuppressive drugs, like corticosteroids, can cause potential worsening of existing tuberculosis; fungal, bacterial,
viral or parasitic infections; or ocular herpes simplex. Chicken pox and measles can have a more serious or even fatal course in susceptible
individuals. Use caution in patients with the above because of the potential for worsening of these infections.
When intranasal corticosteroids are used at very high dosages or at the regular dosage in susceptible individuals, systemic corticosteroid
effects such as hypercorticism and adrenal suppression may appear. If such changes occur, discontinue ZETONNA slowly.
Corticosteroids may cause a reduction in growth velocity in children. Monitor growth routinely in pediatric patients receiving ZETONNA.
In trials 2-6 weeks in duration, the most common adverse events that occurred with an incidence of at least 2% and more frequently with
ZETONNA than with placebo were nasal discomfort, headache and epistaxis.
Please see Brief Summary of Prescribing Information on the following pages.
References: 1. Data on file, CSR 101. Sunovion Pharmaceuticals Inc,
Marlborough, MA. 2. Data on file, CSR 102. Sunovion Pharmaceuticals Inc,
Marlborough, MA. 3. Data on file, CSR 302. Sunovion Pharmaceuticals Inc,
Marlborough, MA. 4. ZETONNA Prescribing Information. Marlborough, MA:
Sunovion Pharmaceuticals Inc; January 2012.
STAYABILITY is a trademark of Sunovion Pharmaceuticals Inc.

Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Dainippon Sumitomo Pharma Co. Ltd.
2012 Sunovion Pharmaceuticals Inc. All rights reserved. 11/12 ZETV312-12
A spray that stays.
ZETONNA (ciclesonide) Nasal Aerosol

For Intranasal Use Only
Initial U.S. Approval: 2006
BRIEF SUMMARY: Please see package insert for full prescribing information.
1 INDICATIONS AND USAGE
1.1 Treatment of Allergic Rhinitis
ZETONNA (ciclesonide) Nasal Aerosol is indicated for the treatment of
symptoms associated with seasonal and perennial allergic rhinitis in adults
and adolescents 12 years of age and older.
4 CONTRAINDICATIONS
ZETONNA Nasal Aerosol is contraindicated in patients with a known hypersensitivity to ciclesonide or any of the ingredients of ZETONNA Nasal
Aerosol [see Warnings and Precautions (5.3)].
5 WARNINGS AND PRECAUTIONS
5.1 Local Nasal Effects
Epistaxis and Nasal Ulceration: In clinical trials of 2 to 26 weeks in duration,
epistaxis was observed more frequently in patients treated with ZETONNA
Nasal Aerosol than those who received placebo. In the 26-week open-label
extension of the perennial allergic rhinitis trial, nasal ulceration was identified in 4 of 824 patients administered ZETONNA Nasal Aerosol (148 mcg).
[see Adverse Reactions (6)]
Nasal Septal Perforation: Nasal septal perforation has been reported in
patients following the intranasal application of ZETONNA Nasal Aerosol.
Three short-term placebo-controlled trials (2 weeks) and one long-term
(26 weeks with placebo control and 26 weeks open-label extension without
placebo control) trial were conducted in patients with seasonal and perennial allergic rhinitis. Nasal septal perforations were reported in 2 patients
out of 2335 treated with ZETONNA Nasal Aerosol compared with none of
892 treated with placebo.
Before starting ZETONNA Nasal Aerosol conduct a nasal examination to
ensure that patients are free of nasal disease other than allergic rhinitis.
Periodically monitor patients with nasal examinations during treatment for
adverse effects in the nasal cavity. If an adverse reaction (e.g. erosion,
ulceration, perforation) is noted, discontinue ZETONNA Nasal Aerosol.
Avoid spraying ZETONNA Nasal Aerosol directly onto the nasal septum.
Candida Infection: In clinical trials with another formulation of ciclesonide,

the development of localized infections of the nose or pharynx with Candida
albicans has occurred. If such an infection develops with ZETONNA Nasal
Aerosol, it may require treatment with appropriate local therapy and discontinuation of ZETONNA Nasal Aerosol.
Impaired Wound Healing: Because of the inhibitory effect of corticosteroids
on wound healing, patients who have experienced recent nasal septal ulcers,
nasal surgery, or nasal trauma should not use ZETONNA Nasal Aerosol until
healing has occurred.
5.2 Glaucoma and Cataracts
Nasal and inhaled corticosteroids may result in the development of glaucoma and cataracts. Therefore, close monitoring is warranted in patients
with a change in vision or with a history of increased intraocular pressure,
glaucoma, or cataracts.
5.3 Hypersensitivity
ZETONNA Nasal Aerosol is contraindicated in patients with a known hypersensitivity to ciclesonide or any of the ingredients of ZETONNA Nasal
Aerosol. Cases of hypersensitivity reactions following administration of
ciclesonide with manifestations such as angioedema, with swelling of the
lips, tongue and pharynx, have been reported.
5.4 Immunosuppression
Patients who are using drugs that suppress the immune system are more
susceptible to infections than healthy individuals. Chicken pox and measles,
for example, can have a more serious or even fatal course in susceptible
children or adults using corticosteroids. In children or adults who have not
had these diseases or been properly immunized, particular care should be
taken to avoid exposure. How the dose, route, and duration of corticosteroid administration affect the risk of developing a disseminated infection
is not known. The contribution of the underlying disease or prior corticosteroid treatment to the risk is also not known. If a patient is exposed to
chicken pox, prophylaxis with varicella zoster immune globulin (VZIG) may
be indicated. If a patient is exposed to measles, prophylaxis with pooled
intramuscular immunoglobulin (IG) may be indicated. (See the respective
package inserts for complete VZIG and IG prescribing information). If
chickenpox develops, treatment with antiviral agents may be considered.
Corticosteroids should be used with caution, if at all, in patients with active
or quiescent tuberculosis infections of the respiratory tract; or in patients
with untreated local or systemic fungal or bacterial infections; systemic
viral or parasitic infections; or ocular herpes simplex because of the potential for worsening of these infections.
5.5 Hypothalamic-Pituitary-Adrenal Axis Effect

Hypercorticism and Adrenal Suppression: When intranasal corticosteroids
are used at higher than recommended dosages or in susceptible individuals
at recommended dosages, systemic corticosteroid effects such as hypercorticism and adrenal suppression may appear. If such changes occur, the
dosage of ZETONNA Nasal Aerosol should be discontinued slowly, consistent with accepted procedures for discontinuing oral steroid therapy.
The replacement of a systemic corticosteroid with a topical corticosteroid
can be accompanied by signs of adrenal insufficiency. In addition, some
patients may experience symptoms of corticosteroid withdrawal, e.g., joint
and muscular pain, lassitude, and depression. Patients previously treated
for prolonged periods with systemic corticosteroids and transferred to topical corticosteroids should be carefully monitored for acute adrenal insufficiency in response to stress. In those patients who have asthma or other
clinical conditions requiring long-term systemic corticosteroid treatment,
rapid decreases in systemic corticosteroid dosages may cause a severe
exacerbation of their symptoms.
5.6 Effect on Growth
Corticosteroids may cause a reduction in growth velocity when administered
to pediatric patients. Monitor the growth routinely (e.g., via stadiometry) in
pediatric patients receiving ZETONNA Nasal Aerosol. [see Pediatric Use (8.4)]
6 ADVERSE REACTIONS
Systemic and local corticosteroid use may result in the following:
Epistaxis, ulcerations, nasal septal perforations, Candida albicans infection, impaired wound healing [see Warnings and Precautions (5.1)]
Glaucoma and cataracts [see Warnings and Precautions (5.2)]
Immunosuppression [see Warnings and Precautions (5.4)]
Hypothalamic-pituitary-adrenal (HPA) axis effects, including growth
reduction [see Warnings and Precautions (5.5, 5.6), Use in Specific Populations (8.4)]
6.1 Clinical Trials Experience
The safety data described below for adults and adolescents 12 years of age
and older are based on 4 clinical trials evaluating doses of ciclesonide nasal
aerosol from 74 to 282 mcg. Three of the clinical trials were 2 to 6 weeks in
duration and one trial was 26 weeks in duration with an additional 26-week
open-label extension. Data from the first 6 weeks of the 26-week trial were
pooled with data from the three 2-week trials. Short-term data (2 to 6 weeks)
included 3001 patients with seasonal and perennial allergic rhinitis, of
these, 884 received ZETONNA Nasal Aerosol 74 mcg once daily and 892
received placebo. The short-term data included 1098 (36.6%) males, 1903
(63.4%) females, 2587 (86.2%) Caucasians, 320 (10.7%) Blacks, 49 (1.6%)
Asians, and 45 (1.5%) patients classified as Other. The 26-week trial was
conducted in 1110 patients with perennial allergic rhinitis [394 (35.5%)
males and 716 (64.5%) females, ages 12 to 78 years old] treated with
ZETONNA Nasal Aerosol 74 mcg, 148 mcg or placebo once daily. Of these
patients, 298 were treated with 74 mcg ZETONNA Nasal Aerosol, 505 with
148 mcg, and 307 with placebo. The racial distribution in this trial included
922 (83.1%) Caucasians, 146 (13.2%) Blacks, 18 (1.6%) Asians, and 24
(2.2%) patients classified as Other. The 26-week open-label extension
included 824 patients [295 (35.8%) males and 529 (64.2%) females, ages
12 to 79 years old] given ZETONNA Nasal Aerosol 148 mcg once daily. The
racial distribution in the open-label extension included 690 (83.7%) Caucasians, 104 (12.6%) Blacks, 15 (1.8%) Asians, and 15 (1.8%) patients
classified as Other.
Because clinical trials are conducted under widely varying conditions,
adverse reaction rates observed in clinical trials of a drug cannot be directly
compared to rates in the clinical trials of another drug and may not reflect
the rates observed in practice.
Adults and Adolescents 12 Years of Age and Older in Short-Term

(2-6 weeks) Trials:
In three short-term trials and the first 6 weeks of one long-term trial, conducted in the US, 884 patients with a history of seasonal or perennial allergic rhinitis were treated with ZETONNA Nasal Aerosol 74 mcg daily. Adverse
reactions did not differ appreciably based on age, gender, or race. The table
below displays reactions that occurred with an incidence of at least 2.0%
and more frequently with ZETONNA Nasal Aerosol 74 mcg than with placebo
in seasonal or perennial allergic rhinitis clinical trials of 2 to 6 weeks duration.
Table 1: Adverse Reactions Occurring with a Frequency of at least 2.0% and

Greater than Placebo from Controlled Clinical Trials 2 to 6 Weeks in
Duration in Patients 12 Years of Age and Older with Seasonal or
Perennial Allergic Rhinitis
Adverse Reaction
ZETONNA Nasal Aerosol

74 mcg Once Daily
N = 884 (%)
Placebo
N = 892 (%)
Nasal discomforta
28 (3.2)
16 (1.8)
Headache
27 (3.1)
11 (1.2)
Epistaxis
26 (2.9)
24 (2.7)
Nasal discomfort includes both nasal discomfort and instillation site discomfort
When considering the data from higher doses evaluated in the short-term
trials, epistaxis demonstrated a dose response. In addition, two patients
treated with ZETONNA Nasal Aerosol 74 mcg experienced nasal septal perforations in the short-term trials compared to no patients treated with
placebo.
Approximately 1.2% of patients treated with ZETONNA Nasal Aerosol 74 mcg
in clinical trials discontinued because of adverse reactions; this rate was
similar for patients treated with placebo.
Discontinuations due to local adverse reactions were similar in ZETONNA
Nasal Aerosol 74 mcg treated patients (0.8%) compared to placebo treated
patients (0.8%). Local adverse reactions leading to discontinuation that
occurred only in ZETONNA Nasal Aerosol treated patients included ear
infection, nasal discomfort, nasal dryness, nasal mucosal/septum disorders, pharyngitis, streptococcal pharyngitis, sinus headache, and tonsillitis.
Pediatric Patients Aged 2 to 11 Years:

Trials of ZETONNA Nasal Aerosol have not been conducted in pediatric
patients aged 2 to 11 years.
Long-Term (26-Week Double-Blind and 26-Week Open-Label) Safety Trial:
In one 26-week double-blind, placebo-controlled safety trial that included
1110 adult and adolescent patients with perennial allergic rhinitis, additional
adverse reactions, with an incidence of at least 2%, that occurred more
frequently with ZETONNA Nasal Aerosol than with placebo were upper respiratory tract infection, urinary tract infection, oropharyngeal pain, nasal
mucosal/septum disorders, viral upper respiratory tract infection, cough,
influenza, bronchitis, streptococcal pharyngitis, muscle strain, and nausea.
Nasal discomfort (5.7%) and epistaxis (11.4%) were also more frequent in
the 26-week safety trial compared to clinical trials 2 to 6 weeks in duration.
Nasal mucosal/septum disorders and cough demonstrated a dose response.
Discontinuations due to adverse reactions were higher in ZETONNA Nasal
Aerosol treated patients compared to placebo treated patients and demonstrated a dose response. Local adverse reactions leading to discontinuation
were also higher in ZETONNA Nasal Aerosol 74 mcg treated patients (1.7%)
compared to placebo treated patients (0.7%). The only local adverse reaction leading to discontinuation that occurred in ZETONNA Nasal Aerosol
treated patients and was not observed in the 2- to 6-week trials was upper
respiratory tract infection.
A total of 824 patients with perennial allergic rhinitis who completed the
26-week double-blind trial enrolled into an open-label extension and received
ZETONNA Nasal Aerosol 148 mcg for 26 weeks. Additional adverse reactions,
observed with an incidence of at least 2% were sinusitis, nasopharyngitis,
and back pain.
A total of 4 nasal septal ulcerations were also reported in the 26-week
open-label extension.
There were no reports of nasal septal perforations in the long-term safety
trial.
6.2 Post-marketing Experience
Additional adverse reactions have been identified during worldwide postmarketing use with other formulations of ciclesonide, ALVESCO Inhalation
Aerosol and OMNARIS Nasal Spray. Because these reactions are reported
voluntarily from a population of uncertain size, it is not always possible to
reliably estimate their frequency or establish a causal relationship to drug
exposure.
ALVESCO Inhalation Aerosol: immediate or delayed hypersensitivity reactions such as angioedema with swelling of the lips, tongue, and pharynx.
OMNARIS Nasal Spray: nasal congestion, nasal ulcer, and dizziness.
Localized infections of the nose or mouth with Candida albicans have also
occurred with OMNARIS Nasal Spray.
7 DRUG INTERACTIONS
In vitro studies and clinical pharmacology studies suggested that desciclesonide has no potential for metabolic drug interactions or protein bindingbased drug interactions [see Clinical Pharmacology (12.3) in the full
prescribing information]. In a drug interaction study, co-administration of
orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of
cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by
approximately 3.6-fold at steady state, while levels of ciclesonide remained
unchanged. Erythromycin, a moderate inhibitor of cytochrome P450 3A4,
had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin following oral inhalation of ciclesonide [see Clinical Pharmacology
(12.3) in the full prescribing information].
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Teratogenic Effects: Pregnancy Category C.
There are no adequate and well-controlled trials in pregnant women.
ZETONNA Nasal Aerosol should be used during pregnancy only if the
potential benefit justifies the potential risk to the fetus. Experience with oral
corticosteroids since their introduction in pharmacologic, as opposed to
physiologic, doses suggests that rodents are more prone to teratogenic
effects from corticosteroids than humans.
Oral administration of ciclesonide in rats at approximately 120 times the
maximum recommended human daily intranasal dose (MRHDID) in adults
(on a mcg/m2 basis at a maternal dose of 900 mcg/kg/day) produced no
teratogenicity or other fetal effects. However, subcutaneous administration
of ciclesonide in rabbits at similar to MRHDID (on a mcg/m2 basis at a
maternal dose of 5 mcg/kg/day) produced fetal toxicity. This included fetal
loss, reduced fetal weight, cleft palate, skeletal abnormalities including
incomplete ossifications, and skin effects. No toxicity was observed at of
the MRHDID in adults (on a mcg/m2 basis at a maternal dose of 1 mcg/kg/day).
Nonteratogenic Effects: Hypoadrenalism may occur in infants born of mothers receiving corticosteroids during pregnancy. Such infants should be
carefully monitored.
8.3 Nursing Mothers
It is not known if ciclesonide is excreted in human milk. However, other
corticosteroids are excreted in human milk. In a study with lactating rats,
minimal but detectable levels of radiolabeled ciclesonide were recovered in
milk. Caution should be used when ZETONNA Nasal Aerosol is administered
to nursing women.
8.4 Pediatric Use
The safety and effectiveness for seasonal and perennial allergic rhinitis in
children 12 years of age and older have been established. The safety and
efficacy of ZETONNA Nasal Aerosol for treatment of the symptoms of seasonal and perennial allergic rhinitis in patients 11 years of age and younger
have not been established.
Controlled clinical trials have shown that intranasal corticosteroids may
cause a reduction in growth velocity in pediatric patients. This effect has
been observed in the absence of laboratory evidence of hypothalamicpituitary-adrenal (HPA)-axis suppression, suggesting that growth velocity is
a more sensitive indicator of systemic corticosteroid exposure in pediatric
patients than some commonly used tests of HPA-axis function. The longterm effects of this reduction in growth velocity associated with intranasal
corticosteroids, including the impact on final adult height, are unknown.
The potential for catch-up growth following discontinuation of treatment
with intranasal corticosteroids has not been adequately studied. The growth
of pediatric patients receiving intranasal corticosteroids, including ZETONNA
Nasal Aerosol, should be monitored routinely (e.g., via stadiometry). A
52-week, multi-center, double-blind, randomized, placebo-controlled parallelgroup trial was conducted to assess the effect of orally inhaled ciclesonide
(ALVESCO Inhalation Aerosol) on growth rate in 609 pediatric patients
with mild persistent asthma, aged 5 to 8.5 years. Treatment groups
included orally inhaled ciclesonide 40 mcg or 160 mcg or placebo given
once daily. Growth was measured by stadiometer height during the baseline, treatment and follow-up periods. The primary comparison was the difference in growth rates between ciclesonide 40 and 160 mcg and placebo
groups. Conclusions cannot be drawn from this trial because compliance
could not be assured. Ciclesonide blood levels were also not measured during
the one-year treatment period. There was no difference in efficacy measures between the placebo and the orally inhaled ciclesonide (ALVESCO
Inhalation Aerosol) groups.
The potential growth effects of prolonged treatment should be weighed

Keep out of reach of children. Avoid spraying in eyes or directly onto th
against clinical benefits obtained and the availability of safe and effective
nasal septum.
noncorticosteroid treatment alternatives. To minimize the systemic effects
ZETONNA Nasal Aerosol 37 mcg, 60 metered actuations; net fill weight
intranasal
corticosteroids,
each
patient
lowest
g.
The potential growthofeffects
of prolonged
treatment
should
be should
weighedbe titrated to the
Keep
out of reach of6.1
children.
Avoid spraying in eyes or directly onto the
dose
that effectively
his/her
symptoms.
against clinical benefits
obtained
and the controls
availability
of safe
and effective
nasal septum.
NDC Number 63402-737-60
The potential
for ZETONNA
Nasal the
Aerosol
to cause
growth suppression
in Nasal Aerosol 37 mcg, 60 metered actuations; net fill weight
noncorticosteroid treatment
alternatives.
To minimize
systemic
effects
ZETONNA
susceptible
patients
when be
given
at higher
recommended6.1
dosages
of intranasal corticosteroids,
each
patientorshould
titrated
to thethan
lowest
g.
ruled out.
dose that effectively cannot
controlsbehis/her
symptoms.
NDC Number 63402-737-60
8.5 Geriatric
Use
The potential for ZETONNA
Nasal Aerosol
to cause growth suppression in
Nasal
Aerosol did dosages
not include sufficient numbers
susceptible patients Clinical
or whentrials
givenofatZETONNA
higher than
recommended
cannot be ruled out. of patients age 65 and over to determine whether they responded differently
Manufactured for:
8.5 Geriatric Use from younger patients. Other reported clinical experience has not identified
Sunovion Pharmaceuticals Inc.
differences
responses
between
thesufficient
elderly and
younger patients. In genClinical trials of ZETONNA
NasalinAerosol
did not
include
numbers
Marlborough, MA 01752 USA
eral,
dose
selection
for
an
elderly
patient
should
be
cautious
reflecting
the
of patients age 65 and over to determine whether they responded differently
Made in the United Kingdom
greater
frequency
of
decreased
hepatic,
renal,
or
cardiac
function,
and
of
Manufactured
for:
from younger patients. Other reported clinical experience has not identified
concomitant
disease
or
other
drug
therapy.
differences in responses between the elderly and younger patients. In genZETONNA
Marlborough, MA 01752
USA is a trademark of Sonovion Pharmaceuticals Inc. Sunovion
10 for
OVERDOSAGE
eral, dose selection
an elderly patient should be cautious reflecting the
Pharmaceuticals Inc. is a U.S. subsidiary of Dainippon Sumitomo Pharma Co
Made in the United Kingdom
overdosage
may result
in signs
or symptoms
greater frequency of Chronic
decreased
hepatic, renal,
or cardiac
function,
and of of hypercorticism
Ltd., and
is a registered trademark of Dainippon Sunitomo Pharma Co. Lt
seeother
Warnings
and Precautions (5.5)]. There are no data on the effects of
concomitant disease[or
drug therapy.
acute
or
chronic
overdosage
with
ZETONNA
Nasal
Aerosol.
2012
Sunovion
All rights reserved.
ZETONNA
is
a
trademark
of
Sonovion
Pharmaceuticals Inc. Sunovion
10 OVERDOSAGE
Pharmaceuticals Inc.May
is a 2012
U.S. subsidiary of Dainippon Sumitomo Pharma Co.
16 STORAGE
Chronic overdosage
may result in signs or symptoms of hypercorticism
Ltd., and
trademark of Dainippon Sunitomo Pharma Co. Ltd
Store at 25C
(77F);
excursions
permitted
to 15-30C
[See is a registered
[see Warnings and Precautions
(5.5)
]. There
are no data
on the effects
of (59-86F)
CIC066-12
USP Controlled
Room Temp].
For optimal results, canister2012
shouldSunovion
be at Pharmaceuticals Inc. All rights reserved.
acute or chronic overdosage
with ZETONNA
Nasal Aerosol.
For customer service, call 1-888-394-7377
room temperature when used.
16 STORAGE
May 2012
To report adverse events, call 1-877-737-7226
PRESSURE
Store at 25C (77F);CONTENTS
excursionsUNDER
permitted
to 15-30C (59-86F) [See
For medical information, call 1-800-739-0565
CIC066-12
USP Controlled Room
Temp].
For
optimal
results,
canister
should
be
at
Do not puncture. Do not use or store near heat or open flame.
Exposureservice,901641R00
For
customer
call 1-888-394-7377
room temperature when
used.
to temperatures
above 49C (120F) may cause bursting. To
Never
throw
report
adverse events,
call 1-877-737-7226
620392213
canister into fire or incinerator.
CONTENTS UNDER PRESSURE
For medical information, call 1-800-739-0565
Do not puncture. Do not use or store near heat or open flame. Exposure
901641R00
to temperatures above 49C (120F) may cause bursting. Never throw
620392213
canister into fire or incinerator.
Thursday, February 21 / Friday, February 22

Friday, February 22
Military Allergy Program
Fellows-in-Training Program
0001 27th Annual Harold S. Nelson Allergy

Immunology Symposium
1011 FIT Symposium
7:20
7:50
8:00
9:00
9:15
11:00
11:30
1:00
2:45
3:00

3:30
3:45
4:00
4:15
4:30
7:20 am to 5:00 pm
Pre-registration and ticket required. No fee. Continental breakfast and
box lunch included.
Credit: 8.00 CME / 9.60 CE
Moderator: Thomas J. Backenson, MD
Registration and Breakfast
Welcome and Overview
Thomas J. Backenson, MD
Morning Address: Update in Mast Cell Biology and Mast Cell
Disorders
Todd Wilson, DO
Break
Fellow Research and Clinical Case Presentations
Vaccine Healthcare Center Update
Renata J.M. Engler, MD FAAAAI
Lunch and Bruton Lecture: VA Disability and Allergic Disease
Chester R. Zeiss, MD FAAAAI
Fellow Case Reports
Break
Military Aeroallergen Extract Laboratory Updates
Susan E. Kosisky, BS MHA
Consultants to the Surgeons General Updates
VHA Allergy Committee
Joseph S. Yusin, MD FAAAAI
Air Force
Stephen E. Scranton, MD
Army
Michael R. Nelson, MD PhD FAAAAI
Navy
Business Meeting and Awards Presentation
Upon completion of this session, participants should be able to: Describe current concepts
in mast cell biology; Identify, evaluate and treat conditions along the spectrum of mast cell
activation syndromes; Identify the VA disability evaluation process as it relates to those
conditions commonly managed by the allergist.
7:00
8:00
8:05

8:15
8:20
8:50
9:20
9:35
9:45
10:15
10:45
11:15
11:45
12:15
7:00 am to 1:30 pm
box lunch included.
Credit: No CME / No CE
Moderator: Silvia Huebner, MD
Networking Breakfast Begins
Introductory Remarks
Mary Beth Fasano, MD FAAAAI
Silvia Huebner, MD
Networking Organizations
American Academy of Pediatrics Section on Allergy and
Immunology
Anne-Marie A. Irani, MD FAAAAI
Federation of Regional, State and Local Allergy, Asthma and
Immunology Societies
James M. Tracy, DO FAAAAI
Joint Council of Allergy, Asthma & Immunology
James L. Sublett, MD FAAAAI
New Allergist/Immunologist Assembly
David W. Hauswirth, MD FAAAAI
World Allergy Organization
Ruby U. Pawankar, MD PhD FAAAAI
American Board of Allergy and Immunology
Stephen I. Wasserman, MD FAAAAI
Atopic Dermatitis and Food Allergy
Jacqueline Pongracic, MD FAAAAI
Gastrointestinal Food Allergy
Robert A. Wood, MD FAAAAI
Break
Welcome from the AAAAI President
Mechanisms of Food Allergy and Immune Tolerance
Pollen-Food Allergy Syndrome
Thomas A.E. Platts-Mills, MD PhD FAAAAI
Food Allergy Evaluation: Oral Food Challenges in the Office
Setting
Anna H. Nowak-Wegrzyn, MD FAAAAI
Oral Immunotherapy for Food Allergy
Kari Nadeau, MD PhD FAAAAI
Putting it Together: NIAID-Sponsored 2010 Guidelines for
Managing Food Allergy
Scott H. Sicherer, MD FAAAAI
Networking Lunch
Upon completion of this session, participants should be able to: Describe the
pathophysiology, initial evaluation and management of patients with food allergy including
gastrointestinal food allergy, oral allergy syndrome and type I food allergy; Identify recent
advances in the field of food allergy and have some familiarity with published guidelines
for managing food allergy; Outline current and emerging treatment modalities for food
allergic patients.
29
Friday, February 22
Allied Health Course
Medical Administrator Workshop
1101 Advanced Practice Course
1102 Human Resources: Essentials of

Employee Handbooks
7:00
7:15
8:00
8:45
9:30
9:45
10:00
10:45
11:30
11:45
12:30
1:15
2:00
7:00 am to 3:30 pm
Pre-registration and ticket required. No fee. Box lunch included.
Moderators: Edward O. Corazalla, MS RPFT
Debra A. Sedlak, MSN CPNP
Nina A. Zimmermann, MSN RN ANP-BC AE-C
Introduction
Update on Rhinosinusitis
Nina A. Zimmerman, MSN RN ANP-BC AE-C
Update on Anaphylaxis
Gabriel Ortiz, MPAS PA-C DFAAPA
Update on Immunology
Mitchell H. Grayson, MD FAAAAI
Question & Answer
Break
Beyond the Basics: Desensitization Protocols in Office
Ashley Marie Hall, MD
Stinging Insect Hypersensitivity
Dewey F. Hahlbohm, PA-C AE-C
Question & Answer
Lunch Break
Changes in Pulmonary Function in World Trade Center Rescue
Workers After 9/11
Edward O. Corazalla, MS RPFT
Stress Management and Asthma Care: Why Should it Matter?
Gailen D. Marshall, Jr., MD PhD FAAAAI
Workshops (Attendees will choose one of the following sessions.)
Pre-registration and ticket required. Fee: $20.
1101A: Punch Biopsy: Indications and Techniques
Marriott Rivercenter, Third Floor, Grand Ballroom I
Jeanette Arnold, MSN RN C-FNP
Don Cui, PA-C AE-C
1101B: Patch Testing
Karol G. Timmons, RN MS CPNP
1101C: Guidelines for IVIG and SCIG Infusions
Carla M. Duff, CPNP MSN
Debra A. Sedlak, MSN CPNP
1101D: Advanced Spirometry
Upon completion of this session, participants should be able to: Discuss concepts
of asthma and clinical immunology including: Evidence-based practice concepts
and application of the diagnosis and treatment of rhinosinusitis, anaphylaxis and
stinging insect hypersensitivity; Discuss desensitization protocols for the office, stress
management and asthma and PFT changes in 9/11 rescue workers.
8:00
8:00 to 9:15 am
Marriott Rivercenter, Third Floor, Grand Ballroom Salon M
Moderator: Jeanette Booker
Essentials of Employee Handbooks
Denise C. Yarborough, Esq.
Upon completion of this session, participants should be able to: Recognize how to write
or update your employee handbook; Describe the legal ramifications of a poorly written
handbook; Discuss how to keep you handbook fresh and up to date.
Clinical Research Workshop

1103 Who Needs a Monitoring Plan? You Do!
8:00 to 9:15 am
Marriott Rivercenter, Third Floor, Grand Ballroom Salon L
Moderator: Sally A. Noone, RN MSN CCRC
Pamela H. Steele, MSN CPNP AE-C
Upon completion of this session, participants should be able to: Discuss the regulatory
concerns in clinical research; Describe the components of a monitoring plan; Recognize
the need for internal monitoring of all research projects.
Chrysalis Project
1111 2013 Chrysalis Project Program
8:00 am to 12:00 pm
box lunch included.
7:30 Breakfast
8:00
Welcome and Introduction to A/I Training
Kimberly A. Risma, MD PhD FAAAAI
8:15
Welcome from the AAAAI President
8:30
Food Allergy
9:00 Immunodeficiency
Thomas A. Fleisher, MD FAAAAI
9:30
Eosinophilic Disorders
Amy D. Klion, MD
10:00 Break
10:15 Asthma
Rohit Katial, MD FAAAAI
10:45 Atopic Dermatitis
Donald Y.M. Leung, MD, PhD
11:15 Academic Career Paths
11:30 Industry Career Paths
Daniel C. Adelman, MD FAAAAI
11:45 Private Practice Career Paths
Adina Kay Knight, MD FAAAAI
Annual Meeting Allied Health Sessions

Programmed by the AAAAI. Allied Health Sessions funded through
an educational grant from Merck.
30
Allied Health Professional
ticket required
fee required
included in the Virtual Annual Meeting
Friday, February 22
TIGERS Program
1201 The 4 International Gastrointestinal
Eosinophil Research Symposium
(TIGERS)
th
8:00 am to 6:00 pm
Programmed by the AAAAI. Funded in part through educational grants
from Abbott Nutrition, American Partnership for Eosinophilic Disorders
(APFED), Campaign Urging Research for Eosinophilic Disease (CURED
Foundation) and Meritage Pharma, Inc.
Convention Center, Grand Ballroom Level, Ballroom C1
Pre-registration and ticket required. Fee varies.
8:00
Overview of Consensus Recommendations: The Structure of
Controversy
Chris A. Liacouras, MD
Pathogenesis
Moderator: Seema Sharma Aceves, MD PhD FAAAAI
8:20
Molecular Factors and Cells
Marc E. Rothenberg, MD PhD FAAAAI
8:35
Genetics
8:50
Fibrosis and Remodeling
Seema Sharma Aceves, MD PhD FAAAAI

New Diagnostic Modalities: Whats Coming Down the Esophageal
Pipeline?
Moderator: Simon P. Hogan, PhD
9:05
Measurement of Histology
Margaret Collins, MD
9:20
New Modalities to Survey the Esophagus and Eosinophils
Glenn Furuta, MD
9:35
QOL and Practicalities of EoE in Adults
Nirmala Gonsalves, MD
9:50
QOL and Practicalities of EoE in Pediatrics
James Franciosi, MD
10:05 Break

Seven Talks on Cutting-Edge Research
Moderator: Marc E. Rothenberg, MD PhD FAAAAI
10:25 Therapeutics
Alex Straumann, MD
10:39 Tissue Remodeling
Steven J. Ackerman, PhD
10:53 EoE Phenotypes
Juan Pablo Abonia, MD
11:07 Endoscopic Modalities
Ikuo Hirano, MD
11:21 Clinical Research
John Leung, MD
11:34 Basic Research
Julie M. Caldwell, PhD
11:47 Translational Research
Arjun Andrew Anilkumar, BS

Controversies in EoE: Pro-Con Debates
2:00
Finding EoE Triggers: To Test or Not?
Moderator: Jonathan M. Spergel, MD PhD FAAAAI

Pro
Terri F. Brown-Whitehorn, MD

Con
ticket required
fee required
Amir F. Kagalwalla, MD
Biopsy vs. Symptoms
Moderator: Carla M. Davis, MD

Symptoms
Fred (Dan) McDaniel Atkins, MD FAAAAI
Bx
Katrina Jane Allen, MD PhD
3:00
Question & Answer
3:15
What is the Best Therapy? Diet or Swallowed CS
Moderator: Mark Holbreich, MD FAAAAI
Diet
Mirna Chehade, MD
CS
Robert P. Schleimer, Phd Faaaai
3:45
Is Eosinophil the Beginning or the End?
Moderator: Matthew J. Greenhawt, MD MBA MSc
Pro
Simon P. Hogan, PhD
Con
Evan Dellon, MD
4:15
Session Summary and Concluding Remarks: EoE: Where are We
and Where Do We Need to Go?
Bruce S. Bochner, MD FAAAAI
4:30
Question & Answer
4:45
Intermission
5:00
Wine & Cheese Poster Session
2:30
Upon completion of this session, participants should be able to: Evaluate the current
diagnostic tools and best diagnostic parameters for EoE; Summarize the current
knowledge on the molecular and genetic pathogenesis of EoE; Explain the role of allergy
testing and optimal therapeutic interventions in EoE.
12:30
TIGERS Program Lunch Breakout Sessions (Attendees can choose

one of the following one-hour sessions.)
Pre-registration and ticket required. Fee varies.
1201A: Diagnostic Tools I Can Use: What is the Best For EoE and
How to Best Monitor Remission
Ikuo Hirano, MD
Javed Sheikh, MD FAAAAI
1201B: BYOP: The Difficult EoE Patient
Mark Holbreich, MD FAAAAI
1201C: How Do I Choose What Treatment to Use? Diet vs. Steroids,
Pros and Cons
Carla M. Davis, MD
Glenn Furuta, MD
1201D: The Ins and Outs of Managing Dietary and Corticosteroid
Therapy Over Time: Maintenance, Dosing, Mixing and Dietary
Advancement
Juan Pablo Abonia, MD
Nirmala Gonsalves, MD
Alex Straumann, MD
1201E: Basic to Translating the Bench to the Bedside: Do Animal
1201F continued on next page.
31
Friday, February 22
Models Reflect Human Disease?

Anil Mishra, PhD FAAAAI
1201F: General Session Panel Discussion
Stephen J. Ackerman, PhD
Chris A. Liacarus, MD
Marc E. Rothenberg, MD PhD FAAAAI
Course
9:50
10:40
12:00
1:00
1:40
2:30
3:00
1204 The Development of the Immune

System: When Does Allergy Begin?
9:00
9:25
9:50
1202 Basic Aeroallergen Course
9:00
Course
9:00 am to 5:00 pm
Convention Center, Concourse Level, Room 214D
Moderator: Estelle Levetin, PhD FAAAAI
Introduction to Fungal Aerobiology
W. Elliott Horner, PhD LEED AP FAAAAI
Fungal Spore Morphology
Estelle Levetin, PhD FAAAAI
Hands-On Instruction; Question & Answer
Lunch Break
Introduction to Pollen Aerobiology
Peter Van De Water, PhD
Pollen Morphology
Richard W. Weber, MD FAAAAI
Setting Up a Sampling Station
Hands-On Instruction; Question & Answer
10:15
10:30
10:55
11:20
11:45
9:00 am to 12:00 pm
Moderator: Alkis Togias, MD FAAAAI
Development of Innate Immunity
Tobias Kollmann, MD PhD
Development of Adaptive Immunity
Charlotte Cunningham-Rundles, MD FAAAAI
Early Signs of Immune Deviation Toward Allergy
Patrick Holt, DSc
Break
Development of Innate and Adaptive Immune Responses in U.S.
Children Living in the Inner City
James Gern, MD FAAAAI
The Role of the Environmental Microbiome in the Development of
Allergy
Susan V. Lynch, PhD
The Role of Airway and Gut Microbiome in the Development of
Allergy
Maria C. Jenmalm, PhD
Question & Answer
Upon completion of this session, participants should be able to: List stages of the innate
and adaptive immune system development in humans and identify potential targets
for immunologic interventions; List early events in the development of allergic immune
responses; Discuss the possible roles of microbial exposure in the development or
prevention of allergic diseases.
Upon completion of this session, participants should be able to: Discuss the fundamentals
of fungal and plant reproductive biology, aerobiology and air sampling; Describe the basic
features of spore and pollen morphology; Identify the major airborne pollen types and
fungal spores.
Course
1203 Drug Hypersensitivity and Allergy:
From Diagnosis to Treatment
9:00
9:30
10:00
10:30
10:45
11:15
11:45
9:00 am to 12:00 pm
Moderator: Anahita Dioun, MD FAAAAI
Diagnostic Skin Testing
Miguel Blanca, MD PhD
Basophil Activation Test
Marta M. Ferrer, MD PhD FAAAAI
Drug Challenges
Antonino G. Romano, MD PhD
Break
Antibiotic Reactions
Anahita Dioun, MD FAAAAI
Chemotherapy Reaction
Joana Caiado, MD
Question & Answer
Upon completion of this session, participants should be able to: Discuss the clinical
presentation of drug allergy and hypersensitivity; Describe the use of skin testing
and drug challenges; Interpret algorithms for the treatment and management of drug
hypersensitivity.
32
ticket required
fee required
Friday, February 22
Course
Course
1205 Aspirin Exacerbated Respiratory

Disease (AERD): From Observation to
Pathophysiology to Treatment (Part 1)
Clinical/Pathological Observations
1206 Developing Clinical Skills to Promote

Adherence and Maximize Asthma
Outcomes (Part 1)
9:00
9:25
9:50
10:15
10:30
10:55
11:20
11:45
(In Memory of Professor Andrew Szczeklik,1938-2012)

9:00 am to 12:00 pm
Convention Center, Concourse Level, Room 214A
Moderator: Donald D. Stevenson, MD FAAAAI
Overview of AERD: Clinical, Physiologic and Pharmacologic
Characteristics
Andrew A. White, MD FAAAAI
Sub-Phenotypes of Aspirin-Exacerbated Respiratory Disease
(AERD)
Ewa Nizankowska-Mogilnicka, MD PhD
Pathophysiologic Lessons: Studies from Aspirin Tolerant and
Intolerant Rhinosinusitis with Nasal Polyps
Robert P. Schleimer, PhD FAAAAI
Break
Pathophysiologic Lessons: Immunohistochemical Analyses of
Biopsies and Tissues
Chris J. Corrigan, MD PhD FAAAAI
Pathophysiologic Lessons: Mediator Measurements and
Idiosyncrasies of Arachidonic Acid Metabolism
Marek L. Kowalski, MD PhD
Desensitization to Aspirin: Mechanisms of Efficacy
Katherine M. Woessner, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Discuss the natural history
of AERD; Describe the potential microbial pathogenesis of AERD; Recognize the potential
for lipid mediator-directed therapy in AERD.
9:00
9:30
10:00
10:30
10:45
11:15
11:45
9:00 am to 12:00 pm
Moderator: Marcus S. Shaker, MD MS FAAAAI
Overview: Why are Patients Non-Adherent?
Bruce G. Bender, PhD FAAAAI
Clinical Management Strategies to Promote Adherence of
Pediatric Asthma Patients and Families
Cynthia S. Rand, PhD
Methods to Diagnose Adherence Status
Andrew G. Weinstein, MD FAAAAI
Break
Shared Decision Making: A Communication Practice Proven to
Enhance Adult Asthma Patients Adherence and Outcomes
Sandra Wilson, PhD
The Role of Motivational Interviewing to Help Guide Patients to
Favorable Asthma Management Actions
Belinda Borrelli, PhD
Question & Answer
Upon completion of this session, participants should be able to: Identify the reasons why
patients are non-adherent with health care providers plans; List objective means to
diagnose adherence status; Demonstrate motivational interviewing and other patientcentered techniques to help patients and families follow asthma treatment plans.
Course
1207 Diagnosis and Treatment of
Angioedema Without Urticaria
9:00
9:30
10:00
10:15
10:45
11:15
11:45
9:00 am to 12:00 pm
Moderator: Marco Cicardi, MD
Treatment of Angioedema
Bruce L. Zuraw, MD
Kinin Generation in Angioedema
Allen P. Kaplan, MD FAAAAI
Break
Mechanisms of Histamine Release in Angioedema
Massimo Triggiani, MD
Sporadic Angioedema
Marco Cicardi, MD
Hereditary Angioedema
Konrad Bork, MD
Question & Answer
Upon completion of this session, participants should be able to: Differentiate angioedema
without urticaria; Derive correct therapy out of the different clinical presentations; List
laboratory tests to be used in patients with angioedema.
ticket required
fee required
33
Friday, February 22
Course
Course
1208 COFSTER: Community-Based Forum for

Systematic Team Evaluation Aimed at
Remission of Cough
1209 Difficult Cases (Part 1)
9:00
9:40
10:20
10:30
11:10
11:50
12:10
1:10
1:50
2:30
2:45
3:25
4:05
4:45
9:00 am to 5:00 pm
Convention Center, Concourse Level, Room 217CD
Moderator: Arvind Madaan, MD FAAAAI
Cough Pathophysiology: Recent Advances in Understanding of
Cough Receptors and Pathways
Brendan J. Canning, PhD
Evolutionary Basis of Cough Reflex
Stuart Brooks, MD
Break
Cough Pathophysiology: Upper Airway Perspective (Including
Idiopathic Cough): Is it Laryngeal Hypersensitivity?
Ronald C. Balkissoon, MD MSc
Cough Pathophysiology: Lower Airway Perspective (Including
Mechanics of Cough Variant Asthma)
Diane Lougheed, MD MSc
Question & Answer
Lunch Break
Current and Emerging Diagnostics in Chronic Cough
Chronic Cough: Overview of Management
Peter Dicpinigaitis, MD
Break
Cough Center Experience in Private Practice
Mandel R. Sher, MD FAAAAI
Cough Center Experience in an Academic Center
Seeing is Believing: Why Visualization Matters in Chronic Cough
Gary J. Stadtmauer, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Present state-of-theart understanding of cough pathophysiology; Discuss appropriate use of available and
investigational diagnostic tools; Encourage use of direct visualization (rhinolaryngoscopy)
by allergists who can be positioned as community cough experts.
9:00
9:35
10:10
10:30
11:05
11:40
9:00 am to 12:00 pm
Moderators: Dorothy S. Cheung, MD FAAAAI
Pramod S. Kelkar, MD FAAAAI
Contact Dermatitis
Luz S. Fonacier, MD FAAAAI
Druhan Howell, MD
Ocular Allergy
Leonard Bielory, MD FAAAAI
Paige G. Wickner, MD
Break
Drug Desensitization
Mariana C. Castells, MD PhD FAAAAI
David R. Stukus, MD FAAAAI
Vaccines: Reactions or Responses
Wan-Yin Chan, MD
Question & Answer
Upon completion of this session, participants should be able to: Identify and address
difficulties in the clinical management of contact dermatitis, ocular allergy and drug
desensitization.
Course
1210 Advances and Novel Approaches in
the Genetics of Allergic Disease: 21st
Century (Part 1)
9:00
9:25
9:50
10:15
10:30
10:55
11:20
11:45
9:00 am to 12:00 pm
Moderator: Ulus Atasoy, MD FAAAAI
Keeping Pace with Technology: What the Allergy Researcher
Should Know
Gurjit K. Khurana Hershey, MD PhD FAAAAI
Making Sense of Genome-Wide Association Studies: Insights
from a Meta-Analysis Study
Dan L. Nicolae
The Filaggrin Story: A Tale of Gene Discovery and Function
Sara Brown, MBChB MD
Break
Genome Sequencing and Rare Variants
Kathleen C. Barnes, PhD FAAAAI
Studying Missing Heritability in Asthma
Carol Ober, PhD
Integrating Genetics and Asthma Heterogeneity: Personalized
Medicine and Translational Research
Eugene R. Bleecker, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Recognize recent
technologic advances and future directions in genetics approaches, including
experimental platforms, database resources and data integration strategies; Analyze the
limitations and successes of genome-wide association studies (the applications of whole
genome sequencing to identify rare variants, and the concept of missing heritability);
Describe how genetic approaches provide insight into asthma phenotypes and contribute
to personalized treatment.
34
ticket required
fee required
Friday, February 22
Course
Course
1211 Allergy Diagnostics and

Immunotherapy: The Nuts, the Bolts,
the Science and the Art (Part 1)
1212 Technology in the Clinical Practice

Made Ridiculously Simple
9:00
9:30
10:00
9:00 am to 12:00 pm
Pre-registration and ticket required. No fee.
Moderator: Ira Finegold, MD FAAAAI
Michael S. Tankersley, MD FAAAAI
Molecular Allergy Diagnostic: Who, Why, When and What
Robert G. Hamilton, PhD D.ABMLI FAAAAI
Accelerated Immunotherapy Schedules: More Convenient? Just
as Safe?
David A. Khan, MD FAAAAI
Hands-On Workshops (Attendees will rotate between two
workshops.)
1211A/C: Allergen Extract Preparation and Take the Media Fill
Test
Michael S. Blaiss, MD FAAAAI
Susan E. Kosisky, MHA
Bryan L. Martin, DO FAAAAI
Cecilia Mikita, MD MPH FAAAAI
1211B/D: Practical Aspects of Allergen Immunotherapy:
Prescription Writing
Christopher W. Calabria, MD
Jose E. Jereda, MD
Richard W. Weber, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss the different
options and application possibilities in U.S. of the new in vitro diagnostic techniques;
Discuss rush and cluster immunotherapy schedules, premedication and patient selection;
Propose immunotherapy schedule adjustments after a gap in administration, adverse
reactions and switching from one manufacturer to another.
9:00
9:20
9:40
10:10
10:20
10:50
11:20
11:50
9:00 am to 12:00 pm
Convention Center, Concourse Level, Room 214BC
Moderator: Tao Le, MD MHS FAAAAI
What Can Technology Do for Your Practice
Tao Le, MD MHS FAAAAI
Making the Technology Work and Pay Off
David J. Shulan, MD FAAAAI
EHRs and the Meaningful Use of Life
Russell B. Leftwich, MD FAAAAI
Break
iPhones, iPads and Androids, Oh My!
Melinda M. Rathkopf, MD FAAAAI
Social Media Tools for Marketing and Communications
Vesselin Dimov, MD
Practice Management Systems and Other Office Automation Tools
Linda D. Green, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Describe EHRs, practice
management systems and office automation technologies appropriate for the clinical
practice; Explain the role of mobile technologies in the practice; List web and social media
tools for practice marketing and communications.
Course
1213 NHLBI: Beyond FEV1: Lung Function
Measures in Assessment of Asthma
9:00
9:20
10:10
10:25
11:15
9:00 am to 12:00 pm
Moderator: Leonard B. Bacharier, MD FAAAAI
James P. Kiley, PhD
Beyond FEV1: Lung Function Tests to Diagnose Adult and
Pediatric Asthma: Diagnostic Pulmonary Function Testing:
Spirometry (FEV1, FVC), Airway Hyper-Responsiveness, Challenge
Testing and Plethysmography
Wayne Joseph Morgan, MD
What Measurements to Use When Monitoring and Managing
Adult and Pediatric Asthma and Why: What to Do if There is
Discordance of Asthma Symptoms and Lung Function Testing
Leonard Bacharier, MD FAAAAI
Anne L. Fuhlbrigge, MD MS
Break
Measures of Airways Disease in the Diagnosis and Management
of the Wheezy Preschooler: Can Asthma be Predicted?
Theresa W. Guilbert, MD
Question & Answer
Upon completion of this session, participants should be able to: Describe the role of lung
function testing in the diagnosis of asthma, and the differential diagnosis in difficultto-treat wheezing; Discuss the role of lung function testing in young children (infants/
preschoolers).
ticket required
fee required
35
Friday, February 22
1301 Coding Audit
1501 Ask the Experts Roundtable Luncheon
9:30 to 10:45 am
Moderator: John D. Milewski, Med. Admin.
Teresa Thompson, CPC CMSCS CCC
12:30 to 1:45 pm
Marriott Riverwalk, Second Floor, Alamo Ballroom Salon AB
Upon completion of this session, participants should be able to: Integrate knowledge
regarding coding audits; Describe options for responding to a negative audit report.

1302 FDA Audit: Whats Involved and How Do
You Prepare?
9:30 to 10:45 am
Moderator: Kathy L. Pinzone, RN AE-C CCRC
Kim E. Mudd, MSN CCRP
Upon completion of this session, participants should be able to: Discuss the various types
of FDA audits; Discuss what is included in an FDA audit; Describe methods to keep a
clinical trial site prepared for an FDA audit.
Upon completion of this session, participants should be able to: Describe skills of a strong
administrator; Recognize practice problems and develop solutions; Identify practice issues
that they are facing.
Program Directors Business Meeting

2:00 to 4:00 pm
All Program Directors and Co-Directors are invited to attend this
business meeting.
Course
1601 Career Development for the Junior
Investigator
1401 Financial: How Do We Use Information

Applicable to Operations, Benchmarks
and RVUs, Etc.
11:00 am to 12:15 pm
Larry Armor, PA MHA
Upon completion of this session, participants should be able to: Interpret financial data;
Recognize where to find benchmarking data; Discuss how to calculate RVUs.
2:00
2:35
3:10
3:30
1402 Environmental Control Measures

11:00 am to 12:15 pm
Moderator: James L. Sublett, MD FAAAAI
James L. Sublett, MD FAAAAI
Upon completion of this session, participants should be able to: Implement evidencebased research when discussing specific targeted interventions to reduce allergen
exposure.
4:05
4:40
2:00 to 5:00 pm
Moderator: Nora A. Barrett, MD
Identifying and Developing Great Mentors and Great Projects
Susan M. MacDonald, MD FAAAAI
Wayne G. Shreffler, MD PhD FAAAAI
Grantsmanship and the NIH
Priti Mehrotra, MD
Break
Preparing a K Award Application: Avoiding Common Pitfalls
David H. Broide, MBChB FAAAAI
R. Stokes Peebles, Jr., MD FAAAAI
Marsha A. Wills-Karp, PhD
Transitioning to Independence: You Got Your K, Now What?
Gurjit K. Khurana Hershey, MD PhD FAAAAI
Sally E. Wenzel, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Describe how to identify,
secure, and develop productive mentoring relationships; Identify NIH funding priorities;
Describe the process of grant review, and common pitfalls in preparing K08, K23, and R01
applications.
1403 Managing Atopic Dermatitis

11:00 am to 12:15 pm
Moderator: Lynda C. Schneider, MD FAAAAI
Karol G. Timmons, RN MS CPNP
Upon completion of this session, participants should be able to: Interpret pathophysiology,
causes and management of atopic dermatitis (AD); Discuss common treatments and
therapies for AD; List common issues in family management of atopic dermatitis.
36

ticket required
fee required
Friday, February 22
Course
Course
1602 Update on Drug Allergy: Penicillin and

Beyond
1604 NIAID Clinical Research: Advances

in Food Allergy, Asthma and Atopic
Dermatitis
2:00
2:25
2:50
3:15
3:30
3:55
4:20
4:45
2:00 to 5:00 pm
Moderator: Antonino G. Romano, MD PhD
Overview of Penicillin and Beta-Lactam Allergy: Epidemiology,
Cross-Reactivity, Costs and Utility of Penicillin Skin Testing
Roland Solensky, MD FAAAAI
Penicillin and Other Beta-Lactam Diagnostic Testing: Skin Testing,
In Vitro Testing and Challenges
Miguel A. Park, MD
Challenging Cases of Beta-Lactam Hypersensitivity
Eric M. Macy, MD FAAAAI
Break
Update on Hypersensitivity Reactions to RCM
Paul A. Greenberger, MD FAAAAI
Evaluation and Management of Hypersensitivity Reactions to
Monoclonal Antibodies
David Sloane, MD
ASA/NSAID Hypersensitivity Without AERD
Katharine M. Woessner, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Evaluate various aspects
of penicillin allergy, including diagnostic testing, cross-reactivity with other betalactams, and utility of penicillin skin testing; Discuss recent advances in diagnosis and
management of immediate and delayed reactions to RCM; Analyze different types of
reactions to monoclonocal antibodies, and the role of skin testing and desensitization.
2:00
2:25
2:50
3:15
3:30
3:55
4:20
4:45
2:00 to 5:00 pm
Moderator: Marshall Plaut, MD FAAAAI
Food Allergen Immunotherapy and Tolerance Induction
Stacie M. Jones, MD
Future Directions in Food Allergen Immunotherapy
Abnormalities in Arachidonic Acid Products in Patients with
Aspirin-Exacerbated Respiratory Disease
Joshua A. Boyce, MD FAAAAI
Break
Phenotypic Analyses of Inner City Children with Asthma
Symptoms
William W. Busse, MD FAAAAI
Atopic Dermatitis and Reduced Cutaneous Immune Responses
Donald Y.M. Leung, MD PhD FAAAAI
Atopic Dermatitis, Vitamin D and Antimicrobial Responses
Lynda C. Schneider, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Discuss current and future
approaches to immunotherapy to treat food allergy; Discuss emerging concepts of asthma
phenotypes in children and the systemic immunologic effects of airway allergen exposure;
List cutaneous immune response abnormalities that have been identified in patients with
atopic dermatitis.
Course
1603 Food Allergy and Its Relation to
Anaphylaxis
2:00
2:25
2:50
3:15
3:30
3:55
4:20
4:45
2:00 to 5:00 pm
Moderators: Motohiro Ebisawa, MD PhD FAAAAI
Anne-Marie A. Irani, MD FAAAAI
Mario Geller, MD FAAAAI
Nelson A. Rosario, MD PhD FAAAAI
Changing Concepts of Food Allergy in the Past Three Decades
Hugh A. Sampson, MD FAAAAI
Early Dietary Exposure to Food Allergens
Mona I. Kidon, MD
Food Allergen Sensitization and Its Relation to Atopic Eczema
George Du Toit, MD FAAAAI
Break
Oral vs. Sublingual Immunotherapy for Food Allergy
Oral Immunotherapy for Anaphylactic Food Allergies
Motohiro Ebisawa, MD PhD FAAAAI
Oral Mite Anaphylaxis
Mario Sanchez-Borges, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Discuss concept change
on food allergy in the past three decades; Explain onset of food allergy and importance of
dietary exposure; Describe food associated anaphylaxis and its countermeasures.
ticket required
fee required
37
Friday, February 22
Course
Course
1605 Aspirin Exacerbated Respiratory

Disease (AERD): From Observation to
Pathophysiology to Treatment (Part
2): Basic Mechanisms of AERD: From
Mouse to Man to Novel Treatment
1607 Finding a Job and Getting Started in

Practice
2:00
2:25
2:50
3:15
3:30

3:55
4:20
4:45
(In Memory of Professor Andrew Szczeklik,1938-2012)

2:00 to 5:00 pm
Moderator: Larry Borish, MD FAAAAI
Mechanisms of AERD: Lessons from Animal Models: More Than
One Way to Get There
Lipid Mediators as Therapeutic Targets in AERD
Sven-Erik Dahln, MD PhD
Genetics of AERD: Candidate Gene and Unbiased Approaches
Hae-Sim Park, MD PhD
Break
Mechanisms of AERD: Identification of New Leukotriene
Receptors as Molecular Targets
Yoshihide Kanaoka, MD PhD
Mechanisms of AERD: Convergence of the Leukotriene and
Prostaglandin Pathways at the Platelet/Leukocyte Complex
Tanya M. Laidlaw, MD
Clinical Trials in AERD: Mechanism-Based Interventions
Tanya M. Laidlaw, MD
Question & Answer
Upon completion of this session, participants should be able to: Explain the natural history
of AERD; Describe the potential genetic pathogenesis of AERD; Recognize the potential for
lipid mediator-directed therapy in AERD.
2:00
2:05
2:40
2:55
3:30
3:40
4:15
4:50
Upon completion of this session, participants should be able to: Explain how to identify
and join the right practice opportunity; Discuss the fundamentals of office management;
Identify strategies for marketing a practice and building a patient base.
Course
1608 Endoscopic Evaluation and
Management of Chronic Rhinosinusitis
(Pre- and Post-Surgery) Including
Cultures
Course
1606 Developing Clinical Skills to Promote
Adherence and Maximize Asthma
Outcomes (Part 2)
2:00
2:00 to 5:00 pm
Hands-On Instruction
Belinda Borrelli, PhD
2:50
Upon completion of this session, participants should be able to describe medication

adherence strategies such as cueing, diaries, reinforcement and tailoring.
2:00 to 5:00 pm
Moderators: Tao Le, MD MHS FAAAAI
Brian A. Smart, MD FAAAAI
Overview and Introductions
Finding a Job and Negotiating the Agreement
Getting Licensed and Transitioning into Practice
Brian A. Smart, MD FAAAAI
Secrets of an Efficient Allergy Practice
David L. Patterson, MD MBA FAAAAI
Break
Practice Finances 101
Marshall P. Grodofsky, MD FAAAAI
Marketing Your Practice and Referral Development
Stanley M. Fineman, MD MBA FAAAAI
Question & Answer
3:40
3:55
4:45
2:00 to 5:00 pm
Moderator: Wellington S. Tichenor, MD FAAAAI
Anatomy of the Sinuses: Surgical Evaluation
Robert Kern, MD
Radiology of the Sinuses
S. James Zinreich, MD
Break
Endoscopic Evaluation of the Sinuses
Wellington S. Tichenor, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Describe the anatomy of
the sinuses and related structures and identify pathology on CT scan; Perform endoscopy
in patients with CRS as well as cultures of middle meatus and/or sinuses; Recall
indications for surgery and complications of surgery.
38
ticket required
fee required
Friday, February 22
Course
Course
1609 Difficult Cases (Part 2)
1611 Allergy Diagnostics and

Immunotherapy: The Nuts, the Bolts,
the Science and the Art (Part 2)
2:00
2:35
3:10
3:30
4:05
4:40
2:00 to 5:00 pm
Moderators: David W. Hauswirth, MD FAAAAI
Michael H. Land, MD, FAAAAI
Chronic Sinusitis
Jonathan Corren, MD
David R. Naimi, DO
Oral Food Challenges
Edwin Kim, MD MS
Jennifer S. Kim, MD FAAAAI
Break
Immunosuppressive Therapy
Ivan Chinn, MD
Lanny Rosenwasser, MD FAAAAI
Mystery Difficult Cases
Jason W. Caldwell, DO
Kevin J. Kelley, MD FAAAAI
Question & Answer
2:00
2:30
Upon completion of this session, participants should be able to: Expose several new forms
of allergen immunotherapy; Discuss positive and negative findings of their use in clinical
trials and argue if they might become available in the future; Discuss the usefulness of
immunotherapy in food allergy and the current status of these investigations.
3:00
Upon completion of this session, participants should be able to: Identify and address
difficulties in the clinical management of chronic sinusitis, oral food challenges and
immunosuppressive therapy.
Course
1610 Advances and Novel Approaches in
the Genetics of Allergic Disease: 21st
Century (Part 2)
2:00
2:25
2:50
3:15
3:30
3:55
4:20
4:45
2:00 to 5:00 pm
Moderators: Dsire E.S. Larenas Linnemann, MD FAAAAI
Punita Ponda, MD FAAAAI
Immunotherapy for Food Allergy
Kari Nadeau, MD PhD FAAAAI
Future of Inhalant Allergen Immunotherapy: Intralymphatic,
Epicutaneous and Peptide Fragments: Are We Just Scratching the
Surface?
Thomas M. Kundig, MD
2:00 to 5:00 pm
Moderator: Kathleen C. Barnes, PhD FAAAAI
Introduction to Gene-Environment Interactions in Asthma:
Nuisance or Opportunity?
Donata Vercelli, MD
Environmental Exposures in Asthma: Regulation of Gene
Expression by Micro RNAs
Avrum Spira, MD MSc
The Epigenome and Asthma: Interactions Between Imprinted
Genes and Environmental Exposures
Rachel L. Miller, MD FAAAAI
Break
The Microbiome and Inflammation
Gary B. Huftnagle, PhD
The Future of Environmental Genomics and Allergic Disease
David Schwartz, MD
Genetics of Host/Virus Interactions and Asthma
James E. Gem, MD FAAAAI
Question & Answer
Hands-On Workshops (Attendees will rotate between two

workshops.)
1611A/C: Allergy Skin Testing
Moderators: Warner Carr, MD FAAAAI
This session will have three 10-minute lectures followed by
30-minutes of hands-on instruction. Attendees will choose one of the
three hands-on activities.
Skin Prick/Puncture Tests and Devices
John Oppenheimer, MD FAAAAI
Skin Prick/Puncture Tests, Allergen and Proficiency Testing
Sten K.G. Dreborg, MD PhD FAAAAI
Skin Tests in Research
Peter Creticos, MD FAAAAI
Upon completion of this session, participants should be able to: Compare the different
devices and other equipment and their characteristics; Explain the importance of
standardized allergen extracts for the test result; Demonstrate the importance of
standardized testing technique and its control by proficiency testing.
1611B/D: Coding, Documentation and ABCs of Regulatory

Guidelines
Donald W. Aaronson, MD FAAAAI
David A. Brown, MD
Gary N. Gross, MD FAAAAI
Upon completion of this session, participants should be able to: Apply adequately the
coding, documentation and regulatory guidelines for immunotherapy.
Upon completion of this session, participants should be able to: Describe current
knowledge of how gene-environment interactions impact transcriptional and posttranscriptional events that regulate gene expression and functional outcomes relevant to
allergic disease; Discuss how the genetics of the airway and gut microbiome contribute to
inflammatory processes; Analyze future directions in environmental epigenomics and the
feasibility of using systems-based genetics approaches to study environmental exposures
in humans.
ticket required
fee required
39
Friday, February 22
Course
2:25
1612 Interpretation of Pulmonary Function

Tests
2:50
2:00
2:05
2:10
2:35
2:45
3:15
3:20
3:25
3:30
2:00 to 5:00 pm
Moderator: Mark F. Sands, MD FAAAAI
Introductory Remarks
Audience Response System Pre-Test
Lung Pathophysiology and the PFT
Mark F. Sands, MD FAAAAI
Performing PFT Video Demonstration
John M. Weiler, MD FAAAAI
Putting It All Together: From Physiology to Interpretation
Audience Response System Post-Test
Question & Answer
Break
Hands-On Workshop
Donald Cockcroft, MD FAAAAI
Meredith C. McCormack, MD
Riccardo Polosa, MD PhD FAAAAI
John M. Weiler, MD FAAAAI
Upon completion of this session, participants should be able to: Describe the physiology
of restrictive and obstructive pulmonary function abnormalities; Recognize simple and
complex pulmonary dysfunction findings on pulmonary function tests; Demonstrate
ability to independently interpret PFTs including flow-volume loop pattern recognition and
technical flaws therein.

1711 Evaluation and Management Coding
Essentials
2:00 to 3:15 pm
Upon completion of this session, participants should be able to: Describe existing
monitoring methods and their application; Discuss the differences between risk-based
monitoring and traditional monitoring methods; Discuss ways to integrate risk-based
monitoring methods.
Allied Health Plenary
4:00
4:15
4:45
AAAAI Federation of RSLAAIS Assembly Forum and

Business Meeting
4:45
5:10
5:20
Clinical Research Symposium
5:45
2:00
4:00 to 5:15 pm
Marriott Riverwalk, Second Floor, Alamo Ballroom Salon ABC
Moderator: Maureen George, PhD RN AE-C
Opening Remarks
Benefits and Risks of Technology
How Technology Can Meet the Needs of the Geriatric Patient
Sameer K. Mathur, MD PhD FAAAAI
Upon completion of this session, participants should be able to: Describe the impact
technology can have on enhancing the patient/practice interaction; Recognize the impact
technology can have on the geriatric population.
5:35
2:00 to 3:15 pm
Moderator: Kim E. Mudd, RN MSN CCRP
Clinical Research Monitoring: How to Integrate Risk-Based
Methods
Sarah D. Knorr, RN MPH CCRP
new
1801 Technology in the Office: Improving

Outcomes While Containing Cost
Upon completion of this session, participants should be able to: Discuss the various levels
for E&M Codes; Interpret and review physician orders for coding; Apply an understanding
of E&M guidelines.
1712 FDA Guidance of Clinical Research:

Risk Based Monitoring Plans
Clinical Research Monitoring Plans: The Current Status

Kathy L. Pinzone, RN AE-C CCRC
Clinical Research Monitoring
Pamela H. Steele, MSN CPNP AE-C
6:05
6:20
4:45 to 6:30 pm
The Federation of Regional, State and Local Allergy, Asthma and
Immunology Societies invites all AAAAI members and delegates to
attend this meeting. No fee. No pre-registration required.
Wine and Cheese Reception
Official RSLAAIS Assembly Business Meeting
Sharon Markovics, MD FAAAAI
A How-to Guide for Advocating for our Patients
Lynn Morrison
Other Members of the AAAAI Advocacy Committee
Building Bridges- Experience with Allergy, Asthma and
Immunology related Lay (Patient-based) Organizations
Frank Twarog, MD PhD FAAAAI
Experience from the Field: Local Issues- National Impact!
James H. Sussman, DO FAAAAI
Andrew Drew Murphy, MD FAAAAI
Open Mic Q & A
RSLAAIS Chair, RSLAAIS Vice Chair, Governors; JCAAI Representative
Where do we go in 2013 and beyond?-Stay Tuned
Sharon Markovics, MD FAAAAI

40
ticket required
fee required
Friday, February 22
Seminars
5:15 to 6:15 pm
Programmed by the AAAAI. Seminars funded through an educational
grant from Merck.
Pre-registration and ticket required. Fee: $40. Refreshments included.
Sessions and refreshments limited to 30 people.
1811 Patients with Antibody Deficiency:

Non-Infectious Complications
Charlotte Cunningham-Rundles, MD PhD FAAAAI
Francisco J. Espinosa-Rosales, MD
Upon completion of this session, participants should be able to: Identify the complications
which occur in patients with primary antibody disorders; Describe clinical elements
and laboratory tests for surveillance of these non-infectious complications; Appreciate
therapeutic approaches to non-infectious complications in primary immunodeficiency.
1812 Challenges of Managing Multiple Food

Allergies
Julie Wang, MD FAAAAI
Michael C. Young, MD FAAAAI
Upon completion of this session, participants should be able to: Identify the diagnostic and
management challenges of multiple food allergies; Recognize the nutritional, feeding and
social risk factors; Develop and implement a feeding plan for adequate nutrition, feeding
skill and social development of children with multiple food allergies
1813 SLIT vs. SCIT in Children
Upon completion of this session, participants should be able to: Summarize experience
with SLIT and compare and contrast its safety/efficacy vs. SCIT; Appreciate recent data
describing SLIT; Appreciate methodologic variation in SLIT.
1814 Approach to the Evaluation of

Immunodeficiency in Adults
Upon completion of this session, participants should be able to: Discuss the workup and
management of adults with suspected immunodeficiency; Compare and contrast the
differential diagnosis for hypogammaglobulinemia in adult patients; List key differences
between the immunodeficiency diagnostic spectrum in adults vs. adolescents and
children.
1815 Exercise-Induced Anaphylaxis and

Food-Dependent Exercise-Induced
Anaphylaxis
Anna M. Feldweg, MD
Kirsi M. Jarvinen-Seppo, MD PhD
Upon completion of this session, participants should be able to: Review the most common
clinical presentations of EIAn and typical foods that can trigger FD-EIAn; Discuss recent
publications relevant to EIAn and FD-EIAn; Describe treatment options for EIAn and FDEIAn.
fee required
Upon completion of this session, participants should be able to: Discuss the results of the
NHANES survey related to vitamin D; Explain the role vitamin D on various allergic and
immune conditions, the science of the immune response, findings in asthmatic children
and steroid resistance; Discuss the importance of both the clinical and basic science of
vitamin D.
1817 Lets Take the Myth-stery Out of Mold

James J. Anderson, MLT
Charles S. Barnes, PhD
Peter J. Pityn, PhD
Upon completion of this session, participants should be able to: Provide evidence that
the risk of mold is often overstated; Describe the proven risk presented by mold; Explore
challenges of workplace mold investigations.
1818 Immunodeficiencies Discovered in the

Last Five Years
Thomas A. Fleisher, MD FAAAAI
Gulbu Uzel, MD
Upon completion of this session, participants should be able to: Discuss the new primary
immunodeficiency Diseases, with a focus on those described during the past five years;
Appreciate the newer technologies used for discovery of these and future disorders;
Appreciate the expanding overlap between immunodeficiency and inflammatory disorders.
Amanda L. Cox, MD
John M. Kelso, MD FAAAAI
Upon completion of this session, participants should be able to: Review allergies which
present a risk of reaction to certain vaccines; Describe the current data on the safety of
the influenza vaccination for egg-allergic individuals; Discuss approaches to testing or
appropriate administration of vaccines where there is a concern about vaccine allergy.
1820 Management of Children and Adult

Patients with Atopic Dermatitis
Zuhair K. Ballas, MD FAAAAI

Joyce E. Yu, MD
ticket required
Audreesh Banerjee, MD
Marianne Frieri, MD PhD FAAAAI
1819 Allergic Reactions to Vaccines
Giovanni Passalacqua, MD
David P. Skoner, MD
1816 Vitamin D in Allergic and Immune

Disorders
Mark Boguniewicz, MD FAAAAI

Dagmar Simon, MD
Upon completion of this session, participants should be able to: Describe the presentation,
pathophysiology and complications of atopic dermatitis; Discuss the management of
these patients, including their education; Discuss possible therapeutic consequences due
to new insights into the pathogenesis of atopic dermatitis.
International Assembly Business Meeting and Reception

5:15 to 7:15 pm
All international members and delegates are invited to attend this
business meeting and reception. No fee. No pre-registration required.
Allied Health Wine and Cheese Reception

5:30 to 6:30 pm
Marriott Riverwalk, Floor P1, Riverview
All allied health members and their guests are invited to attend
this reception for an evening of networking with other allied health
professionals.
41
Seminars
7:00 to 8:00 am
grant from Merck.
Pre-registration and ticket required. Fee: $40. Continental breakfast
included. Sessions and meals limited to 30 people.
2001 Problem-Based Learning: If I Care for

Asthma I Need to Know About Alpha-1Antitrypsin Deficiency
Timothy J. Craig, DO FAAAAI
Laura H. Fisher, MD
Marriott Rivercenter, Third Floor, Grand Ballroom Salon B
Upon completion of this session, participants should be able to: Describe the presentation
of alpha-1 deficiency; Diagnose alpha-1; Improve outcomes by successfully diagnosing
and treating alpha-1 deficiency.
2002 Understanding Modern Flow

Cytometry Testing in Clinical Allergy
and Immunology
Marriott Rivercenter, Third Floor, Grand Ballroom Salon C
Upon completion of this session, participants should be able to: Recognize the technical
and technological advantages and limitations of standard multicolor flow cytometry;
Discuss major advances in flow cytometry technologies and applications to clinical
research; Review the potential clinical applications of new and emerging cytometry
technology.
2003 Problem-Based Learning: Effective

Tools in Making the Diagnosis of
Occupational Asthma
Andr Cartier, MD FAAAAI
Karin A. Pacheco, MD MSPH FAAAAI
Upon completion of this session, participants should be able to: Recognize the history
clues pointing to potential work-related asthma; Develop familiarity with the approach
needed to establish the diagnosis of occupational asthma; Discuss the strengths and
weaknesses of the tools available to establish work-relatedness.
2004 Physical Urticarias

Mario Geller, MD FAAAAI
Upon completion of this session, participants should be able to: Identify physical urticarias;
Evaluate and educate patients with physical allergies; Manage and treat physical
urticarias with the recent data.
2005 Selection and Implementation of an

Electronic Medical Record
Richard L. Wasserman, MD PhD FAAAAI
Upon completion of this session, participants should be able to: Discuss methods to utilize
in EMR selection; Discuss best practices to implement your EMR 3; Discuss aspects of
EMR selection unique to the allergist.
2006 Evaluating Experimental Models of

Allergic Rhinitis
Anne K. Ellis, MD MSc FAAAAI
Martin Wagenmann, MD FAAAAI
Upon completion of this session, participants should be able to: Describe the most
commonly used methodolgies for experimental nasal allergen challenge in the
investigation of allergic rhinitis; Describe the commonly used methodolgies utilized in
environmental exposure unit type studies of allergic rhinitis; Describe the advantages and
disadvantages of both experimental models pertaining to the study of allergic rhinitis.
42
2007 Siglecs and Their Role in Immune

Responses
Bruce S. Bochner, MD FAAAAI
Nives Zimmermann, MD FAAAAI
Upon completion of this session, participants should be able to: Provide examples of
siglecs and their function in immune responses relevant to the allergist and immunologist;
Summarize existing and future therapies involving siglecs and their glycan ligands.
2008 Pulmonary Function Testing in Infants

and Children
Howard Eigen, MD
Amy G. Filbrun, MD MS
Upon completion of this session, participants should be able to: Identify different
pulmonary function techniques used with infants and small children; Discuss the
reliability and predictive values for infant and small child PFTs; Review the indications for
performing PFTs on this population.
2009 When to Suspect and How to Diagnose

and Treat Pediatric Cutaneous and
Systemic Mastocytosis
Melody C. Carter, MD
Dean D. Metcalfe, MD FAAAAI
Upon completion of this session, participants should be able to: Review the diagnosis of
cutaneous vs. systemic disease; Restate how to treat pediatric mastocytosis; Describe
how to identify those whose disease may persist.
2010 Rethinking Allergen Avoidance

Euan Tovey, PhD
Upon completion of this session, participants should be able to: Define current guidelines
for allergen avoidance in asthma management; Describe methods of reducing allergen
exposure and evidence based studies of their effectiveness; Discuss new strategies for
allergen avoidance that take into account the complex interactions between allergens, the
innate immune system and genetic markers.
2011 Perioperative Anaphylaxis: Which Tests

and How to Interpret
Pascal M. Demoly, MD PhD
Gerald W. Volcheck, MD FAAAAI
Upon completion of this session, participants should be able to: Explain to patients the
meaning of allergy tests performed for perioperative anaphylaxis.
2012 Achieving Expertise in Asthma

Adherence
Andrea J. Apter, MD MA MSc FAAAAI
Bruce G. Bender, PhD FAAAAI
Upon completion of this session, participants should be able to: Appreciate the prevalence
and implications of suboptimal adherence in asthma; Recognize clues which may suggest
suboptimal adherence; Develop strategies to facilitate optimal controller use in specific
asthmatic patients.
2013 Mechanisms and Biomarkers Related

to Sublingual and Subcutaneous
Immunotherapy
Carsten B. Schmidt-Weber, PhD
Mohamed H. Shamji, BSc MSc PhD
Upon completion of this session, participants should be able to: Discuss humoral
mechanisms of SCIT and SLIT; Discuss cellular mechanisms of SCIT and SLIT; Discuss
novel biomarkers of successful SCIT and SLIT.
ticket required
fee required
2014 Advanced Seminar: Quantifying Th2
Immunomodulation in Clinical Trials
and Drug Discovery
William W. Kwok, PhD
Calman Prussin, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss the utility of
measuring Th2 responses as a surrogate marker for immunotherapy and drug discovery;
Explain the different techniques available to measure total and allergen specific IgE;
Apply these techniques to clinical trials of allergen immunotherapy and immunomodulator
therapy.
2015 Update on Neutrophils in Asthma and

Allergic Diseases
Dorothy S. Cheung, MD FAAAAI
Larry L. Thomas, PhD
Allied Health Workshop

2024 A Clinicians Experience with FeNO:
Significance of This Biomarker and its
Clinical Application
6:45 to 8:00 am
Marriott Rivercenter, Third Floor, Grand Ballroom Salon D
Moderator: Dee Mallam, RN AE-C
John G. Winant, MD FAAAAI
Upon completion of this session, participants should be able to: Explain FeNO testing as
it relates to asthma; Identify practical applications of FeNO testing; Discuss how FeNO
testing guides asthma management.
Upon completion of this session, participants should be able to: Discuss the expression
and function of the high affinity IgE receptor on neutrophils; Discuss how different subsets
of neutrophils may influence both the innate and adaptive responses; Explain the role of
neutrophils to both initiating and resolving the inflammatory response.

2021 Cybersecurity: Technology in Practice
6:45 to 8:00 am
Speaker to be announced.
2025 Basic Spirometry Interpretation for

Allied Health Professionals
6:45 to 8:00 am
Upon completion of this session, participants should be able to: Identify ATS/ERS criteria
for PFTs; Demonstrate proper PFT maneuvers; Identify basic interpretation schemes.
Presidential Plenary
2101 Sensitization and Tolerance
in Allergic Disease
Upon completion of this session, participants should be able to: Recognize how to detect
and protect hardware and software; Implement security measures to protect a practice;
Discuss how to set up emergency plans in case of a breach.
8:15

2022 Motivational Interviewing: Motivating
Behavior Change in Patients with
Asthma
6:45 to 8:00 am
Moderator: Michael S. Tankersley, MD FAAAAI
Beth A. Allison, NP
8:45
9:15
Upon completion of this session, participants should be able to: Discuss motivation
and confidence about health behavior change; Apply negotiating strategies based on a
patients readiness to consider change; Address patient resistance without confronting or
persuading.
8:15 to 9:45 am
Convention Center, Street Level, Exhibit Hall D
Moderator: A. Wesley Burks, MD FAAAAI
Role of Filaggrin Mutations in Human Disease and Allergic
Sensitization
Alan David Irvine, MD
Early Life Environmental Influences on Development in Allergic
Diseases
Susan Prescott, MD PhD
Immune Tolerance and Allergy: Can We Produce True Tolerance?
Upon completion of this session, participants should be able to: Describe the role of
filaggrin mutations in allergic disease; Identify environmental factors that may impact the
development of allergic disease; Debate the question of whether or not tolerance can be
induced in patients with allergic disease.

2023 Healthy Diet and Allergy
Development: Evidence and
Interpretation for Allergy Practice
6:45 to 8:00 am
Moderator: G. Lynn Christie, MS RD
Kathryn E. Grimshaw, RD
Upon completion of this session, participants should be able to: Develop an appreciation
of the literature concerning the immunomodulatory effect of individual nutrients and the
diet as a whole; List the main constituents of an allergy healthy diet; Discuss how to give
general allergy healthy dietary advice and when referral to a dietitian for specific dietary
advice is needed.
ticket required
fee required

43
Posters
Symposium
2302 Biome and Immune Interactions
9:45 to 10:45 am
Refer to pages 86-139 for abstracts and authors.
2201 Emerging Asthma Therapeutics

2202 Pattern Recognition Receptor, T Cells,
B Cells and Dendritic Cells
2203 Biologic Therapies,Vaccines, HIV
2204 Occupational and Environmental
Exposures
2205 Allergens and Epitopes
2206 Food Allergens/Food Disease Epi/Insect
Hypersensitivity
2207 Urticaria/Angioedema
2208 Provider Education, Knowledge and
Specialty
2209 Treatment of Allergic and Immune
Disorders
2210 Immunotherapy I
2211 Rhinitis I
2212 Allergic Inflammation
2213 Allied Health Saturday Poster 1
10:45
11:05
11:25
11:40
Upon completion of this session, participants should be able to: Appreciate the interaction
between bacterial members of the biome; Discuss how the biome modulates the immune
system; Discover how atopic disease development is affected by the biome.
Symposium
2303 EAACI: Allergen Specific

Immunotherapy From Bench
to Bedside
Symposium
2301 Management of Early Loss of Asthma
Control or What to Do When Your
Patient Reaches the Yellow Zone
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: John Oppenheimer, MD FAAAAI
Our Understanding of Asthma Exacerbations
Pedro C. Avila, MD FAAAAI
Definition of Early Loss of Asthma Control and Present
Recommended Interventions
Chitra Dinakar, MD FAAAAI
Role of the Maintenance and Reliever Approach in Early Loss of
Asthma Exacerbation
Daniel J. Jackson, MD
Question & Answer
10:45 am to 12:00 pm
Moderator: Mitchell H. Grayson, MD FAAAAI
Sorting Out Microbiota, Diet, and Immune Interactions: Lessons
from Malnutrition
Andrew Kau, MD PhD
The Biome in Atopic Disease Development
Harald E. Renz, MD
The Gut Microbiomes Role in the Lung Immune Response
Question & Answer
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderators: Cezmi A. Akdis, MD FAAAAI
The Difference Between Perceptions and Facts in Allergen
Immunotherapy
Pascal M. Demoly, MD PhD
Recent Big Clinical Trials in SCIT and SLIT
Moises A. Calderon, MD PhD
Recombinant Allergen Immunotherapy Vaccines
Marek Jutel, MD PhD
Question & Answer
Upon completion of this session, participants should be able to: Comprehend the
common perceptions and public knowledge compared to scientific evidence for the
clinical usage of allergen immunotherapy; Describe the results of recent big clinical
trials in subcutaneous and sublingual immunotherapy; Discuss novel developments in
recombinant immunotherapy vaccines.
Upon completion of this session, participants should be able to: Examine our
understanding of the causes and pathophysiology of asthma exacerbations; Stratify level
of asthma exacerbations, stressing determinants of early loss of asthma control; Discuss
the evidence regarding therapeutic interventions following the early loss of asthma
control.
44
ticket required
fee required
Symposium
Symposium
2304 Primary Immunodeficiency Diseases

on the Horizon: An International
CONSensus Symposium
2306 Chronic Rhinosinusitis: Surgical

Perspectives from the American
Rhinological Society
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Kathleen E. Sullivan, MD PhD FAAAAI
Induced Pluripotent Stem Cells and Human Primary
Immunodeficiencies
Luigi D. Notarangelo, MD
How Many Immunodeficiencies are Out There?
Francisco A. Bonilla, MD PhD FAAAAI
Use of Genomic Technologies to Diagnose Primary
Immunodeficiency Diseases
John M. Routes, MD FAAAAI
Question & Answer
10:45
11:05
11:25
11:45
Upon completion of this session, participants should be able to: Discuss induced
pluripotent stem cells and their role in evaluating primary immune defects; Describe
how new sequencing technologies may lead to an explosion in the identification of
immunologically important mutations; Recognize how gene chips may be used as future
diagnostic tools.
Symposium
Upon completion of this session, participants should be able to: Discuss indications for
sinus surgery; Describe the goals of sinus surgery for CRS; Review the definition of
surgical success.
Symposium
2307 Accountable Care and Population
Management for the Asthma Patient in
2013 and Beyond
2305 Immunity of Air Pollution and Organic

Particulate Airway Disease
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Neil Alexis, PhD
Particles and Oxidative Stress: Good or Bad?
Steve N. Georas, MD
Ozone Injury and Airway Disease: Mechanistic Focus
John W. Hollingsworth, MD
Innate Immunity of Occupational Organic Dust Exposures
Jill A. Poole, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Outline new and updated
knowledge in the area of air pollutants and organic dust from urban and rural areas
leading to airway diseases; Recognize the innate immune response to complex organic
dusts and air pollutants; Discuss how different environmental exposures activate the
lungs innate immune system, leading to susceptibility to allergic airway inflammation.
10:45 am to 12:00 pm
Moderator: Robert M. Naclerio, MD FAAAAI
The Indications for Sinus Surgery in CRS Management
Robert Kern, MD
Surgical Treatment Outcomes for CRS
Timothy L. Smith, MD MPH
Management of CRS in Special Cases: CF, AFS and ASA Triad
Rodney J. Schlosser, MD
Question & Answer
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Daniel G. Steinberg, MD FAAAAI
Accountable Care, Risk Adjustment and the Future of Allergy/
Asthma Care
Jonathan Niloff, MD
Principles for Management of a Population of Asthma Patients
Barry Lachman, MD MPH
Utilizing Technology to Optimize Disease State Management for
an Asthma Population
Question & Answer
Upon completion of this session, participants should be able to: Describe the organization
of ACOs and reimbursement strategies; Review the methods of managing populations; List
the types of technology that can be used to manage a population of asthma patients.
Symposium
2308 Food Allergy Prevention and
Treatment: How Does it Start and How
Can it Be Stopped?
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Anna H. Nowak-Wegrzyn, MD FAAAAI
Prevention of Food Allergy: Is it Possible?
Susan Prescott, MD PhD
The Role of Food Allergy in EGID
Treatment for Food Allergy
J. Andrew Bird, MD
Question & Answer
Upon completion of this session, participants should be able to: Outline the current
international guidelines for the prevention of food allergy; Discuss the role of food allergy
in EGID and the appropriate diagnostic testing; Review the latest studies and the safety of
the new studies on immunotherapy for food allergy.
ticket required
fee required
45
Allied Health Symposium
2311 Patient Centered Medical Home

(PCMH)
2315 The A Team: A Multidisciplinary

Approach to Asthma Education
10:45 am to 12:00 pm
Richard W. Honsinger, MD ACP FAAAAI
Upon completion of this session, participants should be able to: Interpret how to network
with primacy care to establish PCMH cells; Discuss how to understand your role in this
emerging modality of patient care; Describe the responsibilities of allergist/immunologists.

2312 The Anatomy of the Clinical Research
Contract, Budget and Successful
Negotiation
10:45 am to 12:00 pm
Moderator: Donna W. Mitchell, RN MSN NP
Cheryl Koff Bernstein, RN BSN CCRC
Upon completion of this session, participants should be able to: Identify and discuss
the language used in reciprocal or crossed indemnification and offer alternative
indemnification language; Identify and discuss adherence protocol language that is
acceptable to the research center; Discuss successful methods and techniques used
during contract and budget negotiation with the sponsor and CRO.
10:45
11:10
11:35
Upon completion of this session, participants should be able to: Discuss the components
of an effective multidisciplinary asthma education program; Recognize the roles and
responsibilities of each member of the multidisciplinary asthma education team; Apply
and report on asthma education outcome measures.

2316 IC and FVC: The How To for Reliable
Results
10:45 am to 12:00 pm
Moderator: Karen L. Gregory, DNP APRN-BC RRT AE-C
James M. Quinn, MD FAAAAI

2313 Review of Experience Performing
Baked Milk and Baked Egg Food
Challenges
10:45 am to 12:00 pm
Moderator: Teri Holbrook, CRNP
Kim E. Mudd, RN MSN CCRP
Upon completion of this session, participants should be able to: Identify which children
can be considered for a food challenge to baked milk and baked egg; Describe a protocol
to use in your practice to conduct a baked milk and baked egg food challenge; Describe
how children who pass a baked milk and baked egg food challenge go home and increase
the food in their diet.
Upon completion of this session, participants should be able to: Identify the ATS/ERS
criteria for SVC, IC and FVC maneuvers; Demonstrate proper FVC and IC maneuvers;
Discuss basic interpretation schemas.
Allied Health Professional Assembly Forum

12:30 to 1:30 pm
All allied health professionals are invited to attend this forum. Box lunches included.


2314 2012 NIOSH Report: Is Your Office
Meeting Spirometry Quality Assurance
Standards?
10:45
11:10
11:35
10:45 am to 12:00 pm
Moderator: Stephen J. McGeady, MD FAAAAI
Standards for a Valid Normal Test
Common Errors: Part I
Concettina Tolomeo, DNP APRN FNP-BC AE-C
Common Errors: Part II
Mary Kay Bossard, BS RRT AE-C
Upon completion of this session, participants should be able to describe how common
errors impact spirometry results.
46
10:45 am to 12:00 pm
Moderator: Antonina G. Evans, BSPharm AE-C
Respiratory Therapists: Making a Difference in Asthma Education
and Management
Pharmacist's Role on the A Team
Antonina G. Evans, BSPharm AE-C
Nurse Practitioners on the A Team: Measuring and Reporting
Outcomes
Nina A. Zimmermann, MSN RN ANP-BC AE-C
Seminars
12:30 to 1:30 pm
grant from Merck.
Pre-registration and ticket required. Fee: $40. Box lunch included.
Sessions and meals limited to 30 people.
2501 Comorbidities in Asthma: Which Matter

Most?
Jonathan Corren, MD
Eli O. Meltzer, MD FAAAAI
Upon completion of this session, participants should be able to: Describe the impact of
comorbid conditions on asthma diagnosis; Discuss the effects of comorbid conditions on
asthma severity; Review the effects of specific therapies on asthma outcomes.
ticket required
fee required
2502 An Update on Neutrophil Disorders:
Diagnosis and Treatment
Steven M. Holland, MD
Gulbu Uzel, MD
2509 When is an Elevated IgE Level a Sign of

Immunodeficiency?
Alexandra F. Freeman, MD
Hans D. Ochs, MD
Upon completion of this session, participants should be able to: List current diagnostic
tests, including genetic, for different neutrophil disorders; Review treatment options for
patients with neutrophil disorders including CGD.
Upon completion of this session, participants should be able to: Review the differential
diagnosis of an elevated IgE level; Discuss the work up necessary in patients with
elevated IgE levels; Review the hyper IgE syndromes.
2503 Occupational Disease: New Agents,

New Diseases, Prevention and
Epidemiology
2510 Principles of Healthy Homes
Wanda Phipatanakul, MD MS FAAAAI

Santiago Quirce, MD PhD
Upon completion of this session, participants should be able to: Apply new and updated
knowledge in the areas discussed; Review updated strategies for diagnosis and treatment
of occupational diseases.
2504 Problem-Based Learning: So the

Patient Has Eosinophilia: What Next?
Amy D. Klion, MD
Catherine R. Weiler, MD PhD FAAAAI
Upon completion of this session, participants should be able to: Review diagnosis of
variants of hypereosinophilic syndrome; Describe identification of secondary eosinophilia;
Discuss therapeutic approaches to hypereosinophilic syndrome.
2505 Advanced Coding for the Allergist

Noga Askenazi, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss the use of codes
pertinent to A/I practice; Describe details of coding for patients allergy testing and
immunotherapy.
2506 CRD in Clinical Allergy Practice
Upon completion of this session, participants should be able to: Review evidence-based
clinical use of CRD; Describe molecular allergens with highest clinical significance.
2507 Regulation of Allergic Inflammation by

Airway Epithelium
Zoulfia Allakhverdi, PhD FAAAAI
Angela Haczku, MD PhD FAAAAI
Upon completion of this session, participants should be able to: Describe how epithelial
cells play an active role in the initiation, regulation and resolution of immune responses;
Discuss the role of epithelial cell-derived cytokines/immune modulators in chronic airway
inflammation; Describe the activity of epithelial cell-derived cytokines/immune modulators
on cells of the innate immune system and allergic airways changes.
2508 Exhaled NO: Time to Clear the Air!
Upon completion of this session, participants should be able to: Discuss the application of
eNO in the context of ATS guidelines and AAAAI/ACAAI position statements; Recognize the
relationship between the levels of evidence and practice guidelines for clinical eNO use;
Explain potential weakness/strengths of eNO for managing asthmatics.
fee required
2511 Office Evaluation of Patients with

Multiple Antibiotic Allergies
Rebecca S. Gruchalla, MD PhD FAAAAI
Upon completion of this session, participants should be able to describe how to approach
patients with multiple antibiotic allergies with appropriate diagnostic testing and challenge
procedures.
2512 Efficacy vs. Effectiveness in Asthma

Andrea J. Apter, MD MA MSc FAAAAI
Anne L. Fuhlbrigge, MD MS
Upon completion of this session, participants should be able to: Distinguish between the
concepts of treatment efficacy and treatment effectiveness; Explain how controlled trials
and pragmatic trials measure effectiveness differently; Discuss how to design a pragmatic
trial for asthma treatment.
2513 Problem-Based Learning: The Allergist

and Sleep Disorders
Upon completion of this session, participants should be able to: Describe the relationship
between allergic rhinitis, rhinosinusitis and sleep disorders; Discuss the impact of rhinitisdisturbed sleep; Identify the role of an allergy specialist in the treatment of rhinitisdisturbed sleep and obstructive sleep apnea.
2514 Mechanism of Anaphylaxis

Mary Beth Hogan, MD FAAAAI
Wei Zhao, MD PhD
basophils and neutrophils in the pathogenesis of anaphylaxis; Distinguish IgE from IgG
mediated anaphylaxis.
2515 Managing Stress as a Therapeutic

Option for Allergy Patients

Stanley Szefler, MD FAAAAI
ticket required
Upon completion of this session, participants should be able to: Identify and describe
the 7 principles of healthy homes; Describe the healthy home movement and the
comprehensive approach to housing hazards it represents.
Samuel L. Friedlander, MD
Bernard Silverman, MD FAAAAI
Jean-Christoph Caubet, MD
Peter Schmid-Grendelmeier, MD PD
Carl Grimes, HHS CIEC

Kevin Kennedy, MPH CIEC
Upon completion of this session, participants should be able to: Describe the accurate
definition of psychological stress as it applies to allergy immunology pathophysiology and
care; Describe evidence-based approach to modalities that reduce/manage stress for
allergy, asthma and immunologically diseased patients; Discuss approach to intercating/
advising patients who use stress reduction/management techniques that are not
evidenced-based.
47
Pro/Con Debate
Pro/Con Debate
2521 Multiallergen SCIT is Better Than

Monoallergen SLIT
2525 Genetic Testing is Useful to the

Practicing Allergist
12:30 to 1:30 pm
Moderator: B. Lauren Charous, MD FAAAAI
Pro
Con
Moises A. Calderon, MD PhD
12:30 to 1:30 pm
Moderator: John W. Steinke, PhD FAAAAI
Pro
Scott T. Weiss, MD MS
Con
Larry Borish, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss the benefits of
single allergen IT; Review the benefits of multi-allergen IT; Describe the different expected
benefits of the two methods described above.
Upon completion of this session, participants should be able to: Determine whether or not
the money spent to find allergy genes will lead to clinical diagnostics.
Pro/Con Debate
Pro/Con Debate
2522 Maintenance Steroids Should be Used
for Preschool Wheezers
12:30 to 1:30 pm
Moderator: Dorothy S. Cheung, MD FAAAAI
Pro
Theresa W. Guilbert, MD
Con
Leonard B. Bacharier, MD FAAAAI
2526 Airborne Exposure to Aeroallergens

Has a Role in the Disease Process of
EoE
12:30 to 1:30 pm
Moderator: John Jhe-Yun Lee, MD
Pro
Con
Chris A. Liacouras, MD
Upon completion of this session, participants should be able to: Review the safety of
continuous administration of low dose ICS; Appreciate the effectiveness of intermittent
treatment of preschool asthma; Identify predictors of persistent asthma in children who
present with intermittent preschool wheeze.
Upon completion of this session, participants should be able to: Recognize the
epidemiology of food and aeroallergen sensitivity in EoE; Outline the data on aeroallergen
sensitivity and EoE; Discuss the current controversy on whether aeroallergens can trigger
the disease process of EoE.
Pro/Con Debate
Pro/Con Debate
2523 Pets Prevent Allergies
2527 Accountable Care Organizations

(ACOs) are Good for the Practicing
Allergist
12:30 to 1:30 pm
Moderator: Diane R. Gold, MD
Pro
Dennis R. Ownby, MD FAAAAI
Con
Matthew S. Perzanowski, PhD
Upon completion of this session, participants should be able to: Describe the settings
where pet exposure could be recommended vs. where it should be avoided; Develop tools
to counsel parents on keeping or getting rid of a pet; Summarize the public debate on pets
in the home.
Pro/Con Debate
12:30 to 1:30 pm
Robert J. Holzhauer, MD MBA FAAAAI
Pro
Michael B. Foggs, MD FAAAAI
Con
Daniel Ein, MD FAAAAI
Upon completion of this session, participants should be able to: Describe ACOs in the
greater context of health care reform; Review what an ACO is and how it may affect the
practice of allergy; Develop strategies toward integrating with ACOs if necessary.
2524 Chronic Urticaria is an Autoimmune

Disorder
12:30 to 1:30 pm
Moderator: Sarbjit S. Saini
Pro
Con
Jonathon A. Bernstein, MD FAAAAI
Upon completion of this session, participants should be able to: Increase understanding
of the pathogenic factors in urticaria; Examine the evidence for autoimmune testing in
urticaria.
48
ticket required
fee required
Oral Abstract
Oral Abstract
2601 Asthma and the Environment
2603 How Inner-City Exposures Lead to

Disparities in Childrens Asthma
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Heather K. Lehman, MD
Stephen P. Peters, MD PhD FAAAAI
Contributing and Protective Risk Factors for Asthma Exacerbation
in Latinos (GALA-II Study)
Ulysses W. Burley III
Aeroallergen Sensitization Is Associated with Asthma Severity in
Latinos (GALA-II Study)
SJoy Hsu, MD
Influence of Cigarette Smoking On Airway Inflammation and
Inhaled Corticosteroid Treatment in Asthmatic Patients
Terufumi Schimoda, MD
Correlation Between Aeroallergen Sensitization and Pediatric
Asthma Severity - Data From the Severe Asthma Research
Program (SARP)
Marc D. Ikeda, MD
House Dust Mite Sensitization Is the Main Risk Factor for
the Increase in Prevalence of Wheeze in 13-14 Year Old
Schoolchildren in Guangzhou City, China
Jin Li, MD MSc
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Moderator: Jonathen A. Bernstein, MD FAAAAI
Classroom Fungal Spore Exposure and Asthma Morbidity in
Inner-City School Children
Sachin N. Baxi. MD
Exposure to Polycyclic Aromatic Hydrocarbons Is Associated with
Higher Levels of Total IgE, Decreased Function of T Regulatory
Cells and an Increase of Asthma Occurrence in Children
Annett I. Walker, MD
Association Between Asthma-Related Emergency Department
Visits and Pollen Concentration in the Bronx, 2001-2008
Sayantani B. Sindher, MD
Report of Exercise-Induced Wheeze Predicts Urgent Medical
Visits for Asthma Among Inner-City Children
Matthew S. Perzanowski, PhD
Allergen Exposure Influences the Relationship Between
Community Violence and Asthma Morbidity: The Inner City
Asthma Study
Michelle L. Sever, PhD
Upon completion of this session, participants should be able to discuss recent research
developments in the field of allergy/immunology.
Oral Abstract
Oral Abstract
2602 Immunogenetics
2604 Urticaria/Angioedema
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Christina L. Nance, PhD
Next Generation Sequencing May Be More Efficient and
Economical Than Targeted Gene Testing in Patients with Primary
Immune Deficiency (PID)
Talal Mousallem
Interactions Between SLC22A5, IL13 and SMAD3 Modulate
Spirometric Indices in Chinese Children
Tin Fan Leung, MD FAAAAI
Effects of Maternal Allergy On Umbilical Cord Blood Regulatory T
Cell Forkhead Box Protein 3 (FOXP3) DNA Methylation
Michelle North, PhD
Sequencing of the ST2 Gene Reveals a Haplotype That Determines
Serum Total ST2 Levels in Individuals of African Ancestry
Lili Huang, MPH
Whole Genome Sequence Reveals a Haplotype Conferring
Protection From Asthma Common to Subjects of European and
African Ancestry
Abdellah Hedjoudje
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Pediatric Presentation of Hereditary Angioedema (HAE) Due to C1
Inhibitor Deficiency
Sandra C. Christiansen, MD FAAAAI
High Serum Levels of Mast Cell Chymase and Carboxypeptidase
in Mastocytosis
Xiaoying Zhou, MD
Overexpression of Epidermal Filaggrin in Patients with Chronic
Idiopathic Urticaria Correlates with Urticaria Severity
Young-Min Ye, MD
Genetic Analysis and Etiology of Angioedema
Jonathan Levy
Hereditary Angioedema Type III: Mutation in Factor XII Gene in
Brazilian Families
Adriana S. Moreno, PhD
ticket required
fee required
49
Oral Abstract
Oral Abstract
2605 New Insights in Food Allergy Treatment
2607 Mechanisms in the Control of Asthma
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Moderator: Sami L. Bahna, MD DrPH FAAAAI
Sakina S. Bajowala, MD FAAAAI
Oral Food Challenge and Food Allergy Quality of Life in Caregivers
of Food Allergic Children
Timothy J. Franxman, MD
Racial and Ethnic Disparity in Food Allergy in the United States: A
Systematic Review
Matthew J. Greenhawt, MD MBA
Multi-Allergen Oral Immunotherapy Improves Quality of Life in
Subjects with Food Allergies
Iris Otani, MD
Is Molecular Allergology Cost-Effective and Cost Saving in
Children with Suspected Peanut Allergy Compared to Double
Blind Placebo Controlled Food Challenge (DBPCFC) and Skin Prick
Test in US, Europe and Asia?
Lisse-Lotte Hermansson
Question & Answer
2:00
2:15
2:30
2:45
3:00
Oral Abstract
2606 Rhinosinusitis and Nasal Polyposis:
Pathophysiology
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Moderator: Martin Wagenmann, MD FAAAAI
Excessive Fibrin Deposition Caused by a Fibrinolytic Disorder
Associated with Reduction of Tissue Plaminogen Activator
Expression in Nasal Polyps
Tetsuji Takabayashi, MD PhD
A Proposed Model to Study Immunologic Changes During Chronic
Rhinosinusitis Exacerbations: Data From a Pilot Study
Shefali Samant, MD
The Impact and Nature of Inflammation in the Olfactory Cleft On
Olfaction in Patients with Chronic Rhinosinusitis
Jennifer Lavin
Effect of Prostaglandin E2 On VEGF Production Through the
E-Prostanoid 4 Receptor in Nasal Polyp-Derived Fibroblasts
Byoung Joon Baek
Elevated Presence of Dendritic Cell Subsets in Chronic
Rhinosinusitis
Sarah Peterson, MD
2:00 to 3:15 pm
Moderator: Anthony A. Horner, MD FAAAAI
Elevation of Plasminogen Activator Inhibitor-1 Levels in Sputum
and Nasal Lavage Fluids of Asthmatics with Common Colds
Seong Ho Cho, MD
Human Mast Cells and Nuocytes Activate Gene Expression and
Mucus Secretion in Primary Mucociliary Differentiated Human
Bronchial Epithelial Cells Via IL-13
Deepti Nagarkar
Effects of Cigarette Smoke Exposure On RGS2 Expression and
Airway Hyperresponsiveness
Ningxi Zhu, MD
Exposure to Cigarette Smoke Impacts Myeloid-Derived
Regulatory Cell Function and Exacerbates Airway HyperResponsiveness
Jessy Deshane, PhD
Antagonistic Roles of Thymic Stromal Lymphopoietin (TSLP) and
Surfactant Protein-D (SP-D) in Dendritic Cell Regulation During
Ozone-Induced Exacerbation of Allergic Airway Inflammation in
Mice

2621 Oral Food Challenges: What, Where,
When and Why
2:00 to 3:15 pm
Moderator: Sally A. Noone, RN MSN CCRC
Beth D. Strong, RN CCRC
Upon completion of this session, participants should be able to: Identify types of oral food
challenges and when and why to use each; Discuss how patients are referred for food
challenges.

2622 An Update in the Diagnosis and
Management of the 0-4 Year Old
Asthmatic
2:00 to 3:15 pm
Moderator: Donna R. Oberkfell, RN MSN CPNP
A Review of Current Literature Pertaining to the Diagnosis and
Management of the 0-4 Year-Old Asthmatic
Lila C. Kertz, MSN RN CPNP
Upon completion of this session, participants should be able to discuss the evidence for
diagnosis and treatment of the 0-4 year old asthmatic.
50
ticket required
fee required
Keynote
2623 Immunotherapy Guideline Update:

Third Edition and USP 797 Compliance
2701 Dining in with Trillions of

Fascinating Friends: The
Microbiome in Health and
Disease
2:00 to 3:15 pm
Moderator: Cheryl Koff Bernstein, RN BSN CCRC
Sheelagh Stewart, MPH RN AE-C
Upon completion of this session, participants should be able to: Describe the compliance
requirements for allergen extract preparation according to the USP chapter 797 and
immunotherapy practice parameters guidelines third edition update; Discuss the practical
applications of the guidelines in the private practice and identify practical approaches for
implementation of the guidelines.
2801 An Adult with Chronic Cough
2:00 to 3:15 pm
Moderator: Michael Tankersley, MD FAAAAI
Beth A. Allison, NP
Upon completion of this session, participants should be able to: Describe how to educate
patients about the process of quitting including those who are resistant to quitting;
Discuss evidence-based use of smoking cessation medications; Describe nicotine
dependence and nicotine withdrawal.
Clinical Research Symposium

2625 Psychoneuroimmunology in Atopic
Disease
2:25
Upon completion of this session, participants should be able to describe the impact of the
microbiome on human health and the development of disease.
Problem-Based Learning Workshop
2624 Smoking Cessation: Helping Our

Patients Quit
2:00
3:30 to 4:30 pm
Moderator: Stuart Abramson, MD PhD FAAAAI
Jeffrey Gordon, MD
Dr. Robert J. Glaser Distinguished University Professor and Director
of the Center for Genome Sciences & Systems Biology, Washington
University School of Medicine
2:00 to 3:15 pm
The Physiology of Stress, the Human Immune System and Atopic
Disease
Gerald B. Lee, MD
Mental Health Issues in Primary Care and the Allergy Office:
Opening Pandoras Box
David Wayne Unkle, MSN APN FCCM
Upon completion of this session, participants should be able to: Discuss the
interrelationship between the immune system and the psychoneuroimmune system;
Recognize the role of psychopathology and personality factors in the management of
atopic disease; Describe the relationship between depression, suicidality and atopic
disease.
4:45 to 6:00 pm
Moderator: Steven F. Weinstein, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss an adult who
presents with a chronic cough; Review in depth the differential diagnoses of an adult with
a chronic cough and the appropriate diagnostic evalaution; Debate therapeutic options for
an adult with a chronic cough.
Hands-On Workshop
2802 Contact Dermatitis and Patch Testing:
An Update for the Allergist
4:45 to 6:00 pm
Moderator: Mary Ann Michelis, MD FAAAAI
Instructors: Luz S. Fonacier, MD FAAAAI
correlation of the patch test results to the patient's condition; Develop a current
understanding of allergic contact dermatitis and patch testing to cosmetics, medical
devices and other allergens; Demonstrate the technique of application and interpretation
of non-standardized allergens as in personal products.

ticket required
fee required
51
Q & A Workshop
Hands-On Workshop
2803 The Diagnosis and Management

of Autoimmunity in Primary
Immunodeficiency (PI) Disorders
2806 ABAI: How to Use the Web Portal for

Maintenance of Certification (MOC)
Activities
4:45
5:00
5:15
5:30
4:45 to 6:00 pm
Moderator: Charlotte Cunningham-Rundles, MD PhD FAAAAI
Use of Immunosuppressants in Primary Immunodeficiencies
John M. Routes, MD FAAAAI
Autoimmunity in CVID
Arnold I. Levinson, MD FAAAAI
Autoimmunity in Other Forms of PID (APECED, ALPS, SCID)
Luigi D. Notarangelo, MD
Question & Answer
Upon completion of this session, participants should be able to: Provide a mechanistic
framework on which to think about autoimmunity in the setting of immune deficiency;
Discuss diagnostic and treatment guidelines for common autoimmune features of immune
deficiency for the practicing allergist/immunologist.
Panel Discussion Workshop
4:45 to 6:00 pm
Moderator: Mary Beth Fasano, MD FAAAAI
Instructors: John James, MD FAAAAI
Sarah Johnson
Stephen I. Wasserman, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss the four major
components of the ABAI MOC program; Discuss how to successfully report MOC activities
to the ABAI using the web portal; Demonstrate how to access, navigate and utilize the
ABAI web portal for tracking and documenting personal progress through the MOC
program.
Q & A Workshop
2807 Introductory Course in
Rhinolaryngoscopy
4:45 to 6:00 pm
Ticket included with registration for Workshop 4801: Hands-On
Rhinolaryngoscopy
Moderator: Jerald W. Koepke, MD FAAAAI
2804 IgG Therapy: The Nuts and Bolts of

Gamma Globulin Treatment
4:45 to 6:00 pm
Moderator: Itai Pessach, MD PhD
Panelists: Vincent R. Bonagura, MD FAAAAI
Francisco A. Bonilla, MD PhD FAAAAI
Upon completion of this session, participants should be able to: Understand the factors
to consider in choosing a dose of IgG for PIDD patients; Discuss the different types of
adverse reaction to immunoglobulin therapy; Discuss the strategies to prevent and treat
adverse reactions to immunoglobulin infusion.
BYOP Workshop

2805 The Safety of Allergy and Asthma
Medications During Pregnancy:
Principles and Practice
4:45 to 6:00 pm
Moderator: Nancy K. Ostrom, MD FAAAAI
Panelists: Christina Chambers, PhD MPH
Carol Louik, ScD
Jennifer A. Namazy, MD FAAAAI
2808 Mast Cell Disorders
4:45
5:00
Upon completion of this session, participants should be able to: Discuss the strengths and
limitations of cohort methodology in the study of medication safety during pregnancy;
Review the strengths and limitations of case-control methodology in the study of
medication safety during pregnancy; Apply current information on the gestational safety of
allergy and asthma medications to the clinical care of pregnant patients.
52
Upon completion of this session, participants should be able to: Describe the surgical
anatomy of the upper airway, including the nasal cavity, pharynx and larynx; Identify
examples of normal and abnormal anatomy, as well as disease presentations and post
operative changes found with endoscopic examination of the upper airway; Review the
indications for and the use of the fiberoptic rhinoscope in the allergists office.
5:15
5:30
4:45 to 6:00 pm
Moderator: Cem Akin, MD PhD FAAAAI
Mastocytosis
Pediatric Mastocytosis
Melody Carter, MD
Venom Allergy and Mastocytosis
Patrizia Bonadonna, MD
Question & Answer
Upon completion of this session, participants should be able to: Recognize the patients
with high diagnostic possibility for having mastocytosis; List diagnostic criteria for clonal
and non clonal mast cell disorders.
ticket required
fee required
Q & A Workshop
2809 Cellular Players in Asthma/Allergy
2812 Asthma Guidelines, P4P and the

Medical Home: Notes from an Urban
Allergist and a Health Insurance Payer
4:45
5:00
5:15
5:30
4:45 to 6:00 pm
Moderator: Joshua A. Boyce, MD FAAAAI
T Cell Interaction with Epithelial Cells
Cezmi Akdis, MD FAAAAI
Dendritic Cell and T Cell Responses in Food Allergy
Pamela A. Frischmeyer-Guerrerio, MD PhD
Th9 Cells: In Front and Beyond Th2
Paul S. Foster, PhD DSc
Question & Answer
4:45 to 6:00 pm
Moderator: Michael A. LeNoir, MD FAAAAI
Panelists: Andrea J. Apter, MD MA MSc FAAAAI
Michael A. LeNoir, MD FAAAAI
Upon completion of this session, participants should be able to: Describe how tissues
regulate inflammation; Discuss the interaction of the immune system with epithelial cells;
Review epithelial tight junctions.
Q & A Workshop
2810 Mechanisms of Immune Tolerance to
Allergens
4:45
5:00
5:15
5:30
4:45 to 6:00 pm
Moderator: Monica Vasudev, MD
T and B Regulatory Cells
Mubeccel Akdis, MD PhD
Mucosal Tolerance Mechanisms
Liam OMahony, MD
Dendritic Cells, T Reg and Asthma Protection
Ian P. Lewkowich, PhD
Question & Answer
2814 A Child with Suspected Peanut Allergy

4:45 to 6:00 pm
Moderator: Ray S. Davis, MD FAAAAI
Hugh A. Sampson, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss a child who
presents with suspected food allergy; Evaluate and make recommendations for a patient
with suspected food allery; Discuss food challenges in an office-based practice and
potential use of oral food desensitizaton by clinical allergists.
2811 HAE Treatment: Guideline-Based

Approaches
4:45 to 6:00 pm
Moderators: Henriette Farkas, MD
Henry H. Li, MD PhD
Panelists: Marco Cicardi, MD
Timothy J. Craig, DO FAAAAI
Bruce L. Zuraw, MD
Annual Meeting Workshops
Upon completion of this session, participants should be able to: Discuss the major HAE
treatment guidelines; Outline the similarities and differences in different HAE treatment
guidelines; Describe the practical impact of these guidelines in clinical practice.
fee required
4:45 to 6:00 pm
Moderator: Russell A. Settipane, MD FAAAAI
Peck Y. Ong, MD FAAAAI
ticket required
2813 Atopic Dermatitis
Upon completion of this session, participants should be able to: Identify triggers of atopic
dermatitis; Develop a treatment plan for atopic dermatitis; Design an action plan to treat
worsening of atopic dermatitis.
Upon completion of this session, participants should be able to: Review mechanisms
of immune tolerance by T and B regulatory cells; Discuss how IL-10 and TGF- induce
tolerance; Describe how IgG4 regulated.
Upon completion of this session, participants should be able to: Describe the barriers
to optimal care of asthma and its role in disparities of urban asthmatics; Review the
growing model of health care delivery of the patient centered home in the diagnosis and
management of asthma; Discuss strategies to increase the role of allergist/immunologists
in the patient centered medical home.
Programmed by the AAAAI. Annual Meeting Workshops funded

through an educational grant from Merck.
53
Q & A Workshop
BYOP Workshop
2815 Eating Issues in Eosinophilic

Esophagitis (EoE): Nutritional
Concerns and Feeding Dysfunction
2818 Pediatric Dilemmas: Allergy and

Beyond
4:45
5:00
5:15
5:30
4:45 to 6:00 pm
Moderator: Maya D. Srivastava, MD PhD FAAAAI
Nutritional Issues in EoE
Marion E. Groetch, MS RD
Feeding Dysfunction in Children with EoE
Sherri Cohen, MD MPH
When to Refer to Specialty Services
David Mark Fleischer, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: List the common
nutritional deficiencies in patients presenting with EoE and those that might occur as a
result of dietary management using elimination diets; Describe the important aspects
of monitoring dietary nutritional adequacy longitudinally in patients with EoE; Describe
the aberrant feeding behaviors observed in young children with EoE who have feeding
dysfunction and when referral to a feeding therapist is indicated.
Q & A Workshop
4:45
5:00
5:15
5:30
Upon completion of this session, participants should be able to address diagnostic and
treatment challenges in the care of pediatric patients.
Q & A Workshop
2819 Immunotherapy Preparation for
Allergists
2816 FDA: Update From the U.S. Food and

Drug Administration (FDA)
4:45
5:00
5:15
5:30
4:45 to 6:00 pm
Moderator: F. Estelle R. Simons, MD FAAAAI
Year-in-Review at the FDA
Badrul A. Chowdhury, MD PhD FAAAAI
Immunotherapeutic Lessons for the Allergist from Rheumatology
Keith Hull, MD PhD
Issues in Drug Product Development for Allergic Rhinitis
Susan Lee Limb, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Recognize recent issues
of scientific importance at FDA and their regulatory implications; Review the scientific
importance of potential differences among TNF inhibitors and explore the anaphylactic
potential of immunotherapeutic drugs; Describe issues in the clinical development of drug
products for allergic rhinitis.
4:45
5:00
5:15
5:30

2821 Anaphylaxis: Advancing Proficiency in
Clinical Practice
4:45 to 6:00 pm
Moderator: Dee Mallam, RN AE-C
Karen L. Gregory, DNP APRN-BC RRT AE-C
Gregory M. Metz, MD
2817 Is it SLIT? Understanding the Role,

Mechanisms and Appropriate Use of
SLIT
4:45
5:00
5:15
5:30
Upon completion of this session, participants should be able to: Describe criteria
for anaphylaxis; Identify signs and symptoms of anaphylaxis; Apply in a simulated
environment appropriate treatment for anaphylaxis.
Upon completion of this session, participants should be able to: Summarize the safety and
efficacy of SLIT; Explore the mechanism of action of SLIT; Provide a treatment protocol for
SLIT.
54
4:45 to 6:00 pm
Moderator: John E. Duplantier, MD FAAAAI
Guide to Immunotherapy Administration and Enhancing Safety in
the Office Setting
Dana V. Wallace, MD FAAAAI
Immunotherapy Dosing: Facts and Open Questions
Dsire E.S. Larenas Linnemann, MD FAAAAI
Optimal Duration of Immunotherapy
Stephen R. Durham, MA MD FRCP
Question & Answer
Upon completion of this session, participants should be able to: Achieve competency in
immunotherapy preparation; Discuss the office setting and precautions to ensure safety;
Discuss evidence for duration of immunotherapy and adequate dosing regimens.
Q & A Workshop
4:45 to 6:00 pm
Moderator: Deborah A. Gentile, MD
Update on Safety and Efficacy of SLIT
David P. Skoner, MD
Practical Considerations of SLIT
Peter Creticos, MD FAAAAI
Hurdles of Bringing SLIT to the United States
Question & Answer
4:45 to 6:00 pm
Moderator: Paul V. Williams, MD FAAAAI
The Pediatric Patient with Hypogammaglobulinemia
Vivian P. Hernandez-Trujillo, MD FAAAAI
Idiopathic Anaphylaxis in Children
Scott P. Commins, MD PhD
The Child with Recalcitrant Atopic Dermatitis
Mark Boguniewicz, MD FAAAAI
Question & Answer

ticket required
fee required
2822 Bring Your Own Pediatric Food

Challenge Experience
2826 Hereditary Angioedema: Update in

Classification and Management
4:45 to 6:00 pm
Moderator: Kim E. Mudd, RN MSN CCRP
Teri Holbrook, CRNP
Upon completion of this session, participants should be able to: Discuss solutions to
common problems experienced by health care providers conducting pediatric food
challenges; Identify other health care providers performing similar clinical activities and
network with them as needed throughout the year.

2823 A Walk Through Mast Cell Activation
Disorders for the Allied Health Provider
4:45 to 6:00 pm
Moderator: Kristin E. Olson Kloos, RN

2824 Hands-On Spirometry Training for the
Office
5:10
5:35
5:05
Upon completion of this session, participants should be able to: Develop understanding
of HAE classifications; Develop understanding of HAE evaluation; Recognize the
management and resources available to patients.
Q & A Workshop
2827 Reviewing and Publishing Workshop:
Getting Involved in the JACI and JACI: In
Practice
Upon completion of this session, participants should be able to: Identify diagnostic criteria
of systemic mastocytosis according to WHO; Identify the major triggers for mast cell
activation disorders; Discuss the treatment plan and resources for the patients with mast
cell disorders.
4:45
4:45
4:45 to 6:00 pm
Moderator: Debra A. Sedlak, MSN CPNP
Overview of Types of HAE and Diagnostic Evaluation
Michael Frank, MD FAAAAI
Overview of Management and Resources Available for Patients
William R. Blouin, ARNP
4:45 to 6:00 pm
Pre-registration and ticket required. $20
Moderator: Mary Kay Bossard, BS RRT AE-C
Spirometry Basics
Rosemary Stinson, RN MSN CRNP
Obtaining Good Quality Tests
Mary Kay Bossard, BS RRT AE-C
Data Entry
Concettina Tolomeo, DNP APRN FNP-BC AE-C
4:45
5:00
5:15
4:45 to 5:45 pm
Marriott Riverwalk, Second Floor, Alamo Ballroom Salon AB
Moderator: Donald Y.M. Leung, MD PhD FAAAAI
JACI: In Practice-Desired Contents
Michael Schatz, MD MS FAAAAI
An Editors Tip for Reviewers 1
Stanley J. Szefler, MD FAAAAI
An Editors Tip for Reviewers 2
Scott Sicherer, MD FAAAAI
Upon completion of this session, participants should be able to: Review and evaluate a
scientific journal article; Describe strategies used to identify findings in medical literature
that can be used to improve the practice of allergy/immunology; Compare and contrast
the aims, scope and missions of the two AAAAI journals.
New Allergist/Immunologist Assembly Business Meeting

and Reception
4:45 to 6:15 pm
Upon completion of this session, participants should be able to demonstrate basic skills in
the performance of office spirometry.
The AAAAI invites all new allergy/immunology specialists to attend this business meeting
and reception. No fee. No pre-registration required.
Chrysalis Reception

2825 IgG Testing: Is it All Its Cracked Up to
Be?
4:45 to 6:00 pm
Moderator: Kathy L. Pinzone, RN AE-C CCRC
David R. Naimi, DO
Megan T. Ott, MSN CRNP
6:00 to 7:00 pm
Chrysalis participants are encouraged to attend this closing reception
along with their FIT mentors.
Allergy, Asthma & Immunology Education and Research

Trust Event Lights, Camera, Auction!
Upon completion of this session, participants should be able to: Recognize advertisements
and community claims in regards to benefits of IgG testing for foods; Discuss literature
review regarding efficacy and interpretation of IgG testing for foods.
7:00 to 10:00 pm
Convention Center, Street Level, Lila Cockrell Theatre
All AAAAI members, delegates and guests are invited to attend this
Saturday evening event. The auction, hosted by Steve and Nancy
Carell, will take place at the beautiful Lila Cockrell Theatre. Admission
by ticket only. See page 13 for more details.

ticket required
fee required
55
AMERICAN ACADEMY OF ALLERGY, ASTHMA & IMMUNOLOGY
SAN DIEGO
Sunday, February 24
Seminars
7:00 to 8:00 am
grant from Merck.
3001 Mechanisms of Corticosteroid

Insensitivity in Asthma
3007 Prostaglandins as Regulators of

Allergic Inflammation
Upon completion of this session, participants should be able to: Define the role of
prostaglandins on innate immunity; Discuss the therapeutic options of prostaglandins as
therapy for allergic diseases.
3008 Does Phenotype/Endotype

Identification Help in the Treatment of
Severe Asthma?
Elena Goleva, PhD

Faoud T. Ishmael, MD PhD
Upon completion of this session, participants should be able to: Review current
approaches for clinical evaluation of potential insensitivity to oral and inhaled CS; Discuss
management of patients with suspected CS insensitivity and alternative therapeutic
strategies for these patients; Describe glucocorticoid receptor function and current
understanding of the molecular pathways that lead to CS insensitivity.
3002 Problem-Based Learning: Evaluating

and Managing the Patient with
Recurrent Infections
Kenneth Paris, MD MPH
Richard L. Wasserman, MD PhD FAAAAI
Upon completion of this session, participants should be able to: Recognize which patients
with recurrent infection should be evaluated for primary immunodeficiency; Review which
laboratory studies to perform based on the patients infection history; Explain the options
for managing recurrent infection.
3003 Biodiversity, Environmental Change

and Allergy
Christina E. Ciaccio, MD
Jeffrey G. Demain, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss current research
on how climate variability is impacting allergies; Describe the biodiversity hypothesis in
the context of the effects of changes in our internal and external environment; Describe
how the interaction between our innate immunity and microbes promote allergic disease.
3004 Novel Therapies for Chronic Urticaria

and Angioedema
W. A. Carrock Sewell, MD PhD FAAAAI
David H. Dreyfus, MD PhD FAAAAI
Upon completion of this session, participants should be able to: Discuss novel therapy
for chronic urticaria and angioedema; List novel diagnostic testing for chronic urticaria
and angioedema; Review practical considerations for application of novel therapy and
diagnosis.
3005 Motivational Interviewing to Improve

Adherence and Outcomes
Sandra Wilson, PhD
Upon completion of this session, participants should be able to: Assess a patients
readiness and confidence to accept an asthma treatment recommendation; Help patients
with their ambivalence to change; Diffuse patient resistance.
3006 Chronic Rhinosinusitis Subtypes and

Implications For Treatment
Eugene R. Bleecker, MD FAAAAI

Upon completion of this session, participants should be able to: Describe phenotypes and
endotypes that are present in severe asthma; Review tests that can be performed in the
office to better characterize a patients phenotype and endotype; Review which therapies
are most suited to various phenotypes and endotypes.
3009 When Autoimmunity Mimics Allergy:

How to Recognize and Refer
Mildred Kwan, MD
Teresa K. Tarrant, MD FAAAAI
Upon completion of this session, participants should be able to: Identify and distinguish
between the upper and lower airway mimics of asthma including Churg Strauss, Relapsing
Polychondritis, and ANCA vasculitis; Recognize the overlap in clinical presentations
between Hepatitis C mixed cryoglobulinemia and Systemic Lupus Erythematosus with
urticaria and urticarial vasculitis, and appropriately evaluate these conditions when clinical
symptoms and history are suggestive; Describe the utility of autoantibody assessment in
their sensitivity and specificity of diagnosing autoimmune disease.
3010 Problem-Based Learning: How to Be a

Mold Sleuth
Anupma B. Dixit, PhD
H. James Wedner, MD FAAAAI
Upon completion of this session, participants should be able to: Discern quality of building
inspection for mold colonization and water damage; Interpret mold sampling data to
determine significance of the level of exposure indoors
3011 Anaphylaxis in Pregnancy: The Role of

the Allergist/Immunologist
F. Estelle R. Simons, MD FAAAAI
Upon completion of this session, participants should be able to: Describe the appropriate
workup of the pregnant patient with allergies; Discuss the proper treatment of the
pregnant patient with anaphylaxis.
3012 Making the Most of Your EMR: Meeting

Meaningful Use
Upon completion of this session, participants should be able to: Explain the capabilities of
EMR for meeting proposed meaningful use targets; Discuss how EMR can help improve
clinical and outcomes research activities.
Joseph K. Han, MD
Amber U. Luong, MD PhD
Upon completion of this session, participants should be able to: Describe the classification
of sinusitis; Describe the clinical subtypes of chronic rhinosinusitis; Explain the different
non-surgical treatment options for the different chronic rhinosinusitis subtypes.
ticket required
fee required
57
Sunday, February 24
3013 What to Do with a Patient Who Cannot
Smell
3044 Management of Food Allergy: What is

New at the Table?
Joaquim Mullol, MD PhD FAAAAI

Jayant M. Pinto, MD
Suzanne K. Carlisle, RN BSN CCRP

Sally A. Noone, RN MSN CCRC
Upon completion of this session, participants should be able to: Review the importance of
the sense of smell in patients with sinonasal and broncho-pulmonary diseases; List which
diagnostic tools should be used and in which order; Discuss treatment approaches for
patients with loss of smell.
Upon completion of this session, participants should be able to: Describe the process for
integrating clinical history and laboratory test results to determine when it is appropriate
to offer an open graded food challenge to patients.
3014 Effect of Structural Biology of

Allergens, IgE and IgE Receptors on
Mechanism of Allergic Disease
Plenary
Rob C. Aalberse, PhD

Martin D. Chapman, PhD FAAAAI
3101 Epigenetics: How the Environment

Affects Gene Expression and the
Development of Asthma and Allergic
Disease
Upon completion of this session, participants should be able to: Review the present
knowledge of mechanisms of allergic disease; Recognize how the structural biology of
molecules involved in disease defines molecular interactions and therefore mechanisms
of disease; Describe how molecular interactions determine allergic and/or immunologic
disease and new possible therapies.
8:15
3015 RCM Reactions: Myths, Mechanisms,

Prevention and Treatment
8:45

Suzanne S. Teuber, MD FAAAAI
Upon completion of this session, participants should be able to: List the risk factors for
immediate RCM adverse reactions; Describe the types of delayed cutaneous reactions to
RCM; Write a protocol for initiation of treatment of anaphylaxis in a radiology suite.
Allied Health Seminars

7:00 to 8:00 am
grant from Merck.
9:15
Upon completion of this session, participants should be able to: Describe how specific
exposures during pregnancy can predispose the child to allergic disease and asthma;
Discuss how the environment and epigentics can skew the development of the immune
system; Interpret the epigenetic effects of common environmental exposures on the
expression of asthma.
Posters
7:00 am to 5:30 pm
Posters on display from 7:00 am to 5:30 pm. Authors present from
9:45 to 10:45 am.
3041 Pharmacology Update in Asthma and

Allergy
Mary Lou Hayden, RN MS FNP-C AE-C
Upon completion of this session, participants should be able to: Discuss the recently
approved line extensions of medications for asthma and allergic rhinitis; Describe the
controversy of prescribing antibiotics for acute sinusitis and otitis media.
3042 Climate Change and Air Quality: What

You and Your Patients Need to Know
Wade G. Hill, PhD APRN
Linda Ford, MD FAAAAI
Upon completion of this session, participants should be able to: Interpret how climate
change affects air pollution; Describe to patients how to interpret air quality index alerts;
List critical ways to protect respiratory health in response to climate change.
3043 Providing Asthma and Allergy Care

to Patients with Autistic Spectrum
Disorders: Meeting the Challenge
Jennifer M. Darr, MSW LCSW
Melissa T. Korenblat-Hanin, ACSW LCSW
8:15 to 9:45 am
Moderator: Rachel L. Miller, MD FAAAAI
Epigenetics Overview
Shuk-Mei Ho, PhD
Epigenetic Modulation of Helper T Cell Differentiation and
Plasticity
John J. OShea, Jr., MD
Environmental Exposures and Epigenetics
Ian A. Yang, MBBS FRACP PhD Grad Dip Clin Epid
3201 Diagnostic Methods in Asthma

3202 Autoimmunity and
Immunodiagnostics
3203 Immunodeficiency
3204 How Viral and Bacterial Infections
Drive Asthma
3205 Measuring Pollen Exposures
3206 Food Allergy I
3207 Food Allergy Related Issues/Immune
Mediated Skin Disease
3208 New Developments in the Treatment of
Asthma and Allergic Diseases
3209 Immunotherapy II
3210 Rhinitis/Conjunctivitis I
3211 Mast Cells, Basophils and IGE
3212 Eosinophils
Upon completion of this session, participants should be able to: Identify various autistic
spectrum disorders and the corresponding challenges of managing asthma/allergy within
this population; Apply helpful techniques to improve cooperation during testing/evaluation.
58
ticket required
fee required
Sunday, February 24
Symposium
Symposium
3301 Dermatology for the Allergist
3303 An Update on the Efficacy and Safety

of Subcutaneous (SCIT) vs. Sublingual
(SLIT) Allergen Immunotherapy for the
Practicing Allergist
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: David A. Khan, MD FAAAAI
The Latest in Contact Dermatitis
John Browning, PhD
Atopic Dermatitis and the Skin Barrier
Autoimmune Progesterone Dermatitis
Jonathan A. Bernstein, MD FAAAAI
Question & Answer
10:45
11:05
Upon completion of this session, participants should be able to: Discuss common
dermatological diseases; Review perspectives from both specialties on treatment
of common dermatologic problems; Describe advances in the understanding of the
mechanisms of dermatologic allergy problems such as contact dermatitis, atopic
dermatitis and drug rashes.
11:45
Symposium
3302 Asthma Guidelines: Do They Need
Modification and are Physicians and
Patients Accepting Them?
10:45
11:05
11:25
11:45
11:25
10:45 am to 12:00 pm
Moderator: Nora A. Barrett, MD
Where Do the Current Asthma Guidelines Need Tweaking?
Incorporating Newer Pharmacologic Agents into Existing Asthma
Guidelines
Should Guidelines or Individualized Care be Utilized by
Specialists?
Robert Wise, MD
Question & Answer
Upon completion of this session, participants should be able to: Describe how existing
guidelines should be modified to incorporate newer therapeutic options and safety data;
Describe where and when LABAs, newer inhaled steroids, anticholinergics and biologics
should be employed; Recognize the strengths and weaknesses of utilizing an algorithmic
vs. individualized treatment plan in a specialist practice.
10:45 am to 12:00 pm
Convention Center, GBallroom Level, Ballroom C3
Moderator: Dsire E.S. Larenas Linnemann, MD FAAAAI
How Does the Efficacy of Sublingual Allergen Immunotherapy
Compare with Subcutaneous Immunotherapy?
Ana Isabel Tabar Purroy, MD
Assessing the Relative Risks of Subcutaneous and Sublingual
Allergen Immunotherapy
Tolly Epstein, MD MS
How Can We Measure Adherence and Outcomes with Allergen
Immunotherapy? A Guide for the Practicing Allergist
Cheryl S. Hankin, PhD
Question & Answer
Upon completion of this session, participants should be able to: Describe the clinical
efficacy of subcutaneous and sublingual immunotherapy in treating allergic rhinitis,
sinusitis and atopic dermatitis; Define the relative safety of subcutaneous vs. sublingual
immunotherapy; Synthesize available data regarding clinical outcomes and adherence
patterns in order to develop evidence-based prescribing patterns for subcutaneous and
sublingual immunotherapy.
Symposium
3304 Advances in the Understanding of
Common Variable Immunodeficiency:
An International CONSensus
Symposium
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Francisco A. Bonilla, MD PhD FAAAAI
Morbidity and Mortality: Four Decades of CVID
Charlotte Cunningham-Rundles, MD PhD FAAAAI
B Cell Patterns: What They Tell Us About CVID Pathophysiology
Klaus Warnatz, MD PhD
Calcium Signaling Defects in CVID Disorders
Annick van de Ven, MD PhD
Question & Answer
Upon completion of this session, participants should be able to: Recognize how B cell
pattern analysis contributes to a better understanding of CVID pathogenesis; Discuss
the presence of calcium channel signaling defects in some patients with CVID; Identify
common complications that increase morbidity and mortality in patients with CVID.
ticket required
fee required
59
Sunday, February 24
Symposium
Symposium
3305 Mechanisms of Respiratory Infections

Driving Th2 Immunity: Highlights from
the Work of the Asthma and Allergic
Diseases Cooperative Research
Centers
3307 Practice Parameters on Environment

Assessment and Exposure Reduction
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Tina V. Hartert, MD MPH
Viruses and the Innate IL-13 Axis in Asthma
Mechanisms by Which RSV Induces Th2 Immune Responses
Martin L. Moore, PhD
The Role of Mycoplasma Pneumonia CARDS Toxin in the Induction
and Exacerbation of Th2 Inflammation
Peter Dube, PhD
Question & Answer
Upon completion of this session, participants should be able to: Describe the mechanisms
by which viral infections induce IgE receptor expression on dendritic cells; Define the
mutations in the respiratory syncytial virus genome that induce Th2 immune responses;
Outline the mechanisms behind bacterial induced Th2 inflammation.
10:45
11:05
11:25
11:45
Upon completion of this session, participants should be able to: Recommend measures
to reduce exposure to furry animal allergens even if the animal continues to live in the
house; Identify evidence of a rodent or cockroach infestation; Implement an integrated
pest management program.
Symposium
3308 Asthma Quality Markers: What Should
We Be Measuring?
Symposium
3306 World Allergy Forum:
Advances in Tolerance
Induction to Allergens
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Programmed by the AAAAI and WAO. Funded through an educational
grant from Novartis.
Moderators: A. Wesley Burks, MD FAAAAI, Ruby U. Pawankar, MD PhD
FAAAAI
New Frontiers in the Mechanisms of Tolerance Induction to
Allergens
Paul Bryce, PhD
Early Intervention for Primary Tolerance to Allergens
Update on the Role of SLIT in Tolerance Induction to Allergens:
Safety and Efficacy
Question & Answer
Upon completion of this session, participants should be able to: Discuss the mechanism of
tolerance induction at many levels from molecules to cells and individual subjects; Identify
the role of tolerance in primary prevention in food allergy; Review the practical role of
tolerance in immunotherapy including SLIT.
10:45 am to 12:00 pm
Moderator: James L. Sublett, MD FAAAAI
Practice Parameter on Household Pets
Wanda Phipatanakul, MD MS FAAAAI
Practice Parameter on Rodents
Practice Parameter on Cockroaches
Ginger L. Chew, ScD
Question & Answer
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Chitra Dinakar, MD FAAAAI
Quality Markers for Asthma Care in the Emergency Department
Asthma Quality Markers: Rationale and Interpretation
Sami L. Bahna, MD DrPH FAAAAI
How Do Asthma Quality Markers Correlate with Asthma Morbidity
Markers?
Question & Answer
Upon completion of this session, participants should be able to: Outline the selection
process for asthma quality markers; Describe the evidence base that is used to determine
asthma quality markers; List how quality measures relate to real world outcomes.

3311 C.A.R.E. of Patients with Primary
Immune Deficiency
10:45
11:10
11:35
10:45 am to 12:00 pm
Moderator: William R. Blouin, ARNP
Clinical Care of PIDD Patients
M. Elizabeth M. Younger, CRNP PhD
The Impact of Genetic Discoveries at the Bedside
Karin Chen, MD
Advocacy Strategies to Improve Quality of Life
Margaret R. Dodds, RN MS CPNP
Upon completion of this session, participants should be able to: Describe the impact
genetic testing can have on clinical care of patients with PIDD; Discuss strategies to apply
resources to facilitate improvement in the quality of care and life for patients with PIDD;
Apply strategies to optimize clinical outcomes for patients with PIDD.
60
ticket required
fee required
Sunday, February 24
3312 Vitamin D Update: Implications for

Allergy and Asthma Clinical Practice
3316 Skin Testing for the Allied Health

Professional
10:45
11:10
11:35
10:45 am to 12:00 pm
Moderator: Carla M. Duff, CPNP MSN
A Literature Review
Nicolette De Jong, PhD
Its Emerging Role in Asthma and Allergy
Clinical Pearls: Patient Education and Dosing/Administration
Marciarose Winston, MSN CPNP AE-C
Upon completion of this session, participants should be able to: Discuss vitamin D and its
major forms, as well as the recommended daily intake; Describe the four proposed actions
of vitamin D and how skin types affect its synthesis; Discuss the most recent research on
vitamin D and its implications for allergy and asthma clinical practice.

3313 Chronic Urticaria: Causes, Clinical
Manifestations and Treatment
10:45 am to 12:00 pm
Moderator: Pinkus Goldberg, MD FAAAAI
Karen Rance, DNP RN CPNP AE-C
Pinkus Goldberg, MD FAAAAI
Upon completion of this session, participants should be able to: Identify common causes
of urticaria; Discuss the clinical manifestations of urticaria; Discuss the various treatment
approaches for urticaria.
10:45
10:55
11:05
11:15
Upon completion of this session, participants should be able to: Identify proper technique
for skin testing; Identify how to take a proficiency test; Experiment with different SPT
devices (mono and multitest).
Allied Health Oral Abstract Session

3520 Allied Health Oral Abstract Session
12:15
12:30

3314 The Asthma Toolbox: New Concepts to
Think Outside of the Box
10:45 am to 12:00 pm
Ginger G. LaBelle, CPNP
Amy Polen Stallings, MD

3315 The Psychosocial Dynamics of Living
with Food Allergies
10:45 am to 12:00 pm
Moderator: Melissa T. Korenblat-Hanin, ACSW LCSW
Jennifer M. Darr, MSW LCSW
Melissa T. Korenblat-Hanin, ACSW LCSW
ticket required
fee required
1:15
12:15 to 1:30 pm
Pre-registration and ticket required. Fee: $40. Box lunch included.
Moderator: Maureen George, PhD RN AE-C
Effect of Sensitization and Exposure to Mold On Asthma Morbidity
in Inner-City Children
Jean Curtin-Brosnan, MA
Evaluation of the Animated Cartoon-Aided Teaching of Intranasal
Corticosteroid Administration Technique Among Thai Children
with Allergic Rhinitis
Somying Indradat, MD
Change in Food Allergy Attitudes Among Urban Public School
Nurses After a Standardized Educational Curriculum
Humaira Robinson, RN, BSN
Both Bronchodilator Reversibility and FEV1/FVC, but Neither FEV1
Nor FEF25-75, Are Predictors of Future Acute Visits Among Urban
Children and Adolescents with Persistent Asthma
Mary Jane C. Ong
Circumstances of Medically Unadvised Purposeful Exposure to
Food Allergens in an Observational Study (Consortium of Food
Allergy Research, COFAR)
Kim E. Mudd, RN MSN CCRP
Upon completion of this session, participants should be able to discuss the diversity in
care provided to the allergy and immunology patient population.
Upon completion of this session, participants should be able to: Explore the psychosocial
dynamics of living with food allergies: challenges, emotions and accomplishments;
Discuss approaches that build and enhance stability, security, and sensibility; Identify
successful resources for assisting the food allergic patient and family.
12:45
1:00
Upon completion of this session, participants should be able to: Discuss the impact recent
studies on rhinovirus can have on the management of atopic asthmatics.
10:45 am to 12:00 pm
Moderator: Debra A. Sedlak, MSN CPNP
Minor Details that Can Improve Your Skin Prick Testing Accuracy
Extracts and Devices
Documentation of Skin Test Results
Sheelagh Stewart, MPH, RN, AE-C

61
Sunday, February 24
1:15
Interest Section Forum

3521 ADT: American Lung Association:
Asthma Clinical Research Centers
Research Reports
12:30 to 2:30 pm
Moderator: Stephen I. Wasserman, MD FAAAAI
12:30 Lunch
12:35 Business Meeting
1:05
Question & Answer
1:15
ALA-ACRC Overview and Ongoing Studies
Robert Wise, MD
1:45
Highlights of Completed Studies: SIIVA, LODO, LOCCS, SARA and
SARCA
2:15
Question & Answer
Upon completion of this session, participants should be able to: Be aware of the latest
research findings in asthma; Describe of ongoing research studies conducted by the
ALA-ACRC network.

3522 BCI: Advances in Basic and Clinical
Immunology
12:30 to 2:30 pm
Moderator: Francisco A. Bonilla, MD PhD FAAAAI
12:30 Lunch
1:05
Question & Answer
1:15
Biologic Therapies for Allergic and Immunologic Disease:
Mechanisms and Applications
1:45
Natural Killer Cell Defects: At the Crossroads of Innate and
Adaptive Immunity
Jordan Orange, MD PhD FAAAAI
2:15
Question & Answer
Upon completion of this session, participants should be able to: Describe with NK
cell biology and the implications of NK dysfunction for human disease; Recognize the
mechanisms and applications of new biologic therapies for allergic and immunologic
disorders.

3523 EORD: Sampling the Secrets of
Immunity Through the Skin: Patch
Testing Pearls in Adults and Children
12:30 to 2:30 pm
Moderator: Karin A. Pacheco, MD MSPH FAAAAI
12:30 Lunch
1:05
Question & Answer
62
1:45
2:15
Patch Testing in Adults: Environmental and Occupational

Exposures and Sources of Allergen Panels
Dorothy Linn Holness, MD
Patch Testing in Children: Common Environmental Causes and the
Use of Atopy Patch Testing
Question & Answer
Upon completion of this session, participants should be able to: Identify skin exposures
and allergens specific to different occupations and jobs; Recognize common
environmental causes of contact dermatitis in children; Distinguish the differences in
appearance between positive, negative, irritant, and angry back responses to patch
testing.

3524 FADDA: Primer on Mast Cell Diseases
and Hypersensitivity to Drugs
12:30 to 2:30 pm
12:30 Lunch
1:05
Question & Answer
1:15
Mast Cell Activation Syndromes: Anaphylaxis and Mastocytosis in
the 21st Century
1:45
Hypersensitivity to Drugs: From Skin Testing to Desensitizations
2:15
Question & Answer
development in the field of allergy/immunology.

3525 HEDQ: Where Does the Allergist Reside
in the Patient-Centered Medical Home/
Neighborhood?
12:30 to 2:30 pm
Moderator: Giselle Mosnaim, MD MS FAAAAI
12:30 Lunch
1:05
Question & Answer
1:15
What is a Patient Centered Medical Home? How Do I Get Invited
into the Building?
M. Carol Greenlee, MD
1:45
What is the Role of the Allergist/Immunologist Caring for Asthma
Patients in the Patient Centered Medical Home?
Richaard W. Honsinger, MD MACP FAAAAI
2:15
Question & Answer
Upon completion of this session, participants should be able to: Discuss the key
elements of a successful PCMH and PCMH-N relationship which include: 1) effective
communication, coordination, and integration with PCMH practices in a bidirectional
manner to provide high-quality and efficient care; 2) appropriate and timely consultations
and referrals that complement the aims of the PCMH practice; and 3) efficient,
appropriate, and effective flow of necessary patient and care information.
ticket required
fee required
Sunday, February 24
Allied Health Course
3526 IRSOC: Updates on Ocular Allergy and

Cough
3551 Association of Asthma Educators

National Asthma Educator
Certification and Re-Certification
Review Course
12:30 to 2:30 pm
Moderator: Fuad Baroody, MD FAAAAI
12:30 Lunch
1:05
Question & Answer
1:15
Overview of Ocular Allergy: Pathophysiology and Treatment
Options
Leonard Bielory, MD FAAAAI
1:45
The Role of the Allergist in Cough Management
Arvind Madaan, MD FAAAAI
2:15
Question & Answer
Upon completion of this session, participants should be able to: Review the latest practice
parameters related to ocular allergy; Discuss the management of cough by the allergist.

3527 MAAI: Recent Advances in
Understanding the Mechanisms of
Allergic Disease
12:30 to 2:30 pm
Moderator: Mitchell H. Grayson, MD FAAAAI
12:30 Lunch
1:05
Question & Answer
1:15
Allergy and the Microbiome
Gary B. Huftnagle, PhD
1:45
The Complexity of HRF: Not Just for Allergies Anymore!
Adam Telerman, MD
2:15
Question & Answer
Upon completion of this session, participants should be able to: Describe how the
intestinal microbiome regulates basophil responses; Describe novel discoveries in
mechanisms of allergic disease over the past year.
12:30 to 5:00 pm
Pre-registration and ticket required. Fee varies. Refreshments included.
12:30 Registration
1:00
Asthma Epidemiology/Pathophysiology
2:00
History, Physical Exam and Assessment of Severity/Control
3:30
Co-Morbidities and Treatment Interventions: Behavioral,
Environmental and Pharmacological
4:30
Cultural Sensitive Approaches to Asthma
Upon completion of this session, participants should be able to: Describe trends in asthma
prevalence; Determine individual patients levels of severity and control; Interpret barriers
to adherence as they apply to self-assessment and self-management of asthma.
Oral Abstract
3601 Asthma Epidemiology
3:00
3:15
3:30
3:45
4:00

ticket required
fee required
3:00 to 4:15 pm
Moderator: Mark F. Sands, Md Faaaai
United States Asthma Hospitalization Rates in the 21st Century
Show a Peak Female Predominance in the 5th and 6th Decades of
Life
Robert Yao-wen Lin, Md Faaaai
Comparison of Prepubertal Gender Differences in Pulmonary
Physiologic Outcome Measures
Amy Lynn O'Brien, MD
Estimated Prevalence and Economic Burden of Severe,
Uncontrolled Asthma in the United States
Cheryl S. Hankin, Phd
Factors Associated with Asthma Readmissions in Children in
Rural Wisconsin
Ejaz Yousef, Md
Older Adults with Asthma: Comparisons of Those with LongStanding Asthma to Those with Late Onset Asthma
Alan P. Baptist, Md Mph Faaaai
63
Sunday, February 24
Oral Abstract
Oral Abstract
3602 Dendritic Cells
3604 Food Allergy
3:00
3:15
3:30
3:45
4:00
3:00 to 4:15 pm
Dendritic Cells From X-Linked Hyper-IgM Patients Present
Impaired Responses to Candida Albicans and Paracoccidioides
Brasiliensis That Can Be Reversed by Exogenous Soluble CD40L
Otavio C. Marques
Molecular Mechanisms Involved in Dendritic Cell-Dependent
Regulatory T Cell Generation During Immunotherapy
Marco A. Garcia
Human Dendritic Cells Stimulated with a Novel Peanut Protein
Express High Levels of RALDH2 and Induce RA-Sensitive Genes in
Nave T Cells
Bert Ruiter, PhD
The C-Lectin Receptor Dendritic Cell Immunoreceptor (DCIR)
Mediates the Tolerogenic Effects of Intravenous Immunoglobulin
in Pulmonary Inflammation
Amir Hossein Massoud, PhD
Aspergillus Fumigatus (Af) Induced Airway Epithelial
Accumulation and Decreased Lymph Node Homing of
Myeloid Dentritic Cells (DC) in the Lung of Mice with Chronic
Granulomatous Disease (CGD)
Lisa R. Forbes, MD
3:00
3:15
3:30
3:45
4:00
Oral Abstract
3605 EGID
Oral Abstract
3603 Mother and Child: Prevention and
Disease
3:00
3:15
3:30
3:45
4:00
3:00 to 4:15 pm
Rana S. Bonds, MD FAAAAI
Harald E. Renz, MD
Maternal Vitamin D Status During Pregnancy and Asthma in the
Offspring Among Participants in the Norwegian Mother and Child
Cohort Study
Maria C. Magnus, MPH
Maternal Probiotic Intake and Respiratory and Allergy Outcomes
in Early Childhood
Randi J. Bertelsen
Potential Role for IFN in Promoting Asthma After Prenatal
Exposure to BPA
Terumi Midoro-Horiuti, MD PhD FAAAAI
The Impact of Caesarian Section On the Relationship Between
Inhalent Allergen Exposure and Allergen-Specific IgE At Age 2
Years
Christine Cole Johnson, PhD MPH FAAAAI
Does Presence of Animals in the Home Increase the Risk of
Sensitization to the Same Animals?
Anusha Raj
3:00 to 4:15 pm
Moderator: Stacie M. Jones, MD
Robert A. Wood, MD FAAAAI
Long-Term Outcomes of Milk Oral Immunotherapy in Children
Corinne Keet, MD MS
Tolerance Induction in an Interim Analysis of Peanut Sublingual
Immunotherapy
Edwin Kim, MD MS
Basophil Activation Test Discriminates Between Allergy and
Tolerance Among Peanut Sensitized Children
Alexandra F. Santos, MD MSc
Low-Dose Oral Immunotherapy As an Early Intervention Strategy
for Peanut Allergy
Brian P. Vickery, MD FAAAAI
Development of Tolerance Following Peanut Immunotherapy Is
Associated with Basophil Hyporesponsiveness and Low PeanutIgE:IgG4 Ratio
Michael D. Kulis, Jr., PhD
3:00
3:15
3:30
3:45
4:00
3:00 to 4:15 pm
Carla M. Dauls, MD
Antigen-Specific IL-13 Secretion in Children with Eosinophilic
Esophagitis
Benedicte Michaud, MD
Misregulation of Suppressors of Cytokine Signaling in
Eosinophilic Esophagitis
Maria Paz Zafra
Key Function of Cadherin-Like 26 in Eosinophilic Gastrointestinal
Disorders
Julie M. Caldwell, PhD
A Transforming Growth Factor Beta-1 Gene Single Nucleotide
Polymorphism May Influence Phenotype in Pediatric Eosinophilic
Esophagitis
Arjun Andrew Anilkumar, BS
MMP-14 Is Elevated in Pediatric Subjects with Eosinophilic
Esophagitis
Lisa Beppu, BS
64
ticket required
fee required
Sunday, February 24
Oral Abstract
Oral Abstract
3606 Adherence and Asthma Treatment
3608 Advances in Controlling Allergic

Inflammation
3:00
3:15
3:30
3:45
3:00 to 4:15 pm
Moderator: Marcus S. Shaker, MD MS FAAAAI
Texting for Adherence to Asthma Medication in Adolescents
Wagas Jehangir, MD
The Use of Coping Peer Support and MP3 Technology to Improve
Adherence to Inhaled Corticosteroids Among Low-Income
Minority Adolescents
Giselle Mosnaim, MD MS FAAAAI
Adherence Risk Patterns in Adult Patients with Asthma in an
Inner City Cohort Over a 25 Month Period
Edan Sarid, MD
Association Between Medication Adherence Report Scale (MARS5) and Asthma Outcomes in Inner City Children with Asthma
Seojin Yang
Oral Abstract
3607 Rhinitis Pathophysiology
3:00
3:15
3:30
3:45
4:00
3:00 to 4:15 pm
Moderator : David Amrol, MD FAAAAI
David W. Hauswirth MD FAAAAI
Anti-Histaminergic Responses On TRPV1 Channels
Umesh Singh, MD PhD
Allergen Exposure Affects Sinonasal Microbiota
Chris Choi
Invariant Natural Killer T Cells Populations in Peripheral Blood
From Allergic Rhinitis Patients: Regulatory or Pathologic Role?
Soledad Lopez, PhD
TRPV1 Ion Channel Activation Is Enhanced by Bradykinin in
Sensory Neuronal Cells
Jonathan A. Bernstein, MD
The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC)
a Multicentre Pilot Study to Optimize a Standard Nasal Allergen
Challenge Protocol
Anne K. Ellis, MD MSc
3:00 to 4:15 pm
Moderator : Dorothy S. Cheung, MD FAAAAI
3:00
Role of Mannose Receptor (MR) in Cockroach Allergen-Induced
Peisong Gao, MD PhD
3:15
DNA Methylation Profiling in Asthmatic and Non Asthmatic Nasal
Epithelial Cells During Respiratory Virus Infection
Peter McErlean, PhD
3:30
Vitamin D Supplementation Reduces Airway Hyperresponsiveness
and Allergic Airway Inflammation in a Murine Model
Tanupriya Agrawal
3:45 IL-4R Expression by Airway Epithelial Cells Promotes AllergenInduced Airway Hyperresponsiveness
Christoper G. McKnight, MD
4:00
Novel Phosphodiesterase-4 Inhibitors Decrease Allergic Sinus
Congestion and Inflammation
Bill T. Ameredes
Featured Poster Session and Reception

5:30 to 7:30 pm
Convention Center, Concourse Level, Park View
All Annual Meeting delegates and their guests are invited to attend
this event. No fee and no pre-registration required.
Featured Posters highlight the highest quality abstracts submitted for
presentation at the Annual Meeting. These posters will be displayed
throughout the meeting on the Concourse Level in the Park View
area of the Convention Center. During the Featured Poster Session
and Reception on Sunday evening, authors will be present with their
posters to discuss their research. Take this opportunity to talk with
these authors and network with other meeting delegates.
3801 Asthma Mechanisms

3802 BCI Featured Posters
3803 Allergen Exposures at Home, School
and Work
3804 Best of FADDA
3805 Best of HEDQ
3806 Immunotherapy: Pathophysiology and
Clinical Efficacy
3807 Mechanisms of Allergy: Best of the Best
3811 Allied Health Featured Poster
First Annual 5K Run/Walk - Race for Allergy &

Asthma Research
5:30 pm
HemisFair Park
This event is open to everyone: serious runners, casual runners,
walkers, families and the general public. Registration required. See
page 13 for more information.
ticket required
fee required
65
In a year of market instability,
one of your investments will

pay consistent dividends.
AAAAI Membership Benefit
Savings
Subscription to The Journal of Allergy &

Clinical Immunology (JACI)
$305
Early registration to the Annual Meeting
Priceless
Discounted Annual Meeting registration
$200
Discounts on public education materials
Up to 10%
Subscriptions to monthly and quarterly

member news publications
Priceless
Discounted board review course
$100
Listing in the AAAAI Find an Allergist /

Immunologist Directory
Priceless
Typical Career Connections job posting
$637
AAAAI Membership: An investment you can count on
AAAAI-0112-268
Monday, February 25
Seminars
7:00 to 8:00 am
grant from Merck.
4001 Does Impulse Oscillometry Play a Role

in Asthma Management?
James W. Baker, MD
Joseph Spahn MD
Upon completion of this session, participants should be able to: Discuss the physiologic
basis of impulse oscillometry; Compare impulse oscillometry to other methods for
measuring small airway function; Assess outcomes studies of asthma which employed
impulse oscillometry.
4002 Ordering TLR-Receptor Testing in

Patients with Recurrent Infections
Antonio Condino-Neto, MD PhD
Troy R. Torgerson, MD PhD
Upon completion of this session, participants should be able to: Recognize the clinical
presentation of toll-like receptor defects; State how to interpret results of TLR testing;
Discuss treatment options for patients with TLR defects.
4003 Afterburn: Asthma, Bronchiolitis,

Sarcoidosis and Titanium Lung
Injury After Deployment to Iraq and
Afghanistan
Debra Milek, MD PhD MPH
Anthony Szema, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss the c oncept of
Iraq War Lung Injury; Review potential causes of IAW-LI; Discuss animal models of IAW-LI
and novel therapeutic strategies.
4004 How to Assess and Manage a Child with

Multiple Positive Environmental and
Food Allergy Tests
Kirsi M. Jarvinen-Seppo, MD PhD
Upon completion of this session, participants should be able to: Explain the prevalence
and difference between classic food allergies and pollen-food allergy syndrome; Describe
the utility of skin prick, fresh food skin prick, serum specific IgE testing, component
resolved diagnostics and oral food challenge in assessment of complex patients with
multiple food and environmental sensitizations; Discuss the management of complex
patients with multiple food and environmental sensitizations.
4005 Cracking the Code: Preparing for

ICD-10
4007 The Relationship Between Allergies

and Infections
Soman N. Abraham, PhD
Upon completion of this session, participants should be able to: Discuss the ability of
bacteria to induce basophil activation; Review the data suggesting that the production
of IgE is part of the antiviral immune response; Discuss how mast cells play a role in the
clearance of bacterial and viral infections.
4008 Update on Anti-IL-5: Indications in

Asthma and Beyond
Jonathan Corren, MD
Upon completion of this session, participants should be able to: Review cytokine blockers
in eosinophilic diseases; Identify currently available cytokine blockers; Describe the
effects of cytokine blockers in asthma.
4009 Advances in the Treatment of RA:

Where are We Now?
Clifton O. Bingham, MD
John S. Sundy, MD PhD FAAAAI
Upon completion of this session, participants should be able to: Identify the new
treatments are available for RA; Describe complications induced by the new drugs; List
options for limiting these complications.
4010 Damp Buildings are Unhealthy: What

are Damp Buildings and How Do They
Cause Problems?
W. Elliott Horner, PhD LEED AP FAAAAI
Upon completion of this session, participants should be able to: Review the multiple expert
panels/reports and position statements concluding that there is adequate evidence for
respiratory health impacts, including new onset asthma, due to damp buildings; Describe
the challenges of quantifying dampness and establishing acceptable moisture levels;
Recognize the several plausible mechanisms that underlie the adverse respiratory impacts
of the damp building effect.
4011 Mastocytosis Mimics: Cutting Through

the Clutter
Joseph H. Butterfield, MD FAAAAI
Melody C. Carter, MD
Upon completion of this session, participants should be able to: List the criteria for
diagnosing systemic mastocytosis; Review the criteria for diagnosing mast cell activation
syndrome; List the differential diagnosis possibilities when faced with a patient with
symptoms suggestive of systemic mastocytosis.
4012 The Use of Social Media in Your Practice

Sakina S. Bajowala, MD FAAAAI
Vesselin Dimov, MD
A. Sean McKnight, MD FAAAAI

Upon completion of this session, participants should be able to: Contrast ICD-10 with
ICD-9-CM; Describe the impact of ICD-10 on billing and coding; Identify strategies for
implementing ICD-10 in clinical practice.
Upon completion of this session, participants should be able to: Implement social media
and search engine optimization to market a practice; Identify appropriate tools for
developing and maintaining a practice website; Discuss strategies for optimizing listings
on healthcare rating websites.
4006 Immunotherapy: Practical Office

Paradigms
4013 Local Allergic Rhinitis: How Do You

Make the Diagnosis?
Michael B. Wein, MD FAAAAI

Hugh H. Windom, MD FAAAAI
Paloma Campo, MD PhD

Upon completion of this session, participants should be able to: Maximize your
immunotherapy clinic efficiency in an era of changing reimbursement; Explain purchasing
co-operatives for obtaining immunotherapy supplies; Recall systems to remind patients
and improve compliance as well as complying with regulatory issues.
ticket required
fee required
Upon completion of this session, participants should be able to: Recognize that patients
may still have allergic rhinitis even if skin testing and/or in vitro tests for specific IgE
antibodies are negative; Review the methods for identifying patients with local allergic
rhinitis; Discuss the potential for performing nasal challenge in the office.
67
Monday, February 25
4014 Th17 Cells in Allergy and Asthma
Jay K. Kolls, MD
Dawn C. Newcomb, PhD
Upon completion of this session, participants should be able to: Analyze the current
evidence for involvement of the Th17 subset in allergic diseases and asthma; Define
regulation of Th17 cytokines by Th2 cytokines; Delineate implications of therapies which
target these Th2 cytokine pathways on Th17 driven inflammation.
4015 Outcomes Measures in Allergy Practice

and Research
Mary M. Klote, MD
Sandra Wilson, PhD
Upon completion of this session, participants should be able to: List outcomes measures
for asthma and other allergic diseases; Identify the importance of outcomes measures
in clinical allergy practice; Explain how to design a clinical outcomes research study for
asthma and/or allergy.
Plenary
4101 Immune Defects: Insights and
Opportunities
8:15
8:45
9:15
8:15 to 9:45 am
Moderator: Luigi D. Notarangelo, MD
Patients Dont Lie: Connecting Infections and Immune Phenotypes
Steven M. Holland, MD
Random Germline Mutagenesis in the Analysis of Immunity
Bruce Beutler, MD
New Insights and Opportunities in Curative Therapies for Primary
Immunodeficiency
Lisa Filipovich, MD
Upon completion of this session, participants should be able to: Recognize cardinal
infections and linked immune pathways, using these to identify causative genes;
Understand how one can experimentally create inherited immune deficiencies and rapidly
determine the causative mutations; Outline recent therapeutic developments for patients
with primary immune deficiencies.

68
Asthma Educators Course

4151 Association of Asthma Educators
National Asthma Educator
Certification and Re-Certification
Review Course
8:30 am to 5:30 pm
Pre-registration and ticket required. No fee. Ticket included with
registration for session 3551. See page 63 for more information.
8:30
Spirometry Interpretation for Asthma Educators
Marciarose Winston MSN CPNP AE-C
9:30 Pharmacotherapy
11:30 Educational Needs
12:30 Networking Lunch
1:30
Problem Based-Learning Workshop: Devices
3:00
Professional Networking, Referral and Outcomes
3:30
Problem-Based Learning Workshop: Complicated Asthma
Comprehensive Case
4:30
Taking the National Asthma Educator Certification Exam
Upon completion of this session, participants should be able to: Describe trends in asthma
prevalence; Discuss an individual patients levels of severity and control; Identify barriers
to adherence as they apply to self-assessment and self-management of asthma.
Posters
7:00 am to 6:00 pm
9:45 to 10:45 am.
4201 Nature vs. Nurture in Asthma

4203 Immunogenetics and
Immunodeficiency
4204 Asthma and Epidemiology I
4205 Asthma and Allergy Epidemiology II
4206 Drug Allergy I
4207 EGID/Immunologic GI Disorders II
4208 Immunotherapy III
4209 Rhinitis/Conjunctivitis II
4210 Cytokines and Chemokines
4211 T Cells in Allergic Responses
ticket required
fee required
Monday, February 25
Symposium
Symposium
4301 Anaphylaxis: Novel Mechanisms and

Therapeutic Implications
4304 New Developments in the Pathogenesis

and Treatment of Angioedema
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Vivian P. Hernandez-Trujillo, MD FAAAAI
C-Kit Mutations and Conal Mast Cell Disease in Anaphylaxis
Cem Akin, MD PhD FAAAAI
Fatal Peanut Anaphylaxis: Role of Platelet Activating Factor
Peter Vadas, MD PhD
Vitamin D in Atopy and Anaphylaxis
Augusto A. Litonjua, MD MPH
Question & Answer
Upon completion of this session, participants should be able to: Discuss the role of clonal
mast cell disease in idiopathic and hymenoptera anaphalxis; Recognize the involvement
of PAF and PAF hydrolase levels in anaphylaxis; Learn the relation between vitamin D and
atopic disease and anaphylaxis.
Symposium
4302 New Developments in the
Pathophysiology of Allergic Rhinitis
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Fuad M. Baroody, MD FAAAAI
Understanding the Concept of Local IgE Production
Philippe Gevaert, MD
Cytokine Networks in Allergic Rhinitis
Treatment Choices for Allergic Rhinitis
Question & Answer
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Factor XII-Independent Initiation of the Bradykinin Cascade
Type III Angioedema
Konrad Bork, MD
Idiopathic Angioedema
Aleena Banerji, MD
Question & Answer
Upon completion of this session, participants should be able to: Improve understanding of
angioedema subtypes; Examine the clinical treatments available for angioedema subtypes.
Symposium
4305 What Every Clinician Should Know
About IVIG
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Elena E. Perez, MD PhD FAAAAI
Adverse Reactions to Immunoglobulin Infusions
Rima A. Rachid, MD FAAAAI
New Guidelines: What Do We Know About Dosing and
Administration?
Helen Chapel, MA MD
Mechanisms of IVIG-Mediated Tolerance Induction
Bruce D. Mazer, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Explain the concept
of local IgE production in the nose; Recognize the relevance of cytokines in the
pathophysiology of allergic rhintitis; Review treatment options for allergic rhinitis.
Upon completion of this session, participants should be able to: Describe mechanisms
by which the IgG molecule can suppress inflammation and autoimmunity; Recognize the
strengths and weaknesses of different IVIG dosing strategies; Discuss the use of IVIG in
IgA-deficient patients.
Symposium
Symposium
4303 Key Players in the Immune Basis of

Atopic Dermatitis
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Donald Y.M. Leung, MD PhD FAAAAI
Roles of Dendritic Cells in Atopic Dermatitis
Thomas Werfel, MD
TSLP: A Master Switch for Allergic Disease
Steven Ziegler, PhD
IL-33 and Inflammatory Responses in Atopic Dermatitis
Cezmi A. Akdis, MD FAAAAI
Question & Answer
10:45
11:05
11:25
Upon completion of this session, participants should be able to: Describe the role of TSLP
as a master switch of allergic responses; Review the role of IL-33 in inducing a Th2
response; Identify the dendritic cell as the cell which responds to TSLP and IL-33 and
directs Th0 towards a Th2 response.
ticket required
fee required
4306 Molecular Allergy: Emerging Concepts

for the Practicing Allergist
11:45
10:45 am to 12:00 pm
Moderator: Robert G. Hamilton, PhD D.ABMLI FAAAAI
The World of Protein Allergens: Sources, Structures and
Significance
Heimo Breiteneder, PhD
Allergenic Molecules in Anaphylactic Reactions: Improved
Differentiation and Higher Analytical Sensitivity
Markus Ollert, MD
Relevant Sensitizing Allergens and Optimizing SIT
Thomas B. Casale, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Explain the concept
of protein families and how structurally related allergenic molecules will effect our
interpretation of crossreactivity and (seeming) multisensitizations to protein allergens;
Describe the diagnostic value of inhalant and food components and how they will lead to
improved diagnostic answers and advices to the patient; Appreciate recently identified
components from bee and wasp venom, latex and other protein allergens facilitating
definitive answers in case of presumed sensitizations and enhancing analytical sensitivity.
69
Monday, February 25
Symposium
Oral Abstract
4307 The Allergists View of Green and

Sustainable Housing and Buildings
4602 Biological Therapies
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: W. Elliott Horner, PhD LEED AP FAAAAI
Recent Trends in Buildings and Associated Exposures
Charles Barnes, PhD
Indoor Home Mold Assessments
Evaluation and Effects of Traditional and Green Buildings on
Asthma
Nathan Rabinovitch, MD MPH
Question & Answer
Upon completion of this session, participants should be able to: Review the changes that
have occurred in the last half century and the continuing trends in indoor environments;
Recognize the constraints and benefits of current assessment tools for indoor pollutant
exposure; Apply the results from comparisons of asthmatic children living in different
types of housing.
AAAAI Business Meeting

12:30 to 1:30 pm
All AAAAI Fellows and members should attend this annual business
meeting. Box lunches included. No fee. No pre-registration required.
2:00
2:15
2:30
2:45
3:00
Oral Abstract
4603 Inflammatory Responses to Pollutants,
Pesticides, and Endotoxin
Oral Abstract
4601 Whats New in Asthma Diagnostics
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Convention Center, Concourse Level, Room 214bc
Moderators: Timothy J. Craig, DO FAAAAI
Gisoo Ghaffari, MD FAAAAI
Serum Periostin Levels Correlate with Bronchial
Hyperresponsiveness to Mannitol and Methacholine in Children
with Asthma
Heyshung Baek, MD PhD
Meta Analysis of Asthma Exacerbation Rates in Pediatric Studies
During Asthma Managed Using Fractional Exhaled Nitric Oxide
Versus Standard Clinical Parameters Alone
Joseph D. Spahn, MD
Exhaled Nitric Oxide Concentration During Pediatric Acute
Asthma Exacerbations Is Associated with Severity and AfricanAmerican Race
Emily W. Langley, MD
Mannitol Challenge for Diagnosis of Exercise -Induced
Bronchconstriction
Christopher C. Randolph, MD FAAAAI
Establishing Normal Exhaled Nitric Oxide (FeNO) Values in Young
Children
Chris Cleveland, MD
2:00 to 3:15 pm
Moderator: Ivan Chinn, MD
Persistent Hypogammaglobulinemia After Rituximab Treatment
Yelena Kopyltsova, MD
Thymus Transplantation Restores the Repertoire of Foxp3+ T
Cells in Complete DiGeorge Anomaly
Ivan Chinn, MD
Immunotolerance Mechanisms Depend On High Vs Low Dose of
Sublingual Immunotherapy
Kari Nodeau, MD PhD FAAAAI
Mechanisms of Th2 to Treg Vs Th2 to Th1 in Non Rush Vs Rush
Food OIT
Shu-Chen Lyu
Resolvin D1 Inhibits IL-1beta Induced Alveolar Epithelial Cell
Activation
Ruan R. Cox, Jr.
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Moderator: Neil Alexis, PhD
Interactions of Natural Killer (NK) Cells and Surfactant Protein
D (SP-D) in Regulation of Ozone Induced Airway Inflammation:
Involvement of NKp46
Moyar Q. Ge
Association Between Dichlorophenol Exposure, Asthma
Medication Use, and Serum Immunoglobulin E
Purvi Parikh, MD
MyD88-Dependent Signaling Is Critical for Acute Organic DustInduced Airway Inflammation in Mice
Jill A. Poole, MD FAAAAI
IL-1 Induces IL-8 Production From Human Airway Epithelial
Cells
Michelle L. Hernandez, MD
Exposure to Silica Crystals and Poly (I:C) Induces CaspaseDependent Apoptosis of Human Bronchial Epithelial Cells
Hirotoshi Unno, MD
70
ticket required
fee required
Monday, February 25
Oral Abstract
Oral Abstract
4604 Anaphylaxis
4606 Immunotherapy
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Moderator: Scott P. Commins, MD PhD
Activation of the Plasma Contact-System in Patients with
Anaphylaxis
Anna Sala-Cunill
An IgE Receptor Mimetic Peptide (PepE) Protects Mice From IgE
Mediated Anaphylaxis
Joseph S. Zhou, MD PhD
SHIP-1 Regulates IgG/PAF Mediated Allergen-Induced Fatal
Anaphylaxis Through the PI3 Kinase Pathway
Sun Young Oh, PhD
Preclinical Study: Dose Comparison of New-Generation TasteMasked Epinephrine (E) Sublingual Tablets
Keith Simons, PhD
Anatomical and Anthropometric Determinants of Intramuscular
Versus Subcutaneous Administration in Children with Epinephrine
Auto-Injectors
Peter D. Arkwright, MD PhD FAAAAI
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Moderator: Dsire E.S. Larenas Linnemann, MD FAAAAI
Dose Adjustment During Pollen Seasons in Build-up and
Maintenance Vials Lowers the Risk of Severe Systemic Reactions
(SRs) to Subcutaneous Allergen Immunotherapy (SCIT): Year 4 of
the AAAAI/ACAAI Surveillance Study
Tolly Epstein, MD MS
Is a 30 Minute Vs. 20 Minute Immunotherapy (IT) Waiting Period
Justified?
Leon S. Greos, MD FAAAAI
Local Nasal Protective Immunoglobulin G4 (IgG4) Responses in
Nasal Fluid Following Grass Pollen Sublingual Immunotherapy
Nausheen Saleem, BSc
Antigen-Specific TH Cell Monitoring by CD154 Expression in
Japanese Cedar-Specific SCIT
T. Nomura
Immunological Mechanisem of Sublingual Immunotherapy
Reza Farid, MD FAAAAI
Oral Abstract
Oral Abstract
4605 Management of Allergies: New Insights
4607 The Role of Lymphocytes in Mediating

Asthma and Allergic Inflammation
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Moderator: Melinda M. Rathkopf, MD FAAAAI
Allergic Disease in US Children Is Associated with Increased
Prevalence of Epilepsy
Helen G. Durkin, PhD
Nasal Congestion Worsens Sleep Disturbance and Psychological
Wellness in Allergic Rhinitis Patients
Rosa Munoz-Cano, MD
Relationship Between Maternal Mid Pregnancy Folate Levels and
the Risk of Allergic and Respiratory Diseases in Early Childhood:
The Mothers and Childrens Environmental Health (MOCEH) Study
Ja Hyeong Kim, MD
The Role of Molecular Allergology in Allergen-Specific
Immunotherapy Adherence and Patient Quality of Life in A
Complex Pollen Area: A Simulation Model
Barbara Mascialino
Follow-up Patterns Among Children with Anaphylaxis and Other
Allergic Diseases Referred from an Urban Emergency Department
to Allergy Clinic
Jonathan Hemler, MD
ticket required
fee required
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Moderator: Kari Nadeau, MD PhD
Th2 Mediated Airway Diseases Strongly Linked to Fungal T Cell
Memory
Paul Porter, PhD
LIGHT Is Associated with Increased Cellular Infiltrate and Levels
of Th1 Cytokines As Well As Well As Reduced Lung Function in
Human Asthma
Jonathan Romeo, DO
Immunomodulatory Effects of IL-27 On Allergen-Induced Th2
Responses
Tomakazu Matsuoka
Grass Pollen Allergics Have Fewer IL-10-Producing B Cells Than
Non-Atopic Controls
James E.G. Charlesworth
Rab11+ Recycling Endosomes Controls Signaling Output and
Cellular Response of Memory CD4 T Cells in Asthma
Chaoyu Chen
71
Monday, February 25
Late Breaking Oral Abstract Session
Hands-On Workshop
4611 Late Breaking Oral Abstract I
4801 Hands-On Rhinolaryngoscopy
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Stephen C. Dreskin, MD PhD FAAAAI
Exome Chip Genotyping Reveals Association with LAMA3
(laminin, alpha 3) Gene and Eczema Herpeticum in a Population
of European Descent
Nicholas Rafaels, MS
Identification of Der p 23, a Peritrophin-Like Protein, As a New
Major Dermatophagoides Pteronyssinus Allergen Associated with
the Peritrophic Matrix of Mite Fecal Pellets
Susanne Vrtala
Efficacy and Safety of Omalizumab in Chronic Idiopathic/
Spontaneous Urticaria (CIU/CSU): Results From a Phase III,
Randomized, Double-Blind, Placebo-Controlled Trial
Thomas Casale, MD FAAAAI
Leukotriene D4 Induces Type 2 Innate Lymphoid Cell Cytokine
Production Through CysLT1R
Taylor Alan Doherty, MD
IL-21 Receptor Mutation in Humans Leads to Disseminated
Cryptosporidiosis, Antibody Defects, and Abnormal B and T Cell
Function
Monica G. Lawrence, MD
4:45 to 6:00 pm
Pre-registration and ticket required. No fee. Ticket included
with registration for Workshop 2807: Course in Introductory
Rhinolaryngoscopy.
Allen D. Adinoff, MD FAAAAI
Jerald W. Koepke, MD FAAAAI
Kevin R. Murphy, MD
Garet C. Olson, MD
Donald W. Pulver, MD FAAAAI
C. Ross Westley, MD FAAAAI
Upon completion of this session, participants should be able to: Describe the surgical
anatomy of the upper airway, including the nasal cavity, pharynx and larynx; Identify
examples of normal and abnormal anatomy, as well as disease presentations and post
operative changes found with endoscopic examination of the upper airway; Identify
indications for and the use of the fiberoptic rhinoscope in the allergists office.

4802 Eosinophilic Esophagitis
4:45 to 6:00 pm
Carla M. Davis, MD
Roger A. Friedman, MD FAAAAI
Cutting-Edge Research Keynote

4701 Exploring Frontiers in Innate and
Specific Immune Systems
3:00
3:30
3:30 to 4:30 pm
Moderator: James E. Gem, MD FAAAAI
Personalized Vaccine Therapy as a Strategy for Prevention of
Cancer Relapse
Larry W. Kwak, MD PhD
Phenotypic Diversity of Mast Cell Subsets is Tissue Determined
and Likely Expands Functions
K. Frank Austen, MD FAAAAI
Upon completion of this session, participants should be able to: Describe techniques used
in vaccine therapy for cancer; Describe the mechanisms involved in generating mast cell
diversity and the functional implications..
Upon completion of this session, participants should be able to: Describe the risk benefit
ration of elemental diet; Review team approach to care of complex disease; List the pros
and cons to use of medication vs. diet in EE.
Q & A Workshop
4803 Insect Allergy Update: Unique and New
Antigens and Difficult Cases
4:45 to 6:00 pm
Moderator: Theodore M. Freeman, MD FAAAAI
4:45 New In Vitro Testing vs. Skin Testing for Insect Allergy
David B.K. Golden, MD FAAAAI
5:00
The Alpha-Gal Story and Longhorn Ticks
Scott P. Commins, MD PhD
5:15
When and How to Use Cross-Reactivity in Venom Allergy
5:30
Question & Answer

72
ticket required
fee required
Monday, February 25
Upon completion of this session, participants should be able to: Evaluate insect reactions;
Review treatment of insect allergy; Discuss importance of alpha-gal reactions.
the new journal JACI-In Practice; Outline the process of manuscript review; Review how to
accept critiques and how to handle manuscript revision.
Q & A Workshop
Hands-On Workshop
4804 Vaccines 101: Expanding the Role of

the Allergist/Immunologist
4807 Preparing Your Office for Anaphylaxis

and Other Emergencies
4:45
5:05
5:25
4:45 to 6:00 pm
Moderator: Limone C. Collins, MD
Diagnostic and Therapeutic Uses for Vaccines in the Older Adult
Monroe J. King, DO FAAAAI
IgE-Mediated Adverse Reactions to Vaccines
John M. Kelso, MD FAAAAI
Non-IgE-Mediated Adverse Reactions to Vaccines
Upon completion of this session, participants should be able to: Review the childhood and
adult vaccination schedules; Identify vaccination requirements for specific diseases and
conditions; Discuss types of adverse reactions to vaccines and management options.
Q & A Workshop
5:00
5:15
5:30
4:45
5:00
5:15

4806 How to Get Your Manuscript Published
4:45 to 6:00 pm
Moderator: Michael H. Clayton, MD FAAAAI
Panelists: Donald Y.M. Leung, MD PhD FAAAAI
Hans-Uwe Simon, MD PhD FAAAAI
Question & Answer
ticket required
fee required
5:30
4:45 to 6:00 pm
Moderator: Marsha A. Wills-Karp, PhD
Defining the CD4 Phenotypes of Asthma
Th17 Cells in Asthma
Dawn C. Newcomb, PhD
Th9 Cells in Asthma
Mark H. Kaplan, PhD
Question & Answer
Upon completion of this session, participants should be able to: Determine various
biomarkers used to identify Th2 high and Th2 low asthma patients using periostin as
a biomarker; Define the role of Th9 and Th17 cells in asthma; Describe the crosstalk
between Th2, Th17 and Th9 pathways and cytokines.

4809 Methacholine vs. Mannitol Challenge
in the Evaluation of Asthma
4:45 to 6:00 pm
Moderator: Hee-Bom Moon, MD PhD
Panelists: Sandra D. Anderson, PhD DSc
Louis-Philippe Boulet, MD
James M. Quinn, MD FAAAAI
Upon completion of this session, participants should be able to: Describe best practices for
manuscript preparation; Discuss appropriate journal selection for submission, to include
5:15
Upon completion of this session, participants should be able to: Work with office staff as
a team to manage emergencies; Formulate and execute a logical plan for treatment of
anaphylaxis; Respond appropriately to cardiac emergencies and other non-respiratory
emergencies.
4808 CD4+ T Cell Subsets in Asthma

Phenotypes
4:45 to 6:00 pm
Moderator: Tao Le, MD MHS FAAAAI
Employment Agreements and Partnerships
Marshall Pl Grodofsky, MD FAAAAI
Hiring and Firing
Stanley M. Fineman, MD MBA FAAAAI
Marketing and Referral Development
Weily Soong, MD
Question & Answer
Upon completion of this session, participants should be able to: Evaluate difficult
situations in employment agreements and partnership; Identify and address difficult
situations regarding hiring and firing; Investigate difficult situations in marketing and
referral development.
4:45
5:00
Q & A Workshop
4805 Difficult Situations in Practice

Management
4:45
4:45
4:45 to 6:00 pm
Moderator: Dana V. Wallace, MD FAAAAI
Hands-On Mock Anaphylactic Reaction with CPR on a Mannequin
Dana V. Wallace, MD FAAAAI
Anaphylaxis: Presentation and Management
Nabil El Sanadi, MD
Upon completion of this session, participants should be able to: Compare positive and
negative predictive values of methacholine and mannitol inahalation tests; Evaluate
73
Monday, February 25
methacholine and mannitol as potential tests for monitoring asthma treatment.
4813 Advanced Laboratory Studies for

Primary Immune Deficiency Disorders
4810 Bronchial Thermoplasty for Severe

Asthma
4:45 to 6:00 pm
Moderators: Mark F. Sands, MD FAAAAI
Neil Thomson, MD
Panelists: Mario Castro
Monica Kraft, MD
Upon completion of this session, participants should be able to: Describe the risks and
benefits of bronchial thermoplasty in severe asthma; Review the studies to date on
thermoplasty outcomes; Describe the areas requiring further research.
4:45 to 6:00 pm
Moderator: Richard L. Wasserman, MD PhD FAAAAI
Roshini S. Abraham, PhD FAAAAI
Upon completion of this session, participants should be able to: Explain B cell flow
analysis in CVID; Review application of tests of NK and Cytotoxic T lymphocyte function:
when to order and clinical relevance; Identify the tests of TLR function.
Q & A Workshop
4814 JCAAI: The Allergist and Healthcare in
2013

4811 Difficult Cases in Anaphylaxis:
Biphasic and Protracted Anaphylaxis
4:45 to 6:00 pm
Moderators: James J. Herman, MD FAAAAI
Carmen Vidal, MD PhD
Panelists:
S. Allan Bock, MD FAAAAI
Stephen F. Kemp, MD FAAAAI
Phillip Lieberman, MD FAAAAI
5:10
5:35
Upon completion of this session, participants should be able to: Describe multiphasic and
protracted anaphylactic reactions; Review the literature for risk factors related to reactions
that have been multiphasic and/or protracted; Review proper treatment and current
recommendations for these patients.
Upon completion of this session, participants should be able to: Review requirements for
compliance with federal regulations, rewards and penalties; Identify changing allergy CPT
codes, ICD-10 and other new developments; Describe strategies to position a practice for
success.
Q & A Workshop
Q & A Workshop
4812 Skin Immunity, Barrier and Food

Allergy
4815 Consequences of Perennial Allergic

Rhinitis in Children: Adenotonsillar
Hypertrophy, Sleep Disordered
Breathing and Behavioral Problems
4:45
5:00
5:15
5:30
4:45 to 6:00 pm
Moderator: Lisa A. Beck, MD FAAAAI
Mechanisms of Primary Sensitization to Food Allergens Through
the Skin
Cecilia Berin, PhD
Induction of Tolerance by Epicutaneous Immunotherapy
Christophe Dupont, MD PhD
Impact of Skin Barrier Function on Sensitization
Michiko K. Oyoshi, PhD
Question & Answer
Upon completion of this session, participants should be able to: Describe immune
mechanisms leading to sensitization to food proteins through the skin; Review the
mechanisms underlying tolerance induction by epicutaneous immunotherapy; Discuss
changes in skin barrier function can contribute to allergic sensitization.

through an educational grant from Merck..
74
4:45
4:45 to 6:00 pm
Credit: 1.25 CME / No CE
Moderator: Richard W. Honsinger, MD MACP FAAAAI
Compliance with Guidelines and Federal Regulations: Extract
Preparation, Skin Testing, etc.
Donald W. Aaronson, MD FAAAAI
Legal and Coding Updates: New Codes for Food Challenges,
Venom and Drug Testing
Question & Answer
4:45
5:00
5:15
5:30
4:45 to 6:00 pm
Moderator: Fuad M. Baroody, MD FAAAAI
Evaluation and Treatment of Obstructive Sleep Apnea in Children
Fuad M. Baroody, MD FAAAAI
Contribution of Sleep Disordered Breathing to ADHD and Other
Behavioral Disorders
Hari Bandla, MD
Role of Allergic Rhinitis in Sleep Disordered Breathing and
Behavioral Disorders in Children
Bernard Silverman, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Identify the associations
and theories of causality among allergic rhinitis, adenotonsillar hypertrophy, sleep
disordered breathing and attention related behavioral disorders in children; List the
demonstrated effects and possible benefits of intranasal corticosteroids and other allergic
rhinitis treatment in improving each of the latter three disorders; Define the spectrum of
SDB and OSA in children and the role of rhinoscopy and polysomnography in establishing
the diagnosis and response to treatment; Identify the role of the allergist/immunologist
in identifying these patients and coordinating care among pediatician, ENT, neurolgist/
psychiatrist/developmental pediatrician and sleep specialist.
ticket required
fee required
Monday, February 25
Year-in-Review Workshop
Q & A Workshop
4816 Research From USIDNET
4819 AAP: Hot Topics in Pediatric Allergy and

Immunology
4:45
5:00
5:15
5:30
4:45 to 6:00 pm
Moderator: Charlotte Cunningham-Rundles, MD PhD FAAAAI
What Have We Learned from the U.S. and Other PIDD Registries
and Where Its All Going
Kathleen E. Sullivan, MD PhD FAAAAI
An Example of How the USIDNET Registry Can Empower Research
How You Can Participate in USIDNET
Ramsay Fuleihan, MD
Question & Answer
4:45
5:00
5:15
5:30
4:45 to 6:00 pm
Moderator: John M. James, MD FAAAAI
Pediatric Allergic Respiratory Disease
Atopic Dermatitis
Lynda C. Schneider, MD FAAAAI
Food, Drugs and Bugs
Question & Answer
Upon completion of this session, participants should be able to: Review the efforts of
USIDNET; State how to participate in USIDNET research; Identify less common features of
PIDD that are medically significant and can impact management.
Upon completion of this session, participants should be able to: Describe the most recent
clinical research findings in pediatric asthma, eczema, food, drug and insect allergy; Apply
recent advances in pediatric allergy/immunology.
Q & A Workshop
Seminars
4817 New Tools to Make Specific

Immunotherapy More Specific
4:45
5:00
5:15
5:30
4:45 to 6:00 pm
Moderator: Michael R. Nelson, MD PhD FAAAAI
Identifying the Relevant Sensitizing Allergens and Optimizing SIT:
Is There a Role for Component Resolved During Diagnosis and
Basophil Activation Testing?
Joaquin Sastre, MD PhD FAAAAI
Peptides and Modified Recombinants
Rudolf Valenta, MD
Epicutaneous and Intralymphatic Immunotherapy
Thomas M. Kundig, MD
Question & Answer
Upon completion of this session, participants should be able to: Debate how using new
diagnostic tools might improve the specific selection of immunotherapy; Review the status
of immunotherapy with recombinant, modified recombinant and peptide molecules and on
the safety profiles of these options; Discuss the other application forms being evaluated
in clinical trials and which pitfalls still have to be overcome by this treatment modality to
offer a viable alternative to standard immunotherapy.
4818 Drug Allergy:You Have Questions, We

Have Answers
5:00
5:15
5:30
4:45 to 6:00 pm
Moderator: Rebecca S. Gruchalla, MD PhD FAAAAI
Multiple Antibiotic Allergies
Allergy to Chemotherapeutics
Aleena Banerji, MD
Beta-Lactams Including Issues of Cross-Reactivity
Eric Macy, MD FAAAAI
Question & Answer

Philippe Gevaert, MD
viruses as triggers of asthma exacerbations; Discuss the relevance of Staph aureus for
asthma development and severity.
4822 CVID: Molecular and Immunological

Testing
Elena E. Perez, MD PhD FAAAAI
Upon completion of this session, participants should be able to: Describe the common
features of CVID; Review the lab testing available to be used in the workup of a patient
with suspected CVID.
ticket required
fee required

Alan P. Zelicoff, MD
Upon completion of this session, participants should be able to: Describe how estimates of
pollen production can be determined; Describe the value of remote sensing data in pollen
forecasting; Describe the role of the allergist in using the pollen alerts.
4824 Tree Nut and Peanut: Complexity in

Cross-Reactivity
Soheila J. Maleki, PhD
Suzanne S. Teuber, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss how to approach
patients presenting with multiple antibiotic allergies; Describe how to approach patients
with PCN or other beta lactam allergies; Review how to approach patients with reactions
to chemotherapeutics.
4821 Viral and Bacterial Interactions in

Asthma
4823 Pollen Forecasting and Exposure: A

View from Space
Q & A Workshop
4:45
4:45 to 5:45 pm
grant from Merck.
Pre-registration and ticket required. Fee: $40. Refreshments included.
Sessions and refreshments limited to 30 people.
Upon completion of this session, participants should be able to: Distinguish between
clinical cross-reactivity and in vitro cross-reactivity; List the main seed storage proteins
involved in cross-reactivity; Review the closely related tree nuts that are often clinically
cross-reactive.
75
Monday, February 25
4825 Quality Improvement and Patient
Safety in Allergy Practice
Paul M. Carter, MD MHCM FAAAAI
Matthew A. Rank, MD FAAAAI
Upon completion of this session, participants should be able to: Appreciate the recent
experiences attendees may have had while considering, planning or performing quality
projects; Discuss fundamental principles guiding quality improvement of allergic/
immunologic diseases in the U.S.; Recognize potential quality improvement opportunities
that could positively influence the outcomes of allergy/immunology education, research
and patient care at the local and national level.
4826 The Four Ws of IgE Testing: Why, What,

Who and When?
Joerg Kleine-Tebbe, MD FAAAAI
Upon completion of this session, participants should be able to: Describe how to use
IgE testing to inhalants (pollen, ped, mite, mold allergens/molecules); Discuss how to
use IgE testing to foods (plant- and non-plant-related); Review how to use IgE testing to
hymenoptera venoms (extracts, single venom components).
4827 Highlights in the Cytokine Network of

Allergic Diseases
4829 Identification and Functional

Assessment of Regulatory T Cells in
Health and Disease
Christine M. Seroogy, MD FAAAAI
Dat Q. Tran, MD
Upon completion of this session, participants should be able to: Review markers for
identification of regulatory T Cells and their subsets; Discuss strategies for isolation and
expansion of regulatory T Cells; Describe methods for functional assessment of regulatory
T Cells.
4830 Impact of Tobacco Smoke Exposure

on Atopic Disease and Prevention/
Treatment Strategies
Christina E. Ciaccio, MD
Deborah A. Gentile, MD
Upon completion of this session, participants should be able to: Demonstrate the effects of
exposure to tobacco smoke on the pathogenesis of atopic disorders; Summarize effective
strategies to prevent/treat exposure to tobacco smoke; Emphasize the role of allied health
care providers in prevention/treatment of exposure to tobacco smoke.
Paul S. Foster, PhD DSc

Yui-Hsi Wang, PhD
Upon completion of this session, participants should be able to: Discuss the emerging
roles of novel cytokines, such as TSLP, IL-9 and IL-33 in allergic diseases.
4828 Allergen Immunotherapy or

Omalizumab in Asthma: When to Use
Which?
Thomas B. Casale, MD FAAAAI
Harold S. Nelson, MD FAAAAI
Upon completion of this session, participants should be able to: Review efficacy of IT in
asthma and safety of AIT in moderate to severe asthma; Review studies of omalizumab
alone and in combination with AIT in asthma; Make recommendations on individual use of
these drugs and in combination for asthma.
76
ticket required
fee required
Seminars
7:00 to 8:00 am
grant from Merck.
5001 Recurrent Infections in Pediatrics:

Allergies or Immunodeficiency?
Jason W. Caldwell, DO
Laurence E. Cheng, MD PhD
Upon completion of this session, participants should be able to: Describe the factors that
increase the risk of recurrent infections; Describe the workup of patients to determine if a
clinically significant immune defect is present; Explain the red flags for rare vs. common
presentations of routine infectious presentations to the allergy office.
5002 Approach to Patients Presenting with

Reactions to NSAIDs
Ronald A. Simon, MD FAAAAI
Katharine M. Woessner, MD FAAAAI
Upon completion of this session, participants should be able to: Describe the different
types of pseudoallergic and allergic reactions to ASA/NSAIDs and underlying diseases;
Discuss the approach to the evaluation of patients who give a history of reactions to ASA
and other NSAIDs; Discuss the approach to identifying and describing skin lesions.
5003 Oral Immunotherapy for Food Allergy:

Contrasting Practices in the U.S. and in
Europe
Giovanni B. Pajno, MD FAAAAI
Rushani W. Saltzman, MD
Upon completion of this session, participants should be able to: Discuss the right patients
for the right OIT; Describe food allergens which are worth OIT; Review food allergies which
are worth active treatment.
5004 New Insect Allergens: Fire Ant,

Mosquito, Deerfly and Asian Lady
Beetle
5005 Whats New in Testing for Primary

Immunodeficiency Disorders?
5008 Problem-Based Learning:

Immunodeficiency Evaluation
Mark Ballow, MD FAAAAI
Meredith L. Heltzer, MD
Upon completion of this session, participants should be able to: Determine an alternative
diagnosis of a patient with recurrent infections; Order lab tests to evaluate a patient for
immune deficiency; Interpret lab tests for suspected immune deficiency.
5009 Physical Urticaria and Idiopathic

Urticaria: Clinical Perspectives
Laura M. Gober, MD
David R. Weldon, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss the differential
diagnosis for physical urticaria and idiopathic urticaria; Explain the diagnostic approaches;
Review the treatment options.
5010 Eosinophilic Esophagitis: Practical

Aspects of Assessing Immediate and
Delayed Food Hypersensitivity
Amir F. Kagalwalla, MD
Upon completion of this session, participants should be able to: Complete a
comprehensive food allergy evaluation in children and adults with eosinophilic
esophagitis; Explain the practical aspects of the preparation of food allergens for prick and
patch testing; Describe the role of immunoassays for foods in eosinophilic esophagitis.
Upon completion of this session, participants should be able to: Describe the basic
clinical features of atopic dermatitis, other eczemas, allergic contact dermatitis and drug
eruptions; Discuss the approach to identifying and describing skin lesions; Discuss the
role of biopsy in diagnosis and management.
5012 Theres An App for That: iPhone/iPad,

Android and Web Tools for Clinical
Practice
Linda D. Green, MD FAAAAI
Roshini S. Abraham, PhD FAAAAI

Harry R. Hill, MD
Upon completion of this session, participants should be able to: Review the laboratory
tests used to work up patients with recurrent infection, including a description of the
assays; Describe the clinical value of these tests and interpretation of the results;
Appreciate how newer technologies are being applied to diagnostic laboratories for
primary immunodeficiency.
5006 Food Challenges in the Office Setting

S. Allan Bock, MD FAAAAI
Justin M. Skripak, MD
Upon completion of this session, participants should be able to: Determine which subjects
are suitable for office food challenges; List which foods are most likely to be safely
challenged in an office and how to choose them; Describe which challenge procedures
are most useful, including baked egg and milk challenges.
fee required
Upon completion of this session, participants should be able to: Identify common pitfalls
in the treatment of eczema, with special emphasis on compliance; Describe the rationale
for an extended therapeutic ladder for patients refractory to standard treatments; Evaluate
treatments and interventions that have been shown to be of no benefit in the disease.
Peter Lio, MD
Upon completion of this session, participants should be able to: Describe the epidemiology
and diagnosis of mosquito and deerfly allergy; Discuss eventual indications for
immunotherapy in these cases; Describe the pros and cons of the available whole body
extracts.
ticket required

Marriott Rivercenter, Third Floor, Grand Ballroom A
5011 Dermatology for the Allergist
Christopher W. Calabria, MD
Richard F. Lockey, MD
Marriott Rivercenter, Third Floor, Grand Ballroom Salon E
5007 Advanced Therapeutics: Managing the

Severe and Refractory Eczema Patient
Upon completion of this session, participants should be able to: Discuss novel applications
of the iPhone/iPad, Android and other smart devices in daily practice; Present use case
scenarios of web tools for improving patient care, education and outreach; Navigate and
find features of the new AAAAI website.
5013 Novel Therapies for Chronic Urticaria

and Angioedema
David H. Dreyfus, MD PhD FAAAAI
Marriott Riverwalk, Second Floor Level, Alamo Ballroom Salon A
Upon completion of this session, participants should be able to: Discuss novel therapy
for chronic urticaria and angioedema; List novel diagnostic testing for chronic urticaria
and angioedema; Review practical considerations for application of novel therapy and
diagnosis.
77
5014 Problem-Based Learning: So the
Patient Has Eosinophilia: What Next?
Amy D Klion, MD
Symposium
5301 Assessing Eosinophil Functions in
Asthma, Eosinophilic Esophagitis and
Hypereosinophilic Syndromes
Upon completion of this session, participants should be able to: Review diagnosis of
variants hypereosinophilic syndrome; Describe identification of secondary eosinophilia;
Discuss therapeutic approaches to hypereosinophilic syndrome.
5015 Exhaled NO: Time to Clear the Air!

Upon completion of this session, participants should be able to: Discuss the application of
eNO in the context of ATS guidelines and AAAAI/ACAAI position statements; Recognize the
relationship between the levels of evidence and practice guidelines for clinical eNO use;
Explain potential weakness/strengths of eNO for managing asthmatics.
Plenary
5101 Neurogenic Pathways of Inflammation
8:15
8:45
9:15
8:15 to 9:45 am
Moderator: Michael A. Kaliner, MD FAAAAI
The Cough that is Getting on My Nerves
Bradley Undem, PhD
Your Nose Acts Through Your Nerves
Pruritus Beyond Antihistamines
Gil Yosipovitch, MD
10:45
11:05
11:25
11:45
Upon completion of this session, participants should be able to: Discuss the role of
eosinophils in asthma, eosinophilic esophagitis and hypereosinophilic syndromes;
Describe the power of clinical investigations as an in vivo approach to understand
eosinophil biology; Discuss new insights obtained from specific anti-eosinophil treatment
approaches.
Symposium
5302 New Phenotypes in Pediatric Asthma
Upon completion of this session, participants should be able to: Describe neurogenic
mechanisms and treatment options for chronic non-allergic rhinopathy; Discuss neuroreflex mechanisms for chronic cough; Describe the role of taste receptors and other
related neuronal receptors in airway smooth muscle.
10:45
11:05
Posters
7:00 am to 5:00 pm
9:45 to 10:45 am.
Refer to pages 86-139 for abstracts and authors
5201 Asthma Updates

5202 Other BCI Topics
5203 Anaphylaxis I
5204 Food Allergy II
5205 Rhinitis/Rhinosinusitis
5206 Immunotherapy/Immune Deficiencies
78
10:45 am to 12:00 pm
Moderator: Rafeul Alam, MD PhD FAAAAI
Eosinophils in Immune Regulation and Remodeling: New Insights
Steven J. Ackerman, PhD
Eosinophil Depletion by Antibody Treatment: Lessons Learned
from Clinical Trials
Amy D. Klion, MD
Extracellular Eosinophil DNA Traps: How to Assess and Their Role
in Disease
Question & Answer
11:25
11:45
10:45 am to 12:00 pm
Moderator: Scott T. Weiss, MD MS
New Approaches Identifying Asthma Phenotypes in Childhood
Adnan Custovic, MD PhD FAAAAI
What Clinical Lessons Can We Learn from Phenotyping Asthma in
Childhood?
Anne M. Fitzpatrick, PhD
Prediction of Persistence and Remission of Asthma in
Adolescence: Differences Between Male and Female
Ronina Covar, MD
Question & Answer
Upon completion of this session, participants should be able to: Discuss if different
phenotypes of pediatric asthma require different therapies; Review if genetics help in
phenotyping pediatric asthma.
ticket required
fee required
Symposium
Symposium
5303 Advances in Immunotherapy:

Mechanisms and Approaches
5305 New Insights into Mold-Related

Symptoms and Disease and Potential
Housing-Related Solutions
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Robert A. Wood, MD FAAAAI
Overview of Immunotherapy in Children with Asthma
Jacqueline Pongracic, MD FAAAAI
T Cell Epitope in Immunotherapy
Alessandro Sette, Dr. Biol. Sci.
Blocking Antibodies and their Role in the Effectiveness of
Immunotherapy
Question & Answer
Upon completion of this session, participants should be able to: Review principles of IT
as they apply to inner city asthma; Discuss potential biomarkers in the application of IT;
Discuss the unique contribution and use of T cell epitopes in IT.
Symposium
5304 Evolving Understanding of the
Contributions of Mast Cells to Immune
and Inflammatory Disease Models
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Francesca Levi-Schaffer, PhD FAAAAI
New Insights Into the Contributions of Mast Cells to Immune and
Inflammatory Responses Through New Strains of Mast CellDeficient Mice
Stephen J. Galli, MD
The Adjuvant Effects of Mast Cells
Soman N. Abraham, PhD
Mast Cells and Immune Tolerance
Paul Bryce, PhD
Question & Answer
Upon completion of this session, participants should be able to: Discuss new models of
mast cell deficient mice; Review mast cell models with adjuvant effects; Discuss the
contribution of mast cells in immune tolerance.
ticket required
fee required
10:45
11:05
11:25
10:45 am to 12:00 pm
Moderator: Leslie C. Grammer, MD FAAAAI
Irritant Effects of Mold Exposure: What to Tell Your Patient When
There is No Evidence of Disease
Kari E. Reijula, MD PhD FAAAAI
Effect of Mold Constituents on Innate Immune Responses
Charles S. Barnes, PhD
Unusual But Important Sources of Industrial and Home Mold
Exposure
Upon completion of this session, participants should be able to: Describe how mold
components can drive the innate immune response; Define the irritant effects of mold
exposure in non-mold-allergic patients, and how to diagnose and treat these; Review
potential exposures to mold at work and at home.
Symposium
5306 Response to Viral Infections in the
Atopic Host: Is it Deficient?
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Moderator: Peter W. Heymann, MD
Innate Response to Viral Infections and Asthma
Sebastian L. Johnston, MD PhD
Adaptive Immune Response to Viral Infections and Asthma
Larry Borish, MD FAAAAI
Viral Determinants of Rhinovirus Virulence
James E. Gern, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Describe why allergic
individuals may be more susceptible to symptoms caused by viral infections; Discuss
whether deficiencies in the response to viral infections in the atopic host involve both the
innate and acquired immune systems; Discuss how the susceptibility to symptoms caused
by viral infections affects patients with asthma and atopic dermatitis.
79
Symposium
Pro/Con Debate
5307 Comprehensive Allergy Programs: A

Systematic Approach to Reduce the
Burden
5503 Basophils are Key Antigen Presenting

Cells in Allergic Inflammation
10:45
11:05
11:25
11:45
10:45 am to 12:00 pm
Richard F. Lockey, MD FAAAAI
Global Burden of Allergy and Future Predictions
Ruby U. Pawankar, MD PhD FAAAAI
From Guidelines to Action Programs: The Finnish Experience
Erkka Valovirta, MD PhD
Is Allergy Preventable?
Question & Answer
Upon completion of this session, participants should be able to: Describe how the burden
of allergy (as a disease affecting QoL and as a health cost) has augmented over the last
decades; Comment on strategies that can be used to improve the implementation of
guidelines, meant to enhance the direction of diagnostic and treatment resources; Discuss
methods to reduce the development of allergy, as applied in the National Finnish Allergy
Program.
N
A
C
12:30 to 1:30 pm
Pro
Con
Carla M. Davis, MD
L
E
C
Upon completion of this session, participants should be able to: Describe the evidence
that basophils can function as antigen-presenting cells; Discuss the role of dendritic cells
in Th2 initiation; Describe how to reconcile data on basophils and dendritic cells which
support and refute a role in Th2 initiation.
Pro/Con Debate
5504 Anaphylaxis vs. Mastocytosis: A Bone
Marrow Biopsy is Always Necessary
12:30 to 1:30 pm
Moderator: Mariana C. Castells, MD PhD FAAAAI
Pro
Cem Akin, MD PhD FAAAAI
Con
Pro/Con Debate
5501 Empiric Elimination Diets are Better
than Targeted Elimination Diets for
the Management of Eosinophilic
Esophagitis
D
E
L
12:30 to 1:30 pm
Moderator to be announced.
Pro
Con
Upon completion of this session, participants should be able to: Review the indications for
bone marrow biopsy in patients with anaphylaxis (severe hypotension, hymenoptera sting
reactions, recurrent episodes without trigger); Review the data on frequency of patients
presenting with anaphylaxis and elevated tryptase who have MMCAS or mastocytosis.
Pro/Con Debate
Upon completion of this session, participants should be able to: Highlight the discrepancy
between the approach towards EoE between allergists and gastroenterologist and enable
enhanced communication between the two subspecialties by providing the rationale
behind the diversity of approach; Describe evidence on the effectiveness of various
protocols for dietary elimination; Explain how the choice of elimination diet can have an
impact on patient compliance of both diet as well as the feasibility of endoscopic followup.
5505 Integrative Medicine Should Be a

Component of Allergy/Immunology
Practice
12:30 to 1:30 pm
Moderator: William Silvers, MD FAAAAI
Pro
Con
Richard F. Lockey, MD FAAAAI
Pro/Con Debate
5502 Antibiotics Have a Role in Asthma
Treatment
12:30 to 1:30 pm
Moderator: R. Stokes Peebles, Jr., MD FAAAAI
Pro
Monica Kraft, MD
Con
Upon completion of this session, participants should be able to: List what comprises
the principles of integrative medicine and the evidence-based components that include
allergy-immunology; Describe the components of complementary therapies that can be
useful in the practice of allergy, asthma/immunology; Discuss CAM therapies used in
allergy/immunology patients that have the greatest evidence to support their use.
bacteria and atypical bacteria in provoking asthma symptoms; Discuss whether or when
antibiotics can be used routinely, or selectively in treating flares of asthma; Discuss the
potential of antibiotics to reduce airway inflammation (e.g. azithromycin).
80
ticket required
fee required
Pro/Con Debate
Oral Abstract
5506 SLIT and SCIT Duration: Three Years is

Enough
12:30 to 1:30 pm
Moderator: Andrew M. Smith, MD
Pro
Con
2:00
2:15
Upon completion of this session, participants should be able to: Discuss the duration of
immunotherapy according to findings of clinical trials for SCIT; Discuss the duration of
immunotherapy according to findings of clinical trials for SLIT.
Oral Abstract
2:45
5601 Asthma Therapeutic Updates
2:00
2:15
2:30
2:45
3:00
2:30
2:00 to 3:15 pm
A Randomized Placebo-Controlled Safety and Pharmacodynamic
Study of KB002, a Chimeric Anti-GM-CSF Monoclonal Antibody, in
Patients with Asthma
Nestor A. Molfino, MD MSc
Over-Expression of the LTC4 Synthase Gene in Mice Reproduces
Human Aspirin-Induced Asthma
Tatsuya Yokoyama
Effect of Inhaled Corticosteroids (ICS) Vs. Inhaled Corticosteroid
with Long-Acting Beta2 Agonists (ICS/LABA) On Asthma Control:
Results From National Asthma Survey
Neeth Talreja
A Randomized, Double-Blind, Placebo-Controlled, MultipleDose Study to Evaluate the Safety, Tolerability, and Efficacy of
Brodalumab (AMG 827) in Subjects with Moderate to Severe
Asthma
Calcium-Dependent Pathways Are Essential for Canonical
Glucocorticoid [GR] Receptor Signaling
Ashwini Reddy, MD
3:00
2:00 to 3:15 pm
Evaluation of the B Cell Compartment in CVID and Respi Patients
Tracy Hwangpo, MD PhD
Continuous G-CSF Ttreatment Induces Complete Clinical
Remission and Restoration of IL-17 Secretion in Autosomal
Dominant Chronic Mucocutaneous Candidiasis
Eduardo Shahar, MD
Bacterial Specificity of IgM and Susceptibility to Pneumonia in
Primary Humoral Immunodeficiency
Paul J. Maglione, MD PhD
TREC Newborn Screening Can Identify Patients with Leaky SCID
and May Improve Outcome
Alice Chan, MD PhD
Disseminated HPV Following Stem Cell Transplant (SCT) in NK(-)
Severe Combined Immune Deficiency (SCID) and Association with
NK Cell Dysfunction
Kapil Saxena, MS
Oral Abstract
5603 Effects of Viral and Bacterial Infections
on Asthma
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Moderator: Daniel J. Jackson, MD
Characterization of RV-Specific T Cell Responses in Healthy and
Infected Individuals
John W. Steinke, PhD FAAAAI
Differential Effects of HRV Species On Cold and Asthma Symptoms
Hiba Bashir, MD
Effects of Human Rhinovirus Species On Viral Replication in
Differentiated Sinus Epithelial Cells
Kazuyuki Najagome, MD
Role of Mycoplasma Pneumoniae in Childhood Asthma
Edward G. Brooks, MD
Detection of Streptococcus Pneumoniae and Human Rhinovirus Is
Associated with Loss of Asthma Control
ticket required
fee required
81
Oral Abstract
Oral Abstract
5604 Drug/AD
5606 Rhinitis and Rhinosinusitis

Pathophysiology
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Safely Diagnosing Clinically Significant Penicillin Allergy with
Only Penicilloyl-Poly-Lysine, Penicillin, and Oral Amoxicillin
Eric M. Macy, MD FAAAAI
Protein Haptenation by Amoxicillin: Immunological Detection
with Monoclonal Anti-Amoxicillin Antibodies and Identification of
Candidate Target Proteins in Human Serum
Adriana Ariza
Th2 Cytokines and Filaggrin Deficiency Enhance Staphylococcus
Aureus Alpha-Toxin Induced Keratinocyte Death
Anne M. Brauweiler, PhD
An Open Label Study in Adults with Atopic Dermatitis to Assess
Immune Response to Fluzone Intradermal Vaccine
Selective Transgenic Expression of IL-22 in the Skin Induces
Atopic Dermatitis (AD) Like Dermatitis
Hongfei Lou, MD
2:00
2:15
2:30
2:45
3:00
Oral Abstract
5605 Improving Asthma Outcomes
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
School-Based Asthma Clinic Improves Asthma Outcomes
Alysa G. Ellis, MD
Factors Related to Decision Making and Substance Use in
Adolescents with Asthma: A Presenting Clinical Profile
Mary C. O'Laughlen, PhD RN FNP-BC
Interviewing Adolescents with Asthma: Are We Doing Enough?
Matthew Altman, MD
Comparative Effectiveness of Budesonide/Formoterol
Combination (BFC) and Fluticasone/Salmeterol Combination (FSC)
Among Asthma Patients
Setareh Williams
University and Public Health System Partnership: A Systematic
Intervention for Assistance of Patients with Asthma in Brazil
Marcos R. Goncalves, MD
2:00 to 3:15 pm
Moderator: Anju T. Peters, MD FAAAAI
Jayant M. Pinto, MD
Evaluation of in Vivo and in Vitro Responses to Nole e1 in
Systemic and Local Allergic Rhinitis
Paloma Campo, MD PhD
Levels of the Cytokines IL-5, IL-13 and Rantes in Nasal Lavage
Fluids Parallel the Cytokine Content of Nasal Polyps in Patients
with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Christopher Ocampo, MD PhD
Aeroallergen Wheal Area Especially for Molds At Ages Two and
Three Predicts Allergic Rhinitis At Age Four: The Cincinnati
Childhood Allergy and Air Pollution Study (CCAAPS)
Christopher D. Codispoti, MD PhD
Decreased Production of Antimicrobial Peptides in Chronic
Rhinosinusitis Associated with Age and Elevated Soluble gp130
Sun Hye Lee, PhD
Inhibitory Effects of Mometasone Furoate and Azithromycin On
Phorbol Ester-Induced Mucin Production From Human Airway
Epithelial Cells
Orapan Poachanukoon, MD
Oral Abstract
5607 Recent Advances in Eosinophil and
Mast Cell Biology
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
Moderator: Lisa A. Spencer, PhD
Mice with Attenuated Expression of the 2,3 Sialyltransferase
ST3gal-III (St3gal3) Display Enhanced Allergic Eosinophilic
Airway Inflammation
Epicutaneous Sensitization in Filaggrin Gene-Depleted Mouse
Induces Prolonged Airway Eosinophilia without Obvious
Dermatitis
Yusuke Suzuki
Thymic Stromal Lymphopoietin Promotes Peripheral Blood CD34+
Cell Eosinophilic Lineage Commitment
Claudia C.K. Hui, MSc
Hypoxia Inducible Factor (HIF) Alpha Subunits Modulate
Eosinophil Migration, Oxidative Burst, and Degranulation
Laura E. Crotty Alexander, MD
Functional Expression of the Novel C5a Receptor C5L2 in Human
Mast Cells
Priyanka Pundir, DVM
82
ticket required
fee required
Late Breaking Oral Abstract Session
Q & A Workshop
5611 Late Breaking Oral Abstract II
5703 Allergy Diagnosis 2013: Between

Scientific Progress and Unproven
Methods
2:00
2:15
2:30
2:45
3:00
2:00 to 3:15 pm
William J. Calhoun, MD FAAAAI
Antibiotic Exposure and the Risk of Food Allergy in Young
Children
Bryan L. Love, PharmD BCPS
Deficiency of Inducible PGE2 Is Sufficient to Cause Aspirin
Sensitivity in the Setting of Pulmonary Inflammation
Tao Liu, PhD
VRC 311: Phase I Clinical Trial of a Virus-Like Particle
Chikungunya Vaccine in Healthy Adults
Lee-Jah Chang, MD
Chronic Sub-Cutaneous Exposure to a Staphylococcus
Aureus Superantigen, Staphylococcal Enterotoxin B, Elicits an
Eosinophilic Airway Inflammation in HLA Class II Transgenic Mice
- Linking Atopic Dermatitis (AD) to Asthma
Govindarajan Rajagopalan, DVM PhD
Detection and Quantitation of Total and Allergen-Specific IgE in
the Bronchial Mucosa of Atopic and Non-Atopic Asthmatics
Prathap Chellappan Pillai, MD
3:30
3:45
4:00
4:15
Upon completion of this session, participants should be able to: Acknowledge new
findings in the diagnosis or IgE-mediated reactions and disorders using In vivo, In vitro
and Ex vivo methods; Utilize recent developments in diagnostic methods for advancing
the interpretation of individual test results; Identify unproven methods like kinesiology,
bioresonance, IgG tests with foods.
Q & A Workshop
5704 Chronic Rhinosinusitis: From Bench to
Bedside
5701 Problem-Based Learning: A Child with

a Chronic Cough
3:30 to 4:45 pm
Don A. Bukstein, MD
3:30
3:45
Upon completion of this session, participants should be able to: To interactively discuss
the case of a child with a chronic cough; To discuss in depth the differential diagnoses
of a child with a chronic cough and the appropriate diagnostic evaluation; Debate
therapeutic options for a child with a chronic cough.
3:30 to 4:45 pm
In Vivo Veritas: From Skin Testing to Challenges with Allergens:
Kinesiology
Antibody Based Tests: IgE in Immediate Type Hypersensitivity:
IgG4 to Foods
Cellular Allergy Testing: Basophil and Lymphocyte-Based Tests:
ALCAT
Joerg Kleine-Tebbe, MD FAAAAI
Question & Answer
4:00
4:15
3:30 to 4:45 pm
Moderator: Patricia A. Takach, MD FAAAAI
Research in Mucociliary Clearance in CRS
Noam A. Cohen, MD PhD
Research in Barrier Dysfunction in CRS
Anju Peters, MD
Treatment Modalities In CRSsNP and CRSwNP
Daniel L. Hamilos, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Describe mucociliary
dysfunction in CRS; Describe barrier dysfunction in CRS; Discuss treatment modalities in
CRS.

Intermittently Wheezing Infant
3:30 to 4:45 pm
Moderator: Ray S. Davis, MD FAAAAI
Leonard B. Bacharier, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss how the Asthma
Predictive Index can aid in making a presumptive diagnosis of asthma in an infant
with intermittent wheezing; Discuss the NAEPP Guidelines recommendations for daily
ICS therapy for intermittent wheezing in an infant who needs several courses of oral
corticosteroids per year; Outline the most recent data from the MIST and TREXA studies
from the CARES Network regarding an alternative-high dose ICS/SABA intermittently-for
an infant with intermittent-severe wheezing.
ticket required
fee required

83
Q & A Workshop
Q & A Workshop
5705 Advances in Desensitization
5708 Airway Smooth Muscle Signaling: New

Insights in Asthma
3:30
3:45
4:00
4:15
3:30 to 4:45 pm
Moderator: Aleena Banerji, MD
Desensitization to Drugs
Aleena Banerji, MD
Desensitization to Foods
Stacie M. Jones, MD
Rapid Desensitization to Aeroallergens
Question & Answer
3:30
3:45
4:00
Upon completion of this session, participants should be able to: Discuss the principles
and application of rapid desensitization to drugs, such as antibiotics, chemotherapeutics
and monoclonal antibodies; Describe the current state of knowledge of desensitization to
foods; Discuss the current state of knowledge of rapid desensitization to aeroallergens.

5706 Are Your Baked Milk and Egg
Challenges Half-Baked?
4:15
3:30 to 4:45 pm
Raymond Penn, PhD
Airway Tone and Regulator of G-Protein Signaling (RGS) Proteins:
Intracellular Modulators of Gpcrs
Yaping Tu, PhD
OGR1 a pH Sensor for ASM
Raymond Penn, PhD
New Therapeutic Strategies Targeting Airway Smooth Muscle
Reynold A. Panettieri, Jr., MD
Question & Answer
Upon completion of this session, participants should be able to: Review important
intracellular signaling events controlling airway tone and remodeling; Dicuss the role of
RGS proteins in the pathobiology of asthma; Describe novel approaches aimed at GPCRs
for the management of asthma.
Q & A Workshop
5709 Technology-Based Interventions to
Improve Asthma Management and
Adherence
3:30 to 4:45 pm
Moderators: Pamela H. Steele, MSN CPNP AE-C
Kirsten Beyer, MD
Panelists: Marion E. Groetch, MS RD
Sally A. Noone, RN MSN CCRC
3:30
Upon completion of this session, participants should be able to: Identify when to offer a
baked milk or egg challenge; Conduct a baked milk or egg challenge; Educate patients
about a diet that avoids milk or egg but includes baked milk or egg.
3:45

Approach to a Patient with Primary
Immunodeficiency Disease
3:30 to 4:45 pm
Moderator: Meredith L. Heltzer, MD
Elena E. Perez, MD PhD FAAAAI
4:00
4:15
3:30 to 4:45 pm
Moderator: William Vollmer, PhD
Patient Preferences for Use of Social Media, Text Messaging and
Email for Asthma Management
Alan P. Baptist, MD MPH
Electronic Medical Record-Based Interventions to Improve
Adherence
William Vollmer, PhD
A Smartphone Intervention to Improve Adherence and Asthma
Self-Management in Urban Minority Adolescents
Giselle Mosnaim, MD MS FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Discuss patient
preferences for use of social media, text messaging and email for patient-provider
communication; Explore the use of electronic medical records to improve adherence;
Explore the use of smartphone technologies to improve adherence in urban minority
adolescents.
Upon completion of this session, participants should be able to: Make a differential
diagnosis of patient with recurrent infections; Make a stepwise plan for testing; Interpret
test results in the setting of the patients overall presentation.
84
ticket required
fee required
Q & A Workshop
4:00
5710 Novel Insights into the Pathobiology of

4:15
3:30
3:45
4:00
4:15
3:30 to 4:45 pm
Main Conclusions from Genetic Studies and Future Aspects
The Spectrum of Allergen Sensitization: Similarities and
Differences Between Pediatric and Adult Eosinophilic Esophagitis
Lessons Learned from Investigator-Initiated Trials
Question & Answer
Upon completion of this session, participants should be able to: Describe the
immunopathogenesis of eosinophilic esophagitis; Discuss recent findings obtained in
genetic studies; Discuss the main conclusions of clinical studies performed in pediatric
and adult eosinophilic esophagitis patient groups.
Year-in-Review Workshop
5711 Year-in-Review: Changes in Health
Care Reform
3:30
3:45
4:00
4:15
3:30 to 4:45 pm
Moderator: James C. Sublett, MD FAAAAI
Implementing the Patient Protection and Affordable Care Act in
Your Practice
Richard W. Honsinger, MD MACP FAAAAI
Maintaining Excellence in Subspecialty Care within Accountable
Care Organizations and the Patient Centered Medical Home
Engineering Systems that Work: Meaningful Use, EHR and
Medical Informatics in 2013 and Beyond
James C. Sublett, MD FAAAAI
Question & Answer
Upon completion of this session, participants should be able to: Describe the current
state of proposed models of health care; Discuss the status of EHR implementation and
meaningful use requirements; Review the current health care laws.
5712 Type I Interferons, Rhinovirus and Viral

Infection in the Allergic Response
3:30
3:45
3:30 to 4:45 pm
Moderator: Dorothy S. Cheung, MD FAAAAI
Expression Patterns of Type I IFN in Response to Respiratory
Viruses
Philippa Hillyer, MD
Which is More Important in Asthma Exacerbations: Rhinovirus A
or C?
James Gern, MD FAAAAI
Upon completion of this session, participants should be able to: Describe that despite
signaling through one set of receptors, individual type I IFN family members may have
unique roles or biological functions in mediating the inflammatory response to viral
infection; Clarify the importance of the different groups of rhinoviruses in asthma
exacerbations; Discuss the data suggesting that the production of IgE is part of the
antiviral immune response.
Q & A Workshop
5713 EGIDs: Shining a Light on Eosinophils
Below the Esophagus
3:30
3:45
4:00
4:15
ticket required
fee required
3:30 to 4:45 pm
Moderator: David Mark Fleischer, MD FAAAAI
Eosinophils in the Gut: What is Abnormal?
Recognition and Medical Management of EGIDs
Mirna Chehade, MD
Allergy Testing and Elimination Diets in EGIDs
Question & Answer
presentation and histopathological findings associated with EGIDs; List the differential
diagnosis of eosinophilic inflammation in different areas of the gastrointestinal tract;
Identify difficulties encountered in the clinical management of EGIDs.
Q & A Workshop
5714 FDA CBER Update on Regulation of
Allergenic Products
3:30
3:45
4:00
Q & A Workshop
The Role of IgE in Antiviral Immune Responses

Peter W. Heymann, MD
Question & Answer
4:15
3:30 to 4:45 pm
Moderator: Michael R. Nelson, MD PhD FAAAAI
Current Status of the Categorization of Non-Standardized
Allergenic Extracts
Jay E. Slater, MD
Clinical Proof of Efficacy of Novel Allergenic Therapeutics
Ronald L. Rabin, MD FAAAAI
Statistical Proof of Efficacy of Novel Allergenic Therapeutics
Tammy Massie, PhD
Question & Answer
Upon completion of this session, participants should be able to: Describe the current and
potential future status of non-standardized allergenic extracts in the use of diagnosis and
treatment of allergic diseases; Discuss the requirements for clinical proof of efficacy for
licensure of novel allergenic therapeutics; Discuss the requirements for statistical proof of
efficacy for licensure of novel allergenic therapeutics.

85
AB240 Abstracts
SATURDAY
Scientific Abstract Sessions

Emerging Asthma Therapeutics
2201
Saturday, February 23rd, 2013, 9:45 AM - 10:45 AM
1
86
J ALLERGY CLIN IMMUNOL

FEBRUARY 2013
Induction of IL-10 Production by Dendritic Cells From a Human Myeloblast Cell Line and Peripheral Blood Mononuclear
Cells From Asthmatic Patients by an Alkaloid Compound
From Sophorae Flavescentis
William Holder1, Changda Liu, PhD1, Ying Song, MD1, Nan
Yang, PhD MS1, Jody R. Tversky, MD, PhD1,2 and Xiu-Min Li,
MD1, 1Mount Sinai School of Medicine, New York, NY, 2Johns
Hopkins Medical Center
Efficacy of Tiotropium in Patients with Asthma in Relation to
Allergic Status
Mark L. Vandewalker, MD1, Michael Engel, MD2, Hendrick
Schmidt3, Wolfgang Siebold4, Petra Moroni-Zentgraf2, Huib Kerstjens5,6, Eric Donn Bateman, MD7 and Donald P. Tashkin, MD8,
1
Clinical Research of the Ozarks, Columbia, MO, 2Boehringer
Ingelheim Pharma GmbH & Co. KG, Ingelheim Am Rhein, Germany, 3Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim
am Rhein, Germany, 4Boehringer Ingelheim Pharma GmbH & Co.
KG, Biberach an der Riss, Germany, 5University Medical Center
Groningen, University of Groningen, Groningen, Netherlands,
6
Groningen Research Institute for Asthma and COPD (GRIAC),
Groningen, Netherlands, 7University of Cape Town, Cape Town,
South Africa, 8David Geffen School of Medicine at UCLA, Los
Angeles, Los Angeles, CA
Ganoderic Acid â Suppressed Th2 Responses and Induced Th1/
Tregs in Cultures of Peripheral Blood Mononuclear Cells From
Asthmatic Patients
Changda Liu, PhD1, Ying Song, MD1, Nan Yang, PhD MS1, Jody
R. Tversky, MD, PhD1,2, Jessica Reid-Adam1 and Xiu-Min Li,
MD1, 1Mount Sinai School of Medicine, New York, NY, 2Johns
Hopkins Medical Center
Pre-Clinical Efficacy of RP6503 in PI3Kd/g Mediated Airway
Disorders
Swaroop Vakkalanka, PhD1, Babu Govandarajulu, PhD2,
Kasiviswanath Routhu, PhD2, Sridhar Veeraraghavan, M.Pharm2,
Srikant Viswanadha, PhD2 and Dhanapalan Nagarathnam, PhD3,
1
Rhizen Pharmaceuticals S A, La Chaux-de-Fonds, Switzerland,
2
Incozen Therapeutics Pvt. Ltd., Hyderabad, India, 3DNSK International, Hamden, CT
Preclinical and Early Clinical Development of a GATA-3-Specific
Dnazyme Intended for the Treatment of Th2-Driven Asthma
Agnieszka Turowska1, Ursula Homburg1, Jens Kuhlmann1, Anke
M
uller1, Joachim Bille1, Harald E. Renz, MD2 and Holger Garn2,
1
sterna biologicals GmbH & Co. KG, Marburg, Germany, 2Phillipps
University of Marburg, Marburg, Germany
Incidence of Oral Candidiasis Among Patients with Asthma
Receiving Fluticasone Propionate / Salmeterol Dry Powder Inhaler Versus Beclomethasone Dipropionate Hydrofluoroakane:
Large-Scale Retrospective Claims Analysis
Stephen P. Peters, MD PhD FAAAAI1, Michael Benninger, MD2,
Cheryl S. Hankin, PhD3, Zhaohui Wang, MS3, Amy Bronstone,
PhD3, Philip Buck, PhD, M.P.H.4 and Mark S. Lepore, MD
FAAAAI4, 1Wake Forest University School of Medicine, Winston
Salem, NC, 2Cleveland Clinic, Cleveland, OH, 3BioMedEcon,
LLC, Moss Beach, CA, 4Teva Pharmaceuticals, Inc., Frazer, PA
Accuracy of Canister Weight to Predict the Number of Doses
Remaining in Metered-Dose Inhalers
10
11
12
13
14
Tharinee Sahajarupat, MD, prince of songkla university, Prapasri

Kulalert, MD, Prince of Songkla University, Songkla, Thailand,
Araya Yuenyongviwat, MD, Price of Songkla University,
Songkhla, Thailand and Pasuree Sangsupawanich, MD, Prince
Songkhlanagarind hospital, Hadyai, Thailand
Comparative Effectiveness of Extrafine Hydrofluoroalkane Beclometasone (EF HFA-BDP) and Fluticasone Propionate (FP)
in Smoking Asthmatic Patients a Retrospective, Real-Life
Observational Study in a UK Primary Care Asthma Population
David Price, FRCGP, MRCGP, DRCOG1,2, Richard J. Martin,
MD3, Mark Milton-Edwards4, Elliot Israel, MD, FAAAAI5, Nicolas Roche6, Annie Burden2, Julie von Ziegenweidt2, Shuna E.
Gould2, Elizabeth Hillyer2 and Gene L. Colice, MD7, 1University
of Aberdeen, United Kingdom, 2Research In Real Life, Cambridge,
United Kingdom, 3National Jewish Health, Department of Medicine, Denver, CO, 4TEVA Pharmaceuticals, 5Brigham and
Womens Hospital, Boston, MA, 6Hôpital de lHôtel-Dieu, France,
7
Washington Hospital Centre and George Washington University
School of Medicine, Washington, DC
Trifolirhizin Isolated From Radix Sophorae Flavescentis Inhibited Airway Smooth Muscle Contraction
Nan Yang, PhD MS1, Banghao Liang2, Jixun Zhan3, Joseph Goldfarb2, Hugh A. Sampson, MD, FAAAAI1 and Xiu-Min Li, MD1,
1
Mount Sinai School of Medicine, New York, NY, 2Mount Sinai
School of Medicine, 3Utah State University
Determinants of Prescribing Inhaled Long-Acting Beta-Agonist
Bronchodilators As Monotherapy to Adults with Asthma
Ayad K. Ali, BPharmSc, MSPharm, PhD, University of Florida,
FL; Eli Lilly and Company, IN
Wearing a Mask During Sleep Improved Asthma Control in
Children
Keigo Kainuma, MD, Institute for Clinical Research, Mie
National Hospital, Akihiko Terada, MD, PhD, Terada Pediatric Allergy Clinic, Reiko Tokuda, Tokuda Family Clinic, Mizuho Nagao,
MD, Mie National Hospital, Nobuo Kubo, Unicharm Corporation
and Takao Fujisawa, MD, FAAAAI, Mie National Hospital, Mie,
Japan
Study of Antioxidants in Combination with Choline Chloride in
Mouse Model of Allergic Airway Disease
Preeti Bansal, Sanjay Saw, Dhanapal Govindaraj and Naveen
Arora, CSIR Institute of Genomics and Integrative Biology, New
Delhi, India
The Observed Incidence of Anaphylaxis in Patients Receiving
Omalizumab in a Tertiary Allergy and Asthma Clinic in
Canada
Megan MacRae, RN, BScN1, Stephanie Santucci, RN1, Caroline
Rizk, MD2, Jacob Karsh, MD, FRCPC3 and William H. Yang,
MD, FRCPC, FAAAAI4,5, 1Allergy and Asthma Research Centre,
Ottawa, ON, Canada, 2University of Ottawa, Ottawa, ON, Canada,
3
University of Ottawa, Canada, 4University of Ottawa Medical
School, Ottawa, ON, Canada, 5Allergy and Asthma Research
Corp., Ottawa, ON, Canada
A Double-Blind PlaceboControlled, Multicenter, Cross-Over,
Dose-Ranging Study to Compare the Efficacy and Safety of
Albuterol Spiromax and Proair HFA in Adult and Adolescent
Patients Ages 12 and Older with Persistent Asthma
Edward M. Kerwin, MD, FAAAAI1, Herminia Taveras, PhD2,
Harald Iverson, PhD2, Denise Wayne, PhD2, Tushar Shah, MD3
and Mark S. Lepore, MD FAAAAI3, 1Allergy and Asthma Center
of Southern OR, Medford, OR, 2Teva Pharmaceuticals, Inc.,
Miami, FL, 3Teva Pharmaceuticals, Inc., Frazer, PA
15
16
17
18
19
20
Responder Analysis Evaluating the Effect of Budesonide/

Formoterol Pressurized Metered-Dose Inhaler (BUD/FM
pMDI) in Patients with Moderate to Severe Asthma with Versus
without Fixed Airflow Obstruction (FAO)
Donald P. Tashkin, MD1, Bradley E. Chipps, MD, FAAAAI2, Tom
Uryniak3 and Frank Trudo3, 1University of California, Los Angeles,
CA, 2Capital Allergy & Respiratory Disease Center, Sacramento,
CA, 3AstraZeneca LP, Wilmington, DE
Novel Anti-Allergic Vaccine Candidate From House Dust Mite
Together with a Combination Adjuvant: Treatment or Prevention of Respiratory Allergy
Wendy Ramirez Gonzalez, MSc1, Alexis Labrada, PhD2, Arelis
Mas3, Beatriz Tamargo4, Virgilio Bourg5, Oliver Perez6 and Gustavo Sierra6, 1National Center of Bioproducts, Mayabeque, Cuba,
2
National Center for Bioproducts, Havana, Cuba, 3National Center
of bioproducts, 4Pharmacy and Food Institution, 5National center of
Bioproducts, 6Finlay Institut
Resident Education: Proper Usage of Metered Dose Inhaler and
Chamber
Min Jung Lee and James C. Fagin, MD, Steven & Alexandra Cohen Childrens Medical Center of New York, Great Neck, NY
Anti-IgE Therapy for Asthma in a Patient with Allergic Granulomatosis and Angiitis
Christine Song, MD, FRCPC1 and Jason Kihyuk Lee, MD,
FRCPC1,2, 1University of Toronto, ON, Canada, 2St. Michaels
Hospital, Division of Allergy and Clinical Immunology, Toronto,
ON, Canada
Oral Steroid-Sparing Effect of Omalizumab in Severe Asthma
Patients Treated with Systemic Steroids the Real-Life Experience From Poland
Izabela R. Kuprys-Lipinska, MD PhD1, Damian Tworek2 and
Piotr Kuna, MD PhD1, 1Dept. of Internal Medicine, Asthma and
Allergy, Medical University in Lodz, Poland, 2Dept. of Internal
Medicine, Asthma and Allergy, Barlicki University Hospital of
Medical University in Lodz, Poland
Allergic Bronchopulmonary Mycosis in Non-Atopic Patients: A
Treatment Alternative
Robert M. Ramirez, MD and Robert L. Jacobs, MD, Biogenics
Research Institute, San Antonio, TX
23
24
25
26
27
28
29
Pattern Recognition Receptor, T Cells, B Cells

and Dendritic Cells
2202
21
22
IL-1-Beta Maintains IL-2R-Alpha (CD25) Expression On the

Surface of Th17 Cells and Partially Reverses IL-2 Mediated Inhibition of Th17 Differentiation
Michelle C. Crank, MD, Jane Hu-Li and William E. Paul, MD,
NIAID, National Institutes of Health, Bethesda, MD
Evidence for Expansion of Sinonasal B-Lineage Cells in
Chronic Rhinosinusitis
Kathryn E. Hulse, PhD1, James Norton, MS2, Robert Kern, MD3,
David Conley, MD1, Rakesh Chandra, MD1, Bruce Tan, MD1, Anju
Peters, MD4, Leslie C. Grammer, MD, FAAAAI4, Kathleen E. Harris4, Sudarshan Seshadri, PhD4, Roderick Carter, BSc2, Lydia Suh,
BSc4, Atsushi Kato, PhD2 and Robert P. Schleimer, PhD,
FAAAAI2, 1Northwestern University Feinberg School Medicine,
Chicago, IL, 2Department of Medicine, Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine,
Chicago, IL, 3Northwestern University Feinberg School of Medicine, Chicago, IL, 4Northwestern University Feinberg School of
Medicine, Chicago, IL
30
31
Protective Function of FoxP3+ Regulatory T Cells in Experimental Necrotizing Enterocolitis

Dat Tran, Bridgette Dingle, Nicole Fatheree, Juleen Min, Yuying
Liu and Marc Rhoads, UTHealth, Houston, TX
Protease Activity of Per a 10 Activates Human Airway Derived
Epithelial Cell Line
Sagar Laxman Kale, CSIR-Institute of Genomics and Integrative
Biology, Delhi, India and Naveen Arora, CSIR- IGIB, Delhi, India
Human Primary Central Memory T Lymphocytes As an Ex
Vivo Model in HIV-1 Latency
Christina L. Nance, PhD1, Daniel Grant, BS1 and William T.
Shearer, MD, PhD, FAAAAI2, 1 Baylor College of Medicine, 2Baylor
Defective B-Cell Maturation in Chromosome 22q11.2 Deletion
Syndrome
Solrun Melkorka Maggadottir, MD1, Kelly A Maurer2 and
Kathleen E. Sullivan, MD, PhD, FAAAAI1, 1Childrens Hospital
of Philadelphia, Philadelphia, PA, 2Childrens Hospital of Philadelphia, Philadelphia, PA
Differential Gene Expression in Young Vs Aged Mice Infected
with Respiratory Syncytial Virus
Terianne M. Wong, MSc1, Sandhya Boyapalle, DVM MS PhD1,2,
Siddarth Kamath, MS3, Huy Nguyen, BSc1, Subhra Mohapatra, MS
PhD4 and Shyam S. Mohapatra, PhD, FAAAAI4,5, 1University of
South Florida-Morsani College of Medicine, Tampa, FL, 2JA Haley
VA Hospital, Tampa, FL, 3University of South Florida-College of
Public Health, Tampa, FL, 4The University of South Florida
Morsani College of Medicine, Tampa, FL, 5James A Haley VA
Hospital, Tampa, FL
NLRP3-Deficient Mice Have an Enhanced Neutrophil Apoptosis and a Suppressed Inflammatory Response to Hyperoxia-Induced Acute Lung Injury
Jutaro Fukumoto, MD, PhD1, Itsuko Fukumoto, DMD1, Bao
Huynh1, Ruan R. Cox Jr1, Prasanna Tamarapu Parthasarathy1,
Gurukumar Kollongod Ramanathan1, Rajan Babu Venugopal1, Richard F. Lockey, MD1,2 and Narasaiah Kolliputi, PhD3, 1Morsani
College of Medicine, University of South Florida, Tampa, FL,
2
James A. Haley Veterans Hospital, Tampa, FL, 3Internal Medicine, Morsani College of Medicine, University of South Florida,
Tampa, FL
Type I Interferon Regulates Acute IL-5 and IL-13 Expression
in Human Memory CD4+ T Cells
Sarah R. Gonzales, Jonathan Huber and J. David Farrar, PhD, UT
Southwestern Medical Center, Dallas, TX
Beta2-Adrenergic Receptor (ADRB2) Agonists Inhibit Human
CD8+ T Cell Function
Leonardo D. Estrada, Fatema Chowdhury and J. David Farrar,
PhD, UT Southwestern Medical Center, Dallas, TX
Induction of Regulatory Dendritic Cells in Correlation with
Clinical Efficacy During Grass Pollen Sublingual Immunotherapy
Philippe Moingeon, STALLERGENES
SATURDAY
Abstracts AB241

VOLUME 131, NUMBER 2
Biologic Therapies, Vaccines, HIV

2203
32
Cytokine Profile and Clinical Correlates in Immune Deficient

(HIV-infected) Infants with Severe (hypoxic) Pneumonia
Robin J. Green, MD PhD FAAAAI1, Refiloe Masekela, MD, Cert
Pulm Paed1, Dankwart Wittenberg, MD, Cert Pulm Paed1, Alta Terblanche, Cert Gastro Paed1, Paul Rheeder, PhD2, Piet Becker, PhD3
and Ronald Anderson, PhD4, 1Department of Paediatrics and Child
Health, University of Pretoria, South Africa, 2Division of Clinical
Epidemiology, School of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa, 3Medical Research
87
AB242 Abstracts
SATURDAY
SATURDAY
AB242 Abstracts
33
34
35
36
37
38
39
40
41
Council, South Africa, 4Medical Research Council Unit for Inflammation and Immunity, Department of Immunology, University of
Pretoria and Tshwane Academic Division of National Health Laboratory Service, South Africa
Atheroprotection Conferred by Immunization with 15-Mer
Peptide Fragments From ApoB100
Kevin Tse, MD1, Harley Tse, PhD2, Michael Shaw2, Alessandro
Sette, Biol. Sci.3 and Klaus Ley, MD3, 1UCSD, 2Wayne State
University, 3La Jolla Institute for Allergy and Immunology, La
Jolla, CA
Removal of Coagulation Factors by the Gamunex-C Purification Process
Melanie Williams, PhD, Jeff Willey, Katherine Tull, Glenn Stevenson, Mona Parks, LaToya McElrath, Luda Golovko, Catherine
Russ, John Griffin and Pete Vandeberg, Grifols, Inc., Raleigh, NC
Serum 25-Hydroxyvitamin D Is Associated with Positive Hepatitis B Vaccine Response
Ju-Suk Lee, MD PhD, Sungkyunkwan university, Changwon,
South Korea, Jin-A Jung, MD, Dong-A University Hospital, Busan,
Bong-Seong Kim, MD, Gangneung Asan Hospital, Gangneung-Si,
Hyeon Jong Jong Yang, MD, Soonchunhyang University Hospital,
Seoul; Pediatric Allergy Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital, Seoul, South Korea and
Ja Hyeong Kim, MD, Ulsan University Hospital, Ulsan
Functional Characterization of A Cis-Acting Temperature Sensitive Mutation From A Respiratory Syncytial Virus Vaccine
Candidate
Michael Teng1,2, David J. Fitzhugh, MD1, Kim Tran1, Richard F.
Lockey, MD1,3 and Peter Collins2, 1University of South Florida
Morsani College of Medicine, Tampa, FL, 2NIAID, Bethesda,
MD, 3James A. Haley Veterans Hospital, Tampa, FL
A Fusion Protein Designed with Segments of Different Allergens of Blomia Tropicalis
Dalgys Martinez1, Marlon Munera1, Jose Cantillo1, Leonardo
Puerta1,2 and Luis Caraballo1,2, 1Institute for Immunological Research/University of Cartagena, Cartagena, Colombia, 2Foundation
for the development of medical and biological sciences, Cartagena,
Colombia
Inhibition of IL-1b Mediated Proinflammatory Cytokine
Production by Epigallocatechin Gallate in Human Alveolar
Epithelial Cells
Oluwakemi Phillips1, Ruan R. Cox Jr1, Jutaro Fukumoto, MD,
PhD1, Itsuko Fukumoto, DMD1, Prasanna Tamarapu1, Tran
Luong1, Richard F. Lockey, MD1,2 and Narasaiah Kolliputi,
PhD3, 1Morsani College of Medicine, University of South Florida,
Tampa, FL, 2James A. Haley Veterans Hospital, Tampa, FL, 3Internal Medicine, Morsani College of Medicine, University of South
Florida, Tampa, FL
Safety and Immunogenicity of Flublok, a Highly Purified Recombinant Recombinant Influenza Vaccine Made without Eggs
or Live Influenza Viruses
Ruvim Izikson, MD, Elizabeth N. Ibbitson, RN and Daniel
Adams, JD, Protein Sciences, Meriden, CT
Immune Response Post-Administration of Polyvalent Pneumococcal Vaccine and Implications Regarding Clinical Efficacy
Javaid M. Khan, DO1,2, Hassan Nasir, DO1,2 and Walter Ryan,
DO1,2, 1Larkin Community Hospital, Miami, FL, 2Nova Southeastern University College of Osteopathic Medicine, Davie, FL
Intravenous Immune Globulin Acts in an Fc-Gamma-ReceptorIndependent Manner in an Antigen-Driven Murine Model of
Allergic Asthma
Gabriel N. Kaufman, MSc1, Amir Hossein Massoud1, Ryan
Fiter1, Ciriaco Piccirillo, PhD2 and Bruce D. Mazer, MD
FAAAAI1,3, 1Meakins-Christie Laboratories, Montreal, QC, Canada, 2McGill Centre for the Study of Host Resistance, Montreal,
QC, Canada, 3Montreal Childrens Hospital, Montreal, QC,
Canada

FEBRUARY 2013
Occupational and Envirnmental Exposures

2204
42
43
44
45
46
47
48
49
Predictive Value of Normal Non-Specific Bronchial Responsiveness (NSBR) in the Investigation of Occupational Asthma (OA)
Andre Cartier, MD, FAAAAI, Jacques-Andre Pralong, Manon
Labrecque, Jocelyne LArchevêque and Catherine Lemiere, Hopital
du Sacre-Coeur de Montreal, Montreal, QC, Canada
Relationship of Airway Hyperresponsiveness and RGS2 Expression in Smokers
Harold DelasAlas, MD, PharmD1, Ningxi Zhu, MD, PhD1, Yaping Tu, PhD2 and Thomas B. Casale, MD FAAAAI1, 1Creighton
University School of Medicine, Omaha, NE, 2Creighton University,
Omaha, NE
Muramic Acid in Indoor Air and Dust: Relationship with Home
Characteristics
Atin Adhikari, PhD1, David Popham, PhD2, Christopher
Schaffer1, Reshmi Indugula1, Sergey Grinshpun, PhD1 and Tiina
Reponen, PhD1, 1University of Cincinnati, Cincinnati, OH,
2
Virginia Tech, Blacksburg, VA
Endotoxin in House Dust Mite Extracts Stimulate Human Dermal Fibroblasts
Larry G. Arlian, PhD FAAAAI, Jananie Rockwood and Marjorie
S. Morgan, PhD, Wright State University, Dayton, OH
Specific Inhalation Challenge with Isocyanates Induces Nasal
Congestion in Patients with Probable Occupational Asthma
Roberto Castano, MD, PhD, Hôpital du Sacre-Coeur de Montreal,
Montreal, QC, Canada, Victor Johnson, PhD, BRT-Burleson Research Technologies and Andre Cartier, MD, FAAAAI, Hopital
Identifying Genetic Susceptibility to Sensitization to Cephalosporins in Hospital Workers
Young-Hee Nam, MD1, Jeong-Eun Kim, MD2, Seung-Hyun Kim,
PhD3, Hyun Jung Jin, MD4, Yoo Seob Shin, MD, PhD3, Young Min
Min Ye, MD3 and Hae-Sim Park, MD, PhD3, 1Dong-A University
School of Medicine, Busan, South Korea, 2Samsung Changwon
Hospital, Changwon, South Korea, 3Ajou University School of
Medicine, Suwon, South Korea, 4Yeungnam University College
of Medicine, Daegu, South Korea
House Dust Mite Group 2 Allergen Modulates LPS-Induced
Responses in Airway Sensory Neurons
Mayur Patil, MS1, Edward G. Brooks, MD2, Michael Henry,
D.D.S, PhD1 and Armen Akopian, PhD3, 1UTHSCSA, san antonio,
TX, 2Univ. Texas Health Science Center San Antonio, San Antonio,
TX, 3UTHSCSA, San Antonio, TX
Effect of Recent Acetaminophen Usage in the Development of
Asthma and Bronchial Hyperresponsiveness Is Modified by
Toll Like receptor4 (rs1927911) Polymorphism
Song I Yang, MD1,2, Seung-Hwa Lee, BS3, Mi-Jin Kang, MS3,
Ho-Sung Yu, BS3, Young Ho Jung, MD1,2, Ju-Hee Seo, MD4, JiWon Kwon, MD5, Byoung-Ju Kim, MD, PhD6, Ha-Jung Kim,
PhD, DVM3, Young-Joon Kim, MS3, Hee-Suk Kim3, Kyungmo
Hong7, So-Yeon Lee, MD8, Kang Seo Park, MD9, Jinho Yu, MD,
PhD1,2 and Soo-Jong Hong, MD, PhD1,2, 1Childhood Asthma
Atopy Center, Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea, 2Research Center for Standardization of Allergic Disease, Seoul,
South Korea, 3Asan Institute for Life Sciences, University of Ulsan
College of Medicine, Seoul, South Korea, 4Department of Pediatrics, Korea Cancer Center Hospital, Seoul, South Korea, 5Department of Pediatrics, Seoul National University Bundang Hospital,
Seoul National University College of Medicine, Seongnam, South
Korea, 6Department of Pediatrics, Hae-undae Paik Hospital, Inje
University College of Medicine, Busan, South Korea, 7Goucher
College, Baltimore, USA, 8Department of Pediatrics, Hallym
33
34
35
36
37
38
39
40
41
88
Council, South Africa, 4Medical Research Council Unit for Inflammation and Immunity, Department of Immunology, University of
Pretoria and Tshwane Academic Division of National Health Laboratory Service, South Africa
Atheroprotection Conferred by Immunization with 15-Mer
Peptide Fragments From ApoB100
Kevin Tse, MD1, Harley Tse, PhD2, Michael Shaw2, Alessandro
Sette, Biol. Sci.3 and Klaus Ley, MD3, 1UCSD, 2Wayne State
University, 3La Jolla Institute for Allergy and Immunology, La
Jolla, CA
Removal of Coagulation Factors by the Gamunex-C Purification Process
Melanie Williams, PhD, Jeff Willey, Katherine Tull, Glenn Stevenson, Mona Parks, LaToya McElrath, Luda Golovko, Catherine
Russ, John Griffin and Pete Vandeberg, Grifols, Inc., Raleigh, NC
Serum 25-Hydroxyvitamin D Is Associated with Positive Hepatitis B Vaccine Response
Ju-Suk Lee, MD PhD, Sungkyunkwan university, Changwon,
South Korea, Jin-A Jung, MD, Dong-A University Hospital, Busan,
Bong-Seong Kim, MD, Gangneung Asan Hospital, Gangneung-Si,
Hyeon Jong Jong Yang, MD, Soonchunhyang University Hospital,
Seoul; Pediatric Allergy Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital, Seoul, South Korea and
Ja Hyeong Kim, MD, Ulsan University Hospital, Ulsan
Functional Characterization of A Cis-Acting Temperature Sensitive Mutation From A Respiratory Syncytial Virus Vaccine
Candidate
Michael Teng1,2, David J. Fitzhugh, MD1, Kim Tran1, Richard F.
Lockey, MD1,3 and Peter Collins2, 1University of South Florida
Morsani College of Medicine, Tampa, FL, 2NIAID, Bethesda,
MD, 3James A. Haley Veterans Hospital, Tampa, FL
A Fusion Protein Designed with Segments of Different Allergens of Blomia Tropicalis
Dalgys Martinez1, Marlon Munera1, Jose Cantillo1, Leonardo
Puerta1,2 and Luis Caraballo1,2, 1Institute for Immunological Research/University of Cartagena, Cartagena, Colombia, 2Foundation
for the development of medical and biological sciences, Cartagena,
Colombia
Inhibition of IL-1b Mediated Proinflammatory Cytokine
Production by Epigallocatechin Gallate in Human Alveolar
Epithelial Cells
Oluwakemi Phillips1, Ruan R. Cox Jr1, Jutaro Fukumoto, MD,
PhD1, Itsuko Fukumoto, DMD1, Prasanna Tamarapu1, Tran
Luong1, Richard F. Lockey, MD1,2 and Narasaiah Kolliputi,
PhD3, 1Morsani College of Medicine, University of South Florida,
Tampa, FL, 2James A. Haley Veterans Hospital, Tampa, FL, 3Internal Medicine, Morsani College of Medicine, University of South
Florida, Tampa, FL
Safety and Immunogenicity of Flublok, a Highly Purified Recombinant Recombinant Influenza Vaccine Made without Eggs
or Live Influenza Viruses
Ruvim Izikson, MD, Elizabeth N. Ibbitson, RN and Daniel
Adams, JD, Protein Sciences, Meriden, CT
Immune Response Post-Administration of Polyvalent Pneumococcal Vaccine and Implications Regarding Clinical Efficacy
Javaid M. Khan, DO1,2, Hassan Nasir, DO1,2 and Walter Ryan,
DO1,2, 1Larkin Community Hospital, Miami, FL, 2Nova Southeastern University College of Osteopathic Medicine, Davie, FL
Intravenous Immune Globulin Acts in an Fc-Gamma-ReceptorIndependent Manner in an Antigen-Driven Murine Model of
Allergic Asthma
Gabriel N. Kaufman, MSc1, Amir Hossein Massoud1, Ryan
Fiter1, Ciriaco Piccirillo, PhD2 and Bruce D. Mazer, MD
FAAAAI1,3, 1Meakins-Christie Laboratories, Montreal, QC, Canada, 2McGill Centre for the Study of Host Resistance, Montreal,
QC, Canada, 3Montreal Childrens Hospital, Montreal, QC,
Canada

FEBRUARY 2013
Occupational and Envirnmental Exposures

2204
42
43
44
45
46
47
48
49
Predictive Value of Normal Non-Specific Bronchial Responsiveness (NSBR) in the Investigation of Occupational Asthma (OA)
Andre Cartier, MD, FAAAAI, Jacques-Andre Pralong, Manon
Labrecque, Jocelyne LArchevêque and Catherine Lemiere, Hopital
Relationship of Airway Hyperresponsiveness and RGS2 Expression in Smokers
Harold DelasAlas, MD, PharmD1, Ningxi Zhu, MD, PhD1, Yaping Tu, PhD2 and Thomas B. Casale, MD FAAAAI1, 1Creighton
University School of Medicine, Omaha, NE, 2Creighton University,
Omaha, NE
Muramic Acid in Indoor Air and Dust: Relationship with Home
Characteristics
Atin Adhikari, PhD1, David Popham, PhD2, Christopher
Schaffer1, Reshmi Indugula1, Sergey Grinshpun, PhD1 and Tiina
Reponen, PhD1, 1University of Cincinnati, Cincinnati, OH,
2
Virginia Tech, Blacksburg, VA
Endotoxin in House Dust Mite Extracts Stimulate Human Dermal Fibroblasts
Larry G. Arlian, PhD FAAAAI, Jananie Rockwood and Marjorie
S. Morgan, PhD, Wright State University, Dayton, OH
Specific Inhalation Challenge with Isocyanates Induces Nasal
Congestion in Patients with Probable Occupational Asthma
Roberto Castano, MD, PhD, Hôpital du Sacre-Coeur de Montreal,
Montreal, QC, Canada, Victor Johnson, PhD, BRT-Burleson Research Technologies and Andre Cartier, MD, FAAAAI, Hopital
Identifying Genetic Susceptibility to Sensitization to Cephalosporins in Hospital Workers
Young-Hee Nam, MD1, Jeong-Eun Kim, MD2, Seung-Hyun Kim,
PhD3, Hyun Jung Jin, MD4, Yoo Seob Shin, MD, PhD3, Young Min
Min Ye, MD3 and Hae-Sim Park, MD, PhD3, 1Dong-A University
School of Medicine, Busan, South Korea, 2Samsung Changwon
Hospital, Changwon, South Korea, 3Ajou University School of
Medicine, Suwon, South Korea, 4Yeungnam University College
of Medicine, Daegu, South Korea
House Dust Mite Group 2 Allergen Modulates LPS-Induced
Responses in Airway Sensory Neurons
Mayur Patil, MS1, Edward G. Brooks, MD2, Michael Henry,
D.D.S, PhD1 and Armen Akopian, PhD3, 1UTHSCSA, san antonio,
TX, 2Univ. Texas Health Science Center San Antonio, San Antonio,
TX, 3UTHSCSA, San Antonio, TX
Effect of Recent Acetaminophen Usage in the Development of
Asthma and Bronchial Hyperresponsiveness Is Modified by
Toll Like receptor4 (rs1927911) Polymorphism
Song I Yang, MD1,2, Seung-Hwa Lee, BS3, Mi-Jin Kang, MS3,
Ho-Sung Yu, BS3, Young Ho Jung, MD1,2, Ju-Hee Seo, MD4, JiWon Kwon, MD5, Byoung-Ju Kim, MD, PhD6, Ha-Jung Kim,
PhD, DVM3, Young-Joon Kim, MS3, Hee-Suk Kim3, Kyungmo
Hong7, So-Yeon Lee, MD8, Kang Seo Park, MD9, Jinho Yu, MD,
PhD1,2 and Soo-Jong Hong, MD, PhD1,2, 1Childhood Asthma
Atopy Center, Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea, 2Research Center for Standardization of Allergic Disease, Seoul,
South Korea, 3Asan Institute for Life Sciences, University of Ulsan
College of Medicine, Seoul, South Korea, 4Department of Pediatrics, Korea Cancer Center Hospital, Seoul, South Korea, 5Department of Pediatrics, Seoul National University Bundang Hospital,
Seoul National University College of Medicine, Seongnam, South
Korea, 6Department of Pediatrics, Hae-undae Paik Hospital, Inje
University College of Medicine, Busan, South Korea, 7Goucher
College, Baltimore, USA, 8Department of Pediatrics, Hallym
50
51
52
University Secred Heart Hospital, Anyang, South Korea, 9Department of Pediatrics, Presbyterian Medical Center, Jeonju, South
Korea
Disposition of Toluene Diisocyanate (TDI) Following Dermal
Exposure
Donald H. Beezhold, PhD, FAAAAI, Ajay Nayak, PhD, Stacey
Anderson, PhD, Brett Green, PhD and Paul Siegel, PhD, CDC/
NIOSH, Morgantown, WV
Production of a Methylenediphenyl Diisocyanate HaptenSpecific Monoclonal Antibody
Brett Green, PhD, Ajay Nayak, PhD, Brandon Law, MS, Paul Siegel, PhD and Donald H. Beezhold, PhD, FAAAAI, CDC/NIOSH,
Morgantown, WV
Environmental Assay to Measure Mouse Urine Antigens
Rosa Codina, PhD and Robert Esch, PhD, Greer Laboratories,
Inc., Lenoir, NC
59
60
61
62
Allergens and Epitopes

2205
53
54
55
56
57
58
Novel Grass Pollen Antigens Contribute to the Stimulation of

Th2 Cytokines in Allergic Individuals
Veronique M. Schulten1, Jason Greenbaum1, Ravi Kolla1, Cecilia
Arlehamn-Lindestam1, Carla Oseroff1, Rafeul Alam, MD, PhD,
FAAAAI2, David H. Broide, MB, ChB, FAAAAI3, Howard
Grey1, Alessandro Sette, Biol. Sci.1 and Bjoern Peters1, 1La Jolla
Institute for Allergy and Immunology, La Jolla, CA, 2National Jewish Health, Denver, CO, 3UC San Diego, La Jolla, CA
Structural Analysis Reveals Molecular Basis for Interactions of
Group 1 Allergens with Species Specific and Cross-Reactive
Antibodies
Maksymilian Chruszcz, PhD1, Anna Pomes, PhD, FAAAAI2,
Tomasz Osinski3, Karolina A. Majorek3, Jill Glesner2, Wladek Minor, PhD3, Lisa D. Vailes2 and Martin D. Chapman, PhD,
FAAAAI2, 1University of South Carolina, Columbia, SC, 2Indoor
Biotechnologies, Inc., Charlottesville, VA, 3University of Virginia,
Charlottesville, VA
The Anionic Surfactant Lipid, Palmitoyl-Oleoyl-Phosphatidylglycerol (POPG), Suppresses Der p 2-Stimulated Inflammatory
Responses in Lung Epithelial Cells and Macrophages
Sasipa Tanyaratsrisakul, PhD1, Surapon Piboonpocanun, PhD2
and Dennis R. Voelker, PhD1, 1National Jewish Health, Denver,
2
Institute of Molecular Biosciences, Mahidol University, Thailand
The Cockroach Allergen Bla g 1 Forms Alpha Helical Capsules
with an Internal Lipid Binding Cavity: Implications for Allergenicity
Geoffrey Mueller, PhD1, Lars Pedersen1, Fred Lih1, Jill Glesner2,
Martin D. Chapman, PhD FAAAAI2, Ken Tomer1, Robert London1
and Anna Pomes, PhD FAAAAI2, 1National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, 2Indoor
Biotechnologies, Inc., Charlottesville, VA
De Novo Creation of an Antibody Binding Epitope On Group
1 Mite Allergens
Jill Glesner1, Maksymilian Chruszcz, PhD2, Wladek Minor, PhD3,
Martin D. Chapman, PhD FAAAAI1 and Anna Pomes, PhD
FAAAAI1, 1Indoor Biotechnologies, Inc., Charlottesville, VA,
2
University of South Carolina, Columbia, SC, 3University of
Virginia, Charlottesville, VA
Recombinant Major Ragweed Allergen Amb a 1: Physicochemical Characterization and Immunologic Comparison of Five
Recombinant Ragweed Isoallergens Amb a 1.01 to Amb a 1.05
Andreas Nandy, PhD1, Steffen Augustin, PhD1, Martin Wald,
PhD1, Linda Pump1, Alexis Hermann1, Sven Treder1, Susan
63
Hagen1, Riccardo Asero, MD2 and Steen Klysner, PhD1, 1Allergopharma Joachim Ganzer KG, Reinbek, Germany, 2Clinica San
Carlo, Paderno Dugnano, Italy
Characterization of Native and Recombinant Per a 10 Allergen,
of Periplaneta Americana
Dhanapal Govindaraj1, Shailendra N. Gaur, MD, FAAAAI2 and
Naveen Arora1, 1CSIR Institute of Genomics and Integrative Biology, New Delhi, India, 2University Of Delhi, Delhi, India
Expression of Immunoreactive Recombinant Alt a 1 in Pichia
Pastoris
Audrey Koid, BA, Meredith Lohmann, MS, Martin D. Chapman,
PhD, FAAAAI and Sabina Wunschmann, PhD, INDOOR Biotechnologies, Inc.
Interactions Between Der p 7 Allergen and Human IgE/Mouse
Monoclonal Antibody WH9
Horng-Der Shen, PhD1, Sheh-Yi Sheu2, Hong Chou1, Hsiao-Yun
Tai1 and Yu-Sen Chen1, 1Taipei Veterans General Hospital, Taipei,
2
National Yang-Ming University
Crystal Structure of Korean Pine (Pinus koraiensis) Vicilin
Yuzhu Zhang, PhD1,2, Tengchuan Jin, PhD2 and Yang Wang2,
1
USDA, Albany, CA, 2Illinois Institute of Technology, Chicago, IL
IgE, IgG1, IgG4 Reactivity Profile to Blo t 5 Recombinant
Allergen From Blomia Tropicalis and Its Modified Form in
Atopic and Non-Atopic Patients
Ernesto Akio Taketomi, MD, PhD1, Juliana Miranda2, Karine
Almeida2, Isabella Siman2, Leandro Ynoue2, Helena Penha2, Deise
2
, Laura Tomaz2 and Jair Cunha Junior2,

Silva2, Barbara Avila
1
Federal University of Uberlandia, Uberlandia, Brazil, 2Federal
University of Uberlândia
SATURDAY
Abstracts AB243

Food Allergens/Food Disease Epi/Insect

Hypersensitivity
2206
64
65
66
67
68
Research of the Potential Allergenicity of Recombinant Human

Lactoferrin (rhLF)
Cui Zhou1, Huilian Che, MD1,2, Na Sun1, Jing Wang1 and Kunlun
Huang1,2, 1College of Food Science and Nutritional Engineering,
China Agricultural University, Beijing, China, 2The Supervision,
Inspection and Testing Center of Genetically Modified Organisms,
Ministry of Agriculture, Beijing, China
Study of NEW Lettuce (Lactuca sativa) Allergens
Elisa Haroun Diaz1, Manuel De Las Heras1, Javier Cuesta Herranz2, Esther Mu~noz3, Carlos Pastor3 and Joaquin Sastre, MD,
PhD, FAAAAI1, 1Fundacion Jimenez Diaz, Madrid, Spain, 2Clinica
Nuestra Sra. De la Concepcion, Madrid, Spain, 3Fundacion Jimenez
Diaz
Determining the Most Potent Allergens of Walnut
Pitud Rangsithienchai, MD1,2, Yonghua Zhuang, MD, PhD1, Kirk
Hansen, PhD1 and Stephen C. Dreskin, MD, PhD, FAAAAI1,
1
University of Colorado Denver, Aurora, CO, 2National Jewish
Health, Denver, CO
A Method of Reducing Allergenicity of Legume Proteins
Naveen Arora, CSIR- IGIB, Delhi, India, Ramkrashan Kasera,
CSIR-Institute of Genomics and Integrative Biology, India, Anand
Singh, PhD, Institute of Genomics and Integrative Biology, DELHI,
India, Shakuntala Lavasa, USLavasa Medical & Research Center,
India and Komerla Nagendra, Bengaluru Allergy Centre, India
Comparative Analysis of IgE Binding Proteins in GM and NonGM Rice Varieties Using Atopic Patients Sera
Chandni Mathur, INSTITUTE OF GENOMICS & INTEGRATIVE BIOLOGY, DELHI, India, P.C Kathuria, NATIONAL ALLERGY CENTRE, India, Shakuntala Lavasa, USLavasa Medical
89
AB244 Abstracts
SATURDAY
69
70
71
72
73
74
75
76
77
78
90
& Research Center, India, Pushpa Dahiya, MD University, India

and Anand Singh, PhD, Institute of Genomics and Integrative
Biology, DELHI, India
Analysis of the Association Between Food Allergy and Sensitization to Ltp and Profilin
Felicia Berroa1, M Jose Goikoetxea, PhD, MD2, Marta M. Ferrer,
MD, PhD, FAAAAI2, Paula Cabrera-Freitag, MD, PhD3, Gracia
Javaloyes, MD, PhD1, Maria L Sanz, MD PhD1 and Gabriel Gastaminza, MD, PhD1, 1Department of Allergy, Clinica Universidad de
Navarra, Spain, 2Department of Allergy, Clinica Universidad de
Navarra, Pamplona, Spain, 3Clinica Universidad de Navarra, Pamplona, Spain
Structure and Function of the Peanut Panallergen Ara h 8
Barry K. Hurlburt, PhD1, Lesa Celeste, PhD2, Karolina A. Majorek3, Jane McBride4, Soheila J. Maleki, PhD1, Wladek Minor,
PhD3 and Maksymilian Chruszcz, PhD5, 1USDA-ARS-SRRC,
New Orleans, LA, 2university of south carolina, columbia, SC,
3
University of Virginia, Charlottesville, VA, 4usda-ars-srrc, new orleans, LA, 5University of South Carolina, Columbia, SC
Chemical and Structural Alterations to Ara h 2 Following Simulated Roasting
Tysheena Charles, MS1,2, Casey C. Grimm2, Samuel Landry,
PhD3 and Soheila J. Maleki, PhD2, 1Tulane University, New
Orleans, LA, 2USDA-ARS-SRRC, New Orleans, LA, 3Tulane University Health Sciences Center, New Orleans, LA
Effect of D-Amino Acids On IgE Binding to Peanut Allergens
Si-Yin Chung and Shawndrika Reed, USDA-ARS-SRRC, New Orleans, LA
Repeated Sequences with Similar Physicochemical Properties
May Account for Cross-Reactions Between Peanuts and Tree
Nuts
Soheila J. Maleki, PhD1, Tysheena Charles, MS1,2, Casey C.
Grimm1, Barry K. Hurlburt, PhD1, Maksymilian Chruszcz, PhD3,
Hsiaopo Cheng, MS1 and Catherine Schein, PhD4, 1USDA-ARSSRRC, New Orleans, LA, 2Tulane University, New Orleans, LA,
3
University of South Carolina, Columbia, SC, 4University of Texas
Medical Branch, Galveston, TX
Cross-Reactivity Among Almond, Peanut and Other Tree Nuts
in Almond and Peanut Allergic Patients
Brandi Hunley Dyer, MD1, Anupama Kewalramani, MD
FAAAAI2, Hsiaopo Cheng, MS3, Suzanne S. Teuber, MD
FAAAAI4 and Soheila J. Maleki, PhD3, 1Tulane University,
2
University of Maryland School of Medicine, Laurel, MD,
3
USDA-ARS-SRRC, New Orleans, LA, 4UC Davis
Antibodies to the Physiochemical-Consensus Sequence of Jug r
2 Containing Glutamine-Rich Repeats Bind Allergens in Peanuts and Other Tree Nuts
Catherine Schein, PhD1, Suzanne S. Teuber, MD FAAAAI2,
Hsiaopo Cheng, MS3, Casey C. Grimm3 and Soheila J. Maleki,
PhD3, 1University of Texas Medical Branch, Galveston, TX, 2UC
Davis, 3USDA-ARS-SRRC, New Orleans, LA
Characterization of the Effects of Proteolysis and Reduction On
Cashew Allergens
Christopher P. Mattison1, Wendy A. Desormeaux1, Casey C.
Grimm1 and Richard L. Wasserman, MD, PhD2, 1USDA-ARSSRRC, New Orleans, LA, 2Allergy/Immunology Research Center
of North Texas, Dallas, TX
New Allergens Involved in Shrimp-Mite Cross Reactivity
Cristina Gamez Jr, IIS-Fundacion Jimenez Daz, Madrid, Spain,
Joaquin Sastre, MD, PhD, FAAAAI, Fundacion Jimenez Diaz, Madrid, Spain, Manuel Boquete, MD, Hospital Generla de Calde,
Lugo, Spain and Victoria Del Pozo, PhD, IIS-Fundacion Jimenez
Daz, Madrid, Spain
IgE Cross-Reactivity of Shrimp and Cockroach Tropomyosins
Among Patients with Positive Skin Tests to Shrimp
Thalita Martins1, Adriana S. Moreno, PhD2, Thas Mendonca3,
Luana Delcaro3 and Luisa Karla P. Arruda, MD, PhD, FAAAAI4,

FEBRUARY 2013
79
80
81
82
83
84
85
86
FMRP- University of Sao Paulo, 2University of Sao Paulo, Ribeirao Preto, Brazil, 3University of Sao Paulo, 4School of Medicine
of Ribeirao Preto, Ribeirao Preto, Brazil
Identification of Primary Sensitizers in Patients with Double
Sensitization to House Dust Mite and Shrimp Using Component-Resolved Diagnosis
Sasikarn Suesirisawad, MD1, Narissara Suratannon, MD2, Piyawadee Lertchanaruengrith, MD1, Jarungchit Ngamphaiboon, MD2
and Pantipa Chatchatee, MD2, 1King Chulalongkorn Memorial
Hospital, Bangkok, Thailand, 2Department of Pediatrics King Chulalongkorn Memorial Hospital, Bangkok, Thailand
High Rate of Food Sensitization, but Not Food Allergy, in Latex
Allergy
Pedro Giavina-Bianchi, MD PhD1, Laila Sabino Garro, MD2,
Jorge Kalil, MD, PhD1 and Antonio Ablio Motta, MD PhD3, 1Clinical Immunology and Allergy Division, University of Sao Paulo,
Sao Paulo, Brazil, 2Division of Clinical Immunology and Allergy,
University of S~ao Paulo, Brazil, 3Division of Clinical Immunology
and Allergy, University of S~ao Paulo
Types of Food Allergy and Season of Birth in Outpatient Children
Benjamin Liss, BS, Penn State College of Medicine, Hershey, PA,
Sue Boehmer, MS, Penn State University, Hershey, PA and Tracy
B. Fausnight, MD, FAAAAI, Penn State Childrens Hospital, Hershey, PA
Delivery by Cesarean Section Increases Risk for Food Sensitization At Age 2 Years
Mohammad Younus, MD1, Ganesa Wegienka, PhD2, Suzanne
Havstad, MA2, Christine Joseph, PhD2, Christine Cole Johnson,
PhD, M.P.H., FAAAAI2, Dennis Ownby, MD FAAAAI3 and Edward M. Zoratti, MD, FAAAAI1, 1Division of Allergy and Clinical
Immunology, Henry Ford Hospital, Detroit, MI, 2Department of
Public Health Sciences, Henry Ford Hospital, Detroit, MI, 3Division of Allergy-Immunology and Rheumatology, Georgia Health
Sciences University, Augusta, GA
Levels of TGFb and IL10 in Mothers Breast Milk and Childs
Risk of Sensitization to Egg, Milk, or Peanut in a Birth Cohort
Christine L.M. Joseph, PhD1, Suzanne Havstad, MA1, Kevin
Bobbitt, PhD2, Kimberley J. Woodcroft, PhD2, Christian G.
Nageotte, MD2, Rana T. Misiak, MD3, Jerel M. Ezell, M.P.H.1, Edward M. Zoratti, MD, FAAAAI4, Ganesa Wegienka, PhD1, Dennis
Ownby, MD5 and Christine Cole Johnson, PhD, M.P.H., FAAAAI1,
1
Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, 2Henry Ford Health System, Detroit, MI, 3Henry Ford
Health System, Northville, MI, 4Division of Allergy and Clinical
Immunology, Henry Ford Hospital, Detroit, MI, 5Georgia Health
Sciences University, Augusta, GA
Characterization of Food Allergy in Urban Adults
Shradha Agarwal, MD, Mount Sinai School of Medicine, New
York, NY and Julie Wang, MD FAAAAI, Mt. Sinai School of Medicine, New York, NY
Prevalence of Food Allergy in New York City (NYC) School
Children
Sarah A. Taylor-Black, MD1, Elisabete Weiderpass Vainio, Msc,
PhD2, Paolo Boffetta, MD, MPH3, Scott H. Sicherer, MD,
FAAAAI1 and Julie Wang, MD, FAAAAI1, 1Mt. Sinai School of
Medicine, New York, NY, 2Department of Medical Epidemiology
and Biostatistics, Karolinska Instituetet Cancer Registry of Norway,
Oslo, and Department of Community Medicine, Tromso, Norway,
3
Institute for Translational Epidemiology, Mount Sinai School of
Medicine, New York, NY
Prevalence of Milk, Peanut and Egg Allergies in A Socioeconomically Diverse Cohort of Infants: Identifying Cases of
Food Allergy for Field Studies Using an Expert Panel
Jerel M. Ezell, M.P.H.1, Suzanne Havstad, MA1, Haejin Kim,
MD2, Ganesa Wegienka, PhD1, Dennis Ownby, MD FAAAAI3, Edward M. Zoratti, MD, FAAAAI2, Christine Cole Johnson, PhD,
87
88
89
90
91
92
93
M.P.H., FAAAAI1 and Christine L.M. Joseph, PhD1, 1Department

of Public Health Sciences, Henry Ford Hospital, Detroit, MI,
2
Division of Allergy and Clinical Immunology, Henry Ford Hospital, Detroit, MI, 3Division of Allergy-Immunology and Rheumatology, Georgia Health Sciences University, Augusta, GA
African American Race Is a Robust Risk Factor for Food, but
Not Aeroallergen Sensitization
Haejin Kim, MD1, Suzanne Havstad, MA2, Jerel M. Ezell,
M.P.H.2, Ganesa Wegienka, PhD2, Edward M. Zoratti, MD,
FAAAAI1 and Christine Cole Johnson, PhD, M.P.H., FAAAAI2,
1
Division of Allergy and Clinical Immunology, Henry Ford Hospital, Detroit, MI, 2Department of Public Health Sciences, Henry
Ford Hospital, Detroit, MI
Comparison of Allergy to Multiple Versus Single Foods in a Pediatric Urban Population
Jennifer M. Camacho, MD, Sarah A. Taylor-Black, MD and Julie
Wang, MD, FAAAAI, Mt. Sinai School of Medicine, New York, NY
The Anti-Inflammatory Pro-Resolution Lipoxin A4 Increases
During Ultra-Rush Venom Immunotherapy
Vincenzo Patella1,2, Mario Romano3, Eleonora Cianci4, Salvatore
Saitta5, Stefano Lattanzio4, Giovanni Florio2 and Sebastiano Gangemi5,6, 1School of Allergy and Clinical Immunology, University of
Naples Federico II, Naples, Italy, 2Division of Allergy and Clinical
Immunology, Agropoli General Hospital, ASL Salerno, Salerno,
Italy, 3Department of Experimental and Clinical Sciences, Center
of Excellence on Aging, G. DAnnunzio University Foundation,
Chieti, Italy, 4Department of Medicine and Aging Sciences, Center
of Excellence on Aging, G. DAnnunzio University Foundation,
Chieti, Italy, 5School and Division of Allergy and Clinical Immunology, Department of Human Pathology, University of Messina,
6
IBIM (Istituto di Biomedicina e Immunologia Molecolare
Alberto Monroy), CNR (Consiglio Nazionale delle Ricerche),
Palermo, Italy
Measurement of Hymenoptera Venom Specific IgE by the Immulite 3gAllergy in Subjects with Negative or Positive Results
by Immunocap
Mineaki Watanabe1, Hirokuni Hirata2, Naruo Yoshida1, Taichi
Shiobara1, Tatsuya Yokoyama1 and Takeshi Fukuda3, 1Dokkyo
medical university, Japan, 2dokkyo, 3Dokkyo Medical University
School of Medicine, Mibu, Japan
Evaluation and Validation of A Bee Venom Sting Challenge
Performed by A MICRO-Syringe
Maurizio Giuseppe Severino1, Gabriele Cortellini2, Elisabetta
Francescato3, Stefano Turillazzi4, Igino Spadolini5, Anthi Rogkakou6 and Giovanni Passalacqua, MD6, 1Allergy Clinic, Ospedale
San Giovanni di Dio, Florence, 2Internal Medicine and Rheumatology, Rimini Hospital, 3Entomon sas, Florence, 4Dipartimento di
Biologia Evoluzionistica, University of Florence, 5Anallergo,
Florence, 6Allergy and Respiratory Diseases, IRCCS San Martino
Hospital-IST-University of Genoa
Venom Immunotherapy in Patients with Clonal Mast CELL
Disorders: Efficacy, Safety and Practical Considerations
Patrizia Bonadonna, MD1, David Gonzalez-De-Olano2, Roberta
Zanotti3, Annamaria Riccio4, Laura De Ferrari4, Carla Lombardo1,
Anthi Rogkakou4, Luis Escribano, MD PhD5, Ivan AlvarezTwose6, Almudena Matito6, Arantza Vega, MD7 and Giovanni
Passalacqua, MD4, 1Allergy Unit, Azienda ospedale Universita di
Verona, Italy, 2Allergy Unit, Hospital Universitario de Fuenlabrada,
MAdrid, Spain, 3Department of Clinical and Experimental Medicine, Haematology Section, University of Verona, Italy, 4Allergy
and Respiratory Diseases, IRCCS San Martino Hospital-IST-University of Genoa, 5Instituto de Estudios de Mastocitosis, Hospital
Virgen Del Valle, Toledo, Spain, 6Instituto de Estudios de Mastocitosis,
Hospital Virgen Del Valle, Toledo, Spain, 7Allergy unit, HOSPITAL
UNIVERSITARIO GUADALAJARA, Guadalajara, Spain
Per a 3 Homologue of German Cockroach; A Novel Allergen
Identified Using Avian Scfv Antibodies
94
95
Taruna Khurana, PhD, FDA Center for Biologics Evaluation and

Research, Maggie Collison, FDA Center for Biologics Evaluation
and Resea, Rockville, MD, Fook Tim Chew, PhD, National University Singapore, Singapore, Singapore and Jay E. Slater, MD, FDA/
CBER/OVRR/DBPAP, Rockville, MD
Importance of Component Resolved Diagnosis of Vespula/Polistes Allergic Patients
Guillermo Salamanca, PhD1, Ruth Gutierrez2, Agustn Galan2,
Fernando De La Torre3, Arantza Vega, MD4, Lluis Marques,
MD5, Domingo Barber, PhD2 and Rafael Monsalve, PhD6,
1
ALK-Abello, Madrid, Spain, 2ALK-Abello, Madrid, Spain,
3
ALK Abello, Madrid, Spain, 4Allergy unit, HOSPITAL UNIVERSITARIO GUADALAJARA, Guadalajara, Spain, 5Hospital Santa
Maria- Universitari Arnau, Vilanova (Lleida), Spain, 6ALKABELLO, S. A., Madrid, Spain
Hymenoptera Venom Hypersensitivity Evaluation
Wayne Wolverton, DO, Walter Reed National Military Medical
Center, Bethesda, MD, Douglas E. Beakes, MD, FAAAAI, Walter
Reed Medical Center A/I Dept, Washington, DC and Silvia Huebner, MD, Evans Army Community Hospital, Fort Carson, CO
SATURDAY
Abstracts AB245

Urticaria/Angioedema
2207
96
97
98
99
100
101
A Phase I Assessment of the Safety and Tolerability Profile of

Novel Treatments for Acute Allergic Reactions Administered
by Intravenous and Intramuscular Injection Formulations
Mira Francis1, Mireille Noumeir1, Eric Sicard1, Marc Lefebvre1
and Jie Du2, 1Algorithme Pharma, Laval, QC, Canada, 2JDP Therapeutics Inc., Lansdale, PA
Comparison of Laboratory Findings and Medication Levels to
Control Urticaria According to Asst Reactivity in Chronic Idiopathic Urticaria
Seong-Wook Sohn and Soo-Kyeong Lee, Dongguk University
Ilsan Hospital
Seasonal Variation in Angioedema and Urticaria in an InnerCity Minority Population
Ashlei Mathew, MD1, Rauno O. Joks, MD FAAAAI2 and Gina
Dapul-Hidalgo, MD2, 1Center for Allergy and Asthma Research,
State University of New York Downstate Medical Center, Brooklyn, NY, 2State University of New York Downstate Medical Center,
Brooklyn, NY
The Association Between Strongyloides Stercoralis Infection
and Allergic Diseases
Lahari Rampur, MD, Albert Einstein/Jacobi medical centre,
Bronx, NY, Sunit Jariwala, MD, Albert Einstein/Montefiore Medical Center, New York, NY, Gabriele De Vos, MD, Albert Einstein
College of Medicine, Bronx, NY, Golda Hudes, MD PhD, Albert
Einstein / Montefiore Medical Center, New York, NY and David
L. Rosenstreich, MD FAAAAI, Albert Einstein / Montefiore Medical Center, NY
Clinical Characterization of Chronic Urticaria Phenotypes to
Predict Treatment Outcomes
Priyal Amin1, Tecumseh Bryson1, Danny Krall1, Linda Levin2,
John Eckman2 and Jonathan A. Bernstein3,4, 1University of Cincinnati, College of Medicine, 2University of Cincinnati, 3University of
Cincinnati Medical Center, Cincinnati, OH, 4Bernstein Allergy
Group, Cincinnati, OH
Age-Dependent Increase in Oral Steroid Utilization in the
Treatment of Chronic Urticaria
Roxana I. Siles, MD, Meng Xu and Fred H. Hsieh, MD, Cleveland
Clinic Foundation, Cleveland, OH
91
AB246 Abstracts
SATURDAY
102
103
104
105
106
107
108
109
110
111
112
92
"Choosing Wisely" Diagnostic Tests in Chronic Urticaria: Does

Screening for H. Pylori, Vitamin D Deficiency and Anti-Fceri
Antibodies Have a Role?
Ashvini Varadhi, MD1, Andrew Nickels, MD1,2, Eileen Wang, MD2,
Joseph Hageman, MD1 and Vesselin Dimov, MD1,2, 1Department of
Pediatrics, University of Chicago, Chicago, IL, 2Department of
Medicine, University of Chicago, Chicago, IL
Prevalence of Helicobacter Pylori Infection and Chronic Urticaria
James A. Loh, MD, University of Alberta, Edmonton, AB, Canada,
Amin S. Kanani, MD, University of British Columbia, Vancouver,
BC, Canada and Donald F. Stark, MD, FAAAAI, The University
of British Columbia, Vancouver, BC, Canada
Successful Treatment of Refractory Cholinergic Urticaria with
Omalizumab in a Pediatric Patient
Selene K. Bantz, MD, Jose G. Calderon, MD and David H. Dreyfus, MD, PhD, FAAAAI, Yale University School of Medicine, New
Haven, CT
Post-Treatment Levels of Matrix Metalloproteinase-9 and Vascular Endothelial Growth Factor in Patients with Chronic Urticaria
Denisa Ferastraoaru, MD, Albert Einstein / Jacobi Medical Center, Bronx, NY, Purvi Parikh, MD, Albert Einstein / Montefiore
Medical Center, Sunit Jariwala, MD, Albert Einstein/Montefiore
Medical Center, New York, NY, Golda Hudes, MD, PhD, Albert
Einstein / Montefiore Medical Center, New York, NY and David
L. Rosenstreich, MD FAAAAI, Albert Einstein / Montefiore
Medical Center, NY
Correlation of Cellular Measures and Disease Activity in
Chronic Idiopathic Urticaria
Eric Oliver, MD, Patricia M. Sterba, MS and Sarbjit S. Saini, Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD
Baseline Characteristics of Patients with Refractory Chronic
Idiopathic/Spontaneous Urticaria (CIU/CSU) Enrolled in a
Phase III, Randomized, Placebo-Controlled Trial of Omalizumab
Karin Rosen, Genentech, Inc., South San Francisco, Hsin-Ju
Hsieh, Genentech, Inc., South San Francisco, CA, Panayiotis Georgiou, Novartis Pharmaceuticals UK Limited, Horsham, West
Sussex, United Kingdom, Thomas Casale, Creighton University
Medical Center, Omaha and Marcus Maurer, Charite-Universitatsmedizin Berlin, Berlin, Germany
Autoimmune Phenotype in Refractory Chronic Urticaria Does
Not Affect Response to Omalizumab
Ravi K. Viswanathan, MD1,2 and Sameer K. Mathur, MD, PhD
FAAAAI1,2, 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2William S. Middleton Veterans Hospital,
Madison, WI
Decrease in Fc Epsilon R1 Antibodies with IVIG
Michael J. Radtke, MD, Dreyer Medical Clinic
Does Early Clinical Manifestation of Hereditary Angioedema
(HAE) Influence the Clinical Course of the Disease?
Inmaculada Martinez-Saguer, MD1, Jochen Graff2, Eva Rusicke,
MD1, Emel Aygoren-Pursun1, Thomas Klingebiel1 and Wolfhart
Kreuz, MD3, 1J.-W. Goethe University Hospital, 22Clinical Trial
Center Rhine-Main (KSRM), 3International Research Institute for
Blood Coagulation Disorders and Immunodeficiencies
Presumed Type III Hereditary Angioedema Presenting with Recurrent Abdominal Distention After Estrogen Use
Jennifer E. Fergeson, DO1,2, Richard F. Lockey, MD1,2 and Mark
C. Glaum, MD, PhD, FAAAAI1,2, 1James A. Haley Veterans Hospital, Tampa, FL, 2University of South Florida Morsani College of
Medicine, Tampa, FL
Clinical Characteristics of Hereditary Angioedema (HAE) Type
III Patients Compared with Those with HAE Type I/II
Isabelle Boccon-Gibod1, Laurence Bouillet, MD1 and Clement

FEBRUARY 2013
113
114
115
116
117
118
119
120
121
Olivier2, 1Grenoble University Hospital, Grenoble, France, 2Shire

HGT, Eysins, Switzerland
Angioedema in the ER Department: Predicting Outcomes
S. L. Felder1,2, R. M. Curtis1,2, I. Ball, MD, FRCP1,3 and R. Borici-Mazi, MD, FRCP1,4, 1Queens University, Kingston, ON,
Canada, 2School of Medicine, 3Department of Emergency Medicine, 4Division of Allergy and Immunology
Expanding the Paradigm of Idiopathic Angioedema: A Patient
Who Responds to C1-Esterase Inhibitor (C1INH) Replacement
Therapy
Michael G. Gates, MD and John T. Anderson, MD, University of
Alabama at Birmingham, Birmingham, AL
Efficacy of C1-Inhibitor Concentrate (Berinert) for the Treatment of Cutaneous Attacks of Acute Hereditary Angioedema
Compared to Historical Untreated Controls
Konrad Bork, MD1, Petra Staubach1, Jonathan A. Bernstein2,
Henrike Feuersenger3, Thomas Machnig3 and Timothy J. Craig,
DO, FAAAAI4, 1University of Mainz, Mainz, Germany, 2University
of Cincinnati Medical Center, Cincinnati, OH, 3CSL Behring
GmbH, Marburg, Germany, 4Penn State University College of Medicine, Hershey, PA
Discovery and Characterization of a Fully Human Monoclonal
Antibody Inhibitor of Plasma Kallikrein for the Treatment of
Plasma Kallikrein-Mediated Edema
Daniel Sexton, Ryan Faucette, Malini Viswanathan, Niksa Kastrapeli, Kris Kopacz, Greg Conley, Allison Lindberg, Janja Cosic, Stephen Comeau, Shauna Mason, Jon Kenniston, Mike DiLeo, Jie Chen,
Robert Ladner, Andrew Nixon and Christopher TenHoor, Dyax Corp.
Treatment of Hereditary Angioedema Attacks with Icatibant: A
Comparison of Observational Data with Clinical Trial Data
Marcus Maurer, MD, Charite - Universitatsmedizin Berlin, Berlin,
Germany, Hilary Longhurst, MD, Barts and The London Hospital,
London, United Kingdom, Huamin Henry Li, MD, PhD, FAAAAI,
Institute for Asthma and Allergy, Chevy Chase, MD, Vincent Fabien, PhD, Shire Human Genetic Therapies, Eysins, Switzerland
and William R. Lumry, MD, FAAAAI, Allergy and Asthma Specialists, Dallas, TX
Safety and Convenience of Self-Administered Icatibant for the
Treatment of Acute Hereditary Angioedema Attacks
Werner Aberer, MD, Medizinische Universitat Graz, Graz, Austria, Anette Bygum, MD, Odense University Hospital, Odense,
Denmark, Nitin Nair, PhD, Shire Human Genetic Therapies, Lexington and Shmuel Kivity, MD, The Tel Aviv Medical Center, Tel
Aviv, Israel
Benefits of Early Administration with Icatibant for the Treatment of Hereditary Angioedema Attacks
Hilary Longhurst, MD, Barts and The London Hospital, London,
United Kingdom, Werner Aberer, MD, Medical University of Graz,
Graz, Austria, Laurence Bouillet, MD, Grenoble University Hospital, Grenoble, France, Teresa Caballero, MD PhD, Hospital La Paz
Research Center (IdiPaz), Madrid, Spain, Vincent Fabien, PhD,
Shire Human Genetic Therapies, Eysins, Switzerland, Gisele
Kanny, MD, PhD, University of Lorraine, Vandoeuvre-les-Nancy,
France, Andrea Zanichelli, MD, Luigi Sacco University of Milan,
Milan, Italy and Marcus Maurer, Charite-Universitatsmedizin Berlin, Berlin, Germany
Clinical Response to Treatment of Hereditary Angioedema
(HAE) Type III with Icatibant
Laurence Bouillet, MD1, Isabelle Boccon-Gibod1 and Vincent Fabien, PhD2, 1Grenoble University Hospital, Grenoble, France,
2
Shire Human Genetic Therapies, Eysins, Switzerland
Comparative Economics of On-Demand Treatment Options Approved in the United States for Hereditary Angioedema
Geetika Sabharwal1, Natalia Vernon, MD1, Art Zbrozek2, Thomas
Machnig3 and Timothy J. Craig, DO FAAAAI1, 1Penn State University College of Medicine, Hershey, PA, 2CSL Behring LLC,
King of Prussia, PA, 3CSL Behring GmbH, Marburg, Germany
122
Comparative Economics of On-Demand Treatment Options Approved in the United Kingdom for Hereditary Angioedema
Zoya Panahloo, CSL Behring UK Ltd, Haywards Heath, United
Kingdom, Thomas Machnig, CSL Behring GmbH, Marburg,
Germany and Art Zbrozek, CSL Behring LLC, King of Prussia,
PA
131
Provider Education, Knowledge and Specialty

132
2208
123
124
125
126
127
128
Comparison of Characteristics of Asthma Patients Seeking

Care From Specialists Versus Primary Care Physicians
Kurtis S. Elward, MD1, Thomas B. Casale, MD FAAAAI2, Wilson Pace3, Michael Schatz, MD MS FAAAAI4, Ryan Walters5
and Paul Turner5, 1American Academy of Family Physicians, Charlottesville, VA, 2Creighton University School of Medicine, Omaha,
NE, 3U Colorado, Denver, 4Kaiser Permanente, San Diego, CA,
5
Creighton University
Characteristics of Asthma Visits to Specialists Compared to Primary Care Physicians
Michael Schatz, MD MS FAAAAI1, Thomas B. Casale, MD
FAAAAI2, Wilson Pace3, Ryan Walters4, Paul Turner4 and Kurtis
S. Elward, MD5, 1Kaiser Permanente, San Diego, CA, 2Creighton
University School of Medicine, Omaha, NE, 3U Colorado, Denver,
4
Creighton University, 5American Academy of Family Physicians,
Charlottesville, VA
Tweeting the Meeting: Investigating Twitter Activity At the
2012 AAAAI Conference
Neha Mehrotra, MD, University of Chicago, IL and Vesselin
Dimov, MD, MC 0729, C-150B, Department of Pediatrics, University of Chicago, Chicago, IL
Change in Food Allergy Knowledge Among Urban Public
School Nurses After a Standardized Educational Curriculum
Sarah Twichell, MD, MPH1, Humaira Robinson, RN, BSN1, Eleanor Garrow, BHA2, Maria L. Acebal, JD2 and Hemant P. Sharma,
MD MHS FAAAAI1, 1Childrens National Medical Center, Division of Allergy and Immunology, Washington, DC, 2Food Allergy
& Anaphylaxis Network, Fairfax, VA
Assessing Allergy Knowledge in Internal Medicine Residents
Brynn Everist, PGY3 Pediatric Resident1, Kim Baumann1 and
John B. Hagan, MD FAAAAI2, 1Mayo Clinic, 2Mayo Clinic,
Rochester, MN
A Variable Compass: Practice Parameters and Strength of Recommendation Data
Taylor A. Banks, MD, Julia Savitz and Michael R. Nelson, MD
PhD FAAAAI, Walter Reed National Military Medical Center,
Bethesda, MD
133
Immunotherapy I
2210
134
135
136
137
Treatment of Allergic and Immune Disorders

2209
129
130
Severe Atopic Dermatitis (SAD) and Quality of Life (QOL) in

Children During Background Therapy (BT)
Vladislava Derkach, PhD1,2 and Tatiana Slavyanskaya, MD
PhD1,3, 1Institute of Immunophysiology, Moscow, Russia, 2Vladivostok State Medical University, Vladivostok, Russia, 3University
of Russia, Moscow, Russia
A Qualitative Analysis of Health-Related Quality of Life and
Treatment Satisfaction Associated with Rapid Push Scig
Therapy
Joanne Moreau, MD1, Vincent R. Bonagura, MD, FAAAAI2 and

Eugene Meyer, Psy. D.1, 1Cohen Childrens Medical Center, North
Shore-LIJ Health System, Department of Pediatrics, Division of Allergy & Immunology, Great Neck, NY, 2Hofstra, Northshore-LIJ
School of Medicine, Great Neck, NY
The Hygiene Hypothesis : Aeroallergen Sensitization in Allergic
Rhinitis Patients Living in Rural and Urban Areas of Lebanon
Carla Irani, MD FAAAAI1,2 and Maya Mouzannar1, 1Hotel Dieu
de France hospital, Beirut, Lebanon, 2University of Alberta, Edmonton, Canada
The Immunoglobulin Diagnosis, Evaluation, and Key Learnings
(IDEaL) Patient Registry: An Initial Two-Year Data Survey
From a Longitudinal Registry of Patients On Immunoglobulin
Replacement Therapy in an Alternate Care Setting
Sean Kearns, PhD1, Keith Crawford1, Loretta Kristofek, RN1,
Robbyn Kirylo1 and Luqman Seidu, MD2, 1Coram Clinical Trials,
Denver, CO, 2Allergy and Asthma of Atlanta, LLC, Atlanta, GA
Epinephrine Preparedness in a Food-Allergic Pediatric Patient
Population
Casey Curtis, MD1, David R. Stukus, MD FAAAAI2, Rebecca
Scherzer, MD FAAAAI3 and Kara Simonson, MD1, 1Nationwide
Childrens Hospital, 2Nationwide Childrens Hospital, New Albany,
OH, 3Nationwide Childrens Hospital, Columbus, OH
SATURDAY
Abstracts AB247

138
139
Multi-Grass Pollen Immunotherapy Confers Quality Broad

Spectrum Treatment
Alan D. Bullimore and Murray Skinner, Allergy Therapeutics
Safety and Tolerability of Escalating Doses of House Dust MitePeptide Antigen Desensitization (HDM-PAD)
Mark Larche, Division of Clinical Immunology & Allergy, Department of Medicine, McMaster University, Hamilton, ON,
Canada, Pascal Hickey, Adiga Life Sciences, Hamilton, ON, Canada, Jacques Hebert, MD, Centre de Recherche Applique en Allergie de Quebec, Quebec City, QC, Canada and Rod Hafner, PhD,
Circassia, Oxford, United Kingdom
Non-Detectable IgE Binding of an Amb a 1 Derived, Contiguous
Overlapping Peptide Based, SIT Product Candidate Against
Ragweed Allergy
Christophe Reymond1, Alexander Kettner, PhD1, Valerie Boand1,
Adrien Manighetti1, Anne-Christine Thierry2, Regine Audran,
PhD2 and Francois Spertini, MD2, 1ANERGIS SA, EPALINGES,
Switzerland, 2Division of Immunology and Allergy, CHUV,
LAUSANNE, Switzerland
Efficacy of House Dust Mite Sublingual Immunotherapy in
Adults with Allergic Rhinitis: Results of an Environmental Exposure Chamber Study
Michel Roux1, William H. Yang, MD, FRCPC, FAAAAI2, Agnes
Viatte1, Veronique Cadic1, Kathy Abiteboul1 and Robert K. Zeldin1,
1
Stallergenes, Antony, France, 2Allergy and Asthma Research Corp.,
Ottawa, ON, Canada
Onset of Action of Sublingual Tablets of House Dust Mite Allergen Extracts in Adults
Pascal M. Demoly, MD, PhD1, Karl-Christian Bergmann2, Michel
Melac3, Helene Nguyen3, Marine Frereux3 and Robert K. Zeldin3,
1
University Hospital of Montpellier, Montpellier, France, 2Charite
Campus Mitte, Berlin, Germany, 3Stallergenes, Antony, France
Molecular Differences in Major and Minor Allergens From US
Grass Species Support the Association of Several Pollens for
Specific Immunotherapy
Thierry Batard, PhD1, Henri Chabre, PhD2, Veronique Baron-Bodo,
93
AB248 Abstracts
SATURDAY
140
141
142

FEBRUARY 2013
PhD2, Emmanuel Nony2, Aurelie Lautrette2, Marie-Noelle Couret2,

Pierrick Lemoine2, Nathalie Berjont2, Maud Hrabina2, Karine Jain2
and Philippe Moingeon, PhD3, 1Stallergenes, Antony, France, 2Stallergenes, 3Stallergenes SA, Antony, France
Safety and Tolerability of Fel d 1-Derived Peptide Antigen Desensitization
Brett Haumann, MD, John Powell, MD and Rod Hafner, PhD,
Circassia Ltd, Oxford UK
High-Dose IgG Completely Inhibited TNF-a-Induced, but Not
IL-1b- or Poly (I:C)-Induced, G-CSF Expression by Human
Coronary Artery Endothelial Cells
Akio Matsuda, PhD, Hideaki Morita, MD, PhD, Hirotoshi Unno,
MD, Hirohisa Saito, MD, PhD, Kenji Matsumoto, MD, PhD and
Jun Abe, MD, PhD, Department of Allergy and Immunology,
National Research Institute for Child Health and Development,
Tokyo, Japan
Allergen Specific IgE Titers Are Suppressed by Increased IgG4
Levels When Analyzed by Multiplex Molecular Allergen Chip
but Not by Fluoroenzyme Immunoassay
Johannes M. Schmid, MD1, Peter A, Wuertzen2, Ronald Dahl,
MD3 and Hans Jurgen Hoffmann, PhD1, 1Aarhus University, Aarhus, Denmark, 2Dept. of Experimental Immunology, ALK-abello,
Hoersholm, Denmark, 3Department of Respiratory Medicine,
Aarhus University Hospital, Aarhus C, Denmark
148
149
Rhinitis I
2211
143
144
145
146
147
94
Focalin Inhibits Allergen and Histamine Skin Testing

Honorable Steve L. Kagen, MD, FAAAAI1, Michael Kagen,
MD2, Zainab Nayeri, MD2 and Joe Zondlo, MD1, 1Kagen Allergy
Clinic, Appleton, WI, 2University of Tennessee-Chattanooga, Chattanooga, TN
Qnasl Non-Aqueous Nasal Aerosol Delivers Softer Sprays
Than Aqueous Flonase, Nasacort AQ, and Nasonex
Jade Ly, Armando Morales, Katherine Salas, Julio Cabrera, Mukul
Dalvi and Zian-Ming Zeng, Teva Branded Pharmaceutical Products
R&D, Inc.
Caregivers Reported Prevalence of Symptom and Psychosocial
Problem in Children with Allergic Rhinitis in South Korea
Sun-Hee Choi, MD, PhD, Gangdong Kyung Hee University
Hospital, Hyun Hee Kim, MD, PhD, Dept. of Pediatrics Bucheon
St. Marys Hospital The Catholic University of Korea, Bucheonsi, South Korea, Young Yull Y. Koh, MD, PhD, Seoul National University Hospital, Seoul, South Korea, Yong-Mean Park, MD, PhD,
Depart. of Pediatrics / Konkuk Univ. Hospital, Seoul, Man-Yong
Han, MD, PhD, CHA University Hospital, Hye Young Yum, MD,
PhD, Seoul Medical Center and Yeong-Ho Rha, MD, PhD, Kyung
Hee University Hospital
RNA-Seq-Derived Whole Genome Transcriptomic Profiling
Following Challenge to Mt. Cedar in a Pollen Challenge Chamber Uncover Novel Insights Into Allergic Rhinoconjunctivitis
Pathogenesis
Nathan Harper, BS1,2, John Castiblanco, MS1,2, Cynthia Rather,
CCRC3, Charles Andrews, MD3, Daniel Ramirez, MD3, Robert
L. Jacobs, MD3, Weijing He, MD1,2 and Sunil Ahuja, MD1,2, 1Veterans Administration Center for Personalized Medicine, South
Texas Veterans Health Care System, San Antonio, TX, 2Department
of Medicine, University of Texas Health Science Center, San
Antonio, TX, 3Biogenics Research Chamber, San Antonio, TX
Comparison of Efficacy At Steady State of Levocetrizine, Fexofenadine and Desloratadine On Aeroallergen-Induced Wheal
and Flare Responses in Allergic Rhinitis Patients
150
151
152
153
Krittapoom Akrawinthawong, MD1,2, Pavarat Saengaram, MD2,

Wisit Cheungpasitporn, MD3,4 and Kiat Ruxrungtham, MD2,
1
St.John Hospital & Medical Center, Detroit, MI, 2Chulalongkorn
University, Bangkok, Thailand, 3Bassett Health Care Network,
Cooperstown, NY, 4Faculty of Medicine, Chulalongkorn University,
Bangkok, Thailand
Natural Evolution of Local Allergic Rhinitis
Carmen Rondon, MD PhD1, Paloma Campo, MD, PhD1, Rocio
Herrera, NR2, Inmaculada Do~na, MD PhD3, Miriam Osorio3, Jaime
Garca, MD1, Enrique Gomez, PhD4 and Miguel Blanca, MD PhD5,
1
Allergy Service Carlos Haya Hospital, Malaga, Spain, 2Alergy
Service Carlos Haya Hospital, Malaga, Spain, 3IMABIS Foundation, Malaga, Spain, 4Research Laboratory, Carlos Haya HospitalFIMABIS, Malaga, Spain, 5Allergy Service, Carlos Haya Hospital,
Malaga, Spain
Phenotypical Features of Obstructive Sleep Apnea (OSA) in
Children with Chronic Rhinitis
Maria J. Gutierrez, MD, Division of Pulmonary, Allergy & Immunology and Critical Care Medicine, Pennsylvania State University College of Medicine, Hershey, PA; Division of Pediatric
Rheumatology, Pennsylvania State University College of Medicine,
Hershey, PA, Carlos Rodriguez-Martinez, MD, Division of Pediatric Pulmonology, National University of Colombia, Bogota, Colombia, Cesar Nino, PhD, Department of Electronics Engineering,
Javeriana University, Bogota, Colombia, Anjani Ravindra, MD, Department of Pediatrics, Division of Pediatric Pulmonology, Hershey,
PA and Gustavo Nino, MD, Penn State Sleep Research and Treatment Center, Pennsylvania State University College of Medicine,
Hershey, PA; Department of Pediatrics, Division of Pediatric Pulmonology, Pennsylvania State University College of Medicine
Skin Prick Test and Serum Specific IgE May Not Be Sufficient for
the Diagnosis of Perennial Allergic Rhinitis in Atopic Patients
Miguel Blanca, MD, PhD1, Carmen Rondon, MD, PhD2, Paloma
Campo, MD, PhD2, Francisca Gomez, MD, PhD3, Rosa Garca Mendoza2, Maria Isabel Sanchez Rivas2, Lidia Melendez, Lab. Tech.4,
Taha Fernandez, PhD3 and Mara Jose Torres, MD, PhD1, 1Allergy
Service, Carlos Haya Hospital, Malaga, Spain, 2Allergy Service
Carlos Haya Hospital, Malaga, Spain, 3IMABIS Foundation,
Malaga, Spain, 4Research Laboratory, Hospital Carlos Haya, Malaga, Spain
Underutilization of Rhinolaryngoscopy in Allergy Practices:
Results of National Survey of Allergists and Fellows in Training
(FITs)
Puneet Bajaj, MD1 and Timothy J. Craig, DO, FAAAAI1,2,3, 1Hershey Medical Center, Hershey, PA, 2Penn State University College
of Medicine, Hershey, PA, 3Penn State University
Eosinophils and CD8+ Lymphocytes in the Inflammation and
Remodeling Process in Nasal Mucosa in Chinese CRS Patients
Wei Zhang, MD1, Leandra Mfuna Endam2, Sawsan Al-Mot2, Ying
Li1, Erzhong Fan1, Luo Zhang, MD1 and Martin Desrosiers, MD2,
1
Beijing Tongren Hospital, Capital Medical University, Beijing,
China; Beijing Institute of Otolaryngology, Beijing, China;, 2Centre
de Recherche du Centre Hospitalier de lUniversite de Montreal
(CRCHUM), Montreal, PQ, Canada; Division of Otolaryngology,
Centre Hospitalier de lUniversite de Montreal (CHUM), Montreal,
PQ, Canada
Comparison of Allergic Rhinitis Responses During Grass Pollen
Season to Those Induced by Controlled Grass Pollen Exposure
in the Environmental Exposure Unit (EEU)
Emily Kay, MD1, Lisa Steacy, BSc2, Terry Walker, BA2, Barnaby
Hobsbawn2, Wilma Hopman, BSc.3 and Anne K. Ellis, MD, MSc
FRCPC FAAAAI2,4, 1Department of Pediatrics, Queens University,
Kingston, ON, Canada, 2Allergy Research Unit, Kingston General
Hospital, Kingston, ON, Canada, 3Clinical Research Unit, Kingston
General Hospital, Kingston, ON, Canada, 4Departments of Medicine and Biomedical & Molecular Science, Queens University,
Kingston, ON, Canada
163
2212
154
155
156
157
158
159
160
161
162
Allergen Challenge Induces Recruitment of CD49d+ Neutrophils to the Nasal Mucosa of Atopic Individuals
Jerome Sigua, MD, Becky Buelow, MD, Meribeth Klancnik, Desire Hunter, Erika Buell, Monica Vasudev, MD, Dorothy S. Cheung,
MD, FAAAAI and Mitchell H. Grayson, MD, FAAAAI, Medical
College of Wisconsin, Milwaukee, WI
CD49d+ Neutrophils Connect the Viral and Hygiene Hypotheses
Sheila S. Bhat1, Desire Hunter2, Erika Buell2, Dorothy S. Cheung,
MD, FAAAAI2 and Mitchell H. Grayson, MD, FAAAAI2, 1Medical
College of Wisconsin, 2Medical College of Wisconsin, Milwaukee,
WI
Different Roles of Interleukin-23 During the Epicutaneous Sensitization and the Antigen Exposure to the Airways On Airway
Inflammation and Responsiveness in Mice
Katsunori Masaki1, Yusuke Suzuki1, Shizuko Kagawa1, Motohiro
Kodama1, Hiroki Kabata1, Jun Miyata1, Kyuto Tanaka1, Koichi Fukunaga1, Tsuyoshi Oguma2, Tomoko Betsuyaku1 and Koichiro
Asano2, 1Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan, 2Department of Pulmonary Medicine, Tokai University School of
Medicine, Isehara, Japan
Autophagy Contributes to Release of IL-18 From Epithelial
Cells in Alternaria Exposure
Hiroki Murai, MD PhD1,2, Motoko Yasutomi, MD, PhD1, Hisako
Hayashi, MD1, Akiko Kawakita, MD1, Koji Suzuki, MD1, Istvan
Boldogh, PhD2, Sanjiv Sur, MD2 and Yusei Ohshima, MD, PhD1,
1
University of Fukui, Yoshida-gun, Japan, 2University of Texas
Semaphorin4C: A Molecule May Aggravate Murine Allergic
Airway Disease
Di Xue, Mcgill university and Bruce D. Mazer, MD, FAAAAI,
Montreal Childrens Hospital, Montreal, QC, Canada; MeakinsChristie Laboratories, Montreal, QC, Canada
Effect of Cholesterol Depletion On Interleukin-8 Production in
Human Respiratory Epithelial Cells
Min Jung Kim, MD1, Jung Yeon Hong1, Kyung Eun Lee, PhD1,
Hwan Soo Kim, MD2, Yoon Ki Han, MD1, Hye Mi Jee, MD3,
Kyung Won Kim, MD, PhD1, Myung Hyun Sohn, MD, PhD1 and
Kyu-Earn Kim, MD, PhD1, 1Yonsei University College of Medicine, Seoul, Korea, 2Yonsei University School of Medicine, Seoul,Korea, 3CHA University School of Medicine, Seongnam, Korea
TGase 2 Induces Allergic Asthma by up-Regulating IgE and
Mediators in Cross-Talk of B and Mast Cells Via CD40/
CD40L in Mice
Jai Youl Ro1, Gwan Ui Hong1, Bum Soo Park1, Nam Goo Kim1
and Young Min Ahn2, 1Sungkyunkwan University School of Medicine, 2Eulji University School of Medicine
Hyaluronan and Nitric Oxide Collaborate As Inflammatory
Mediators in Asthma
Ahila Subramanian, MD1, Alana Majors, PhD2, Suzy AA Comhair, PhD2, Serpil C. Erzurum, MD1,2 and Mark A. Aronica,
MD1,2, 1Respiratory Institute, Cleveland Clinic, 2Department of
Pathobiology, Cleveland Clinic
Molecular Pattern in Olive Pollen Response
Blanca Cardaba1,2, Miriam Aguerri1, David Calzada1, David
Montaner3, Manuel Mata2,4, Fernando Florido5, Joaqun Dopazo3
and Carlos Lahoz1,2, 1Immunology Department, IIS-Fundacion
Jimenez Daz, Madrid, Spain, 2CIBERES, Spain, 3Functional Genomics, Unit Bioinformatic Department, Centro de Investigacion
Prncipe Felipe, Valencia, Spain, 4Genomic Department, Fundacion
de Investigaci
on, Hospital Universitario, Valencia, Spain, 5Allergy
Department, Hospital Universitario San Cecilio, Granada, Spain
164
165
166
167
168
169
170
171
Bronchial Epithelial Cells From Asthmatic Patients Express

FceRIg At Higher Levels During Rhinovirus Infection
Sandy R. Durrani, MD1, Yury Bochkov, PhD1, Nizar N. Jarjour,
MD1 and Daniel J. Jackson, MD2, 1University of Wisconsin School
of Medicine and Public Health, Madison, WI, 2Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison,
WI
Exposure to Juniperus Ashei (Mt. Cedar) Pollen in a Pollen
Challenge Chamber Elicits Changes in White Blood Cell
Counts and Cytokines in Mountain Cedar Positive and Negative
Subjects
Weijing He, MD1,2, Andrew Carrillo, BS1,2, Nathan Harper, BS1,2,
Fabio Jimenez, BS1,2, Hernan Martinez, MD1,2, Seema Ahuja,
MD1,2, Cynthia Rather, CCRC3, Daniel Ramirez, MD3, Charles
Andrews, MD3, Robert L. Jacobs, MD3 and Sunil Ahuja, MD1,2,
1
Department of Medicine, University of Texas Health Science
Center, San Antonio, TX, 2Veterans Administration Center for Personalized Medicine, South Texas Veterans Health Care System, San
Antonio, TX, 3Biogenics Research Chamber, San Antonio, TX
Reduction of CD49d+ Neutrophil Accumulation and Post-Viral
Airway Hyperreactivity with CysLTR1 Blockade
Dorothy S. Cheung, MD FAAAAI, Erika Buell, Desire Hunter and
Mitchell H. Grayson, MD FAAAAI, Medical College of Wisconsin,
Milwaukee, WI
Magnetic Stimulation of Left TPO Cerebral Cortex of Allergic
Humans Increases Blood/Serum Substance P Levels, and CD4
and CD8+ T Cell Numbers, While Suppressing IgE Responses.
Substance P Suppresses P38 MAP Kinase Expression by Their
PBL
Bryan McCarthy, BS, Seto M Chice, MS, Rauno Joks, MD, Jonathan I Silverberg, MD, PhD, MPH, Mark Stewart, MD, PhD, Vahe
Amassian, MD and Helen G Durkin, PhD, Center for Allergy and
Asthma Research at SUNY Downstate, Brooklyn, NY
Early Aeroallergen Sensitization Is Associated with Higher
Fractional Exhaled Nitric Oxide Levels in School Age Children
Independent of Asthma Diagnosis
Matthew C. Bell, MD1, Michael D. Evans, MS1, Christopher J.
Tisler, MT1, James Gern, MD FAAAAI1, Robert F. Lemanske Jr.,
MD FAAAAI1 and Daniel J. Jackson, MD2, 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Pediatrics, University of Wisconsin School of Medicine and Public
Health, Madison, WI
Eosinophil and Neutrophil Derived Mediators in Nasal Washes
From Children Treated for Asthma
Patricia Jorge, MD1, Holliday T. Carper, BS1, Manuel SotoQuiros2, Lydiana Avila2, Deborah D. Murphy, RN1, Joshua L.
Kennedy, MD1, Thomas Platts-Mills, MD PhD FAAAAI FRS1
and Peter W. Heymann, MD1, 1University of Virginia, Charlottesville, VA, 2Hospital Nacional de Ni~nos, San Jose, Costa Rica
Non-Canonical Activation and Phosphorylation of the Glucocorticoid Receptor [GR] Phosphorylation Reduces Pro-Inflammatory in Human Bronchial Smooth Muscle Cells [Hbsmc]
Lata Kaphalia, PhD1, Bill T. Ameredes, PhD2 and William J.
Calhoun, MD FAAAAI2, 1UTMB, 2University of Texas Medical
Branch, Galveston, TX
The Role of IL-33 in Allergic Disease and Atherosclerosis
Tania Mucci, MD1, Michael Littlefield, BA2, Allison Reiss, MD2,
Luz S. Fonacier, MD FAAAAI3, Steven Carsons, MD1 and Iryna
Voloshyna, PhD2, 1Winthrop University Hospital, Mineola, NY,
2
Winthrop Research Institute, Mineola, NY, 3Winthrop University
Hospital, Allergy & Immunology, Mineola, NY
STAT6-Dependent and -Independent Regulation of Lung Natural Helper Cell Responses During Alternaria-Induced Airway
Inflammation
Naseem Khorram1, Jinny Chang, MD2, Hee-Kyoo Kim, MD3, Michael Croft, PhD4, David H. Broide, MB ChB FAAAAI1 and Taylor
Alan Doherty, MD5, 1UC San Diego, La Jolla, CA, 2Scripps Clinic,
SATURDAY
Abstracts AB249

95
AB250 Abstracts
SATURDAY
172
173
La Jolla, CA, 3Kosin University College of Medicine, South Korea,

4
La Jolla Institute for Allergy and Immunology, La Jolla, CA,
5
Medicine, Univ of CA - San Diego, La Jolla, CA
Pro-Inflammatory Actions of the Exodomain Shed From Protease Activated Receptor 2 (PAR-2)
Mogib El-Rahman Khedr1,2, Ahmed Abdelmotelb, PhD1, Laurie
Lau, PhD1, Matthew Arno, PhD3, Sylvia Pender, PhD1, Xiaoying
Zhou, MD1 and Andrew F. Walls, PhD, FAAAAI1, 1University of
Southampton, Southampton General Hospital, Southampton,
United Kingdom, 2Suez Canal University,Faculty of Medicine, Ismailia, Egypt, 3Kings College London, Genomics Centre, London,
United Kingdom
Lung Resident Cells Are Independently Capable of Maintaining
Chronic Asthma in Mice After Immune Ablation
Christina Christianson, PhD, Chaoyu Chen, MS, Magdalena Gorska, MD, PhD and Rafeul Alam, MD, PhD, FAAAAI, National
Jewish Health, Denver, CO

FEBRUARY 2013
181
182
183
Allied Health Saturday Poster 1

2213
174
175
176
177
178
179
180
96
Infant Feeding Practices Changed Following Publication of

2000 American Academy of Pediatrics Guidelines
Shannon Seopaul, BS, Johns Hopkins University School of
Medicine and Corinne Keet, MD, MS, Pediatrics, Johns Hopkins
University School of Medicine, Baltimore, MD
Shift in Aeroallergen Indices, Allergy and Asthma Cases and an
AHPCO Air Purifier to Reduce Indoor Airborne Pathogens and
VOCs
Nabarun K. Ghosh, PhD1, Jeff Bennert, PhD, CTN2, Constantine
K. Saadeh, MD, FAAAAI3 and Griselda Estrada, BS1, 1West Texas
A&M University, Canyon, TX, 2AIR OASIS, Amarillo, TX,
3
Allergy ARTS ACCR, Amarillo, TX
Epinephrine (E) for Self-Administration: Autoinjectors and Alternatives
Dona Shearer, RN, University of South Florida, Tampa, FL and
Richard F. Lockey, MD, James A. Haley Veterans Hospital,
Tampa, FL; University of South Florida Morsani College of
Medicine, Tampa, FL
Exposure to Juniperus Ashei (Mt. Cedar) and Virginia Live
Oak Pollen in a Pollen Challenge Chamber Elicits Similar
Symptomology When Compared to Natural Season
Daniel Ramirez, MD1, Cynthia Rather, CCRC1, Nathan Harper,
BS2,3, Andrew Carrillo, BS2,3, Weijing He, MD2,3, Charles
Andrews, MD1, Sunil Ahuja, MD2,3 and Robert L. Jacobs, MD1,
1
Biogenics Research Chamber, San Antonio, TX, 2Veterans Administration Center for Personalized Medicine, South Texas Veterans
Health Care System, San Antonio, TX, 3Department of Medicine,
University of Texas Health Science Center, San Antonio, TX
A 10 Year Follow up of Food Allergy in Central Sydney Childcare Centres
Brooke L. McKinnon, BSc(Nutrition & Dietetics) Hons 1, Velencia Soutter, MB BS, FRACP (Paed), Robert Loblay, MD PhD
FRACP and Anne Swain, PhD, Royal Prince Alfred Hospital
Allergy Unit, Sydney, Australia
Nurses Perceptions of the Efficacy, Tolerability, and Quality of
Life in Patients Treated with Subcutaneous Immunoglobulin
Annette R. Zampelli, NP1, Carla M. Duff, CPNP MSN2 and Ann
Bullinger, PharmD1, 1CSL Behring, King of Prussia, PA, 2University of South Florida, Tampa, FL
Using an Established Root Cause Analysis Framework to Evaluate an Unusual Allergen Immunotherapy Error
184
185
Kari L. Rossow, PA-C, Kimberly Poe, RN and James T. Li, MD,

PhD, FAAAAI, Mayo Clinic, Rochester, MN
The Role of Education in Achieving Bronchial Asthma Control
Differences Between Genders
Andrzej M. Fal, Beata Jankowska-Polanska, Izabella Uchmanowicz and Mariola Sen, Wroclaw Medical University
The Influence of Operators On the Obtaining of Successful
Bronchial Biopsies in Asthma Research
Kheem Keem Jones, RN1, L.Q.C. Siew, MD1, P. Pillai, MD1, C.
Reinholtz, RN1, H. Bull, RN2, M. Rabuya, RN2, E. Fuerst, PhD3,
D.B. Wright, PhD student4, Y. Shaifta, PhD4, Ying. S, MD, PhD4,
Q. Meng, Research Assistant4 and C. J. Corrigan, MD, PhD,
FAAAAI5, 1Kings College London, School of Medicine, London,
United Kingdom, 2Guys & St. Thomas Foundation Trust, London,
United Kingdom, 3Kings College London, London, United Kingdom, 4Kings College London, London, United Kingdom, 5Kings
College London School of Medicine, London, United Kingdom
Effects of Outliers From Indoor Pollutants On the Relationships to Respiratory Health Outcomes
Charles Aloe, MPH1, Elizabeth Matsui, MD1, Nadia Hansel, MD2,
DAnn Williams, DrPH2 and Roger Peng, PhD2, 1Johns Hopkins
University School of Medicine, Baltimore, MD, 2Johns Hopkins
University, Baltimore, MD
First Person Narratives of Pediatric Allergy Nurse Coordinators Describing the Nursing Practice Embedded in the Role
Lisa P. Talarico, RN MS1, Sally A. Noone, RN MSN CCRC1,2,
Beth D. Strong, RN CCRC3, Sarah D. Knorr, RN MPH CCRP4,
Kim E. Mudd, RN MSN CCRP4 and Eloise Cathcart, RN MSN5,
1
Mount Sinai School of Medicine, New York, NY, 2Mount Sinai
School of Medicine, 3Mt. Sinai School of Medicine, New York,
NY, 4Johns Hopkins University, Baltimore, MD, 5New York University School of Nursing
Profiling Attendees of a Food Allergy Cooking Class
April Clark, Registered Dietitian, Childrens Medical Center,
Dallas, TX, Nithya Swamy, MD, University of Texas Southwest
Medical Center, Dallas, TX and J. Andrew Bird, MD, UT Southwestern Medical Center, Dallas, TX
Asthma and the Environment

2601
Saturday, February 23rd, 2013, 2:00 PM - 3:15 PM
186
Contributing and Protective Risk Factors for Asthma Exacerbation in Latinos (GALA-II Study)
Ulysses Burley1, Joy Hsu, MD2, Elizabeth Nguyen, BS3, Lindsey
Roth, MA4, Joshua Galanter, MD4, Sam Oh, PhD, MPH4, Celeste
Eng, BS4, Fred Lurmann, MS5, Rajesh Kumar, MD, MS,
FAAAAI6,7, Harold J. Farber, MD, MSPH8, Denise Serebrisky,
MD9,10, Luisa Borrell, DDS, PhD11, Saunak Sen, PhD12, William
Rodriguez-Cintron, MD13, Jose Rodriguez-Santana, MD14, Esteban
Gonza Burchard, MD, MPH4,15 and Pedro C. Avila, MD,
FAAAAI2,16, 1Feinberg School of Medicine, Northwestern University, Chicago, Illinois, 2Feinberg School of Medicine, Northwestern
University, Chicago, IL, 3Department of Medicine, University of
California, San Francisco, California, San Francisco, CA, 4Department of Medicine, University of California, San Francisco, San
Francisco, CA, 5Sonoma Technology, Inc., Petaluma, CA, 6Childrens Memorial Hospital, Chicago, IL, 7Pediatric allergy, Ann &
Robert H. Lurie Childrens Hospital of Chicago, Chicago, IL,
8
Texas Childrens Hospital, Houston, TX, 9Pediatric Pulmonary Division, Jacobi Medical Center, Bronx, NY, 10Mount Sinai School of
Medicine, New York, NY, 11Department of Health Sciences, Graduate Program in Public Health, Lehman College, City University of
New York, Bronx, NY, 12Department of Epidemiology and
187
188
189
190
Biostatistics, University of California, San Francisco, San Francisco, CA, 13Veterans Caribbean Health Care System, San Juan,
PR, 14Centro de Neumologia Pediatrica, San Juan, PR, 15UCSF,
San Francisco, CA, 16Northwestern University Feinberg School of
Medicine, Chicago, IL
Aeroallergen Sensitization Is Associated with Asthma Severity
in Latinos (GALA-II Study)
Joy Hsu, MD1, Ulysses Burley, MPH1, Elizabeth Nguyen, BS2, Lindsey Roth, MA3, Joshua Galanter, MD3, Sam Oh, PhD, MPH3, Celeste
Eng, BS3, Fred Lurmann, MS4, Rajesh Kumar, MD, MS, FAAAAI5,
Harold J. Farber, MD, MSPH6, Denise Serebrisky, MD7, Luisa
Borrell, DDS, PhD8, Saunak Sen, PhD9, William Rodriguez-Cintron,
MD10, Jose Rodriguez-Santana, MD11, Esteban Gonza Burchard,
MD, MPH3 and Pedro C. Avila, MD, FAAAAI1, 1Feinberg School
of Medicine, Northwestern University, Chicago, IL, 2Department of
Medicine, University of California, San Francisco, California, San
Francisco, CA, 3Department of Medicine, University of California,
San Francisco, San Francisco, CA, 4Sonoma Technology, Inc., Petaluma, CA, 5Pediatric allergy, Ann & Robert H. Lurie Childrens
Hospital of Chicago, Chicago, IL, 6Texas Childrens Hospital, Houston, TX, 7Pediatric Pulmonary Division, Jacobi Medical Center,
Bronx, NY, 8Department of Health Sciences, Graduate Program in
Public Health, Lehman College, City University of New York, Bronx,
NY, 9Department of Epidemiology and Biostatistics, University of
California, San Francisco, San Francisco, CA, 10Veterans Caribbean
Health Care System, San Juan, PR, 11Centro de Neumologia Pediatrica, San Juan, PR
Influence of Cigarette Smoking On Airway Inflammation and
Inhaled Corticosteroid Treatment in Asthmatic Patients
Terufumi Shimoda, MD1, Yasushi Obase, MD2, Michiyoshi Imaoka, MD3, Reiko T. Kishikawa, MD3 and Tomoaki Iwanaga,
MD4, 1The National Hospital Organization Fukuoka Hospital,
Fukuoka, Japan, 2Kawasaki Medical School, Kurashiki, Japan,
3
Fukuoka National Hospital, Fukuoka, Japan, 4The National Hospital Organization Fukuoka Hospital, Fukuoka, Japan
Correlation Between Aeroallergen Sensitization and Pediatric
Asthma Severity - Data From the Severe Asthma Research Program (SARP)
Marc D. Ikeda, MD1,2, Merritt L. Fajt, MD1, Shean Aujla, MD2,
Paul Rebovich, MS2 and Sally E. Wenzel, MD, FAAAAI1, 1The
University of Pittsburgh Asthma Institute at UPMC and the University of Pittsburgh School of Medicine, Department of Pulmonary,
Allergy and Critical Care Medicine, Pittsburgh, PA, 2The Childrens
Hospital of Pittsburgh, Pittsburgh, PA
House Dust Mite Sensitization Is the Main Risk Factor for the
Increase in Prevalence of Wheeze in 13-14 Year Old Schoolchildren in Guangzhou City, China
Jing Li, MD, MSc1, Yan Chen2, Jingping Zheng1, Gary W. K.
Wong3 and Nanshan Zhong1, 1The First Affiliated Hospital of
Guangzhou Medical College, State Key Laboratory of Respiratory
Disease, Guangzhou Institute of Respiratory Disease, Guangzhou,
China, 2Guangdong Pharmaceutical University, Clinical Medical
College, Guangzhou, China, 3Department of Paediatrics, The
Chinese University of Hong Kong, Hong Kong
192
193
194
195
PhD2 and Rebecca H. Buckley, MD, FAAAAI1, 1Department of

Pediatrics, Duke University Medical Center, Durham, NC, 2Center
for Human Genome Variation, Duke University Medical Center,
Durham, NC
Interactions Between SLC22A5, IL13 and SMAD3 Modulate
Spirometric Indices in Chinese Children
Ting Fan Leung, MD, FRCPCH, FAAAAI1, Man Fung Tang1,
Susan Shuxin Wang1, Alice P. S. Kong2, Hing Yee Sy1 and Gary
W. K. Wong1, 1Department of Paediatrics, The Chinese University
of Hong Kong, Hong Kong, 2Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong
Effects of Maternal Allergy On Umbilical Cord Blood Regulatory T Cell Forkhead Box Protein 3 (FOXP3) DNA Methylation
Michelle North, PhD1, Sarah Mah, BSc.2, Lisa Steacy, BSc3, Jeffrey Brook, PhD4,5, Michael Kobor, PhD2,6 and Anne K. Ellis, MD,
MSc, FRCPC, FAAAAI1,3, 1Departments of Medicine and Biomedical & Molecular Science, Queens University, Kingston, ON, Canada, 2Centre for Molecular Medicine & Therapeutics, Child &
Family Research Institute, Vancouver, BC, Canada, 3Allergy Research Unit, Kingston General Hospital, Kingston, ON, Canada,
4
Environment Canada, Toronto, ON, Canada, 5University of
Toronto, Toronto, ON, Canada, 6University of British Columbia,
Vancouver, BC, Canada
Sequencing of the ST2 Gene Reveals a Haplotype That
Determines Serum Total ST2 Levels in Individuals of African
Ancestry
Lili Huang, MPH1, Li Gao, MD, PhD1, Camila Figueiredo, PhD2,
Nicholas M. Rafaels, MS1, Candelaria I. Vergara, MD, PhD1, Ingo
Ruczinski, PhD3, Terri H Beaty, PhD3, Kathleen C. Barnes, PhD,
FAAAAI1 and Rasika A. Mathias, ScD1,3, 1Division of Allergy
and Clinical Immunology, Department of Medicine, Johns Hopkins
University, Baltimore, MD, 2Instituto de Ciências da Saude, Universidade Federal da Bahia, Salvador, Bahia, Brazil, Salvador, Brazil,
3
Johns Hopkins Bloomberg School of Public Health, Johns Hopkins
University, Baltimore, MD
Whole Genome Sequence Reveals a Haplotype Conferring
Protection From Asthma Common to Subjects of European
and African Ancestry
Abdellah Hedjoudje1,2,3, Lili Huang, MPH1,4, Nicholas M. Rafaels, MS1,4, Candelaria I. Vergara, MD PhD1,4, Margaret Taub,
PhD5, Ingo Ruczinski, PhD6,7, Carole Ober, PhD8, Esteban Gonza
Burchard, MD, MPH9,10, Terri H Beaty, PhD6,7, Donata Vercelli,
MD11, Kathleen C. Barnes, PhD, FAAAAI1,4, Rasika A. Mathias,
ScD1,7, EVE Consortium12 and C.A.A.P.A. Consortium4, 1Division
of Allergy and Clinical Immunology, Department of Medicine,
Johns Hopkins University, Baltimore, MD, 2Universite Paris Descartes, Paris, France, 3INSERM, Unit 909, Cardiovascular Epidemiology and Sudden Death, Hopital Europeen Georges Pompidou,
Paris, France, 4Johns Hopkins University, Baltimore, MD, 54Johns
Hopkins Bloomberg School of Public Health, Johns Hopkins
University, Baltimore, MD, 6Johns Hopkins University School of
Public Health, Baltimore, MD, 7Johns Hopkins Bloomberg School
of Public Health, Johns Hopkins University, Baltimore, MD,
8
University of Chicago, Chicago, IL, 9UCSF, San Francisco, CA,
10
Department of Medicine, University of California, San Francisco,
San Francisco, CA, 11The University of Arizona, Tucson, AZ,
12
University of Chicago
SATURDAY
Abstracts AB251

Immunogenetics
2602
191
Next Generation Sequencing May Be More Efficient and Economical Than Targeted Gene Testing in Patients with Primary
Immune Deficiency (PID)
Talal Mousallem, MD1,2, Thomas J. Urban, PharmD, PhD2, Joseph
L. Roberts, MD, PhD1, Roberta E. Parrott, BS1, David B. Goldstein,
How Inner-City Exposures Lead to Disparities in

Childrens Asthma
2603
196
Classroom Fungal Spore Exposure and Asthma Morbidity in

Inner-City School Children
97
AB252 Abstracts
SATURDAY
197
198
199
200

FEBRUARY 2013
Sachin N. Baxi, MD1, Carter R. Petty, MA1, Chunxia Fu, MS2,

William J. Sheehan, MD1, Perdita Permaul, MD3, Lianne Kopel,
MD1, Watcharoot Kanchongkittiphon, PhD, MD1, Jonathan M.
Gaffin, MD, MMSc1, Christine A. Rogers, PhD4, Michael L.
Muilenberg, MS4, Diane R. Gold, MD5 and Wanda Phipatanakul,
MD, MS, FAAAAI1, 1Boston Childrens Hospital, Boston, MA,
2
Harvard School of Public Health, Boston, MA, 3Division of
Pediatric Allergy/Immunology, Massachusetts General Hospital,
Boston, MA, 4University of Massachusetts, Amherst, MA, 5Channing Laboratory, Boston, MA
Exposure to Polycyclic Aromatic Hydrocarbons Is Associated
with Higher Levels of Total IgE, Decreased Function of T Regulatory Cells and an Increase of Asthma Occurrence in
Children
Annett I. Walker, MD1, Arunima Kohli1, Aleena Syed1, Ellen A.
Eisen, ScD2, Elizabeth M. Noth, PhD2, Boriana Pratt, MA2, S.
Katharine Hammond, PhD2 and Kari Nadeau, MD, PhD,
FAAAAI1, 1Department of Pediatric Allergy and Immunology,
Stanford University, California, USA, 2Division of Environmental Health Sciences, University of California, Berkeley,
California, USA
Association Between Asthma-Related Emergency Department
Visits and Pollen Concentration in the Bronx, 2001-2008
Sayantani B. Sindher, MD, Albert Einstein/Montefiore Medical
Center, Sunit Jariwala, MD, Albert Einstein/Montefiore Medical
Center, New York, NY, Gabriele De Vos, MD, Albert Einstein College of Medicine, Bronx, NY, Jennifer Toh, Montefiore Medical
Center, New York, NY, Anna Tavdi, BA, Albert Einstein College
of Medicine, Division of Allergy/Immunology and David L.
Rosenstreich, MD, FAAAAI, Albert Einstein / Montefiore Medical
Center, NY
Report of Exercise-Induced Wheeze Predicts Urgent Medical
Visits for Asthma Among Inner-City Children
Matthew S. Perzanowski, PhD, Department of Environmental
Health Sciences, Columbia University, New York, NY, Timothy
Mainardi, MD, Division of Pulmonary, Allergy and Critical Care
Medicine, Columbia University, Kathleen Donohue, MD, Division
of General Medicine, Columbia University, Lori Hoepner, Data Coordinating Center, Columbia University, Inge Goldstein, Department of Epidemiology, Columbia University, Frederica P. Perera,
PhD, Columbias Center for Childrens Environmental Health,
Columbia University and Rachel L. Miller, MD, FAAAAI, Division
of Pulmonary, Allergy and Critical Care Medicine, Columbia
University, New York, NY
Allergen Exposure Influences the Relationship Between Community Violence and Asthma Morbidity: The Inner City
Asthma Study
Michelle L. Sever, PhD1,2, James Thomas, PhD2, Agustin Calatroni3, Karin Yeatts, PhD2, Cynthia Visness, PhD3, Herman Mitchell, PhD3 and Darryl C. Zeldin, MD1, 1NIEHS, Research Triangle
Park, NC, 2Department of Epidemiology, Gillings School of Global
Public Health, University of North Carolina at Chapel Hill, Chapel
Hill, NC, 3Rho, Inc., Chapel Hill, NC
Urticaria/Angioedema
2604
201
98
Pediatric Presentation of Hereditary Angioedema (HAE) Due to

C1 Inhibitor Deficiency
Sandra C. Christiansen, MD, FAAAAI1,2, Donna Davis3,
Anthony J. Castaldo3 and Bruce L. Zuraw, MD2,4, 1Southern CA
Permanente Med Grp, San Diego, CA, 2University of California
202
203
204
205
San Diego, La Jolla, CA, 3US Hereditary Angioedema Association,

Honolulu, HI, 4San Diego VA Healthcare, San Diego, CA
High Serum Levels of Mast Cell Chymase and Carboxypeptidase in Mastocytosis
Xioaying Zhou, PhD1, Laura B. Sanchez-Munoz, MD, PhD2,3, Alberto Orfao, MD, PhD3,4, Luis Escribano, MD, PhD2,3 and Andrew
F. Walls, PhD, FAAAAI5, 1University of Southampton, Southampton, United Kingdom, 2Instituto de Estudios de Mastocitosis, Hospital Virgen Del Valle, Toledo, Spain, 3Spanish Network on
Mastocytosis (REMA), 4University of Salamanca, Salamanca,
Spain, 5University of Southampton, Southampton General Hospital,
Southampton, United Kingdom
Overexpression of Epidermal Filaggrin in Patients with
Chronic Idiopathic Urticaria Correlates with Urticaria Severity
Young Min Ye, MD1,2, Byung Eui Kim, MD2, Yoo Seob Shin, MD,
PhD1, Hae-Sim Park, MD, PhD1 and Donald Y.M. Leung, MD,
PhD2, 1Ajou University School of Medicine, Suwon, South Korea,
2
Department of Pediatrics, Division of Allergy-Immunology, National Jewish Health, Denver, CO
Genetic Analysis and Etiology of Angioedema
Jonathan Levy1, Georges-Etienne Rivard2, Eric Wagner3, Don
Beezhold4, Noam Berlin, BSc5, Li Fan2 and Gordon L. Sussman,
MD, FAAAAI6, 1University of Alberta, Edmonton, AB, Canada,
2
Service of Hematology and Oncology, Universite de Montreal
and Centre de Recherche, CHU-Saint-Justine, Montreal, QC,
Canada, 3Rheumatology-Immunology Research Center, Centre
Hospitalier Universitaire de Quebec and Department of Microbiology-Infectious Diseases and Immunology, Universite Laval, Quebec City, QC, Canada, 4NIOSH, Morgantown, WV, 5Gordon
Sussman Clinical Research, Toronto, ON, Canada, 6University of
Toronto, Toronto, ON, Canada
Hereditary Angioedema Type III: Mutation in Factor XII Gene
in Brazilian Families
Adriana S. Moreno, PhD, University of Sao Paulo, Ribeirao Preto,
Brazil, Solange Valle, Clementino Fraga Filho University HospitalUFRJ, Rio de Janeiro, Brazil, Alfeu Franca, Clementino Fraga
Filho University Hospital, UFRJ, Rio de Janeiro, Brazil, Soloni
Levy, Clementino Fraga Filho University Hospital - UFRJ, Brazil,
Wagner Campos, Department of Medicine, School of Medicine of
Ribeirao Preto - FMRP, Ribeir~ao Preto, Brazil, Wilson da Silva
Junior, Department of Genetics, School of Medicine of Ribeirao
Preto - FMRP, Ribeirao Preto, Brazil and Luisa Karla P. Arruda,
MD, PhD, FAAAAI, School of Medicine of Ribeirao Preto, Ribeirao Preto, Brazil
New Insights in Food Allergy Treatment

2605
206
207
Oral Food Challenge and Food Allergy Quality of Life in Caregivers of Food Allergic Children
Timothy J. Franxman, MD, Laura E. Howe, MD and Matthew J.
Greenhawt, MD, MBA, MSc, University of Michigan, Ann Arbor,
MI
Racial and Ethnic Disparity in Food Allergy in the United
States: A Systematic Review
Matthew J. Greenhawt, MD, MBA, MSc, Department of Internal
Medicine, The University of Michigan Medical School, Division of
Allergy and Clinical Immunology, Ann Arbor, MI, Christopher C.
Weiss, PhD, Global Food Protection Institute, Battle Creek, MI,
Marisa Conte, University of Michigan, Taubman Health Sciences
Library, Ann Arbor, MI, Marlie Doucet, MPH, Oak Ridge Institute
for Science and Education Fellow, Division of Adolescent and
School Health, Centers for Disease Control and Prevention, Atlanta,
208
209
GA, Amy Engler, eHuman Biology Department, Stanford University, Palo Alto, CA and Carlos Camargo Jr., MD, DrPH, Department
of Emergency Medicine, Massachusetts General Hospital, Harvard
Medical School, Boston, MA
Multi-Allergen Oral Immunotherapy Improves Quality of Life
in Subjects with Food Allergies
Iris Otani, MD1, Tina L.R. Dominguez, PA-C MMS2, Alicia
Sciancalepore, RN2, Anjuli Mehrotra, MD3, Daniela Pineda, MA2
and Kari Nadeau, MD, PhD, FAAAAI4, 1Santa Clara Valley Medical Center, San Jose, CA, 2Stanford Alliance for Food Allergy Research, Palo Alto, CA, 3Silicon Valley Allergy and Asthma Inc.,
Mountain View, CA, 4Stanford Univ School Medicine, Stanford,
CA
Is Molecular Allergology Cost-Effective and Cost Saving in
Children with Suspected Peanut Allergy Compared to Double
Blind Placebo Controlled Food Challenge (DBPCFC) and
Skin Prick Test in US, Europe and Asia?
Lisse-Lotte Hermansson1, Barbara Mascialino1, Susanne Glaumann, MD2, Magnus Borres1, Gijs Hubben3 and Caroline Nilsson2,
1
Thermo Fisher Scientific IDD, Uppsala, Sweden, 2Sodersjukhuset,
Stockholm, Sweden, 3BaseCase, Berlin, Germany
Rhinosinusitis and Nasal Polyposis:

Pathophysiology
214
Mechanisms in the Control of Asthma

2607
215
2606
210
211
212
213
Excessive Fibrin Deposition Caused by a Fibrinolytic Disorder

Associated with Reduction of Tissue Plaminogen Activator
Expression in Nasal Polyps
Tetsuji Takabayashi, MD1, Atsushi Kato, PhD1, Anju Peters,
MD2, Kathryn E. Hulse, PhD1, Lydia Suh, BSc2, Roderick Carter,
BSc3, James Norton, MS1, Leslie C. Grammer, MD, FAAAAI2,
Seong Ho Cho, MD1, Bruce Tan, MD1, Rakesh Chandra, MD1, David Conley, MD1, Robert Kern, MD4, Shigeharu Fujieda, MD5 and
Robert P. Schleimer, PhD, FAAAAI2, 1Northwestern University
Feinberg School Medicine, Chicago, IL, 2Northwestern University
Feinberg School of Medicine, Chicago, IL, 3Department of Medicine, Division of Allergy-Immunology, Northwestern University
Feinberg School of Medicine, Chicago, IL, 4Northwestern University Feinberg School of Medicine, Chicago, IL, 5University of
Fukui, Fukui, Japan
A Proposed Model to Study Immunologic Changes During
Chronic Rhinosinusitis Exacerbations: Data From a Pilot
Study
Shefali Samant, MD1, Matthew A. Rank, MD, FAAAAI2, John
B. Hagan, MD, FAAAAI1 and Hirohito Kita, MD1, 1Mayo Clinic,
Rochester, MN, 2Mayo Clinic, Scottsdale, AZ
The Impact and Nature of Inflammation in the Olfactory Cleft
On Olfaction in Patients with Chronic Rhinosinusitis
Jennifer Lavin, MD1, Eric Meen, MD1, Kent Lam, MD1, Atsushi
Kato, PhD2, He Huang, DDS1, James Norton, MS2, Lydia Suh,
BSc1, Roderick Carter, BSc2, Mahboobeh Mahdavinia, MD,
PhD3, Kathryn E. Hulse, PhD3, David Conley, MD3, Rakesh Chandra, MD3, Robert Kern, MD4, Robert P. Schleimer, PhD, FAAAAI2
and Bruce Tan, MD3, 1Northwestern University Feinberg School of
Medicine, Chicago, IL, 2Department of Medicine, Division of Allergy-Immunology, Northwestern University Feinberg School of
Medicine, Chicago, IL, 3Northwestern University Feinberg School
Medicine, Chicago, IL, 4Northwestern University Feinberg School
of Medicine, Chicago, IL
Effect of Prostaglandin E2 On VEGF Production Through the
E-Prostanoid 4 Receptor in Nasal Polyp-Derived Fibroblasts
Byoung Joon Baek, Department of Otolaryngology-Head and
Neck Surgery, Cheonan Hospital, Soonchunhyang University,

Cheonan, South Korea and Dong Yeol Han, Department of Otolaryngology-Head and Neck Surgery, Cheonan Hospital, Soonchunhyang University
Elevated Presence of Dendritic Cell Subsets in Chronic Rhinosinusitis
Sarah Peterson, MD1, Kate Welch, MD1, Julie Poposki, MS1, Lydia Suh, BSc2, Roderick Carter, BSc1, James Norton, MS3, Kathryn
E. Hulse, PhD1, Anju Peters, MD2, Leslie C. Grammer, MD,
FAAAAI2, Bruce Tan, MD3, Rakesh Chandra, MD3, David Conley,
MD3, Robert Kern, MD3, Robert P. Schleimer, PhD, FAAAAI3 and
Atsushi Kato, PhD1, 1Northwestern University Feinberg School of
Medicine, 2Department of Medicine, Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Northwestern University Feinberg School of Medicine,
Chicago, IL
SATURDAY
Abstracts AB253

216
217
218
219
Elevation of Plasminogen Activator Inhibitor-1 Levels in Sputum and Nasal Lavage Fluids of Asthmatics with Common
Colds
Seong Ho Cho, MD1,2, Seung Hong, MD/PhD2, Haimei Chen,
PhD1, Ali Habib1, David Cho1, Il Kim, MD/PhD1, Sun Hye Lee,
PhD1, Homer A. Boushey Jr., MD, FAAAAI3, Theresa Ward3, Robert P. Schleimer, PhD, FAAAAI1 and Pedro C. Avila, MD,
FAAAAI1, 1Northwestern University Feinberg School of Medicine,
Chicago, IL, 2Kyung Hee University, Seoul, South Korea, 3University of California at San Francisco, San Francisco, CA
Human Mast Cells and Nuocytes Activate Gene Expression and
Mucus Secretion in Primary Mucociliary Differentiated Human
Bronchial Epithelial Cells Via IL-13
Deepti Nagarkar, Vladimir Corrozzi, David Choy, Alex Abbas,
Rajita Pappu and Joseph R. Arron, Genentech, Inc., South San
Francisco, CA
Effects of Cigarette Smoke Exposure On RGS2 Expression and
Airway Hyperresponsiveness
Ningxi Zhu, Abdo Berra, Zhihao Zhu, Carl Stokes, Yaping Tu, PhD
and Thomas B. Casale, MD FAAAAI, Creighton University School
of Medicine
Exposure to Cigarette Smoke Impacts Myeloid-Derived
Regulatory Cell Function and Exacerbates Airway HyperResponsiveness
Jessy Deshane, PhD1, Toni Jin2, Aisha Farhana2, Jason Freeman2,
Kim Estell2, Jaroslaw Zmijewski2, Victor Thannickal2, Lisa M.
Schwiebert, PhD3 and Andries Steyn2, 1University of Alabama at
Birmingham, AL, 2University of Alabama at Birmingham, 3University of Alabama at Birmingham, Birmingham, AL
Antagonistic Roles of Thymic Stromal Lymphopoietin (TSLP)
and Surfactant Protein-D (SP-D) in Dendritic Cell Regulation
During Ozone-Induced Exacerbation of Allergic Airway Inflammation in Mice
Angela Haczku, MD, PhD, FAAAAI1, Blerina Kokalari1, Moyar
Q. Ge1,2, Cynthia Koziol-White1, Imre Redai1, Martine Loubeau3, Carla Bauer3, Christopher Stevenson3 and Lisa R. Forbes,
MD4,5, 1University of Pennsylvania, Philadelphia, PA, 2National
University of Singapore, Singapore, Singapore, 3Inflammation
Discovery,pRED Pharma Research and Early Development,
Hoffmann-La Roche, Nutley NJ, 4Baylor College of Medicine,
Texas Childrens Hospital, Houston, TX, 5University of
Pennsylvania
99
AB254 Abstracts

FEBRUARY 2013
Diagnostic Methods in Asthma

3201
Sunday, February 24th, 2013, 9:45 AM - 10:45 AM
220
221
SUNDAY
222
223
224
225
226
227
228
229
100
Does Monitoring of the Spirometric Values by Office Reflect

Asthma Control After Discontinuing Controller Medication in
Children with Controlled Asthma?
Dong In Suh, MD, Ju Kyung Lee, Jun-Hyuk Song and Young Yull
Y. Koh, MD, PhD, Seoul National University Hospital, Seoul, South
Korea
Should Allergists Be Caring for Alpha-1 Antitrypsin Deficiency?
Yoon M. Kim, DO1,2, Yuqing Gao1, Puneet Bajaj, MD1 and Timothy J. Craig, DO, FAAAAI1,3, 1Hershey Medical Center, Hershey,
PA, 2Pinnacle Health, Harrisburg, PA, 3Penn State University
College of Medicine, Hershey, PA
Relationships Between Exhaled Nitric Oxide and Atopy Profiles
(Mono-sensitization/Poly-sensitization) in Children with
Asthma
Young Yoo, MD, PhD, Department of Pediatrics, Korea University
Anam Hospital, Seoul, South Korea, Siegfried Bauer, MD, Korea
University Hospital, Seoul, Samuel Harmin, Department of Pediatrics, Korea University Anam Hospital, South Korea, South Korea,
Sungchul Seo, Korea University, Seoul, Wonsuck Yoon, Department of Life Science and Biotechnology, Seoul, South Korea and
Ji Tae Choung, MD, Korea Univ. Medical Center, Seoul
The Role of the FACT Score in Predicting Antibody Responses
to Pneumococcal Antigens in Asthmatics and Non-Asthmatics
Jenna Podjasek, MD, Ji A Jung, MD, Hirohito Kita, MD, Miguel
A. Park, MD and Young J. Juhn, MD, MPH, Mayo Clinic, Rochester, MN
Spirometry Flow Volume Tracings Predict Vocal Cord Dysfunction Diagnosis in Children and Adults
Monica Vasudev, MD, Jonathan Tam, MD, Jerome Sigua, MD,
Kathleen Divine, MS, Mahua Dasgupta, MS and Raymond Hoffmann, PhD, Medical College of Wisconsin, Milwaukee, WI
Characterization of Asthmatic Patients with Vocal Cord
Dysfunction
Rosana C. Agondi, MD, PhD, Violeta Galv~ao, Marcelo Aun, MD,
Carla Bisaccioni, MD, Jorge Kalil, MD, PhD and Pedro GiavinaBianchi, MD, PhD, Clinical Immunology and Allergy Division,
University of Sao Paulo, Sao Paulo, Brazil
The Simplified Method for Eucapnic Voluntary Hyperventilation (EVH) Challenge May Be Useful to Discriminate Exercise
Induced Asthma (EIA) From Deconditioning
Richard R. Rosenthal, MD1,2, Lorie Shora, MSN, FNP3, Harvey
Howe, BS3 and Paul Knause, BS3, 1Allergy and Clinical Immunology, Johns Hopkins School of Medicine, Baltimore, MD, 2INOVA
Fairfax Hospital, Fairfax, VA, 3Self
A Retrospective Analysis Comparing Subjects with Isolated and
Co-Existent Vocal Cord Dysfunction and Asthma
Russell Traister, MD, PhD1, Merritt L. Fajt, MD2, Emily Whitman-Purves1, William C. Anderson III, MD3 and Andrej Petrov,
MD4, 1University of Pittsburgh Medical Center, 2UPMC Montefiore, Pittsburgh, PA, 3University of Colorado, Denver/National
Jewish Health, Denver, CO, 4University of Pittsburgh Medical Center, Pittsburgh, PA
Clinical Outcomes of Subjects with Non-Specific Respiratory
Symptoms and High Feno Who Were Not Diagnosed with
Asthma A Retrospective Review of Outcomes 6 Months Following the Initial Evaluation
Barbara Yawn, MD, MSc, FAAFP1, Kathy Rickard, MD2, Nancy
Herje, BSN, RN, MBA2 and Paul M. Dorinsky, MD2, 1Olmsted
Medical Center, Rochester, MN, 2Aerocrine, Inc., Morrisville, NC
Plasma Complement Levels and Peripheral Blood Complement
Receptor Levels of Adults with Asthma Requiring Emergency
230
231
232
233
Department Treatment Correlate with IgE Responses and

QOL Scores
David Erstein, MD1, Jane Yee, BS1, Richard Sinert, DO2, Seto
Chice, MS1, Helen G Durkin, PhD1 and Rauno Joks, MD1, 1Center
for Allergy and Asthma Research at SUNY Downstate, Brooklyn,
NY, 2Kings County Hospital Center, Brooklyn, NY
Exhaled Nitric Oxide Level and School Absenteeism in Rural
High School Students with Current Asthma
Jeremiah Bivins, MD1, Dennis Ownby, MD, FAAAAI1, Jennifer
Waller, PhD2 and Martha Tingen, PhD2, 1Division of Allergy-Immunology and Rheumatology, Georgia Health Sciences University,
Augusta, GA, 2Georgia Health Sciences University, Augusta, GA
Mannitol Challenge Test, Sputum Eosinophils and Exhaled
Nitric Oxide (FENO) for Diagnosis of Asthma
Gyu-Young Hur, MD1, Jee Youn Oh2, Jong-Hyun Choi2, JaeKyeom Sim2, Kyung Hoon Min2, Sung-Yong Lee2, Jae-Jeong
Shim2 and Kyung-Ho Kang2, 1Korea University College of Medicine, Seoul, South Korea, 2Korea University College of Medicine,
South Korea
Feasibility of Spirometry Testing in Preschool Children
Jordan Kampschmidt1, Edward G. Brooks, MD1, Debra Cherry,
MD2 and Pamela R. Wood, MD1, 1Univ. Texas Health Science Center San Antonio, 2Univ. Texas Health Science Center Tyler
Clinical Implication of Exhaled Breath Temperature in Pediatric Asthma
Yoon Ki Han, MD1, Yoon Hee Kim, MD1, Hyun Bin Park, MD1,
Min Jung Kim, MD1, Hwan Soo Kim, MD1, Hee Seon Lee, MD1,
Hyun Hee Lee, MD, PhD2, Kyung Won Kim, MD, PhD1, Myung
Hyun Sohn, MD, PhD1 and Kyu-Earn Kim, MD, PhD1, 1Yonsei
University College of Medicine, Seoul, Korea, 2Kwandong University College of Medicine, Seoul
Autoimmunity, Immunodiagnostics
3202
234
235
236
237
238
Elevated Interleukin-6 Levels in Irritable Bowel Syndrome and

Non-Ulcerative Dyspepsia
Mahta Mortezavi, MD1, P.W.N, Keeling, MD2, Eamonn M.M .
Quigley, MD3 and Timothy G. Dinan, MD3, 1University at Buffalo,
Buffalo, NY, 2Trinity College, Dublin, Ireland, 3Alimentary Pharmabiotic Centre, University College Cork, Ireland
Serum IgE and Skin Test Using Partially Purified Specific Gnathostoma Spinigerum Antigen by Immunoblot Test Detecting
24kD Protein Among Patients with Angioedema or Eosinophilia
Wirach Maek-a-nantawat, MD, DTM H, Benjaluck Phonrat, Valai Bussaratid, Supaporn Nuamtanong, Wallop Pakdee and Paron
Dekumyoy, Faculty of Tropical Medicine, Mahidol University,
Bangkok, Thailand
Intravenous Methylprednisolone Pulse Therapy Target CD8+
Regulatory T Cell in Lupus Nephritis with Refractory Proteinuria
Ching-Yuang Lin, MD, PhD, Clinical Immunology Center, China
Medical University Hospital
Factors Associated with Methotrexate Dosing and Therapeutic
Decisions in Veterans with Rheumatoid Arthritis
Bernard Soo-Kian. Ng, MD, FAAAAI, Michael E. DeBakey
Veteran Affairs Medical Center and Adeline Chu, University of
Houston - Victoria
Use of Component Assays, ISAC, and Serial Dilution to Identify
Sera with IgE Antibodies Specific for a Minor Component
Lisa J. Workman, BA1, Anubha Tripathi, MD1, Alicia Clark, BA1,
Scott P. Commins, MD, PhD1, Elizabeth Erwin, MD2, Robert G.
Hamilton, PhD, D.ABMLI, FAAAAI3 and Thomas Platts-Mills,
239
240
241
242
243
244
245
MD, PhD, FAAAAI FRS1, 1University of Virginia, Charlottesville,

VA, 2Nationwide Childrens Hospital, Columbus, OH, 3Johns Hopkins University School of Medicine, Baltimore, MD
NY-ESO-1 Expression Is Associated with Melanoma Thickness,
but Not Mortality
Mara Giavina-Bianchi, MD1, Miriam Nacagamo Sotto, MD,
PhD1, Luciane Kanashiro2, Andrew J. Simpson3, Pedro GiavinaBianchi, MD, PhD4, Jorge Kalil, MD, PhD4 and Cyro Festa, MD,
PhD1, 1Division of Dermatology, University of S~ao Paulo, 2University of S~ao Paulo, 3Ludwig Institute for Cancer Research, 4Clinical
Immunology and Allergy Division, University of Sao Paulo, Sao
Paulo, Brazil
Immune Abnormalities in Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)
Katie Miro, MD, Razan Alghanmi, MD, James Rankin, MBS, Lee
Geng, PhD and Harumi Jyonouchi, MD, UMDNJ-New Jersey Medical School, Newark, NJ
Plasma IL-16 Concentration and Recurrent Wheeze At Age 3 in
Inner-City Children in the Ureca Birth Cohort
William W. Cruikshank, PhD1, Marina Tuzova, MD, PhD1, Katy
Jaffee2, George T. OConnor, MD1, Gordon R. Bloomberg, MD,
FAAAAI3, Meyer Kattan, MD4, Robert A. Wood, MD, FAAAAI5
and James Gern, MD, FAAAAI6, 1Boston University School of
Medicine, Boston, MA, 2Rho, Inc., Chapel Hill, NC, 3Campus
Box 8116, St. Louis Childrens Hospital, Saint Louis, MO, 4NewYork-Presbyterian/Columbia, New York, NY, 5Johns Hopkins University School of Medicine, Baltimore, MD, 6University of
Wisconsin School of Medicine and Public Health, Madison, WI
Normal B Cell Subpopulations in the Pediatric Age Groups and
Adults
Matthew Plassmeyer, PhD, Mark Ryherd, Margaret Brown, B.S.,
Raavi Gupta, MD, Ley Lacbawan and Oral Alpan, MD, Amerimmune, LLC, VA
Utility of Double-Negative T-Cells As a Marker for Autoimmunity in 22q11 Deletion Syndrome Patients
Bradley A. Locke, DO, Mary Hintermeyer, APNP, Trivikram
Dasu, PhD, John M. Routes, MD, FAAAAI and James W. Verbsky,
MD, PhD, Medical College of Wisconsin, Milwaukee, WI
Immune Complex-Mediated Damage Is Under Complement
Pathway Control
Eveline Y. Wu, MD, Garren Hester, BS, Haixiang Jiang, MD, PhD
and Michael Frank, MD, FAAAAI, Duke University Medical Center
Simultaneous Detection of Total and Allergen-Specific IgE in
Human Plasma Using Multiplex Array Technology
Meredith Lohman, MS, Martin D. Chapman, PhD FAAAAI and
Eva King, MSc, PhD, Indoor Biotechnologies, Inc., Charlottesville,
VA
Immunodeficiency
248
249
250
251
252
253
3203
246
247
Primary Immunodeficiencies in Patients with Recurrent Ear

and Sinus Infections
Chadi Makary, MD1, Rafka Chaiban, MD2, Benjamin Addicks2
and Yesim Yilmaz Demirdag, MD2, 1West Virginina University
School of Medicine, Morgantown, WV, 2West Virginia University
School of Medicine, Morgantown, WV
Late Onset Invasive Pneumococcal Disease in a Patient with
IRAK4 Deficiency
Michael David OSullivan1, Catherine Stroud2, Mario Abinun3,4,
Rainer Doffinger5, Steven OReilly3, Marzena Ciechomska3,
Dawn Barge2, Rebecca Treacy6, Stephen Owens4, Terry Flood4,
Andrew Gennery3,4 and Sophie Hambleton3,4, 1Immunology
254
255
Department, PathWest Laboratory Medicine, Perth, Australia, 2Department of Immunology, Royal Victoria Infirmary, Newcastle upon
Tyne, United Kingdom, 3Institute of Cellular Medicine, Newcastle
University, Newcastle upon Tyne, United Kingdom, 4Paediatric
Immunology & Infectious Diseases Department, Great North Childrens Hospital, Newcastle upon Tyne, United Kingdom, 5Department of Clinical Biochemistry and Immunology, Addenbrookes
Hospital, Cambridge, United Kingdom, 6East Anglian Medical Genetics Service, Addenbrookes Hospital, Cambridge, United
Kingdom
Nurses Perceptions of Wear-off Effects Following Immunoglobulin Replacement Therapy
Carla M. Duff, CPNP, MSN1, Annette R. Zampelli, NP2 and Ann
Bullinger, PharmD2, 1University of South Florida, Tampa, FL,
2
CSL Behring, King of Prussia, PA
Chronic Non-Iatrogenic Chylous Loss Syndromes in Children:
Are They Primary Immune Deficiencies?
Niti Y. Chokshi, MD1, Neha Seth1, Maria Afanador, MD2, Filiz
Seeborg, MD, MPH3, Barbara Reid, MD4, Timothy Vece, MD5, Jordan Orange, MD, PhD, FAAAAI3 and I. Celine Hanson, MD,
FAAAAI6, 1Baylor College of Medicine and Texas Childrens Hospital, Section of Immunology, Allergy and Rheumatology, Houston,
TX, 2Baylor College of Medicine and Texas Childrens Hospital,
Section of Neonatology, Houston, TX, 3Baylor College of Medicine
and Texas Childrens Hospital, Section of Immunology, Allergy and
Rheumatology, 4Baylor College of Medicine and Texas Childrens
Hospital, Section of Pediatric Gastroenterology, Hepatology, and
Nutrition, Houston, TX, 5Baylor College of Medicine and Texas
Childrens Hospital, Section of Pediatric Pulmonology, Houston,
TX, 6Baylor College of Medicine-Texas Childrens Hospital, Section of Immunology, Allergy and Rheumatology, Houston, TX
Report of Eight Patients with Immunodeficiency After Receiving Rituximab Therapy
Jennifer Welch, MD, Washington University School of Medicine,
Saint Louis, MO and H. James Wedner, MD, FAAAAI, Washington
University School Medicine, Saint Louis, MO
Idiopathic CD4 Lymphocytopenia: Clinical and Immunological
Aspects
Norma de Paula Motta Rubini, Albertina Varandas Capelo, Eliane Miranda da Silva, Mary Jane Lisboa Valory, Rafael Figueredo
Poleshuck, Fernando Samuel Sion, Jo~ao Negreiros Tebyrica and
Carlos Alberto Morais-de-Sa, Federal University of the State of
Rio de Janeiro, Rio de Janeiro, Brazil
Impaired in Vitro Capacity to Undergo IgG Isotype ClassSwitching (ICS) in Response to Interleukin-21 (IL21) Stimulation in Common Variable Immunodeficiency (CVID)
Marylin Desjardins, MD, McGill University Health Centre, Montreal, QC, Canada; Meakins Christie Laboratories, Montreal, QC,
Canada and Bruce D. Mazer, MD, FAAAAI, Montreal Childrens
Hospital, Montreal, QC, Canada; Meakins-Christie Laboratories,
Montreal, QC, Canada
IVIG Trademark Head to Head Analysis of Adverse Events in
1394 Intravenous Immunoglobulin Replacement Treatments
Blas Javier Larrauri1, Diego Fernandez Romero1, Maria Cecilia
Juri, MD2 and Alejandro Malbran, MD1, 1British Hospital of Buenos Aires, Buenos Aires, Argentina, 2Hospital Britanico de Buenos
Aires, Buenos Aires, Argentina
A Case of Bare Lymphocyte Syndrome: A Combined Immunodeficiency Missed by Newborn Screening?
Caroline Kuo, MD, E. Richard Stiehm, MD, FAAAAI and Maria
Garcia-Lloret, MD, FAAAAI, Division of Allergy and Immunology, Department of Pediatrics, David Geffen School of Medicine
at UCLA, Los Angeles, CA
Indications of Autoimmunity and Auto-Inflammation in
X-Linked Agammaglobulinemia
Vivian P. Hernandez-Trujillo, MD, FAAAAI, Miami Childrens
Hospital, Pembroke Pines, FL, Christopher Scalchunes, MPA,
SUNDAY
Abstracts AB255

101
AB256 Abstracts
256
257
258
SUNDAY
259
260
261
262
263
264
265
102
Immune Deficiency Foundation, Charlotte Cunningham-Rundles,

MD, PhD, FAAAAI, Mt. Sinai Medical Center, New York, NY,
Hans D. Ochs, MD, M/S C9S-7, Seattle Childrens Institute/University of Washington, Seattle, WA; Seattle Childrens Research Institute and University of Washington, Seattle, WA; University of
Washington, Seattle, WA and Kathleen E. Sullivan, MD, PhD,
FAAAAI, Childrens Hospital of Philadelphia, Philadelphia, PA
Cost-Effectiveness of Screening for Complement Deficiency
After Initial Meningococcal Infection
Gina D. Kubicz, MD, Gil G. Magpantay, MD and Paul B. Keiser,
MD, Walter Reed National Military Medical Center, Bethesda
The Duke University Medical Center (DUMC) Experience with
Common Variable Immune Deficiency (CVID)
Michele R. Henson, MD, Duke University, Durham, NC and Patricia L. Lugar, MD, MS, Duke University Medical Center, Durham,
NC
Poliovirus Antibodies in Patients with Antibody Deficiency
Having Regular Intravenous Immunoglobulin Therapy
Patricia M. Fontes, Beatriz Tavares Costa-Carvalho, MD, Maria
Isabel de Moraes Pinto, Celso Granato and Elaine dos Santos
Lima, Federal University of Sao Paulo, Brazil
Polyomavirus Excretion in Immune Compromised Patients
Margaret Hollister, MD, Gloria McClure, John Vanchiere, MD,
PhD and Adrian Casillas, MD, FAAAAI, Louisiana State University Health Shreveport, Shreveport, LA
Outcomes of Newborn Screening (NBS) for Severe Combined
Immunodeficiency (SCID) in Delaware
Archana Mehta, MD1,2, Stephen J. McGeady, MD, FAAAAI1,2
and Christopher Chang, MD, PhD, FAAAAI1,2, 1Thomas Jefferson
University Hospital, Philadelphia, PA, 2Alfred I duPont Hospital for
Children, Wilmington, DE
Novel RAB27A Mutation Distinguishes Hypopigmentation
From Cytotoxic Dysfunction in Griscelli Syndrome Type 2
Sanny K. Chan, MD, PhD1, Pinaki Banerjee, PhD1, Lenora Mendoza Noroski, MD, MPH2, Linda Monaco-Shawver3, Javier Chinen, MD, PhD, FAAAI4, I. Celine Hanson, MD, FAAAAI2 and
Jordan Orange, MD, PhD, FAAAAI1, 1Baylor College of Medicine
and Texas Childrens Hospital, Section of Immunology, Allergy and
Rheumatology, Houston, TX, 2Baylor College of Medicine-Texas
Childrens Hospital, Section of Immunology, Allergy and Rheumatology, Houston, TX, 3Childrens Hosptial of Philadelphia, 4Lake
Houston Asthma Allergy Immunology, Humble, TX
Impaired Nave B Cell Differentiation in a Kabuki Syndrome
Patient with an MLL-2 Nonsense Mutation
Andrew W. Lindsley, MD-PhD, Cincinnati Childrens Hospital
Medical Center, Marsha A. Wills-Karp, PhD, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD and
Jonathan A. Bernstein, MD, University of Cincinnati Medical Center, Cincinnati, OH
TREC <30 in Infants without SCID As A Marker for High
Mortality
Millard L. Tierce IV, DO1, Mary Ruehle, RN, MS, CPN1, Karen
Andruszewski, BS2, Kevin Cavanagh, PhD2, Karen Dahl, MD3,
Mary Kleyn, MS2, Patrick Michael Long, PhD1, Kelly Walkovich,
MD4, Heather Wood, MS2, William Young, PhD2 and Elizabeth A.
Secord, MD, FAAAAI1, 1Wayne State University, 2Michigan Department of Community Health, 3Helen DeVos Childrens Hospital,
4
University of Michigan
Atopic Dermatitis in Patients with Agammaglobulinemia Is Associated with Cutaneous Staphylococcal Infections
Rongras Damrongwatanasuk, MD1,2, Panida Sriaroon, MD2 and
John Sleasman, MD3, 1Childrens Research Institute, Saint Petersburg, FL, 2University of South Florida, Saint Petersburg, FL,
3
USF/All Childrens Hospital, St Petersburg, FL
B-Cell Phenotypes in Solid Organ Transplant Pediatric Patients
with Hypogammaglobulinemia
Jennifer A. Shih, MD, Emory University, Atlanta, GA and Lisa J.

FEBRUARY 2013
Kobrynski, MD, MPH, FAAAAI, Emory Childrens Center, Atlanta,

GA; Emory University School of Medicine, Atlanta, GA
How Viral and Bacterial Infections Drive Asthma

3204
266
267
268
269
270
271
272
Respiratory Syncytial Virus (RSV) Infection and Replication in

Mesenchymal Stem Cells (MSCs)
Michael B. Cheung, MS1,2, Subhra Mohapatra, MS, PhD1,2 and
Shyam S. Mohapatra, PhD, FAAAAI1,2, 1The University of South
Florida Morsani College of Medicine, Tampa, FL, 2James A Haley
VA Hospital, Tampa, FL
Interactive Effect of Sodium Sulfite and Rhinovirus Infection in
Chemokines Production by Airway Epithelial Cells
Hyun Hee Kim, MD, PhD1, Yoon Hong Chun2, Jong-seo Yoon2
and Joon Sung Lee, MD, PhD2, 1Dept. of Pediatrics Bucheon St.
Marys Hospital The Catholic University of Korea, Bucheon-si,
South Korea, 2Dept. of Pediatrics The Catholic University of Korea
Assessment of Bacterial Colonization in Airways of Children
with Asthma and Chronic Cough by Culture and 16S rRNA
Gene Sequencing
Pia J. Hauk, MD1, Elena Goleva, PhD2, Leisa P. Jackson, BS2, J.
Kirk Harris, PhD3, J. Tod Olin, MD MSCS4, Susan M. Brugman,
MD4, Dave P. Nichols, MD4, Marzena Krawiec, MD5 and Donald
Y. Leung, MD, PhD1, 1National Jewish Health, Department of Pediatrics, Division Pediatric Allergy/Immunology, Denver, CO, 2National Jewish Health, Department of Pediatrics, Denver, CO,
3
University of Colorado Anschutz Medical Campus, Department
of Pediatrics, Aurora, CO, 4National Jewish Health, Department
of Pediatrics, Division Pediatric Pulmonology, Denver, CO, 5Eastern Carolina University, Pediatric Pulmonology, Greenville, NC
Inhibition of Pim1 Kinase Attenuates Respiratory Syncytial
Virus (RSV) Re-Infection-Induced Enhanced Airway Hyperresponsiveness (AHR) and Inflammation
Junyan Han, PhD, Wanjiang Zeng, MD, Meiqin Wang, MD, PhD,
Katsuyuki Takeda, MD, Shigeru Ashino, PhD, Yi Jia, PhD, Yoo
Seob Shin, MD, PhD and Erwin W. Gelfand, MD, National Jewish
Health, Denver, CO
Allergic Airway Inflammation (AAI) Decreased Lung Klebsiella
Pneumoniae Burden in a Mouse Model of Acute Pneumonia
Daniel E. Dulek, MD1, Sara Reiss, MS2, Kasia Goleniewska, MS2,
Dawn C. Newcomb, PhD2, Shinji Toki, PhD2 and R. Stokes Peebles
Jr., MD, FAAAAI2, 1Pediatric Infectious Diseases; Department of
Pediatrics; Vanderbilt University School of Medicine, Nashville,
TN, 2Allergy, Pulmonary, and Critical Care Medicine; Department
of Medicine; Vanderbilt University School of Medicine, Nashville,
TN
RSV Infection Causes Lung Epithelial Cells Secretion of the
Proinflammatory Cytokine HMGB1
Yashoda M. Hosakote, PhD1, Roberto P. Garofalo, MD1 and Alexander Kurosky, PhD2, 1University of Texas Medical Branch, Galveston, TX, 2University of Texas Medical Branch, League City, TX
Correlation of Development of Asthma to Previous Infections in
Chinese and Hispanic Immigrant Populations Residing in
Brooklyn
Maria-Anna Vastardi, MD1, Irina Katayeva, MD1, Haijun Yao,
MD2, Daniel Puebla-Neira, MD2, Kobkul Chotikanatis, MD1,
Jeremy Weedon, PhD3, Helen G. Durkin, PhD1, Stephan A. Kohlhoff, MD1 and Rauno O. Joks, MD, FAAAAI1, 1SUNY Downstate
Medical Center, Center for Allergy and Asthma Research, Brooklyn, NY, 2Lutheran Medical Center, Brooklyn, NY, 3Scientific Computing Center, SUNY Downstate Medical Center, Brooklyn,
NY
Measuring Pollen Exposures

3205
273
274
275
276
277
278
279
280
281
282
283
Evaluation of a Compact Ionic Capture Device for Airborne

Allergens with the Use of a Controlled Environmental Chamber
Julian Gordon, PhD1, Prasanthi Gandhi, MBA, MPH1, David Alburty, President2 and Pam Murowchick, Director of Lab Operations2, 1Inspirotec LLC, Chicago, IL, 2AlburtyLab Inc, Drexel, MO
Climate Variability and Pollen: More Hay Fever or Less?
Estelle Levetin, PhD, FAAAAI, University of Tulsa and Claudia
Owens, MS, University of Tulsa, Tulsa
Heightened Responses to Quercus Virginiana (Virginia Live
Oak) Pollen During Natural Seasonal Exposure Versus Pollen
Challenge Chamber Exposure: Role of Co-Factors
Robert L. Jacobs, MD1, Weijing He, MD2, Nathan Harper, BS2,
Charles P. Andrews, MD3, Cynthia Rather, CCRC1, Daniel Ramirez, MD1 and Sunil Ahuja, MD2, 1Biogenics Research Chamber,
San Antonio, TX, 2Department of Medicine, University of Texas
Health Science Center, San Antonio, TX, 3Diagnostices Research
Group, San Antonio, TX
Is There Such a Thing As a Hypoallergenic Dog?
Betty Ann Petrak-Ron, MD, FAAAAI, Boulder Community Hospital, Boulder, CO, Eric Ron, Colorado State University, Ft. Collins,
CO and Judy St. Clair, CSU
Comparison of Airborne Allergen Levels Collected On Filters
with Dust Borne Allergen Levels Collected by Vacuum
Freddy Pacheco, MS, Childrens Mercy Hospital, Kansas City,
MO, Ryan Allenbrand, Childrens Mercy Hospital, Jay M. Portnoy, MD, FAAAAI, Childrens Mercy Hospital & Clinics, Kansas
City, MO, Charles S. Barnes, PhD, Childrens Mercy Hospitals
and Clinics, Kansas City, MO and Childrens Mercy Center for
Environmental Health, Childrens Mercy Hospitals and Clinics
Reduction of Domestic Allergen Levels in Carpets and Soft
Furnishings in US Homes Using a Proprietary Hot Water Extraction Cleaning Process
Bruce Mitchell, Maire Fox, Claire Mernagh, John Fallon and Vivienne Mahon, airmid healthgroup ltd, Dublin, Ireland
Digital Pathology Techniques in Pollen Assessment
Marissa B. Lewis, University of Delaware, East Brunswick, NJ and
Leonard Bielory, MD, FAAAAI, Rutgers University, New Brunswick, NJ
A Side-by-Side Comparison of Rotorod and Burkard Pollen and
Spore Collections
Howard C. Crisp, MD1, Robert Anthony Gomez2, James M.
Quinn, MD, FAAAAI1 and Kevin M. White, MD1, 1Wilford Hall
Ambulatory Surgical Center, San Antonio, TX, 2Wilford Hall Ambulatory Surgical Center, Lackland AFB, TX
Personalized Forecasting of Pollen-Induced Symptoms for HayFever Sufferers
Uwe E. Berger, MBA1, Siegfried Jaeger1, Matt Smith1 and KarlChristian Bergmann2, 1Medical University Vienna, Vienna, Austria,
2
Charite Campus Mitte, Berlin, Germany
Comparison of the Allergenic Potency of Old (1997) and Fresh
(2008) Grass Pollens
Renato Ariano1, Gianni Mistrello2, Giuseppe Frenguelli3, Emma
Tedeschini3, Raphael C. Panzani4 and Giovanni Passalacqua,
MD5, 1Department of Internal Medicine, Bordighera, Imperia, Italy,
2
Research Dept. Lofarma SpA, Milan, Italy, 3Department of Vegetable Biology of Perugia, University of Perugia, Perugia, Italy,
4
Centre de Recherche en Allergologie, Marseille, France, Marseille,
France, 5Allergy and Respiratory Diseases, IRCCS San Martino
Hospital-IST-University of Genoa
Increase in Midwestern Airborne Elm Pollen Over 14 Years
Manika Girdhar, DO1,2, Charles Barnes, PhD1, Minati Dhar, PhD1
284
285
286
287
288
289
290
291
292
293
294
and Jay M. Portnoy, MD, FAAAAI1, 1Childrens Mercy Hospital &

Clinics, Kansas City, MO, 2University of Missouri - Kansas City
Measuring Individual Pollen Exposure
Torsten Sehlinger1, Klaus Boehm2, Frank Goergen1 and KarlChristian Bergmann3, 1Bluestone Technology GmbH, Woerrstadt,
Germany, 2Univeristy of Applied Science Mainz, Mainz, Germany,
3
Charite Campus Mitte, Berlin, Germany
Myxomycete Spores: Unrecognized Aeroallergens?
Michelle B. Lierl, MD, FAAAAI, Cincinnati Childrens Hospital,
Cincinnati, OH
Shifting Trends of Ragweed (Ambrosia) Measurements During
a 22 Year Period in Northern and Southern New Jersey (NJ)
Jonathan Maik, Yeshiva University and Leonard Bielory, MD,
FAAAAI, STARx Allergy and Asthma Center, Springfield, NJ
The Effect of Local Temperature, Wind Velocity and Rain On
Aerobiology Sampling; Ten Year Study (2001-2011), Sarasota,
Fl
Gregory Michael Cowan, MD1, Neetu Talreja, MD2, Jennifer E.
Fergeson, DO3, Mary Jelks, MD1, Dennis K. Ledford, MD,
FAAAAI2 and Richard F. Lockey, MD2, 1University of South Florida Morsani College of Medicine, 2Morsani College of Medicine
University of South Florida and James A. Haley Veteran Hospital,
3
University of South Florida Morsani College of Medicine, Tampa,
FL
Distribution of Indoor Fungal Spore Levels
Minati Dhar, PhD1, Freddy Pacheco, MS2, Jay M. Portnoy, MD,
FAAAAI1, Charles S. Barnes, PhD3 and . Childrens Mercy Center
for Environmental Health4, 1Childrens Mercy Hospital & Clinics,
Kansas City, MO, 2Childrens Mercy Hospital, Kansas City, MO,
3
Childrens Mercy Hospitals and Clinics, Kansas City, MO, 4Childrens Mercy Hospitals and Clinics
The Effect of Increasing Ragweed Pollen Counts On Skin Prick
Reactions
Sunena C. Argo, MD1, Nikita Raje, MD, MBBS1, Ravneet Donegan, MD1, Charles S. Barnes, PhD2 and Paul J. Dowling, MD,
FAAAAI2, 1Childrens Mercy Hospitals and Clinics/University of
Missouri-Kansas City, Kansas City, MO, 2Childrens Mercy Hospitals and Clinics, Kansas City, MO
House Dust Mite Crustacean-Mollusk-Insect Syndrome
(HCMIS) in A Patient Resident of A Tropical ZONE
Kaddy Juliana Beltran1, Kaddy Juliana Beltran2, Ruth Helena
Ramirez1 and Ricardo Cardona-Villa, MD3, 1Universidad de
Antioquia, 2Universidad de Antioquia, Medellin, Colombia,
3
Universidad de Antiquia, Colombia
Correlation of Yearly Poaceae Pollen and January to July Rainfall
Charles S. Barnes, PhD1, Minati Dhar, PhD2 and Jay M. Portnoy,
MD, FAAAAI2, 1Childrens Mercy Hospitals and Clinics, Kansas
City, MO, 2Childrens Mercy Hospital & Clinics, Kansas City, MO
Juniper Pollen Hotspots in the Southwest
Landon Bunderson, University of Tulsa, Tulsa, OK, Jeffrey Luvall, NASA Marshall Space Flight Center, Huntsville, AL, Peter
Van De Water, PhD, California State University, Fresno, Fresno,
CA and Estelle Levetin, PhD, FAAAAI, University of Tulsa
Correlation Between Mold Sensitization and Proximity to
Mushroom Farms
Mary K. Paul, MD1,2, Christopher Chang, MD, PhD, FAAAAI2,3
and Gang Ye, PhD4, 1A.I. DuPont Hospital, Wilmington, DE,
2
Thomas Jefferson University Hospital, Philadelphia, PA, 3Alfred
I duPont Hospital for Children, Wilmington, DE, 4Nemours
Monitoring Japanese Allergenic Pollen Using Durhams and
Burkard Sampler for Asia Pollen Allergy Network
Reiko Kishikawa, MD1, Akemi Saito, PhD2, Hiroyuki Nanba,
PhD3, Norio Sahashi, PhD4, Yoshinori Higaki5, Eiko Koto1, Terufumi Shimoda, MD6, Kazuo Akiyama, MD2 and Tomoaki Iwanaga,
MD1, 1The National Hospital Organization Fukuoka Hospital, Fukuoka, Japan, 2The National Hospital Organization Sagamihara
SUNDAY
Abstracts AB257

103
AB258 Abstracts

FEBRUARY 2013
Hospital, Sagamihara, Japan, 3Matsuyama University, Matsuyama,

Japan, 4Toho University, Funabashi, Japan, 5Saijo Agriculture
High School, Saijo, Japan, 6The National Hospital Organization Fukuoka Hospital, Fukuoka, Japan
303
Food Allergy I
3206
295
SUNDAY
296
297
298
299
300
301
302
104
Outcomes and Safety of Oral Food Challenges in a UniversityBased Clinic

Timothy P. Moran, MD, PhD1, Ginger S. LaBelle, CPNP1, Debra
A. Sedlak, MSN, CPNP1, P. Brian Smith, MD MHS MPS1, Brian P.
Vickery, MD, FAAAAI2 and Joseph L. Roberts, MD, PhD1, 1Duke
University Medical Center, Durham, NC, 2University of North Carolina at Chapel Hill, Chapel Hill, NC
Exercise Should Be Added to Food Challenge Tests to Predict
Anaphylaxis During Oral Tolerance Induction for Severe Milk
Allergy Patients
Kazuyo Kuzume, Ehime Prefectual Niihama Hospital, Niihama,
Ehime, Japan, Yu Kuwabara, Ehime Prefectual Niihama Hospital,
Munemitsu Koizumi, Ehime Prefectual Central Hospital, Koji Nishimura, Uwajima City Hospital and Yoshitaka Murakami, Ehime
Prefectual Imabari Hospital
Utility of Ovomucoid and Egg White Specific IgE and Skin
Prick Testing in Predicting Baked Egg Challenge Outcomes
Lisa Bartnikas, MD1,2, William J. Sheehan, MD1,2, Katherine Larabee, BA3, Lynda C. Schneider, MD, FAAAAI1,2 and Wanda Phipatanakul, MD, MS, FAAAAI1,2, 1Boston Childrens Hospital,
Boston, MA, 2Harvard Medical School, Boston, MA, 3Boston University School of Medicine, Boston, MA
CoAle Multicenter Study: Diagnostic Tests As Predictors of
Clinical Reactivity in the Follow-up of the Milk-Allergic Infants
Mariangelica Bermudez Martinez1, Cristina Vlaicu1, Melissa
Olano Rocha1, Ibon Eguiluz Gracia2, Soledad Terrados Cepeda1,
Inmaculada Cerecedo Carballo3, Maria Del Carmen Dieguez3, Belen De La Hoz, MD, PhD1 and Montserrat Fernandez-Rivas2, 1Hospital Universitario Ramon y Cajal, Madrid, Spain, 2Hospital Clinico
San Carlos, Madrid, Spain, 3Hospital del Sureste, Arganda del Rey,
Spain
Basophil Allergen Threshold Sensitivity, CD-Sens, and IgE Antibodies to Wheat, Hydrolysed Wheat, v-5 Gliadin and Timothy
Grass in Relation to Wheat Challenge Outcome
Nora Nilsson, Astrid Lindgrens Childrens Hospital, Stockholm,
Sweden
Oral Food Challenge: Experience in a Brazilian Food Allergy
Outpatient Terciary Service
Camila Pereira1, Leila Borges2, Renata R. Cocco1, Lucila
Camargo1, Marcia Mallozi1 and Dirceu Sole, MD PhD3, 1Federal
University of S~ao Paulo, 2Federal University of Sao Paulo, 3Federal
University of Sao Paulo, Sao Paulo, Brazil
Tolerance to Extensively Heated (Baked) Milk-Clinical and Immunologic Phenotype
Hugh A. Sampson, MD, FAAAAI1, George N. Konstantinou, MD,
PhD, MSc1, Jacob Daniel Kattan, MD1, Madhan Masilamani, PhD1,
Beth D. Strong, RN, CCRC2, Elizabeth Paynter, MA3, Tee Bahnson, BS, MPH3 and Anna H. Nowak-Wegrzyn, MD, FAAAAI2,
1
Mount Sinai School of Medicine, New York, NY, 2Mt. Sinai
School of Medicine, New York, NY, 3Rho Federal Systems Division, Inc., Chapel Hill, NC
Efficacy & Safety of Abbreviated Oral Food Challenges in Ruling Out Food Allergy in a Pediatric Allergy Clinic
Kelly M. Maples, MD1,2, Tyler Thompson1,3, Amy Perkins, MS1,2
and Madison Smart, MA1, 1Childrens Hospital of The Kings
304
305
306
307
308
309
310
Daughters, Norfolk, VA, 2Eastern Virginia Medical School, Norfolk, VA, 3Campbell University, Buies Creek, NC
Basophil Reactivity and Allergen Specific-IgE Levels but Not
Total IgE, Skin Prick Test Size, or Specific IgG4 Are Correlated
with Severity of Double-Blind, Placebo-Controlled Food Challenge Reactions
Nicole Leung1, Ying Song, MD1, Julie Wang1, Li Xin Wang1,
Jaime Ross1, Scott H. Sicherer, MD, FAAAAI1, June Straw2, Stacie
M. Jones, MD2, Hugh A. Sampson, MD, FAAAAI1 and Xiu-Min
Li, MD1, 1Mount Sinai School of Medicine, New York, NY, 2University of Arkansas for Medical Sciences, Little Rock, AR
Oral Immunotherapy At Fixed Low Dose for Mild to Moderate
Hens Egg Allergy
Noriyuki Yanagida1,2, Takanori Minoura1 and Motohiro Ebisawa,
MD, PhD, FAAAAI2, 1Sendai Medical Center, 2Sagamihara National Hospital
The Absence of Oil Body Proteins in Allergenic Extract Might
Be Involved in False-Negative Diagnosis of Some Peanut Allergic Patients
Marta M. Ferrer, MD, PhD, FAAAAI1, Fernando Pineda, PhD2,
Gracia Javaloyes, MD, PhD3, Miguel Blanca, MD, PhD4, Ana Aranda, PhD5, Francisca Gomez, MD, PhD6, Gabriel Gastaminza, MD,
PhD3, Juliana de Souza, PhD7, Maria L Sanz, MD, PhD3 and M
Jose Goikoetxea, PhD, MD1, 1Department of Allergy, Clinica Universidad de Navarra, Pamplona, Spain, 2Diater Laboratorios, Madrid, Spain, 3Department of Allergy, Clinica Universidad de
Navarra, Spain, 4Carlos Haya Hospital, Malaga, Spain, 5Research
Laboratory, Carlos Haya Hospital-FIMABIS, Malaga, Spain, 6IMABIS Foundation, Malaga, Spain, 7Department of Microbiology,
Universidad de Navarra, Spain
Patterns of Serum Peanut-Specific IgE in Peanut Allergic Children Over Time
Lisanne P. Newton, MD, Cleveland Clinic Foundation, Cleveland,
OH and Alton Lee Melton Jr., MD, Cleveland Clinic
Basophil Response to Peanut Allergens in Mediterranean Peanut-Allergic Patients
Cristobalina Mayorga, PhD1,2, Mara Jose Torres, MD, PhD3, Ana
Belen Blazquez, PhD1, Francisca Gomez, MD, PhD3, Ignacio Garcia, MD, PhD3, Ana Aranda Guerrero, PhD1, Stef Koppelman,
PhD4, Araceli Diaz-Perales, PhD5, Stefan Vieths, PhD6 and Miguel
Blanca, MD, PhD3, 1Research Laboratory, Carlos Haya Hospital,
Malaga, Spain, 2Pediatric Service, Carlos Haya Hospital, Malaga,
Spain, 3Allergy Service, Carlos Haya Hospital, Malaga, Spain,
4
TNO Quality of Life, Zeist, Netherlands, 5Biotechnology Department, Center for Plant Biotechnology and Genomics, Madrid,
Spain, 6Paul-Ehrlich-Institut, Langen, Germany
The Use of the ISAC Microarray Platform in Food Allergic
Patients
Jacob Daniel Kattan, MD, Gustavo Gimenez, BA, Jay Lieberman,
MD and Hugh A. Sampson, MD, FAAAAI, Mount Sinai School of
Diagnosis of Peanut Allergy Using Component-Resolved Diagnosis in Asian Population From A Country with Low Prevalence
Sadudee Boonmee, MD1, Narissara Suratannon, MD1, Jarungchit
Ngamphaiboon, MD1, Jongkonnee Wongpiyabovorn, MD2 and
Pantipa Chatchatee, MD1, 1Department of Pediatrics King Chulalongkorn Memorial Hospital, Bangkok, Thailand, 2Faculty of Medicine Chulalongkorn University, Bangkok, Thailand
Ara h1 T-Cell Epitope Identification in Peanut Allergic Patients
Manish Ramesh, MD, PhD1, Araya Yuenyongviwat, MD1,2,
George N. Konstantinou, MD, PhD MSc1,3, Jay Lieberman,
MD1,4, Madhundra Sivakumar1, Mariona Pascal, PhD1,5,6, Madhan
Masilamani, PhD1 and Hugh A. Sampson, MD, FAAAAI1, 1Mount
Sinai School of Medicine, New York, NY, 2Price of Songkla
University, Songkhla, Thailand, 3424 General Military Training
Hospital, 4University of Tennessee, 5Centre de Diagnostic Biomedic, 6Institut dInvestigacions Biomediques August Pi i Sunyer
311
312
313
314
315
316
Induction of Antigen-Specific B Cells During Peanut Oral Immunotherapy Using Novel Tetramer-Based Approach
Sarita U. Patil, MD1, Stephanie Kubala, B.S.2, Alisa K. Brennan,
B.S.3, Alex Ma, B.S.3, James Moon, PhD3 and Wayne G. Shreffler,
MD, PhD, FAAAAI3,4, 1Allergy and Immunology, Massachusetts
General Hospital, Boston, MA, 2Temple University School of Medicine, Philadelphia, PA, 3Massachusetts General Hospital, Boston,
MA, 4Harvard Medical School, Boston, MA
Outcomes Using a Graded Protocol for Open Food Challenges
Alisa K. Brennan, B.S.1, Sarita U. Patil, MD2, Jude Fleming, BS3,
Joshua A. Boyce, MD, FAAAAI4, Elisabeth S. Stieb, RN, BSN,
AE-C5, Margaux Nichols, BSN1, Rajashri Shuba Iyengar, MD1,
Perdita Permaul, MD6, Jolan E. Walter, MD, PhD1, Paul Hesterberg, MD1 and Wayne G. Shreffler, MD, PhD, FAAAAI1,7, 1Massachusetts General Hospital, Boston, MA, 2Allergy and Immunology,
Massachusetts General Hospital, Boston, MA, 3Division of Asthma
and Allergy, Department of Pediatrics, Rhode Island Hospital, Alpert School of Medicine at Brown University, Providence, RI,
4
Brigham and Womens Hospital, Division of Rheumatology, Immunology and Allergy, Boston, MA, 5Massachusetts General Hospital, South Weymouth, MA, 6Division of Pediatric Allergy/
Immunology, Massachusetts General Hospital, Boston, MA, 7Harvard Medical School, Boston, MA
Baked Milk Oral Food Challenges: A Single-Center Pediatric
Hospital Experience
Rushani W. Saltzman, MD1, Mary E. Kelleher, RN, CPN, AE-C2
and Jonathan M. Spergel, MD, PhD, FAAAAI2,3, 1The Childrens
Hospital of Philadelphia, Voorhees, NJ, 2Childrens Hospital of
Philadelphia, Philadelphia, PA, 3Perelman School of Medicine at
Univ of Pennsylvania
Subjects Sensitized to Sunflower Seed (Helianthus annuus) Are
Tolerant in a High Proportion of Cases
Ana Aranda Guerrero, PhD1, Maria Luisa Macias2, Francisca
Gomez, MD, PhD3, Natalia Blanca-Lopez, MD, PhD4, Elena
Seoane, MD, PhD2, Gabriela Canto, MD, PhD5, Miriam Osorio3,
Cristina Gomez-Casado6, Araceli Diaz-Perales, PhD7 and Miguel
Blanca, MD, PhD8, 1Research Laboratory, Carlos Haya Hospital,
Malaga, Spain, 2Foundation IMABIS, 3IMABIS Foundation, Malaga, Spain, 4Allergy Service, Infanta Leonor Hospital, Madrid,
Spain, 5Allergy Service, Infanta Leonor Hospital, 6Biotechnology
Department, Center for Plant Biotechnology and Genomics, 7Biotechnology Department, Center for Plant Biotechnology and Genomics, Madrid, Spain, 8Allergy Service, Carlos Haya Hospital,
Malaga, Spain
Profile of Sensitization to Sunflower Seedin a Large Population
Highly Exposed
Mara Luisa Macias Ramirez1, Ana Aranda, PhD2, Francisca Gomez, MD, PhD3, Natalia Blanca-Lopez, MD, PhD4, Elena Seoane,
MD, PhD4,5, Gabriela Canto, MD, PhD6, Jose Luis RodriguezBada, Lab. Tech.7, Leticia Tordesillas8, Araceli Diaz Perales9 and
Miguel Blanca, MD, PhD10, 1FIMABIS, Malaga, Spain, 2Research
Laboratory, Carlos Haya Hospital-FIMABIS, Malaga, Spain, 3IMABIS Foundation, Malaga, Spain, 4Allergy Service, Infanta Leonor
Hospital, Madrid, Spain, 5Foundation IMABIS, 6Allergy Service,
Infanta Leonor Hospital, 7Research Laboratory, Carlos Haya Hospital-Fundaci
on IMABIS, Spain, 8Biotechnology Departament, center
for plant biotechnology and genomics, Madrid, Spain, 9Plant Biotechnology Institute (UPM-INIA), Madrid, Spain, 10Allergy Service, Carlos Haya Hospital, Malaga, Spain
Characterization of Apple Allergy in A Mediterranean Population
Mara Jose Torres, MD, PhD1, Francisca Gomez, MD, PhD1, Ana
Aranda, PhD2, Cristobalina Mayorga, PhD3,4, Ignacio Garcia, MD,
opez, MD,
PhD1, Araceli Diaz-Perales, PhD5, Natalia Blanca-L
PhD6, Elena Seoane, MD, PhD6, Arantxa Palacin, PhD5, Maria
Garrido, PhD5, Stefan Vieths, PhD7 and Miguel Blanca, MD,
PhD1, 1Allergy Service, Carlos Haya Hospital, Malaga, Spain,
317
318
319
320
321
322
323
324
325
2
Research Laboratory, Carlos Haya Hospital-FIMABIS, Malaga,
Spain, 3Research Laboratory, Carlos Haya Hospital, Malaga, Spain,
4
Pediatric Service, Carlos Haya Hospital, Malaga, Spain, 5Biotechnology Department, Center for Plant Biotechnology and Genomics,
Madrid, Spain, 6Allergy Service, Infanta Leonor Hospital, Madrid,
Spain, 7Paul-Ehrlich-Institut, Langen, Germany
Food Specific IgE Levels in Children Should Be Interpreted in
Context of Total IgE
Tara J. Federly, MD1,2, Bridgette L. Jones, MD, FAAAAI1, Hongying Dai, PhD1 and Chitra Dinakar, MD, FAAAAI1,2, 1Childrens
Mercy Hospital & Clinics, Kansas City, MO, 2University of Missouri-Kansas City
Threshold Dose for Shrimp: A Risk Characterization Based On
Objective Reactions in Clinical Studies
Julie A. Nordlee, MS1, Benjamin C. Remington, BS1, Barbara K.
Ballmer-Weber, MD2, Samuel B. Lehrer, PhD, FAAAAI3, Joe L.
Baumert, PhD1 and Steve L. Taylor, PhD1, 1Food Allergy Research
and Resource Program, University of Nebraska-Lincoln, Lincoln,
NE, 2University Hospital of Zurich, Zurich, Switzerland, 3Tulane
University Medical Center, New Orleans, LA
Desensitization by Sublingual Immunotherapy for Crustacean
Allergy
Maged Refaat, MD1, Khalid El-Damhougy, MD2, Adham Sadiq,
MD2, Mohamed Attia, PhD1 and Mabrouk Mabrouk2, 1Department
of Allergy and Clinical immunology,Ain Shams university, Cairo,
Egypt, 2Department of Zoology and Entomology, Faculty of Science, Al-Azhar university, Egypt
Clinical and Laboratory Predictors of the Outcome of Oral
Food Challenges
Farah Khan, DO1,2, Stephen J. McGeady, MD, FAAAAI1,2 and
Christopher Chang, MD, PhD, FAAAAI1,2, 1Alfred I duPont Hospital for Children, Wilmington, DE, 2Thomas Jefferson University
Hospital, Philadelphia, PA
The Difference of Positive Predictive Value of Ovm-Specific IgE
for Heated Hens Egg Oral Food Challenge by Transition of
Ovm-Specific IgE
Osamu Natsume, MD, Fukuie Tatsuki, Matsunaga Mayumi, Tajima Iwao, Suzuki Tsukasa, Taguchi Tomohide and Ogata Tsutomu,
Hamamatsu university school of medicine, Hamamatsu, Japan
Egg White Skin Prick Tests: A Reliable Predictor of Heated Egg
Tolerance in Egg-Allergic Children
Nithya Swamy, MD, University of Texas Southwest Medical Center, Dallas, TX, Maria G. Crain, RN, Childrens Medical Center,
Dallas, TX and J. Andrew Bird, MD, Childrens Medical Center
Slow Stepwise Resolution Protocol for Children with Food Allergies
Kumiko Mukaida, MD, PhD, Takashi Kusunoki, MD, PhD, Ikuko
Hiejima, MD, Fumihito Nozaki, MD, Anri Hayashi, MD, Tomohiro
Kumada, MD, PhD, Tomoko Miyajima, MD and Tatsuya Fujii,
MD, PhD, Department of Pediatrics, Shiga Medical Center for
Children, Shiga, Japan
Ovo-Des Nm, a Future Treatment for Egg Allergy
Maria Eulalia Landivar Encalada1, Maria Eulalia Landivar Encalada1, Monica Ruiz-Garcia2, Elisa Haroun Diaz2, Jose A. Torres
Hernandez, MD2 and Joaquin Sastre, MD, PhD, FAAAAI2, 1FUNDACION JIMENEZ DIAZ, MADRID, Spain, 2Fundacion Jimenez
Diaz, Madrid, Spain
Early Treatment of Food-Induced Allergic Reactions with Epinephrine Is Associated with Lower Risk of Hospital Admission
Jude Fleming, BS1, Sunday Clark, MPH, ScD2, Carlos Camargo
Jr., MD, DrPH3 and Susan A. Rudders, MD1, 1Division of Asthma
and Allergy, Department of Pediatrics, Rhode Island Hospital, Alpert School of Medicine at Brown University, Providence, RI,
2
Department of Emergency Medicine, Weill Cornell Medical
College, New York, NY, 3Department of Emergency Medicine,
Massachusetts General Hospital, Harvard Medical School,
Boston, MA
SUNDAY
Abstracts AB259

105
AB260 Abstracts
326
327
328
SUNDAY
329
330
331
332
333
334
335
106
Multiple Epinephrine Doses in Food-Induced Anaphylaxis in

Children
Angela Tsuang, MD1, Nikhil Menon, Medical student1, Natasha
Setia, Medical student1, Larry Geyman, Medical student1 and
Anna H. Nowak-Wegrzyn, MD, FAAAAI2, 1Mount Sinai School
of Medicine, 2Mt. Sinai School of Medicine, New York, NY
Peanut Oral Immunotherapy Induces Desensitization At 2g
Maintenance Dosing
Matthew Feldman, MD1, Amy Arneson, RN2, Caitlin Burk3,
Michael D. Kulis Jr, PhD3, A. Wesley Burks, MD, FAAAAI3 and
J. Andrew Bird, MD1, 1UT Southwestern Medical Center, Dallas,
TX, 2Childrens Medical Center, Dallas, TX, 3University of North
Carolina at Chapel Hill, Chapel Hill, NC
Predictors of Clinical Tolerance After Peanut Oral Immunotherapy
Yamini Virkud, MD, MA1, Stacy Chin, MD2, Nik Kamilaris3,
Michael D. Kulis Jr., PhD4, Janet S. Kamilaris, RN4, Pamela H.
Steele, MSN, CPNP, AE-C4, P. Brian Smith, MD, MHS, MPS5,
Brian P. Vickery, MD, FAAAAI4 and A. Wesley Burks, MD,
FAAAAI4, 1Duke University, Durham, NC, 2FDA/CDER, Washington, DC, 3University of North Carolina, Chapel Hill, NC, 4University of North Carolina at Chapel Hill, Chapel Hill, NC, 5Duke
University Medical Center, Durham, NC
Epicutaneous Immunotherapy (EPIT) Is Safe for the Treatment
of Peanut Allergy in Allergic Patients
Wence Agbotounou, PhD1, Laurent Martin, PharmD1, Bertrand
Dupont1, Isabelle Pascal1, Cecile Vauleon1 and Pierre Henri
Benhamou, MD2, 1DBV Technologies, Bagneux, France, 2DBV
Technologies, Paris, France
Safety of Peanut Oral Immunotherapy (OIT) Using a Modified
Dosing Protocol
Amy Arneson, RN1, Matthew Feldman, MD2 and J. Andrew Bird,
MD2, 1Childrens Medical Center, Dallas, TX, 2UT Southwestern
Medical Center, Dallas, TX
Life with Peanut: Follow up of Tolerant Versus Desensitized
Subjects After Peanut OIT
Saira Zafar Sheikh, MD1, Brian P. Vickery, MD, FAAAAI1, Pamela H. Steele, MSN, CPNP, AE-C1, Janet S. Kamilaris, RN1, Michael D. Kulis Jr, PhD1, Suzanne K. Carlisle, RN, BSN, CCRP2, G.
Lynn Christie, MS, RD2, Stacie M. Jones, MD2 and A. Wesley
Burks, MD, FAAAAI1, 1University of North Carolina at Chapel
Hill, Chapel Hill, NC, 2University of Arkansas for Medical
Sciences, Little Rock, AR
Comparison Between Two Maintenance Feeding Regimens After Successful Cows Milk Oral Desensitization
Giovanni B. Pajno, MD, FAAAAI1, Lucia Caminiti1, Giuseppina
Salzano1, Giuseppe Crisafulli1, Tommaso Aversa1, Francesca Maria
Messina1, Malgorzata Wasniewska1 and Giovanni Passalacqua,
MD2,3, 1Dept of Pediatrics, Allergy Unit, University of Messina,
2
University of Genoa, Genoa, Italy, 3Allergy and Respiratory Diseases, IRCCS San Martino Hospital-IST-University of Genoa
Predictors for the Successful Outcome of Oral Immunotherapy
to Milk
Michael B. Levy, MD, FAAAAI, Arnon Elizur, MD, Michael
Goldberg, MD, PhD, Liat Nachshon, MD and Yitzhak Katz, MD,
FAAAAI, Assaf Harofeh
Perinatal Environmental Influences Contributing to Goats and
Sheeps Milk Allergy without Cows Milk Allergy
Rani Maskatia, MD, Baylor College of Medicine, Houston, TX
and Carla M. Davis, MD, Baylor College of Medicine/Texas Childrens Hospital, Department of Pediatrics, Houston, TX; Texas
Childrens Hospital, Houston, TX
Bystander Suppression in Food Allergy
Megan S. Motosue, MD1, Tina Dominquez, PA-C2, Alicia Sciancalepore, RN2, Daniela Pineda, MA2, Anjuli Mehrotra, MD3, Lisa
Hoyte, NP2 and Kari Nadeau, MD, PhD, FAAAAI4, 1Santa Clara
Valley Medical Center, San Jose, 2Stanford Alliance for Food

FEBRUARY 2013
336
337
338
339
340
341
342
343
344
Allergy Research, Palo Alto, CA, 3Silicon Valley Allergy and

Asthma Inc., Mountain View, CA, 4Stanford Univ School Medicine,
Stanford, CA
Efficacy of Oral Immunotherapy in Patients with Multiple Food
Allergies
Shruti P. Wilson, MD, Tina L.R. Dominguez, PA-C MMS, Alicia
Sciancalepore, RN, Daniela Pineda, MA, Anjuli Mehrotra, MD,
Steven W. Rubinstein, MD, Alan B. Goldsobel, MD, FAAAAI,
Michael J. Mulligan, MD, Robert C. Bocian, MD, PhD, FAAAAI,
Nancy Cummings, MD, FAAAAI and Kari Nadeau, MD, PhD,
FAAAAI, Stanford University School of Medicine
Role of Omalizumab in Rush Cows Milk Desensitization in the
Outpatients Office
Paloma Poza-Guedes1, Ruperto Gonzalez Perez1, Inmaculada
Sanchez Machn1 and Victor Matheu, MD2, 1Hospital del ToraxOfra, Sta Cruz de Tenerife, Spain, 2Hospital Ofra, Tenerife, Spain
Efficacy of Oral Immunotherapy and Anti-IgE Antibody-Adjunctive Treatment in Patients with Multiple Food Allergies
Tina L.R. Dominguez, PA-C MMS, Shruti P. Wilson, MD, Alicia
Sciancalepore, RN, Daniela Pineda, MA, Anjuli Mehrotra, MD,
Steven W. Rubinstein, MD, Alan B. Goldsobel, MD, FAAAAI, Michael J. Mulligan, MD, Robert C. Bocian, MD, PhD, FAAAAI,
Nancy Cummings, MD, FAAAAI and Kari Nadeau, MD, PhD,
Rapid Oral Desensitization for Severe Peanut Allergy Enabled
with Omalizumab
Lynda C. Schneider, MD FAAAAI, Rima A. Rachid, MD,
FAAAAI, Jennifer S. LeBovidge, PhD, Dionne Graham, PhD, Timothy Harrington, BA, Mudita Mittal, MD and Dale T. Umetsu, MD,
PhD, FAAAAI, Boston Childrens Hospital, Boston, MA
Increased IL-17A Responses in Food Allergic Children
Nashmia Qamar, DO1, Anna B. Fishbein2, Kristin A. Erickson2,
Mary J. Kwasny3, Miao Cai2, Ramsay L. Fuleihan2 and Anne Marie
Singh2, 1Division of Allergy & Immunology, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann &
Robert H. Lurie Childrens Hospital of Chicago, Chicago, IL,
2
Division of Allergy & Immunology, Department of Pediatrics,
Northwestern University Feinberg School of Medicine, Chicago,
IL, 3Department of Preventive Medicine, Northwestern University
Feinberg School of Medicine, Chicago, IL
Preliminary Results Comparing the Sensitizing Potential of Purified -Lactoglobulin (BLG) Versus Whey Protein in Germfree
(GF) and Conventional C3H/Hen Mice
Nathan L. Marsteller1,2, Kwame Andoh-Kumi1, Daniel A. Peterson3, Joe L. Baumert, PhD1 and Richard E. Goodman1, 1Food
Allergy Research and Resource Program, University of NebraskaLincoln, Lincoln, NE, 2School of Biological Sciences, University
of Nebraska-Lincoln, 3Johns Hopkins School of Medicine, Baltimore, MD
Peanut Tolerance in Offspring of Female Mice Fed Peanut and
Cholera Toxin B Subunit Is Associated with Epigenetic Regulation of Foxp3 Promoter and Induction of Mucosal Foxp3 and
IL-10 Gene Expression
Yiqun Hui, MD, PhD1, Ying Song, MD2, Hugh A. Sampson, MD,
FAAAAI2 and Xiu-Min Li, MD2, 1The Mount Sinai Hospital,
2
Mount Sinai School of Medicine, New York, NY
Negative Association of FoxP3 Regulatory T Cells with Anaphylaxis Upon Food Challenge in Murine Models of Peanut Allergy
Laurie M. McWilliams, MD1, Michael D. Kulis Jr., PhD2, Rishu
Guo, PhD2, A. Wesley Burks, MD, FAAAAI2 and Patrick Seed1,
1
Duke University, Durham, NC, 2University of North Carolina at
Chapel Hill, Chapel Hill, NC
In Vitro Immunomodulatory Effects of FAHF-2 (Food Allergy
Herbal Formula-2) On PBMCs From Food Allergy Patients
Xiu-Min Li, MD1, Ying Song, MD1, Julie Wang1, Paul Faybusovich1, Min-Li Hong1, Jaime Ross1, Scott Sicherer1, June Straw2,
Stacie M. Jones, MD2 and Hugh A. Sampson, MD, FAAAAI1,
345
346
347
Mount Sinai School of Medicine, New York, NY, 2University of

Arkansas for Medical Sciences, Little Rock, AR
Prevention and Treatment of Poly-Lysine Modified Arah2 DNA
Vaccine On Arah2 Protein Induced Allergy
Wei Li1,2, Yuan Niu1, Zhuo Zhang3, Andrew Saxon, MD,
FAAAAI2 and Ke Zhang2, 1Xijing Hospital, Fourth Military Medical University, Xian, China, 2UCLA Medical School, Los Angeles, CA, 3Tangdu Hospital, Fourth Military Medical University,
Xian, China
The Deadly Dessert: Transfer of Food Allergy Following Lung
Transplantation From the Donor to the Recipient
Priyanka Lall, MD, Emory University, Atlanta
Food Allergy in Pediatrics Liver Transplant Recipients
Ratchaneewan Sinitkul, PhD, Suporn Treepongkaruna, Sumate
Teeraratkul, Wasu Kamchaisatian, MD, Wiparat Manuyakorn,
MD, Soamarat Vilaiyuk, MD, Cherapat Sasisakulporn, BSc, Wanlapa Teawsomboonkit, RN and Suwat Benjaponpitak, MD, Ramathibodi Hospital, Bangkok, Thailand
355
Food Allergy Related Issues/Immune Mediated

Skin Disease
3207
348
349
350
351
352
353
354
Risk Factors of Extrinsic and Intrinsic Atopic Dermatitis in Korean Adolescents

Kyung-Suk Lee, MD, PhD1, Sun-Hee Choi, MD, PhD2 and
Yeong-Ho Rha, MD, PhD1, 1Kyung Hee University Hospital,
2
Gangdong Kyung Hee University Hospital
Relationship Between Socioeconomic and Sociodemographic
Risk Factors and Atopic Dermatitis in Korean Adolescents
Yeong-Ho Rha, MD, PhD1, Kyung Suk Lee, MD, PhD1 and SunHee Choi, MD, PhD2, 1Kyung Hee University Hospital, 2Gangdong
Kyung Hee University Hospital
Delayed Introduction of Food and Effect On Incidence of Food
Allergy in a Population At High Risk for Atopy: The Canadian
Asthma Primary Prevention Study (CAPPS)
Tiffany Wong, MD1, Moira Chan-Yeung, MB2, Roxanne Rousseau, BSc2, Anne Dybuncio, BS2, Anita L. Kozyrskyj, PhD3, Clare
Ramsey, MD, MSc, FRCPC4, Allan Becker, MD, FAAAAI5 and
Edmond S. Chan, MD, FAAAAI1, 1Department of Pediatrics, Faculty of Medicine, University of British Columbia, 2Department of
Medicine, Faculty of Medicine, University of British Columbia,
3
University of Manitoba, Edmonton, AB, Canada, 4Department of
Medicine, Faculty of Medicine, University of Manitoba, 5University Of Manitoba, Winnipeg, MB, Canada
Differentiating Cause and Severity of Allergic Reaction to Soy
Based On Component Testing to PR-10 and Storage Proteins
Rabia Q. Chaudhry, MD, Stephen Bigelsen, MD, Alan H. Wolff,
MD and Danyoul Yamin, UMDNJ, Newark, NJ
Severe Reactions to a Soy Containing Beverage in Peanut Allergic Individuals Not Avoiding Soy
Benjamin Remington, BS1, Julie A. Nordlee, MS1, John R. Bacon,
MD, FAAAAI2, Marc E. Dyer, MD3, Steve L Taylor, PhD1 and Joe
L. Baumert, PhD1, 1Food Allergy Research and Resource Program,
University of Nebraska-Lincoln, Lincoln, NE, 2Private Practice,
Towson, MD, 3Private Practice, Laguna Niguel, CA
Clinical Features of Sulfite Hypersensitivity
Ga Young Ban, Ajou University School of Medicine
The Development of A Diet-Focused Allergy History Tool
Isabel J. Skypala, PhD, RD, Royal Brompton and Harefield NHS
Foundation Trust, London, United Kingdom, Carina Venter, PhD,
RD, The David Hide Asthma and Allergy Research Center, Isle
of Wight, United Kingdom, Louiza Damianidi, RD, University of
356
357
358
359
360
361
Athens, Athens, Greece, Nicolette De Jong, PhD, Erasmus MC,

Dept of Internal Medicine, Rotterdam, Netherlands, Adam T.
Fox, MD, Guys and St Thomas Hospitals NHS Foundation Trust
and Kings College, London, United Kingdom, Marion E. Groetch,
MS, RD, Mount Sinai School of Medicine, Rosan Meyer, PhD, RD,
Great Ormond Street NHS Foundation Trust, London, United Kingdom, Hanneke Oude Elberink, MD, University Medical Center of
Groningen, Groningen, Netherlands, Aline Sprikkelman, MD,
Emma Childrens Hospital Academic Medical Centre, Amsterdam,
Netherlands and Berber Vlieg-Boerstra, PhD, RD, Emma Childrens Hospital, Academic Medical Center, Amsterdam, Brummen,
Netherlands
Long Term Nutritional Outcome of Children Fed by an AminoAcid Formula
Diana Colson, Nutricia Nutrition Clinique, Saint Ouen, France,
Benedicte Michaud, MD, Laboratoire dimmunologie Biologie,
Hôpital Necker-enfants Malades, Paris, France, Paris, France; Universite Paris Descartes, Hôpital Necker-Enfants Malades, INSERM
U1013, Paris, France, Pascale Soulaines, Hôpital Cochin-Saint Vincent de Paul, Universite Paris V Rene Descartes (Paris, France),
Paris, France; Hôpital Necker, Enfants Malades, Universite Paris
V Rene Descartes (Paris, France), Paris, France and Christophe Dupont, MD, PhD, Universite Paris V Rene Descartes, Paris, France;
Hopital Necker Enfants Malades, Paris, France; DBV Technologies,
Paris, France
Reduction of Bone Mineral Density (BMD) in IgE-Mediated
Cows Milk Protein (CMP) Allergy and Normalization After
Tolerance Acquisition by Oral Immunotherapy
Liat Nachshon, MD, Michael Goldberg, MD, PhD, Arnon Elizur,
MD, Michael B. Levy, MD, FAAAAI and Yitzhak Katz, MD,
FAAAAI, Assaf Harofeh
Family Management of Childrens Food Allergies: Patterns of
Food Avoidance and Reaction Response Preparation in Relation
to Anxiety
Mary D. Klinnert, PhD1, Elizabeth McQuaid, PhD2, Anna Forssen1, Sophia Cohen1, David Fedele2, Jane Robinson1, David
Mark Fleischer, MD, FAAAAI1,3, Jonathan O. Hourihane4 and
Fred (Dan) McDaniel Atkins, MD, FAAAAI1,3, 1National Jewish
Health, Denver, CO, 2Brown School of Medicine, Rhode Island
Hospital, Providence, RI, 3University of Colorado School of Medicine, 4University College Cork, Cork, Ireland
Parental Reporting of Allergenic Food Introduction: A Study of
Urban and Suburban Populations
Heather N. Hartman, MD1, Caitlin Dodd, MS1 and Amal H. Assaad, MD, FAAAAI2, 1Cincinnati Childrens Hosptial Medical
Center, Cincinnati, OH, 2Cincinnati Childrens, cincinnati, OH
Nutritional Features of Children with Multiple Food Allergies
Who Require Elemental Formula Supplementation
Karen Robbins, MD1, Anthony Guerrerio, MD, PhD1, Elizabeth
Matsui, MD1, Pamela A. Frischmeyer-Guerrerio, MD, PhD2, Susan
Oh, MS, MPH, RD1, Sara Hauck, RD, LDN1 and Robert A. Wood,
MD, FAAAAI1, 1Johns Hopkins University School of Medicine,
Baltimore, MD, 2Pediatrics, Johns Hopkins University School of
Medicine, Baltimore, MD
Comparison of Growth Parameters Between Children with and
without Food Allergies in 2 Different Demographic Populations
Harshna Mehta, MD, Mount Sinai School of Medicine, New York,
NY, Elizabeth Feuille, MD, Mount Sinai School of Medicine and
Julie Wang, MD, FAAAAI, Mt. Sinai School of Medicine, New
York, NY
Impact of Food Allergy On Growth in the Pediatric Population
Caroline B. Hobbs, MD1, Asheley C. Skinner, PhD2, A. Wesley
Burks, MD, FAAAAI1 and Brian P. Vickery, MD1, 1Division of Pediatric Allergy, Immunology, Rheumatology, and Infectious Disease, University of North Carolina, Chapel Hill, NC, 2Division of
General Pediatrics and Adolescent Medicine, University of North
Carolina, Chapel Hill, NC
SUNDAY
Abstracts AB261

107
AB262 Abstracts
362
363
364
SUNDAY
365
366
367
368
369
370
108
Differences in Dietary Management of Infant Atopic Dermatitis

Among Pediatricians, Allergists, and Dermatologists in the
United States
Laura Czerkies, MS, RD1, Erica Horodniceanu2, Vardhaman Patel2,3, Marc Botteman, MSc2 and Jose Saavedra, MD1, 1Nestle Nutrition, Florham Park, NJ, 2Pharmerit International, Bethesda, MD,
3
College of Pharmacy, University of Illinois, Chicago, IL
The Multiple Open Food Allergen Challenge Test in Children
with Moderate to Severe Atopic Dermatitis
Jae Ho Lee, MD, PhD1, Eun Kyung Lim2 and Eun Ae Yang1, 1Department of Pediatrics, Chungnam National University, Taejeon,
South Korea, 2Department of Pediatrics, Cungnam National University, Taejeon, South Korea
Parental Survey Concerning Pediatric Atopic Dermatitis and
Bathing Frequency Recommendations by Providers: An Area
of Uncertainty and Frustration
Erin Kempe1, Ivan D. Cardona, MD1,2 and Neal Jain, MD,
FAAAAI3, 1Maine Medical Center, Portland, ME, 2Allergy and
Asthma Associates of Maine, Portland, ME, 3San Tan Allergy,
Gilbert, AZ
Allergen-Specific Immunotherapy (ASIT) Effect On Quality of
Life (QOL) in Children with Moderate (MAD) and Severe
(SAD) Atopic Dermatitis
Tatiana Slavyanskaya, MD, PhD1,2 and Vladislava Derkach,
PhD2,3, 1University of Russia, Moscow, Russia, 2Institute of
Immunophysiology, Moscow, Russia, 3Vladivostok State Medical
University, Vladivostok, Russia
Allergen Specific Immunotherapy in Cases of Severe Atopic
Dermatitis
Inmaculada Sanchez-Machn, MD, Hospital Ofra-Torax, Tenerife, Spain, Paloma Poza, Hospital Ofra-Torax, santa cruz de tenerife, Spain, Ruperto Gonzalez, Hospital Ofra-Torax, S/C de Tenerife,
Spain and Victor Matheu, MD, Hospital Ofra, Tenerife, Spain
A Randomized, Open-Label, Parallel Group Study to Evaluate
the Efficacy and Safety of Proactive Management in Pediatric
Subjects with Moderate to Severe Atopic Dermatitis
Tatsuki Fukuie, MD, PhD1,2, Ichiro Nomura, MD, PhD3, Masami
Narita, MD, PhD2, Tsukasa Suzuki, MD1, Iwao Tajima, MD1,
Osamu Natsume, MD1, Tomohide Taguchi, MD1, Tsutomu Ogata,
MD, PhD1, Yoshiki Tokura, MD, PhD4, Kenji Matsumoto, MD,
PhD3 and Yukihiro Ohya, MD, PhD2, 1Department of Pediatrics,
Hamamatsu University School of Medicine, Shizuoka, Japan, 2Division of Allergy, Department of Medical Subspecialties, National
Center for Child Health and Development, Tokyo, Japan, 3Department of Allergy and Immunology, National Research Institute for
Child Health and Development, Tokyo, Japan, 4Department of
Dermatology, Hamamatsu University School of Medicine, Shizuoka, Japan
Evaluation of People with Atopic Dermatitis Applying Patch
Test with Mites, Cockroach and Mouse
Lihua Yang, MD1, Rauno O. Joks, MD, FAAAAI2 and Hamid
Moallem, MD1, 1SUNY Downstate Medical Center, Brooklyn,
NY, 2SUNY Downstate Medical Center, Center for Allergy and
Asthma Research, Brooklyn, NY
The Effect of Outdoor Air Pollutants On the Severity of Atopic
Dermatitis
Mi-ran Park1, Jihyun Kim, MD1, Youngshin Han, PhD1, HaeKwan Cheong2, Eun-Hye Kim2, Kwon Jung3 and Kangmo Ahn,
MD, PhD1, 1Samsung Medical Center, Seoul, 2Department of Social and Preventive Medicine, and Samsung Biomedical Research
Institute, Suwon, South Korea, 3Seoul Research Institute of Public
Health and Environment, Gwacheon, South Korea
Association of Stress, Pruruitis and Illness Severity in Children
with Atopic Dermatitis
Kimberly Kelsay, MD1, Eleni Weisnicht2,3, Bruce G. Bender, PhD,
FAAAAI4, Donald Y.M. Leung, MD, PhD, FAAAAI4 and Mary D.
Klinnert, PhD4,5, 1University of Colorado, School of Medicine,

FEBRUARY 2013
Aurora, 2National Jewish Health, 3Univeristy of Colorado, Boulder,

National Jewish Health, Denver, CO, 5University of Colorado
School of Medicine
Human Basophils Express Novel TSLPR Variants Including a
Putative Secreted Form
Martin J. Romeo, PhD1, Rachana Agrawal, PhD1, Anna Pomes,
PhD, FAAAAI2 and Judith A. Woodfolk, MBChB, PhD, FAAAAI1,
1
University of Virginia, Charlottesville, VA, 2Indoor Biotechnologies, Inc., Charlottesville, VA
Early Life Transepidermal Water Loss (TEWL) Values Can
Predate Atopic Dermatitis At Six and Twelve Months in
Asymptomatic Infants: Results From the Baseline Study
Maeve M. Kelleher1, Audrey Dunn Galvin1, Deirdre Murray1,
Alan David Irvine2, Jonathan O. Hourihane1 and Baseline Team1,
1
University College Cork, Ireland, 2Trinity College Dublin, Dublin,
Ireland
Leukotriene B4 Driven Neutrophil Recruitment to the Skin Is
Essential for Allergic Skin Inflammation
Michiko K. Oyoshi, PhD1, Rui He1, Yitang Li1, Subhanjan Mondal1, Juhan Yoon1, Roshi Afshar2, Mei Chen3, David M. Lee,
MD, PhD3, Hongbo Luo1, Andrew D. Luster, MD, PhD2, John
Cho4, Lloyd Miller4, Allison Larson3, George Murphy5 and Raif
Geha, MD1, 1Boston Childrens Hospital, Boston, MA, 2Massachusetts General Hospital, Charlestown, MA, 3Brigham and Womens
Hospital, 4University of California Los Angeles, 5Brigham and
Womens Hospital/Harvard Medical School, Boston, MA
Initial Presentation of Severe Neutropenia Mimicking Atopic
Dermatitis
Laura E. Noonan, MSN, FNP-C1, Oral Alpan, MD2,3, Denise Loizou, RN1, Margaret Brown, B.S.2, Mark Ryherd2 and Matthew
Plassmeyer, PhD2, 1O&O Alpan, Fairfax, VA, 2Amerimmune,
LLC, VA, 3O&O ALPAN, LLC
T Helper Cytokines (Th1, Th2 and Th17) Differentially Regulate the Epidermal Tight Junction Barrier
I-Hsin Kuo, MS1, Anna De Benedetto, MD1, Takeshi Yoshida,
PhD1, Donald Y. Leung, MD PhD2 and Lisa A. Beck, MD,
FAAAAI1, 1Department of Dermatology, University of Rochester
Medical Center, Rochester, NY, 2National Jewish Health, Department of Pediatrics, Division Pediatric Allergy/Immunology, Denver, CO
The Role of Transient Receptor Potential Ankyrin-1 (TRPA1) in
Chronic Itch in Atopic Dermatitis (AD)
Min-Hee OH, PhD Student1, Hongfei Lou, MD1, Allen Myers,
PhD1, Zhou Zhu, MD, PhD2 and Tao Zheng, MD1, 1Johns Hopkins
University, Baltimore, MD, 2The Johns Hopkins University School
of Medicine, Baltimore, MD
Correlation Between Serum 25-Hydroxyvitamin D Concentration and Methicillin - Resistant Staphylococcus Aureus Skin Infection in Atopic Dermatitis
Taek Ki Min, MD1, You Hoon Jeon, MD1, Hyeon Jong Yang,
MD1, Hae Won Lee, RN2 and Bok Yang Pyun, MD, PhD1, 1Pediatric Allergy Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital, Seoul, South Korea, 2Pediatric
Allergy Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital, South Korea
Biomarkers of Disease Severity and Th2 Polarity Are Predictors of Atopic Dermatitis Subjects Who Are Colonized with S.
Aureus
Lisa A. Beck, MD, FAAAAI1, Takeshi Yoshida, PhD1, Anna De
Benedetto, MD, FAAAAI2, Seungshin Rhee, MS3, I-Hsin Kuo,
MS1, Jamie Reese4, Gloria David, PhD3, Lynda C. Schneider,
MD, FAAAAI5,6, Amy Paller, MD7, Jon M. Hanifin, MD,
FAAAAI8, Mark Boguniewicz, MD FAAAAI9, Kathleen C. Barnes,
PhD, FAAAAI10 and Donald Y.M. Leung, MD, PhD, FAAAAI11,
1
Department of Dermatology, University of Rochester Medical
Center, Rochester, NY, 2University of Rochester Medical Center,
3
Rho, Inc., Chapel Hill, NC, 4Rho, Inc., 5Boston Childrens
4
371
372
373
374
375
376
377
378
Abstracts AB263

382
383
384
385
386
New Developments in the Treatment of Asthma

and Allergic Diseases
3208
387
388
389
390
391
392
393
394
395
396
Identifying Physicians Who Care for Hereditary Angioedema

(HAE) for Targeted Awareness & Education
Gregory H. Bennett, DO, Penn State Hershey Childrens Hospital,
Hershey, PA, Nimish Mehta, PhD, MBA, Medscape Education, NJ
and Timothy J. Craig, DO, FAAAAI, Penn State University College
of Medicine, Hershey, PA
Physical Activity, BMI, and Asthma Control Among Adolescents: A Cross-Sectional Analysis
Aimee L. Speck, MD, University of Michigan, Division of Allergy
and Clinical Immunology, Ann Arbor, MI and Alan P. Baptist, MD,
MPH, University of Michigan, Division of Allergy, Ann Arbor, MI
Characteristics of Asthma Patients Seeking Specialist Care
Thomas B. Casale, MD FAAAAI1, Kurt Elward2, Wilson Pace3,
Paul Turner4, Ryan Walters4 and Michael Schatz, MD, MS,
FAAAAI5, 1Creighton University School of Medicine, Omaha,
NE, 2U Virginia, 3U Colorado, Denver, 4Creighton University, 5Kaiser Permanente, San Diego, CA
Associations Between Patient Perceived Health Status, Disease
Severity, and Specific Demographic or Individual Factors in
Primary Immunodeficiency
Filiz Seeborg, MD, MPH1, Marcia Boyle2, Christopher Scalchunes, MPA2, Linzhi Xu, MS3 and Jordan Orange, MD, PhD,
FAAAAI1, 1Baylor College of Medicine and Texas Childrens Hospital, Section of Immunology, Allergy and Rheumatology, 2Immune
Deficiency Foundation, 3Baylor College of Medicine/Texas Childrens Hospital, Department of Pediatrics, TX
Asthma Knowledge Level of Teachers in Child Daycare Center
Ahmet Akcay, MD, Associate Professor of Pediatrics, Istanbul
University, Istanbul School of Medicine, Department of Pediatrics,
Division of Pediatric Allergy, Istanbul, Turkey., Zeynep Tamay,
MD, Associate Professor of Pediatrics, Istanbul University, Istanbul
School of Medicine, Department of Pediatrics, Division of Pediatric
Allergy, Istanbul, Turkey, Saime Ulker Ones, MD, FAAAAI, Istanbul Medical Faculty, Istanbul, Turkey and Nermin Guler, MD, Professor of Pediatrics, Istanbul University, Istanbul School of
Medicine, Department of Pediatrics, Division of Pediatric Allergy,
Turkey
Status of the Allergy and Immunology Clinical Trials Portfolio:
Data From Clinicaltrials.Gov
Ankoor Shah, MD1, Samuel Broderick, PhD1, Karen Chiswell,
PhD2, Asba Tasneem, PhD2 and John S. Sundy, MD, PhD,
FAAAAI1, 1Duke University Medical Center, Durham, NC,
2
Duke University Medical Center
Preferred Learning Methods for Parents of Asthmatic Children
Nabeel Farooqui, MD, Nationwide Childrens Hospital; The Ohio
State University and David R. Stukus, MD, FAAAAI, Nationwide
Childrens Hospital, New Albany, OH
The Annual Subspecialty Retreat in Allergy and Immunology an Innovative Model for Reflection and Program Excellence
Lenora Mendoza Noroski, MD, MPH, Baylor College of Medicine-Texas Childrens Hospital, Section of Immunology, Allergy
and Rheumatology, Houston, TX
Evaluating the Differences in Characteristics of Asthma Patients Initiating Budesonide/Formoterol Combination (BFC)
and Fluticasone/Salmeterol Combination (FSC)
Frank Trudo1, Ozgur Tunceli2, David Kern2, Ned Pethick1, Hanaa
Elhefni1, Catrin Wessman1, Siting Zhou2 and Setareh Williams1,
1
AstraZeneca, 2HealthCore
Parental Education On Asthmatic Severity in the Emergency
Department and Primary Care Follow-up Rates
Kelli W. Williams, MD, MPH, Carolyn Word, MD, Maria R.
SUNDAY
379
Hospital, Boston, MA, 6Division of Allergy/Immunology, Boston

Childrens Hospital, Harvard Medical School, Boston, MA, 7Northwestern University Feinberg School of Medicine, Chicago, IL, 8Oregon Health & Science University, Portland, OR, 9National Jewish
Health, Denver, CO, 10Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University, Baltimore, MD, 11National Jewish Health, Department of Pediatrics,
Denver, CO
Differences of Serum Cytokine Levels and Sensitization Rates
to Allergen
Jin-A Jung, MD1, Hyun-jin Yun, MD2, Eun-jung Choi3, Hye-sung
Ahn4, Ja Hyeong Kim, MD5 and Ju-Suk Lee, MD, PhD6, 1Dong-A
University Hospital, Busan, 2Ilsin Christian Hospital, Busan, South
Korea, 3Ilsin Christian Hospital, 4Good Moonhwa Hospital, 5Ulsan
University Hospital, Ulsan, 6Sungkyunkwan university, Changwon,
South Korea
Interactions Between CD14/IL-13 Genes and Cesarean Section
Delivery May Affect the Development of Atopic Dermatitis in
a Cocoa Study
Eun Lee1, So-Yeon Lee2, Kangmo Ahn, MD, PhD3, Kyung Won
Kim, MD, PhD4, Youn Ho Shin, MD, PhD5, Gyeong-shin Lee6,
Young Ho Jung, MD1, Jinho Yu, MD, PhD1, Ju-Hee Seo, MD7,
Hyo-Bin Kim, MD, PhD8, Ji-Won Kwon, MD9, Byoung-Ju Kim,
MD, PhD10, Woo Kyung Kim, MD, PhD8, Dae Jin Song, MD,
PhD11, Gwang Cheon Jang, MD, PhD12, Jung Yeon Shim, MD,
PhD13, Soo-Young Lee , MD, PhD14 and Soo-Jong Hong, MD,
PhD1, 1Department of Pediatrics, Childhood Asthma Atopy Center,
Asan Medical Center, University of Ulsan College of Medicine,
Seoul, South Korea, 2Department of Pediatrics, Hallym University
College of Medicine, 3Samsung Medical Center, Seoul, 4YongDong Severance Hospital, Seoul, 5Yong Dong Severance Hospital,
Seoul, 6Childhood Asthma Atopy Center, Asan Medical Center,
University of Ulsan College of Medicine, 7Department of Pediatrics, Korea Cancer Center Hospital, 8Inje University Sanggye
Paik Hospital, Seoul, 9Department of Pediatrics, Seoul National
University Bundang Hospital, Seoul National University College
of Medicine, Seongnam, South Korea, 10Department of Pediatrics,
Hae-undae Paik Hospital, Inje University College of Medicine, Busan, South Korea, 11Department of Pediatrics, Korea University
Guro Hospital, 12Department of Pediatrics, National Health Insurance Corporation Ilsan Hospital, 13Sungkyunkwan University
School of Medicine, K, Seoul, 14Ajou University School of Medicine, Suwon
Targeted Resequencing Identified Novel Variants in Candidate
Genes Associated with Increased Risk of Atopic Dermatitis
Complicated by Eczema Herpeticum
Li Gao, MD, PhD1, Lili Huang, MS1, Nicholas M. Rafaels, MS1,
Rachel Lewis, MS1, Rasika A. Mathias, ScD1, Lisa A. Beck,
MD, FAAAAI2, Donald Y. Leung, MD, PhD3 and Kathleen C.
Barnes, PhD, FAAAAI1, 1Johns Hopkins University, Baltimore,
MD, 2University of Rochester, Rochester, NY, 3Department of Pediatrics, Division of Allergy-Immunology, National Jewish Health,
Denver, CO
Methylation Patterns in Whole Blood From Healthy Controls
and Patients with Atopic Dermatitis with and without a History
of Eczema Herpeticum
Chris Cheadle, JHU
Severe Protein-Loss in Atopic Dermatitis in Infancy: Summary
of 10 Patients
Iwao Tajima, MD1,2, Tatsuki Fukuie, MD, PhD1, Osamu Natsume,
MD1, Tsukasa Suzuki, MD1, Tomohide Taguchi, MD1 and Tsutomu
Ogata, MD, PhD1, 1Department of Pediatrics, Hamamatsu University School of Medicine, Shizuoka, Japan, 2Department of Pediatrics, Iwata city hospital, Shizuoka, Japan
A Study of 77 Infants with Atopic Dermatitis Investigated the
Risk Factors for Hypoproteinemia
Geunhwa Park, Busan St. Marys Medical Center
109
AB264 Abstracts

FEBRUARY 2013
Streck, MD and M. Olivia Titus, MD, Medical University of South

Carolina, Charleston, SC
405
Immunotherapy II
3209
397
398
SUNDAY
399
400
401
402
403
404
110
JTF-Recommended Allergen Dosing Used in Multi-Allergen

Immunotherapy Induces Loss of Skin Test Reactivity
Michael Vaughn, MD, PhD, Alamo Asthma & Allergy, San Antonio, TX and Adrianne Vaughn, MD, Alamo Allergy & Asthma, San
Antonio, TX
Switching From Monthly Intravenous to Biweekly Subcutaneous Immunoglobulin: A Pharmacokinetic Modeling and Simulation Approach
Mikhail Rojavin, PhD, Clinical Research and Development, CSL
Behring LLC, King of Prussia, PA, Cornelia Landersdorfer, Centre
for Medicine Use and Safety, Monash University, Parkville, Australia, Martin Bexon, MD, CSL Behring AG, Bern 22, Switzerland,
Marc Pfister, Quantitative Solutions, Inc., Bridgewater, NJ and Jagdev S. Sidhu, Clinical Pharmacology & Early Development, CSL
Ltd, Parkville, Australia
The Role of Murine Myeloid Cells On Stimulation with Amino
Acid Copolymers
Norio Kawamoto, MD, PhD1,2, Hidenori Ohnishi, MD, PhD1, Naomi Kondo, MD, PhD1 and Jack Strominger, MD2, 1Gifu University, Gifu, Japan, 2Harvard University, Cambridge, MA
Berinert (C1-Esterase Inhibitor Concentrate) Treatment Is
Not Related to Prothrombotic Risk Based On Preclinical
Efficacy and Safety Investigations
Eva Herzog, Daniel Schuermann, Elmar Raquet, Sabine Zollner
and Ingo Pragst, CSL Behring GmbH, Marburg, Germany
Depigmented-Polymerized and Native Extracts of Birch Pollen Exhibit Different IgG Epitopes Specific to Bet v 1 and
Bet v 2
Jer
onimo Carnes, Ma Angeles Lopez Matas, Ma Teresa Gallego,
Tamara Aranda, Mara Morales, Jose Ramon Leonor and Victor
Miguel Iraola, Laboratorios LETI, S.L., Tres Cantos, Spain
Enzymatic Activity of Grass Native Allergenic Extracts Is Eliminated in Depigmented Allergoids
Victor Miguel Iraola, Jose Ramon Leonor, Mara Morales, Ma
Angeles Lopez Matas, Ma Teresa Gallego and Jeronimo Carnes,
Laboratorios LETI, S.L., Tres Cantos, Spain
Characterizing the 12 Amb a 1-U Ragweed Allergy Immunotherapy Tablet Adverse Event Profile in Adults with Ragweed-Induced Allergic Rhinoconjunctivitis
Jennifer Maloney, MD1, Gary D. Berman, MD, FAAAAI2, David
I. Bernstein, MD, FAAAAI3,4, Bobby Q. Lanier, MD, FAAAAI5,
Amarjot Kaur, PhD1, Nancy Liu, PhD6 and Hendrik Nolte, MD,
PhD1, 1Merck Sharp & Dohme Corp., a subsidiary of Merck &
Co., Inc, Whitehouse Station, NJ, 2Allergy and Asthma Specialists,
Minneapolis, MN, 3University of Cincinnati, Cincinnati, OH,
4
Bernstein Clinical Research Center, LLC, Cincinnati, OH, 5North
TX Institute for Clinical Trials, Fort Worth, TX, 6Merck, Whitehouse Station, NJ
Prevalence of IgE Specific to Profilin in a Texas and California
Population
Greg A. Plunkett, PhD1, Domingo Barber, PhD2, Eliseo M. Villalobos, MD, FAAAAI3, Joshua S. Jacobs, MD4, Jeffrey S. Hallett,
MD, FAAAAI5, Tara Mostofi4, Agustin Galan Nieto2 and Tricia
Moore1, 1ALK-Abello, Inc, Round Rock, TX, 2ALK-Abello, Madrid, Spain, 3Allergy Institute of San Antonio, PA, San Antonio,
TX, 4Allergy and Asthma Medical Group of the Bay Area, Walnut
Creek, CA, 5Jeffery Hallett, Round Rock, TX
406
Safety of Ragweed Allergy Immunotherapy Tablet: Results

From Four Placebo-Controlled Trials
Hendrik Nolte, MD, PhD1, Peter Creticos, MD, FAAAAI2, Gary
D. Berman, MD, FAAAAI3, Amarjot Kaur, PhD1, Nancy Liu,
PhD4, Jacques Hebert, MD5, David I. Bernstein, MD, FAAAAI6,7
and Jennifer Maloney, MD1, 1Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc, Whitehouse Station, NJ, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Allergy and
Asthma Specialists, Minneapolis, MN, 4Merck, Whitehouse Station, NJ, 5Centre de Recherche Applique en Allergie de Quebec,
Quebec City, QC, Canada, 6University of Cincinnati, Cincinnati,
OH, 7Bernstein Clinical Research Center, LLC, Cincinnati, OH
Immunological Characterization of Patients with Systemic and
Localized Seminal Plasma Hypersensitivity
Debajyoti Ghosh, PhD, University of Cincinnati College of Medicine, Cincinnati, OH and Jonathan A. Bernstein, MD, University of
Cincinnati Medical Center, Cincinnati, OH
Rhinitis/Conjunctivitis I
3210
407
408
409
410
411
Lifestyle Risk Factors for Allergic Rhinitis in Schoolchildren:

Are Sports Activities a Negative Factor?
Jiro Takeuchi, MD1,2,3, Takashi Kusunoki, MD, PhD1,4, Takeshi
Morimoto, MD, PhD1,5, Mio Sakuma, MD, PhD1,5, Kumiko Mukaida, MD, PhD1,4,6, Takahiro Yasumi, MD, PhD1,7, Ryuta Nishikomori, MD, PhD1,7 and Toshio Heike, MD, PhD1,7, 1Shiga LAKE
Study Group, Japan, 2Osaka Saiseikai Nakatsu Hospital, Osaka,
Japan, 3Kyoto University Health Service, Kyoto, 4Department of
Pediatrics, Shiga Medical Center for Children, Shiga, Japan,
5
Center for General Internal Medicine and Emergency Care, Kinki
University School of Medicine, Osaka, Japan, 6Kumiko Allergy
Clinic, Kyoto, Kyoto, Japan, 7Department of Pediatrics, Graduate
School of Medicine, Kyoto University, Kyoto, Japan
Fluticasone Furoate Decreases Nasal Eosinophilic Inflammation
by Inhibiting Both Cytokine Secretion From Nasal Mucosa Epithelial Cells Cytokine Secretion and Eosinophil Survival
Jordi Roca-Ferrer, PhD1, Laura Pujols, PhD1, Maria Perez, MS1,
Mireya Fuentes, MS1, Francisco de Borja Callejas, MS1, Isam Alobid, MD, PhD1,2, Antonio Valero, MD, PhD1,3, Cesar Picado, MD,
PhD1,3 and Joaquim Mullol, MD, PhD, FAAAAI1,2, 1IDIBAPS,
Barcelona, Spain, 2HOSPITAL CLINIC. Unitat de Rinologia i
Clnica de lOlfacte, Servei dOtorrinolaringologia, Barcelona,
Spain, 3HOSPITAL CLINIC. Servei de Pneumologia i Aldlergia
Respiratoria, Barcelona, Spain
Improvement of Nasal Congestion and Sleep Quality Following
Once-Daily Treatment with Beclomethasone Dipropionate Nasal Aerosol in Patients with Seasonal Allergic Rhinitis
Eli O. Meltzer, MD, FAAAAI1, Julius H. Van Bavel, MD2, Gordon
Raphael, MD3, Paul H. Ratner, MD, FAAAAI4, Yu Ding5 and Sudeesh Tantry, PhD5, 1Allergy and Asthma Medical Group & Research Center, San Diego, CA, 2Isis Clinical Research, Austin,
TX, 3Gordon D. Raphael, Bethesda, MD, 4Sylvana Research, San
Antonio, TX, 5Teva Branded Pharmaceutical Products R&D, Inc.
Tear Meniscus Height by Optical Coherence Tomography
(OCT) and Ocular Itch
Milton M. Hom, OD FAAO, Private Practice, Azusa, CA, Andrew
Nguyen, PhD, California State University, Fullerton, Fullerton, CA
and Leonard Bielory, MD, FAAAAI, Robert Wood Johnson University Hospital, New Brunswick, NJ; Rutgers University, New Brunswick, NJ; STARx Allergy and Asthma Center, Springfield, NJ
Relationship Between ARIA and ISAAC Questionnaires Regarding to the Classification and Severity of Rhinitis in School
Children
412
413
414
415
416
Yuichi Adachi, MD, PhD1, Koichi Yoshida, MD2, Toshiko Itazawa, MD, PhD1, Yukihiro Ohya, MD, PhD3, Hiroshi Odajima,
MD, PhD4, Akira Akasawa, MD, PhD2 and Toshio Miyawaki,
MD, PhD1, 1Department of Pediatrics, University of Toyama,
Toyama, Japan, 2Division of Allergy, Tokyo Metropolitan Childrens Medical Center, Tokyo, Japan, 3Division of Allergy, National
Center for Child Health and Development, Tokyo, Japan, 4Department of Pediatrics, Fukuoka National Hospital, Japan
Baseline Challenge Responses During Repeated, Daily Controlled Exposures to Grass Pollen in the Environmental Exposure Unit (EEU)
Lisa Steacy, BSc1, Terry Walker, BA1, Barnaby Hobsbawn1 and
Anne K. Ellis, MD, MSc, FRCPC, FAAAAI1,2, 1Allergy Research
Unit, Kingston General Hospital, Kingston, ON, Canada, 2Departments of Medicine and Biomedical & Molecular Science, Queens
University, Kingston, ON, Canada
Once-Daily Treatment with Beclomethasone Dipropionate Nasal Aerosol Provides Long-Term and Sustained 24-Hour Nasal
Symptom Relief in Patients with Perennial Allergic Rhinitis
Eric R. Schenkel, MD1, William R. Lumry, MD, FAAAAI2, Harold B. Kaiser, MD, FAAAAI3, Gary D. Berman, MD, FAAAAI4, Yu
Ding5 and Sudeesh Tantry, PhD5, 1Valley Clinical Research Center,
Bethlehem, PA, 2AARA Research Center, Dallas, TX, 3Clinical
Research Institute, Inc, Minneapolis, MN, 4Clinical Research Institute, Inc., Plymouth, MN, 5Teva Branded Pharmaceutical Products
R&D, Inc.
Once-Daily Treatment with Beclomethasone Dipropionate Nasal Aerosol Effectively Improves the Symptom of Itchy Ear or
Palate Associated with Seasonal Allergic Rhinitis
Niran J. Amar, MD, FAAAAI, Allergy Asthma Research Institute,
Waco, TX, Frank Hampel, MD, Central Texas Allergy and Asthma,
New Braunfels, TX, Paul H. Ratner, MD, FAAAAI, Sylvana Research, San Antonio, TX, Julius Van Bavel, MD, Isis Clinical Research, LLC, Austin, TX, Amy Melchior, MS, MT, Teva Branded
Pharmaceutical Products R&D, Inc, Frazer, PA and Sudeesh Tantry,
PhD, Teva Branded Pharmaceutical Products R&D, Inc.
Once-Daily Treatment with Beclomethasone Dipropionate Nasal Aerosol 320 mg Provides 24-Hour Nasal Symptom Relief
in Patients with Seasonal Allergic Rhinitis
Albert F. Finn Jr., MD, FAAAAI, National Allergy, Asthma and
Urticaria Center, Charleston, SC, Bruce Prenner, Allergy Associates Medical Group Inc., San Diego, CA, Robert A. Nathan, MD,
FAAAAI, Asthma and Allergy Associates, Colorado Springs, CO,
Michael Ruff, Dallas Allergy and Asthma Center, Dallas, TX, Leith
Kelley, Teva Branded Pharmaceutical Products R&D, Inc., Frazer,
PA and Sudeesh Tantry, PhD, Teva Branded Pharmaceutical Products R&D, Inc.
MP29-02 Provides Rapid and More Complete Nasal Symptom
Relief Than Two First-Line Therapies: A Retrospective Analysis
of a Randomized, Double-Blind, Placebo-Controlled Trial
Warner E. Carr, MD, Allergy and Asthma Associates of SC,
Mission Viejo, CA, Julius Van Bavel, MD, Allergy and Asthma Research Associates, Austin, TX, Phillip Lieberman, MD, University
of Tennessee College of Medicine, Frank Hampel, MD, Central Texas
Health Research, Eli O. Meltzer, MD, FAAAAI, Allergy and Asthma
Medical Group & Research Center, San Diego, CA and Paul H.
Ratner, MD, FAAAAI, Sylvana Research, San Antonio, TX
Mast Cells, Basophils and IGE

3211
417
Diagnostic Agreement of Different IgE Assay Methods, Immunocap and Extended Range Immulite 2000 3gAllergy in
418
419
420
422
423
424
425
426
Japanese School Age Children

Mari Kondo1, Mayumi Sugimoto, MD2, Keigo Kainuma, MD3,
Reiko Tokuda2, Mizuho Nagao, MD2 and Takao Fujisawa, MD,
FAAAAI3, 1Mie National Hospital, Tsu, Japan, 2Mie National Hospital, 3Mie National Hospital, Mie, Japan
Establishment of the Hermansky Pudlak Mastocyte (HPM) Cell
Line Which Has the HPS1 16-Bp Duplication (c.1470_1486dup16)
Arnold Kirshenbaum, MD, FAAAAI1, Avanti Desai, MS2, Geethani
Bandara, PhD2, Glenn Cruse, PhD2, Elizabeth Fischer, PhD2, Alasdair
M. Gilfillan, PhD2, William Gahl, MD, PhD3 and Dean D. Metcalfe,
MD, FAAAAI2, 1Laboratory of Allergic Diseases, NIAID, NIH, Bethesda, MD, 2Laboratory of Allergic Diseases, NIAID, NIH, 3NHGRI,
NIH
Elevated Presence of Basophils in Chronic Rhinosinusitis with
Nasal Polyposis
Mahboobeh Mahdavinia, MD, PhD1, Kathryn E. Hulse, PhD1,
Roderick Carter, BSc2, James Norton, MS2, Lydia Suh, BSc3, Atsushi Kato, PhD1, Anju Peters, MD3, Rakesh Chandra, MD1, David
Conley, MD1, Robert Kern, MD4, Bruce Tan, MD1, Leslie C. Grammer, MD, FAAAAI3, Lawrence B. Schwartz, MD, PhD, FAAAAI5
and Robert P. Schleimer, PhD, FAAAAI2, 1Northwestern University
Feinberg School Medicine, Chicago, IL, 2Department of Medicine,
Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Northwestern University
Feinberg School of Medicine, Chicago, IL, 4Northwestern University Feinberg School of Medicine, Chicago, IL, 5Virginia Commonwealth University, Richmond, VA
Aspirin Augments IgE-Mediated Histamine Release From Human Peripheral Basophils Via Syk Kinase Activation
Hiroaki Matsuo1, Tomoharu Yokooji1, Hironobu Morita1, Mina
Ooi1, Kana Urata1, Shunsuke Takahagi2, Kaori Ishii2, Yuhki
Yanase2, Takaaki Hiragun2, Shoji Mihara2 and Michihiro Hide2,
1
Department of Pathophysiology and Therapeutics, Graduate
School of Biomedical and Health Sciences, Hiroshima University,
Hiroshima, Japan, 2Department of Dermatology, Graduate School
of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
Genetic Variation of the Histamine Pathway in Subjects with
Asthma
Nikita Raje, MD, MBBS1,2, Carrie A. Vyhlidal, PhD1, Amanda K.
Riffel1, Hongying Dai, PhD1 and Bridgette L. Jones, MD,
FAAAAI1, 1Childrens Mercy Hospital & Clinics, Kansas City,
MO, 2University of Missouri- Kansas City
The Mastocytosis Society Survey On Mast Cell Disorders: Patient Experiences and Perceptions
Susan Jennings1, Nancy C. Russell1, Blair Jennings1, Valerie
Slee1, Lisa Sterling1, Mariana C. Castells, MD, PhD, FAAAAI2, Peter Valent3 and Cem Akin, MD, PhD, FAAAAI2, 1The Mastocytosis
Society, Hastings, NE, 2Brigham and Womens Hospital, Harvard
Medical School, Boston, MA, 3Medical University of Vienna,
Vienna, Austria
Mast Cell Activation Syndrome Associated with Elevation in
Serum Tryptase or 24-Hour Urine 11b-Prostaglandin- F2a
Anupama Ravi, MD, Joseph H. Butterfield, MD, FAAAAI and
Catherine R. Weiler, MD, PhD, FAAAAI, Mayo Clinic, Rochester,
MN
Exploring an Inhibitory Role for Basophils in Atopic
Dermatitis
Rachana Agrawal, PhD, Julia Wisniewski, MD and Judith A.
Woodfolk, MBChB, PhD, FAAAAI, University of Virginia, Charlottesville, VA
Loss of Cell Surface Siglec-8 Expression Following Its Engagement On Human Mast Cells
Adriano N. Salicru, MD, PhD1, Sherry Hudson, MS1, John W.
Steinke, PhD, FAAAAI2, Larry Borish, MD, FAAAAI2 and Bruce
S. Bochner, MD, FAAAAI1, 1Department of Medicine, Division
of Allergy and Clinical Immunology, Johns Hopkins University
SUNDAY
Abstracts AB265

111
AB266 Abstracts
427
428
429
SUNDAY
430
431
432
433
434
435
436
112
School of Medicine, Baltimore, MD, 2Asthma and Allergic Disease

Center, Carter Center for Immunology Research, University of Virginia, Charlottesville, VA
Rhinovirus Specific IgE Can Be Detected in Human Sera
Jonathan Tam, MD1, William Jackson, PhD1, David Proud, PhD2
and Mitchell H. Grayson, MD, FAAAAI1, 1Medical College of
Wisconsin, Milwaukee, WI, 2University Of Calgary, Calgary, AB,
Canada
Comparative Studies On the Allergenicity of Native Ovalbumin
and Ovomucoid in Biological and Serologic Assays
Na Sun1, Huilian Che, MD1,2, Cui Zhou1, Jing Wang1 and Kunlun
Huang1,2, 1College of Food Science and Nutritional Engineering,
China Agricultural University, Beijing, China, 2The Supervision,
Inspection and Testing Center of Genetically Modified Organisms,
Ministry of Agriculture, Beijing, China
Evidence for a Role of IgE in Altered Basophil Phenotypes in
Peanut Allergic Adults
Emily C. McGowan, MD1, Patricia M. Sterba, MS2, John-Paul
Courneya, MS3, Jessica Rabe Savage, MD, MHS4, Robert A.
Wood, MD, FAAAAI4 and Sarbjit S. Saini5, 1Johns Hopkins
University, Baltimore, MD, 2Johns Hopkins University, Mount
Airy, MD, 3Johns Hopkins Hospital, Baltimore, MD, 4Johns
Hopkins University School of Medicine, Baltimore, MD, 5Johns
Hopkins, Baltimore, MD
IgE Anti-Hepatitis B Surface Antigen Antibodies Detected in
Serum From Inner City Serum IgE Positive Asthmatic and Serum IgE Negative Nonasthmatic Children
Elizabeth Tam, BS1, Kevin Norowitz, MD2, Kobkul Chotikanatis,
MD1, Helen G. Durkin, PhD1, Martin H. Bluth, MD, PhD3, Stephan
A. Kohlhoff, MD1 and Tamar A. Smith-Norowitz, PhD1, 1SUNY
Downstate Medical Center, Center for Allergy and Asthma Research, Brooklyn, NY, 2SUNY Downstate Medical Center, Center
for Allergy and Asthma Research, 3Wayne State University Medicine, Detroit, MI
Soybean Isoflavones Suppress Basophil Degranulation in Vitro
in Subjects with Food Allergy
Mohanapriya Kamalakannan, MS1, Matthew Stadler1, Hugh A.
Sampson, MD, FAAAAI2 and Madhan Masilamani, PhD2, 1Mt. Sinai School of Medicine, New York, NY, 2Mount Sinai School of
Basophil Activation Following Cold Challenge in Patients with
Cold-Induced Urticaria
Hirsh D. Komarow, MD1, Cameron Waites, BS1, Michael L.
Young, RN, MPH2, Celeste Nelson, NP1, Sarah Arceo, RN1 and
Dean D. Metcalfe, MD, FAAAAI1, 1NIH/NIAID/Laboratory of
Allergic Diseases, Bethesda, MD, 2SAICl-Frederick, Inc., Bethesda, MD
Nanomaterials for Mast Cell and Basophil Stabilization
Through Non-FceRI Stimuli
Anthony Dellinger1, Brad Brooks2, Beverly Plunkett3, Becky M.
Vonakis, PhD, FAAAAI3, Zhiguo Zhou2 and Christopher L. Kepley,
PhD, MBA, FAAAI4, 1Joint School of Nanoscience and Nanoengineering, 2Luna Innovations, Danville, VA, 3Johns Hopkins University School of Medicine, Baltimore, MD, 4Joint School of
Nanoscience and Nanoengineering, Greensoro, NC
Mouse Mast Cell Protease 4 Mediates Epidermal Injury
Through Targeted Disruption of Tight Junctions
Lora Georgieva Bankova, Maria Cecilia Lezcano, George F. Murphy, K. Frank Austen and Michael Gurish, Brigham and Womens
Hospital/Harvard Medical School, Boston, MA
Primary Human Mast Cells Possess the Ability to Endocytose
Both Particulate and Fluid-Phase Antigens in Vitro
Brant Ward, MD, PhD, Sahar Lotfi-Emran and Lawrence B.
Schwartz, MD, PhD, FAAAAI, Virginia Commonwealth University, Richmond, VA
Study the Effect of Methernal Factor On Cord Blood IgE
Mohammad Fereidouni, MD, PhD, Shaghayeghsadat Nourani

FEBRUARY 2013
437
hasan kiade and Arefe Nami, Asthma, Allergy & Immunology Research Center,Birjand University of Medical Sciences, Iran
Systemic Mastocytosis in the Elderly
Joseph H. Butterfield, MD, FAAAAI and Catherine R. Weiler,
MD, PhD, FAAAAI, Mayo Clinic, Rochester, MN
Eosinophils
3212
438
439
440
441
442
443
444
445
446
The Development of Scleroderma in a Young Child Following

Resolution of Hypereosinophilic Syndrome (HES)
Ilisten Jones, MD1, Bob Geng, MD1 and Robert L. Roberts, MD,
PhD2, 1UCLA, Los Angeles, CA, 2UCLA Medical Center, Los
Angeles, CA
Hypereosinophilic Syndrome Presenting As Acute Pancreatitis
Manar Mohammad Abdalgani, MD and Anne-Marie A. Irani,
MD, FAAAAI, Virginia Commonwealth University Health Systems, Richmond, VA
IL-5, GM-CSF, and FMLP-Stimulated Eosinophil Degranulation Is Inhibited by Olopatadine, but Not Other Drugs in the
Same Class
Ellen B. Cook, PhD1, James Stahl, PhD1, Elizabeth Schwantes, BS1,
Sameer K. Mathur, MD, PhD, FAAAAI1,2 and Neal P. Barney, MD1,
1
University of Wisconsin School of Medicine and Public Health, Madison, WI, 2William S. Middleton Veterans Hospital, Madison, WI
Hypereosinophilic Syndrome and Thrombosis: A Retrospective
Review
Kara L. Wallace, PAC1, Martha K. Elias, MD2, Joseph H. Butterfield, MD, FAAAAI1 and Catherine R. Weiler, MD, PhD,
FAAAAI1, 1Mayo Clinic, Rochester, MN, 2Dartmouth- Hitchcock
Medical Center, Lebanon, NH
Negative Regulation of Eosinophil Production by Toll-Like Receptors
Patricia C. Fulkerson, MD, PhD1, Kaila L. Schollaert, MS2 and
Marc E. Rothenberg, MD, PhD, FAAAAI2, 1Allergy and Immunology, Cincinnati Childrens Hospital Medical Center, Cincinnati,
OH, 2Cincinnati Childrens Hospital Medical Center, Cincinnati,
OH
Cytokine Expression in Eosinophilic Sinusitis: Prominent
Role for Interferon- g in Aspirin-Exacerbated Respiratory
Disease
Larry Borish, MD, FAAAAI1, Lixia Liu, MD2, Phillip Huyett,
MD2, Julie Negri, B.S.2, Spencer Payne, MD2 and John W. Steinke,
PhD, FAAAAI1, 1Asthma and Allergic Disease Center, Carter
Center for Immunology Research, University of Virginia, Charlottesville, VA, 2University of Virginia, Charlottesville, VA
CLC3 Transcript Variants in the Activation and Migration of
Eosinophils in Allergic Asthmatics
Rohit Gaurav1, Min-Jung Kim1, Againdra Bewtra2 and Devendra
K. Agrawal1, 1Center for Clinical and Translational Science and
Department of Biomedical Sciences, Creighton University School
of Medicine, Omaha, NE, 2Department of Medicine, Division of
Allergy and Immunology, Creighton University Medical Center,
Omaha, NE
Eosinophils Through the CXCR4 Chemokine Receptor
Christof Straub, University of Texas Medical Branch, Galveston,
TX, Konrad Pazdrak, MD, PhD, Univ. of TX Medical Branch, Galveston, TX and Alexander Kurosky, PhD, University of Texas Medical Branch, League City, TX
Correlations Between Eosinophil Markers in Allergic Disorders
Mahsheed Taeb, DO1, Katrina Elio, DO1 and Oral Alpan, MD2,3,
1
Inova Fairfax Hospital, 2Amerimmune, LLC, VA, 3O&O ALPAN,
LLC
AH Sunday Oral Abstract Luncheon

3520
Sunday, February 24th, 2013, 12:15 PM - 1:30 PM
447
448
449
450
451
Effect of Sensitization and Exposure to Mold On Asthma Morbidity in Inner-City Children

Jean Curtin-Brosnan, MA1, Patrick J. Lenehan2, Patrick Breysse,
PhD3, Gregory B. Diette, MD, MHS1 and Elizabeth Matsui, MD1,4,
1
Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University, 3Johns Hopkins School of Public Health, 4Johns Hopkins
Evaluation of the Animated Cartoon-Aided Teaching of Intranasal Corticosteroid Administration Technique Among Thai
Children with Allergic Rhinitis
Somying Indradat, MD, Siriraj hospital, Mahidol University,
Thailand
Change in Food Allergy Attitudes Among Urban Public School
Nurses After a Standardized Educational Curriculum
Humaira Robinson, RN, BSN1, Sarah Twichell, MD, MPH1, Eleanor Garrow, BHA2, Maria L. Acebal, JD2 and Hemant P. Sharma,
MD, MHS, FAAAAI1, 1Childrens National Medical Center, Division of Allergy and Immunology, Washington, DC, 2Food Allergy
& Anaphylaxis Network, Fairfax, VA
Both Bronchodilator Reversibility and FEV1/FVC, but Neither
FEV1 Nor FEF25-75, Are Predictors of Future Acute Visits
Among Urban Children and Adolescents with Persistent
Asthma
Mary Jane C. Ong, Johns Hopkins University, Meredith C. McCormack, MD, Johns Hopkins Pulmonary, Baltimore, MD, Gregory
B. Diette, MD, MHS, Johns Hopkins University, Baltimore, MD,
Patrick Breysse, PhD, Johns Hopkins School of Public Health and
Elizabeth Matsui, MD, Johns Hopkins University School of Medicine, Baltimore, MD
Circumstances of Medically Unadvised Purposeful Exposure to
Food Allergens in an Observational Study (Consortium of Food
Allergy Research, COFAR)
Kim E. Mudd, RN MSN CCRP, Johns Hopkins University, Baltimore, MD, Jill Ellingson, Department of Pediatrics, National Jewish Health, Denver, CO, Phyllis Mayfield, University of Arkansas
for Medical Sciences, Pediatric Allergy and Immunology Arkansas,
Childrens Hospital, Little Rock, AR, Lisa P. Talarico, RN MS,
Mount Sinai School of Medicine, New York, NY, Janet S. Kamilaris, RN, Division of Pediatric Allergy and ImmunologyUniversity
of North Carolina, Chapel Hill, NC and Scott H. Sicherer, MD,
FAAAAI, Mt. Sinai School of Medicine, New York, NY
454
455
456
Dendritic Cells
3602
457
458
Asthma Epidemiology
3601
452
453
United States Asthma Hospitalization Rates in the 21st Century

Show a Peak Female Predominance in the 5th and 6th Decades
of Life
Robert Yao-Wen Lin, FAAAAI1,2,3, William Liao1 and Rong Ji,
MD1, 1New York Downtown Hospital, New York, NY, 2New
York Medical College, Valhalla, NY, 3Weill Cornell Medical College, New York, NY
Comparison of Prepubertal Gender Differences in Pulmonary
Physiologic Outcome Measures
Amy Lynn OBrian, MD1, Daniel J. Jackson, MD2, Michael D.
Evans, MS1, Sean Fain3, Ronald Sorkness , PhD3, James Gern,
MD, FAAAAI1 and Robert F. Lemanske Jr., MD, FAAAAI1, 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Pediatrics, University of Wisconsin School of Medicine
and Public Health, Madison, WI, 3University of Wisconsin, Madison, WI

Estimated Prevalence and Economic Burden of Severe, Uncontrolled Asthma in the United States
Cheryl S. Hankin, PhD1, Amy Bronstone, PhD1, Zhaohui Wang,
MS1, Mary Buatti Small2 and Philip Buck, PhD, MPH2, 1BioMedEcon, LLC, Moss Beach, CA, 2Teva Pharmaceuticals, Inc., Frazer,
PA
Factors Associated with Asthma Readmissions in Children in
Rural Wisconsin
Ejaz Yousef, MD, FAAAAI1,2, Diane Kessler, MS1 and Gerald A.
Bucholtz, MD1, 1Marshfield Clinic, Marshfield, WI, 2St Joseph
Hospital
Older Adults with Asthma: Comparisons of Those with LongStanding Asthma to Those with Late Onset Asthma
Alan P. Baptist, MD, MPH, University of Michigan, Division of
Allergy, Ann Arbor, MI, Jacqueline A. Ross, MD, University of
Michigan, Ann Arbor, MI and Noreen Clark, PhD, Center for Managing Chronic Disease, University of Michigan, Ann Arbor,
MI
459
460
Dendritic Cells From X-Linked Hyper-IgM Patients Present

Impaired Responses to Candida Albicans and Paracoccidioides
Brasiliensis That Can Be Reversed by Exogenous Soluble
CD40L
Otavio C. Marques1, Christina Arslanian2, Rodrigo N. Ramos2,
Mariana M. Marques2, Lena F. Schimke3, Paulo V.S. Pereira2, Sonia Jancar2, Janaira F. S Ferreira4, Cristina W. Weber5, Gisele Kuntze6, Nelson Augusto Rosario-Filho7, Beatriz C. Carvalho8, Patrcia
C. Bergami-Santos2, Mary J. Hackett9, Hans D. Ochs9, Troy R.
Torgerson9, Jose Alexandre M. Barbuto2,10 and Antonio CondinoNeto2,10, 1Institute of Biomedical Sciences, Department of
Immunology, University of S~ao Paulo, Sao Paulo, Brazil, S~ao
Paulo, Brazil, 2University of S~ao Paulo, 3Institute of Biomedical
Sciences, Department of Immunology, University of S~ao Paulo,
Sao Paulo, Brazil, 4Albert Sabin Hospital, 5Pediatric and Immunology Clinic, RS, 6Pequeno Principe Hospital, 7Federal University of
Parana, 8Federal University of S~ao Paulo, 9University of Washington, 10*Contributed Equally
Molecular Mechanisms Involved in Dendritic Cell-Dependent
Regulatory T Cell Generation During Immunotherapy
Marco A. Garcia, Stanford University, Mountain View, CA and
Kari Nadeau, MD, PhD, FAAAAI, Stanford University School of
Medicine
Human Dendritic Cells Stimulated with a Novel Peanut Protein
Express High Levels of RALDH2 and Induce RA-Sensitive
Genes in Nave T Cells
Bert Ruiter, PhD1, Galina Grishina, MSc2, Stans den Hartog Jager,
BSc3, Edward F. Knol, PhD3, Peggy Ozias-Akins, PhD4, Hugh A.
Sampson, MD, FAAAAI2 and Wayne G. Shreffler, MD, PhD,
FAAAAI1, 1Massachusetts General Hospital, Boston, MA, 2Mount
Sinai School of Medicine, New York, NY, 3University Medical
Center, Utrecht, Netherlands, 4University of Georgia, Tifton, GA
The C-Lectin Receptor Dendritic Cell Immunoreceptor (DCIR)
Mediates the Tolerogenic Effects of Intravenous Immunoglobulin in Pulmonary Inflammation
Amir Hossein Massoud1,2, Aidan Ablona2,3, Gabriel N. Kaufman,
MSc4, Ciro Piccirillo, PhD5 and Bruce D. Mazer, MD, FAAAAI2,6,
1
McGill University Health Center, 2Meakins-Christie Laboratories,
Montreal, QC, Canada, 3McGill University, 4McGill University,
SUNDAY
Abstracts AB267

113
AB268 Abstracts
461
AB268 Abstracts
461

FEBRUARY 2013
Montreal, QC, Canada, 5McGill University Health Centre, Canada,

6
Montreal Childrens Hospital, Montreal, QC, Canada
Aspergillus Fumigatus (Af) Induced Airway Epithelial Accumulation and Decreased Lymph Node Homing of Myeloid Dentritic
Cells (DC) in the Lung of Mice with Chronic Granulomatous
Disease (CGD)
Lisa R. Forbes, MD1, Akshit Gupta2, Blerian Kolkalari2, Imre Redai3 and Angela Haczku, MD, PhD, FAAAAI3, 1Baylor College of
2
of
468
Medicine, Texas Childrens Hospital, Houston, TX, University

Pennsylvania, 3University of Pennsylvania, Philadelphia, PA
Mother and Child: Prevention and Disease

3603
SUNDAY
462
463
464
465
466
Maternal Vitamin D Status During Pregnancy and Asthma in

the Offspring Among Participants in the Norwegian Mother
and Child Cohort Study
Maria C. Magnus, MPH1, Per Nafstad, MD, PhD1,2, Lars Chrisaberg, MD, PhD1, Stephanie J.
tian Stene, PhD1, Siri Eldevik H
London, MD, DrPH3, Hein Stigum, PhD4 and Wenche Nystad,
PhD1, 1Norwegian Institute of Public Health, Oslo, Norway, 2University of Oslo, Oslo, Norway, 3NIEHS, Research Triangle Park,
NC, 4Norwegian Institute of PublicHealth, Oslo, Norway
Maternal Probiotic Intake and Respiratory and Allergy Outcomes in Early Childhood
Randi J. Bertelsen1,2, Anne Lise Brantsaeter3, Margaretha Haugen1, Helle Margrethe Meltzer1 and Stephanie J. London, MD,
DrPH4, 1Norwegian Institute of Public Health, Oslo, Norway, 2National Institute of Environmental Health Sciences (NIEHS/NIH),
Research Triangle Park, NC, 3Norwegian Institue of Public Health,
Oslo, Norway, 4NIEHS, Research Triangle Park, NC
Potential Role for IFNg in Promoting Asthma After Prenatal
Exposure to BPA
Terumi Midoro-Horiuti, MD, PhD, FAAAAI1, Xiang Zhang,
PhD2, Yoichi Nakajima, MD, PhD1, Yueqing Zhang, BS1, Deepthi
Kolli, PhD1, Shuk-Mei Ho, PhD2 and Randall M. Goldblum, MD1,
1
University of Texas Medical Branch, Galveston, TX, 2University
of Cincinnati, Cincinnati, OH
The Impact of Caesarian Section On the Relationship Between Inhalent Allergen Exposure and Allergen-Specific IgE At Age 2 Years
Christine Cole Cole Johnson, PhD, MPH, FAAAAI1, Suzanne Havstad, MA2, Dennis Ownby, MD3, Ganesa Wegienka, PhD2 and Edward
M. Zoratti, MD, FAAAAI4, 1Henry Ford Hospital & Health System,
Detroit, MI, 2Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, 3Georgia Health Sciences University, Augusta, GA,
4
Division of Allergy and Clinical Immunology, Henry Ford Hospital,
Detroit, MI
Does Presence of Animals in the Home Increase the Risk of Sensitization to the Same Animals?
Anusha Raj .K, Under grad Med student1, Padukudru Mahesh, Prof
of Medicine2, Amrutha D Holla, MBBS, DAA3, B.S Jayaraj, Prof of
Medicine2 and Pudupakkam Vedanthan, Clinical Professor Medicine4,
1
Mysore Medical College & Research Institute, Mysore, India, 2JSS
Medical college, Mysore, India, 3Allergy, Asthma & Chest Centre,
Mysore, India, 4University of Colorado, Lakewood, CO
469
470
471
Corinne Keet, MD, MS1, Shannon Seopaul, BS2, Sarah D. Knorr,

RN, MPH, CCRP2, Satya Narisety, MD2, Justin M. Skripak, MD3
and Robert A. Wood, MD, FAAAAI4, 1Pediatrics, Johns Hopkins
University School of Medicine, 3ENT & Allergy Associates, Hoboken, NJ, 4Johns Hopkins University School of Medicine, Baltimore,
MD
Tolerance Induction in an Interim Analysis of Peanut Sublingual Immunotherapy
Edwin Kim, MD, MS1, Stacy Chin, MD2, Pamela H. Steele, MSN,
CPNP, AE-C1, Janet S. Kamilaris, RN1, Nikolas Kamilaris1, Caitlin
Burk1, Brian P. Vickery, MD1, Michael D. Kulis Jr., PhD1 and A.
Wesley Burks, MD, FAAAAI1, 1University of North Carolina at
Chapel Hill, Chapel Hill, NC, 2FDA/CDER, Washington, DC
Alexandra F. Santos, MD, MSc1,2, Natalia Becares, BSc1, ShihYing Wu, MSc1, Suzana Radulovic, MD2, Alick Stephens, PhD1,
Victor Turcanu, PhD1, George Du Toit, MD, FAAAAI2 and Gideon
Lack, MD, FRCPCH1,2, 1Kings College London, London, United
Kingdom, 2St Thomas Hospital, London, United Kingdom
Low-Dose Oral Immunotherapy As an Early Intervention
Strategy for Peanut Allergy
Brian P. Vickery, MD, Pamela H. Steele, MSN, CPNP, AE-C, Janet S. Kamilaris, RN, Caitlin Burk, Nikolas Kamilaris, Michael D.
Kulis Jr., PhD and A. Wesley Burks, MD, FAAAAI, University of
North Carolina at Chapel Hill, Chapel Hill, NC
Michael D. Kulis Jr., PhD, Rishu Guo, PhD, Edwin Kim, MD,
MS, Brian P. Vickery, MD and A. Wesley Burks, MD, FAAAAI,
University of North Carolina at Chapel Hill, Chapel Hill, NC
Montreal, QC, Canada, 5McGill University Health Centre, Canada,

6
Montreal Childrens Hospital, Montreal, QC, Canada
Aspergillus Fumigatus (Af) Induced Airway Epithelial Accumulation and Decreased Lymph Node Homing of Myeloid Dentritic
Cells (DC) in the Lung of Mice with Chronic Granulomatous
Disease (CGD)
Lisa R. Forbes, MD1, Akshit Gupta2, Blerian Kolkalari2, Imre Redai3 and Angela Haczku, MD, PhD, FAAAAI3, 1Baylor College of
Medicine, Texas Childrens Hospital, Houston, TX, 2University of
Pennsylvania, 3University of Pennsylvania, Philadelphia, PA
468
EGID
3605
472
473
Food Allergy
3604
467

FEBRUARY 2013
474

Esophagitis
Benedicte Michaud, MD1, Diana Colson2, Pascale Soulaines2, Sophie Candon, MD, PhD1, Marie-Alexandra Alyanakian, MD, PhD3,
Jocelyne Just, MD, PhD4, Lucienne Chatenoud, MD, PhD1 and
opital
Christophe Dupont, MD, PhD5, 1Universite Paris Descartes, H^
opital
Necker-Enfants Malades, INSERM U1013, Paris, France, 2H^
Necker, Enfants Malades, Universite Paris V Rene Descartes (Paris,
France), Paris, France, 3Hopital Necker Enfants Malades, Laboratoire dimmunologie biologie, Paris, France, 4Universite Pierre et
Marie Curie, H^
opital Armand Trousseau, Centre de lAsthme et
des Allergies, Paris, France, 5Universite Paris V Rene Descartes,
Paris, France
Misregulation of Suppressors of Cytokine Signaling in Eosinophilic Esophagitis
Maria Paz Zafra1, Nataly Cancelliere, MD2, Pablo Rodriguez Del
Rio3, Monica Ruiz Garcia4, Laura Estevez1, Maria Victoria Andregnette5, Silvia Sanchez-Garcia3, Ana Fiandor6, Joaquin Sastre, MD,
PhD, FAAAAI4, Santiago Quirce, MD, PhD7, Maria Dolores Iba~
on Jimenez Daz,
nez3 and Victoria Del Pozo, PhD5, 1IIS-Fundaci
2
University Hospital La Paz, Madrid, Spain, 3Hospital Ni~
no Jesus,
4
Fundacion Jimenez Diaz, Madrid, Spain, 5IIS-Fundacion Jimenez
Daz, Madrid, Spain, 6Hospital La Paz, 7Hospital La Paz Institute
for Health Research, Dept. of Allergy, Madrid, Spain
Key Function of Cadherin-Like 26 in Eosinophilic Gastrointestinal Disorders
Mother and Child: Prevention and Disease

3603
SUNDAY
462
463
464
465
466
Maternal Vitamin D Status During Pregnancy and Asthma in

the Offspring Among Participants in the Norwegian Mother
and Child Cohort Study
Maria C. Magnus, MPH1, Per Nafstad, MD, PhD1,2, Lars Chrisaberg, MD, PhD1, Stephanie J.
tian Stene, PhD1, Siri Eldevik H
3
London, MD, DrPH , Hein Stigum, PhD4 and Wenche Nystad,
PhD1, 1Norwegian Institute of Public Health, Oslo, Norway, 2University of Oslo, Oslo, Norway, 3NIEHS, Research Triangle Park,
NC, 4Norwegian Institute of PublicHealth, Oslo, Norway
Maternal Probiotic Intake and Respiratory and Allergy Outcomes in Early Childhood
Randi J. Bertelsen1,2, Anne Lise Brantsaeter3, Margaretha Haugen1, Helle Margrethe Meltzer1 and Stephanie J. London, MD,
DrPH4, 1Norwegian Institute of Public Health, Oslo, Norway, 2National Institute of Environmental Health Sciences (NIEHS/NIH),
Research Triangle Park, NC, 3Norwegian Institue of Public Health,
Oslo, Norway, 4NIEHS, Research Triangle Park, NC
Potential Role for IFNg in Promoting Asthma After Prenatal
Exposure to BPA
Terumi Midoro-Horiuti, MD, PhD, FAAAAI1, Xiang Zhang,
PhD2, Yoichi Nakajima, MD, PhD1, Yueqing Zhang, BS1, Deepthi
Kolli, PhD1, Shuk-Mei Ho, PhD2 and Randall M. Goldblum, MD1,
1
University of Texas Medical Branch, Galveston, TX, 2University
of Cincinnati, Cincinnati, OH
The Impact of Caesarian Section On the Relationship Between Inhalent Allergen Exposure and Allergen-Specific IgE At Age 2 Years
Christine Cole Cole Johnson, PhD, MPH, FAAAAI1, Suzanne Havstad, MA2, Dennis Ownby, MD3, Ganesa Wegienka, PhD2 and Edward
M. Zoratti, MD, FAAAAI4, 1Henry Ford Hospital & Health System,
Detroit, MI, 2Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, 3Georgia Health Sciences University, Augusta, GA,
4
Division of Allergy and Clinical Immunology, Henry Ford Hospital,
Detroit, MI
Does Presence of Animals in the Home Increase the Risk of Sensitization to the Same Animals?
Anusha Raj .K, Under grad Med student1, Padukudru Mahesh, Prof
of Medicine2, Amrutha D Holla, MBBS, DAA3, B.S Jayaraj, Prof of
Medicine2 and Pudupakkam Vedanthan, Clinical Professor Medicine4,
1
Mysore Medical College & Research Institute, Mysore, India, 2JSS
Medical college, Mysore, India, 3Allergy, Asthma & Chest Centre,
Mysore, India, 4University of Colorado, Lakewood, CO
469
470
471
EGID
3605
472
473
Food Allergy
3604
467
114
Corinne Keet, MD, MS1, Shannon Seopaul, BS2, Sarah D. Knorr,

RN, MPH, CCRP2, Satya Narisety, MD2, Justin M. Skripak, MD3
and Robert A. Wood, MD, FAAAAI4, 1Pediatrics, Johns Hopkins
University School of Medicine, 3ENT & Allergy Associates, Hoboken, NJ, 4Johns Hopkins University School of Medicine, Baltimore,
MD
Tolerance Induction in an Interim Analysis of Peanut Sublingual Immunotherapy
Edwin Kim, MD, MS1, Stacy Chin, MD2, Pamela H. Steele, MSN,
CPNP, AE-C1, Janet S. Kamilaris, RN1, Nikolas Kamilaris1, Caitlin
Burk1, Brian P. Vickery, MD1, Michael D. Kulis Jr., PhD1 and A.
Wesley Burks, MD, FAAAAI1, 1University of North Carolina at
Chapel Hill, Chapel Hill, NC, 2FDA/CDER, Washington, DC
Alexandra F. Santos, MD, MSc1,2, Natalia Becares, BSc1, ShihYing Wu, MSc1, Suzana Radulovic, MD2, Alick Stephens, PhD1,
Victor Turcanu, PhD1, George Du Toit, MD, FAAAAI2 and Gideon
Lack, MD, FRCPCH1,2, 1Kings College London, London, United
Kingdom, 2St Thomas Hospital, London, United Kingdom
Low-Dose Oral Immunotherapy As an Early Intervention
Strategy for Peanut Allergy
Brian P. Vickery, MD, Pamela H. Steele, MSN, CPNP, AE-C, Janet S. Kamilaris, RN, Caitlin Burk, Nikolas Kamilaris, Michael D.
Kulis Jr., PhD and A. Wesley Burks, MD, FAAAAI, University of
North Carolina at Chapel Hill, Chapel Hill, NC
Michael D. Kulis Jr., PhD, Rishu Guo, PhD, Edwin Kim, MD,
MS, Brian P. Vickery, MD and A. Wesley Burks, MD, FAAAAI,
University of North Carolina at Chapel Hill, Chapel Hill, NC
474

Esophagitis
Benedicte Michaud, MD1, Diana Colson2, Pascale Soulaines2, Sophie Candon, MD, PhD1, Marie-Alexandra Alyanakian, MD, PhD3,
Jocelyne Just, MD, PhD4, Lucienne Chatenoud, MD, PhD1 and
Christophe Dupont, MD, PhD5, 1Universite Paris Descartes, Hôpital
Necker-Enfants Malades, INSERM U1013, Paris, France, 2Hôpital
Necker, Enfants Malades, Universite Paris V Rene Descartes (Paris,
France), Paris, France, 3Hopital Necker Enfants Malades, Laboratoire dimmunologie biologie, Paris, France, 4Universite Pierre et
Marie Curie, Hôpital Armand Trousseau, Centre de lAsthme et
des Allergies, Paris, France, 5Universite Paris V Rene Descartes,
Paris, France
Misregulation of Suppressors of Cytokine Signaling in Eosinophilic Esophagitis
Maria Paz Zafra1, Nataly Cancelliere, MD2, Pablo Rodriguez Del
Rio3, Monica Ruiz Garcia4, Laura Estevez1, Maria Victoria Andregnette5, Silvia Sanchez-Garcia3, Ana Fiandor6, Joaquin Sastre, MD,
PhD, FAAAAI4, Santiago Quirce, MD, PhD7, Maria Dolores Iba~nez3 and Victoria Del Pozo, PhD5, 1IIS-Fundacion Jimenez Daz,
2
University Hospital La Paz, Madrid, Spain, 3Hospital Ni~no Jesus,
4
Fundacion Jimenez Diaz, Madrid, Spain, 5IIS-Fundacion Jimenez
Daz, Madrid, Spain, 6Hospital La Paz, 7Hospital La Paz Institute
for Health Research, Dept. of Allergy, Madrid, Spain
Key Function of Cadherin-Like 26 in Eosinophilic Gastrointestinal Disorders
Abstracts AB269

476
Rhinitis Pathophysiology
3607
481
482
483
484
Adherence and Asthma Treatment

3606
477
478
479
480
Texting for Adherence to Asthma Medication in Adolescents

Waqas Jehangir, MD, Childrens Hospital of Michigan, detorit, MI,
Wafa Alame, RN, Childrens Hospital of Michigan, Detorit, MI,
Elizabeth A. Secord, MD, FAAAAI, Wayne State University, Jenny
M. Montejo, MD, Childrens Hospital of MI, Detroit, MI and Milind
V. Pansare, MD, FAAAAI, Childrens Hospital Of Michigan,
Grosse Pointe Woods, MI
The Use of Coping Peer Support and MP3 Technology to Improve Adherence to Inhaled Corticosteroids Among Low-Income Minority Adolescents
Giselle Mosnaim, MD, MS, FAAAAI1, Hong Li, PhD2, Molly
Martin, MD, MAPP2, Paula Jo Belice, MS2, Elizabeth Avery,
MS2, Norman Ryan, MD2, Bruce G. Bender, PhD, FAAAAI3 and
Lynda Powell, PhD2, 1Rush University Medical Center, Chicago,
2
Rush University Medical Center, Chicago, IL, 3National Jewish
Health, Denver, CO
Adherence Risk Patterns in Adult Patients with Asthma in an
Inner City Cohort Over a 25 Month Period
Edan Sarid, MD and Rauno O. Joks, MD, FAAAAI, SUNY Downstate Medical Center, Center for Allergy and Asthma Research,
Brooklyn, NY
Association Between Medication Adherence Report Scale
(MARS-5) and Asthma Outcomes in Inner City Children with
Asthma
Seojin Yang1, Mona G. Tsoukleris, PharmD1, Cassie Lewis-Land,
MA2, Jennifer Walker, MS2, Mary E. Bollinger, DO3 and Arlene
Butz, RN, ScD.2, 1University of Maryland School of Pharmacy,
Baltimore, MD, 2Johns Hopkins University School of Medicine,
Baltimore, MD, 3University MD School of Medicine, Baltimore,
MD
485
Anti-Histaminergic Responses On TRPV1 Channels

Umesh Singh1, Jonathan A. Bernstein, MD2,3, Kristin Luther1,
Lauren Haar1 and W. Keith Jones1, 1University of Cincinnati, Cincinnati, OH, 2Bernstein Allergy Group, Cincinnati, OH, 3University
of Cincinnati Medical Center, Cincinnati, OH
Allergen Exposure Affects Sinonasal Microbiota
Chris Choi1, Valeriy Poroyko1, So Watanabe2, Duo Jiang1, James
Lane3, Marcella DeTineo4, Fuad M. Baroody, MD, FAAAAI5, Robert M. Naclerio, MD, FAAAAI5 and Jayant M. Pinto, MD5, 1Univ
of Chicago, 2Showa University, Toyko, Japan, 3University of Chicago, Chicago, IL, 4Univ. of Chicago, 5The University of Chicago,
Chicago, IL
Invariant Natural Killer T Cells Populations in Peripheral
Blood From Allergic Rhinitis Patients: Regulatory or Pathologic Role?
Soledad Lopez, PhD1,2, David Pozo, PhD1,2, Jose Luis RodriguezBada, Lab. Tech.3, Lidia Melendez, Lab. Tech.4, Cristobalina Mayorga, PhD4 and Miguel Blanca, MD, PhD5, 1NIR Lab, Department
of Cell Signalling CABIMER-Andalusian Center for Molecular Biology and Regenerative Medicine, Spain, 2Department of Medical
Biochemistry, Molecular Biology and Immunology, University of
Seville Medical School, 3Research Laboratory, Carlos Haya Hospital-Fundacion IMABIS, Spain, 4Research Laboratory, Carlos Haya
Hospital-FIMABIS, Malaga, Spain, 5Allergy Service, Carlos Haya
Hospital, Malaga, Spain
TRPV1 Ion Channel Activation Is Enhanced by Bradykinin in
Sensory Neuronal Cells
Jonathan A. Bernstein, MD1,2,3, Umesh Singh4, Lauren Haar4,
Kristin Luther4 and W. Keith Jones4, 1Bernstein Allergy Group,
Cincinnati, OH, 2University of Cincinnati Medical Center, Cincinnati, OH, 3University of Cincinnati, 4University of Cincinnati, Cincinnati, OH
The Allergic Rhinitis Clinical Investigator Collaborative (ARCIC) a Multicentre Pilot Study to Optimize a Standard Nasal
Allergen Challenge Protocol
Anne K. Ellis, MD, MSc, FRCPC, FAAAAI1,2, Louis-Philippe
Boulet, MD3, Harissios Vliagoftis, MD4, Paul Keith, MD,
FAAAAI5, Susan Waserman, MD, FAAAAI5, Marie-Eve Boulay3,
Lisa Steacy, BSc1 and Helen Neighbour6, 1Allergy Research Unit,
Kingston General Hospital, Kingston, ON, Canada, 2Departments
of Medicine and Biomedical & Molecular Science, Queens University, Kingston, ON, Canada, 3Institut Universitaire de Cardiologie et
de Pneumologie de Quebec, Quebec City, QC, Canada, 4Pulmonary
Research Group, University of Alberta, 5Department of Medicine,
McMaster University, Hamilton, ON, Canada, 6Firestone Institute
for Respiratory Health, McMaster University, Hamilton, ON,
Canada
SUNDAY
475
Julie M. Caldwell, PhD1, Margaret Collins, MD2, Carine Blanchard, PhD3, Emily Stucke, BA1, Katherine Kemme, BS1, Lissa
Amin, BA1, Philip Putnam, MD1, James Franciosi, MD4, Juan Pablo Pablo Abonia, MD1 and Marc E. Rothenberg, MD, PhD,
FAAAAI1, 1Cincinnati Childrens Hospital Medical Center, Cincinnati, OH, 2Cincinnati Childrens Hospital Medical Center, Cincinnati, OH, 3Cincinnati Children Hospital, Cincinnati, OH,
4
Nemours Childrens Hospital, Orlando, FL
A Transforming Growth Factor Beta-1 Gene Single Nucleotide
Polymorphism May Influence Phenotype in Pediatric Eosinophilic Esophagitis
Arjun Andrew Anilkumar, BS 1,2, Robert Newbury, MD3,4, Ranjan Dohil, MD4,5, James Mueller, BS1,4, Hal M. Hoffman, MD,
FAAAAI1,4, David H. Broide, MB, ChB, FAAAAI1,2 and Seema
Sharma Aceves, MD, PhD, FAAAAI2,6,7, 1Division of Allergy,
Immunology, 2Department of Medicine, 3Division of Pathology,
4
Department of Pediatrics, 5Division of Gastroenterology,
UCSD, Rady Childrens Hospital, San Diego, 6Pediatrics,
UCSD, La Jolla, CA, 7UCSD, Department of Pediatrics, La Jolla,
CA
MMP-14 Is Elevated in Pediatric Subjects with Eosinophilic
Esophagitis
Lisa Beppu, BS1,2, Arjun Andrew Anilkumar, BS2,3, Ranjan Dohil,
MD1,4, David H. Broide, MB, ChB, FAAAAI2,3 and Seema Sharma
Aceves, MD, PhD, FAAAAI3,5,6, 1Department of Pediatrics, 2Division of Allergy, Immunology, 3Medicine, 4Division of Gastroenterology, UCSD, Rady Childrens Hospital, San Diego, 5Pediatrics,
UCSD, La Jolla, CA, 6UCSD, Department of Pediatrics, La Jolla,
CA
Advances in Controlling Allergic Inflammation

3608
486
Role of Mannose Receptor (MR) in Cockroach Allergen-Induced Allergic Inflammation

Peisong Gao, MD, PhD1, Ying-Ming Tsai, MD1,2, Shih-Chang
Hsu3, Yufeng Zhou, MD, PhD1, Beverly Plunkett1 and Shau-Ku
Huang, PhD1,3, 1Johns Hopkins University School of Medicine,
Baltimore, MD, 2Kaohsiung Medical University, Taiwan, 3National
Health Research Institutes, Taiwan
115
AB270 Abstracts
487
488
489
SUNDAY
490

FEBRUARY 2013
DNA Methylation Profiling in Asthmatic and Non Asthmatic

Nasal Epithelial Cells During Respiratory Virus Infection
Peter McErlean, PhD1, Silvio Favoreto Jr., PhD1, Fabricio Costa,
PhD2, Junquing Shen, PhD1, Assel Biyasheva, PhD1, Maria de Fatima Bonaldo, PhD2, Denise Scholtens, PhD1, Hehuang Xie, PhD2,
Marcelo B. Soares, PhD2 and Pedro C. Avila, MD, FAAAAI3,
1
Northwestern University, Chicago, IL, 2Childrens Memorial Hospital Research Center, Chicago, IL, 3Northwestern University Feinberg School of Medicine, Chicago, IL
Vitamin D Supplementation Reduces Airway Hyperresponsiveness and Allergic Airway Inflammation in a Murine Model
Tanupriya Agrawal, Gaurav Gupta and Devendra K. Agrawal,
Center for Clinical and Translational Science and Department of
Biomedical Sciences, Creighton University School of Medicine,
Omaha, NE
IL-4Ra Expression by Airway Epithelial Cells Promotes Allergen-Induced Airway Hyperresponsiveness
Christopher G. McKnight, MD1,2,3, Charles Perkins2, Crystal
Potter1 and Fred D. Finkelman, MD1,2,3, 1University of Cincinnati,
2
Cincinnati Childrens Hosp. Med. Center, 3Veterans Administration Med. Center Cincinnati
Novel Phosphodiesterase-4 Inhibitors Decrease Allergic Sinus
Congestion and Inflammation
Bill T. Ameredes, PhD, Walter C. Spear, MS, Anita Reno, BS,
Jesse Parks, IV and Spotswood Miller, University of Texas Medical
Baltimore, MD, 2Johns Hopkins University School of Public

Health, Baltimore, MD, 3Hospital Universitario Professor Edgard
Santos, Brazil, 4Federal University of Bahia, Salvador, Brazil
BCI Featured Posters

3802
496
497
498
Featured Poster Sessions
Asthma Mechanisms
3801
491
492
493
494
495
116
The Effect of LTD4 On Glucocorticoid Receptor [GR] Translocation

Jennifer McCracken, MD1, Ashwini Reddy, MD1, Lata Kaphalia,
PhD2 and William J. Calhoun, MD, FAAAAI3, 1UTMB, Galveston,
TX, 2UTMB, 3University of Texas Medical Branch, Galveston, TX
Salivary Alpha-Amylase As a Measure of b-Adrenergic Receptor Activity in Physically Active Individuals with and without
Exercise-Induced Bronchoconstriction
Sindhura Bandi, MD1,2, Jay Estrada1, Ben Xu1, Kainat Khalid1
and James Moy1,2, 1Rush University Medical Center, Chicago,
IL, 2John H. Stroger Hospital of Cook County, Chicago, IL
Microbiome of the Lower Airways Alters Corticosteroid Responsiveness in Asthma
Elena Goleva, PhD1, Leisa P. Jackson, BS1, J. Kirk Harris, PhD2,
Richard J. Martin, MD3 and Donald Y.M. Leung, MD, PhD,
FAAAAI1, 1National Jewish Health, Department of Pediatrics, Denver, CO, 2University of Colorado Anschutz Medical Campus, Department of Pediatrics, Aurora, CO, 3National Jewish Health,
Department of Medicine, Denver, CO
The Importance of Hyaluronan As a Contributor to Asthma
Progression
S.P. Evanko1, S.D. Potter-Perigo1, L. C. Altman2 and T.N. Wight1,
1
Benaroya Research Institute, 2Northwest Asthma & Allergy
Center
Novel IL33 Gene Polymorphisms Associated with Asthma Are
Associated with Resistance to Schistosoma Mansoni
Hironori Masuko, MD, PhD1, Li Gao, MD, PhD1, Nicholas M.
Rafaels, MS1, Candelaria I. Vergara, MD, PhD1, Lili Huang,
MS1, Monica Campbell1, Ingo Ruczinski, PhD2, Terri H Beaty,
PhD2, Ricardo Oliveira3, Alvaro A. Cruz, MD3, Edgar M. Carvalho,
MD, PhD4, Rasika A. Mathias, ScD1, Maria Ilma Araujo, MD4 and
Kathleen C. Barnes, PhD FAAAAI1, 1Johns Hopkins University,
499
500
A Novel Method for Newborn Screening for 22q11.2 Deletion

Syndrome Using Dried Blood Spots
Lisa J. Kobrynski, MD, MPH, FAAAAI, Emory University
School of Medicine, Atlanta, GA
The Oxidant-Modified Lipid Lysophosphatidylserine (lysoPS)
Made by Exudate Neutrophils Limits Neutrophil Accumulation
in Vivo
Donna Bratton, MD1, Ruby Fernandez-Boyanapalli, PhD1, Karin
Zemski-Berry, PhD2, Robert Murphy, PhD3 and S. Courtney
Frasch, PhD4, 1National Jewish Health, Denver, CO, 2University
of Colorado Denver, Aurora, CO, 3University of Colorado Denver,
4
National Jewish Health
Application of Anti-Viral Adoptive T-Cell Therapy to Primary
Immunodeficiency Patients
Sarah K. Nicholas, MD1, Caridad Martinez, MD1, Ann Leen,
PhD1, Cliona Rooney, PhD1, Catherine Bollard, MD1, Stephen
Gottschalk, MD1, Helen Heslop, MD1, I. Celine Hanson, MD,
FAAAAI1, Malcolm Brenner, MD1 and Jordan Orange, MD, PhD,
FAAAAI2, 1Baylor College of Medicine/Texas Childrens Hospital,
Houston, TX, 2Baylor College of Medicine and Texas Childrens
Hospital, Section of Immunology, Allergy and Rheumatology
IFR2BP2 Mutations Identified As a Novel Genetic Cause of Familial Common Variable Immunodeficiency Identified Via Support Vector Algorithm and Whole Exome Sequencing
Michael Keller, MD1, Joseph Glessner2, Hakon Hakonarson, MD,
PhD3 and Jordan Orange, MD, PhD, FAAAAI1, 1Childrens Hospital of Philadelphia, Philadelphia, PA, 2Childrens Hospital of Philadelphia, 33615 Civic Center Blvd., Childrens Hospital of
Philadelphia, Philadelphia, PA
Exome Sequencing Reveals Novel Genetic Underpinnings of
Common Variable Immune Deficiency (CVID)
Patricia L. Lugar, MD MS1, Michele R. Henson, MD2, Cassandra
Love3, Heather Rivera Gutekunst, MD4, Zhen Sun3 and Sandeep
Dave3, 1Duke University Medical Center, Durham, NC, 2Duke
University, Durham, NC, 3Duke University, 4Duke Medicine, Raleigh, NC
Allergen Exposures at Home, School and Work

3803
501
502
Allergen Exposure of Table and Desk Surfaces in Preschools

and Elementary Schools of Urban Children with Asthma
Watcharoot Kanchongkittiphon, PhD, MD, Boston Childrens
Hospital, Boston, MA; Ramathibodi Hospital, Mahidol University,
Bangkok, Thailand
Most House Dust Mite Aeroallergen Exposure Occurs During
the Day, Not in Bed
Euan Tovey, PhD1,2, Christiana Willenborg, BSc3, Daniel Crisafulli, MSc1, Janet Rimmer, MD1, Jason Sercombe, MSc2 and Guy
Marks, PhD, MD1, 1Woolcock Institute of Medical Research, Sydney, Australia, 2University of Sydney, Australia, 3Prince of Wales
Hospital, Sydney, Australia
Abstracts AB271

504
505
Mouse Allergen Exposure in Urban Schools and Its Effect On

Childhood Asthma Morbidity
Perdita Permaul, MD1, Carter R. Petty, MA2, William J. Sheehan,
MD2, Sachin N. Baxi, MD2, Jonathan M. Gaffin, MD, MMSc2,
Lianne S. Kopel, MD2, Watcharoot Kanchongkittiphan, MD,
PhD2, Ann Bailey, BA3, Chunxia Fu, MS3, Diane R. Gold, MD3
and Wanda Phipatanakul, MD MS FAAAAI2, 1Division of Pediatric
Allergy/Immunology, Massachusetts General Hospital, Boston,
MA, 2Boston Childrens Hospital, Boston, MA, 3Channing Laboratory, Boston, MA
Endotoxin Exposure May Modify the Relationship Between
Mouse Allergen Exposure and Incident Sensitization to Mouse
Sharon K. Ahluwalia, MD1, Roger Peng, PhD2, Charles Aloe,
MPH1, Wayne G. Shreffler, MD PhD FAAAAI3,4, Mary Krevans,
RN5, Karol A. Hagberg, BSN FNP5, Peter S. Thorne, PhD6 and
Elizabeth Matsui, MD1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD,
3
Massachusetts General Hospital, Boston, MA, 4Harvard Medical
School, Boston, MA, 5The Jackson Laboratory, Bar Harbor, ME,
6
University of Iowa, Iowa City, IA
Effect of Dermatophagoides Pteronyssinus Allergens On Expression of Genes Involved in Inflammation and Tissue Remodeling by Peripheral Blood Mononuclear Cells of Allergic
Asthma Patients
Krzysztof Kowal, MD PhD1, Pawel Bernatowicz, MD2, Lech
Chyczewski, MD, PhD2 and Anna Bodzenta Lukaszyk, PhD2,
1
Medical University of Bialystok, Bialystok, Poland, 2Medical University of Bialystok
510
Best of HEDQ
3805
511
Best of FADDA
3804
506
507
508
509
Increased Prevalence of Compound Heterozygous Filaggrin

Mutations in Severe Atopic Dermatitis in the United States
Maaz Mohiuddin, MD1, Preveen Ramamoorthy, PhD2, Paul R.
Reynolds, PhD2, Douglas Curran-Everett, PhD3 and Donald Y.M.
Leung, MD, PhD1, 1Department of Pediatrics, Division of Allergy-Immunology, National Jewish Health, Denver, CO, 2Department of Medicine, Division of Pathology, National Jewish Health,
Denver, CO, 3National Jewish Health, Division of Biostatistics
and Bioinformatics, Denver, CO
Smad-3 Deficient Mice Have Reduced Esophageal Fibrosis in a
Model of Eosinophilic Esophagitis
Ashmi Doshi, MD1, JaeYoun Cho, MD, PhD1, Peter Rosenthal1,
Seema Sharma Aceves, MD PhD FAAAAI2 and David H. Broide,
MB ChB FAAAAI3, 1University of California, San Diego,
2
UCSD, Department of Pediatrics, La Jolla, CA, 3Division of Allergy, Immunology
Double-Blind Placebo Controlled (DBPC) Trial of Dapsone in
Antihistamine Refractory Chronic Idiopathic Urticaria (CIU)
Andrew J. Cooke, MD, University of Texas Southwestern, Dallas,
TX, Matt Morgan, MD, FAAAAI, Allergy, Asthma and Immunology of North TX, Allen, TX, Laura Rogers, MD, University of
Texas Southwestern, Chicago, IL, Beverley Huet-Adams, MS,
University of Texas Southwestern Medical Center, Dallas, TX
and David A. Khan, MD FAAAAI, University Texas SW Medical
Center, Dallas, TX
Clinical Factors and Laboratory Correlates of Egg Allergy Resolution in a Cohort of Infants with Egg Allergy (COFAR)
Scott H. Sicherer, MD, FAAAAI1, Robert A. Wood, MD,
FAAAAI2, Brian P. Vickery, MD, FAAAAI3, David Mark Fleischer,
MD, FAAAAI4, Stacie M. Jones, MD5, Alice Henning6, A. Wesley
Burks, MD, FAAAAI7, Andrew H. Liu, MD, FAAAAI8, Alexander
V. Grishin, PhD1, Lloyd F. Mayer, MD9, Donald Stablein6 and

Hugh A. Sampson, MD, FAAAAI10, 1Mt. Sinai School of Medicine, New York, NY, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3University of North Carolina at Chapel
Hill, Chapel Hill, NC, 4National Jewish Health, Denver, CO,
5
Slot 512-13, University of Arkansas for Medical Sciences, Little
Rock, AR, 6EMMES Corporation, Rockville, MD, 7Division of Pediatric Allergy, Immunology, Rheumatology, and Infectious Disease, University of North Carolina, Chapel Hill, NC, 8National
Jewish Medical Research Center, Denver, CO, 9Mt. Sinai Medical
Center, New York, NY, 10Mount Sinai School of Medicine, New
York, NY
Activation of the Steroidogenic Enzyme Cyp11a1 Is Essential
for Development of Peanut-Induced Intestinal Anaphylaxis
Meiqin Wang, MD, PhD, Julita Ramirez, PhD, Junyan Han, PhD,
Yi Jia, PhD, Joanne Domenico, BS, Max Seibold, PhD, James Hagman, PhD and Erwin W. Gelfand, MD, National Jewish Health,
Denver, CO
512
513
514
515
Anaphylaxis Deaths in Ontario: A Retrospective Review of

Cases From 1986 to 2011
Ya Sophia Xu, FRCPC, McMaster University, Hamilton, ON,
Canada, Susan Waserman, MD, FAAAAI, Department of Medicine,
McMaster University, Hamilton, ON, Canada and Monika Kastner,
PhD, University of Toronto, Toronto, ON, Canada
Reduced Prevalence of Allergic Disease in Foreign Born American Children Is Reversed After US Residence
Jonathan I. Silverberg, MD, PhD, MPH, St. Lukes-Roosevelt
Hospital Center, New York, NY, Eric Simpson, MD, MCR,
OHSU, Helen G. Durkin, PhD, SUNY Downstate Medical Center,
Center for Allergy and Asthma Research, Brooklyn, NY and Rauno
O. Joks, MD, FAAAAI, SUNY-HSC, Brooklyn, NY
Poor Asthma Control Results in Decreased Productivity and
More Exacerbations
Patrick W. Sullivan, PhD1, David Magid, MD, MPH2, Jon Campbell, PhD3, Gary Globe, PhD4, Vahram Ghushchyan, PhD3, Karen
Smith, B.S. Pharm, PhD1, Bruce G. Bender, PhD, FAAAAI5 and
Shao-Lee Lin, MD, FAAAAI4, 1Regis University, 2Kaiser Permanente Colorado, 3University of Colorado Denver, 4Amgen, Inc.,
Thousand Oaks, CA, 5National Jewish Health, Denver, CO
Evidence-Based Standardized Order Set (EBSOS) Improves
Adherence to National Asthma Guidelines (NAG) for Treatment
of Children Presenting to the Pediatric Emergency Department
(PED) in Status Asthmaticus (SA)
Moira E. Breslin, MD1, Andrew Miller2, Leslie Claracay, MD3
and James Fox, MD3, 1Duke University Medical Center, Durham,
2
Duke University Medical Center, Department of Respiratory
Care Services, Durham, NC, 3Duke University Medical Center,
Durham, NC
Long Term Mortality in Young Adults with Asthma and Allergic Disease: Results From the Nhanes I Epidemiologic Follow
up Study
Jessica Savage, MD, MHS1, Elizabeth Matsui, MD2, Meredith C.
McCormack, MD3, Robert A. Wood, MD, FAAAAI2 and Corinne
Keet, MD, MS4, 1Brigham and Womens Hospital, Division of
Rheumatology, Immunology and Allergy, Boston, MA, 2Johns
Hopkins University School of Medicine, Baltimore, MD, 3Johns
Hopkins Pulmonary, Baltimore, MD, 4Pediatrics, Johns Hopkins
MONDAY
503
117
AB272 Abstracts

FEBRUARY 2013
Immunotherapy: Pathophysiology and Clinical

Efficacy
3806
516
517
518
519
MONDAY
520
Epicutaneous Immunotherapy Prevents Further Sensitization

to Peanut in a Model of Mice Sensitized to Milk
Lucie Mondoulet1, Vincent Dioszeghy, PhD2, Emilie Puteaux2,
Melanie Ligouis2, Veronique Dhelft2, Christophe Dupont, MD,
PhD3 and Pierre Henri Benhamou, MD4, 1DBV Technologies, Bagneux, France, 2DBV Technologies, France, 3Universite Paris V
Rene Descartes, Paris, France, 4DBV Technologies, Paris, France
Immunotherapy-Induced Regulatory T Cells in Mice Sensitized
to Peanut: Epicutaneous Vs Sublingual
Vincent Dioszeghy, PhD1, Lucie Mondoulet2, Veronique Dhelft1,
Melanie Ligouis1, Emilie Puteaux1, Christophe Dupont, MD,
PhD3 and Pierre Henri Benhamou, MD4, 1DBV Technologies,
France, 2DBV Technologies, Bagneux, France, 3Universite Paris
V Rene Descartes, Paris, France, 4DBV Technologies, Paris, France
IL-35+ Regulatory T Cells Suppress Grass Pollen-Driven Th2
Responses and Are Induced Following Grass Pollen-Specific
Sublingual Immunotherapy
Mohamed Shamji, PhD.CS1,2, Janice Layhadi, BSc( Hons)1,2,
Alan Perera-web, BSc( Hons)1,2, Guy Scadding, MRCP1,2 and Stephen R. Durham, MA, MD, FRCP2, 1Imperial College London,
2
Medical Research Council and Asthma UK Centre for Allergic
Mechanisms of Asthma, UK
A Randomized, Double-Blind, Placebo-Controlled, Parallel
Trial of Standardized Short Ragweed (RW) Sublingual Allergy
Immunotherapy Liquid Extract (RW-SAIL) in Adult Subjects
with Ragweed-Induced Allergic Rhinoconjunctivitis
Peter Creticos, MD1,2, Robert E. Esch, PhD, FAAAAI3, Peter
Couroux, MD4, Deborah A. Gentile, MD5, Pina DAngelo, PhD6,
Brad Whitlow, BS3, Michael Alexander, MD7 and Terrance Coyne,
MD3, 1Creticos Research Group, Crownsville, MD, 2Allergy &
Asthma Specialists Greater Washington, Warrenton, VA, 3Greer
Laboratories, Inc, Lenoir, NC, 4Topstone Research, Toronto,
ON, Canada, 5Temple University School of medicine, Allegheny
General Hospital, 6PRACS Institute, Mississauga, ON, Canada,
7
Niagara Clinical Research Inc, Niagara Falls, ON, Canada
Two Year Persistent Treatment Effect Achieved After 4 Doses of
Cat-Peptide Antigen Desensitization (Cat-PAD) in an Environmental Exposure Chamber (EEC) Model of Cat Allergy
Rod Hafner, PhD, Circassia, Oxford, United Kingdom, Peter Couroux,
MD, Cetero Research, Missisauga, ON, Canada, Kristen Armstrong,
Adiga Life Sciences Inc., Hamilton, ON, Canada, Deepen Patel, Cetero
Research, Mississauga, ON, Canada and Mark Larche, PhD, McMaster
University/St. Josephs Healthcare, Hamilton, ON, Canada
523
524
525
MS3, Loretha Meyers3, Marc Halushka, MD3, Maria Oliva-Hemker,

MD3, Robert A. Wood, MD, FAAAAI2 and Harry Dietz, MD3, 1Pediatrics, Johns Hopkins University School of Medicine, Baltimore,
MD, 2Johns Hopkins University School of Medicine, Baltimore,
MD, 3Johns Hopkins University School of Medicine
The Notch Mediator RBP-J in CD4 T Cells Plays a Crucial Role
in the Induction of Allergic Asthma in Mice
Alex KleinJan1, Marjolein de Bruijn1, Menno van Nimwegen1, Ingrid Bergen1, Henk C. Hoogsteden1, Derk Amsen2 and Rudi W.
Hendriks1, 1Erasmus MC, Rotterdam, Netherlands, 2AMC, Amsterdam, Netherlands
Relationships Among FceRI Expression, IgE, Allergic Sensitization and Recurrent Wheezing in Preschool Inner City Children
Daniel J. Jackson, MD1, Mark DeVries2, Katy Jaffee3, Gordon R.
Bloomberg, MD, FAAAAI4, Meyer Kattan, MD5, George T. OConnor, MD6, Robert A. Wood, MD, FAAAAI7 and James Gern, MD,
FAAAAI2, 1Pediatrics, University of Wisconsin School of Medicine
and Public Health, Madison, WI, 2University of Wisconsin School of
Medicine and Public Health, Madison, WI, 3Rho, Inc., Chapel Hill,
NC, 4Campus Box 8116, St. Louis Childrens Hospital, Saint Louis,
MO, 5NewYork-Presbyterian/Columbia, New York, NY, 6Boston
University School of Medicine, Boston, MA, 7Johns Hopkins University School of Medicine, Baltimore, MD
Vitamin D Decreases the Protein Expression of Suppressors of
Cytokine Signaling in the Lungs of Murine Model of Allergic
Airway Inflammation
Ankita Aggarwal1, Vikash Kansal2, Christian Andreen2 and Devendra K. Agrawal2, 1Center for Clinical and Translational Science and
Department of Medical Microbiology and Immunology, Creighton
University School of Medicine, Omaha, NE, 2Center for Clinical
and Translational Science and Department of Biomedical Sciences,
Creighton University School of Medicine, Omaha, NE
Allied Health Featured Poster

3811
526
Evaluation of a Food Allergy Education Module Delivered Live

for Illinois Schoolteachers
Christine Szychlinski, MS, APN, CPNP1, Katherine A. Schmeissing, MS, R.N.2, Ruchi Gupta, MD2, Claudia Lau1 and Jacqueline
Pongracic, MD, FAAAAI1, 1Ann & Robert H Lurie Childrens Hospital of Chicago, Chicago, IL, 2Ann & Robert H. Lurie Childrens
Hospital of Chicago, Chicago, IL
Nature Vs. Nurture in Asthma

4201
Monday, February 25th, 2013, 9:45 AM - 10:45 AM
Mechanisms of Allergy: Best of the Best

3807
521
522
118
Skin Mast Cells Acquire IgE by Directly Sampling the Blood

Laurence E. Cheng, MD, PhD, UCSFMedical Center, San Francisco, CA, Axel Roers, University of Technology Dresden, Dresden, Germany, Max Krummel, PhD, University of California San
Francisco, San Francisco, CA and Richard M. Locksley, MD, University of California - San Francisco, HHMI, San Francisco, CA
A Mendelian Presentation of Multiple TH2-Mediated Allergic
Diseases
Pamela A. Frischmeyer-Guerrerio, MD, PhD1, Anthony Guerrerio, MD, PhD2, Gretchen Oswald, MS3, Kristin Chichester,
527
528
Maternal Supplementary Vitamin Intake During Lactation Is

Positively Associated with the Cumulative Incidence of Bronchial Asthma in Their Infants in Japan
Miwa Shinohara, MD, PhD1,2, Hirohisa Saito, MD, PhD3 and
Kenji Matsumoto, MD, PhD3, 1Department of Pediatric Allergy
and Clinical Research, Shimoshizu National Hospital, Yotsukaido,
Japan, 2Department of Pediatrics, Kochi Medical University, Namgoku, 3Department of Allergy and Immunology, National Research
Institute for Child Health and Development, Tokyo, Japan
Association Between Weight Gain and the Prevalence and Severity of Wheezing and Asthma in the First Year of Life
Gustavo Wandalsen, MD1, Leila Borges2, Nathalia Barroso2, Fabiola Suano2, Elaine Prestes3, Herberto J. Chong Neto, MD, PhD,
Abstracts AB273

530
531
532
533
534
Seoul, 4Research Center for Standardization of Allergic Diseases,

Department of Pediatrics, Korea Cancer Center Hospital, Seoul,
South Korea, 6Childhood Asthma Atopy Center, Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
The Impact of Ethnicity On Incidence Rates for Development of
Allergic Disease in Immigrants to Brooklyn
Edward Kleiman, MD, Maria-Anna Vastradi, MD, Irina Katayeva,
MD and Rauno O. Joks, MD, FAAAAI, SUNY Downstate Medical
Center, Center for Allergy and Asthma Research, Brooklyn, NY
The Identification of Associations Between the Expression of
TGF Beta 1 and the Level of Asthma Control in the Polish
Asthma Population - Pilot Study
Michal Gabriel Panek, MD, PhD1, Tadeusz Pietras, MD, PhD2,
Artur Fabijan3, Lukasz Wieteska, MA4, Michal Chojnacki, MA4,
Pawel Gorski, MD, PhD2, Janusz Szemraj, MD, PhD4 and Piotr
Kuna, MD, PhD1, 1Department of Internal Medicine, Asthma and
Allergy, Medical University of Lodz, Poland, 2Department of Pneumology and Allergology, Medical University of Lodz, Poland, 3Students Research Group at the Department of Pneumology and
Allergology, Medical University of Lodz, Poland, 4Department of
Medical Biochemistry, Medical University of Lodz, Poland
Asthma and Risk of Community-Acquired Blood Stream
Infection Caused by Escherichia Coli: A Population-Based
Case-Control Study
Hyeon Jong Jong Yang, MD1, Duk Won Bang2, Eell Ryoo3, Larry
Baddour2, Majdi Al-Hasan4, Barbara Yawn, MD, MSc, FAAFP5
and Young J. Juhn, MD, MPH6, 1Soonchunhyang University Hospital, Seoul, 2Mayo Clinic, 3Gil Hospital, South Korea, 4University of
Kentucky Medical Center, 5Olmsted Medical Center, Rochester,
MN, 6Mayo Clinic, Rochester, MN
Effect of Breastfeeding On Lung Function of Asthmatic Children
Hwan Soo Kim, MD1, Yoon Ki Han, MD2, Min Jung Kim, MD2,
Hyun Bin Park, MD1, Yoon Hee Kim, MD3, Hee Seon Lee, MD3,
Hyun Hee Lee, MD, PhD4, Kyung Won Kim, MD, PhD2, Myung
Hyun Sohn, MD, PhD2 and Kyu-Earn Kim, MD, PhD2, 1Yonsei
University College of Medicine, 2Yonsei University College of
Medicine, Seoul, Korea, 3Yonsei University College of Medicine,
Seoul, 4Kwandong University College of Medicine, Seoul
Characteristics and Prognosis of Phenotypic Clusters in Childhood Asthma: A Population Based School-Aged Cohort
Ji-Won Kwon, MD1, Young Ho Jung, MD2,3, Eun Lee2, HyungYoung Kim2, Ju-Hee Seo, MD4, Byoung-Ju Kim, MD, PhD5,
Hyo-Bin Kim, MD, PhD6, So-Yeon Lee7, Jinho Yu, MD, PhD2,3,
Ho-Jang Kwon, MD, PhD8 and Soo-Jong Hong, MD, PhD2,3, 1Department of Pediatrics, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam,
South Korea, 2Childhood Asthma Atopy Center, Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea, 3Research Center for Standardization of
Allergic Disease, Seoul, South Korea, 4Department of Pediatrics,
Korea Cancer Center Hospital, Seoul, South Korea, 5Department
of Pediatrics, Hae-undae Paik Hospital, Inje University College of
Medicine, Busan, South Korea, 6Inje University Sanggye Paik Hospital, Seoul, 7Department of Pediatrics, Hallym University College
of Medicine, 8Dankook University, Cheonan
5
535
536
537
538
539
MONDAY
529
FAAAAI4, Nelson A. Rosario, MD, PhD, FAAAAI5, Ana Carolina

Dela Bianca6, Carolina Aranda1, Decio Medeiros6, Emanuel Sarinho6, Lillian SANCHEZ LACERDA Moraes, MD, MSc7, Javier
Mallol8 and Dirceu Sole, MD, PhD1, 1Federal University of Sao
Paulo, Sao Paulo, Brazil, 2Federal University of Sao Paulo, 3State
University of Para, 4Federal University of Parana, Brazil, 5Federal
University of Parana, Curitiba, Brazil, 6Federal University of Pernambuco, 7Federal University of Mato Grosso, 8University of Santiago de Chile
High Asthma Prevalence Among Inner-City Schoolchildren in
Antananarivo (Madagascar)
Peter Th. Wolff, MD1, Lala Arison, MD2, Abel Rahajamiakatra,
MD2, Francis Raserijaona, MD2 and Bodo Niggemann, MD,
FAAAAI3, 1Pediatric Practice am Stadtsee, Pfullendorf, Germany,
2
Clinique MM 24/24 Mpitsabo Mikambana, Antananarivo, Madagascar, 3Hedwig-Von-Rittberg-Zentrum, Berlin, Germany
The Association of Obesity and Severity of Acute Asthma Exacerbations in Children
Michelle J. De Vera, MD, FAAAAI and Maria Celeste Gomez,
MD, The Medical City Hospital, Pasig City, Philippines
The Role of Chitinase-Like Protein YKL-40 in Childhood Asthma
Carah Santos, MD, Joshua Davidson, MD, Ronina Covar, MD, Eleanor Brown, BS and Joseph D. Spahn, MD, National Jewish Health,
Denver, CO
Vitamin D Levels and FoxP3 Treg Cells Expression in North Indian Children with Atopic Diseases
Anil Chauhan1, Meenu Singh, MD2, Savita Attri1 and Amit Agarwal1,
1
Post Graduate Institute of Medical Education and Research,
Chandigarh, India, 2Advanced Pediatrics Centre, Chandigarh, India
Envirionment-Environment Interactions Between Bronchiolitis
and PM10 Exposure Could Be Modified by the TLR4 Polymorphism in the Development of Asthma
Young Ho Jung, MD1,2, Byoung-Ju Kim, MD, PhD3, Ju-Hee Seo,
MD4, Ji-Won Kwon, MD5, Hyo-Bin Kim, MD, PhD6, So Yeon
Lee, MD, PhD7, Gwang Cheon Jang, MD, PhD8, Dae Jin Song,
MD, PhD9, Woo-Kyung Kim, MD, PhD6, Jung Yeon Shim, MD,
PhD10, Hwan-Cheol Kim, MD11, Jong-Han Leem, MD11, Hyung
Young Kim, MD12,13 and Soo-Jong Hong, MD, PhD1,2, 1Childhood
Asthma Atopy Center, Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea,
2
Research Center for Standardization of Allergic Disease, Seoul,
South Korea, 3Department of Pediatrics, Hae-undae Paik Hospital,
Inje University College of Medicine, Busan, South Korea, 4Department of Pediatrics, Korea Cancer Center Hospital, Seoul, South
Korea, 5Department of Pediatrics, Seoul National University Bundang Hospital, Seoul National University College of Medicine,
Seongnam, South Korea, 6Inje University Sanggye Paik Hospital,
Seoul, 7Department of Pediatrics, Hallym University College of
Medicine, 8Department of Pediatrics, National Health Insurance Corporation Ilsan Hospital, 9Department of Pediatrics, Korea University
Guro Hospital, 10Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine, 11Department
of Occupational and Environmental Medicine, Inha University Hospital, 12Childhood Asthma Atopy Center, Department of Pediatrics,
13
Research Center for Standardization of Allergic Diseases
Changes of Sensitization to Pollen Allergens in Children with
Allergic Disease of Seoul Area Over the Last 10 Years
Keum Hee Hwang1, Young Ho Jung, MD2, kyung Hee Kim1, Min
Ju Kim1, Geun Mi Park3, Hyung Young Kim, MD1,4, Ju-Hee Seo,
MD5, Jinho Yu, MD, PhD6 and Soo-Jong Hong, MD, PhD6, 1Childhood Asthma Atopy Center, Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, 2Department
of Pediatrics, Childhood Asthma Atopy Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea,
3
Childhood Asthma Atopy Center, Department of Pediatrics,
Immunodeficiency
4202
540
Identification of TLR3 and PTPN22 Mutations in One Cohort

with Chronic Mucocutaneous Candidiasis (CMC)
119
AB274 Abstracts
541
542
543
544
545
MONDAY
546
547
548
549
120
Samantha Gendelman, MD, Yingchun Han and Fred H. Hsieh,

MD, Cleveland Clinic Foundation, Cleveland, OH
Pneumococcal Meningitis in a Patient with Irak-4 Deficiency: A
Case of Failed Prophylactic Therapy
Meredith A. Dilley1,2, Stacie M. Jones, MD1,2, Amy M. Scurlock,
MD1,2, Tamara T. Perry, MD1,2 and Robbie D. Pesek1,2, 1University
of Arkansas for Medical Sciences, Little Rock, AR, 2Arkansas Childrens Hospital
Hypogammaglobulinemia with Adequate Pneumococcal Antibody Response Progressing to Common Variable Immunodeficiency (CVID)
Tania Aung, MD, University of Iowa Hosptals and Clinics, Iowa
City, IA, Antoine Azar, MD, FAAAAI, University of Iowa Hospitals and Clinics and Zuhair K. Ballas, MD, FAAAAI, University
of Iowa Health Care, Iowa City, IA
Successful Lung Transplantation in a CVID Patient with Recalcitrant Bronchiectasis
Heena Shah, MD and Prem Kumar, MD, FAAAAI, Louisiana State
University, New Orleans, LA
Disseminated Aspergillosis in Adult-Onset Severe Combined
Immunodeficiency: A Case of Xcind Syndrome
Kellie J. Lim, MD, UCLA, Department of Pediatrics, Division of
Allergy and Immunology, Los Angeles, CA, E. Richard Stiehm,
MD, FAAAAI, Division of Allergy and Immunology, Department
of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, Richard Gatti, MD, UCLA, Department of Pathology &
Laboratory Medicine and Otto Yang, MD, UCLA, Department of
Medicine, Division of Infectious Disease
Abnormalities in CD4 and CD8 Lymphocyte Subpopulations in
Patients with Common Variable Immunodeficiency
Amanda J. Seba, Norma de Paula Motta Rubini, Albertina
Varandas Capelo, Eliane Miranda da Silva, Fernando Samuel
Sion, Clety Larissa Angulo Llerena and Carlos Alberto Moraisde-Sa, Federal University of the State of Rio de Janeiro, Rio de
Janeiro, Brazil
Experience with a 20% Subcutaneous Immunoglobulin (Hizentra) in Children with Primary Immunodeficiency Diseases - A
Single-Center Review
Rebecca Gregory1, Clare Malcolmson1, Chetan Patel1, Terry
Woolley2 and Alison Jones1, 1Great Ormond Street Hospital, London, United Kingdom, 2CSL Behring, West Sussex, United
Kingdom
Correction of Signal Transduction and Activator of Transcription 3 (STAT3) Function in an Adolescent with Autosomal
Dominant Hyper-IgE Syndrome (AD-HIES) Following Hematopoietic Stem Cell Transplantation (HSCT)
Joel L. Gallagher1, Andrew Gilman1, Troy R. Torgerson, MD,
PhD2 and Niraj C. Patel, MD1, 1Levine Childrens Hospital at Carolinas Medical Center, Charlotte, NC, 2University of Washington
School of Medicine and Seattle Childrens Hospital, Seattle, WA
Patient Satisfaction with 20% Subcutaneous Immunoglobulin
(Hizentra) Treatment: Results From a Single-Center Study
in Children with Immunodeficiencies
Clare Malcolmson1, Rebecca Gregory1, Chetan Patel1, Zoya Panahloo2 and Alison Jones1, 1Great Ormond Street Hospital, London,
United Kingdom, 2CSL Behring UK Ltd, Haywards Heath, United
Kingdom
Adverse Reactions Related to Endovenous Human Immunoglobulin Infusion for the Treatment of Patients with Primary
Immudeficiency
Flavio Sano, MD1, Danielli Christinni Bichuete-Silva, MD1,
Fernanda Furlan, MD1, Anna Tereza Negrini Fagundes, MD1, Fernanda Aimee Nobre, MD1, Camila Teles Machado Pereira, MD1,
Tessa Rachel Tranquilini Goncalves, MD1, Mariana Gouveia-Pereira, MD1, Rafael Rota, MD1 and Beatriz Tavares Costa-Carvalho,
MD2, 1Federal University of Sao Paulo, Sao Paulo, Brazil, 2Federal
University of Sao Paulo, Brazil

FEBRUARY 2013
550
551
552
553
554
555
556
557
The Spectrum of Primary Immunodeficiency Diseases in A

Saudi Tertiary Care Hospital Over Two Years
Bandar Al-Saud, MD1,2, S Al-Muhsen, MD3,4, A Al-Ghonaium,
MD1, S Al Gazlan, MD5, H Al-Dhekri, MD3, R Arnaout, MD3,
A Al-Seraihy, MD6, N Elsayed7, M Shoukri, PhD8, J Afzal, MD9
and H Al-Mousa, MD2,3, 1King Faisal Specialist Hospital & Research Center, 2Alfaisal University, College of Medicine, 3Pediatric,
King Faisal Specialist Hospital & Research Center, 4King Saud
University, College of Medicine, Riyadh, Saudi Arabia, 5Madicine,King Faisal Specialist Hospital & Research Center, 6Pediatric
Hematology/Oncology King Faisal Specialist Hospital & Research
Center, 7Nursing Affairs, King Faisal Specialist Hospital & Research Center, 8Biostatistics, Epidemiology & Scientific Computing
King Faisal Specialist Hospital & Research Center, 9Biostatistics,
Epidemiology & Scientific Computing, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Shift in Patterns in Previous Immunoglobulin Therapy Use in
Patients Prescribed 20% Subcutaneous Immunoglobulin
Marc Botteman, MSc, Pharmerit International, Bethesda, MD, Art
Zbrozek, CSL Behring LLC, King of Prussia, PA, Ann Bullinger,
PharmD, CSL Behring, King of Prussia, PA and Alan P. Baptist, MD,
MPH, University of Michigan, Division of Allergy, Ann Arbor, MI
Immunologists Attitudes On "Wear-off" Effects of IgG Replacement Therapy for Primary Immunodeficiency Disease
(PIDD) Patients
Mark Ballow, MD, FAAAAI, SUNY Buffalo, Sarasota, FL,
Ann Bullinger, PharmD, CSL Behring, King of Prussia, PA, Elyse
A. Murphy, RN, CSL Behring, Vienna, VA and Melvin Berger, MD,
PhD, FAAAAI, CSL Behring, LLC, King of Prussia, PA
Long-Term Efficacy and Tolerability of 20% Scig in the Treatment of Patients with Primary Immunodeficiency Disease
Michael Borte, Academic Teaching Hospital of the University of
Leipzig, Germany, Richard L. Wasserman, MD, PhD, FAAAAI, Allergy/Immunology Research Center of North Texas, Dallas, TX,
Mikhail Rojavin, PhD, Clinical Research and Development, CSL
Behring LLC, King of Prussia, PA, Martin Bexon, MD, CSL
Behring AG, Bern 22, Switzerland and Stephen Jolles, University
Hospital of Wales, Cardiff, United Kingdom
Sickle Cell Disease and Poor Response to Pneumococcal Vaccination
Elizabeth Bertucci, MD, Tulane School of Medicine and Ochsner
Medical Center, New Orleans, LA, Jane M. El-Dahr, MD, FAAAAI,
Tulane University Health Sciences Center, New Orleans, LA and Julie Kanter-Washko, Tulane University School of Medicine
A Pediatric Case of Hypogammaglobinemia in a Patient with
Fanconi Anemia: A Case Report and Review of the Literature
Julia A. Savitz, MD, Walter Reed, potomac, MD and Barabara
Martinez, MD, Walter Reed
MBL Polymorphisms in a US Cohort of Children with Recurrent Infection
Catherine Kubiak, MD, John Sleasman, MD and Morna J. Dorsey,
MD, MMSc, FAAAAI, USF/All Childrens Hospital, St Petersburg, FL
Clinical and Immunological Features of Four Patients with
X-Linked Lymphoproliferative Disease (XLP) Presenting
Over a One-Year Period, Including a Novel Mutation in the
SH2D1A Gene
Luke Wall, MD and Kenneth Paris, MD, MPH, LSUHSC, New
Orleans, LA
Immunogenetics, Immunodeficiency
4203
558
First-in-Human Study of REGN668/SAR231893 (IL-4Ra

mAb): Safety, Tolerability and Biomarker Results of a
Abstracts AB275

560
561
562
563
564
565
567
568
569
570
571
Asthma and Allergy Epidemiology II

4205
572
Asthma and Epidemiology I

4204
566
Characteristics of Allergic Sensitization Among Adult Asthmatics Older Than 55 Years: Results From the National Health
and Nutrition Examination Survey 2005-2006
Paula Busse, MD, FAAAAI1, Richard Cohn, PhD2, Paivi M. Salo,
PhD3 and Darryl C. Zeldin, MD3, 1Mount Sinai School of
Medicine, New York, NY, 2SRA International, Inc, Durham, NC,

NIEHS, Research Triangle Park, NC
Comparison of Four Different Skin Prick Test Devices in Allergic and Non-Allergic Subjects
Timothy J. Campbell, MD, Kathy Caruso, RN, Susan Golubski,
LPN, Stephanie Slattery, RN and Alton Lee Melton Jr., MD, Cleveland Clinic
Increases in Ocular and Nasal Symptoms in the United States in
All Age Groups: Analysis of National Health and Nutrition Examination Survey (NHANES) Database (1976-1994)
Panagiotis Koutsoupias, Rutgers University Center for Environmental Prediction, Qingyu Meng, PhD, UMDNJ - School of Public
Health and Leonard Bielory, MD, FAAAAI, Robert Wood Johnson
University Hospital, New Brunswick, NJ; Rutgers University, New
Brunswick, NJ; STARx Allergy and Asthma Center, Springfield, NJ
Assessment of Health Literacy and Asthma Outcomes in the
Primary Care Setting
Mark Stevens, MD, University of Iowa College of Medicine, Iowa
City, IA, M. Bridget Zimmerman, PhD, Department of Biostatistics,
College of Public Health, University of Iowa, Iowa City, IA and
Mary Beth Fasano, MD, FAAAAI, C42-E6 GH, University of
Iowa College Medicine, Iowa City, IA
Theres an App for That: A Pilot and Feasibility Study of
Mobile-Based Asthma Action Plans
AJ Burbank1,2, J Hall-Barrow1, RR Denman1,2, SD Lewis1,
M Hewes1, D E Schellhase1,2, M Rettiganti1,2, C Luo1,2,
L A Bylander1,2, R H Brown1,2 and T T Perry1,2, 1University of Arkansas for Medical Sciences, Little Rock, AR, 2Arkansas Childrens
Hospital, Little Rock, AR
Increases in Allergen Sensitivity by United States Region: Analysis of National Health and Nutrition Examination Survey
(NHANES) Database (1976-1994)
Qingyu Meng, PhD, UMDNJ - School of Public Health, Panagiotis
Koutsoupias, Rutgers University Center for Environmental Prediction and Leonard Bielory, MD FAAAAI, Robert Wood Johnson
University Hospital, New Brunswick, NJ; Rutgers University,
New Brunswick, NJ; STARx Allergy and Asthma Center, Springfield, NJ
3
573
An Analysis of Asthma Exacerbations and Weather Conditions

in Chuncheon
Jae-Woo Kwon1, Young-Ji Han2, Moo Kyung Oh3, Chang
Ryul Lee4, Seon-Sook Han5, Seung-Joon Lee5 and Woo Jin
Kim5, 1Division of Allergy and Clinical Immunology, Department
of Internal Medicine, Kangwon National University College of
Medicine, Chuncheon, South Korea, 2Department of Environmental
Science, Kangwon National University, Chuncheon, South Korea,
3
Department of Health Policy and Management, Kangwon National
University, Chuncheon, South Korea, 4Department of Internal Medicine, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, South Korea, 5Division of
Pulmonology, Department of Internal Medicine, Kangwon National
University College of Medicine, Chuncheon, South Korea
Implications of Serum Specific Immunoglobulin E for the Progression From Autumn Pollen Induced Allergic Rhinitis to
Asthma
Le Cui, Department of Allergy, Peking Union Medical College
Hospital, Chinese Academy of Medical Science, Beijing, China
and Jia Yin, Department of Allergy, Peking Union Medical College
Hospital, Chinese Academy of Medical Science
MONDAY
559
Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers

Allen Radin, MD1, Haobo Ren, PhD2, Pamela Papino-Wood1,
Usman Chaudhry, PhD1 and Jennifer D. Hamilton, PhD1,
1
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 2Regeneron
Pharmaceuticals, Inc., Basking Ridge, NJ
Variation in the Management of C2 Deficiency in the USA: A
Need for Consensus?
Jordan K. Abbott, MD and Erwin W. Gelfand, MD, National Jewish Health, Denver, CO
Low Levels of Serum B-Cell Activating Factor (BAFF) Among
Humans with High IgE Reactivity to the Nematode Ascaris
Adriana P. Bornacelly1,2, Nathalie Acevedo1,2 and Luis Caraballo1,2, 1Institute for Immunological Research/University of Cartagena, Cartagena, Colombia, 2Foundation for the development of
medical and biological sciences, Cartagena, Colombia
Genetics of Periodic Fever, Aphthous Stomatitis, Pharyngitis,
Adenitis (PFAPA) Syndrome
Lori Broderick, MD, PhD1, Daniela Carvalho2, Anthony
Magit2, Wen Jiang2, Shelby Leuin2, Marcella Bothwell2, Donald
Kearns2, Seth Pransky2 and Hal M. Hoffman, MD, FAAAAI1,2,
1
University of California, San Diego, 2Rady Childrens Hospital-San Diego
Targeted Deep Resequencing of Thirteen Candidate Genes Reveals Novel Variants Determining Asthma Risk in Individuals of
African Ancestry
Rasika A. Mathias, ScD1, Lili Huang, MPH1, Li Gao, MD, PhD1,
Nicholas M. Rafaels, MS1, Candelaria I. Vergara, MD, PhD1, Ingo
Ruczinski, PhD2, Terri H Beaty, PhD2 and Kathleen C. Barnes,
PhD, FAAAAI1, 1Division of Allergy and Clinical Immunology,
Department of Medicine, Johns Hopkins University, Baltimore,
MD, 2Johns Hopkins Bloomberg School of Public Health, Johns
Hopkins University, Baltimore, MD
Novel Interleukin-7Ra (IL-7Ra) Mutations Causing Delayed
Onset Isolated T Cell Immunodeficiency Disease
Jean Brown, MD1, John Sleasman, MD2, Morna J. Dorsey, MD,
MMSc, FAAAAI2 and Panida Sriaroon, MD3, 1University of South
Florida, Tampa, FL, 2USF/All Childrens Hospital, St Petersburg,
FL, 3University of South Florida, Saint Petersburg, FL
Genetic Variations On IL10 Gene and Helicobacter Pylori
Infection
Shirleide Assis, MsC1, Cintia R Marques, MsC1, Ryan S Costa,
MsC1, Neuza M Alcantara-Neves, PhD1, Mauricio L Barreto,
PhD2, Kathleen C. Barnes, PhD, FAAAAI3 and Camila A Figueiredo, PhD1, 1Instituto de Ciências da Saude, Universidade Federal
da Bahia, Salvador, BA, Brazil, Brazil, 2Instituto de Saude Coletiva,
UFBa, Salvador, BA, Brazil, 3Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University,
Baltimore, MD
IBD Presenting Decades Prior to the Diagnosis of CVID
Anna Kochin, MD, Montefiore Medical Center, Bronx, NY and
Arye Rubinstein, MD, FAAAAI, Albert Einstein College of Medicine, Bronx, NY
121
AB276 Abstracts
574
575
576
577
578
579
MONDAY
580

FEBRUARY 2013
Differences in Allergen Exposures Between American Asthmatic and Nonasthmatic Homes

Jianfeng JM Meng, MD, Childrens Mercy Hospitals and Clinics,
Kansas City, MO; UMKC School of Medicine, Charles Barnes,
PhD, Childrens Mercy Hospital & Clinics, Kansas City, MO and
Lanny Rosenwasser, MD, FAAAAI, Childrens Mercy Hospital,
Kansas City, Kansas City, MO
Bronchial Asthma Correlates with Vitamin D Status of Adult
Women in North Jordan
Shaher M. Samrah, MBBS, FCCP, Ibrahim Khatib, Basheer
Khassawneh, MBBS, FCCP, Suleiman Momany, MBBS, FCCP
and Ammar K. Daoud, MD, FAAAAI, Faculty of Medicine, Jordan
University of Science and Technology (J.U.S.T), Irbid, Jordan
Prevalence of Sensitization to the Storage Mite Acarus Siro in
Middle-East of Brazil
Natasha R. Ferraroni, MD, PhD, Hospital de Base, Brasilia-DF,
Brazil; Clinim Alergoclnica, Brasilia-DF Brazil., Brasilia-DF, Brazil, Sabrina Oliveira, Biomedichal, Centro Universitario de Brasilia
- UniCEUB, Brasilia-DF, Brazil and Jose Joao Ferraroni, MD PhD,
Clinim Alergoclnica, Brasilia-DF, Brazil., Brasilia-DF, Brazil
Prevalence and Related Factors of Multiple Chemical Sensitivity in Patients Having Allergic Diseases
Jae-Hyun Lee, MD, PhD1, Inchul Jeong2 and Inah Kim2, 1Department of Internal Medicine, Yonsei University College of Medicine,
2
Graduate School of Public Health, Yonsei University
The Frequency of Pollen Hypersensitivity Among Children with
Bronchial Asthma and Allergic Rhinoconjunctivitis in Alexandria, Egypt
Dalia El-Ghoneimy, MD, PhD1, Zeinab El-Sayed1 and Ahmed
Aborahma2, 1Ain Shams University, 2Alexandria University
Indoor Environmental and Demographic Factors of Malaysian
Allergic Children
Aravind Yadav, MD1,2 and Rakesh Naidu1,3, 1University of
Malaya, Malaysia, 2Pediatric Pulmonary, University of Texas
Health Science (Houston), Houston, TX, 3School of Medicine and
Health Sciences, Monash University Sunway Campus, Malaysia
Determining the Prevalence of Mites in Kindergartens and
Childrens Room in Bogota
Gustavo Cuadros, MSc1, Maria M. Olivares, MD2, Libardo Rente~
MD3, Nidia Garzon, technician4, David
ria, MD3, Javier PeNuela,
Rodriguez, MD1, Enrique Fernandez-Caldas, PhD5 and Camila
Marquez, MD1, 1District Department of Health of Bogota, Bogota,
Colombia, 2group of Clinical and Experimental Allergy University
of Antioquia, MEDELLIN, Colombia, 3District Department of
Health of Bogota, BOGOTA, Colombia, 4District Department of
Health of Bogota, bogota, Colombia, 5Inmunotek, Madrid,
Spain
583
584
585
586
587
588
589
590
591
Drug Allergy I
4206
581
582
122
Delayed Reaction to Paclitaxel

Maria Alicia Urena Tavera, MD1, Denisse Angel2, Ricardo
Madrigal-Burgaleta, MD1, Pilar Berges, MD, PhD.1, Emilio
Alvarez-Cuesta, MD, PhD3 and Rafael Perez Arango4, 1Ramon y
Cajal University Hospital, Madrid, Spain, 2Hospital Universitario
Ramon y Cajal, 3Ramon & Cajal University Hospital, Madrid,
Spain, 4Ramon y Cajal Hospital
Desensitization to Methylprednisolone Succinate in a Patient
with Multiple Sclerosis
Denisse Angel Pereira, MD, Ricardo Madrigal-Burgaleta, MD, Pilar Berges, MD, PhD., Maria Alicia Urena Tavera, MD, Ximena
592
593
Rodrguez, MD and Emilio Alvarez-Cuesta, MD, PhD, Ramon y

Cajal University Hospital, Madrid, Spain
Allergy to Heparins and Their Cross-Reactivity
Patricia Martinez-Lezcano, MD1, Blanca Noguerado, MD2,
Rafael Pineda, MD3, Manuel De Barrio, MD3 and Pilar Tornero,
MD2, 1Hospital General Universitario Gregorio Mara~non, Madrid,
Spain, 2Hospital General Universitario Gregorio Mara~non, 3Hospital General Universitario Gregorio Mara~non, Madrid, Spain
Allergy Suspicion to Proton Pump Inhibitors - Taking Advantage of Cross-Reactivity
Diana Silva, Eunice Castro, MD and Josefina Cernadas, Servico de
Imunoalergologia, Centro Hospitalar S~ao Jo~ao E.P.E., Porto,
Portugal
Hypersensitivity Reactions to Taxanes and Platins
A. Gomez Infante, MD, J.M. Escobar Montalvo, MD, E. Alejo
Almanzar, MD, MA Jimenez Blanco, MD, A. Enriquez Matas,
MD, R. Vives Conesa, MD and R. Mielgo Ballesteros, MD, Hospital Universitario 12 de Octubre, Madrid, Spain
Oxaliplatin Hypersensitivity: Management and Comparison
with Carbo/Cisplatin
Morris Ling, MD1,2, Sarita U. Patil, MD2,3 and Johnson T. Wong,
MD, FAAAAI1,2, 1Massachusetts General Hospital, Boston, MA,
2
Harvard Medical School, Boston, MA, 3Allergy and Immunology,
Massachusetts General Hospital, Boston, MA
Hypersensitivity Reactions to Oxaliplatin: Outcomes of Premedication and Desensitization
Suh-Young Lee1,2, Mi-Yeong Kim1,2, Min-Hye Kim1,2,3,
Woo-Jung Song1,2, Hye-Ryun Kang1,2,3, Kyung-Up Min1,2 and
Sang Heon Cho, MD PhD2,3,4, 1Department of Internal Medicine,
Seoul National University College of Medicine, Seoul, Korea, 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea, 3Seoul National
University Hospital Regional Pharmacovigilance Center, 4Department of Internal Medicine, Seoul National University College of
Medicine, Seoul, South Korea
Successful Desensitization to Voriconazole
Ricardo D. Zwiener, MD1, Gustavo Marino2, Milagros Moreno
Danna2, Brodsky Tamara2 and Tisi Ba~na Matas2, 1Hospital Universitario Austral, Pilar, Argentina, 2Hospital Universitario Austral
Novel Echinocandin Desensitization in a Pediatric Patient with
Hypersensitivity to Micafungin
Stephanie L. Logsdon, MD, Childrens Hospital Boston, Boston,
MA and John Jhe-Yun Lee, MD, Childrens Hospital of Boston,
Needham, MA
Clinical Manifestations and Diagnostic Methods of Immediate
Hypersensitivity Reaction to Oral Cefaclor
Park Chan Sun1, Choi Gil soon2, Park Seung hyun1 and Lee Joo Won1,
1
Inje University, Haeundae Paik hospital, 2Kosin University gospel
hospital
DAP: New Products for Skin Tests Diagnosis of Penicillin Allergy
F. Javier Fernandez, MD, PhD1, Mara Jose Torres, MD, PhD2,
Julian Campos, Biologist3, Francisca Arribas-Poves, Pharmacist3,
Miguel Blanca, MD, PhD2 and Angel Vallverdu, MD3, 1UMH
Alicante G.University Hospital - Allergy Sect., Alicante, Spain,
2
Allergy Service, Carlos Haya Hospital, Malaga, Spain, 3Diater
Laboratory, Madrid, Spain
Aspirin Allergy in a VA Population: Is There Potential Benefit
for Evaluation in the Allergy Clinic?
Bhavisha Patel, MD1,2, Peter Mason, MD, MPH1,2, Sujani
Kakumanu, MD1,2 and Sameer K. Mathur, MD, PhD, FAAAAI1,2,
1
University of Wisconsin School of Medicine and Public Health,
Madison, WI, 2William S. Middleton Veterans Hospital, Madison,
WI
Rapid Outpatient Aspirin Desensitization/Challenge for Urticaria/Angioedema and AERD
Johnson T. Wong, MD, FAAAAI, Massachusetts General
594
595
596
597
598
599
600
Hospital, Boston, MA; Harvard Medical School, Boston, MA;

Newton-Wellesley Hospital, Newton, MA
Food Allergy Is Not A Risk Factor in Cross-Intolerance to
Nsaids for Induction of Symptoms
Francisca Gomez, MD, PhD1, Inmaculada Do~na, MD, PhD2,
Natalia Blanca-Lopez, MD, PhD3, Maria J Torres, MD, PhD2,
Maria Salas, MD, PhD4, Carmen Rondon, MD, PhD5, Paloma
Campo, MD, PhD5, Teresa Posadas2, Maria Auxiliadora Guerrero4,
Gabriela Canto, MD, PhD6 and Miguel Blanca, MD, PhD2,
1
IMABIS Foundation, Malaga, Spain, 2Allergy Service, Carlos
Haya Hospital, Malaga, Spain, 3Allergy Service, Infanta Leonor
Hospital, Madrid, Spain, 4Allergy Service, Carlos Haya Hospital,
Spain, 5Allergy Service, Carlos Haya Hospital, Malaga, Spain, 6Allergy Service, Infanta Leonor Hospital
Patients with Acute Urticaria/Angioedema to Nsaids Do Not
Evolve to Chronic Urticaria
Inmaculada Do~
na, MD, PhD1, Carmen Rondon, MD, PhD2, Paloma
Campo, MD, PhD2, Maria J Torres, MD, PhD1, Natalia
Blanca-L
opez, MD, PhD3, Francisca Gomez, MD PhD4, Maria Salas,
MD, PhD5, Maria Dolores Ruiz5, Gabriela Canto, MD, PhD6 and
Miguel Blanca, MD, PhD1, 1Allergy Service, Carlos Haya Hospital,
Malaga, Spain, 2Allergy Service, Carlos Haya Hospital, Malaga,
Spain, 3Allergy Service, Infanta Leonor Hospital, Madrid, Spain,
4
IMABIS Foundation, Malaga, Spain, 5Allergy Service, Carlos
Haya Hospital, Spain, 6Allergy Service, Infanta Leonor Hospital
Influence of the Basophil Selection Strategy and Death Cells
Exclusion in BAT for Nsaids Patients
Taha Fern
andez, PhD1, Ana Aranda, PhD1, Inmaculada Do~na,
2
MD, PhD , Maria J Torres, MD, PhD2, Lidia Melendez, Lab.
Tech.1, Maria I Monta~nez, PhD1, Enrique Gomez, PhD1, Miguel
Blanca, MD, PhD2 and Cristobalina Mayorga, PhD1,3, 1Research
Laboratory, Carlos Haya Hospital-FIMABIS, Malaga, Spain,
2
Allergy Service, Carlos Haya Hospital, Malaga, Spain, 3Pediatric
Service, Carlos Haya Hospital, Malaga, Spain
Non-Immediate Hypersensitivity Reactions to Non-Steroideal
Anti-Inflammatory Drugs (NSAIDs)
Rafael Pineda, MD, Patricia Martinez Lezcano, Tamara Fernandez, Gabriela Zambrano, Roberto Pelta and Manuel De Barrio,
MD, Hospital General Universitario Gregorio Mara~non, Madrid,
Spain
Drug Provocation Tests in the Diagnosis of Hypersensitivity Reactions to Non-Steroidal Anti-Inflamatory Drugs in Children
Maria Angeles Zambonino1, Mara Jose Torres, MD, PhD2,
Candelaria Mu~noz1, Gloria Requena1, Cristobalina Mayorga,
PhD1, Teresa Posadas2, Antonio Urda1, Miguel Blanca, MD,
PhD2 and Jose Luis Corzo Higueras, MD1, 1Pediatric Service, Carlos Haya Hospital, Malaga, Spain, 2Allergy Service, Carlos Haya
Association of Thymic Stromal Lymphopoietin Genetic Variants in Urticaria/Angioedema Induced by Multiple Nsaids
Maria del Carmen Plaza-Seron, Bsc1, Pedro Ayuso Parejo, PhD2,
Natalia Blanca-Lopez, MD, PhD2, Inmaculada Do~na, MD, PhD3,
Mara Jose Torres, MD, PhD4, Javier Fernandez5, Jose Julio
Laguna6, Veronique Goidenau4, Luisa Galindo, RN7, Rocio Herrera, NR8, Gabriela Canto, MD, PhD9, Miguel Blanca, MD,
PhD10 and Jose Antonio Cornejo-Garca4, 1Allergy Service, Infanta
Leonor Hospital, Malaga, Spain, 2Allergy Service, Infanta Leonor
Hospital, Madrid, Spain, 3IMABIS Foundation, Malaga, Spain,
4
Imabis Foundation, 5Alicante Hospital, 6Hospital De La Cruz
Roja, Madrid, Spain, 7Carlos Haya Hospital, Malaga, Spain,
8
Alergy Service Carlos Haya Hospital, Malaga, Spain, 9Allergy
Service, Infanta Leonor Hospital, 10Allergy Service, Carlos Haya
Association Study of Functional Polymorphisms in Genes Involved in Histamine Homeostasis and Multiple NSAIDTriggered Urticaria and/or Angioedema and Anaphylaxis in
Patients without Pre-Existing Chronic Urticaria (MNSAID-UA)
601
602
603
604
605
Pedro Ayuso Parejo, PhD1,2, Jose Augusto Garca-Agundez, MD,

PhD3, Jose A Cornejo-Garcia, PhD4, Miguel Blanca, MD, PhD5,
Mara Jose Torres, MD, PhD5, Inmaculada Do~na, MD, PhD5, Maria
Salas, MD, PhD6, Natalia Blanca-Lopez, MD, PhD2, Gabriela
Canto, MD, PhD7, Carmen Rondon, MD, PhD8, Paloma Campo,
MD, PhD9, Jose Julio Laguna, MD, PhD10, F. Javier Fernandez,
MD, PhD11, Carmen Martnez, MD, PhD3 and Elena GarcaMartn, MD, PhD1, 1Dept. Bioqumica Biologa Molecular y
Genetica.Universidad de Extremadura., Caceres, Spain, 2Allergy
Service, Infanta Leonor Hospital, Madrid, Spain, 3Dept. Farmacologa, Universidad de Extremadura, Caceres, Spain, 4Laboratorio de Investigacion, FIMABIS, Malaga, Spain, 5Allergy
Service, Carlos Haya Hospital, Malaga, Spain, 6Allergy Service,
Carlos Haya Hospital, Spain, 7Allergy Service, Infanta Leonor
Hospital, 8Allergy Service Carlos Haya Hospital, Malaga, Spain,
9
Allergy Service, Carlos Haya Hospital, Malaga, Spain, 10De La
Cruz Roja Hospital, Madrid, Spain, 11UMH Alicante G.University
Hospital - Allergy Sect., Alicante, Spain
A Genome-Wide Association Study of Non-Steroidal Antiinflammatory Drugs (NSAIDs)-Induced Acute Urticaria in the
Spanish Population
Mike TM Lee1,2, Jose A Cornejo-Garcia, PhD3, Yuan-Tsong
Chen1, Chien-Hsiun Chen1, Natalia Blanca-Lopez, MD, PhD4, Inmaculada Do~na, MD, PhD5, Maria J Torres, MD, PhD5, Carmen
Rondon, MD, PhD6, Paloma Campo, MD, PhD6, Jose Julio Laguna,
MD, PhD7, F. Javier Fernandez, MD, PhD8, Pedro Ayuso Parejo,
PhD4, Maria del Carmen Plaza-Seron, Bsc9, Maria Del Mar Gandolfo Cano, MD, PhD10, Ana Rosado Ingelmo, MD, PhD11, Gabriela Canto, MD, PhD12 and Miguel Blanca, MD, PhD5, 1Institute of
Biomedical Sciences, Academia Sinica, Taipei, Taiwan, 2Center for
Genomic Medicine, RIKEN, Yokohama, Japan, 3Laboratorio de Investigacion, FIMABIS, Malaga, Spain, 4Allergy Service, Infanta
Leonor Hospital, Madrid, Spain, 5Allergy Service, Carlos Haya
Hospital, Malaga, Spain, 6Allergy Service, Carlos Haya Hospital,
Malaga, Spain, 7De La Cruz Roja Hospital, Madrid, Spain,
8
UMH Alicante G.University Hospital - Allergy Sect., Alicante,
Spain, 9Allergy Service, Infanta Leonor Hospital, Malaga, Spain,
10
Allergy Service, Fuenlabrada Hospital, Madrid, Spain, 11Allergy
Service, Alcorcon Hospital, Madrid, Spain, 12Allergy Service, Infanta Leonor Hospital
Profiling Gene Expression Changes in Cytokines and MicroRNAs As a Novel Assay in the Diagnosis of Drug Hypersensitivity
Neeti Bhardwaj, MD, MS, Penn State Milton S. Hershey Medical
Center, Hershey, PA, Heather Rouse, PharmD., Penn State Milton
S. Hershey Medical Center and Faoud T. Ishmael, MD, PhD, The
Pennsylvania State University College of Medicine, Hershey, PA
Drug Resistant Infections with Methicillin-Resistant Staphylococcus Aureus, Clostridium Difficile, and Vancomycin Resistant
Enterococcus Are Associated with a Higher Prevalence of Penicillin Allergy
Vinitha Reddy, MD1, Neil S. Baman, MD1, Cynthia Whitener1 and
Faoud T. Ishmael, MD, PhD2, 1Penn State Hershey Medical Center,
Hershey, PA, 2Penn State University College of Medicine, Hershey,
PA
Acetaminophen Hypersensitivity: Myth or Reality
Renata P. Bittar, Marcelo Aun, MD, Laila Sabino Garro, MD,
Marisa Rosimeire Ribeiro, MD, Jorge Kalil, MD, PhD, Pedro Giavina-Bianchi, MD, PhD and Antonio Ablio Motta, MD, PhD, Division of Clinical Immunology and Allergy, University of S~ao
Paulo, Brazil
Sulfonamide Hypersensitivity in Patients with Systemic Erythematosus
Masato Okada, MD, FAAAAI1, Yasuhiro Suyama, MD2, Ryo Rokutanda, MD2, Yuri Ohara, MD2, Chisun Min, MD2 and Ken-ichi
Yamaguchi, MD2, 1St.Lukes International Hospital, 2St. Lukes International Hospital, Tokyo, Japan
MONDAY
Abstracts AB277

123
AB278 Abstracts
606
607
608
609
MONDAY
610
611
124
Induction of Drug Tolerance to Trimethoprim/Sulfamethoxazole in Non-HIV Patients with a History of Sulfonamide Allergy
Regan Pyle, DO1, Miguel A. Park, MD1, Gerald W. Volcheck, MD,
FAAAAI2, Kimberly Poe, RN1, Jenna Podjasek, MD1, Matthew A.
Rank, MD, FAAAAI3 and Joseph H. Butterfield, MD, FAAAAI1,
1
Mayo Clinic, Rochester, MN, 2Mayo Clinic and Foundation, Rochester, MN, 3Mayo Clinic, Scottsdale, AZ
Results of Drug Provocation Tests in Patients with a History of
Drug Hypersensitivity Reaction
Wantida Dampanrat, MD, prince of Songkla university, Hatyai+,
Thailand, Prapasri Kulalert, MD, Prince of Songkla University,
Songkla, Thailand, Araya Yuenyongviwat, MD, Price of Songkla
University, Songkhla, Thailand and Pasuree Sangsupawanich,
MD, Prince Songkhlanagarind hospital, Hadyai, Thailand
Effects of Steroid Treatment On Outcomes in Patients with
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome
Elina Jerschow, MD, MSc, Albert Einstein College of Medicine/
Montefiore Medical Center, Bronx, NY, Mili Shum, MD, Cornell
Medical Center, Denisa Ferastraoaru, MD, Albert Einstein / Jacobi
Medical Center, Bronx, NY, Sharon Yee, MD, University of Colorado, Denver/National Jewish Health, Denver, CO, Sunit Jariwala,
MD, Albert Einstein/Montefiore Medical Center, New York, NY,
Anna Tavdy, New York Medical Center, Golda Hudes, MD PhD,
Albert Einstein / Montefiore Medical Center, New York, NY and
David L. Rosenstreich, MD, FAAAAI, Albert Einstein / Montefiore
Medical Center, NY
DRESS Syndrome Induced by Piperacillin-Tazobactam in Eight
Patients
Oscar Calderon1, Ana Fiandor2, Teresa Caballero, MD, PhD3,
Teresa Bellon4, Nieves Prior Gomez, MD5, MC Lopez-serrano6,
Santiago Quirce, MD, PhD7 and Rosario Caba~nas6, 1La Paz University Hospital, 2Hospital La Paz, 3Hospital La Paz Research Center
(IdiPaz), Madrid, Spain, 4La Paz University Hospital, ME, Spain,
5
Hospital Universitario La Paz, Madrid, Spain, 6La Paz University
Hospital, Spain, 7Hospital La Paz Institute for Health Research,
Dept. of Allergy, Madrid, Spain
Management of Adverse Drug Reactions with Suspected Immune Mechanisms in Latin America
Mario S
anchez Borges1, Ricardo Cardona-Villa, MD2, Luis Felipe
C. Ensina, MD3, Dirceu Sole, MD, PhD4, Alfredo Arias Cruz5, Sandra Gonzalez Daz5, Alejandra Macias-Weinmann, MD6, Maximiliano G
omez7, Carlos Serrano8, Mabel Noemi Cuello, MD9, Paola
Toche Pinaud10, Ruth Ramirez Giraldo11, Miguel Vinuesa, MD,
PhD12, Adolfo Salvatierra13, Camila Telles14, Djanira Andrade14,
Alicia De Falco15, Gregorio Mercovich16, Adriana Weisz16 and
Edgardo J. Jares, MD17, 1Centro Medico-Docente La Trinidad, Caracas, Venezuela, 2Universidad de Antiquia, Colombia, 3Universidade Federal de S~ao Paulo, Brazil, 4Federal University of Sao
Paulo, Sao Paulo, Brazil, 5Hospital Universitario, Monterrey, Mexico, 6Hospital Universitario UANL, Monterrey, N.L., Mexico,
7
Hospital San Bernardo, Salta, Argentina, 8Fundacion Valle del
Lili, Cali, Colombia, 9Consultorios San Juan, San Juan, Argentina,
10
Clnica Las Condes, Santiago, Chile, 11Universidad de Antioquia,
Medellin, Colombia, 12Universidad de Rosario, Rosario, Argentina,
13
Fundair, San Luis, Argentina, 14Universidade Federal de S~ao
Paulo, S~ao Paulo, Brazil, 15Universidad Nacional de La Plata, La
Plata, Argentina, 16Hospital Municipal Bernardo A. Houssay,
Vicente L
opez, Argentina, 17Hospital Nacional Alejandro Posadas,
Buenos Aires, Argentina
A Survey On Drug Reactions in Latin America
Edgardo J. Jares, MD1, Mario Sanchez Borges2, Luis Felipe C.
Ensina, MD3, Maximiliano Gomez4, Galie Mimessi4, Alfredo Arias
Cruz5, Carlos Serrano6, Susana Diez-Zuloaga7, Mabel Noemi
Cuello, MD8, Sandra Gonzalez Daz5, Alejandra Macias Weinmann5, Dirceu Sole, MD, PhD9, Alicia De Falco10, Inês Camelo
Nunes11, Susana Barayazarra12, Ivan Cherrez, MD13, Andrea

FEBRUARY 2013
612
613
614
615
616
617
618
619
620
621
Zanacchi12, Juan F. Schuhl, MD, FAAAAI14, Adolfo Salvatierra15

and Ricardo Cardona-Villa, MD16, 1Hospital Nacional Alejandro
Posadas, Buenos Aires, Argentina, 2Centro Medico-Docente La Trinidad, Caracas, Venezuela, 3Universidade Federal de S~ao Paulo,
Brazil, 4Hospital San Bernardo, Salta, Argentina, 5Hospital Universitario, Monterrey, Mexico, 6Fundacion Valle del Lili, Cali, Colombia, 7Universidad de Antiquia, Medellin, Colombia, 8Consultorios
San Juan, San Juan, Argentina, 9Federal University of Sao Paulo,
Sao Paulo, Brazil, 10Universidad Nacional de La Plata, La Plata,
Argentina, 11Universidade Federal de S~ao Paulo, S~ao Paulo, Brazil,
12
Nuevo Hospital San Roque, Cordoba, Argentina, 13Hospital
Kennedy, Guayaquil, Ecuador, 14British Hospital, Montevideo, Uruguay, 15Fundair, San Luis, Argentina, 16Universidad de Antiquia,
Colombia
Prevalence and Characteristics of Penicillin Allergy in Urban
Adults
Stephanie Albin, MD, Mount Sinai School of Medicine and
Shradha Agarwal, MD, Mount Sinai School of Medicine, New
York, NY
Characterization of Penicillin Allergy Among VA Patients
Mark Biagtan, MD1,2, Sujani Kakumanu, MD1,2 and Sameer K.
Mathur, MD, PhD, FAAAAI1,2, 1University of Wisconsin School
of Medicine and Public Health, Madison, WI, 2William S. Middleton Veterans Hospital, Madison, WI
Prevalence of Quinolones Allergy in an Allergy Unit
Silvia Uriarte, Pamela Jara, Mar Fernandez- Nieto and Joaqun
Sastre, Fundacion Jimenez Daz, Madrid, Spain
Reported Antibiotic Allergy History and Outcomes in Patients
Hospitalized with Community-Acquired Pneumonia
DJahna Akinyemi, MD1, Andrea J. Apter, MD, MA, MSc,
FAAAAI2, Brian Strom3 and Rui Feng3, 1Johns Hopkins Asthma
and Allergy Center, Baltimore, MD, 2University of Pennsylvania,
Media, PA, 3University of Pennsylvania
Penicillin Allergy At A Tertiary Centre in Cape Town, South
Africa
Tamara Kerbelker, MBChB and Michael E. Levin, MBBCh, Red
Cross War Memorial Childrens Hospital, Cape Town, South Africa
Characterization of Single and Multiple Antibiotic Allergies in
Cystic Fibrosis Patients
Shenil Shah, MD, Sapna Shah, MD, Erik Lehman, MS, Robert L.
Vender, MD, Gavin Graff, MD and Faoud T. Ishmael, MD, PhD,
The Pennsylvania State University College of Medicine, Hershey,
PA
A Novel Desensitization Protocol for Inhaled Aztreonam
E. Kwak, T.R. Mainardi, S.M. Canfield, R.L. Miller and E.A. Dimango, Columbia Presbyterian Medical Center, New York, NY
A Retrospective Study of Drug-Induced Anaphylaxis Treated in
the Emergency Department (ED) or Hospital: Patients Characteristics and Their Receipt of Preventive Care
Susan A. Rudders, MD, Division of Asthma and Allergy, Department of Pediatrics, Rhode Island Hospital, Alpert School of Medicine at Brown University, Providence, RI, Sunday Clark, MPH,
ScD, Department of Emergency Medicine, Weill Cornell Medical
College, New York, NY, Wenhui Wei, PhD, MS, MBA, Evidence
Based Medicine, sanofi US, Bridgewater, NJ and Carlos Camargo
Jr., MD, DrPH, Department of Emergency Medicine, Massachusetts
General Hospital, Harvard Medical School, Boston, MA
Prevalence of Pediatric Drug Allergy Based On Drug Provocation Testing
Gita Ram1, Vidya Puthenpura1 and Antonella Cianferoni, MD,
PhD2, 1Childrens Hospital of Philadelphia, 23615 Civic Center
Boulevard, Childrens Hospital of Philadelphia, Philadelphia, PA
Incidence and Severity of Pediatric Allergic/Immunologic Adverse Drug Reactions in a Tertiary Care Center
Janelle Sher, MD1, Katherine Hahn, MD, MPH2, Misu Paul3, Marcella R. Aquino, MD, FAAAAI1, Mark Davis-Lorton, MD,
FAAAAI1, Shan Wang, PhD2, Brian Malone, PhD2 and Luz S.
622
623
624
625
626
627
Fonacier, MD, FAAAAI1, 1Winthrop University Hospital, Allergy

& Immunology, Mineola, NY, 2Winthrop University Hospital,
Mineola, NY, 3Stonybrook University School of Medicine
Increasing Radiocontrast Associated Adverse Effects in Cardiovascular Angiography Hospitalizations: New York State 19962010
Marialina Martell Gravie1 and Robert Yao-Wen Lin, FAAAAI1,2,3,
1
New York Downtown Hospital, New York, NY, 2New York Medical
College, Valhalla, NY, 3Weill Cornell Medical College, New York, NY
The Utility of Skin Testing in a Patient with Anaphylaxis to Contrast Media During Cardiac Catheterization: A Case Report
Shaili Shah, MD, University of North Carolina, Chapel Hill, NC, Vinod Doreswamy, MD, The Polyclinic, Seattle, WA, Samuel McDowell, MD, LeBauer Heartcare, Cone Health, Greensboro, NC and
Maya R. Jerath, MD, PhD, University of North Carolina at Chapel
Hill, Chapel Hill, NC
Clinical Feature and Progress of Contrast Media Anaphylaxis
Min-Hye Kim1, Min-Suk Yang2, Woo-Jung Song1, So-Hee Lee3,
Sae-Hoon Kim4, Hye-Ryun Kang1, Heung-Woo Park3, Sun-Sin
Kim3, Yoon-Seok Chang4, Kyung-Up Min, MD, PhD5, You-Young
Kim6 and Sang Heon Cho, MD, PhD7, 1Department of Internal
Medicine, Seoul National University College of Medicine, Seoul,
Korea, 2Seoul National University Boramae Medical Center, 3Seoul
National University Hospital, 4Seoul National University Bundang
Hospital, 5Seoul National University Hospital, Seoul, 6National
Medical Center, Seoul, 7Department of Internal Medicine, Seoul
National University College of Medicine, Seoul, South Korea
Effectiveness of Electronic Medical Record-Embedded Consultation Support System for Iodinated Radiocontrast Media Hypersensitivity Prevention an Observational Study in a
Tertiary Hospital
Min-Suk Yang1, Min-Hye Kim2, Sang-Il Choi3, Jae-Hyoung Kim3,
Woo-Jung Song2, Sae-Hoon Kim4, Hye-Ryun Kang2, Heung-Woo
Park5, Yoon-Seok Chang4, Sang Heon Cho, MD, PhD6 and
Kyung-Up Min, MD, PhD7, 1SMG-SNU Boramae Medical Center,
Seoul, South Korea, 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, 3Seoul National University Bundang Hospital, Seongnam, GyeongGi, South
Korea, 4Seoul National University Bundang Hospital, 5Seoul National University Hospital, 6Department of Internal Medicine, Seoul
National University College of Medicine, Seoul, South Korea,
7
Seoul National University Hospital, Seoul
Comprehensive Allergy Consultation Minimizes Risk of Hypersensitivity Reaction During Subsequent Anesthesia
Autumn Chandler Guyer, MD1, Michelle Conroy, MD1, Carlos
Camargo Jr., MD, DrPH2, Aidan Long, MD1 and Aleena Banerji,
MD1, 1Massachusetts General Hospital, Harvard Medical School,
Boston, MA, 2Department of Emergency Medicine, Massachusetts
General Hospital, Harvard Medical School, Boston, MA
Incidence of Intraoperative Anaphylaxis in A University General Hospital in Brazil
Laila Sabino Garro, MD1, Maria Jose Carvalho Carmona2, Iracy
Silvia Corrêa Soares2, Marcelo Vivolo Aun, MD1, Marisa Rosimeire Ribeiro, MD1, Adriana Teixeira Rodrigues1, Jorge Kalil,
MD, PhD1, Pedro Giavina-Bianchi, MD, PhD1 and Antonio Ablio
Motta, MD, PhD1, 1Division of Clinical Immunology and Allergy,
University of S~ao Paulo, Brazil, 2Anesthesia Division, University of
S~ao Paulo, Brazil
629
630
631
632
633
634
635
636
637
638
EGID/Immunologic GI Disorders II
4207
628
Knowledge of Food Protein-Induced Enterocolitis (FPIES)

Among General Pediatricians
639
Nikhil Menon, Medical student1, Elizabeth Feuille, MD1, Faith

Huang, MD2 and Anna H. Nowak-Wegrzyn, MD, FAAAAI3,
1
Mount Sinai School of Medicine, 2Mount Sinai Hospital, New
York, NY, 3Mt. Sinai School of Medicine, New York, NY
M. Pneumoniae Is a Potential Trigger for Eosinophilic
Esophagitis
Maya D. Srivastava, MD, PhD, FAAAAI, SUNY at Buffalo, East
Amherst, NY
Eosinophilic Esophagitis : Clinical Spectrum of Puertorrican
Children
Vylma Velazquez, MD, Hospiyal Episcopal San Lucas, Ponce, PR
A Predictive Score for the Presence of Eosinophils in the
Esophagus
Margaret Redmond, MD1, Jean Brown, MD2, Dale Rhoda1, Wei
Wang1, John Russo, MD1, Thomas Platts-Mills, MD, PhD,
FAAAAI FRS3 and Elizabeth Erwin, MD1, 1Nationwide Childrens
Hospital, Columbus, OH, 2University of South Florida, Tampa, FL,
3
University of Virginia, Charlottesville, VA
The Relationship Between Atopic Disease, Mast Cell Counts
and Irritable Bowel Syndrome-Diarrhea Predominant (IBS-D)
R. Joseph Mittel1, Mark Demeo1, Shiram Jakate1, Sue Mikolaitis1,
Sandra Tilmon2 and Mary C. Tobin1, 1Rush University, 2Department of Public Health, Chicago, IL
Understanding the Role of Familial Allergies in Children with
Nicol Awadalla, MD, Inova Fairfax Hospital, VA, Oral Alpan, MD,
O&O ALPAN, LLC, Denise Loizou, RN, O&O Alpan, Fairfax, VA
and Girish Hiremath, MD, O & O ALPAN, LLC
Evidence That Low Titer IgE Antibodies to Milk and
Wheat in Adults and Children with Eosinophilic
Esophagitis May Be Directed Against a Minor Component
of the Extract
Anubha Tripathi, MD1, Lisa J. Workman, BA1, Alicia Clark,
BA1, Princess U. Ogbogu, MD, FAAAAI2, Barrett Barnes,
MD1, Scott P. Commins, MD, PhD1, Thomas Platts-Mills, MD,
PhD, FAAAAI FRS1, Robert G. Hamilton, PhD, D.ABMLI,
FAAAAI3 and Elizabeth Erwin, MD4, 1University of Virginia,
Charlottesville, VA, 2The Ohio State University, Columbus,
OH, 3Johns Hopkins University School of Medicine, Baltimore,
MD, 4Nationwide Childrens Hospital, Columbus, OH
Perennial Distribution of Pediatric Eosinophilic Esophagitis Diagnoses
C. R. Schlegel1, N. M. Quintanilla1, A. P. Olive2, D. P. Duvan3,
L. Xu1 and C. M. Davis4, 1Baylor College of Medicine/Texas
Childrens Hospital, Department of Pediatrics, TX, 2Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine/Texas Childrens Hospital, TX,
3
Houston Department of Health and Human Services (HDHHS),
TX, 4Immunology, Allergy and Rheumatology, Department of
Pediatrics, Baylor College of Medicine/Texas Childrens Hospital, TX
Allergen Sensitization Profiles in A Pediatric Cohort with Eosinophilic Esophagitis
S. Nicole Chadha, MD, Li Wang and Donna Sedlak Hummell,
MD, Vanderbilt University Medical Center, Nashville, TN
Food Allergy Testing in Adult Eosinophilic Esophagitis, Clarifying the Role of the Allergist
Manujendra Ray, MD, PhD and Benjamin P. Soule, MD, University of Pennsylvania, Philadelphia, PA
Comparison of Atopic Features Between Children and Adults
with Eosinophilic Esophagitis
Natalia Vernon, MD, Shenil Shah, MD, Sapna Shah, MD and Gisoo Ghaffari, MD, FAAAAI, Penn State Milton S. Hershey Medical
Center, Hershey, PA
Eosinophilic Esophagitis: A Comparison of Clinical Approaches
towards Pediatric and Adult Patients in a Large HMO
Rani Reddy Vatti, MD, Kaiser Permanente, Roseville, CA;
MONDAY
Abstracts AB279

125
AB280 Abstracts
640
641
642
643
644
MONDAY
645
646
647
648
126
University of California, Davis, Suzanne S. Teuber, MD, FAAAAI,

UC Davis and Machelle Wilson, PhD, CTSC UC Davis Public
Health Sciences/School of Medicine, Davis, CA
Comparison of Various Treatment Options of Eosinophilic
Esophagitis: Patient Perspective
Neelu Kalra, MD, Amy Welch, MD and Gisoo Ghaffari, MD,
FAAAAI, Penn State Hershey Medical Centre, Hershey, PA
Combination Therapy Is Effective in Patients with Eosinophilic
Esophagitis
N. Seth1, A. P. Olive2 and C. M. Davis1, 1Immunology, Allergy and
Rheumatology, Department of Pediatrics, Baylor College of Medicine/Texas Childrens Hospital, TX, 2Gastroenterology, Hepatology
and Nutrition, Department of Pediatrics, Baylor College of Medicine/Texas Childrens Hospital, TX
Swallowed Fluticasone Is an Effective Maintenance Therapy for
Children with Eosinophilic Esophagitis
Doerthe A. Andreae, MD, Oksana Yershov, MS and Mirna Chehade, MD, Mount Sinai School of Medicine, New York, NY
Review of Treatment Outcomes in Pediatric Patients with
Concomitant Eosinophilic Esophagitis and Celiac Disease
Kathryn D. Convers, MD, St. Louis University School of
Medicine, St. Louis, MO, Jeffrey Teckman, MD, Cardinal Glennon
Childrens Medical Center, St. Louis, MO and Bradley A. Becker,
MD, FAAAAI, Saint Louis University School of Medicine, Saint
Louis, MO
3-Months Elimination Diet in Childhood Eoe: Nutritional and
Immunological Aspects
Nicolas Kalach, MD, PhD1,2,3, Diana Colson2,3, Pascale Soulaines2,3, Benedicte Michaud, MD4,5, Lucienne Chatenoud, MD,
PhD5 and Christophe Dupont, MD, PhD6,7, 1Hôpital Saint Vincent
de Paul, Groupe Hospitalier de lInstitut Catholique de Lille (GHICL), Lille, France, 2Hôpital Necker, Enfants Malades, Universite
Paris V Rene Descartes (Paris, France), Paris, France, 3Hôpital Cochin-Saint Vincent de Paul, Universite Paris V Rene Descartes
(Paris, France), Paris, France, 4Laboratoire dimmunologie Biologie, H^
opital Necker-enfants Malades, Paris, France, Paris, France,
5
Universite Paris Descartes, Hôpital Necker-Enfants Malades,
INSERM U1013, Paris, France, 6Universite Paris V Rene Descartes, Paris, France, 7Hopital Necker Enfants Malades, Paris,
France
Tolerance of Baked Milk in a Subset of Patients with Cows
Milk-Mediated Eosinophilic Esophagitis
John Leung, MD1, Aubrey J. Katz, MD2, Qian Yuan, MD, PhD2,
Rajashri Shuba Iyengar, MD2, Perdita Permaul, MD3, Jolan E. Walter, MD, PhD2, Jyoti Ramakrishna, MD2, Navneet Hundal, MD2,
Theadora Swenson, BA2, Alexandra R. Alejos, BA2, Wayne G.
Shreffler, MD, PhD, FAAAAI2 and Paul E. Hesterberg, MD2,
1
Rheumatology, Allergy and Immunology, Massachusetts General
Hospital, Boston, MA, 2Massachusetts General Hospital, Boston,
MA, 3Division of Pediatric Allergy/Immunology, Massachusetts
General Hospital, Boston, MA
Dietary Avoidance in Children with Eosinophilic Esophagitis Is
Associated with Improved Growth Parameter
Karen A. DeMuth, MD, FAAAAI, Emory University, Atlanta, GA
Impact of Eosinophilic Disorders On Daily Activities and Frustration with Healthcare Provider Interactions
Julia Eismin, MPH1, Gillian Mayman, MLIS1, Wendy Book,
MD2, Harvey L. Leo, MD1 and Noreen Clark, PhD1, 1Center for
Managing Chronic Disease, University of Michigan, Ann Arbor,
MI, 2American Partnership for Eosinophilic Disorders, Atlanta, GA
Quality of Life in a Racially Diverse Cohort of Children with
Eosinophilic Esophagitis and Comparison to Other Chronic
Pediatric Illnesses
Thomas Weiler, MD1, Saul Rubin2, Hemant Sharma, MD, MHS3
and Irene Mikhail, MD1, 1Childrens National Medical Center,
2
University of Pittsburgh, 3Childrens National Medical Center,
Division of Allergy and Immunology, Washington, DC

FEBRUARY 2013
649
650
651
652
653
654
655
656
Infants with Food Protein-Induced Enterocolitis Syndrome

(FPIES) Can Be Classified Into Two Distinct Subgroups Based
On the Presence or Absence of Bloody Stool and Their Antigen-Specific Cytokine Production Profiles
Hideaki Morita, MD, PhD1, Ichiro Nomura, MD, PhD1, Tetsuo
Shoda, MD1, Hirotoshi Unno, MD1,2, Akio Matsuda, PhD1, Hirohisa Saito, MD, PhD1 and Kenji Matsumoto, MD, PhD1, 1Department of Allergy and Immunology, National Research Institute for
Child Health and Development, Tokyo, Japan, 2Department of Pediatrics, Jikei University School of Medicine, Japan
Systemic Cytokine Responses in Acute Food Protein-Induced
Enterocolitis (FPIES)
Anna H. Nowak-Wegrzyn, MD, FAAAAI1, Thomas Kraus, PhD2,
Ramon Bencharitiwong, PhD3, Thomas Moran, PhD2 and Hugh A.
Sampson, MD, FAAAAI4, 1Mt. Sinai School of Medicine, New
York, NY, 2Mount Sinai School of Medicine, 3Mount Sinai School
Medicine, New York, NY, 4Mount Sinai School of Medicine, New
York, NY
T Cell Responses to Food Protein in Acute Food Protein-Induced Enterocolitis (FPIES)
Jean-Christoph Caubet, MD1, Ramon Bencharitiwong, PhD2,
Madhan Masilamani, PhD3, Hugh A. Sampson, MD, FAAAAI3,
Cecilia Berin, PhD3 and Anna H. Nowak-Wegrzyn, MD, FAAAAI4,
1
University Hospitals of Geneva, Department of Child and Adolescent, Geneva, Switzerland, 2Mount Sinai School Medicine, New
York, NY, 3Mount Sinai School of Medicine, New York, NY,
4
Mt. Sinai School of Medicine, New York, NY
Multiparameter Assay to Investigate the Inflammatory Profile
of Pediatric Celiac Disease Patients
Yvelise Barrios, MD, PhD1, Inmaculada Sanchez-Machn, MD2,
Andres Franco, MD1, Honorio Armas, MD1 and Victor Matheu,
MD3, 1Hospital Universitario de Canarias, Tenerife, Spain, 2Hospital Ofra-Torax, Tenerife, Spain, 3Hospital Ofra, Tenerife, Spain
A New Synbiotic Can Increase Weight Gain in Infants with
Cows Milk Allergy: A Randomized-Controlled Trial
Hamid Ahanchian, MD1, Hamid Reza Kianifar2, Reza Farid, MD,
FAAAAI1 and Seyyed Ali Jafari2, 1Allergy Research Center, Mashhad University of Medical Sciences, 2Department of Pediatric Gastroenterology, Mashhad University of Medical Sciences, Mashhad,
Iran
Distinct Differences Between Cluster 3 and 4 of Non-IgE Mediated Gastrointestinal Allergy in Allergen-Specific Lymphocyte
Proliferation Test and Histological Findings of the GI Mucosa
Ichiro Nomura, MD, PhD1,2, Hideaki Morita, MD, PhD2, Tetsuo
Shoda, MD2, Kumiko Morita, MD1, Akio Matsuda, PhD2, HIrotaka
Shimizu, MD3, Katsuhiro Arai, MD3, Atsuko Nakazawa, MD,
PhD4, Yukihiro Ohya, MD, PhD1, Hirohisa Saito, MD, PhD2 and
Kenji Matsumoto, MD, PhD2, 1Division of Allergy, National Center
for Child Health and Development, Tokyo, Japan, 2Department of
Allergy and Immunology, National Research Institute for Child
Health and Development, Tokyo, Japan, 3Division of Gastroenterology, National Center for Child Health and Development, Tokyo,
Japan, 4Department of Pathology, National Center for Child Health
and Development, Tokyo, Japan
Toll-Like Receptor Expression with Testosterone in Peripheral
Blood Lymphocytes in Adults with Eosinophilic Esophagitis
Elizabeth Erwin, MD1, Nicholas Young, PhD2, Alexandra Friedman2, Wael Jarjour, MD2 and Thomas Platts-Mills, MD, PhD
FAAAAI, FRS3, 1Nationwide Childrens Hospital, Columbus, OH,
2
Ohio State University, 3University of Virginia, Charlottesville, VA
Elucidating Mechanisms of Allergic Inflammation in Eosinophilic Esophagitis
Denise Loizou, RN1, Otto Louis-Jacques, MD2, Benjamin Enav,
MD2, Julie Kim, MD2, Peter Lee, MD2, Catherine Chao, MD2,
Lynn Duffy, MD2, Ian Leibowitz, MD2, Suhasini Kaushal, MD1,
Annu Farwah1, Ozlem Goker-Alpan, MD1 and Oral Alpan, MD1,
1
O&O ALPAN, LLC, 2Inova Fairfax Hospital
Abstracts AB281

Immunotherapy III
Research Associates, Rolling Hills Estates, CA and Desiree E.S.

~
Larenas Linnemann, MD, FAAAAI, Hospital MAdica
Sur, Mexico D.F., Mexico
4208
658
659
660
661
662
663
664
Biweekly Administration of Subcutaneous Immunoglobulin:

Predicting Pharmacokinetic Outcomes Using Modeling and
Simulation
Jagdev S. Sidhu, Clinical Pharmacology & Early Development,
CSL Ltd, Parkville, Australia, Martin Bexon, MD, CSL Behring
AG, Bern 22, Switzerland, Mikhail Rojavin, PhD, Clinical
Research and Development, CSL Behring LLC, King of Prussia,
PA, Marc Pfister, Quantitative Solutions, Inc., Bridgewater, NJ
and Cornelia Landersdorfer, Centre for Medicine Use and Safety,
Monash University, Parkville, Australia
Prospective Trial of a Novel Modified Rush Immunotherapy
Protocol
Elena Resnick, MD, Mount Sinai School of Medicine, New York,
NY, Maria Rosalinda Reyes, RN, Mt. Sinai School of Medicine,
New York, NY, Beth Eve Corn, MD, FAAAAI, Mt. Sinai Medical
Center, New York, NY and Jody R. Tversky, MD, PhD, Johns Hopkins Medical Center
Path to Immunotherapy What Is Driving Immunotherapy
Use? : The Allergies, Immunotherapy, & Rhinoconjunctivitis
(AIRS) Patient Survey
David P. Skoner, MD, West Penn Allegheny Health System,
Cranberry TWP, PA, Michael S. Blaiss, MD, FAAAAI, Allergy
and Asthma Care, Memphis, TN, Mark S. Dykewicz, MD,
FAAAAI, Wake Forest University School of Medicine, Winston
Salem, NC, Bryan D. Leatherman, MD, Coastal Ear, Nose and
Throat Associates, Gulfport, MS, Nancy Smith, MS, Merck &
Co, INc, WhiteHouse Station, NJ and Felicia C. Allen-Ramey,
PhD, Merck & Co, Inc, West Point, PA
Safety of Subcutaneous Immunotherapy with House Dust Mites
in Patients with Allergic Rhinitis in Real World
Mario Henrique de Almeida Fonseca, Norma de Paula Motta Rubini, Albertina Varandas Capelo, Eliane Miranda da Silva,
Fernando Samuel Sion, Jo~ao Negreiros Tebyrica and Carlos Alberto
Morais-de-Sa, Federal University of the State of Rio de Janeiro, Rio
de Janeiro, Brazil
Improvement of Allergic Rhinitis Symptoms in Children Receiving Hymenoptera Immunotherapy
Savitree Padungpak, MD, Wiparat Manuyakorn, MD, Wasu
Kamchaisatian, MD, Suwat Benjaponpitak, MD, Soamarat
Vilaiyuk, MD, Cherapat Sasisakulporn, BSc and Wanlapa Teawsomboonkit, RN, Ramathibodi Hospital, Bangkok, Thailand
Rate of Systemic Reactions to Standardized Allergen Subcutaneous Immunotherapy in Pediatric Patients
Elena Crestani, MD, MS1, Tatyana Sare, PharmD2, Rocco
Anzaldi, PharmD2, Al Patterson, PharmD2, Lynda C. Schneider,
MD FAAAAI1 and Rima A. Rachid, MD, FAAAAI1, 1Division of
Allergy/Immunology, Boston Childrens Hospital, Harvard Medical
School, Boston, MA, 2Pharmacy Department, Boston Childrens
Hospital, Boston, MA
Persistence with Specific Immunotherapy (SCIT & SLIT)
Among AR Patients in A US Allergy Practice
Robert Anolik, MD, FAAAAI, Allergy and Asthma Specialists,
PC, Blue Bell, PA, Ann M. Schwartz, RN, CCRC, Allergy and
Asthma Specialists, PC, East Norriton, PA, Shiva Sajjan, Merck
& Co. , Inc. and Felicia C. Allen-Ramey, PhD, Merck & Co, Inc,
West Point, PA
AAAAI Membership Experience with Allergen Immunotherapy
(AIT) Safety in Young Children and Pregnant Women
Matthew A. Rank, MD, FAAAAI, Mayo Clinic, Scottsdale, AZ,
David W. Hauswirth, MD, FAAAAI, The Ohio State University,
Columbus, OH, Christopher W. Calabria, MD, Dilley Allergy and
Asthma, Helotes, TX, Lawrence D. Sher, MD, FAAAAI, Peninsula
Rhinitis/Conjunctivitis II
4209
665
666
667
668
669
670
671
672
Prevalence of Ocular Symptoms in Patients with Allergic

Rhinitis: Korean Multicenter Study
Dong-Young Kim, Seoul National University College of Medicine,
Seoul, South Korea
More Seasonal Allergic Rhinitis Patients Improve with
Diphenhydramine Compared with Loratadine and Placebo: A
Responder Analysis
Eduardo Urdaneta, MD1, Mitesh Patel, PharmD1, Kathleen B.
Franklin, BSN, RN2 and Mei-Miau Wu, Dr PH3, 1McNeil Consumer Healthcare, Fort Washington, PA, 2Franklin Consultants,
LLC., Phoenixville, PA, 3J & J Consumer Products, US, Morris
Plain, NJ
A Post-Hoc Responder Analysis of Improvement in Symptoms
Following Treatment with Ciclesonide Hydrofluoroalkane Nasal
Aerosol in Patients with Seasonal and Perennial Allergic
Rhinitis
John Karafilidis, PharmD1, Holly Huang, PhD, MPH1 and Eli O.
Meltzer, MD, FAAAAI2, 1Sunovion Pharmaceuticals, Marlborough, MA, 2Allergy and Asthma Medical Group & Research Center, San Diego, CA
A Post-Hoc Analysis of Improvement in Individual Nasal
Symptoms by Their Baseline Severity Following Treatment
with Ciclesonide Hydrofluoroalkane Nasal Aerosol in Patients
with Seasonal Allergic Rhinitis
Dale E. Mohar, MD1, Holly Huang, PhD, MPH2 and John Karafilidis, PharmD2, 1Kerrville Research Associates, Kerrville, TX,
2
Sunovion Pharmaceuticals, Marlborough, MA
Diagnosis of Nasal and Eye Allergies - the Allergies, Immunotherapy,& Rhinoconjunctivitis (AIRS) Patient Survey
Michael S. Blaiss, MD, FAAAAI, Allergy and Asthma Care,
Memphis, TN, Mark S. Dykewicz, MD, FAAAAI, Wake Forest
University School of Medicine, Winston Salem, NC, Bryan D.
Leatherman, MD, Coastal Ear, Nose and Throat Associates,
Gulfport, MS, David P. Skoner, MD, West Penn Allegheny Health
System, Cranberry TWP, PA, Nancy Smith, MS, Merck & Co, INc,
WhiteHouse Station, NJ and Felicia C. Allen-Ramey, PhD, Merck
& Co, Inc, West Point, PA
Relevance of Aspirin or Allergen Sensitivity On Rhinitis Among
Residents of Puerto Rico
Javier A. Mendez, MD, Angel M. Rivera, MD, Rafael H. Zaragoza, MD, PhD, Cristina J. Ramos, MD, Fernando J. Lopez, MD,
Iona K. Malinow, MD, Arnaldo E. Perez, MD, Carmen Acantilado,
MD and Sylvette Nazario, MD, University of Puerto Rico School of
Medicine, San Juan, PR
Visual Analog Scale Showed a Good Correlative with Allergic
Rhinitis and Its Impact On Asthma(ARIA ) Classification in
School Children
Akira Akasawa, MD, PhD1, Yuichi Adachi, MD, PhD2, Koichi
Yoshida, MD3, Mayumi Furukawa3 and Hiroshi Odajima, MD,
PhD4, 1Tokyo Metropolitan Childrens Medical Center, Tokyo,
Japan, 2University of Toyama, Toyama, Japan, 3Division of Allergy,
Tokyo Metropolitan Childrens Medical Center, Tokyo, Japan, 4Department of Pediatrics, Fukuoka National Hospital, Japan
Mobile Natural Exposure Chamber Technology Standardizes
Controlled Environmental Exposure Chamber Challenges
Across Multicenter National and International Allergy Trials
MONDAY
657
127
AB282 Abstracts
673
674
675
Piyush Patel, MD, FRCP, Harry Nandkeshore, MT (AMT), CCRP

and Karen Shields, RT, Inflamax Research, Mississauga, ON,
Canada
Total Ocular Symptom Score (TOSS) and Dry Eyes
Leonard Bielory, MD, FAAAAI, Robert Wood Johnson University Hospital, New Brunswick, NJ; Rutgers University, New
Brunswick, NJ; STARx Allergy and Asthma Center, Springfield,
NJ, Milton M. Hom, OD, FAAO, Private Practice, Azusa, CA
and Andrew Nguyen, PhD, California State University, Fullerton,
Fullerton, CA
Improvement in the Frequency of Allergic Rhinitis Symptoms
After Four Weeks of Treatment with Intranasal Ciclesonide
200 Mcg Qd
Francisco Javier Saynes-Marin1, Carmen Cano-Salas2,3, Araceli
Arellano-Plancarte2, Jazmin Chiu-Ugalde2, Jose Antonio VargasRomero2 and Juan Carlos Lopez-Alvarenga2,4, 1Hospital Angeles
Metropolitano, Mexico City, Mexico, 2Takeda Mexico SA de CV,
Edo. de Mex., Mexico, 3Instituto Nacional de Enfermedades
Respiratorias, Mexico City, Mexico, 4Direccion de Investigacion,
Hospital General de Mexico OD, Mexico City, Mexico
Correlation of Development of Allergic Rhinoconjunctivitis to
Previous Infections in Chinese and Hispanic Immigrant Populations Residing in Brooklyn
Irina Katayeva, MD1, Maria-Anna Vastardi, MD1, Haijun Yao,
MD2, Daniel Puebla-Neira, MD2, Kobkul Chotikanatis, MD3,
Jeremy Weedon, PhD4, Helen G Durkin, PhD1, Stephan Kohlhoff,
MD1,3 and Rauno Joks, MD1, 1Center for Allergy and Asthma Research at SUNY Downstate, Brooklyn, NY, 2Lutheran Medical Center, Brooklyn, NY, 3Pediatric Infectious Disease, SUNY Downstate,
4
Scientific Computing Center, SUNY Downstate

FEBRUARY 2013
680
681
682
683
Cytokines and Chemokines
MONDAY
4210
676
677
678
679
128
Cytokine-Stimulated Human Dermal Microvascular Endothelial Cells and Fibroblasts Produce Thymus and ActivationRegulated Chemokine (TARC)
Tetsuo Shoda, MD, Kyoko Futamura, MD, PhD, Kenichiro Motomura, MD, Hirohisa Saito, MD, PhD, Kenji Matsumoto, MD, PhD
and Akio Matsuda, PhD, Department of Allergy and Immunology,
National Research Institute for Child Health and Development,
Tokyo, Japan
Decreased IL-4 and TGFâ1 in Allergen-Stimulated A549 Cells
with Combined Formoterol and Mometasone
Anthony Szema, MD, FAAAAI, Stony Brook University School of
Medicine, Stony brook, NY, Andrea Harrington, MS, Stony Brook
University Department of Geosciences, Stony Brook, NY, Sayyed
Hamidi, Stony Brook University School of Medicine, Stony Brook,
NY and Marianne Frieri, MD, PhD, FAAAAI, Nassau University
Medical Center, East Meadow, NY; State University of NY @
Stony brook, Stony Brook, NY
Elevated MIP-1a and IL-17 Production in Antigen-Sensitized
Mice Infected with Respiratory Syncytial Virus
Masahiko Kato, MD, FAAAAI1, Taisei Ishioka2, Yoshiyuki
Yamada1, Hirokazu Kimura3, Hiroyuki Tsukagoshi2, Masakazu
Yoshizumi2, Kunihisa Kozawa2, Kenichi Maruyama1 and Yasuhide
Hayashi1, 1Gunma Childrens Medical Center, Shibukawa, Japan,
2
Gunma Prefectural Institute of Public Health and Environmental
Sciences, Maebashi, Japan, 3National Institute of Infectious Diseases, Musashimurayama, Japan
Transcription of Interleukin-25 and Extracellular Release of the
Protein Is Regulated by Allergen Proteases in Airway Epithelial
CELLS
684
Hideaki Kouzaki, MD, PhD, Shiga University of Medical Science,

Otsu, Shiga, Japan, Ichiro Tojima, Shiga University of Medical Science, Shiga, Otsu, Japan, Hirohito Kita, MD, Mayo Clinic, Rochester, MN and Takeshi Shimizu, Shiga University of Medical Science,
Otsu, SHiga, Japan
Chlamydia Pneumoniae (Cpn) - Induced in Vitro Interferon
Gamma (IFN-g) and Interleukin 2 (IL-2) Responses of PBMC
From Asthmatics
Kobkul Chotikanatis, MD1, Diana Weaver, MD2, Danielle
Lent3, Eva Estrella3, Margaret R. Hammerschlag, MD3, Rauno
O. Joks, MD, FAAAAI4 and Stephan A. Kohlhoff, MD1,
1
SUNY Downstate Medical Center, Center for Allergy and
Asthma Research, Brooklyn, NY, 2Kings County Hospital Center,
Brooklyn, NY, 3SUNY Downstate Medical Center, Brooklyn, NY,
4
State University of New York Downstate Medical Center, Brooklyn, NY
Prostaglandin I2 Receptor (IP) Signaling Inhibits Lung Type I
Interferon Expression by RSV Infection
Shinji Toki, PhD1, Sara Reiss1, Kasia Goleniewska, MS1, Martin
L. Moore, PhD2, Garret FitzGerald, MD3 and R. Stokes Peebles
Jr., MD FAAAAI1, 1Vanderbilt University School of Medicine,
Nashville, TN, 2Emory University, Atlanta, GA, 3University of
Pennsylvania, Philadelphia, PA
Rhinovirus Induces Differential Expression of Th2-Promoting
Epithelial Cytokines From Asthmatics Ex Vivo
Joshua L. Kennedy, MD1, Larry Borish, MD, FAAAAI2, Peter W.
Heymann, MD1 and John W. Steinke, PhD, FAAAAI2, 1University
of Virginia, Charlottesville, VA, 2Asthma and Allergic Disease
Center, Carter Center for Immunology Research, University of
Genetic Variants in Thymic Stromal Lymphopoietin (TSLP)
and Receptor (TSLPR) and Their Influence On the Humoral
Immune Response
Luis Fang, Cesar Mu~noz, Luz Hernandez, Beatriz Martinez and
Javier Marrugo, University of Cartagena, Cartagena, Colombia
Immune Modulatory Effects of IL-22 On Allergen-Induced
Pulmonary Inflammation
Ping Fang, asthma & allergy center,Johns Hopkins University
School of Medicine
T Cells in Allergic Responses

4211
685
686
The Steroidogenic Enzyme Cyp11a1 Is Essential for CD8+ Tc2

Conversion to Enhance Allergen-Induced Airway Hyperresponsiveness and Inflammation
Yi Jia, PhD, Joanne Domenico, BS, Katsuyuki Takeda, MD, Junyan Han, PhD, Meiqin Wang, MD, PhD, Michael Armstrong,
PhD, Nichole Reisdorph, PhD, Brian P. OConnor, PhD, Joseph J.
Lucas, PhD and Erwin W Gelfand, National Jewish Health, Denver,
CO
T Cell-Induced Late Phase Asthmatic Response in Mice
Akio Mori, MD PhD1, Satoshi Kouyama2, Akemi Abe2, Miyako
Yamaguchi2, Yo Iijima2, Chihiro Mitsui2, Chiyako Oshikata1, Hidenori Tanimoto2, Yuma Fukutomi, MD1, Kiyoshi Sekiya2, Masami
Taniguchi2, Yuji Maeda2, Mamoru Ohtomo2, Maki Hasegawa2,
Kazuo Akiyama, MD3, Takayuki Ohtomo4 and Osamu Kaminuma,
PhD5, 1Sagamihara National Hospital, Sagamihara, Japan,
2
Sagamihara National Hospital, 3The National Hospital Organization Sagamihara Hospital, Sagamihara, Japan, 4Tokyo University
of Pharmacy and Life Science, Tokyo, Japan, 5Tokyo Metropolitan
Institute of Medical Science, Tokyo, Japan
Abstracts AB283

688
689
690
691
692
693
A Potential Th2 Cell Survival Factor, Amphiregulin Production

Is Enhanced Following Neurotransmitter Signaling
Kanami Orihara, PhD, Sonia S. Charran, Kent T. HayGlass, PhD
and Redwan Moqbel, PhD, FRCPath FAAAAI, University of Manitoba, Winnipeg, MB, Canada
Invariant NKT Cells Recognize Ragweed Pollen Lipid and Promote Humoral and Cellular Immune Response in a Mouse
Model of Allergic Rhinitis
Mohamed Elfatih Bashir, MS, PhD, Abu Bekr Mohamed, MD,
Marwa Eltayeb, MD, Fuad M. Baroody, MD, FAAAAI, Jayant
M. Pinto, MD and Robert M. Naclerio, MD, FAAAAI, The University of Chicago, Chicago, IL
Foxp3+-Treg Cells Enhanced by Repeated Low-Dose GammaIrradiation Attenuate Ovalbumin-Induced Allergic Asthma in
Mice
Gwan Ui Hong, Jai Youl Ro, Bum Soo Park and Nam Goo Kim,
Sungkyunkwan University School of Medicine
Hyperpolarized Helium-3 Image Directed Analysis of Lung T
Cells in Children with Severe Asthma
Julia Wisniewski, MD, W. Gerald Teague, MD, Briana Ciampi,
Tallissa Altes, Kai Ruppert and Judith A. Woodfolk, MBChB,
PhD, FAAAAI, University of Virginia, Charlottesville, VA
Cross Reactivity Patterns of DRB1*0401 Restricted T- Cells
Specific for Epitopes From the Pooideae Grass Species
Luis Diego Archila1, Jonathan Delong1, Eric Wambre, PhD1,
Eddie A. James1, David Robinson2 and William W. Kwok,
PhD1,3, 1Benaroya Research Institute at Virginia Mason, Seattle,
WA, 2Virginia Mason Medical Center, 3Department of Medicine,
University of Washington
Adiponectin Influences the Effects of Acrolein On T Cells of
Atopic Individuals in Vitro
Christina E. Ciaccio, MD, Brianna Stecklein and Lanny Rosenwasser, MD, FAAAAI, Childrens Mercy Hospital, Kansas City,
MO
Inter-Individual Variations of the Specific Immune Response to
Peanut Allergic Components: Prospect for Specific Therapy
Eric Wambre, PhD1, Eddie A. James1, David Robinson2 and William W. Kwok, PhD1,3, 1Benaroya Research Institute at Virginia
Mason, Seattle, WA, 2Virginia Mason Medical Center, 3Department
of Medicine, University of Washington
697
698
Biological Therapies
4602
Monday, February 25th, 2013, 2:00 PM - 3:15 PM
699
700
Whats New in Asthma Diagnostics

4601
694
695
696
Serum Periostin Levels Correlate with Bronchial Hyperresponsiveness to Mannitol and Methacholine in Children with
Asthma
Heysung Baek, MD, PhD1, Jae-Won Oh, MD, PhD, FAAAAI2,
Ha-Baik Lee, MD, PhD2 and Kenji Izuhara, MD, PhD3, 1Hallym
University College of Medicine, Seoul, Korea, 2Hanyang University
College of Medicine, Seoul, Korea, 3Saga Medical School, Saga,
Japan
Meta Analysis of Asthma Exacerbation Rates in Pediatric
Studies During Asthma Managed Using Fractional Exhaled
Nitric Oxide Versus Standard Clinical Parameters Alone
Joseph D. Spahn, MD, National Jewish Health, Denver, CO, Jonathan Malka, MD, Pediatric Associates, Aventura, FL, Todd A.
Mahr, MD, FAAAAI, Gundersen Lutheran Medical Center, La
Crosse, WI and Paul M. Dorinsky, MD, Aerocrine, Inc., Morrisville, NC
Exhaled Nitric Oxide Concentration During Pediatric Acute
Asthma Exacerbations Is Associated with Severity and
African-American Race
Emily W. Langley, MD, Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University
School of Medicine, Nashville, Tennessee, Tebeb Gebretsadik,
MPH, Department of Biostatistics, Vanderbilt University School
of Medicine, Nashville, Tennessee, Tina V. Hartert, MD, MPH, Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, and Center for Asthma and Environmental
Sciences Research, Vanderbilt University School of Medicine,
Nashville, Tennessee, R. Stokes Peebles Jr., MD, FAAAAI, Allergy,
Pulmonary, and Critical Care Medicine; Department of Medicine;
Vanderbilt University School of Medicine, Nashville, TN and Donald Arnold, MD, MPH, Departments of Pediatrics and Emergency
Medicine, Vanderbilt University School of Medicine, Nashville,
Tennessee
Mannitol Challenge for Diagnosis of Exercise -Induced Bronchconstriction
Christopher C. Randolph, MD FAAAAI1,2, David H. Dreyfus,
MD, PhD, FAAAAI3, Denise M. Kearney, MD2 and Barbara A.
Fraser, CCRC4, 1Center for Allergy, Asthma,immunology, Waterbury, CT, 2Center for Allergy, Asthma & Immunology, Waterbury,
CT, 3Center for Allergy, Asthma Immunology, Waterbury, CT,
4
Center for Allergy,Asthma ,Immunology, Waterbury, CT
Establishing Normal Exhaled Nitric Oxide (FeNO) Values in
Young Children
Chris Cleveland, MD1, Summer E. Monforte, MD2 and Joseph D.
Spahn, MD2, 1University of Colorado, Denver, CO, 2National Jewish Health, Denver, CO
701
702
703
Persistent Hypogammaglobulinemia After Rituximab Treatment

Yelena Kopyltsova, MD, North Shore LIJ, Great Neck, NY, Blanka
M. Kaplan, MD, FAAAAI, Cohen Childrens Medical Center of
New York, Great Neck, NY and Vincent R. Bonagura, MD,
FAAAAI, Hofstra, Northshore-LIJ School of Medicine, Great
Neck, NY
Thymus Transplantation Restores the Repertoire of Foxp3+ T
Cells in Complete DiGeorge Anomaly
Ivan Chinn, MD1, Joshua D. Milner, MD2, Phillip Scheinberg3,4,
Daniel Douek4 and M. Louise Markert, MD, PhD, FAAAAI1,
1
Duke University Medical Center, Durham, NC, 2National Institute
of Allergy and Infectious Diseases (NIAID), Bethesda, MD, 3National Heart, Lung, and Blood Institute, Bethesda, MD, 4National
Institute of Allergy and Infectious Diseases, Bethesda, MD
Immunotolerance Mechanisms Depend On High Vs Low Dose
of Sublingual Immunotherapy
Kari Nadeau, MD, PhD, FAAAAI, Stanford University School of
Medicine and Soujanya Vissamsetti, MD, Stanford University
Mechanisms of Th2 to Treg Vs Th2 to Th1 in Non Rush Vs
Rush Food OIT
Shu-Chen Lyu, Stanford University and Kari Nadeau, MD, PhD,
Resolvin D1 Inhibits IL-1beta Induced Alveolar Epithelial Cell
Activation
Ruan R. Cox Jr.1, Oluwakemi Phillips1, Jutaro Fukumoto, MD,
PhD1, Itsuko Fukumoto, DMD1, Prasanna Tamarapu1, Tran Luong1,
Richard F. Lockey, MD1,2 and Narasaiah Kolliputi, PhD3, 1Morsani
College of Medicine, University of South Florida, Tampa, FL,
2
James A. Haley Veterans Hospital, Tampa, FL, 3Internal Medicine, Morsani College of Medicine, University of South Florida,
Tampa, FL
MONDAY
687
129
AB284 Abstracts

FEBRUARY 2013
Inflammatory Responses to Pollutants, Pesticides,

and Endotoxin
711
4603
704
705
706
707
MONDAY
708
Interactions of Natural Killer (NK) Cells and Surfactant

Protein D (SP-D) in Regulation of Ozone Induced Airway Inflammation: Involvement of NKp46
Moyar Q. Ge1,2, Jin Hwang1, Imre Redai1, Blerina Kokalari1, David M. Kemeny, PhD, FAAAAI2, Kerry S. Campbell, PhD3 and Angela Haczku, MD, PhD, FAAAAI1, 1University of Pennsylvania,
Philadelphia, PA, 2National University of Singapore, Singapore,
Singapore, 3Fox Chase Cancer Center, Philadelphia, PA
Association Between Dichlorophenol Exposure, Asthma Medication Use, and Serum Immunoglobulin E
Purvi Parikh, MD, Albert Einstein / Montefiore Medical Center,
Gabriele De Vos, MD, Albert Einstein College of Medicine, Bronx,
NY, Sunit Jariwala, MD, Albert Einstein/Montefiore Medical Center, New York, NY, David L. Rosenstreich, MD, FAAAAI, Albert
Einstein / Montefiore Medical Center, NY, Golda Hudes, MD,
PhD, Albert Einstein / Montefiore Medical Center, New York,
NY and Elina Jerschow, MD, MSc, Albert Einstein College of
Medicine/Montefiore Medical Center, Bronx, NY
MyD88-Dependent Signaling Is Critical for Acute Organic
Dust-Induced Airway Inflammation in Mice
Jill A. Poole, MD, FAAAAI1, Christopher Bauer1, William West,
MD2, Debra Romberger, MD3, Angela Gleason, MA2, Todd Wyatt,
PhD4 and Tammy Kielian, PhD2, 1University of Nebraska Medical
Center, Omaha, NE, 2University of Nebraska Medical Center,
3
UNMC, Omaha, 4UNMC, Omaha, NE
IL-1 Induces IL-8 Production From Human Airway Epithelial
Cells
Michelle L. Hernandez, MD1, Katherine Mills, BA1, Weidong
Wu, MD, PhD2 and Matthew Kesic, PhD3, 1University of North
Carolina Chapel Hill School of Medicine, Chapel Hill, NC,
2
UNC Center for Environmental Medicine, Asthma, and Lung Biology, Chapel Hill, NC, 3Methodist University, Fayetteville, NC
Exposure to Silica Crystals and Poly (I:C) Induces CaspaseDependent Apoptosis of Human Bronchial Epithelial Cells
Hirotoshi Unno, MD, Kyoko Futamura, MD, PhD, Reiji Kojima,
Hideaki Morita, MD, PhD, Hirohisa Saito, MD, PhD, Kenji Matsumoto, MD, PhD and Akio Matsuda, PhD, Department of Allergy
and Immunology, National Research Institute for Child Health
and Development, Tokyo, Japan
Anaphylaxis
4604
709
710
130
Activation of the Plasma Contact-System in Patients with

Anaphylaxis
Anna Sala-Cunill1,2, Mar Guilarte1,2, Vicky Cardona1,2, Jenny
Bj
orkqvist3, Moises Labrador1,2, Katrin Nickel3, Olga Luengo1,2
and Thomas Renne3,4, 1Allergy Section, Internal Medicine Department. Hospital Universitari Vall dHebron, 2Allergy Research Unit,
Allergy Department, Institut de Recerca Vall dHebron, Universitat
Aut
onoma de Barcelona, Barcelona, Spain, 3Center of Molecular
Medicine Karolinska Institutet, Stockholm, Sweden., 4) Clinical
Chemistry, Department of Molecular Medicine and Surgery
An IgE Receptor Mimetic Peptide (PepE) Protects Mice From
IgE Mediated Anaphylaxis
Joseph S. Zhou, MD, PhD1, Annamaria Sandomenico2, Oliver
Burton1, Hans C. Oettgen, MD, PhD, FAAAAI1 and Menotti
712
713
Ruvo2, 1Boston Childrens Hospital, Boston, MA, 2Istituto di

Biostrutture e Bioimmagini, Napoli, Italy
SHIP-1 Regulates IgG/PAF Mediated Allergen-Induced Fatal
Anaphylaxis Through the PI3 Kinase Pathway
Sun Young Oh, PhD1, Fan Wu, B.S.1, Fred D. Finkelman, MD2,
Tao Zheng, MD1 and Zhou Zhu, MD, PhD1, 1Johns Hopkins
University, Baltimore, MD, 2Cincinnati Veterans Affairs Medical
Center, Cincinnati, OH
Preclinical Study: Dose Comparison of New-Generation TasteMasked Epinephrine (E) Sublingual Tablets
Keith Simons1, Ousama Rachid1, Mutasem Rawas-Qalaji2 and F.
Estelle R. R. Simons, MD, FAAAAI1, 1University of Manitoba,
Winnipeg, MB, Canada, 2Nova Southeastern University, Fort Lauderdale, FL
Anatomical and Anthropometric Determinants of Intramuscular Versus Subcutaneous Administration in Children with
Epinephrine Auto-Injectors
Peter Arkwright, MD, PhD, FAAAAI1, Neville Wright2 and Daniel Bewick1, 1University of Manchester, Manchester, United Kingdom, 2Royal Manchester Childrens Hospital, Manchester, United
Kingdom
Management of Allergies: New Insights

4605
714
715
716
Allergic Disease in US Children Is Associated with Increased

Prevalence of Epilepsy
Helen G. Durkin, PhD, SUNY Downstate Medical Center, Center
for Allergy and Asthma Research, Brooklyn, NY, Rauno O. Joks,
MD, FAAAAI, State University of New York Downstate Medical
Center, Brooklyn, NY and Jonathan I. Silverberg, MD, PhD,
MPH, St. Lukes-Roosevelt Hospital Center, New York, NY
Nasal Congestion Worsens Sleep Disturbance and Psychological
Wellness in Allergic Rhinitis Patients
Rosa Munoz-Cano, MD1,2, Vanesa Gonzalez, MD3, Maria Rueda,
MD1,3, Joaquim Mullol, MD, PhD, FAAAAI1,4, M Herdman5,
Jaime Sanchez-Lopez, MD1,2, Joan Bartra, MD, PhD1,2 and Antonio Valero, MD, PhD1,2, 1Institut dInvestigacions Biomediques
August Pi i Sunyer (IDIBAPS). Centro de Investigaciones Biomedicas en Red de Enfermedades Respiratorias (CIBERES), Spain,
2
Servei de Pneumologia i Al.lergia Respiratoria.Hospital Clinic,
Barcelona, Spain, 3Hospital Quiron, Barcelona, Spain, 4Unitat de
Rinologia i Clinica de lOlfacto. Servei dOtorrinolaringologia.
Hospital Clinic., Barcelona, Spain, 5Insight Consultin & Research,
Barcelona, Spain
Relationship Between Maternal Mid Pregnancy Folate Levels
and the Risk of Allergic and Respiratory Diseases in Early
Childhood: The Mothers and Childrens Environmental Health
(MOCEH) Study
Ja Hyeong Kim, MD, Ulsan University Hospital, Ulsan, KyoungSook Jeong, MD, Department of Occupational and Environmental
Medicine, Dongguk University-Seoul, Graduate School of Medicine, Dongguk University Ilsan Hospital, Ilsan, South Korea,
Eun-Hee Ha, MD, 3Department of Preventive Medicine, School
of Medicine, Ewha Womans University, South Korea, Hye sook
Park, MD, 3Department of Preventive Medicine, School of
Medicine, Ewha Womans University, Mi na Ha, MD, Department
of Preventive Medicine, Dankook University College of Medicine,
Yun-Chul Hong, MD, Department of Preventive Medicine, Seoul
National University College of Medicine, Soo-Young Bhang, MD,
Department of Psychiatry, University of Ulsan, College of medicine, Ulsan University Hospital, Soo-Jeong Lee, MD, Department
of Obstetrics and Gynecology, University of Ulsan, Collage of
Abstracts AB285

718
723
The Role of Lymphocytes in Mediating Asthma

and Allergic Inflammation
4607
724
725
Immunotherapy
4606
719
720
721
722
Dose Adjustment During Pollen Seasons in Build-up and Maintenance Vials Lowers the Risk of Severe Systemic Reactions
(SRs) to Subcutaneous Allergen Immunotherapy (SCIT): Year
4 of the AAAAI/ACAAI Surveillance Study
Tolly Epstein, MD, MS1,2, Gary M. Liss, MD, MS, FRCPC3,
Karen Murphy Berendts, BS, RRT, CCRC4 and David I. Bernstein,
MD, FAAAAI1, 1University of Cincinnati, Cincinnati, OH, 2Cincinnati VA Medical Center, Cincinnati, OH, 3Ontario Ministry of Labour, Toronto, ON, Canada, 4Bernstein Clinical Research Center,
LLC, Cincinnati, OH
Is a 30 Minute Vs. 20 Minute Immunotherapy (IT) Waiting Period Justified?
Leon S. Greos, MD FAAAAI, Colorado Allergy and Asthma Centers, P.C., Centennial, CO, Mary H. Thal, BS, RN, Colorado Allergy and Asthma Centers PC, Denver, CO and Allen D. Adinoff,
MD, FAAAAI, Colorado Allergy and Asthma Center, Highlands
Ranch, CO
Local Nasal Protective Immunoglobulin G4 (IgG4) Responses
in Nasal Fluid Following Grass Pollen Sublingual Immunotherapy
Nausheen Saleem, BSc( Hons)1, Adam Chaker, MD1,2,3, Ulrich
Zissler4, Carsten B. Schmidt-Weber, PhD1, Stephen R. Durham,
MA, MD, FRCP5,6 and Mohamed H. Shamji, BSc, MSc, PhD7,8,
1
Imperial College London, 2Universitatsklinkum Dusseldorf, Dusseldorf, Germany, 3ENT department, TU Munich, Munchen, Germany, 4ENT department, TU Munich, 5Imperial College, London,
United Kingdom, 6Medical Research Council and Asthma UK Centre for Allergic Mechanisms of Asthma, UK, 7MRC & Asthma UK
Centre in Allergic Mechanisms of Asthma, 8Imperial College London, United Kingdom
Antigen-Specific TH Cell Monitoring by CD154 Expression in
Japanese Cedar-Specific SCIT
T. Nomura1,2, I. Tsuge1, C. Inuo1, Y. Nakajima1, K. Tanaka1, N.
Naruse3, S. Suzuki3, H. Ando3, Y. Kondo3, S. Saitoh2 and A. Urisu3,
Department of Pediatrics, School of Medicine, Fujita Health University, Toyoake, Japan, 2Department of Pediatrics and Neonatology, Graduate School of Medical Sciences, Nagoya City
University, Nagoya, Japan, 3Department of Pediatrics, The Second
Teaching Hospital, Fujita Health University, Nagoya, Japan
Immunological Mechanisem of Sublingual Immunotherapy
Reza Farid, MD, FAAAAI, Allergy Research Center, Mashhad
University of Medical Sciences, Farahzad Jabbari, mashhad university, Mashhad, Iran and Homa Sadri, Dr, Mashhad Universiti,
Mashhad, Iran
726
727
728
Th2 Mediated Airway Diseases Strongly Linked to Fungal T

Cell Memory
Paul Porter, PhD1, Chu-Lin Tsai, MD, PhD2, Martin Citardi, MD3,
Samer Fakhri, MD3, David B. Corry, MD1 and Amber U. Luong,
MD, PhD4, 1Baylor College of Medicine, Houston, TX, 2University
of Texas School of Public Health, Houston, TX, 3University of
Texas Medical School at Houston, Houston, TX, 4University of
Texas Medical School at Houston
LIGHT Is Associated with Increased Cellular Infiltrate and
Levels of Th1 Cytokines As Well As Well As Reduced Lung
Function in Human Asthma
Jonathan Romeo, DO, Annette T. Hastie, PhD, Susan Foster, PhD,
Wendy Moore, MD, Stephen P. Peters, MD, PhD, FAAAAI, Eugene
R. Bleecker, MD, FAAAAI and Mark S. Dykewicz, MD, FAAAAI,
Wake Forest University School of Medicine, Winston Salem, NC
Immunomodulatory Effects of IL-27 On Allergen-Induced Th2
Responses
Tomokazu Matsuoka1,2, Faith Wing chun, BSc( Hons)1, Bryony
Stott, MSc.1, Stephen R. Durham, MA, MD, FRCP2,3 and Mohamed H. Shamji, BSc, MSc, PhD4,5, 1Imperial College London,
2
Medical Research Council and Asthma UK Centre for Allergic
Mechanisms of Asthma, UK, 3Imperial College, London, United
Kingdom, 4MRC & Asthma UK Centre in Allergic Mechanisms
of Asthma, 5Imperial College London, United Kingdom
Grass Pollen Allergics Have Fewer IL-10-Producing B Cells
Than Non-Atopic Controls
James E G Charlesworth1,2, Andrea Goldstone1, Moises A. Calderon, MD, PhD2,3, David Cousins2, Stephen R. Durham, MA,
MD, FRCP2,3 and Mohamed H. Shamji, BSc, MSc, PhD4,5, 1Imperial College London, 2Medical Research Council and Asthma UK
Centre for Allergic Mechanisms of Asthma, UK, 3Imperial College,
London, United Kingdom, 4MRC & Asthma UK Centre in Allergic
Mechanisms of Asthma, 5Imperial College London, United
Kingdom
Rab11+ Recycling Endosomes Controls Signaling Output and
Cellular Response of Memory CD4 T Cells in Asthma
Chaoyu Chen, MS, Dipa Sheth, MD, Dave Gupta, MD, Magdalena
Gorska, MD, PhD and Rafeul Alam, MD, PhD, FAAAAI, National
Jewish Health, Denver, CO
Asthma Updates
5201
Tuesday, February 26th, 2013, 9:45 AM - 10:45 AM
729
Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) in African-American Patients with
TUESDAY
717
Medicine, Ulsan University Hospital, Kyung Yeon Lee, MD, Department of pediatrics, University of Ulsan, Collage of Medicine,
Ulsan University Hospital, Seon-Ho Lee, MD, Department of Laboratory Medicine, University of Ulsan, College of Medicine, Ulsan
University Hospital, Yang ho Kim, MD, Department of Occupational and Environmental Medicine, University of Ulsan, Collage
of Medicine, Ulsan University Hospital, Ju-Suk Lee, MD, PhD,
Samsung Changwon hispital; Sungkyunkwan university, Changwon, South Korea; 1, South Korea, Jin-A Jung, MD, Dong-A University Hospital, Busan and Nam Soo Chang, PhD, Department of
Nutritional Science and Food Management, Ewha Womans University, Seoul, Korea
The Role of Molecular Allergology in Allergen-Specific Immunotherapy Adherence and Patient Quality of Life in A Complex
Pollen Area: A Simulation Model
Barbara Mascialino1, Lisse-Lotte Hermansson1 and Joaquin
Sastre, MD, PhD, FAAAAI2, 1Thermo Fisher Scientific IDD, Uppsala, Sweden, 2Fundacion Jimenez Diaz, Madrid, Spain
Follow-up Patterns Among Children with Anaphylaxis and
Other Allergic Diseases Referred from an Urban Emergency
Department to Allergy Clinic
Jonathan Hemler, MD1, Amanda Troger1, Darlene Kassab Mansoor, MD1, Hemant Sharma, MD, MHS2 and Irene Mikhail, MD1,
1
Childrens National Medical Center, 2Childrens National Medical
Center, Division of Allergy and Immunology, Washington, DC
131
AB286 Abstracts
730
731
732
733
734
735
TUESDAY
132
736
737
Moderate to Severe Asthma: Responder Analysis in Patients

with Versus without Fixed Airflow Obstruction (FAO)
Bradley E. Chipps, MD, FAAAAI1, Donald P. Tashkin, MD2, Tom
Uryniak3 and Frank Trudo3, 1Capital Allergy & Respiratory
Disease Center, Sacramento, CA, 2University of California, Los
Angeles, CA, 3AstraZeneca LP, Wilmington, DE
CC10 A38G Polymorphism (rs3741240) Is Associated with
Asthma Susceptibility and Bronchial Hyperresponsiveness Mediated by the Eosinophilic Inflammation in Korean Children
Kyungmo Hong1, Hyun-Kyung Kim2, Mi-Jin Kang, MS3, HoSung Yu, BS3, Byoung-Ju Kim, MD, PhD4, Young Ho Jung,
MD5,6, Jinho Yu, MD, PhD5 and Soo-Jong Hong, MD, PhD5,6,
1
Goucher College, Baltimore, USA, 2Childhood Asthma Atopy
Center, Department of Pediatrics, Asan Medical Center, University
of Ulsan College of Medicine, 3Asan Institute for Life Sciences,
University of Ulsan College of Medicine, Seoul, South Korea, 4Department of Pediatrics, Hae-undae Paik Hospital, Inje University
College of Medicine, Busan, South Korea, 5Childhood Asthma Atopy Center, Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea,
6
Research Center for Standardization of Allergic Disease, Seoul,
South Korea
Safety of Modified Dust Mite Subcutaneous Immunotherapy in
Severe Allergic Asthma
Ruperto Gonzalez, Hospital Ofra-Torax, S/C de Tenerife, Spain,
Paloma Poza, Hospital Ofra-Torax, santa cruz de tenerife, Spain,
Victor Matheu, MD, Hospital Ofra, Tenerife, Spain and Inmaculada
Sanchez-Machn, MD, Hospital Ofra-Torax, Tenerife, Spain
The Role of Exhaled Nitric Oxide in Guiding Asthma Management
Dermot Ryan1, Mike David Thomas2, Paul M. Dorinsky, MD3,4,
Annie Burden5, Julie von Ziegenweidt5, Catherine Hutton6, Alison
Chisholm6 and David Price, FRCGP, MRCGP, DRCOG5,7, 1Woodbridge Medical Centre, Loughborough, United Kingdom,
2
University of Southampton, Southampton, United Kingdom,
3
Teva Pharmaceuticals, Blue Bell, PA, 4Aerocrine, Inc., Morrisville,
NC, 5Research In Real Life, Cambridge, United Kingdom, 6Research in Real Life, Cambridge, United Kingdom, 7University of
Aberdeen, United Kingdom
The Influences of Low BMI On the Treatment of Fixed Airway
Obstruction
June-Hyuk Lee1, Sung-Woo Park, MD2, Dojin Kim1 and Ansoo
Jang, MD3, 1Soonchunhyang univ bucheon hospital, 2Soonchunhyang Univ. Hospital, Bucheon, 3Soon Chum Hyang University
Hospital, Bucheon
A Study of Vitamin D Levels in Children with Asthmatic
Exacerbation At Queen Sirikit National Institute of Child
Health
Varuit Thongbai, MD, Mukda Vangveeravong, MD, Tassalapa
Daengsuwan, MD and Gun Phongsamart, MD, Queen Sirikit National Institute of Child Health, Bangkok, Thailand
Safety and Tolerability of Fel d 1-Derived Peptide Antigen Desensitization in Subjects with Controlled Asthma
Pascal LC Hickey, BPharm, PhD, Adiga Life Sciences, Hamilton,
Canada, Amarjit Singh Cheema, MD, Alpha Medical Research,
Mississauga, ON, Canada, Mark Larche, PhD, McMaster
University/St. Josephs Healthcare, Hamilton, ON, Canada and
Rod Hafner, PhD, Circassia, Oxford, United Kingdom
Longitudinal Evaluation of the Prognostic Value for Difficult
Asthma of Rhinitis Clusters
Ioana Octavia Agache, MD1, Cristina Ciobanu2, Valentina
Barbieru3 and Liliana Rogozea3, 1Transylvania University Brasov,
Brasov, Romania, 2Theramed Medical Center, 3Transylvania University Brasov
Childhood Asthma Profile in Participants of Asthma Control
Program
Gesmar Segundo1,2 and Juliana Ribeiro1, 1Universidade Federal de

FEBRUARY 2013
738
739
740
741
742
743
744
745
Uberlandia, Uberlandia, Brazil, 2Centro Universitario de Patos de

Minas, Patos de Minas, Brazil
Churg-Strauss Syndrome in Japan
Shunsei Hirohata, Kitasato University School of Medicine, Sagamihara, Japan
An Application of Computerized Asthma-Specific QOL in
Korean Asthmatics
Kim Mi-Ae1, Ye Young-Min1, Park Jung-Won2, Lee Jae-Hyun2,
Lee Soo-Keol3, Kim Cheol-Woo4, Jung Ki-Suck5, Kim Joo-Hee5,
Yoo Hye-Soo1, Lee Seung Ihm1, Kim Seung-Hyun1, Shin Yoo
Seob1 and Park Hae-Sim1, 1Ajou University School of Medicine,
Suwon, South Korea, 2Yonsei University College of Medicine,
Seoul, South Korea, 3Dong-A University College of Medicine, Pusan, South Korea, 4Inha University College of Medicine, Incheon,
South Korea, 5Hallym University Medical School, Pyungchon,
South Korea
Reproducibility of Acq-7 Questionnaire in the Assessment of
Asthma Control
Mariana N. Cardoso, MD1, Herberto J. Chong Neto, MD, PhD
FAAAAI1, Carlos Antonio Riedi, MD PhD1 and Nelson A. Rosario,
MD, PhD, FAAAAI1,2, 1Federal University of Parana, Curitiba,
Brazil, 2Federal University of Parana, Curitiba, Brazil
Follow-up of Wheezing in Preschool Children From Cuiaba,
MT, Brazil
Lillian SANCHEZ LACERDA Moraes, MD, MSc, Federal University of Mato Grosso, Dirceu Sole, MD, PhD, Federal University
of Sao Paulo, Sao Paulo, Brazil and Olga Takano, MD, PhD, Federal University of Mato Grosso, cuiaba, Brazil
How Does Asthma Related Internet Search Correlate with Extrinsic Triggers in Urban Centers?
Rohit Divekar, MBBS, PhD and Suresh Bhavnani, PhD, Univ. of
Texas Medical Branch at Galveston, Galveston, TX
Analysis of Relationship Between Asthma and Rhinitis Symptoms in Patients Treated in University Hospital by Using Sacra
Questionnaire
Hiroyuki Nagase, MD, PhD1, Naoya Sugimoto1, Yuko Nakase1,
Yusuke Tanaka1, Asae Kamiyama1, Yasuhiro Kojima1, Hisanao
Yoshihara1, Michio Kuramochi1, Hiroyuki Tashimo1, Hidenori
Arai1, Masao Yamaguchi1 and Ken Ohta1,2, 1Teikyo University
School of Medicine, Tokyo, Japan, 2National Hospital Organization
Tokyo National Hospital, Tokyo, Japan
Associations Between Asthma and Puberty in Swedish Children
Jennifer Protudjer, PhD, Cecilia Lundholm, MSc, Anna Bergstrom, PhD, Inger Kull, PhD and Catarina Almqvist, MD, PhD,
Karolinska Institute, Stockholm, Sweden
Outcome of Pre-School Children with Asthma: A Japanese Cohort Study
Mayumi Furukawa, Division of Allergy, Tokyo Metropolitan
Childrens Medical Center, Tokyo, Japan, Mari Sasaki, Division
of Allergy Tokyo Metropolitan Childrens Medical Center, Hiriko
Watanabe, NHO Kanagawa Hospital, Hiroshi Odajima, MD, PhD,
Department of Pediatrics, Fukuoka National Hospital, Japan, Takao
Fujisawa, MD, FAAAAI, Mie National Hospital, Mie, Japan, Motohiro Ebisawa, MD, PhD, FAAAAI, Sagamihara National Hospital
and Akira Akasawa, MD, PhD, Tokyo Metropolitan Childrens
Medical Center, Tokyo, Japan
Other BCI Topics

5202
746
Association Between Polymorphisms of Itpkc and CASP3 in

IVIG Unresponsiveness and Coronary Artery Lesion in Kawasaki Disease
Abstracts AB287

748
749
750
751
752
753
754
755
756
757
758
759
Factor XII-Independent Activation of the Complex of Prekallikrein with High Molecular Weight Kininogen: Implications for
Hereditary Angioedema
Kusumam Joseph, PhD, Medical University of South Carolina,
Charleston, Baby Tholanikunnel, PhD, Medical University of South
Carolina and Allen P. Kaplan, Medical University of South Carolina, Charleston, SC
Multiplexed Analysis of Primary Cord Blood Adherent-Mononuclear Cell-Supernatants Related to Maternal Atopy
Jenny Thiele, MSc1, Yifei Zhu1 and Anne K. Ellis, MD, MSc,
FRCPC, FAAAAI2,3, 1Queens University, 2Allergy Research Unit,
Kingston General Hospital, Kingston, ON, Canada, 3Departments
of Medicine and Biomedical & Molecular Science, Queens University, Kingston, ON, Canada
Q-PCR Analysis of GATA-1 in Umbilical Cord Blood: Optimizing RNA Extraction and Reverse Transcription Techniques
Vanessa N. Omana, BSc, Queens University, Jenny Thiele, MSc,
Queens University and Anne K. Ellis, MD, MSc, FRCPC, FAAAAI,
Allergy Research Unit, Kingston General Hospital, Kingston, ON,
Canada; Departments of Medicine and Biomedical & Molecular Science, Queens University, Kingston, ON, Canada
Anaphylaxis I
5203
760
761
762
763
Tryptase Levels in Children Presenting with Anaphylaxis to the

Montreal Childrens Hospital
Michelle Halbrich, MD1, Ann Elaine Clarke, MD, MSc2, Sebastian La Vieille, MD3, Harley Eisman, MD1, Reza Alizadehfar,
MD1, Lawrence Joseph, PhD1, Judy Morris, MD4 and Moshe
Ben-Shoshan, MD, MSc1, 1McGill University, Montreal, QC,
Canada, 2McGill University Health Centre, Montreal, Canada,
3
Food Directorate, Ottawa, ON, Canada, 4University de Montreal,
Anaphylaxis in Children Treated At the Montreal Childrens
Hospital: Rate, Clinical Characteristics, Triggers and Management
Moshe Ben-Shoshan, MD, MSc1,2, Sebastian La Vieille, MD3,
Harley Eisman, MD1,4, Reza Alizadehfar, MD4,5, Emma Perkins,
BSc6, Lawrence Joseph, PhD1, Judy Morris, MD7,8 and Ann Elaine
Clarke, MD, MSc9,10, 1McGill University, Montreal, QC, Canada,
2
Montreal Childrens Hospital, Montreal, Canada, 3Food Directorate, Ottawa, ON, Canada, 4Montreal Childrens Hospital, Montreal,
QC, Canada, 5McGill University, Brossard, Canada, 6McGill Unioversity Health Center, Montreal, QC, Canada, 7University de Montreal, Montreal, QC, Canada, 8Sacre-Coeur Hospital, 9McGill
University Health Centre, Montreal, Canada, 10Montreal General
Hospital
Auvi-Q Versus Epipen: Preferences of Adults, Caregivers, and
Children
Adriana Guana1, F. Estelle R. R. Simons, MD, FAAAAI2, Sheldon
Wang1 and Carlos Camargo Jr., MD, DrPH3, 1Sanofi US, 2University of Manitoba, Winnipeg, MB, Canada, 3Department of Emergency Medicine, Massachusetts General Hospital, Harvard
Medical School, Boston, MA
Characterization of Cannabis Sativa Allergens
Ajay Nayak, PhD1, Brett Green, PhD1, Gordon L. Sussman, MD,
FAAAAI2, Noam Berlin, BSc3, Hemant Lata, PhD4, Suman Chandra, PhD4, Mahmoud ElSohly, PhD4, Justin Hettick, PhD1 and Donald H. Beezhold, PhD FAAAAI1, 1CDC/NIOSH, Morgantown, WV,
2
University of Toronto, Toronto, ON, Canada, 3Gordon Sussman
Clinical Research, Toronto, ON, Canada, 4University of Mississippi, Oxford, MS
TUESDAY
747
Ho-Chang Kuo, MD, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Department of Pediatrics, Kaohsiung
Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Clinical and Immunologic Role of Mannose Binding Lectin Deficiency
Payal Patel, MD1, Mariam S. Rasheed, MD2, Ernest Visconti3,
Jenny Shliozberg, MD, FAAAAI4 and Arye Rubinstein, MD,
FAAAAI1, 1Albert Einstein College of Medicine, Bronx, NY, 2Albert Einstein College of Medicine, New York, NY, 3Staten Island
University Hospital, Staten Island, NY, 4Montefiore Medical Center, New York, NY
Strategies to Query and Display Allergy-Derived Epitope Data
From the Immune Epitope Database (IEDB)
Kerrie C. Vaughan1, Bjoern Peters1, Mark Larche2, Anna Pomes3,
David Broide4 and Alessandro Sette1, 1La Jolla Institute for Allergy
and Immunology, La Jolla, CA, 2Division of Clinical Immunology
& Allergy, Department of Medicine, McMaster University, Hamilton, ON, Canada, 3Indoor Biotechnologies, Charlottesville, VA,
4
Allergy and Immunology, Department of Medicine, University of
California, San Diego, San Diego, CA
Immune System Dysregulation Persists During Long-Duration
Spaceflight
Brian Crucian1, Sara Zwart2, Satish Mehta3, Raymond Stowe4, Peter Uchakin5, Heather Quiriarte6, Duane Pierson1, Scott M. Smith1
and Clarence Sams1, 1NASA Johnson Space Center, Houston, TX,
2
Universities Space Research Association, Houston, TX, 3Enterprise Advisory Services Inc., Houston, TX, 4Microgen Laboratories, La Marque, TX, 5Mercer University, Macon, GA, 6JES Tech,
Houston, TX
A Simple, Sensitive and Selective Fluorogenic Assay to Monitor
Kallikrein Activity in Activated Plasma
Jianwen Zhang, Debra Kellogg, Ramanda Wilson, Leigh Harman,
Shanta Bantia and YS Babu, BioCryst Pharmaceuticals, Inc, Birmingham, AL
A Human Monoclonal IgE Resource - a Tool to Understand Allergen-IgE Interactions
Mats Ohlin and Mattias Levin, Lund University, Sweden
Upper Respiratory Cytokine Production in Children with Pandemic H1N1 Versus Seasonal H3N2 Influenza A Infection
Hazar Kobayaa, MD1, Joseph Domachowske2, Basim Asmar3,
Cynthia Bonville4 and Elizabeth A. Secord, MD, FAAAAI3,
1
Wayne State Medical Center, 2SUNY Upstate Medical Center,
3
Wayne State University, 4Upstate Medical Center
The Effects of Diabetes Mellitus and in Vitro Hyperglycemia
On Cytokine Secretion From Peripheral Blood Leucocytes
Najwan Ibraheem, Jordan University of Science and Technology,
Nizar Abuharfil, Faculty of Science and Arts - Jordan University of
Science and Technology, Fawaz Ammari, Faculty of Medicine JUST and Ammar K. Daoud, MD, FAAAAI, Faculty of Medicine,
Jordan University of Science and Technology (J.U.S.T), Irbid, Jordan
Immune Responses to Allopurinol in A Patient with DRESS
Syndrome
Krikor Manoukian, MD, University of California Irvine, CA,
Sudhanshu Agrawal, University of California Irvine and Sudhir
Gupta, MD, PhD, FAAAAI, University Of CA - Irvine, Irvine, CA
Altered Frequency and Composition of Cultured Peripheral
Blood Natural Killer Cells From Cows Milk Allergic Subjects
Madhan Masilamani, PhD1, Akshay Bhatt, MS2, Lara Ford, MD2,
Jacob Daniel Kattan, MD1 and Hugh A. Sampson, MD, FAAAAI1,
1
Mount Sinai School of Medicine, New York, NY, 2Mt. Sinai
School of Medicine
BCX-4161, a Small Molecule and Orally Bioavailable Plasma
Kallikrein Inhibitor for the Treatment of Hereditary Angioedema
Shanta Bantia, Jianwen Zhang, Ramanda Wilson, Cynthia D.
Parker, Debra Kellogg, Pravin Kotian and YS Babu, BioCryst Pharmaceuticals, Inc, Birmingham, AL
133
AB288 Abstracts
764
765
766
767
768
769
770
771
TUESDAY
134
772
773
Allergic Sensitization in Transfusion Recipients, Not Blood Donors, Is a Risk Factor for Allergic Transfusion Reactions
Gabriel Verzino, MHS1, Aaron Tobian, MD, PhD2, Dayand Borge,
MD, PhD3, Jessica Rabe Savage, MD, MHS1, Paul Ness, MD2, Robert
G. Hamilton, PhD, D.ABMLI, FAAAAI4 and William Savage, MD,
PhD1, 1Brigham and Womens Hospital, 2Johns Hopkins University
School of Medicine, 3Greater Chesapeake and Potomac Red Cross,
4
Johns Hopkins University School of Medicine, Baltimore, MD
Using Omega-5 Gliadin ( rTri a 19) in the Diagnosis of Anaphylaxis
Sai Hurng Kham Murng, MBBS MRCP (UK), William Egner,
MD, PhD, Anna Shrimpton, MBChB, FRCPath and Ravishankar
B. Sargur, MD, MBBS, MRCP, Northern General Hospital, Sheffield, United Kingdom
Characterization of the Causative Allergens for Wheat-Dependent Exercise-Induced Anaphylaxis Sensitized with Hydrolyzed
Wheat Proteins in Facial Soap
Tomoharu Yokooji1, Saki Kurihara1, Tomoko Murakami1, Yuko
Chinuki2, Susumu Harada3, Hitoshi Takahashi2, Eishin Morita2,
Kaori Ishii4, Makiko Hiragun4, Michihiro Hide4 and Hiroaki Matsuo1, 1Department of Pathophysiology and Therapeutics, Graduate
School of Biomedical and Health Sciences, Hiroshima University,
Hiroshima, Japan, 2Department of Dermatology, Shimane University, Izumo, Japan, 3Harada Skin Clinic, Nishinomiya, Japan, 4Department of Dermatology, Graduate School of Biomedical and
Health Sciences, Hiroshima University, Hiroshima, Japan
Streptomycin in a Blueberry Pie? Risk of Allergic Sensitization
and Reaction to Antibiotics Contained in Foods
Francois Graham, MD, MSc1, Philippe Begin, MD, MSc1, Louis
P. Paradis, MD, FAAAAI1, Yves Babin, PhD2 and Anne M. Des
Roches, MD, FAAAAI3, 1CHUM, Hôpital Notre-Dame, Montreal,
QC, Canada, 2Ministere de lAgriculture, des Pêcheries et de lAlimentation du Quebec, Quebec, QC, Canada, 3CHU Sainte-Justine,
Severe Marijuana Allergy Controlled with Omalizumab
David B. Engler, MD, FAAAAI, Houston Allergy & Asthma
Clinic, Houston, TX, Alnoor A. Malick, MD, FAAAAI, The Allergy Clinic, Pasadena, TX, Sunil K. Saraf, MD, The Allergy
Clinic, The Woodlands, TX and Lisa Adams Dargel, PA-C, The Allergy Clinic, Manvel, TX
A Patient with Carminic Acid-Induced Anaphylaxis; Usefulness
of the Basophil Activation Test
Naoya Sugimoto1, Masao Yamaguchi1, Yuko Nakase1, Yusuke Tanaka1, Hiroyuki Tashimo1, Hidenori Arai1, Hiroshi Akiyama2, Hiroyuki Nagase, MD, PhD1 and Ken Ohta1,3, 1Teikyo University
School of Medicine, Tokyo, Japan, 2National Institute of Health
Sciences, Tokyo, Japan, 3National Hospital Organization Tokyo National Hospital, Tokyo, Japan
Anaphylactic Shock in Oral Allergy
Parwinder Gill and Gordon L. Sussman, MD, FAAAAI, University
of Toronto, Toronto, ON, Canada
Bullous Mastocytosis; Cutaneous or Systemic Disease?
Lauren Kinneman, MD1, Barbara Molloy, MD1, Robert Silverman, MD1, Jasbir Johal, MD1, Noel Mensah-Bonsu1 and Oral Alpan, MD2, 1Inova Fairfax Hospital, 2Amerimmune, LLC, VA
IgE Specific to Oxycodone Identified by ELISA Inhibition in a
Young Woman with Symptoms of Anaphylaxis Following Oral
Ingestion: First Case Report of Oxycodone-Mediated Anaphylaxis
Daniel A. Steigelman, MD, David Rose, MD, Robert Anthony Gomez and Tonya S. Rans, MD, Wilford Hall Ambulatory Surgical
Center, Lackland AFB, TX
Characteristics of Patients with Delayed Allergic Reactions to
Mammalian Meat Presenting to a Tertiary Care Academic
Medical Center in North Carolina
Maya R. Jerath, MD, PhD and Saira Zafar Sheikh, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC

FEBRUARY 2013
774
775
776
777
778
779
780
Pediatric Alpha-Gal: IgE Antibodies to Galactose-Alpha-1,3Galactose in Children Presenting with Delayed Urticaria or Anaphylaxis
Hayley James1, Josh L. Kennedy, MD1, Thomas Platts-Mills, MD
PhD, FAAAAI, FRS1, Amy Polen Stallings, MD2, Lisa J. Workman, BA1, Anubha Tripathi, MD1, Shawna Pochan, DNP, CNM1,
Charles Lane, MD3, Luis A. Matos, MD, MBA, FAAAAI4, Saju
S. Eapen, MD4, Dane C. McBride, MD, FAAAAI4, Peter W.
Heymann, MD1 and Scott P. Commins, MD, PhD1, 1University of
Virginia, Charlottesville, VA, 2Duke University, NC, 3Allergy Partners, Lynchburg, VA, 4Asthma and Allergy Center, Roanoke, VA
Appearance of CD63+ Basophils After Food Challenge Occurs
in Both Alpha-Gal Positive Subjects and Controls
Susan Mozzicato, MD1, Hayley James1, Michael H. Land, MD,
FAAAAI2, Shawna Pochan, DNP, CNM1, Lisa J. Workman, BA1,
Thomas Platts-Mills, MD, PhD, FAAAAI FRS1 and Scott P. Commins, MD PhD1, 1University of Virginia, Charlottesville, VA, 2Allergy, Southern California Permanente Medical Group, San Diego, CA
Positive Basophil Activation Test in a Patient with ExerciseInduced Anaphylaxis
Rafael Firszt, MD, University of Utah, Salt Lake City, UT
Maternal Transmission of Peanut Allergy Susceptibility Is Associated with IL-4 Promoter Demethylation in Offspring
Ying Song, MD, Ching-feng Huang, ChangDa Liu, Paul Faybusovich, Jia Chen, PhD and Xiu-Min Li, MD, Mount Sinai School of
Oral Sensitization to Peanut in Balb/c Mice Is Enhanced by
Dietary Elimination of Soybean Components - towards a Better
Mouse Model for Food Allergy
Lisa Chang, BS1, Hugh A. Sampson, MD, FAAAAI2 and Madhan
Masilamani, PhD2, 1Mt. Sinai School of Medicine, New York, NY,
2
Mount Sinai School of Medicine, New York, NY
Epicutaneous Sensitization Results in IgE-Dependent Intestinal
Mast Cell Expansion and Food Anaphylaxis
Raif Geha, MD1, Lisa Bartnikas, MD1, Michael Gurish2, Oliver
Burton1, Sabine Leisten1, Erin Janssen1, Hans C. Oettgen, MD,
PhD, FAAAAI1, Jacqueline Beaupre1, Christopher Lewis1, K.
Frank Austen3, Stephanie Schulte2, Jason L. Hornick, MD, PhD2
and Michiko K. Oyoshi, PhD1, 1Boston Childrens Hospital, Boston, MA, 2Brigham and Womens Hospital, MA, 3Brigham and
Womens Hospital/Harvard Medical School, Boston, MA
Anisakis Simplex Excretion/Secretion Antigens Inhibit Anaphylactic Response in a Murine Model
Guadalupe Marco Martn, MD, Alejandro La Rotta Hernandez,
MD, Patricia Martnez Lezcano, MD, Jose Manuel Zubeldia Ortuno,
MD, PhD and Mara L. Baeza Ochoa de Ocarz, MD, PhD, Hospital
General Universitario Gregorio Mara~non, Madrid, Spain
Food Allergy II
5204
781
782
Real-Time Surveillance of Epinephrine Administration in

Schools Supports the Argument for Stock Epinephrine
Availability
Elizabeth Ferzacca1,2, Alexandra R. Alejos, BA2, Robert Leibowitz,
PhD3, Michael Pistiner, MD, MMSc4, Wayne G. Shreffler, MD, PhD,
FAAAAI2,5 and Anne Sheetz, RN, BSN, MPH3, 1Barnard, 2Massachusetts General Hospital, Boston, MA, 3Massachusetts
Department of Public Health, Boston, MA, 4Harvard Vanguard Medical Associates, Boston, MA, 5Harvard Medical School, Boston, MA
24-Hour Helpline Access for Food Allergic Reaction Treatment
Advice in Children Prescribed Epinephrine Auto-Injectors:
Randomised Controlled Trial
783
784
785
786
787
788
Audrey Dunn Galvin1, Maeve M. Kelleher2, Aziz Sheikh3, Claire

Cullinane2, John Fitzsimons4 and Jonathan O. Hourihane1, 1University College Cork, Cork, Ireland, 2University College Cork, Ireland,
3
The University of Edinburgh, United Kingdom, 4Our Lady of
Lourdes Hospital Drogheda, Ireland
Events Reported to a 24 Hour Helpline for Food Allergic Reaction Treatment Advice in Children Prescribed Epinephrine
Auto-Injectors: Randomised Controlled Trial
Jonathan O. Hourihane1, Maeve M. Kelleher2, Audrey Dunn Galvin1, Claire Cullinane2, John Fitzsimons3 and Aziz Sheikh4, 1University College Cork, Cork, Ireland, 2University College Cork,
Ireland, 3Our Lady of Lourdes Hospital Drogheda, Ireland, 4The
University of Edinburgh, United Kingdom
Adult Food Allergy Knowledge and Attitudes Among Internists
and Family Practice Providers
Gillian Bassirpour, MD, University of Michigan, Division of Internal Medicine, Ann Arbor, MI and Alan P. Baptist, MD, MPH,
University of Michigan, Division of Allergy, Ann Arbor, MI
Perspectives of Parents and Caregivers Regarding Timing the
Transfer of Responsibilities for Anaphylaxis Recognition and
Use of an Epinephrine Auto-Injector From Adults to Children
and Teenagers
Elinor Simons, MD, MS, FAAAAI, Hospital for Sick ChildrenCHES, Toronto, ON, Canada, Scott H. Sicherer, MD, FAAAAI,
Mt. Sinai School of Medicine, New York, NY, Christopher C.
Weiss, PhD, Food Allergy & Anaphylaxis Network, Fairfax, VA
and F. Estelle R. R. Simons, MD, FAAAAI, University of Manitoba, Winnipeg, MB, Canada
Knowledge of the Ibero-American Physicians On Anaphylaxis:
Results of the Ibero-American Online Survey for Physicians On
the Management and Treatment of Anaphylaxis (IOSPTA) Latin American Society of Allergy, Asthma & Immunology
(LASAAI)
Dirceu Sole, MD PhD, Federal University of Sao Paulo, Sao Paulo,
Brazil, Juan C. Ivancevich, MD, Division of Immunology, Medical
School, Universidad del Salvador, Buenos Aires. Head of the Division of Allergy and Immunology, Clnica Santa Isabel, Buenos
Aires, Argentina and Victoria Cardona, MD, PhD, Hospital Universitari Vall DHebron, Barcelona, Spain
Anaphylaxis in the Adult Population: Are We Following Current Treatment Guidelines?
Yarden Yanishevsky, MD1, Ann Elaine Clarke, MD, MSc2,3, Sebastian La Vieille, MD4, Scott Delaney, MD5, Reza Alizadehfar, MD1,
Lawrence Joseph, PhD2,6, Judy Morris, MD7 and Moshe Ben-Shoshan,
MD, MSc1, 1Division of Paediatric Allergy and Clinical Immunology,
Department of Paediatrics, McGill University Health Center, Montreal, QC, Canada, 2Division of Clinical Epidemiology, Department
of Medicine, McGill University Health Centre, Montreal, QC, Canada,
3
Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada, 4Food
Directorate, Health Canada, Ottawa, ON, Canada, 5Department of
Emergency Medicine, McGill University Health Center, Montreal,
QC, Canada, 6Departments of Epidemiology and Biostatistics, McGill
University, Montreal, Canada, 7Department of Emergency Medicine ,
H^
opital du Sacre-Coeur, Montreal, QC, Canada
Anaphylaxis: Hospital Doctors Knowledge of Management
Guidelines
Jae Won Jeong, Inje University Ilsan Paik Hospital, Goyang, South
Korea, Chan Sun Park, Inje University Haeundae Paik Hospital, Busan, South Korea, Jae Woo Jung, Chungang University, Seoul,
South Korea, Hye Kyung Park, Pusan National University, Busan,
South Korea, Se Hoon Kim, Seoul National University Bundang
Hospital, Seongnam, South Korea, Tae Bum Kim, Asan Medical
Center, Seoul, South Korea, Seong Wook Son, Dongkuk University,
Goyang, South Korea, Jae Woo Kwon, Kangwon University, Chuncheon, South Korea and Sang Rok Lee, Cheongju St Marys Hospital, Cheongju, South Korea
789
790
791
792
793
794
795
796
Simulation-Based Education Is an Effective Teaching Tool for

Pediatric Trainees, in the Diagnosis and Management of
Pediatric Anaphylaxis
Natalie Beaven Miller, MD1, James Fehr1, Andrew White1,
Leonard B. Bacharier, MD, FAAAAI2 and Alysa G. Ellis, MD1,
1
Washington University, Saint Louis, MO, 2Department of
Pediatrics, Washington University School of Medicine and St.
Louis Childrens Hospital, Saint Louis, MO
Knowledge, Attitudes and Behaviors of Pediatric Residents Regarding Anaphylaxis Diagnosis and Management
Artemio M. Jongco III, MD, PhD, MPH1,2, Robert Sporter, MD1,
Sheila Bina, MD3, Marie A. Cavuoto Petrizzo, MD, FAAAAI4,
Susan Schuval, MD, FAAAAI5 and Blanka M. Kaplan, MD
FAAAAI1, 1Cohen Childrens Medical Center of New York, Great
Neck, NY, 2Feinstein Institute for Medical Research, Manhasset,
NY, 3Stony Brook University Hospital, Stony Brook, NY, 4ProHealth Care LLP, Westbury, NY, 5Stony Brook U Medical Cente,
Stony Brook University Medical Center, Stony Brook, NY
Creation and Validation of Web-Based Audiovisual Educational
Materials for Caregivers of Children with Food Allergy
Jamie Rosen and Scott H. Sicherer, MD, FAAAAI, Mt. Sinai
School of Medicine, New York, NY
Correct Parental Reaction Perception Affects Quality of Life in
Food Allergy
Laura E. Howe, MD1, Timothy J. Franxman, MD1 and Matthew J.
Greenhawt, MD, MBA, MSc2, 1University of Michigan, Ann Arbor,
MI, 2Department of Internal Medicine, The University of Michigan
Medical School, Division of Allergy and Clinical Immunology,
Ann Arbor, MI
Accuracy of Allergists Estimation of Anxiety in Children with
Food Allergy
Melissa Rubes1, Anna Podolsky2, Nicole Caso1, Rachel Annunziato1, Scott H. Sicherer, MD, FAAAAI3 and Eyal Shemesh2,
1
Fordham University, Bronx, NY, 2Mt. Sinai School of Medicine,
NY, NY, 3Mount Sinai School of Medicine, New York, NY
Treatment of Allergic Reactions and Quality of Life Among
Caregivers of Food Allergic Children
Claire E. Ward, MD, CS Mott Childrens Hospital, University of
Michigan, Department of Pediatrics, Ann Arbor, MI, Lynda Mitchell, Kids WIth Food Allergies Foundation, Doylestown, PA and
Matthew J. Greenhawt, MD, MBA, MSc, Department of Internal
Medicine, The University of Michigan Medical School, Division
of Allergy and Clinical Immunology, Ann Arbor, MI
The High Economic Burden of Childhood Food Allergy in the
United States
Ruchi Gupta, MD, MPH1,2, David Holdford, BSPharm, MS, PhD,
FAPhA3, Lucy Bilaver, PhD, MS, MPP1,4, Ashley Dyer, MPH1 and
David Meltzer, MD, PhD5, 1Northwestern University Feinberg
School of Medicine, Chicago, IL, 2Ann & Robert H. Lurie Childrens Hospital of Chicago, Chicago, IL, 3Virginia Commonwealth
University, Richmond, VA, 4Northern Illinois University, DeKalb,
IL, 5University of Chicago, Chicago, IL
Anaphylaxis Identification Using Direct and Combined ICD-9
Methods
Timothy Trojan, MD, University of Texas Southwestern at Dallas,
Dallas, TX, Ying Ma, PhD, Center for Clinical Innovation, Parkland
Health and Hospital System, Dallas, TX and David A. Khan, MD,
FAAAAI, University Texas SW Medical Center, Dallas, TX
Rhinitis/Rhinosinusitis
5205
797
CT-Imaging of the Upper Sinus Airways in a Model of Allergic

Sinus Congestion and Treatment
TUESDAY
Abstracts AB289

135
AB290 Abstracts
798
799
800
801
802
TUESDAY
136
803
804
Walter C. Spear, MS, Igor Patrikeev, PhD, Massoud Motamedi,

MD and Bill T. Ameredes, PhD, University of Texas Medical
Allergic Fungal Sinusitis: A Challenging Disorder for the Clinician
T.M. Nsouli1,2,3, C. Schluckebier3 and J. Bellanti1,2, 1Georgetown
University Medical Center, Washington, DC, 2International Center
for Interdisciplinary Studies of Immunology, Washington, DC,
3
Watergate and Burke Allergy and Asthma Centers, Washington,
DC
Post-Translational Modification of CCL23 in Chronic Rhinosinusitis with Nasal Polyps
Anjeni Keswani, MD1, Julie Poposki, MS1, Sarah Peterson,
MD1, Lydia Suh, BSc1, James Norton, MS2, Anju Peters, MD1,
Leslie C. Grammer, MD, FAAAAI1, Bruce Tan, MD3, Rakesh
Chandra, MD3, David Conley, MD3, Juan Jaen, PhD4, Thomas
Schall, PhD4, Robert Kern, MD5, Robert P. Schleimer, PhD,
FAAAAI2 and Atsushi Kato, PhD2, 1Northwestern University
Feinberg School of Medicine, Chicago, IL, 2Department of
Medicine, Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Northwestern
University Feinberg School Medicine, Chicago, IL, 4Chemocentryx Inc, 5Northwestern University Feinberg School of Medicine,
Chicago, IL
Increased Expression of the Epithelial Anion Transporter Pendrin in Nasal Polyp Tissues of Patients with Chronic Rhinosinusitis
Sudarshan Seshadri, PhD1, Xiang Lu, MD, PhD1, Andrew
Choi1, Roderick Carter, BSc1, James Norton, MS1, Atsushi
Kato, PhD1, Lydia Suh, BSc1, Anju Peters, MD1, David Conley,
MD2, Rakesh Chandra, MD2, Bruce Tan, MD2, Leslie C. Grammer, MD, FAAAAI1, Robert Kern, MD2 and Robert P. Schleimer,
PhD, FAAAAI1,2, 1Department of Medicine, Division of
Allergy-Immunology, Northwestern University Feinberg School
of Medicine, Chicago, IL, 2Department of Otolaryngology,
Northwestern University Feinberg School of Medicine,
Chicago, IL
Evaluation of Allergies in Children with Recurrent Ear and Sinus Infections
Rafka Chaiban, MD, Chadi A. Makary, MD, Benjamin Addicks
and Yesim Yilmaz Demirdag, MD, West Virginia University School
of Medicine, Morgantown, WV
Patients Living with Allergy Symptoms: The Allergies, Immunotherapy,
Mark S. Dykewicz, MD, FAAAAI, Wake Forest University School
of Medicine, Winston Salem, NC, Michael S. Blaiss, MD,
FAAAAI, Allergy and Asthma Care, Memphis, TN, Bryan D.
Leatherman, MD, Coastal Ear, Nose and Throat Associates, Gulfport, MS, David P. Skoner, MD, West Penn Allegheny Health System, Cranberry TWP, PA, Nancy Smith, MS, Merck & Co, INc,
WhiteHouse Station, NJ and Felicia C. Allen-Ramey, PhD, Merck
& Co, Inc, West Point, PA
A Novel Validated Electronic Patient Data Acquisition Tool
Standardizes Patient Reported Outcomes (PRO) Data Acquisition Across Multi-Center Environmental Exposure Chamber
and Field Studies
Dan Wilson1, Giles Wilson1 and Piyush Patel, MD, FRCP2, 1Logos
Technologies Inc, London, United Kingdom, 2Inflamax Research,
Mississauga, ON, Canada
Novel Natural Exposure Chamber Technology Mimics Environmental Allergen Levels Whilst Providing Well-Controlled Airborne Allergen Exposures with High Specificity to Allergic
Patients
Harry Nandkeshore, MT (AMT), CCRP, Karen Shields, RT, Stephanie Recker, MSC, CCRP and Piyush Patel, MD, FRCP, Inflamax
Research, Mississauga, ON, Canada

FEBRUARY 2013
Immunotherapy/Immune Deficiencies
5206
805
806
807
808
809
810
Efficacy of and Adherence with Subcutaneous Allergen Immunotherapy: Comparison Between Allergic Rhinitis and Mixed
Rhinitis
Gang Cheng, MD, PhD1, Andrew M. Smith, MD 1,2 and Jonathan
A. Bernstein, MD3, 1Division of Immunology Allergy & Rheumatology, University of Cincinnati Medical Center, CINCINNATI,
OH, 2Cincinnati VA Medical Center, CINCINNATI, OH, 3University of Cincinnati Medical Center, Cincinnati, OH
Experience with Scig Infusion in Patients with Primary Immunodeficiencies: From Clinical Trials to Real-World Practice
Emily Carne1, Zoya Panahloo2, Gillian Potter3, Nicola SalomeBentley4, Christine Symons5, Jane Gilliam5, Sarita Workman6, Sophie Barber1, Katrin Morris1, Tariq El-Shanawany1 and Stephen
Jolles1, 1University Hospital of Wales, Cardiff, United Kingdom,
2
CSL Behring UK Ltd, Haywards Heath, United Kingdom, 3University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, 4John Radcliffe Hospital, Oxford, United
Kingdom, 5Plymouth Hospital NHS Trust, Plymouth, United Kingdom, 6Royal Free Hospital, London, United Kingdom
Individuals, Subgroups or Cohorts? A Population Pharmacokinetic Modeling Approach to Optimize Dosing of Hizentra
Martin Bexon, MD1, Jonathan M. Edelman, MD2, Mikhail Rojavin, PhD2, Jutta Neufang-Hueber3, Jagdev S. Sidhu4 and Cornelia
Landersdorfer5, 1Clinical Research and Development, CSL Behring
AG, Berne, Switzerland, 2Clinical Research and Development, CSL
Behring LLC, King of Prussia, PA, 3Global Clinical Operations,
CSL Behring AG, Berne, Switzerland, 4Clinical Pharmacology &
Early Development, CSL Ltd, Parkville, Australia, 5Centre for
Medicine Use and Safety, Monash University, Parkville, Australia
Use of Modified (Cluster) Rush Immunotherapy to Safely
Reach Maintenance in Pediatric Patients Who Fail a Conventional Schedule
Julia A. Cronin, MD1, Deborah D. Murphy, RN1, Amy Polen Stallings, MD2, Scott P. Commins, MD, PhD1 and Peter W. Heymann,
MD1, 1University of Virginia, Charlottesville, VA, 2Duke University, NC
Ragweed Allergy Immunotherapy Tablet Reduces Use of Ocular Antihistamines in Patients with Ragweed PollenInduced
Allergic Rhinoconjunctivitis
David I. Bernstein, MD, FAAAAI1,2, Hendrik Nolte, MD, PhD3,
Peter Creticos, MD, FAAAAI4, Amarjot Kaur, PhD3, Nancy Liu,
PhD5, Gary D. Berman, MD, FAAAAI6, Jacques Hebert, MD7
and Jennifer Maloney, MD3, 1University of Cincinnati, Cincinnati,
OH, 2Bernstein Clinical Research Center, LLC, Cincinnati, OH,
3
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc,
Whitehouse Station, NJ, 4Johns Hopkins University School of Medicine, Baltimore, MD, 5Merck, Whitehouse Station, NJ, 6Allergy
and Asthma Specialists, Minneapolis, MN, 7Centre de Recherche
Applique en Allergie de Quebec, Quebec City, QC, Canada
Effect of Allergy Immunotherapy Tablet in Patients with or
without Local Application-Site Reactions
Gary D. Berman, MD, FAAAAI1, Michael S. Blaiss, MD,
FAAAAI2, Peter Creticos, MD, FAAAAI3, Jennifer Maloney, MD4,
Kevin R. Murphy, MD5, Harold S. Nelson, MD, FAAAAI6, Amarjot
Kaur, PhD4, Nancy Liu, PhD7 and Hendrik Nolte, MD, PhD4, 1Allergy and Asthma Specialists, Minneapolis, MN, 2University of Tennesse Health Science Center, Memphis, TN, 3Johns Hopkins
University School of Medicine, Baltimore, MD, 4Merck Sharp &
Dohme Corp., a subsidiary of Merck & Co., Inc, Whitehouse Station,
NJ, 5Boys Town National Research Hospital, Boys Town, NE, 6National Jewish Health, Denver, CO, 7Merck, Whitehouse Station, NJ
Abstracts AB291

812
813
The Effects of Pollen Season On Adverse Reactions to SCIT

Devi Jhaveri, DO1, Julie Abraham, MD2, Shiela Bigelow, DO2,
Lyndsy Boggs, DO2, Megan Betteley, BS3, Mary Ann ORiordan,
MS2, David A. Swender, DO4, Leah W. Chernin, DO5, Theodore
H. Sher, MD, FAAAAI6, Robert W. Hostoffer, DO6 and Haig
Tcheurekdjian, MD, FAAAAI6, 1University Hospitals, South Euclid, OH, 2Rainbow Babies and Childrens Hospital, Cleveland,
OH, 3Case Western Reserve University School of Medicine, Cleveland, OH, 4Oaklawn Medical Group, Marshall, MI, 5University
Hospitals Richmond Medical Center, Cleveland Heights, OH, 6Allergy/Immunology Associates, Inc., South Euclid, OH
AAAAI Survey On Allergen Immunotherapy (AIT) in Patients
with Specific Medical Conditions
Desiree E.S. Larenas Linnemann, MD, FAAAAI, Hospital
Medica Sur, Mexico city, Mexico, David W. Hauswirth, MD,
FAAAAI, The Ohio State University, Columbus, OH, Christopher
W. Calabria, MD, Dilley Allergy and Asthma, Helotes, TX,
Lawrence D. Sher, MD, FAAAAI, Peninsula Research Associates,
Rolling Hills Estates, CA and Matthew A. Rank, MD, FAAAAI,
Mayo Clinic, Scottsdale, AZ
The Incidence of Systemic Allergic Reaction During Subcutaneous and Cluster Immunotherapy: A Retrospective Chart
Review
Danielle S. Seiden, Jefferson Medical College, Philadelphia, PA,
Jayeon Lee, RN, NYEE, New York, NY, Gabriele De Vos, MD,
Albert Einstein College of Medicine, Bronx, NY and Jennifer S.
Collins, MD, New York Eye and Ear Infirmary, New York,
NY
Asthma Therapeutic Updates
818
Immunodeficiency
5602
Tuesday, February 26th, 2013, 2:00 PM - 3:15 PM
819
820
821
822
5601
814
815
816
817
A Randomized Placebo-Controlled Safety and Pharmacodynamic Study of KB002, a Chimeric Anti-GM-CSF Monoclonal
Antibody, in Patients with Asthma
Nestor A. Molfino, MD, MSc1, Philip G. Bardin, MD, PhD2, Philip
J. Thompson, MD3, Alison Luckey, BM, DPM4 and Geoffrey Yarranton, PhD1, 1Kalobios, 2Monash University and Medical Centre,
Melbourne, Australia, 3University Department of Medicine, Claremont, Australia, 4Primorus Health, New Zealand
Over-Expression of the LTC4 Synthase Gene in Mice Reproduces Human Aspirin-Induced Asthma
Tatsuya Yokoyama1, Hirokuni Hirata2, Mineaki Watanabe1, Naruo
Yoshida1, Taichi Shiobara1 and Takeshi Fukuda3, 1Dokkyo medical
university, Japan, 2dokkyo, 3Dokkyo Medical University School of
Medicine, Mibu, Japan
Effect of Inhaled Corticosteroids (ICS) Vs. Inhaled Corticosteroid with Long-Acting Beta2 Agonists (ICS/LABA) On Asthma
Control: Results From National Asthma Survey
Neetu Talreja, MD, Dennis K. Ledford, MD, FAAAAI and Richard F. Lockey, MD, Morsani College of Medicine University of
South Florida and James A. Haley Veteran Hospital
A Randomized, Double-Blind, Placebo-Controlled, MultipleDose Study to Evaluate the Safety, Tolerability, and Efficacy
of Brodalumab (AMG 827) in Subjects with Moderate to Severe
Asthma
William W. Busse, MD, FAAAAI, University of Wisconsin School
of Medicine and Public Health, Madison, WI, Stephen T. Holgate,
MD, DSc, FAAAAI, Southampton General Hospital, Southampton,
United Kingdom, Edward M. Kerwin, MD, FAAAAI, Allergy and
Asthma Center of Southern OR, Medford, OR, Yun Chon, PhD,
Amgen Inc, Thousand Oaks, CA, JingYuan Feng, Amgen, Inc,
Thousand Oaks, CA, Joseph H. Lin, MD, Amgen, Newbury Park,
CA and Shao-Lee Lin, MD, FAAAAI, Amgen, Inc., Thousand

Oaks, CA
Calcium-Dependent Pathways Are Essential for Canonical Glucocorticoid [GR] Receptor Signaling
Ashwini Reddy, MD, UTMB, Galveston, TX, Lata Kaphalia, PhD,
UTMB and William J. Calhoun, MD, FAAAAI, University of Texas
823
Evaluation of the B Cell Compartment in CVID and Respi Patients

Tracy Hwangpo, MD, PhD1, Ewa Szymanksa1, Cunren Liu1,
Marsha Brand1, Elizabeth Brown1 and Harry Schroeder2, 1UAB,
2
UAB, AL
Continuous G-CSF Ttreatment Induces Complete Clinical
Remission and Restoration of IL-17 Secretion in Autosomal
Dominant Chronic Mucocutaneous Candidiasis
Eduardo Shahar, MD1,2, G Wildbaum2, R Katz1, N Karin2, Amos
Etzioni, MD2,3 and Shimon Pollack, MD1,2, 1Rambam Medical
Center, Haifa, Israel, 2Rappaport Faculty of Medicine-Technion,
Haifa, Israel, 3Meyer Children Hospital, Haifa, Israel
Bacterial Specificity of IgM and Susceptibility to Pneumonia in
Primary Humoral Immunodeficiency
Paul J. Maglione, MD, PhD, Mount Sinai Medical Center, New
York, NY and Charlotte Cunningham-Rundles, MD, PhD, FAAAAI,
Mt. Sinai Medical Center, New York, NY
TREC Newborn Screening Can Identify Patients with Leaky
SCID and May Improve Outcome
Alice Chan, MD, PhD1, Morton Cowan, MD2, Jennifer M. Puck,
MD1,2 and Laurence E. Cheng, MD, PhD3, 1UCSF, San Francisco,
CA, 2University of California San Francisco, San Francisco, CA,
3
UCSFMedical Center, San Francisco, CA
Disseminated HPV Following Stem Cell Transplant (SCT) in
NK(-) Severe Combined Immune Deficiency (SCID) and Association with NK Cell Dysfunction
Kapil Saxena, MS21, Sarah K. Nicholas, MD2, Pinaki Banerjee,
PhD3, Filiz Seeborg, MD, MPH3, Theresa Wright, MD4, Caridad
Martinez, MD5, Jordan Orange, MD, PhD, FAAAAI3 and I. Celine
Hanson, MD, FAAAAI3, 1Baylor College of Medicine/Texas Childrens Hospital, Houston, TX, 2Pediatric Immunology, Allergy, and
Rheumatology, Baylor College of Medicine, Houston, TX, 3Allergy
and Immunology Service/Texas Childrens Hospital/Baylor College
of Medicine, Houston, TX, 4Dermatology Service/Texas Childrens
Hospital/Baylor College of Medicine, Houston, TX, 5Center for
Cell and Gene Therapy/Texas Childrens Hospital/Baylor College
of Medicine, Houston, TX
Effects of Viral and Bacterial Infections on Asthma

5603
824
Characterization of RV-Specific T Cell Responses in Healthy

and Infected Individuals
John W. Steinke, PhD, FAAAAI1, Lixia Liu, MD2, Joshua L. Kennedy, MD2, Peter W. Heymann, MD2, Thomas J. Braciale, MD3 and
Larry Borish, MD, FAAAAI1, 1Asthma and Allergic Disease Center, Carter Center for Immunology Research, University of Virginia,
Charlottesville, VA, 2University of Virginia, Charlottesville, VA,
3
University of Virginia Hospital, Charlottesville, VA
TUESDAY
811
137
AB292 Abstracts
825
826
827
828

FEBRUARY 2013
Differential Effects of HRV Species On Cold and Asthma Symptoms

Hiba Bashir, MD1, Yury Bochkov, PhD2, Fue Vang3, Tressa Pappas, BS2, Kristine Grindle3, Theresa Kang, RN2, Lisa Salazar,
BS2, Elizabeth L. Anderson, BSN, MA2, Sheila Turcsanyi3, Michael D. Evans, MS2, Ronald E. Gangnon, PhD2, Kirsten Kloepfer,
MD3, Daniel J. Jackson, MD4, Robert F. Lemanske Jr., MD
FAAAAI2 and James Gern, MD, FAAAAI2, 1University of Wisconsin Hospitals and Clinics, Madison, WI, 2University of Wisconsin
School of Medicine and Public Health, Madison, WI, 3University
of Wisconsin, Madison, WI, 4Pediatrics, University of Wisconsin
School of Medicine and Public Health, Madison, WI
Effects of Human Rhinovirus Species On Viral Replication in
Differentiated Sinus Epithelial Cells
Kazuyuki Nakagome, MD, Yury Bochkov, PhD, Shamaila Ashraf,
PhD, Rebecca Brockman-Schneider, MS and James Gern, MD,
FAAAAI, University of Wisconsin School of Medicine and Public
Health, Madison, WI
Role of Mycoplasma Pneumoniae in Childhood Asthma
Edward G. Brooks, MD, Vanessa Hill, MD, Margaret Burks, BS,
Jay Peters, MD, Harjinder Singh, MD, Thirumalai Kannan, PhD,
Schruthi Vale, MS, Mariana Cagle, Molly Principe, Joel Barry
Baseman, PhD and Pamela R. Wood, MD, Univ. Texas Health Science Center San Antonio, San Antonio, TX
Detection of Streptococcus Pneumoniae and Human Rhinovirus
Is Associated with Loss of Asthma Control
Kirsten Kloepfer, MD, Rose Vrtis, BS, Tressa Pappas, BS, Theresa
Kang, RN, Lisa Salazar, BS, Elizabeth L. Anderson, BSN MA,
Yury Bochkov, PhD, Wai-Ming Lee, PhD, Michael D. Evans,
MS, Ronald E. Gangnon, PhD, Robert F. Lemanske Jr., MD
FAAAAI and James Gern, MD, FAAAAI, University of Wisconsin
School of Medicine and Public Health, Madison, WI
833
Improving Asthma Outcomes

5605
834
835
Drug/AD
5604
829
830
TUESDAY
138
831
832
Safely Diagnosing Clinically Significant Penicillin Allergy with

Only Penicilloyl-Poly-Lysine, Penicillin, and Oral Amoxicillin
Eric M. Macy, MD, FAAAAI, 5th Floor, SCPMG-Kaiser Permanente San Diego, San Diego, CA and Eunis Ngor, MS, Kaiser Permanente Heath Care Program, Department of Research and
Evaluation, Pasadena, CA
Protein Haptenation by Amoxicillin: Immunological Detection
with Monoclonal Anti-Amoxicillin Antibodies and Identification
of Candidate Target Proteins in Human Serum
Adriana Ariza1,2, Daniel Ruiz-Abanades1,2, Vivian de los Ros1,
Miguel Blanca, MD, PhD3, Mara Jose Torres, MD, PhD3 and Dolores Perez-Sala1, 1Department of Chemical and Physical Biology,
Centro de Investigaciones Biologicas, C.S.I.C., Madrid, Spain, 2Research Unit for Allergic Diseases, Fundacion IMABIS-Hospital
Carlos Haya, Malaga, Spain, 3Allergy Service, Carlos Haya Hospital, Malaga, Spain
Th2 Cytokines and Filaggrin Deficiency Enhance Staphylococcus Aureus Alpha-Toxin Induced Keratinocyte Death
Anne M. Brauweiler, PhD1, Elena Goleva, PhD2, Michiko K.
Oyoshi, PhD3, Raif S. Geha, MD3 and Donald Y.M. Leung,
MD, PhD1, 1Department of Pediatrics, Division of Allergy-Immunology, National Jewish Health, Denver, CO, 2National Jewish
Health, Department of Pediatrics, Denver, CO, 3Division of Immunology, Childrens Hospital, Harvard Medical School, Boston,
MA
An Open Label Study in Adults with Atopic Dermatitis to Assess Immune Response to Fluzone Intradermal Vaccine
Donald Y.M. Leung, MD, PhD1, Chris Cheadle, PhD2, Joanne

Streib, BA3, Trudi Madigan, RN3, Susan B. Leung, RN3, Caroline
Bronchick, RN3, Seungshin Rhee, MS4, Kathleen C. Barnes, PhD,
FAAAAI2, Gloria David, PhD4 and Adriana Weinberg, MD5, 1Department of Pediatrics, Division of Allergy-Immunology, National
Jewish Health, Denver, CO, 2Johns Hopkins University, Baltimore, MD, 3Department of Pediatrics, Division of Allergy- Immunology, National Jewish Health, Denver, CO, 4Rho, Inc.,
Chapel Hill, NC, 5University of Colorado Heath Sci Ctr., Denver,
CO
Selective Transgenic Expression of IL-22 in the Skin Induces
Atopic Dermatitis (AD) Like Dermatitis
Hongfei Lou, MD1, Min-Hee OH, PhD Student1, Li Zhou, PhD1,
Fan Wu, B.S.1, Zhou Zhu, MD, PhD2 and Tao Zheng, MD1, 1Johns
Hopkins University, Baltimore, MD, 2The Johns Hopkins University School of Medicine, Baltimore, MD
836
837
838
School-Based Asthma Clinic Improves Asthma Outcomes

Alysa G. Ellis, MD1, Emily Glynn, PNP-BC2, Lisa D. Henry, PNPBC2, Lisa A. Meadows, PNP-BC2, Deborah Loman, PhD, CPNP3,
Diana Sundara3, Anyah Land2, Catherine Rains2, Jonathan Strutt,
MD4, Kali Svarczkopf, MD4 and Robert C. Strunk IV, MD,
FAAAAI4, 1Washington University, Saint Louis, MO, 2St. Louis
Childrens Hospital, Saint Louis, MO, 3St. Louis University School
of Nursing, Saint Louis, MO, 4Washington University School of
Medicine, Saint Louis, MO
Factors Related to Decision Making and Substance Use in Adolescents with Asthma: A Presenting Clinical Profile
Mary C. OLaughlen, PhD, RN, FNP-BC, Patricia J. Hollen,
PhD, RN, FAAN, Wenjun Xin, MS, James T. Patrie, MS, Ivora
D. Hinton, PhD and Martha A. Hellems, MD, MS, University of
Interviewing Adolescents with Asthma: Are We Doing
Enough?
Matthew Altman, MD, University of Washington, Seattle, WA,
Andrea J. Apter, MD, MA, MSc, FAAAAI, University of Pennsylvania, Media, PA, Kenneth Ginsburg, MD, The Childrens Hospital of Philadelphia, Philadelphia, PA and David R. Naimi, DO,
Northwest Asthma and Allergy Center, Seattle, WA
Comparative Effectiveness of Budesonide/Formoterol Combination (BFC) and Fluticasone/Salmeterol Combination (FSC)
Among Asthma Patients
Setareh Williams1, Ozgur Tunceli2, David Kern2, Ned Pethick1,
Hanaa Elhefni1, Catrin Wessman1, Siting Zhou2 and Frank Trudo1,
1
AstraZeneca, 2HealthCore
University and Public Health System Partnership: A Systematic
Intervention for Assistance of Patients with Asthma in Brazil
Marcos R. Goncalves, MD1, Janaina Melo, MD2, Adriana S. Moreno, PhD2, Virginia Ferriani, MD, PhD2, Ana Carla Araujo, MD,
PhD2, Elcio Vianna, MD, PhD2, Marcos Borges, MD, PhD2, Persio
Roxo Jr, MD, PhD2, Rosa Ferreira, MD, PhD3, Luane Mello, MD,
PhD2, Jorgete Silva, MD, PhD2, Patricia Stefanelli, MD2, Larissa
Oliveira, MD2, Andrea Vernier, MD2, Luana Queiroz, MD2, Rosangela Villela, MD2, Marina Dias2, Davi Aragon2, Nelio Domingos,
MD4 and L. Karla Arruda, MD, PhD, FAAAAI2, 1School of Medicine of Ribeirao Preto - University of Sao Paulo, Ribeirao Preto,
Brazil, 2School of Medicine of Ribeirao Preto - University of Sao
Paulo, 3University Center Barao de Maua, Ribeirao Preto, Brazil,
4
Department of Pediatrics - Prefeitura Municipal, Ribeirao
Prto
Abstracts AB293

Sittichai Koontongkaew2, 1Thammasat University, Pathumtani,

Thailand, 2Thammasat University, Pathumtani
Rhinitis and Rhinosinusitis Pathophysiology

5606
840
841
842
843
Evaluation of in Vivo and in Vitro Responses to Nole e1 in Systemic and Local Allergic Rhinitis
Paloma Campo, MD, PhD1, Carmen M. Rondon Segovia, MD2,
Mayte Villalba, PhD3, Cristobalina Mayorga, PhD4, MJ SanchezQuintero, BS5, Oscar Palomares, PhD3, Luisa Galindo, RN2, Lidia
Melendez, Lab. Tech.5, Jose Luis Rodriguez-Bada, Lab. Tech.5 and
Miguel Blanca, MD, PhD2, 1Allergy Service Carlos Haya Hospital,
Malaga, Spain, 2Carlos Haya Hospital, Malaga, Spain, 3Department
of Biochemistry and Molecular Biology, Faculty of Chemistry, Madrid, Spain, 4Research Laboratory, Carlos Haya Hospital, Malaga,
Spain, 5Research Laboratory, Hospital Carlos Haya, Malaga, Spain
Levels of the Cytokines IL-5, IL-13 and Rantes in Nasal Lavage
Fluids Parallel the Cytokine Content of Nasal Polyps in Patients
with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Christopher Ocampo, MD, PhD, Lydia Suh, BSc, Robert Kern,
MD, Atsushi Kato, PhD, David Conley, MD, Rakesh Chandra,
MD, Bruce Tan, MD, James Norton, MS, Anju Peters, MD, Leslie
C. Grammer, MD, FAAAAI and Robert P. Schleimer, PhD,
FAAAAI, Northwestern University Feinberg School of Medicine,
Chicago, IL
Aeroallergen Wheal Area Especially for Molds At Ages Two
and Three Predicts Allergic Rhinitis At Age Four: The Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS)
Christopher D. Codispoti, MD, PhD1, Grace K. LeMasters, PhD2,
Linda Levin, PhD2, Patrick Ryan, PhD3, Tiina Reponen, PhD2, Gurjit K. Khurana Hershey, MD, PhD, FAAAAI4, Manuel S. Villareal,
MD, FAAAAI2,5, James E. Lockey, MD, MS, FAAAAI6 and David
I. Bernstein, MD, FAAAAI2, 1University of Cincinnati, 2University
of Cincinnati, Cincinnati, OH, 3Cincinnati Childrens Hospital
Medical Center, Cincinnati, OH, 4Childrens Hospital Medical Center, Cincinnati, OH, 5Fragge Allergy and Asthma Clinics, PSC, Fort
Mitchell, KY, 6University Cincinnati College Medicine, Cincinnati,
OH
Decreased Production of Antimicrobial Peptides in Chronic
Rhinosinusitis Associated with Age and Elevated Soluble gp130
Sun Hye Lee, PhD1, Seong Ho Cho, MD1, Kathryn E. Hulse,
PhD1, James Norton, MS1, Jason Siebert1, David Conley, MD2, Rakesh Chandra, MD2, Anju Peters, MD1, Robert Kern, MD1,2, Leslie
C. Grammer, MD, FAAAAI1 and Robert P. Schleimer, PhD,
FAAAAI1,2, 1Department of Medicine, Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine,
Chicago, IL, 2Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, IL
Inhibitory Effects of Mometasone Furoate and Azithromycin
On Phorbol Ester-Induced Mucin Production From Human
Airway Epithelial Cells
Orapan Poachanukoon, MD1, Napaporn Pattanacharoenchai2 and
Recent Advances in Eosinophil and Mast Cell

Biology
5607
844
845
846
847
848
Mice with Attenuated Expression of the a2, 3 Sialyltransferase

ST3gal-III (St3gal3) Display Enhanced Allergic Eosinophilic
Airway Inflammation
Takumi Kiwamoto, MD, PhD, Mary E. Brummet, Mary Motari,
Ronald Schnaar, PhD, Zhou Zhu, MD, PhD and Bruce S. Bochner,
MD, FAAAAI, The Johns Hopkins University School of Medicine,
Baltimore, MD
Epicutaneous Sensitization in Filaggrin Gene-Depleted Mouse
Induces Prolonged Airway Eosinophilia without Obvious Dermatitis
Yusuke Suzuki1,2, Katsunori Masaki1, Shizuko Kagawa1,2, Hiroshi
Kawasaki3,4, Keisuke Nagao3, Akiharu Kubo3,5, Tomoko Betsuyaku1, Masayuki Amagai3 and Koichiro Asano6, 1Division of
Pulmonary Medicine, Department of Medicine, Keio University
School of Medicine, Tokyo, Japan, 2MSD Endowed Program for
Allergy Research, Tokyo, Japan, 3Department of Dermatology,
Keio University School of Medicine, Tokyo, Japan, 4The Association for Preventive Medicine of Japan, Tokyo, Japan, 5Center of
Integrated Medical Research, Tokyo, Japan, 6Department of Pulmonary Medicine, Tokai University School of Medicine, Isehara,
Japan
Thymic Stromal Lymphopoietin Promotes Peripheral Blood
CD34+ Cell Eosinophilic Lineage Commitment
Claudia C.K. Hui, MSc, Sina Rusta-Sallehy, BSc, Delia Heroux,
BSC and Judah Aryeh Denburg, MD, FRCPC, FAAAAI, McMaster
University, Hamilton, ON, Canada
Hypoxia Inducible Factor (HIF) Alpha Subunits Modulate Eosinophil Migration, Oxidative Burst, and Degranulation
Laura E. Crotty Alexander, MD1,2, Shari Nicatia, BSc1,3, Elisa
McEachern, BS1, Randall Johnson, PhD4, David H. Broide, MB,
ChB, FAAAAI5 and Victor Nizet, MD2, 1VA San Diego Healthcare
System, La Jolla, CA, 2University of California, San Diego, La
Jolla, CA, 3Utrecht University, Utrecht, Netherlands, 4University
of Cambridge, United Kingdom, 5Division of Allergy, Immunology
Functional Expression of the Novel C5a Receptor C5L2 in Human Mast Cells
Priyanka Pundir, DVM1,2 and Marianna Kulka, PhD2, 1Department of Biomedical Sciences, Atlantic Veterinary College, Charlottetown, PE, Canada, 2National Research Council Canada,
Charlottetown, PE, Canada
TUESDAY
839
139
ACGME Competency Index

To contribute to the development of our members as lifelong learners
and to enhance the effectiveness of the CME activities it provides, the
AAAAI uses the six competencies defined by the Accreditation Council
for Graduate Medical Education (ACGME) to guide its educational
programming decisions. The six competencies are:
Patient Care
Medical Knowledge
Practice-Based Learning and Improvement
Interpersonal and Communication Skills
Professionalism
Systems-Based Practice
All sessions at the Annual Meeting address the competencies of
Patient Care and Medical Knowledge. Below is a list of sessions that
address the other competencies:
Interpersonal and Communication Skills

0001, 1101C, 1203, 1206, 1208, 1209, 1211, 1501, 1601, 1602, 1603,
1606, 1611, 1611B, 1611D, 1812, 2004, 2012, 2022, 2023, 2311,
2621, 2624, 2625, 2801, 2802, 2803, 2811, 2822, 2827, 3005, 3011,
3315, 3524, 3551, 4006, 4011, 4806, 4807, 4830, 5007, 5504
Practice-Based Learning and

Improvement
Professionalism
0001, 1102, 1208, 1501, 1601, 1605, 1607, 1816, 1820, 2007, 2014,
2015, 2021, 2022, 2302, 2311, 2312, 2315, 2507, 2512, 2514, 2808,
2809, 2810, 3007, 3009, 3014, 3302, 3305, 3520, 3521, 3527, 4007,
4014, 4015, 4301, 4806, 4807, 4808, 4812, 4814, 4816, 4827, 5001,
5007, 5008, 5301, 5304, 5504, 5505, 5708, 5710, 5711
System-Based Practice
0001, 1011, 1103, 1201, 1201A, 1201B, 1201C, 1201D, 1203, 1204,
1205, 1207, 1208, 1209, 1210, 1211, 1211A, 1211B, 1211C, 1211D,
1213, 1301, 1302, 1401, 1402, 1403, 1501, 1602, 1603, 1604, 1605,
1608, 1610, 1611, 1611A, 1611B, 1611C, 1611D, 1612, 1711, 1712,
1811, 1812, 1813, 1814, 1815, 1816, 1818, 1819, 1820, 2001, 2002,
2004, 2007, 2008, 2009, 2011, 2013, 2014, 2015, 2021, 2023, 2301,
2302, 2303, 2304, 2306, 2307, 2308, 2502, 2504, 2507, 2508, 2509,
2511, 2513, 2514, 2515, 2522, 2525, 2527, 2624, 2625, 2802, 2803,
2804, 2805, 2808, 2809, 2810, 2811, 2812, 2813, 2814, 2815, 2816,
2818, 2819, 2824, 3004, 3007, 3011, 3014, 3041, 3301, 3302, 3303,
3304, 3305, 3306, 3308, 3522, 3524, 3525, 3526, 3527, 4001, 4002,
4004, 4006, 4007, 4010, 4011, 4013, 4014, 4101, 4301, 4305, 4804,
4807, 4808, 4809, 4810, 4812, 4813, 4815, 4816, 4819, 4822, 4827,
4828, 4829, 5001, 5002, 5005, 5007, 5008, 5009, 5010, 5011, 5013,
5014, 5015, 5301, 5302, 5304, 5307, 5501, 5503, 5504, 5701, 5702,
5705, 5706, 5707, 5708, 5710, 5712, 5713
0001, 1011, 1101, 1101A, 1101B, 1101C, 1101D, 1103, 1201, 1201A,
1201B, 1201C, 1201D, 1202, 1203, 1204, 1205, 1207, 1208, 1209,
1210, 1211, 1211A, 1211B, 1211C, 1211D, 1212, 1213, 1301, 1302,
1401, 1402, 1403, 1501, 1602, 1603, 1604, 1605, 1608, 1609, 1610,
1611, 1611A, 1611B, 1611C, 1611D, 1612, 1712, 1801, 1811, 1812,
1813, 1814, 1815, 1816, 1817, 1818, 1819, 1820, 2001, 2002, 2003,
2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2013, 2014, 2015,
2021, 2023, 2024, 2025, 2301, 2302, 2303, 2304, 2305, 2306, 2308,
2312, 2313, 2314, 2315, 2316, 2501, 2502, 2503, 2504, 2505, 2506,
2507, 2508, 2509, 2510, 2511, 2513, 2514, 2515, 2521, 2522, 2523,
2524, 2525, 2526, 2621, 2622, 2623, 2624, 2625, 2802, 2803, 2804,
2805, 2806, 2807, 2808, 2809, 2810, 2811, 2813, 2814, 2815, 2816,
2817, 2818, 2819, 2821, 2822, 2823, 2824, 2825, 2826, 3001, 3002,
3003, 3004, 3006, 3007, 3008, 3009, 3010, 3011, 3012, 3013, 3014,
3015, 3041, 3042, 3043, 3044, 3101, 3301, 3302, 3303, 3304, 3305,
3306, 3307, 3311, 3312, 3313, 3314, 3315
141
Exhibits
Abbott Nutrition
ALK, Inc.
3300 Stelzer Road

Columbus, OH 43219
Phone: (614) 624-7677
www.abbottnutrition.com
Booth #254
Abbott Nutrition is one of the worlds leading authorities in sciencebased nutrition for all stages of life. As your nutrition partner, we invite
you to visit us and explore our portfolio of products, including EleCare,
PediaSure Peptide, and PediaSure to help your patients grow and
achieve greater well being. Nutritional Products: EleCare, PediaSure
Peptide and PediaSure.
1700 Royston Ln.

Round Rock, TX 78664
Phone: (800) 325-7354
www.ask.net/us
Booth #361
Actient Pharmaceuticals LLC

150 S. Saunders Rd., Ste. 120
Lake Forest, IL 60045
Phone: (847) 582-9853
www.actientpharma.com
Booth #558
Actient Pharmaceuticals LLC is a Chicago-area based specialty
therapeutics company currently focused on urology and respiratory
conditions. Our product line includes Semprex-D and Theo-24. Actient
is thrilled to be participating in our second AAAAI Annual Meeting!
Aerocrine
5151 McCrimmon Parkway, Suite 260
Morrisville, NC 27560
Phone: (919) 518-3073
www.aerocrine.com/
Booth #146
Aerocrine AB is a medical technology company focused on the
improved management and care of patients with inflammatory airway
diseases. As the pioneer and leader in the technology to monitor and
manage airway inflammation, Aerocrine markets NIOX Flex and NIOX
MINO. Both products enable fast and reliable management of airway
inflammation and may therefore play a critical role in more effective
diagnosis, treatment and follow-up of patients with inflammatory
airway diseases such as asthma. Aerocrine is based in Sweden with
subsidiaries in the US, Germany and the UK. Aerocrine shares were
listed on the Stockholm Stock Exchange on 15 June 2007.
Alcon Laboratories Inc.

6201 South Freeway
Fort Worth, TX 76134
Phone: (817) 551-4067
www.alconlabs.com
Booth #308
Alcon, the global leader in eye care, provides innovative products that
enhance quality of life by helping people see better. The three Alcon
businesses - Surgical, Pharmaceutical and Vision Care - offer the
widest spectrum of products addressing the worlds most pressing eye
care needs. For more information, visit www.alcon.com.
142
Allergan
2525 Dupont Drive
Irvine, CA 92612
Phone: (714) 246-4500
www.allergan.com
Booth #442
Recently celebrating its 60th anniversary, Allergan is a global leader
in discovering and developing therapeutic agents to advance patient
care. Allergan is also one of the fastest-growing eye care companies
worldwide. Eye care professionals and patients rely on Allergan
products to treat a variety of eye conditions. Visit www.allergan.com for
more information. APC46QR11
Allergy & Asthma Network Mothers of

Asthmatics
8201 Greensboro Drive, Suite 300
McLean, VA 22102
Phone: (800) 878-4403
www.aanma.org
Booth #272
National patient centered non-profit organization dedicated to eliminate
death and suffering due to allergies, asthma and related conditions.
Allergy and Asthma Proceedings

95 Pitman Street
Providence, RI 2906
Phone: (401) 331-2510
www.allergyandasthmaproceedings.com
Booth #358
The primary focus of Allergy & Asthma Proceedings is directed to the
publication of articles with the highest degree of clinical relevance
for the practicing allergist/immunologist. Additionally the Proceedings
is committed to medical education, having recently published the
teaching tool, Northwestern University A-I Syllabus for Medical
Students & Residents. Academically, the Proceedings has established
a 33 year reputation as a National Library of Medicine/PubMed
indexed journal with circulation at 5000 and has tripled its impact
factor to (2.17). For sale at our exhibit booth will be copies of the 2012
Northwestern A-I Syllabus and Immunology IV by Author Joseph A.
Bellanti, MD, who will be available for book signing.
Exhibits
Allergy Control Products
Alpha-1 Foundation
1620 Satellite Boulevard, Suite D

Duluth, GA 30097
Phone: (800) 255-3749
www.AllergyControl.com
Booth #445
For almost 30 years, Allergy Control Products has been a trusted source
for helpful allergen avoidance information and effective allergy relief
products. We value our relationship with AAAAI physicians and look
forward to seeing physicians who have supported us throughout the
years and to meeting new physicians who wish to learn more about
environmental controls.
2937 SW 27th Ave, #302

Miami, FL 33133
Phone: (305) 567-9888 x241
Booth #548
The Alpha-1 Foundation is a not-for-profit Florida corporation
founded in 1995 by John Walsh, Susan Stanley and Sandy Lindsey,
three individuals diagnosed with Alpha-1 Antitrypsin Deficiency (AAT
Deficiency or Alpha-1). The Foundation is dedicated to providing
the leadership and resources that will result in increased research,
improved health, worldwide detection, and a cure for Alpha-1.
Allergy Guardian
7422 Executive Park, Suite 310-B
Charlotte, NC 28226
Phone: (770) 910-8075
www.allergyguardian.com
Booth #367
Welcome to Allergy Guardian! Please stop by our booth to learn about
our company, our staff and the services we offer. Our Ready, Set,
Guard program will assist your patients in Taking Action Against
Allergens and help identify the best allergen avoidance program for
their condition. In addition to our Allergy Guardian encasings, we offer
a range of effective products for relief from allergies, asthma, sinusitis,
dermatitis and more. Our team has many years of experience in the
allergy industry and we have carefully selected the effective products
found on our website, www.allergyguardian.com for a healthier home
and a healthier lifestyle.
Allergy Laboratories, Inc.

1005 SW 2nd Street
Oklahoma City, OK 73109
Phone: (800) 654-3971
www.allergylabs.com
Booth #259
Allergy Laboratories, Inc. is proud to be the oldest American owned
allergenic extract manufacturer. We produce a full range of diagnostic
and therapeutic allergens, as well as sterile empty vials and pre-filled
vials of allergenic extract diluting solutions. We invite your inquires.
Allergy Therapeutics
Dominion Way
Worthing, West Sussex
United Kingdom
Phone: +44 01903 844796
www.allergytherapeutics.com
Booth #281
Allergy Therapeutics is a speciality pharmaceutical company focused
on the treatment and prevention of allergy. We have a long-term
commitment to research and have a patent protected development
pipeline of allergy vaccines with the potential to transform allergy
treatment.
American Board of Allergy and

Immunology
111 S. Independence Mall East, Suite 701
Philadelphia, PA 19106
Phone: (215) 592-9466
www.abai.org
Booth #568
The ABAI was established in 1971 as one of the 24 medical specialty
boards that make up the American Board of Medical Specialties.
Through ABMS, the boards work together to set and sustain common
standards of expertise and professionalism that each uses to evaluate
candidates for board certification and specialists to maintain their
certification.
American Express Open

200 Vessey Street
New York, NY 10285
Phone: (212) 640-2000
www.open.com
Booth #261
Financial Services
American Latex Allergy Association

P.O. Box 198
Slinger, WI 53086
Phone: (262) 677-9707
www.latexallergyresources.org
Booth #562
A national, non-profit, 501(c)3, educational and support organization,
founded in 1993. The American Latex Allergy Associations mission
is to create awareness of latex allergy through education, and to
provide support to allergists and their patients who have developed
latex allergy.We emphasize the reinforcement of the doctor-patient
relationship through the provision of our educational materials. Our
web page, www.latexallergyresources.org, provides alternative product
lists, educational support, news updates and links. Our Online Locate
an Allergist Registry is helping individuals seeking diagnosis and
treatment for latex allergy.If you have expertise in latex allergy you
can register for our Online Locate an Allergist. Join our professional
membership. Stop by our booth 562 and see the Latex Allergy 101
program and other resource materials that are available.
143
Exhibits
American Partnership For Eosinophilic
Disorders (APFED)
P.O. Box 29545
Atlanta, GA 30359
Phone: (713) 493-7749
www.apfed.com
Booth #557
APFED is a non-profit organization dedicated to patients and their
families coping with eosinophilic disorders. APFED strives to expand
education, create awareness and support research while promoting
advocacy among its members.
Axelacare Health Solutions

9801 Renner Blvd., Ste 275
Lenexa, KS 66215
Phone: (913) 747-3703
www.axelacare.com
Booth #368
AxelaCare specializes in the administration of Immune Globulin and
other infusible medications. We provide medications, treatment
management, insurance support, home infusion nursing and advocacy
services for patients with rare and chronic diseases. CareLogix is our
proprietary clinical outcomes measurement system, using our infusion
nurses and patients to enter physical assessments, quality of life,
and disability/activities of daily living data into iPads. Validated data
is collected and presented in simple graphical display via secure web
access to clinicians to determine optimal care based on dose vs. time
and collected outcomes. Our mission is to empower people in the
pursuit and delivery of exceptional patient care.
Bank of America Practice Solutions

600 N. Cleveland Ave., Suite 300
Westerville, OH 43082
Phone: (800) 428-2847
www.bankofamerica.com/small_business/practicesolutions
Booth #158
Bank of America Practice Solutions specializes in financial services
for new & existing medical practices providing loans for start-ups,
business debt consolidation, refinancing, equipment, relocations,
remodeling, improvements/expansions, practice sales/acquisitions, real
estate & more. Our competitive fixed & variable rates range in terms
from 12 months up to 25 years.
Bausch+Lomb
7 Giralda Farms
Madison, NJ 07940
Phone: (877) 442-6925
www.bausch.com/
Booth #449
Bausch+Lomb is dedicated to protecting and enhancing the gift of
sight from birth through every phase of life. Its a mission that
can be conveyed in four simple words: See Better. Live Better.
Our portfolio includes contact lenses, lens care, eye vitamins,
pharmaceuticals and intraocular lenses. Visit www.bausch.com.
144
Baxter
One Baxter Parkway
Deerfield, IL 60015
Phone: (800) 422-9837
www.baxter.com
Booth #409
Baxter provides purified plasma treatments containing antibodies
called immunoglobulins that help Primary Immune Deficiency
patients fight off infection. Immunoglobulins are also indicated to
treat a number of conditions including Kawasaki Syndrome, Chronic
Lymphocytic Leukemia (CLL) and Idiopathic Thrombocytopenic Purpura
(ITP).
Baxter Global Medical Affairs

One Baxter Parkway
Deerfield, IL 60015
Phone: (800) 422-9837
www.baxter.com
Booth #535
The BioTherapeutics Medical Affairs booth will be staffed by Baxter
Medical Affairs representatives who are able to answer medical and
scientific questions about Baxters immune globulin products. For
more information on BioTherapeutics, please visit www.baxter.com.
Bio Products Laboratories

4445 N A1A, Suite 225
Vero Beach, FL 32963
Phone: (772) 453-9084
www.gammaplex.com
Booth #553
Bio Products Laboratory Inc. (BPL) is a manufacturer of a wide range of
high quality plasma-derived products including Gammaplex (Immune
Globulin Intravenous (Human) 5% Liquid). For further information,
please visit our exhibition booth.
BioMed Central
236 Grays Inn Road
London
United Kingdom
Phone: +44 20 3192 2009
www.biomedcentral.com
Booth #376
BioMed Central is the open access publisher committed to the free
widespread dissemination of scientific research. BioMed Central
publishes over 230 peer-reviewed open access journals across
biology and medicine, including BMC Immunology, Allergy, Asthma &
Clinical Immunology, Clinical and Molecular Allergy and Clinical and
Translational Allergy.
Exhibits
BioPlus Specialty Pharmacy
BreatheAmerica, Inc.
376 Northlake Blvd.

Altamonte Springs, FL 32701
Phone: (407) 830-8820
www.bioplusrx.com
Booth #171
BioPlus is a pharmacist-owned, URAC accredited, national specialty
infusion pharmacy providing high-touch services and specialty
pharmaceuticals for patients with chronic diseases such as hepatitis,
bleeding disorders, cancer, and other conditions. Licensed in all 50
states, BioPlus is one of the nations largest independent specialty
pharmacies. Accredited by VIPPS, Accreditation Commission for Health
Care (ACHC) and the Community Health Accreditation Program (CHAP).
One Burton Hills Blvd., Suite 375

Nasville, TN 37209
Phone: (615) 665-7103
www.breatheamerica.com
Booth #466
BreatheAmerica, Inc. partners with allergists across the U.S. to develop
and operate outpatient centers treating chronic airway disease
patients. Our centers bring an innovative, academic-level approach to
the delivery of care for allergies, asthma and sinusitis, with the goals
of improving outcomes, lowering costs and providing patients with an
exceptional, differentiated experience.
Biotest Pharmaceuticals Corporation
MMJ Labs, LLC

322 Sutherland Place NE
Atlanta, GA 30307
Phone: (877) 805-2899
www.buzzy4shots.com
Booth #546
Help your patients BEE empowered! Improve patient experience and
procedural success with Buzzy. Buzzy uses cold and vibration to
minimize sharp pain on contact, helping patients avoid unnecessary
pain and anxiety. Buzzy is a hand-held, reusable device that naturally
reduces needle pain. Buzzy works even better with our DistrACTION
badge cards & posters. Outfit your entire department with our Comfort
Oriented Pain Equipment (COPE) Kits - enough posters, badge cards,
and Buzzy kits to take the sting out of any procedure.
5800 Park of Commerce Blvd NW

Boca Raton, FL 33487
Phone: (561) 989-5800
www.biotestpharma.com
Booth #142
Biotest Pharmaceuticals researches and manufactures biotherapeutic
products with a specialization in immunology and hematology. Biotest
Pharmaceuticals is a leader in the collection of source plasma and is
currently involved in the development of plasma protein products in
the field of Primary Immune Deficiency (PID) and various hyperimmune
(IG) products which are antibody specific to high titer for treatment of
modality.
Blaine Labs, Inc.

11037 Lockport Pl.
Santa Fe Springs, CA 90670
Phone: (800) 307-8818
www.blainelabs.com
Booth #476
Blaine Labs is the creator and sole distributor of the internationally
acclaimed and patented Vibration Anesthesia Device. Otherwise known
as the VAD, this revolutionary injection tool is 100% safe for all patients
when used to diminish the discomfort associated with injections.
Come by our booth for a free demonstration and ask about the 30 day
risk-free trial.
Boston Scientific
888 Ross Drive, Suite 100
Sunnyvale, CA 94089
Phone: (408) 419-0100
www.BTforAsthma.com
Booth #386
Boston Scientific has developed a bronchoscopic procedure for the
treatment of severe persistent asthma in adults not well controlled
on ICS and LABA alone. The Alair Bronchial Thermoplasty System
reduces the amount of excessive airway smooth muscle, decreasing
the ability of the airway walls to contract and narrow during an asthma
attack, providing long-lasting and improved asthma control for adult
severe asthma patients. For more information, please visit www.
BTforAsthma.com.Rx Only.
Buzzy4shots.com
CarePoint Partners
8280 Montgomery Road, Suite 101
Cincinnati, OH 45236
Phone: (513) 891-6666
www.carepointpartners.com
Booth #164
Home Infusion Pharmacy - IVIG
Carestream
1765 The Exchange
Atlanta, GA 30339
Phone: (888) 477-4359
www.carestream.com/ent-allergy
Booth #181
An affordable point-of-care CT system designed to meet the imaging
needs of allergists, the CS 9300 delivers an attractive return on
investmenteven at low scan volumes. Produced by Carestream
Healtha company that has designed, manufactured, and serviced
medical imaging and healthcare IT solutions worldwide for more
than 100 yearsthe CS 9300 is so compact that it fits into virtually
any office. Customers can also expect expert onsite CT accreditation
support, training and technical support provided by a Carestream team
with years of experience serving physician practices.
145
Exhibits
Chattem - A Sanofi Company
Corpus Christi Allergy & Asthma Center
35 Corporate Drive
Bridgewater, NJ 08807
Phone: (800) 981-2491
www.sanofi.com
Booth #477
Chattem, Inc. is part of the sanofi-aventis Group. Sanofi-aventis
U.S. is an affiliate of sanofi-aventis a leading global pharmaceutical
company that discovers, develops and distributes therapeutic solutions
to improve the lives of everyone. Sanofi-aventis is listed in Paris
(EURONEXT: SAN) and in New York (NYSE: SNY). For more information,
visit: www.sanofi-aventis.us or www.sanofiaventis.com.
2502 Morgan Avenue

Corpus Christi, TX 78405
Phone: (361) 888-6782
www.asthmaandallergy.com
Booth #269
Currently seeking a Physician to join the practice; The Corpus Christi
Allergy Asthma Dermatology Center is offering an outstanding
opportunity for a BC/BE allergist to join one of the largest most
prestigious solo Allergy Asthma Immunology practice in the country
and has been directed by James A. Caplin, MD for the past 33
years. Hospitals are dangerous places for asthmatics. The Corpus
Christi Allergy-Asthma-Dermatology Center is committed to keeping
asthmatics, of all ages, well and out of the hospital. It is our belief that,
The Best Allergist Uses the Fewest Medicines and thus avoids
their dangerous side effects.
Clinical Immunology Society

555 E. Wells Street, Suite 1100
Milwaukee, WI 53202
Phone: (414) 224-8095
www.clinimmsoc.org
Booth #577
The Clinical Immunology Society (CIS) is devoted to fostering
developments in the science and practice of clinical immunology. CIS
is an international professional organization which includes more than
600 clinicians, investigators, and trainees. The mission of CIS is to
facilitate education, translational research and novel approaches to
therapy in clinical immunology to promote excellence in the care of
patients with immunologic/inflammatory disorders.
Coram Specialty Infusion Services

555 17th Street, Suite 1500
Devner, CO 80202
Phone: 1-(800)-CORAMHC
www.coramhc.com
Booth #537
Coram is a leading national provider of specialty home infusion and
specialty pharmacy services with more than 30 years of experience
servicing the needs of complex patients. With more than 85 branches
and over 65 infusion suites throughout the country, Coram offers
both national presence and comprehensive local coverage. Corams
nurses, pharmacists, dietitians and other clinical staff are known in
the industry for providing an exceptional level of personalized care to
thousands of home and infusion suite IV patients every day. For more
information, please visit our website at coramhc.com.
Crowell Systems
4235 South Stream Blvd., Suite 100
Charlotte, NC 28217
Phone: (704) 665-2000
www.crowellsystems.com
Booth #264
Medformix with ALL New Technology. Complete make over with a
fast new visual interface comprehensive allergy software. EMR & PM &
Shots & Extract-You Have to See Medformix To Believe it! Visit Booth
264.
CSL Behring
1020 1st Avenue
King of Prussia, PA 19406
Phone: (610) 878-4000
www.cslbehring-us.com
Booth #520
CSL Behring is a global leader in plasma protein therapeutics. The
company manufactures safe and effective plasma-derived and
recombinant therapies for treating coagulation disorders , primary
immune deficiencies, hereditary angioedema and inherited respiratory
disease, and for use in cardiac surgery, organ transplantation, burn
treatment and to prevent hemolytic disease of the newborn. CSL
Behring is a subsidiary of CSL Limited, a biopharmaceutical company
with headquarters in Melbourne, Australia. For more information: www.
cslbehring-us.com.
Dyax Corp.
55 Network Drive
Burlington, MA 01803
Phone: (617) 225-2500
www.dyax.com
Booth #434
Dyaxs mission is to discover, develop and comercialize innovative
biopharmaceuticals for unmet medical needs while delivering
outstanding value to patients and stockholders.
146
Exhibits
Elsevier
Forest Pharmaceuticals, Inc.
1600 JFK Blvd., Suite 1800

Philadelphia, PA 19103
Phone: (215) 239-3900
www.elsevierhealth.com
Booth #355
Elsevier is a leading publisher of health science publications, advancing
medicine by delivering superior reference information and decision
support tools to doctors, nurses, health practitioners and students. With
an extensive media spectrum - print, online and handheld, we are able
to supply the information you need in the most convenient format.
13600 Shoreline Drive

St. Louis, MO 63045
Phone: (800) 678-1605
www.forestpharm.com
Booth #460
Forest Pharmaceuticals, Inc. is a wholly-owned subsidiary of New
York City-based Forest Laboratories, Inc. Forests longstanding
global partnerships and track record developing and marketing
pharmaceutical products in the USA have yielded its well-established
central nervous system and cardiovascular franchises and an emerging
portfolio in anti-infective and respiratory medicine.
European Academy of Allergy and

Clinical Immunology
Genferstrasse 21
Zurich, 8002
Switzerland
Phone: +41 44 205 55 33
www.eaaci.org
Booth #136
The European Academy of Allergy and Clinical Immunology (EAACI) is a
non-profit organisation active in the field of allergic and immunologic
diseases such as asthma, rhinitis, eczema, occupational allergy, food
and drug allergy and anaphylaxis. EAACI was founded in 1956 in
Florence and has become the largest medical association in Europe
in the field of allergy and clinical immunology. It includes over 7,700
members from 121 countries, as well as 42 National Allergy Societies.
EAACIs mission is to promote basic and clinical research; to collect,
assess and diffuse scientific information; to act as a scientific
reference body for other scientific, health and political organisations;
to encourage and provide training and continuous education, and to
collaborate with patients and lay organisations. The Academy aims to
provide the most efficient platform for scientific communication and
education in the field of allergy and immunology, ultimately striving to
ease patients lives.
FARE
7925 Jones Branch Drive, Suite 1100
McLean, VA 22102
Phone: (800) 929-4040
www.foodallergy.org
Booth #563
Founded in 2012 as a result of a merger between the Food Allergy &
Anaphylaxis Network and the Food Allergy Initiative, FARE is a nonprofit
organization dedicated to food allergy research and education. FAREs
mission is to ensure the safety and inclusion of food-allergic individuals
while relentlessly seeking a cure.
Genentech USA
1 DNA Way
MS - 69
South San Francisco, CA 94080
Phone: (650) 225-1000
www.gene.com
Booth #144
Clinical Study - EXPECT XOLAIR Pregnancy Registry
Genentech USA
1 DNA Way
MS - 69
South San Francisco, CA 94080
Phone: (650) 225-1000
www.gene.com
Booth #162
Gerber Products Company d/b/a Nestl

Infant Nutrition
12 Vreeland Road
Florham Park, NJ 07932
Phone: (800) 628-BABY
www.medical.gerber.com
Booth #447
Gerber Products Company, the maker of GERBER GOOD START
formulas, GERBER baby foods, and GERBER GRADUATES toddler
and preschooler foods, is committed to nourishing a healthier
generation. The GERBER Start Healthy, Stay Healthy Nutrition
System of Education, Services, and Products is designed to help health
care professionals and parents guide healthy growth and development
and establish healthy eating habits for children 0 to 48 months.
Greer Laboratories, Inc.

639 Nuway Circle
Lenoir, NC 28645
Phone: (828) 754-5327
www.greerlabs.com
Booth #248
GREER is devoted to furthering the specialty of allergy
immunotherapy. We provide allergy professionals with allergenic
extracts, sterile empty vials, sterile diluting fluids, skin testing devices,
and a full line of ancillary products needed to successfully test and
treat allergic patients.
147
Exhibits
Greer Laboratories, Inc. Medical Affairs
Immune Epitope Database
639 Nuway Circle

Lenoir, NC 28645
Phone: (828) 754-5327
www.greerlabs.com
Booth #252
GREER is devoted to furthering the specialty of allergy
immunotherapy. We provide allergy professionals with allergenic
extracts, sterile empty vials, sterile diluting fluids, skin testing devices,
and a full line of ancillary products needed to successfully test and
treat allergic patients.
9420 Athena Circle

La Jolla, CA 92037
www.iedb.org
Booth #575
The IEDB is an NIH-supported, freely available resource that provides
access to published data related to antibody and T cell epitopes, as
well as online tools for prediction and further analysis of immune
epitopes. The IEDB has data for infectious and autoimmune diseases,
allergens, and alloantigens.
HAE: Learn About It, Talk About It
3121 Universal Drive

Mississauga, ON
Canada
Phone: (905) 282-1808
www.inflamaxresearch.com
Booth #372
Inflamax Research is a full service Contract Research Organization
that specializes in allergy, asthma and dermatology studies. Inflamax
has proprietary Natural Environmental Exposure Chamber models
available for clinical research studies. Models have been validated
for Ragweed, Grass, Tree, House Dust Mite, and Cat. Inflamax has a
unique patented mobile EEC model available which can be located
anywhere worldwide for use in clinical research. Inflamax is developing
a consortium of specialized investigators who can conduct EEC studies.
For more information, please contact Dr. Piyush Patel at: ppatel@
inflamaxresearch.com.
730 Stockton Drive

Exton, PA 19341
Phone: (646) 664-4720
Booth # 166
HAE: Learn About It, Talk About It is a peer-to-peer clinician education
program aimed at uniting various specialties that could see patients
with hereditary angioedema (HAE) to help advance care for patients.
HollisterStier Allergy
3525 N Regal Street
Spokane, WA 99207
Phone: (800) 992-1120
www.hsallergy.com
Booth #531
HollisterStier Allergy manufactures a full line of products needed for
allergy practices. Our product line includes allergenic extracts for
diagnostic testing and immunotherapy; complete skin testing systems;
latex-free vials/diluents, and other ancillary supplies.
Hycor Biomedical, Inc.

7272 Chapman Avenue
Garden Grove, CA 92841
Phone: (800) 382-2527
www.hycorbiomedical.com
Booth #542
Founded in 1981, HYCOR manufactures high quality diagnostic
instrumentation and in-vitro diagnostic kits for allergy and autoimmune
testing. HYCOR develops new products, technologies and medical
education materials designed to improve patient care and advance
healthcare globally.
Immune Deficiency Foundation

40 W. Chesapeake Ave., Suite 308
Towson, MD 21204
Phone: (800) 296-4433
www.primaryimmune.org
Booth #569
The Immune Deficiency Foundation is the national patient organization
dedicated to improving the diagnosis, treatment & quality of life of
persons with primary immunodeficiency diseases through advocacy,
education & research.
148
Inflamax Research Inc.
International Eosinophil Society, Inc.

555 E. Wells Street, Suite 1100
Milwaukee, WI 53202
Phone: (414) 276-6445
www.eosinophil-society.org
Booth #566
IES has been established to bring together scientists around the world
who are engaged in research in the field of eosinophil biology and
eosinophil disorders with a view to facilitating exchange of ideas and
information about this inflammatory cell type and its role in diseases.
Intra Pump Infusion Systems

920 Minters Chapel Road
Grapevine, TX 76051
Phone: (866) 211-7867
www.intrapump.com
Booth #277
Crono S PID-50 pump - the most accurate on the market neria Multi the newest high quality patient friendly multi-furcated infusion set.
Exhibits
IVEDCO
Kaz, Inc / Honeywell
2310 Lyndon B. Johnson Fwy., Ste.100

Dallas, TX 75234
Phone: (800) 333-0660
www.ivedco.com
Booth #576
IVEDCO is a pharmacist-owned, Accreditation Commission for Health
Care(ACHC) accredited provider of Infusion Therapy. For 20 years,
IVEDCO has been dedicated to providing patients with the highest
quality of care. IVEDCO makes it possible for patients to receive IV
Therapy at home. Highly skilled clinicians are available to travel to the
patients location to instruct both the patient and/or caregiver in proper
treatment methods. The wide array of services offered by IVEDCO
promotes continuity of care and eases the transition from the in-patient
environment to the home.
250 Tumpike Road

Southborough, MA 01772
Phone: (508) 490-7214
www.kaz.com
Booth #161
Honeywell is the market leader in portable air purification products,
offering True Hepa permanent filtration providing your patients with
superior air cleaning products for over 25 years!
The JAMA Network

515 North State Street
Chicago, IL 60654
Phone: (312) 464-4868
www.jamanetwork.com
Booth #246
Building on a tradition of editorial excellence, The JAMA Network brings
JAMA together with nine specialtyjournalsto offer enhanced access
to the research, viewpoints, and medical news shaping medicine today
and into the future.Publishedcontinuously since 1883by the American
Medical Association,JAMAisone of the most widely circulated, peerreviewed, general medical journals in the world.
Jones Medical Instrument Co.

200 Windsor Drive
Oak Brook, IL 60523
Phone: (630) 571-1980
www.jonesmedical.com
Booth #533
Spirometry - While on the exhibit floor, stop by the Jones Medical booth
for the latest advances in spirometry for the Allergy practice. On display
will be the NEW Satellite/Base Station3 System, the most efficient and
cost effective spirometer for the Allergists office. Stop by today for our
Spirometry Reimbursement Guide and take advantage of our special
convention offer!
Karger Publishers
26 West Avon Rd
PO Box 529
Unionville, CT 06085
Phone: (860) 675-7834
www.karger.com
Booth #551
Publications include the monograph Handbook of Clinical Gender
Medicine; the book series Chemical Immunology and Allergy, Current
Directions in Autoimmunity, and Progress in Respiratory Research; and
the journals International Archives of Allergy and Immunology, Journal
of Innate Immunity, Neuroimmunomodulation, and Respiration.
Kidzpace Interactive, Inc

PO Box 550
Collingwood, ON
Canada
Phone: (705) 444-2300
www.kidzpace.com
Booth #260
North Americas leading manufacturer of interactive entertainment for
professional office waiting areas.
Kirkman Group, Inc.

6400 SW Rosewood Street
Lake Oswego, OR 97035
Phone: (503) 694-1600
www.kirkmanlabs.com
Booth #472
Kirkman is the leading manufacturer of hypoallergenic nutritional
supplements for sensitive individuals. Every product manufactured by
Kirkman is tested for more than 950 environmental contaminants. No
other supplement company offers this degree of purity testing. For 60+
years, our customers have relied on us for the purity and effectiveness
of our products.
Lippincott Williams & Wilkins

1114 Jack Pine
San Antonio, TX 78232
Phone: (210) 643-1745
Booth #373
Lippincott is a World Leader in medical publishing. We have the new
edition of The Manual of Allergy & Immunology.
Lysosomal and Rare Disorders Treatment

and Research Center
11212 Waples Mill Rd, Suite 100
Fairfax, VA 22030
Phone: (571) 308-1900
Booth #177
Educational Materials on Rare disorders. Research in Rare disorders
including immune deficiencies and severe asthma.
149
Exhibits
The Mastocytosis Society
Meditab Software, Inc.
P.O. Box 129

Hastings, NE 68902
Phone: (952) 905-6778
www.tmsforacure.org
Booth #570
The Mastocytosis Society is a 501 3(c) non profit dedicated to
supporting patients with Mastocytosis and mast cell activation
disorders as well as their families, caregivers and physicians through
research, education and advocacy.
333 Hegenberger Road, Suite 800

Oakland, CA 94621
Phone: (510) 632-8021
www.meditab.com
Booth #462
Meditab Software Inc. develops and supports IMS (Intelligent
Medical Software), a multi-award-winning, multi-certified, integrated
system that provides EHR, Practice Management and Document
Image Management at an affordable cost. These solutions maximize
productivity and efficiency, enhance patient care, and reduce
operational costs.
McNeil Consumer Healthcare

750 Camp Hill Road
Fort Washington, PA 19034
Phone: (800) 962-5352
www.mcneil-consumer.com
Booth #271
Meda Pharmaceuticals
265 Davidson Avenue, Suite 400
Somerset, NJ 08873
Phone: (732) 564-2200
www.meda.us
Booth #322
Meda Pharmaceuticals is a global specialty pharmaceutical company
that develops, markets, and promotes branded prescription products
in the respiratory, pain, womens health and mens health therapeutic
areas.
Medex BioCare
8024 Stage Hills Blvd., Suite 107
Bartlett, TN 38133
Phone: (800) 962-6339
www.medexbiocare.com
Booth #276
Medex BioCare provides comprehensive patient management services
and distributes pharmaceuticals nationwide for people with chronic
conditions such as Hemophilia, HIV/AIDS, Cancer, Growth Hormone
Deficiency, Multiple Sclerosis, Hepatitis, etc. We work directly with
patients, physicians, healthcare providers, insurance companies and
other 3rd party payors to improve clinical and financial outcomes.
Medical College of Wisconsin

8701 Watertown Plank Road
Wauwatosa, WI 53226
Phone: (414) 955-7495
Booth #552
The Clinical Immunodiagnostic & Research Laboratory (CIRL) at MCW
offers diagnostic flow cytometry for Primary Immunodeficiency (PID)
diseases. CIRL and CHWs PID Clinics function as Jeffrey Modell
Diagnostic & Patient Referral Center in Wisconsin since 2007. IDC
is first in USA to pioneer statewide newborn screening for Severe
Combined Immunodeficiency.
150
Merck, Sharp & Dohme, Corp.

351 N. Sunneytown Pike
UG 3AB-20
North Wales, PA 19454
Phone: (267) 305-7406
www.merck.com
Booth #300
Todays Merck is working to help the world be well. Through our
medicines, vaccines, biologic therapies, and consumer and animal
products, we work with customers and operate in more than 140
countries to deliver innovative health solutions.
Merck, Sharp & Dohme, Corp.

351 N. Sunneytown Pike
UG 3AB-20
North Wales, PA 19454
Phone: (267) 305-7406
www.merck.com
Booth #514
Todays Merck is working to help the world be well. Through our
medicines, vaccines, biologic therapies, and consumer and animal
products, we work with customers and operate in more than 140
countries to deliver innovative health solutions.
Methapharm
81 Sinclair Boulevard
Brantford, ON
Canada
Phone: (519) 751-3602
www.metharpharm.com
Booth #244
Provocholine (methacholine chloride for inhalation) is indicated for
the diagnosis of bronchial airway hyperreactivity in subjects who do
not have clinically apparent asthma. The methacholine challenge test
provides for a sensitive and generally accurate diagnosis of bronchial
hyperreactivity as well as the severity of asthma. The methacholine
challenge can also be used to confirm occupational asthma. Visit
www.provocholine.com/ssm for 2.0 no cost CRCE hours, review
the educational information and complete the 25 multiple choice
questions.
Exhibits
Micro Direct, Inc.
803 Webster Street
Lewiston, ME 04212
Phone: (207) 786-7808
www.micro-direct.com
Booth #159
Micro Direct is pleased to offer Total Spirometry Solutions with six
models priced from $1,595 to $2,395, all designed to meet your needs;
and each with your choice of inexpensive cardboard mouthpieces,
one-way mouthpieces or full protection pulmonary filters. Micro Direct
also offers low cost screening spirometers and inexpensive peak flow
meters for office and home use. Micro Direct Inc. is the primary source
of sales, technical support and service for all Micro Medical products.
Our sales and support staff has over 100 years of combined experience
in the medical equipment industry. Our staff is ready to advise you on
the best product for your practice and will be there after the sale to
provide technical support on equipment operation and proper patient
testing techniques. All products sold by Micro Direct include a 30-day
money back guarantee. At Micro Direct our mission is clear - to provide
innovative, high-quality products at a fair price... and the customer
support and great service you expect.
Mission Pharmacal Company

P.O. Box 786009
San Antonio, TX 78278
Phone: (210) 696-8400
Booth #273
Mission Pharmacal Company is a privately held Pharmaceutical
company based in San Antonio, Texas. For sixty-five years, the
company has been dedicated to identifying unmet health needs in
the marketplace and developing innovative prescription and over-thecounter products to meet them.
Mission: Allergy
28 Hawleyville Road
Hawleyville, CT 06440
Phone: (203) 364-1570 x 2000
www.missionallergy.com
Booth #251
Mission: Allergy manufactures products for allergen-avoidance,
including the highest quality allergen-proof microfiber pillow and
mattress encasings. Our Allergy Self-Help Guide for patients contains
scientifically accurate advice on environmental control. Please stop
by our booth to sign up to receive your free supply--and to view an
unusual display of live dust mites!
Module MD, LLC

8359 Office Park Drive
Grand Blanc, MI 48439
Phone: (248) 434-0444
www.modulemd.com
Booth #354
Module MD is the leader in Allergy EMR and Practice Management,
Billing and Revenue Management for Allergy practices and physician
groups. With its fully integrated skin testing module, immunotherapy,
vaccine preparation, lab ordering and reporting, eRx, scheduling,
charge entry, claims submission and revenue collection and reporting
modules Module MD is fulfilling the needs of Meaningful Use in the
most integrated manner for allergy practices.
Mylan, Inc.
110 Allen Road, 4th Floor
Basking Ridge, NJ 07920
Phone: (908) 542-1999
www.mylan.com
Booth #414
National Allergy Supply

1620 Satellite Boulevard, Suite D
Duluth, GA 30097
Phone: (800) 522-1448
www.NationalAllergy.com
Booth #443
Just like you, National Allergy believes that avoiding airborne allergens
can help improve patient outcomes. We are firmly established as
the leader in the allergen avoidance products market having sold to
hundreds of thousands of customers through the referrals of thousands
of doctors since our start in 1988. Our colorful patient flyers are super
easy to use and offer your patients free shipping on their first order
with us. Our BedCare barrier encasings are Made In The USA and set
the standard for comfort, quality, and affordable allergen protection.
See for yourself by visiting our booth and well be happy to give you a
Standard Size Pillow Encasing.
National Eczema Association

4460 Redwood Hwy, Ste 16D
San Rafael, CA 94903
Phone: (415) 499-3474
www.nationaleczema.org
Booth #572
The National Eczema Association (NEA) improves the health and quality
of life of all persons living with atopic dermatitis/eczema, by providing
support, information, and resources to those who have the disease as
well as their loved ones, while raising public awareness of and funding
research on the disease.
151
Exhibits
Natures One, Inc.
8754 Cotter St
Lewis Center, OH 43035
Phone: (740) 657-6456
Booth #461
Natures One is a privately held company founded in 1997 and
based in Columbus, Ohio. The company is a pioneer in the organic
medical nutrition category introducing the first organic baby formula
to the United States in 1999 under the brand name Babys Only
Organic. Natures One heavily invests in research and development
to offer the very best in organic and nutritional science. Today most
of Natures One organic medical nutritionals remain the first and
only in their product categories. These products are sold nationwide
and internationally through a wide range of retail outlets, medical
distributors and DME companies.
ndd Medical Technologies

Two Dundee Park, Suite 301
Andover, MA 01810
Phone: (978) 470-0923
www.nddmed.com
Booth #455
ndd Medical Technologies is committed to setting new standards
in pulmonary function testing by offering innovative, easy to use
products and excellent customer support. The EasyOne Pro is the first
lung function instrument to allow Single Breath DLCO measurement
outside of the lung function laboratory. The EasyOne Plus series of
spirometers are based on the best technology, packed with features
and easy to use. While the Easy On-PC offers real time curves and
pediatric incentives. Please visit our booth to determine which product
is right for you.
NeilMed Pharmaceuticals
601 Aviation Blvd.
Santa Rosa, CA 95403
Phone: (707) 525-3784
www.neilmed.com
Booth #331
The mission of the company is to create and maintain safe, affordable
and effective products to sustain long-term growth and create drug
free and effective nasal/sinus care devices for millions of consumers
worldwide. Please visit the website www.neilmed.com for more details.
Nosk USA
15-09 132nd Street
College Point, NY 11356
Phone: (718) 961-3577
www.noskus.com
Booth #377
Nosk USA is the exclusive distributor of Nosk Anti-allergy nasal filters
developed and manufactured by Sam Joung International, Korea for the
North and South American market.
152
Novartis Pharmaceuticals Corp.

One Health Plaza, Building 701
East Hanover, NJ 07936
Phone: (973) 781-7003
www.novartis.com
Booth #340
Novartis Pharmaceuticals is dedicated to discovering, developing,
manufacturing and marketing prescription drugs that help meet our
customers medical needs and improve their quality of life. Please
visit the Novartis exhibit where our sales representatives will be
available to discuss our products.
nSpire Health, Inc.

1830 Lefthand Circle
Longmont, CO 80501
Phone: (800) 574-7374 or (303) 666-5555
www.nspirehealth.com
Booth #350
nSpire Health develops and manufactures respiratory care products
and provides related services. nSpire Health is the exclusive provider
of premier digital whole body plethymography, KoKo Spirometry, Piko
electronic lung home health monitoring, and the only premium flow
and volume based pulmonary function solutions provider worldwide.
NUTRICIA
9900 Belward Campus Drive, Ste 100
Rockville, MD 20850
Phone: 1-800-NEOCATE
www.nutricia-na.com
Booth #143
Octapharma
121 River Street, Suite 1201
Hoboken, NJ 07030
Phone: (201) 604-1122
www.octapharma.com
Booth #280
Octapharma, a Swiss-based independent fractionation specialist, is
one of the largest plasma product manufacturers in the world. Our core
business is the development, production and sale of premium human
proteins from both human plasma and human cell-lines. Octapharma
employs more than 4,500 people in 28 countries. Patients in over
80 countries are treated with products in the following therapeutic
areas: Haematology (coagulation disorders), Immunotherapy (immune
disorders), Intensive Care and Emergency Medicine.
Octapharma has dedicated resources to develop the first recombinant
FVIII expressed in the human cell line. This unique approach is intended
to reduce the immunogenic potential and sets Octapharma apart from
other companies whose recombinant products are based on animal
cells. Octapharma owns five state of the art production facilities in
Austria, France, Germany, Sweden and Mexico. For more information
visit www.octapharma.com
Exhibits
Organization of Teratology Info
Specialists (OTIS)/UCSD
9500 Gilman Drive, #0828
La Jolla, CA 92093
Phone: (877) 311-8972
www.otispregnancy.org
Booth #262
The Organization of Teratology Information Specialists (OTIS) is a
non-profit organization made up of individual teratology information
services located throughout the United States and Canada. Teratology
Information Specialists provide accurate and current information to
health-care professionals and the general public regarding effects to
the fetus of exposures that may occur in pregnancy.
Panatrex, Inc.
1648 Sierra Madre Circle
Placentia, CA 92870
Phone: (714) 630-5582
www.panatrex.com
Booth #454
Quanti-test system provides depth control ensures reproducible results
more accurate. This will wipe out excessive allergens.
Patient Services, Inc.

P.O. Box 5930
Midlothian, VA 23112
Phone: (804) 744-3813
www.patientservicesinc.org
Booth #560
PSI is a national non-profit organization whose caring staff is
committed to supporting people with expensive chronic illnesses
and conditions through locating solutions with health insurance and
assisting with premiums and prescription co-payments to facilitate
positive health and well being.
Perrigo Company
515 Eastern Avenue
Allegan, MI 49010
Phone: (269) 673-8451
www.perrigo.com
Booth #378
PERRIGO is the worlds largest manufacturer of store-brand OTC
medicines for the nations leading retailers, club stores and pharmacy
chains. Store-brand products offer consumers significant savings
over national brands and contain the same FDA-approved active
ingredients. In addition to Fexofenadine (Allegra), Perrigos portfolio of
allergy products includes all the big name brand equivalents from B to
Z (Benadyl to Zyrtec), and other popular store-brands in between.
Philips Respiratory Drug Delivery

1010 Murry Ridge Lane
Murrysville, PA 15668
Phone: (724) 387-5200
www.respironics.com
Booth #147
Philips Respironics Respiratory Drug Delivery, through the development
of innovative devices and on-going research, provides breakthrough
solutions to pharmaceutical companies, healthcare providers and their
patients at all points of care. The business units product lines include
compressor nebulizer systems, holding chambers and spacers, peak
flow meters and complete Asthma PACK personal asthma care kits, as
well as intelligent drug delivery of precise and reproducible doses of
drugs.
Physicians Angels
5006 Valencia Drive
Toledo, OH 43623
Phone: (419) 318-4471
www.physiciansangels.com
Booth #360
Physicians Angels is the sole provider of Virtual Medical Scribes to
medical practices throughout the United States. Physicians Angels
Virtual Medical Scribes allow healthcare providers to manage the data
within their Electronic Health Records more efficiently by completing
patient documentation in real time during exams. To learn more
about Virtual Medical Scribes and our free-trial offer, visit www.
physiciansangels.com, call (419) 318-4471, or email us at contactus@
physiciansangels.com.
Protein Sciences Corporation

1000 Research Parkway
Meriden, CT 06450
Phone: (203) 686-0800
www.proteinsciences.com
Booth #459
Protein Sciences uses modern recombinant technology to develop
and produce prophylactic and therapeutic vaccines. Flublok is our
seasonal influenza vaccine that was recently approved by FDA. Unlike
other licensed flu vaccines it is highly purified, is made without eggs,
live influenza viruses or antibiotics and does not contain thimerosal.
You absolutely cannot get the flu from Flublok.
Red River Commodities

501 42nd St. N.
Fargo, ND 58102
Phone: (877) 873-4501
www.sunbutter.com
Booth #140
SunButter sunflower seed spread made from U.S. grown specially
selected dry roasted sunflower kernel. It is processed in a peanut free
& tree-nut free facility made for those diagnosed with nut & other food
allergies.
153
Exhibits
Regeneron Pharmaceuticals, Inc.
Shire Human Genetic Therapies
777 Old Saw Mill River Road

Tarrytown, NY 10591
Phone: (914) 847-7000
www.regeneron.com
Booth #463
Regeneron is a fully integrated biopharmaceutical company that
discovers, invents, develops, manufactures, and commercializes
medicines for the treatment of serious medical conditions. Sanofi,
a global and diversified healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients needs. The
companies jointly have six fully human monoclonal antibodies in
development.
300 Shire Way

Lexington, MA 02421
Phone: (617) 349-0200
www.shire.com
Booth #236
As one of the worlds leading specialty biopharmaceutical companies,
Shire has emerged as a company fully focused on a single purpose: to
enable people with life-altering conditions to lead better lives. Through
our Human Genetic Therapies business, we pursue opportunities to
develop therapies on behalf of patients and families living with orphan
diseases.
Rosch Visionary Systems, Inc.
300 Shire Way

Lexington, MA 02421
Phone: (617) 349-0200
www.shire.com
Booth #242
As one of the worlds leading specialty biopharmaceutical companies,
Shire has emerged as a company fully focused on a single purpose: to
enable people with life-altering conditions to lead better lives. Through
our Human Genetic Therapies business, we pursue opportunities to
develop therapies on behalf of patients and families living with orphan
diseases.
501 Howard Avenue, Suite A204

Altoona, PA 16601
Phone: (800) 307-3320
www.roschvisionary.com
Booth #154
At Rosch Visionary Systems, were your allergy technology specialists.
Our Rosch Immunotherapy software, the most widely used allergy
extract and injection management program, is an efficient, cost
effective analysis and management tool. Rosch Immunotherapy
identifies, verifies, and tracks patient allergy vials (extracts/
aeroallergens and venoms) as well as other biologics such as Xolair
and vaccines. Rosch Immunotherapy is specifically designed to
address the issues of allergen extract administration errors by verifying
patients with photo, birth date, and most importantly vial barcode
verification. Interface with your EHR or use as a standalone software;
client-server, hosted, or Citrix options available.
Sanofi
55 Corporate Drive
Bridgewater, NJ 08807
Phone: (800) 981-2491
www.Auvi-Q.com/hcp
Booth #400
Sanofi, a global and diversified healthcare leader, discovers, develops
and distributes therapeutic solutions focused on patients needs.
Following an approach that starts with patient insights, Sanofi works
to create innovative healthcare solutions that make a difference in
the lives of people. Products such as Auvi-Q (epinephrine injection,
USP), support Sanofis goal of being recognized as a Company that
transforms scientific advancement into hope and solutions for patients
everywhere.
154
Shire Human Genetic Therapies
Shire Human Genetic Therapies (Global

Medical Affairs)
300 Shire Way
Lexington, MA 02421
www.shire.com
Booth #153
Global Medical Affairs Learning Lab presented by Shire Human Genetic
Therapies providing medical education and disease awareness for
certain rare diseases including hereditary angioedema (HAE).
Siemens Healthcare Diagnostics

511 Benedict Ave
Tarrytown, NY 10591
Phone: (914) 631-8000
www.usa.siemens.com/diagnostics
Booth #268
Siemens Healthcare Diagnostics, a global leader in clinical diagnostics,
provides healthcare professionals in hospital, reference, and physician
office laboratories and point-of-care settings with the vital information
required to accurately diagnose, treat, and monitor patients. Our
innovative portfolio of performance-driven solutions and personalized
customer care combine to streamline workflow, enhance operational
efficiency, and support improved patient outcomes.
Exhibits
SmartPractice
3400 E. McDowell Road

Phoenix, AZ 85008
Phone: (800) 878-3837
www.smartpractice.com
Booth #453
SmartPractice, the global leader in All Things Contact Dermatitis
provides the highest quality products and services in support of Patch
Testers and their patients including TRUE TEST (Thin-layer Rapid
Use Epicutaneous Patch Test System), Finn Chambers, allergEAZE,
Reveal & Conceal (Nickel and Cobalt Spot Tests), patchProtect,
patchMap and patchTransport. Contact:smartpractice.com.
84 Waterford Drive
Marlborough, MA 01752
Phone: (508) 481-6700
www.sunovion.com
Booth #314
Sunovion is a leading pharmaceutical company dedicated to
discovering, developing and bring to market therapeutic products
that advance the science of medicine to improve the lives of patients,
their families and communities. Sunovion is a subsidiary of Dainippon
Sumitomo Pharma Co., Ltd. To learn more visit www.SunovionProFile.
com.
Sol Millennium Medical Inc.
Systemedx Healthcare Technology, Inc.
5415 Sugarloaf Parkway, Suite 2203

Lawrenceville, GA 30019
Phone: (770) 331-0617
www.sol-millenniumna.com
Booth #550
Sol Millennium Medical manufactures the SOL-CARE safety syringe
for allergy practices. Available in both individually wrapped and allergy
trays as well as standard and IDB needles. Stop by to see our spring
specials!
Solutionreach
3098 Executive Pkwy, Suite 300
Lehi, UT 84043
Phone: (866) 605-6867
www.solutionreach.com
Booth #169
Solutionreach is a patient engagement software service designed to
maintain and retain existing patients while identifying and acquiring
new patients. Utilizing the latest automated text/email messaging
technologies and social media tools, Solutionreach helps you to
increase productivity and grow your practice, while you focus on your
patients.
Sun Products
60 Danbury Rd.
Wilton, CT 06897
Phone: (800) 298-2408
www.all-laundry.com/freeclear/
Booth #359
Sun Products Corporation, a leading North American manufacturer
and marketer of fabric care and other household products will feature
information and provide samples of all Free Clear laundry detergent.
all Free Clear is specially formulated for patients with sensitive
skin, as it is hypoallergenic, free of fragrances, clear of dyes, and is
preservative free.
PO Box 1846
Cullman, AL 35056
Phone: (256) 739-1398
www.systemedx.com
Booth #258
We are a fully integrated EHR and PM solution.
Televox Software Inc.

1110 Montlimar Drive, Suite 700
Mobile, AL 36609
Phone: (251) 706-3777
www.televox.com
Booth #160
TeleVox communication solutions enable you to engage with patients
throughout the patient lifecycle. With greater impact and for less
expense than mailed or manual staff efforts, you can connect for
appointment reminders, recalls, patient balance notifications, test
results communications, wellness initiatives and more!
Teva Respiratory
41 Moores Rd
Frazer, PA 19355
Phone: (888) 483-9522
www.tevarespiratory.com
Booth #500
Stop by our booth to learn more about Qvar (beclomethasone
dipropionate HFA) & ProAir HFA (albuterol sulfate). Information,
educational materials, and resources to benefit your practice will be
available.
155
Exhibits
Thermo Fisher Scientific
US Hereditary Angioedema Association
4169 Commercial Avenue

Portage, MI 49002
Phone: (800) 346-4364
www.thermoscientific.com/phadia
Booth #362
As the immunodiagnostic experts within Thermo Fisher Scientific, we
work to dramatically improve the management of allergy, asthma and
autoimmune diseases. We do this by providing healthcare professionals
with innovative diagnostic technologies and clinical expertise. This
results in better healthcare and quality of life for millions of patients
and their families. The following diagnostic technologies are marketed
under the Thermo Scientific brand: ImmunoCAP specific IgE blood
test, Phadia Laboratory Systems, uKnow Peanut, and EliA
Autoimmune Assays.
Seven Waterfront Plaza

500 Ala Moana Blvd.
Honolulu, HI 96813
Phone: (866) 788-5598
www.haea.org
Booth #564
The US HAEA provides a wide range of patient services, patient
advocacy programs and clinical research for this rare genetic blood
disease. We display information on HAE diagnosis and treatment as well
as our scientific registry - Patient Driven Research for a Cure.
UpToDate Wolters Kluwer Health

95 Sawyer Road
Waltham, MA 02453
Phone: (781)392-2000
www.uptodate.com
Booth #539
UpToDate, a Wolters Kluwer Health company, is an evidencebased, physician-authored clinical decision support resource used
by 600,000+ clinicians worldwide. Our world-renowned authors,
editors and peer reviewers use a rigorous editorial process to
synthesize the most recent medical information into evidence-based,
recommendations clinicians trust to make the right point of care
decisions.
US Bioservices
3101 Gaylord Parkway
Frisco, TX 75034
Phone: (888) 518-7246
www.usbioservices.com
Booth #458
For more than 18 years, US Bioservices has delivered nationwide
specialty pharmacy and nursing services that meet the unique needs
of patients needing infusions. Through our Pathpoint Ig program,
we provide access to all available brands of immune globulin,
coordinate comprehensive nursing services for every infusion and
deliver scheduled status reports to the physician. In addition, we
invest additional time in verifying each patients insurance benefits,
attempting to minimize out of pocket expenses whenever possible.
Our dedicated clinical staff of nurses and pharmacists assures that all
patients receive the quality, high touch services that lead to maximized
therapeutic success.
156
USIDNET
40 W. Chesapeake Ave., Suite 308
Towson, MD 21204
Phone: (800) 296-4433
www.usidnet.com
Booth #571
The United States Immunodeficiency Network (USIDNET) is a research
consortium established to advance scientific research in the field of
primary immunodeficiency disorders. The current focus of this initiative
is on the Primary Immunodeficiency Disease Registry & Education
mentoring for your investigators.
Vidara Therapeutics Inc.

2475 Northwinds Parkway, Second Floor
Alpharetta, GA 30009
Phone: (770) 753-6332
www.vidararx.com
Booth #165
ACTIMMUNE (interferon gamma-1b), a biologic response modifier, is
a sterile, clear, colorless solution, in a single-use vial for subcutaneous
injection. ACTIMMUNE is indicated for reducing the frequency and
severity of serious infections associated with Chronic Granulomatous
Disease (CGD) and delaying time to disease progression in patients with
Severe, Malignant Osteopetrosis.
Viracor-IBT Laboratories
1001 NW Technology Drive
Lees Summit, MO 64086
Phone: (816) 554-5171
www.ViracorIBT.com
Booth #471
Viracor-IBT Laboratories is accelerating medicine through innovative
molecular and immunodiagnostics, excellence in science and
exceptional service. With nearly 30 years of specialized expertise in
infectious disease, immunology and allergy testing, Viracor-IBT is
committed to helping medical professionals and biopharmaceutical
companies solve challenging and often life-threatening problems.
Viracor-IBT is passionate about delivering timely, actionable information,
never losing site of the connection between the testing it performs
and the patients it ultimately serves. For more information, please visit
www.viracoribt.com.
Exhibits
ViroPharma, Inc.
730 Stockton Drive
Exton, PA 19341
Phone: (610) 458-7300
www.viropharma.com
Booth #448
ViroPharma Incorporated is an international biopharmaceutical
company committed to developing and commercializing innovative
products that address unmet medical needs. CINRYZE (C1 esterase
inhibitor [human]) is an FDA-approved therapy for patients with
hereditary angioedema (HAE, also known as C1 esterase inhibitor
deficiency). CINRYZE is a C1 esterase inhibitor that is used to prevent
attacks and swelling in teenagers and adults with HAE.
Vitalograph, Inc.
Xoran Technologies
5210 South State Rd.
Ann Arbor, MI 48108
Phone: (800) 709-6726
www.xorantech.com
Booth #150
Xoran Technologies is the innovator and market leader in compact,
specialized medical CT scanners. The Xoran MiniCAT generates
immediate, digitally versatile images of exceptional quality, allowing
physicians to accelerate patient diagnosis and treatment. MiniCAT is a
compact, upright in-office CT scanner designed for high-resolution, low
radiation dose bone window imaging of the sinuses, temporal bones
and skull base. MiniCAT provides immediate access to images at the
patients point-of-care resulting in a faster diagnosis and treatment.
13310 W. 99th Street

Lenexa, KS 66215
Phone: (913) 888-4221
www.vitalograph.com
Booth #541
Vitalograph is a leading manufacturer of cardio-respiratory testing
devices for use in the physician clinic as well as in support of
pharmaceutical clinical development. In 2013, Vitalograph celebrate a
50 year history of producing high quality medical instumentation for
diagnosing and monitoring cardio-respiratory diseases. In addition,
Vitalograph supports pharmaceutical development by providing an
integrated solution to collect, centralize and report both site generated
and patient reported outcomes for clinical trials.
Xtract Solutions
World Allergy Organization
50 W. 23rd Street
New York, NY 10010
Phone: (877) 276-5104
www.yodle.com
Booth #152
Yodle, a leader in local online marketing, connects thousands of local
businesses with consumers in a process so simple and effective that
business owners cant imagine any other way to advertise.
555 East Wells Street, Suite 1100

Milwaukee, WI 53202
Phone: (414) 276-1791
www.worldallergy.org
Booth #565
The World Allergy Organization (WAO) is an international umbrella
organization whose members consist of 89 regional and national
Allergology and clinical immunology societies from around the world.
By collaborating with member societies, WAO is a global resource
and advocate in the field of allergy, advancing excellence in clinical
care through education, research and training as a worldwide alliance
of allergy and clinical immunology societies in nearly 100 countries
around the globe. Visit our booth to learn more about WAAC 2013 from
22-26 June in Milan, Italy.
9495 SW Locust St, Suite E

Portland, OR 97223
Phone: (503) 379-0110
www.xtractsolutions.com
Booth #369
The Allergen Mixing Assistant (AMA) from Xtract Solutions provides
nurses with a valuable tool to continuously refrigerate, organize and
mix allergenic extracts. Combined with the Xtract Preparation System
(XPS), a customized software solution built to maximize workflow
efficiency and verify the accuracy of the mixing process, there is now a
complete solution for the modern IT bottle lab.
Yodle
157
Exhibits
Allergenic Extracts
Health/Body Care
ALK, Inc . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 361

Allergy Laboratories, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 259
HollisterStier Allergy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 531
Kirkman Group, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Nosk USA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Perrigo Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sun Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Clinical Research Organizations

Alpha-1 Foundation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 548
American Latex Allergy Association. . . . . . . . . . . . . . . . . . . . . . . . . 562
Inflamax Research Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 372
Computer Hardware/Software
Crowell Systems. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meditab Software, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Module MD, LLC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rosch Visionary Systems, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Solutionreach. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Systemedx Healthcare Technology, Inc. . . . . . . . . . . . . . . . . . . . . .
264
462
354
154
169
258
Diagnostic Equipment
Carestream. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
ndd Medical Technologies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 455
Xoran Technologies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
Diagnostic Testing
Aerocrine. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hycor Biomedical, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Medical College of Wisconsin. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Methapharm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Siemens Healthcare Diagnostics. . . . . . . . . . . . . . . . . . . . . . . . . . .
SmartPractice. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thermo Fisher Scientific. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Viracor-IBT Laboratories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
146
542
552
244
268
453
362
471
Environmental Products
Allergy Control Products. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Allergy Guardian. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Kaz, Inc / Honeywell. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mission: Allergy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
National Allergy Supply. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
445
367
161
251
443
Equipment/Supplies
Buzzy4shots.com. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intra Pump Infusion Systems. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Panatrex, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Philips Respiratory Drug Delivery . . . . . . . . . . . . . . . . . . . . . . . . . .
Sol Millennium Medical Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
158
546
277
454
147
550
472
377
378
359
Immunotherapy
Allergy Therapeutics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Baxter. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Baxter Global Medical Affairs . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Greer Laboratories, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Greer Laboratories, Inc - Medical Affairs. . . . . . . . . . . . . . . . . . . . .
281
409
535
248
252
Other
Abbott Nutrition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 254
American Express Open. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 261
Axelacare Health Solutions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 368
Bank of America Practice Solutions. . . . . . . . . . . . . . . . . . . . . . . . . 158
BioPlus Specialty Pharmacy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
Everyday Health, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forest Pharmaceuticals, Inc . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 460
Genentech USA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
Gerber Products Company d/b/a Nestl Infant Nutrition. . . . . . . . . 447
Immune Epitope Database . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 575
Kidzpace Interactive, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 260
Lysosomal and Rare Disorders Treatment and Research Center . . . 177
McNeil Consumer Healthcare. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271
Natures One, Inc . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 461
NUTRICIA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
Patient Services, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 560
Physicians Angels. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 360
Televox Software Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
World Allergy Organization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 565
Xtract Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 369
Yodle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
Patient/Public Education
American Partnership For Eosinophilic Disorders (APFED). . . . . . . .
FARE. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Immune Deficiency Foundation. . . . . . . . . . . . . . . . . . . . . . . . . . . .
National Eczema Association . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Organization of Teratology Info Specialists (OTIS)/UCSD . . . . . . . . .
Red River Commodities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
US Hereditary Angioedema Association. . . . . . . . . . . . . . . . . . . . . .
557
563
569
572
262
140
564
Exhibits
Pharmaceuticals
Actient Pharmaceuticals LLC. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Alcon Laboratories Inc . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Allergan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bausch+Lomb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bio Products Laboratories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Biotest Pharmaceuticals Corporation. . . . . . . . . . . . . . . . . . . . . . . .
Blaine Labs, Inc . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Boston Scientific. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CarePoint Partners . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Chattem - A Sanofi Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CSL Behring. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dyax Corp.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Grifols. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IVEDCO. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Meda Pharmaceuticals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Medex BioCare. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Merck, Sharp & Dohme, Corp.. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Merck, Sharp & Dohme, Corp.. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mission Pharmacal Company. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mylan, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
NeilMed Pharmaceuticals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Novartis Pharmaceuticals Corp. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Octapharma. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Protein Sciences Corporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regeneron Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .
Sanofi. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Shire Human Genetic Therapies . . . . . . . . . . . . . . . . . . . . . . . . . . .
Shire Human Genetic Therapies . . . . . . . . . . . . . . . . . . . . . . . . . . .
Shire Human Genetic Therapies (Global Medical Affairs). . . . . . . . .
Sunovion Pharmaceuticals Inc . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Teva Respiratory. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
US Bioservices. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vidara Therapeutics Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ViroPharma, Inc . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Physician Education
558
308
442
449
553
142
476
386
164
477
520
434
334
576
322
276
300
514
273
414
331
340
280
459
463
400
236
242
153
314
500
458
165
448
American Board of Allergy and Immunology . . . . . . . . . . . . . . . . . .

Clinical Immunology Society. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
European Academy of Allergy and Clinical Immunology. . . . . . . . . .
Genentech USA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
International Eosinophil Society, Inc . . . . . . . . . . . . . . . . . . . . . . . .
The Mastocytosis Society. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
568
577
136
144
566
570
Physician Recruitment
BreatheAmerica, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 466
Corpus Christi Allergy & Asthma Center. . . . . . . . . . . . . . . . . . . . . . 269
USIDNET. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 571
Publications
Allergy and Asthma Proceedings. . . . . . . . . . . . . . . . . . . . . . . . . . .
BioMed Central. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Elsevier. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Karger Publishers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lippincott Williams & Wilkins . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The JAMA Network. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
UpToDate Wolters Kluwer Health. . . . . . . . . . . . . . . . . . . . . . . . . . .
358
376
355
551
373
246
539
Spirometry
Jones Medical Instrument Co.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 533
Micro Direct, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
nSpire Health, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 350
Vitalograph, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 541
The American Board of Allergy and Immunology. . . . . . . . . . . . . . 1527
159
Exhibit Hall Floor Plan
EAACI
2013
Milan
EAACI
Red
River
Biotest
Nutricia
North
America
Shire
Shire
Sunovion
Pharmaceuticals
Inc.
Mylan
sanofi
Meda
Pharmaceuticals
Alcon
Laboratories
Inc.
Merck
Teva
Respiratory
Merck
CSL
Behring
JAMA
Network
National
Allergy
Supply,
Inc.
Allergy
Control
Products
Hycor
Biomedical
Baxter
Medical
Affairs
Up
To
Date
Vitalograph
Yodle
Gerber
Buzzy4
shots
Rosch
Shire
Global
Medical
Greer
Medical
Affairs
Greer
Abbott
Mission:
Allergy
nSpire
Module
MD
Health
Elsevier
Viro
Pharma
Allergan
Hollister
Stier
Xoran
COFFEE
STATION
Neil
Med
Jones
160
Aerocrine,
Inc.
Philips
Respiratory
Methapharm
Norvartis
Dyax
Corp
Baxter
Genentech
Bausch
+
Lomb
Alpha-1
Sol
Millennium
Karger
Publishers
Panatrex,
Inc.
Smart
Practice
ndd
Medical
College
of
WI
Bio
Products
APFE
Exhibit Hall Floor Plan
Aerocrine,
Inc.
Xoran
Yodle
Shire
Global
Medical
Philips
Respiratory
AMA
twork
Greer
Medical
Affairs
Greer
uzzy4
hots
Viro
Pharma
Bausch
+
Lomb
Alpha-1
Sol
Millennium
Karger
Publishers
Smart
Practice
Abbott
Systemedx
Allergy
Labs
Allergy
and
Asthma
Proceedings
TeleVox
Kaz
Kidzpace
Vidara
Siemens
American
Express
Open
Physicians
Angels
Corpus
Christi
ALK,
Inc.
Panatrex,
Inc.
US
Bioservices
Forest
Meditab
Software,
Inc.
ndd
Protein
Sciences
Nature's
One,
Inc.
Regeneron
Actient
Patient
Services
Food
Allergy
Research
McNeil
Consumer
Healthcare
Axelacare
Health
Solutions
Thermo
Fisher
ALERT,
Inc.
BioPlus
Solutionreach
Crowell
Systems
OTIS
Sun
Products
APFED
TAKE
ONE
BOOTH
CarePoint
Partners
Genentech
Elsevier
Medical
College
of
WI
Bio
Products
Bank
of
America
Micro
Direct,
Inc.
Mission:
Allergy
nSpire
Module
MD
Health
FFEE
TION
erber
Rosch
Allergy
Guardian
Breathe
America,
Inc.
US
IES
HAA
WAO
Xtract
Solutions
IDF
Mastocytosis
USIDNET
Carestream
Medex
Biocare
Octapharma
Intra
Pump
Mission
Pharmacal
Inflamax
Research
Inc
Biomed
Central
Lippincott
Nosk
USA
Kirkman
Group,
Inc.
Blaine
Labs
Perrigo
Company
Boston
Scientific
Inc.
Chattem,
Inc
Viracor-IBT
Laboratories
ABAI
Lysosomal
National
Eczema
IVEDCO
La
Jolla
Clinical
Immunology
Society
161

River Level
008A
007C
A L A M O
007B
GROTTO
ESCALATORS
007D
007A
S T R E E T
006D
006C
006B
ESCALATORS
006A
GREEN
ROOM
005
REHEARSAL
HALL
003B
003A
002B
004
VIP
ROOM
002A
001B
001A
RIVER LEVEL
ESCALATOR
M A R K E T
162
S T R E E T

Street Level
ESCALATORS
WALKWAY
ESCALATORS
EXHIBT HALL
BRIDGE
HALL
REGISTRATION
EXHIBIT HALL C
EXHIBIT HALL D
GENERAL SESSION
POSTER HALL
Member
Resource
Center
ESCALATORS
EAST
REGISTRATION
LOB B Y B R I DGE
CAF
LILA COCKRELL
THEATRE
ARTrust
BENEFIT
M A R K E T
S T R E E T
MAIN
ENTRANCE
To Grand Hyatt
To Hilton and Westin
To Marriotts
163

Concourse Level
218
217D 217C 217B 217A
216B
FEATURED POSTERS
215
214D 214C 214B 214A
216A
213B 213A 212B 212A 210B 210A 208
TOWER V I EW
R EGI S T R AT I ON
ESCALATORS
PAR K V I EW
R EGI S T R AT I ON
211
209
ESCALATORS
BRIDGE
HALL
BELOW
EXHIBIT HALL C
BELOW
EXHIBIT HALL D
SPEAKER RESOURCE ROOM

PRESS ROOM
207B
207A
206B
206A
205
THEATRE
M A R K E T
Ballroom Level
S T R E E T
PREFUNCTION
GRAND
BALLROOM C
C3
164
C2
C1
GRAND BALLROOM LEVEL
ESCALATORS
E XHIB IT HALL C
B ELOW
E XHIB IT HALL D
BELOW
B ELOW
RIVER
BELOW

Marriott
Rivercenter
SPEAKER
RESOURCE
ROOM
Third Floor
165
Marriott Riverwalk
Second Floor Ballrom Level
First Floor P1
166
Keyword Index
ABPA / AFS 4010
Acquired (Secondary) Immunodeficiencies: HIV/AIDS-related
4002
Congenital (Primary) Immunodeficiencies: T Cell Deficiencies

1818, 2304, 3311, 4101, 4816, 4822, 5005
Conjunctivitis 1209, 3526
Acquired (Secondary) Immunodeficiencies: Non-HIV/AIDs-related

4002, 4009
Contact Hypersensitivity 1209, 2802
Adverse Event Reporting 2805, 4804
Controversial Treatments 1101, 2515, 5505
Aerobiology 1202, 2305, 2526, 3010, 4823
COPD 2001
AIDS-Related Disorders: Pathogenesis
Cytokine and Cytokine Receptor-Mediated Therapy (IFNs, CSFs,

ILs) 3527
Allergen Avoidance 1402, 2010, 2523, 3307, 4307, 4823, 5706

Allergen immunotherapy 1211, 1211A, 1211B, 1211C, 1211D,
1611, 1611B, 1611D, 1813, 2013, 2521, 2623, 2810, 2817, 2819,
3303, 4803, 4817, 5506, 5714
Anaphylaxis (including Idiopathic, Exercise, Latex) 1203, 1603,
1815, 2004, 2011, 2514, 2808, 2821, 2825, 3011, 3015, 3524, 4301,
4807, 4811
Controversial Tests / Misuse of Standard Tests 2825, 5703
Cytokines 3007, 4014, 4303, 4827

Cytokines / Chemokines and Their Receptors 2507, 4008
Data Analysis and Biostatistics 2827
Delayed Type Hypersensitivity Tests 2802
Dermatologic and Ophthalmic Treatments 1820
Anti-inflammatory Agents (including COX-1 & 2) 1205, 1605,

3007
Drug Reactions 1101, 1203, 1209, 1602, 1816, 2511, 3015, 3301,
3524, 4818, 5002, 5705
Antibody-Mediated Immune Regulation 4009

Anticholinergics 3302
Eczema / Atopic Dermatitis 1403, 2813, 2818, 3043, 4303, 4819,

4827, 5007, 5011, 5306
Antigens / Antigen Presentation/Superantigens 3014, 5503
EHR/EMR 1212, 1501, 2005, 2021, 3012, 5711
Asthma: Adults 1205, 1206, 1605, 1612, 2001, 2003, 2012, 2022,
2024, 2025, 2301, 2314, 2315, 2501, 2503, 2508, 2512, 2525, 2625,
2801, 2805, 2809, 2812, 2824, 3001, 3005, 3008, 3041, 3042, 3302,
3308, 3312, 3314, 3521, 3551, 4001, 4003, 4008, 4014, 4151, 4808,
4809, 4810, 4821, 4827, 4828, 4830, 5101, 5301, 5306, 5502, 5708
Endothelial / Epithelial / Smooth Muscle / Fibroblasts 2507,

2809, 5708
Asthma: Children 1206, 1213, 2008, 2010, 2012, 2022, 2024,

2301, 2314, 2315, 2508, 2510, 2512, 2522, 2525, 2622, 2824, 3001,
3005, 3008, 3041, 3043, 3101, 3302, 3305, 3308, 3314, 3521, 3551,
4001, 4151, 4307, 4808, 4819, 4821, 4830, 5302, 5303, 5306, 5502,
5701, 5702, 5709
Environmental Controls 1402, 2510, 2523, 3307, 3523

Eosinophils 1201A, 2007, 2504, 2526, 2815, 4802, 5301, 5501,
5710
Epidemiology 2023, 3008, 5302, 5712
Evidence-based/Clinical Practice Guidelines 1208, 1801, 2515,
2624, 2811, 3044, 3303, 3307, 4825, 5505, 5702
Experimental Design 1601, 2006
Autoantigens 2524, 2803
Flow Cytometry / Cell Surface Markers 2002, 4829
Billing and Coding 1301, 1401, 1501, 1607, 1611B, 1611D, 1711,
2505, 4005
Food Allergy 1011, 1201, 1603, 1604, 1812, 2023, 2308, 2313,
2621, 2814, 2815, 2818, 2822, 2825, 3043, 3306, 3312, 3315, 4004,
4802, 4803, 4812, 4819, 4824, 5003, 5010, 5705, 5706, 5713
Bronchial Provocation 2801, 4809, 5701

Bronchiolitis 4003
CD4+ Cells (TH1, TH2) and T regulatory cells 3101, 4303, 4829,
5712
Food Challenge 1815, 2313, 2621, 2814, 2822, 3044, 4824, 5006,
5706
Foods 2023, 2515, 2621, 5501
Cell Surface Markers and Receptors (Flow Cytometry) 2002,

4813
Gastrointestinal System 1011, 1201, 1201, 2302, 2308, 2526,

2815, 4802, 5501, 5710, 5713
Complement / Kinins 1207
Glucocorticoids 3001
Congenital (Primary) Immunodeficiencies: B Cell / Antibody

Deficiencies 1818, 2304, 2804, 2818, 3002, 3304, 3311, 4101,
4816, 4822, 5005
Health Informatics 1712, 2307, 3012, 4012, 4805, 5711
Congenital (Primary) Immunodeficiencies: Complement

Deficiencies 5005
Congenital (Primary) Immunodeficiencies: Neutrophil Deficiencies
2304, 5707
Health Literacy 2527, 4806

Healthcare Disparities 2527, 2812, 4825, 5307, 5709
Hereditary and Acquired Angioedema 2811, 2826, 4304
Hypereosinophilic Syndromes 2504, 5301, 5713
Hypersensitivity Pneumonitis 1612
167
Keyword Index
Ig Measurement / Total & Specific 2506, 2509, 2814, 3002, 4306
Occupational Diseases 2003, 2305, 2503, 3523, 4003
IgE Receptor / Allergen Binding 3014
Patch testing 1101B, 5010
IgE-Mediated Biochemical Events 1101, 2524, 3305
Patient Education 1403, 1606, 1607, 1801, 2022, 2315, 2624,

2821, 2827, 3315, 4012, 4804, 4830, 5007
Immune Complex- Mediated Responses 2625, 3009, 5503

Immunogenetics / Molecular Biology 1204, 1210, 1610, 2525,
2701, 3522, 5710
Phagocytosis / Killing 5707
Immunoglobulin Replacement Therapy 2804, 3002
Pollutants 2305, 3003, 3042
Immunoglobulins (including IgE) 4007, 4305, 4826
Pulmonary Function Tests 1612, 2008, 2025, 2316, 4001
Immunohematologic Diseases 2803, 4822

Immunologic Aspects of Infectious Diseases (Lyme Disease, TB,
Leprosy, Hepatitis, Syphilis) 3009
Quality and Outcomes 1102, 1103, 1206, 1302, 1601, 1712,

2012, 2307, 2311, 2512, 2527, 2806, 3005, 3012, 3308, 3525, 4015,
4805, 4814, 4816, 4825, 5012, 5505, 5709
Immunologic Skin Diseases 3004, 3301, 4812
Reproductive Immunology 2805
Immunomodulators / Suppressives (including anti-IgE, DNA,CpG

ODNs) 3004, 4008, 4009, 4305, 4828
Rhinitis 2006, 2501, 2513, 2816, 3013, 3041, 3303, 3312, 3521,
4004, 4013, 4302, 4815, 5101
Immunoregulation / Tolerance 2013, 2014, 2803, 2809, 2810,

3101, 4305, 4808, 4829, 5303, 5304
Rhinoscopy 1208, 1608, 2807, 4801, 4815
Immunotherapy 1011, 1609, 1811, 1813, 1814, 2013, 2014,

2303, 2308, 2506, 2521, 3306, 4006, 4812, 4826, 4828, 5003, 5004,
5008, 5303
Indoor Allergens 2010, 2510, 2523, 4307
Infectious Agents 3305, 4007, 5001, 5712
Innate Immunity/TLRs 2007, 2015, 3003, 3014, 4010, 5304, 5305
Sinusitis 1608, 2306, 2501, 2513, 2801, 2807, 3006, 3013, 4801,
4821, 5704
Skin 1207, 1403, 1820, 2503, 2802, 3301, 5007
Skin Testing: Scratch and Intradermal 1611A, 1611C, 3316,
4004, 5010, 5307
Skin tests (Immunoassay for Total and Specific IgE) 1203,
4826, 5703
Insurance Issues (e.g. contracts, appeals) 1607, 2307, 2312,

2812, 4005, 4805
Spirometry 1101D, 2025, 2314, 2316, 2824
Intracellular Signaling/Mediator Detection 5708
Standardization of Antigens 1611A, 1611C, 2623
Lipid Mediators 1205, 1605
Stinging Insect Allergy 5004
Lymphocyte Function: Proliferation, Cytotoxicity 4813, 5703
Surgical Intervention with Sinuses / Middle Ear 1608, 2306
Lymphocytes: T cells/B cells/NK cells/LAK cells 2002, 2014,

2810
Systemic Autoimmune Disease: RA/SLE/Vasculitis/Other Disorders

3009
Mast Cell Stabilizers 0001, 2009, 2823
Upper Airway, Nose, Sinuses, Middle Ear 1208, 2006, 2513,

2807, 3006, 3013, 3526, 4302, 4801, 4815, 5305
Mast Cells / Basophils 0001, 2004, 2007, 2009, 2514, 2808,

2823, 3524, 3527, 4007, 4011, 4301, 5304, 5503
Stability of Antigens 2623
Urticaria 2004, 2524, 2625, 3004, 3313, 5009
Mastocytosis 2009, 2808, 4011, 4301
Vaccine (Principles and Reactions) 1819, 4804
Modulation of Mediator Release 1207, 3007
Venoms 4803
Molds and Fungi 1202, 1817, 3010, 4010, 5305

Molecular Biology Technology including TRECs. RTPCR, in situ
hybridization, cell purification, gene chips 1210, 1610
Molecular Diagnostics / Tissue Typing 2506, 3311, 4306, 4817
Mucosal Immunity 2015, 2302, 2306, 2507
Nasal Provocation 4013, 4302
Neutrophils 2015, 2502, 2514, 5707
NK / NKT Cells 4813
Non-invasive diagnostic measures 2003, 2024, 2508
168
Pollens 1202, 3003, 3042, 4823
Speaker Index
A
Aalberse, Rob C., PhD, Duivendrecht, Netherlands - 3014
Aaronson, Donald W., MD FAAAAI, Chicago, IL - 1611B, 1611D, 4814
Abonia, Juan Pablo, MD, Cincinnati, OH - 1201, 1201D
Abraham, Roshini S., PhD FAAAAI, Rochester, MN - 4813, 5005
Abraham, Soman N., PhD, Durham, NC - 4007, 5304
Abramson, Stuart L., MD PhD FAAAAI, Houston, TX - 2701
Aceves, Seema Sharma, MD PhD FAAAAI, La Jolla, CA - 1201, 1201D,
2308, 5710
Ackerman, Steven J., PhD, Chicago, IL - 1201, 1201D, 5301
Adelman, Daniel C., MD FAAAAI, Redwood City, CA - 1111
Adinoff, Allen D., MD FAAAAI, Highlands Ranch, CO - 4801
Akdis, Cezmi A., MD FAAAAI, Davos, Switzerland - 2303, 2809, 4303
Akdis, Mubeccel, MD PhD, Davos, Switzerland - 2810
Akin, Cem, MD PhD FAAAAI, Boston, MA - 2808, 4301, 5504
Alam, Rafeul, MD PhD FAAAAI, Denver, CO - 5301
Alexis, Neil, PhD, Chapel Hill, NC - 2305
Allakhverdi, Zoulfia, PhD FAAAAI, Montreal, Canada - 2507
Allen, Katrina Jane, MD PhD, Parkville, VIC, Australia - 1201, 3306,
5501
Allison, Beth A., NP, Tualatin, OR - 2022, 2624
Anderson, James J., MLT, London, Canada - 1817
Anderson, Sandra D., PhD DSc, Camperdown, Australia - 4809
Apter, Andrea J., MD MA MSc FAAAAI, Media, PA - 2012, 2512, 2812
Armor, Larry, PA MHA, Skyland, NC - 1401
Arnold, Jeanette, MSN RN C-FNP, Jackson, MS - 1101A, 2315, 3316
Askenazi, Noga, MD FAAAAI, Crystal Lake, IL - 2505
Atasoy, Ulus, MD FAAAAI, Columbia, MO - 1210
Atkins, Fred (Dan) McDaniel, MD FAAAAI, Denver, CO - 1201, 1201B,
5713
Austen, K. Frank, MD FAAAAI, Boston, MA - 4701
Avila, Pedro C., MD FAAAAI, Chicago, IL - 2301
B
Bacharier, Leonard B., MD FAAAAI, Saint Louis, MO - 1213, 2522, 5702
Backenson, Thomas J., MD, Alexandria, VA - 0001
Bahna, Sami L., MD DrPH FAAAAI, Shreveport, LA - 3308
Bajowala, Sakina S., MD FAAAAI, North Aurora, IL - 4012
Baker, James W., MD, Lake Oswego, OR - 4001
Balkissoon, Ronald C., MD MSc, Denver, CO - 1208
Ballas, Zuhair K., MD FAAAAI, Iowa City, IA - 1814
Ballow, Mark, MD FAAAAI, Sarasota, FL - 5008
Bandla, Hari, MD, Chicago, IL - 4815
Banerjee, Audreesh, MD, Philadelphia, PA - 1816
Banerji, Aleena, MD, Boston, MA - 4304, 4818, 5705
Baptist, Alan P., MD MPH, Ann Arbor, MI - 5709
Barnes, Charles S., PhD, Kansas City, MO - 1817, 4307, 5305
Barnes, Kathleen C., PhD FAAAAI, Baltimore, MD - 1210, 1610
Baroody, Fuad M., MD FAAAAI, Chicago, IL - 3526, 4302, 4815
Barrett, Nora A., MD, Boston, MA - 1601, 3302
Beck, Lisa A., MD FAAAAI, Rochester, NY - 4812
Bender, Bruce G., PhD FAAAAI, Denver, CO - 1206, 2012
Berin, Cecilia, PhD, New York, NY - 4812
Bernstein, Cheryl Koff, RN BSN CCRC, Cincinnati, OH - 2312, 2623
Bernstein, Jonathon A., MD FAAAAI, Cincinnati, OH - 2524, 3307
Beutler, Bruce, MD, Dallas, TX - 4101
Beyer, Kirsten, MD, Berlin, Germany - 5706

Bielory, Leonard, MD FAAAAI, Springfield, NJ - 1209, 3526
Bingham, Clifton O., MD, Baltimore, MD - 4009
Bird, J. Andrew, MD, Dallas, TX - 2308
Blaiss, Michael S., MD FAAAAI, Memphis, TN - 1211A, 1211C
Blanca, Miguel, MD PhD, Mlaga, Spain - 1203
Bleecker, Eugene R., MD FAAAAI, Winston Salem, NC - 1210, 3008
Blouin, William R., ARNP, North Miami, FL - 2826, 3311
Bochner, Bruce S., MD FAAAAI, Baltimore, MD - 1201, 2007
Bock, S. Allan, MD FAAAAI, Boulder, CO - 4811, 5006
Boguniewicz, Mark, MD FAAAAI, Denver, CO - 1820, 2818
Bonadonna, Patrizia, MD, Italy - 2808
Bonagura, Vincent R., MD FAAAAI, Great Neck, NY - 2804
Bonilla, Francisco A., MD PhD FAAAAI, Boston, MA - 2804, 3304, 3522,
2304
Booker, Jeanette, Chandler, AZ - 1102, 1501, 2021, 2311
Borish, Larry, MD FAAAAI, Charlottesville, VA - 1605, 2525, 5306
Bork, Konrad, MD, Mainz, Germany - 1207, 4304
Borrelli, Belinda, PhD, Providence, RI - 1206, 1606
Bossard, Mary Kay, BS RRT AE-C, Cleveland, OH - 2314, 2824
Boulet, Louis-Philippe, MD, Quebec City, Canada - 4809
Boyce, Joshua A., MD FAAAAI, Boston, MA - 1604, 1605, 2809, 3007
Breiteneder, Heimo, PhD, Vienna, Austria - 4306
Broide, David H., MB ChB FAAAAI, San Diego, CA - 1601
Brooks, Stuart, MD, Tampa, FL - 1208
Brown, David A., MD, Skyland, NC - 1611B, 1611D
Brown, Sara, MBChB MD, Scotland, United Kingdom - 1210
Browning, John, MD, San Antonio, TX - 3307
Brown-Whitehorn, Terri F., MD, Philadelphia, PA - 1201
Bryce, Paul, PhD, Chicago, IL - 3306, 5304
Bukstein, Don A., Madison, WI - 5701
Burks, A. Wesley, MD FAAAAI, Chapel Hill, NC - 1011, 1111, 1603,
2101, 2303, 3306
Busse, William W., MD FAAAAI, Madison, WI - 1604, 3302, 3522, 4821
Butterfield, Joseph H., MD FAAAAI, Rochester, MN - 4011
C
Caiado, Joana, MD, Lisbon, Portugal - 1203
Calabria, Christopher W., MD, Helotes, TX - 1211B, 1211D, 5004
Calderon, Moises A., MD PhD, London, United Kingdom - 2303, 2521
Caldwell, Jason W., DO, Winston Salem, NC - 1609, 5001
Campo, Paloma, MD PhD, Malaga, Spain - 4013
Canning, Brendan J., PhD, Baltimore, MD - 1208
Carlisle, Suzanne K., RN BSN CCRP, Little Rock, AR - 3044
Carr, Warner W., MD FAAAAI, Mission Viejo, CA - 1611C, 1611A
Carter, Melody C., MD, Bethesda, MD - 2009, 2808, 4011
Carter, Paul M., MD MHCM FAAAAI, Knoxville, TN - 4825
Cartier, Andr, MD FAAAAI, Montreal, Canada - 2003
Casale, Thomas B., MD FAAAAI, Omaha, NE - 4306, 4828
Castells, Mariana C. , MD PhD FAAAAI, Boston, MA - 1209, 2808, 3524,
5504
Castro, Mario, MD MPH, St. Louis, MO - 4810
Caubet, Jean-Christoph, MD, Geneva, Switzerland - 2506
Chambers, Christina, PhD MPH, La Jolla, CA - 2805
Chan, Wan-Yin, MD, Orange, CA - 1209
Chapel, Helen, MA MD, Path, United Kingdom - 4305
169
Speaker Index
Chapman, Martin D., PhD, Charlottesville, VA - 3014
Charous, B. Lauren, MD FAAAAI - 2521
Chehade, Mirna, MD, New York, NY - 1201, 5713
Chen, Karin, MD, Salt Lake City, UT - 3311
Cheng, Laurence E., MD PhD, San Francisco, CA - 5001
Cheung, Dorothy S., MD FAAAAI, Milwaukee, WI - 1209, 2015, 2522,
5712
Chew, Ginger L., ScD, Atlanta, GA - 3307
Chinn, Ivan, MD, Durham, NC - 1609
Chowdhury, Badrul A., MD PhD FAAAAI, Potomac, MD - 2816
Christie, G. Lynn, MS RD, Little Rock, AR - 2023
Ciaccio, Christina E., MD, Kansas City, MO - 3003, 4830
Cicardi, Marco, MD, Milan, Italy - 1207, 2811
Clayton, Michael H., MD FAAAAI, Albuquerque, NM - 4806
Cockcroft, Donald, MD FAAAAI, Saskatoon, Canada - 1612
Cohen, Noam A., MD PhD, Philadelphia, PA - 5704
Cohen, Sherri, MD MPH, Philadelphia, PA - 2815
Collins, Limone C., MD, Silver Spring, MD - 4804
Collins, Margaret, MD, Cincinnati, OH - 1201, 5713
Commins, Scott P., MD PhD, Charlottesville, VA - 2818, 4803
Condino-Neto, Antonio, MD PhD, Sao Paulo, Brazil - 4002
Corazalla, Edward O., MS RPFT, Minneapolis, MN - 1101, 1101D, 2025
Corren, Jonathan, MD, Los Angeles, CA - 1609, 2501, 4008
Corrigan, Chris J., MD PhD FAAAAI, London, United Kingdom - 1205
Covar, Ronina, MD, Denver, CO - 5302
Cox, Amanda L., MD, New York, NY - 1819
Cox, Linda, MD FAAAAI, Fort Lauderdale, FL - 1611A, 1611C, 2521
Craig, Timothy J., DO FAAAAI, Hershey, PA - 2001, 2811
Creticos, Peter, MD FAAAAI, Baltimore, MD - 1611C, 1611A, 2817
Cui, Don, PA-C AE-C, Litchfield, IL - 1101A
Cunningham-Rundles, Charlotte, MD PhD FAAAAI, New York, NY - 1204,
1811, 2803, 3304, 4816
Custovic, Adnan, MD PhD FAAAAI, Manchester, United Kingdom - 5302
D
Dahln, Sven-Erik, MD PhD, Stockholm, Sweden - 1605
Dalan, Dan, MD FAAAAI, Fargo, ND - 2005
Darr, Jennifer M., MSW LCSW, Denver, CO - 3043, 3315
Davis, Carla M., MD, Houston, TX - 1201C, 1201, 4802, 5501
Davis, Ray S., MD FAAAAI, St. Louis, MO - 2814, 5702
De Jong, Nicolette, PhD, Rotterdam, Netherlands - 3312
Dellon, Evan, MD, Chapel Hill, NC - 1201
Demain, Jeffrey G., MD FAAAAI, Anchorage, AK - 3003
Demoly, Pascal M., MD PhD, Montpellier, France - 2011, 2303
Dicpinigaitis, Peter, MD, Bronx, NY - 1208
Dimov, Vesselin, MD, Chicago, IL - 1212, 4012
Dinakar, Chitra, MD FAAAAI, Prairie Village, KS - 2301, 2508, 3308,
4819
Dioun, Anahita, MD FAAAAI, Boston, MA - 1203
Dixit, Anupma B., PhD, St. Louis, MO - 3010
Dodds, Margaret R., RN MS CPNP, Houston, TX - 3311
Dreborg, Sten K.G., MD PhD FAAAAI, Uppsala, Sweden - 1611C, 1611A
Dreyfus, David H., MD PhD FAAAAI, Waterbury, CT - 3004, 5013
Du Toit, George, MD FAAAAI, London, United Kingdom - 1603
Dube, Peter, PhD, San Antonio, TX - 3305
Duff, Carla M., CPNP MSN, Parrish, FL - 1101C, 3312
170
Duplantier, John E., MD FAAAAI, Indianapolis, IN - 2819

Dupont, Christophe, MD PhD, Paris, France - 4812
Durham, Stephen R., MA MD FRCP, United Kingdom - 2819, 5303,
5506
E
Ebisawa, Motohiro, MD PhD FAAAAI, Kanagawa, Japan - 1603
Eigen, Howard, MD, Indianapolis, IN - 2008
Ein, Daniel, MD FAAAAI, Washington, DC - 2527
Ellis, Anne K., MD MSc FRCPC FAAAAI, Kingston, Canada - 2006
Engler, Renata J.M., MD FAAAAI, Silver Spring, MD - 0001, 1209, 2515,
4804
El Sanadi, Nabil, MD, Fort Lauderdale, FL - 4807
Epstein, Tolly, MD, MS, Cincinnati, OH - 3303
Espinosa-Rosales, Francisco J., MD, Naucalpan de Juarez, Mexico 1811
Evans, Antonina G., BSPharm AE-C, Las Vegas, NV - 2315
F
Farkas, Henriette, MD, Budapest, Hungary - 2811
Fasano, Mary Beth, MD FAAAAI, Iowa City, IA - 1011, 2806
Feldweg, Anna M., MD, Boston, MA - 1815
Ferrer, Marta M., MD PhD FAAAAI, Pamplona, Spain - 1203
Filbrun, Amy G. MD MS, Ann Arbor, MI - 2008
Filipovich, Lisa, MD, Cincinnati, OH - 4101
Finegold, Ira, MD FAAAAI, New York, NY - 1211
Fineman, Stanley M., MD MBA FAAAAI, Marietta, GA - 1607, 4805
Fisher, Laura H., MD, Manheim, PA - 2001
Fitzpatrick, Anne M., PhD, Atlanta, GA - 5302
Fleischer, David Mark, MD FAAAAI, Denver, CO - 2815, 5713
Fleisher, Thomas A., MD FAAAAI, Bethesda, MD - 1111, 1818
Foggs, Michael B., MD FAAAAI, Chicago, IL - 2527, 2812, 5711
Fonacier, Luz S., MD FAAAAI, Mineola, NY - 1209, 2802, 3523, 5007
Ford, Linda, MD FAAAAI - 3042
Foster, Paul S., PhD DSc, Callaghan, Australia - 2809, 4827
Franciosi, James, MD, Orlando, FL - 1201
Frank, Michael, MD FAAAAI, Durham, NC - 2826
Freeman, Alexandra F., MD, Bethesda, MD - 2509
Freeman, Theodore M., MD FAAAAI, Helotes, TX - 4803
Friedlander, Samuel L., MD, Solon, OH - 2513
Friedman, Roger A., MD FAAAAI, Columbus, OH - 4802
Frieri, Marianne, MD PhD FAAAAI, East Meadow, NY - 1816
Frischmeyer-Guerrerio, Pamela A., MD PhD, Baltimore, MD - 2809
Fuhlbrigge, Anne L., MD MS, Boston, MA - 1213, 2512
Fuleihan, Ramsay, MD, Chicago, IL - 4816
Furuta, Glenn, MD, Aurora, CO - 1201C, 1201
G
Galli, Stephen J., MD, Stanford, CA - 5304
Geller, Mario, MD FAAAAI, Philadelphia, PA - 1603, 2004
Gentile, Deborah A., MD, Pittsburgh, PA - 2817, 4830
Georas, Steve N., MD, Rochester, NY - 2305
George, Maureen, PhD RN AE-C, Philadelphia, PA - 1101D, 1801, 2314,
3041, 3520
Gereda, Jose E., MD, San Isidro, Peru - 1211D, 1211B
Gern, James E., MD FAAAAI, Madison, WI - 1204, 1610, 4701, 5306,
5712
Speaker Index
Gevaert, Philippe, MD, Gent, Belgium - 4821, 4302
Gober, Laura M., MD, Ardmore, PA - 5009
Gold, Diane R., MD, Boston, MA - 2523
Goldberg, Pinkus, MD FAAAAI, Indianapolis, IN - 3313
Golden, David B.K., MD FAAAAI, Baltimore, MD - 4803
Goleva, Elena, PhD, Denver, CO - 3001
Gonsalves, Nirmala, MD, Chicago, IL - 1201, 1201D
Gordon, Jeffrey, MD, Saint Louis, MO - 2701
Gould, Hannah J., PhD, London, United Kingdom - 3014
Grammer, Leslie C., MD FAAAAI, Chicago, IL - 5305
Grayson, Mitchell H., MD FAAAAI, Milwaukee, WI - 1101, 2302, 3527,
4007
Green, Linda D., MD FAAAAI, Havertown, PA - 1212, 5012
Greenberger, Paul A., MD FAAAAI, Chicago, IL - 1602, 2004, 5504
Greenhawt, Matthew J., MD, MBA, MSc, Ann Arbor, MI - 1201
Greenlee, M. Carol, MD, Grand Junction, CO - 3525
Gregory, Karen L., DNP APRN-BC RRT AE-C, Washington, DC - 2316,
2821, 3312, 3551, 4151
Grimes, Carl, HHS, CIEC, Denver, CO - 2510
Grimshaw, Kathryn E., RD, Southampton, United Kingdom - 2023
Grodofsky, Marshall P., MD FAAAAI, West Hartford, CT - 1607, 4805
Groetch, Marion E., MS RD, New York, NY - 2815, 5706
Gross, Gary N., MD FAAAAI, Dallas, TX - 1611D, 1611B, 2817, 4814
Gruchalla, Rebecca S., MD PhD FAAAAI, Dallas, TX - 2511, 4818
Guilbert, Theresa W., MD, Madison, WI - 1213, 2522
H
Haczku, Angela, MD PhD FAAAAI, Philadelphia, PA - 2507
Hahlbohm, Dewey F., PA-C AE-C, Helena, MT - 1101
Hall, Ashley Marie, MD, Jackson, MS - 1101
Hamilos, Daniel L., MD FAAAAI, Boston, MA - 5704
Hamilton, Robert G., PhD D.ABMLI FAAAAI, Baltimore, MD - 1211, 4306,
4826, 5703
Han, Joseph K., MD, Norfolk, VA - 3006
Hankin, Cheryl S., PhD, Moss Beach, CA - 3303
Hartert, Tina V., MD MPH, Nashville, TN - 3305
Hauswirth, David W., MD FAAAAI, Columbus, OH - 1011, 1609
Hayden, Mary Lou, RN MS FNP-C AE-C, Charlottesville, VA - 3041
Heltzer, Meredith L., MD, Springfield, VA - 5008, 5707
Herman, James J., MD FAAAAI, Lubbock, TX - 4811
Hernandez-Trujillo, Vivian P., MD FAAAAI, Pembroke Pines, FL - 2818,
3015, 4301, 4816
Heymann, Peter W., MD, Charlottesville, VA - 5306, 5712
Hill, Harry R., MD, Salt Lake City, UT - 5005
Hill, Wade G., PhD APRN, Bozeman, MT - 3042
Hillyer, Philippa, , Bethesda, MD - 5712
Hirano, Ikuo, MD, Chicago, IL - 1201A, 1201
Ho, Shuk-Mei, PhD, Cincinnati, OH - 3101
Hogan, Mary Beth, MD FAAAAI, Reno, NV - 2514
Hogan, Simon P., PhD, Cincinnati, OH - 1201
Holbreich, Mark, MD FAAAAI, Indianapolis, IN - 1201, 1201B, 5010,
5501
Holbrook, Teri, CRNP, Baltimore, MD - 2313, 2822
Holland, Steven M., MD, Bethesda, MD - 2502, 4101
Hollingsworth, John W., MD, Durham, NC - 2305
Holness, Dorothy Linn, MD FRCPC, Toronto, Canada - 3523
Holt, Patrick, DSc, West Perth, Australia - 1204

Holzhauer, Robert J., MD MBA FAAAAI, San Luis Obispo, CA - 2527
Honsinger, Richard W., MD MACP FAAAAI, Albuquerque, NM - 2311,
3525, 4814, 5711
Horner, W. Elliott, PhD LEED AP FAAAAI, Marietta, GA - 1202, 4010,
4307
Howell, Druhan, MD, Mobile, AL - 1209
Huebner, Silvia, MD, Bethesda, MD - 1011
Huftnagle, Gary B., PhD, Ann Arbor, MI - 1610, 3527
Hull, Keith, MD PhD, Silver Spring, MD - 2816
I
Irani, Anne-Marie A., MD FAAAAI, Richmond, VA - 1011, 1603
Irvine, Alan David, MD, Dublin, Ireland - 2101
Ishmael, Faoud T., MD PhD, Hershey, PA - 3001
J
Jackson, Daniel J., MD, Madison, WI - 2301
James, John M., MD FAAAAI, Fort Collins, CO - 2806, 4819
Jarvinen-Seppo, Kirsi M., MD PhD, Albany, NY - 1815, 4004
Jenmalm, Maria C., PhD, Linkoping, Sweden - 1204
Johnson, Sarah, Philadelphia, PA - 2806
Johnston, Sebastian L., MD PhD, London, United Kingdom - 5306
Jones, Stacie M., MD, Little Rock, AR - 1604, 5705
Jutel, Marek, MD PhD, Wroclaw, Poland - 2303
K
Kagalwalla, Amir F., MD, Chicago, IL - 1201, 5010
Kaliner, Michael A., MD FAAAAI - 5101
Kanaoka, Yoshihide, MD PhD, Boston, MA - 1605
Kaplan, Allen P., MD FAAAAI, Charleston, SC - 1207, 2524, 4304
Kaplan, Mark H., PhD, Indianapolis, IN - 4808
Katial Rohit, MD FAAAAI, Denver, CO - 1111
Kau, Andrew, MD PhD, Saint Louis, MO - 2302
Kelkar, Pramod S., MD FAAAAI, Maple Grove, MN - 1209
Kelly, Kevin J., MD FAAAAI, Wauwatosa, WI - 1609
Kelso, John M., MD FAAAAI, San Diego, CA - 1819, 4804
Kemp, Stephen F., MD FAAAAI, Jackson, MS - 4811
Kennedy, Kevin, MPH CIEC, Kansas City, MO - 2510, 4010, 4307
Kern, Robert, MD, Chicago, IL - 1608, 2306
Kertz, Lila C., MSN RN CPNP, St. Louis, MO - 2622
Khan, David A., MD FAAAAI, Dallas, TX - 1211, 3301, 3524, 5705
Khurana Hershey, Gurjit K., MD PhD FAAAAI, Cincinnati, OH - 1210,
1601
Kiley, James P., PhD, Bethesda, MD - 1213
Kidon, Mona I., MD, Rishon, Israel - 1603
Kim, Edwin, MD MS, Chapel Hill, NC - 1609
Kim, Jennifer S., MD FAAAAI, New York, NY - 1609, 4819, 5007
King, Monroe J., DO FAAAAI, Largo, FL - 4804
Kleine-Tebbe, Joerg, MD FAAAAI, Berlin, Germany - 4826, 5703
Klion, Amy D., MD, Bethesda, MD - 1111, 2504, 5014, 5301
Klote, Mary M., MD, Great Falls, VA - 4015
Knight, Adina Kay, MD FAAAAI - 1111
Knorr, Sarah D., RN MPH CCRP, Baltimore, MD - 1712
Knowlton, Kim, PhD, New York, NY - 3042
Koepke, Jerald W., MD FAAAAI - 2807, 4801
Kollmann, Tobias, MD PhD, Vancouver, Canada - 1204
171
Speaker Index
Kolls, Jay, MD, Pittsburgh, PA - 4014
Korenblat-Hanin, Melissa T., ACSW LCSW, St. Louis, MO - 3043, 3315
Kosisky, Susan E., BS, MHA, Burtonsville, MD - 0001, 1211A, 1211C
Kowalski, Marek L., MD PhD, Lodz, Poland - 1205
Kraft, Monica, MD, Durham, NC - 4810, 5502
Kundig, Thomas, MD, Zurich, Switzerland - 1611, 4817
Kwak, Larry W., MD PhD, Houston, TX - 4701
Kwan, Mildred, MD, Berwyn, PA - 3009
Kwok, William W., PhD - 2014
L
LaBelle, Ginger S., CPNP, Cary, NC - 3314
Lachman, Barry, Dallas, TX - 2307
Laidlaw, Tanya M., MD, Boston, MA - 1605
Land, Michael H., MD, FAAAAI, San Diego, CA - 1609
Larenas Linnemann, Dsire E.S., MD FAAAAI, Mexico D.F., Mexico 1611, 2819, 3303
Le, Tao, MD MHS FAAAAI, Elizabethtown, KY - 1212, 1607, 4805
Lee, Gerald B., MD, Louisville, KY - 2625
Lee, John Jhe-Yun, MD, Needham, MA - 2526
Leftwich, Russell B., MD FAAAAI, Nashville, TN - 1212
LeNoir, Michael A., MD FAAAAI, Oakland, CA - 2812
Leung, Donald Y.M., MD PhD FAAAAI, Denver, CO - 1111, 1604, 2827,
3301, 4303, 4806
Levetin, Estelle, PhD FAAAAI, Tulsa, OK - 1202, 4823
Levi-Schaffer, Francesca, PhD FAAAAI, Jerusalem, Israel - 5304
Levinson, Arnold I., MD FAAAAI, Wayne, PA - 2803
Lewkowich, Ian P., Cincinnati, OH - 2810
Li, Henry H., MD PhD, Chevy Chase, MD - 2811
Liacouras, Chris A., MD, Philadelphia, PA - 1201, 1201D, 2526
Lieberman, Phillip, MD FAAAAI, Germantown , TN - 4811
Limb, Susan Lee, MD FAAAAI, Ellicott City, MD - 2816
Lio, Peter, MD, Chicago, IL - 5011
Litonjua, Augusto A., MD MPH, Boston, MA - 4301
Lockey, Richard F., MD, Tampa, FL - 5004, 5505
Lougheed, Diane, MD MSc, Kingston, Canada - 1208
Louik, Carol, ScD, Boston, MA - 2805
Luong, Amber U., MD PhD - 3006
Lynch, Susan V., PhD, San Francisco, CA - 1204
M
MacDonald, Susan M., MD FAAAAI, Baltimore, MD - 1601
Macy, Eric M., MD FAAAAI, San Diego, CA - 1602, 4818
Madaan, Arvind, MD FAAAAI, Charlottesville, VA - 1208, 3526
Maleki, Soheila J., PhD, New Orleans, LA - 4824
Mallam, Dee, RN AE-C, Mercerville, NJ - 2024, 2821
Marshall, Gailen D., MD PhD FAAAAI, Jackson, MS - 1101, 2515, 5505
Martin, Bryan L., DO FAAAAI, Columbus, OH - 1211C, 1211A
Massie, Tammy, Rockville, MD - 5714
Mathur, Sameer K., MD PhD FAAAAI, Madison, WI - 1801
Matsui, Elizabeth, MD, Baltimore, MD - 2010, 3307
Mazer, Bruce D., MD FAAAAI, Montreal, Canada - 4305
McCormack, Meredith C., MD, Baltimore, MD - 1612
McGeady, Stephen J., MD FAAAAI, Philadelphia, PA - 2314, 2625, 3314
McKnight, A. Sean, MD FAAAAI, Henderson, NV - 4005
Mehrotra, Priti, MD, Bethesda, MD - 1601
Meltzer, Eli O., MD FAAAAI, San Diego, CA - 2501
172
Metcalfe, Dean D., MD FAAAAI, Bethesda, MD - 2009

Metz, Gregory M., MD, Edmond, OK - 2821
Michelis, Mary Ann, MD FAAAAI, Hackensack, NJ - 2802
Mikita, Cecilia, MD MPH FAAAAI, Bethesda, MD - 1211A, 1211C
Milek, Debra, MD PhD MPH, Seattle, WA - 4003
Milewski, John D., Med. Admin., Denver, CO - 1301, 1401, 1711
Miller, Rachel L., MD FAAAAI, New York, NY - 1610, 3101
Mishra, Anil, PhD FAAAAI, Cleveland, OH - 1201E
Mitchell, Donna W., RN MSN NP, Richmond, VA - 2312
Moon, Hee-Bom, MD PhD, Seoul, South Korea - 4809
Moore, Martin L., PhD, Atlanta, GA - 3305
Morgan, Wayne Joseph, MD, Tucson, AZ - 1213
Mosnaim, Giselle, MD MS FAAAAI, Chicago, IL - 3525, 5709
Mudd, Kim E., RN MSN CCRP, Baltimore, MD - 1302, 1712, 2313, 2822
Mullol, Joaquim, MD PhD FAAAAI, Barcelona, Spain - 3013
Murphy, Kevin R., MD, Boys Town, NE - 4801
N
Naclerio, Robert M., MD FAAAAI, Chicago, IL - 2306, 4013
Nadeau, Kari C., MD PhD FAAAAI, Palo Alto, CA - 1011, 1611
Naimi, David R., DO, Philadelphia, PA - 1609, 2825
Namazy, Jennifer A., MD FAAAAI, San Diego, CA - 2805
Nelson, Harold S., MD FAAAAI, Denver, CO - 4828
Nelson, Michael R., MD PhD FAAAAI, Olney, MD - 0001, 1211A, 1211C,
2623, 4817, 5714
Newcomb, Dawn C., PhD, Nashville, TN - 4014, 4808
Nicolae, Dan L., Chicago, IL - 1210
Niloff, Jonathan, MD, Waltham, MA - 2307
Nizankowska-Mogilnicka, Ewa, MD PhD, Krakow, Poland - 1205
Noone, Sally A., RN MSN CCRC, New York, NY - 1103, 2621, 3044,
5706
Notarangelo, Luigi D., MD, Newton, MA - 2304, 2803, 4101
Nowak-Wegrzyn, Anna H., MD FAAAAI, New York, NY - 1011, 2308,
4004, 5706
O
OMahony, Liam, MD, Davos, Switzerland - 2810
OShea, John J., Jr., MD, Bethesda, MD - 3101
Ober, Carole, PhD, Chicago, IL - 1210
Oberkfell, Donna R., RN MSN CPNP, St. Louis, MO - 2622
Ochs, Hans D., MD, Seattle, WA - 2509
Ollert, Markus, MD, Munich, Germany - 4306
Olson, Grant C., MD, Denver, CO - 4801
Olson Kloos , Kristin E., RN, Rochester, MN - 2823
Ong, Peck Y., MD FAAAAI, Los Angeles, CA - 2813
Oppenheimer, John, MD FAAAAI, Denville, NJ - 1611C, 1611A, 2301,
2801, 3316
Orange, Jordan, MD PhD FAAAAI, Philadelphia, PA - 3522
Ortiz, Gabriel, MPAS, PA-C, DFAAPA, Arnold, MO - 1101
Ostrom, Nancy K., MD FAAAAI, San Diego, CA - 2805
Ott, Megan T., MSN CRNP, Philadelphia, PA - 2825
Ownby, Dennis R., MD FAAAAI, Augusta, GA - 2523
Oyoshi, Michiko K., Brookline, MA - 4812
Speaker Index
P
Pacheco, Karin A., MD MSPH FAAAAI, Denver, CO - 2003, 2802, 3523,

5305
Pajno, Giovanni B., MD FAAAAI, Messina, Italy - 5003
Panettieri, Reynold A., Jr., MD, Philadelphia, P A - 5708
Paris, Kenneth, MD MPH, New Orleans, LA - 3002
Park, Hae-Sim, MD, PhD, Suwon - 1605
Park, Miguel A., MD, Rochester, MN - 1602
Passalacqua, Giovanni, MD, Genova, Italy - 1813, 3306, 5506
Patterson, David L., MD, MBA FAAAAI, Fishers, IN - 1607
Pawankar, Ruby U., MD PhD FAAAAI, Saitama-ken, Japan - 1011, 3306,
5307
Peebles, R. Stokes, Jr., MD FAAAAI, Nashville, TN - 1601, 3007, 3305,
5502
Penn, Raymond, PhD, Winston Salem, NC - 5708
Perez, Elena E., MD PhD FAAAAI, Miami, FL - 4305, 4822, 5707
Perzanowski, Matthew S., PhD, New York, NY - 2523
Pessach, Itai M., MD PhD, Tel-HaShomer, Israel - 2804
Peters, Anju, MD, Chicago, IL - 5704
Peters, Stephen P., MD PhD FAAAAI, Winston Salem, NC - 3008, 3302,
3521
Phipatanakul, Wanda, MD MS FAAAAI, Boston, MA - 2503
Pinto, Jayant M., MD, Chicago, IL - 3013, 5606
Pinzone, Kathy L., RN AE-C CCRC - 1302, 1712, 2825
Pityn, Peter J., PhD, London, Canada - 1817
Platts-Mills, Thomas A.E., MD PhD FAAAAI, Charlottesville, VA - 1011,
1601, 5307, 5502
Plaut, Marshall, MD FAAAAI, Bethesda, MD - 1604
Polosa, Riccardo, MD PhD FAAAAI, S. Gregorio, Italy - 1612
Poms, Anna, PhD FAAAAI, Charlottesville, VA - 3014
Ponda, Punita, MD FAAAAI, Great Neck, NY - 1611
Pongracic, Jacqueline, MD FAAAAI, Chicago, IL - 1011, 5303
Poole, Jill A., MD FAAAAI, Omaha, NE - 2305
Prescott, Susan, MD PhD, Perth, Australia - 2101, 2308
Prussin, Calman, MD FAAAAI, Bethesda, MD - 2014
Pulver, Donald W., MD FAAAAI, Rochester, NY - 4801
Saini, Sarbjit S., MD FAAAAI, Baltimore, MD - 2524, 3524, 4304, 5703

Saltzman, Rushani W., MD, Voorhees, NJ - 5003
Sampson, Hugh A., MD FAAAAI, New York, NY - 1603, 2814
Sanchez-Borges, Mario, MD FAAAAI, Caracas, Venezuela - 1603
Sands, Mark F., MD FAAAAI, Buffalo, NY - 1612, 4810, 5015
Sastre, Joaquin, MD PhD FAAAAI, Madrid, Spain - 4817
Schatz, Michael, MD MS FAAAAI, San Diego, CA - 2827, 3011, 3308,
4806
Schleimer, Robert P., PhD FAAAAI, Chicago, IL - 1201, 1205
Schlosser, Rodney J., MD, Charleston, SC - 2306
Schmid-Grendelmeier, Peter, MD PD, Zurich, Switzerland - 2506
Schmidt-Weber, Carsten B., PhD, Munich, Germany - 2013
Schneider, Lynda C., MD FAAAAI, Boston, MA - 1403, 1604, 4819
Schwartz, David, MD, Perth, Australia - 1610
Scranton, Stephen Eric, MD, Davis, CA - 0001
Sedlak, Debra A., MSN CPNP, Durham, NC - 1101C, 1101, 2826, 3316
Seroogy, Christine M., MD FAAAAI, Madison, WI - 4829
Sette, Alessandro, Dr. Biol. Sci., La Jolla, CA - 5303
Settipane, Russell A., MD FAAAAI, Providence, RI - 2813
Sewell, W. A. Carrock, MD PhD FAAAAI, North Lincolnshire, United
Kingdom - 3004
Shaker, Marcus S., MD MS FAAAAI, Lebanon, NH - 1206
Shamji, Mohamed H., BSc MSc PhD, South Kensington, United Kingdom
- 2013
Sheikh, Javed, MD FAAAAI, Brookline, MA - 1201A
Sher, Mandel R., MD FAAAAI, Largo, FL - 1208
Shreffler, Wayne G., MD PhD FAAAAI, Boston, MA - 1601, 1604
Shulan, David J., MD FAAAAI, Albany, NY - 1212, 2005, 3012
Sicherer, Scott H., MD FAAAAI, New York, NY - 1011, 2827
Silverman, Bernard, MD FAAAAI - 2513, 4815
Silvers, William, MD FAAAAI, Englewood, CO - 5505
Simon, Dagmar, MD, Bern, Switzerland - 1820
Simon, Hans-Uwe, MD PhD FAAAAI, Bern, Switzerland - 4806, 5301,
5710
Simon, Ronald A., MD FAAAAI, San Diego, CA - 5002
Simons, F. Estelle R., MD FAAAAI, Winnipeg, Canada - 2816, 3011
Skoner, David P., MD, Pittsburgh, PA - 1813, 2817
Skripak, Justin M., MD, Hoboken, NJ - 5006
Slater, Jay E., MD, Rockville, MD - 5714
Sloane, David, MD - 1602
Smart, Brian A., MD FAAAAI, Lake Zurich, IL - 1607
Smith, Andrew M., MD , Cincinnati, OH - 5506
Smith, Timothy L., MD MPH, Portland, OR - 2306
Solensky, Roland, MD FAAAAI - 1602, 2511, 4818
Soong, Weily, MD, Birmingham, AL - 4805
Spahn, Joseph, MD, Denver, CO - 4001
Spergel, Jonathan M., MD PhD FAAAAI, Philadelphia, PA - 1201, 2526,
5710
Spira, Avrum, MD MSc, Boston, MA - 1610
Srivastava, Maya D., MD PhD FAAAAI, East Amherst, NY - 2815
Stadtmauer, Gary J., MD FAAAAI, New York, NY - 1208
Stallings, Amy Polen, MD, Raleigh, NC - 3314
Steele, Pamela H., MSN CPNP AE-C, Durham, NC - 1103, 1712, 5706
Steinberg, Daniel G., MD FAAAAI, Chestnut Hill, MA - 2307
Steinke, John W., PhD FAAAAI, Charlottesville, VA - 2525
Q
Quinn, James, M., MD FAAAAI, San Antonio, TX - 2316, 4809
Quirce, Santiago, MD PhD, Madrid, Spain - 2503
R
Rabin, Ronald L., MD FAAAAI, Bethesda, MD - 5714
Rabinovitch, Nathan, MD, MPH, Denver, CO - 4307
Rachid, Rima A., MD FAAAAI, Boston, MA - 4305
Rance, Karen S., DNP RN CPNP AE-C, Indianapolis, IN - 3313
Rand, Cynthia S., PhD, Baltimore, MD - 1206
Rank, Matthew A., MD FAAAAI, Scottsdale, AZ - 4825
Rathkopf, Melinda M., MD FAAAAI, Anchorage, AK - 1212, 5012
Reijula, Kari E., MD PhD FAAAAI, Helsinki, Finland - 5305
Renz, Harald E., MD, Marburg, Germany - 2302
Risma, Kimberly A., MD PhD FAAAAI, Cincinnati, OH - 1111, 2002
Romano, Antonino G., MD PhD, Rome, Italy - 1203, 1602
Rosario, Nelson A., MD PhD FAAAAI, Curitiba, Brazil - 1603
Rosenwasser, Lanny, MD FAAAAI, Kansas City, MO - 1609
Rothenberg, Marc E., MD PhD FAAAAI, Cincinnati, OH - 1201, 1201D
Routes, John M., MD FAAAAI, Milwaukee, WI - 2304, 2803
173
Speaker Index
Stevenson, Donald D., MD FAAAAI, La Jolla, CA - 1205
Stewart, Sheelagh, MPH, RN, AE-C, Wilmington, DE - 2623, 3316
Stinson, Rosemary, RN, MSN, CRNP, Havertown, PA - 2824
Straumann, Alex, MD, Olten, Switzerland - 1201, 1201D
Strong, Beth D., RN CCRC, New York, NY - 2621
Stukus, David R., MD FAAAAI, New Albany, OH - 1209
Sublett, James L., MD FAAAAI, Louisville, KY - 1011, 1402, 3307, 5711
Sullivan, Kathleen E., MD PhD FAAAAI, Philadelphia, PA - 2304, 4816
Sundy, John S., MD PhD FAAAAI, Durham, NC - 4009
Szefler, Stanley J., MD FAAAAI, Denver, CO - 2508, 2827, 4806, 5015
Szema, Anthony, MD FAAAAI, South Setauket, NY - 4003
T
Tabar Purroy, Ana Isabel, MD, Pamplona, Spain - 3303
Takach, Patricia A., MD FAAAAI, Philadelphia, PA - 5704
Tankersley, Michael S., MD FAAAAI, San Antonio, TX - 1211, 2022, 2624
Tarrant, Teresa K., MD FAAAAI, Chapel Hill, NC - 3009
Tashkin, Donald P., MD, Los Angeles, CA - 1612
Telerman, Adam, MD PhD, France - 3527
Teuber, Suzanne S., MD FAAAAI - 3015, 4824
Thomas, Larry L., PhD, Chicago, IL - 2015
Thompson, Teresa, CPC CMSCS CCC, Carlsborg, WA - 1301, 1501,
1711, 2505
Thomson, Neil, MD, Glasgow, Scotland - 4810
Tichenor, Wellington S., MD FAAAAI - 1608
Timmons, Karol G., RN MS CPNP, Boston, MA - 1101B, 1403
Togias, Alkis, MD FAAAAI, Bethesda, MD - 1204, 1601, 4302, 5101
Tolomeo, Concettina, DNP APRN FNP-BC AE-C, North Haven, CT - 2314,
2824
Torgerson, Troy R., MD PhD, Seattle, WA - 4002
Tovey, Euan, PhD, Sydney, Australia - 2010
Tracy, James M., DO FAAAAI, Omaha, NE - 1011, 4803, 5711
Tran, Dat Q., MD, Houston, TX - 4829
Triggiani, Massimo, MD, Baronissi (Salerno), Italy - 1207
Tu, Yaping, PhD, Omaha, NE - 5708
U
Undem, Bradley, PhD, Cincinnati, OH - 5101
Unkle, David Wayne, MSN APN FCCM, Trenton, NJ - 2625
Uzel, Gulbu, MD, Bethesda, MD - 1818, 2502
V
Vadas, Peter, MD PhD, Toronto, Canada - 4301
Valenta, Rudolf, MD, Wien, Austria - 4817
Valovirta, Erkka, MD PhD, Turku, Finland - 5307
van de Ven, Annick, MD PhD, Utrecht, Netherlands - 3304
Van De Water, Peter, PhD, Fresno, CA - 1202
Vasudev, Monica, MD, Milwaukee, WI - 2810
Vercelli, Donata, MD, Tucson, AZ - 1610
Vidal, Carmen, MD PhD - 4811
Volcheck, Gerald W., MD FAAAAI, Rochester, MN - 2011
Vollmer, William, PhD, Portland, OR - 5709
W
Wagenmann, Martin, MD FAAAAI, Dsseldorf, Germany - 2006, 4302,
5703
Wallace, Dana V., MD FAAAAI, Fort Lauderdale, FL - 2819, 4807
174
Wang, Julie, MD FAAAAI, New York, NY - 1812

Wang, Yui-Hsi, PhD, Cincinnati, OH - 4827
Warnatz, Klaus, MD PhD, Freiburg, Germany - 3304
Wasserman, Richard L., MD PhD FAAAAI, Dallas, TX - 2005, 3002, 4813
Wasserman, Stephen I., MD FAAAAI, La Jolla, CA - 1011, 2806, 3521
Weber, Richard W., MD FAAAAI, Denver, CO - 1202, 1211D, 1211B
Wedner, H. James, MD FAAAAI, Saint Louis, MO - 3010
Weiler, Catherine R., MD PhD FAAAAI, Rochester, MN - 2504, 2823,
5014
Weiler, John M., MD FAAAAI, Iowa City, IA - 1612
Wein, Michael B., MD FAAAAI, Vero Beach, FL - 4006
Weinstein, Andrew G., MD FAAAAI, Wilmington, DE - 1206, 2307, 3005
Weinstein, Steven F., MD FAAAAI, Huntington Beach, CA - 2801
Weiss, Scott T., MD MS, Boston, MA - 2525, 5302
Weldon, David R., MD FAAAAI, College Station, TX - 5009
Wenzel, Sally E., MD FAAAAI, Pittsburgh, PA - 1601, 4008, 4810
Werfel, Thomas, MD, Hannover, Germany - 4303
Westley, Ross C., MD FAAAAI, Arvada, CO - 4801
White, Andrew A., MD FAAAAI, San Diego, CA - 1205
Wickner, Paige G., MD, Boston, MA - 1209
Williams, Paul V., MD FAAAAI, Seattle, WA - 2818
Wills-Karp, Marsha A., PhD, Baltimore, MD - 1601, 4808
Wilson, Sandra, PhD, Palo Alto, CA - 1206, 3005, 4015
Wilson, Todd, DO, Bethesda, MD - 0001
Winant, John G., MD FAAAAI, Mercerville, NJ - 2024
Windom, Hugh H., MD FAAAAI - 4006
Winston, Marciarose, MSN CPNP AE-C, Philadelphia, PA - 3312, 3551,
4151
Wise, Robert, MD, Baltimore, MD - 3302, 3521
Woessner, Katharine M., MD FAAAAI, San Diego, CA - 1205, 1602, 5002
Wood, Robert A., MD FAAAAI, Baltimore, MD - 1011, 5303
X
Y
Yang, Ian A., MBBS FRACP PhD Grad Dip Clin Epid, Brisbane, Australia
- 3101
Yarborough, Denise C., Esq., Asheville, NC - 1102, 1501, 1801
Yosipovitch, Gil, MD, Winston Salem, NC - 5101
Young, Michael C., MD FAAAAI, South Weymouth, MA - 1812
Younger, M. Elizabeth M., PhD CRNP, Baltimore, MD - 3311
Yu, Joyce E., MD, New York, NY - 1814
Yusin, Joseph S., MD FAAAAI, Los Angeles, CA - 0001
Z
Zeiss, Chester R., MD FAAAAI, Evanston, IL - 0001
Zelicoff, Alan P., MD, Albuquerque, NM - 4823
Zhao, Wei, MD PhD, Richmond, VA - 2514
Ziegler, Steven, PhD, Seattle, WA - 4303
Zimmermann, Nina A., MSN RN ANP-BC AE-C, Arnold, MO - 1101,
2315, 3551, 4151
Zimmermann, Nives, MD FAAAAI, Cincinnati, OH - 2007
Zinreich, S. James, MD, Baltimore, MD - 1608
Zuraw, Bruce L., MD, San Diego, CA - 1207, 2811
AAAAI Staff
Executive Office
Support Staff
555 East Wells Street, Suite 1100

Milwaukee, WI 53202-3823
Tel: (414) 272-6071
Fax: (414) 272-6070
Email: annualmeeting@aaaai.org
annualmeeting.aaaai.org
Jaimee Acevedo, Information Services Specialist

David Baumann, Chief Operating Officer
Kesha Brooks, Systems Administrator
Amanda Darkow, Human Resources Coordinator
Scott Daveley, Software Architect
James Degnan, Operations Assistant
Shawn Dimmer, Director of Web Services
Dan Ellenberger, Accountant
Peggy Goetsch, Graphic Designer
Jennifer Gubbin, Graphic Designer
Debbie Kucharski, Receptionist
Carrie La Barr, Information Services Specialist
Laura Ludwig, Director of Creative Services
Christy Madore, Accountant
Louis Nguyen, Web Designer/Developer
Maureen OConnell, Executive Assistant
Kathy Olejnik, Executive Assistant
Michael Peltz, Web Developer
Wendy Ramm, Office Assistant
Celeste Rom, Associate Director of Corporate and Human Resources
Paul Rushizky, Director of Information Services
Paula Schulze, Web Designer/Developer
Joriah Siemann, Systems Administrator
Annette Strini, Receptionist
Patrick Sullivan, Associate Director of Information Services
Lee Szymczak, Mail Services and Operations Manager
Anna Torres-Garcia, Information Services Specialist
Adam Woznicki, Associate Director of Finance
Mark Zbikowski, Director of Technology Services
AAAAI Staff
Kay Whalen, MBA CAE, Executive Director
Roberta Slivensky, Associate Executive Director
MK Buenz, MS Ed, CMP, Executive Assistant to the Board of Directors
Rachel McCormick, Executive Assistant
Daniel A. Nemec, MBA CAE, Director of Finance
Tara Withington, CAE, Director of Development
Communications & Membership Team

Laura Scheele, Director of Communications & Membership
John Augustyniak, Constituency Groups Manager
Shauna Barnes, Membership Development Manager
Megan Brown, Media & Member Communications Manager
Amanda Hoff, Membership Relations Manager
Laura Plizka, Online Communications Manager
Education & Meetings Team

Steven Folstein, MFA MEd, Director of Education and Meetings
Brian Balistreri, MS, Program Manager
Katy Boeck, Program Manager
Amanda Buckley, Program Manager
Kathy Murphy-Ott, Education & Meetings Coordinator
Jaime Sattler, MSW, Program Manager
Margaret Trotter, Meetings Manager
Stephanie Zimmer, Senior Meetings Manager
Practice & Policy Team

Sheila Heitzig, JD MNM CAE, Director of Practice & Policy
Lauri Sweetman, Program Manager
Research & Training Team

Mari Durn, Program Manager
John Galati, JACI Senior Editorial Assistant
Mattie Gorman, JACI Editorial Assistant
Jerome Schultz, Program Manager, Manager AAAAI Awards
Charlotte Surmer, Development Coordinator
175
Notes
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
176

AM13 Final-Program LowRes PDF

Transféré par

Informations du document

Description originale:

Titre original

Copyright

Formats disponibles

Partager ce document

Partager ou intégrer le document

Options de partage

Avez-vous trouvé ce document utile ?

Ce contenu est-il inapproprié ?

Droits d'auteur :

Formats disponibles

AM13 Final-Program LowRes PDF

Transféré par

Droits d'auteur :

Formats disponibles

FINAL PROGRAM

Annual Meeting Program Committees..... 2

Other Meetings and Events................... 10

Continuing Education & Accreditation.... 22

Floor Plans.......................................... 160

Speaker Index..................................... 169

A. Wesley Burks, MD FAAAAI

Stuart L. Abramson, MD PhD FAAAAI

Annual Meeting Program Committees

Stuart L. Abramson, MD PhD FAAAAI, Chair

Jonathan M. Spergel, MD PhD FAAAAI, Chair

Interest Section Chairs,Vice Chairs and

Annual Meeting Program Committees

Allied Health Education Committee

Christine M. Seroogy, MD FAAAAI, Chair

Stephen J. McGeady, MD FAAAAI, Co-Chair

Abstracts programmed at the 2013 Annual Meeting were published

Convention Center, Street Level, Exhibit Hall C

Exhibit and Resource Hall Hours

Convention Center, Concourse Level

Children and Guests

Exhibit Hall Coffee Break

Handouts at the 2013 Annual Meeting will be available in two formats:

All registered attendees at the 2013 Annual Meeting will receive a

Convention Center, River Level

JACI and JACI: In Practice

Member Resource Center

Mobile Annual Meeting App

Networking and Recharging Lounge

Special Dietary Requirements

Many of the scientific sessions will be audio recorded and available

If items on the daily, pre-arranged menu do not meet your special

Speaker Resource Room

Virtual Annual Meeting Recordings

Business and Committee Meetings

Allied Health Professional Assembly

Allied Health Wine & Cheese Reception

Interest Section Forums

International Business Meeting and

New Allergist/Immunologist Assembly

Program Directors Business Meeting

AAAAI Federation of RSLAAIS Assembly

Business and Committee Meetings

Joint Task Force on Quality and Performance Measures

Veterans Health Administration Allergists Committee

Latin America Region Committee

Website, Internet and Related Technologies Committee

Middle East and Africa Region Committee Meeting

Needs Assessment and Outcomes Subcommittee

New Allergist/Immunologist Assembly Executive Committee

Interest Section Committee Meetings

Program Directors In-Training Examination Committee

Asthma and Allergic Diseases in the Elderly Committee

Business and Committee Meetings

Rhinitis, Rhinosinusitis and Ocular Allergy Committee

Cells and Mediators of Allergic Inflammation Committee

Sports Medicine Committee

Committee on the Underserved

Vaccines and Biological Threats Committee

Complimentary and Alternative Practices in Allergy Committee

Other AAAAI Meetings

JACI In Practice Editorial Board Meeting